pmid,year,mesh,meshTreeNumber
18171996,2008-01-02T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
18171996,2008-01-02T00:00:00,ADAM Proteins,D09.400.430.500
18171996,2008-01-02T00:00:00,ADAM Proteins,D12.776.395.033
18171996,2008-01-02T00:00:00,Animals,B01.050
18171996,2008-01-02T00:00:00,Bacterial Proteins,D12.776.097
18171996,2008-01-02T00:00:00,Cell Movement,G04.299.283
18171996,2008-01-02T00:00:00,Cell Movement,G07.700.560.500.180
18171996,2008-01-02T00:00:00,Cell Proliferation,G04.299.233.750
18171996,2008-01-02T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18171996,2008-01-02T00:00:00,Epithelial Cells,A11.436
18171996,2008-01-02T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18171996,2008-01-02T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18171996,2008-01-02T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18171996,2008-01-02T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
18171996,2008-01-02T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
18171996,2008-01-02T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
18171996,2008-01-02T00:00:00,Oxidative Stress,G03.495.710
18171996,2008-01-02T00:00:00,Oxidative Stress,G07.700.830.750
18171996,2008-01-02T00:00:00,Quinazolines,D03.438.786
18171996,2008-01-02T00:00:00,Rabbits,B01.050.150.900.649.521.700
18171996,2008-01-02T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18171996,2008-01-02T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18171996,2008-01-02T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18171996,2008-01-02T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18171996,2008-01-02T00:00:00,Wound Healing,G16.100.856.891
18171996,2008-01-02T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
18172066,2008-01-02T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
18172066,2008-01-02T00:00:00,Animals,B01.050
18172066,2008-01-02T00:00:00,"Animals, Newborn",B01.050.050.282
18172066,2008-01-02T00:00:00,"Embryo, Nonmammalian",A13.350
18172066,2008-01-02T00:00:00,"Embryo, Nonmammalian",A16.331
18172066,2008-01-02T00:00:00,Environmental Exposure,N06.850.460.350
18172066,2008-01-02T00:00:00,Environmental Pollutants,D27.888.284
18172066,2008-01-02T00:00:00,Estradiol,D04.808.365.415.248
18172066,2008-01-02T00:00:00,Estradiol,D06.472.334.851.437.500
18172066,2008-01-02T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
18172066,2008-01-02T00:00:00,Phosphoproteins,D12.776.744
18172066,2008-01-02T00:00:00,Population Dynamics,I01.240.600
18172066,2008-01-02T00:00:00,Population Dynamics,N01.224.625
18172066,2008-01-02T00:00:00,Population Dynamics,N06.850.505.400.700
18172066,2008-01-02T00:00:00,"RNA, Messenger",D13.444.735.544
18172066,2008-01-02T00:00:00,Reproduction,G08.686.785.760
18172066,2008-01-02T00:00:00,Sex Characteristics,G08.686.815
18172066,2008-01-02T00:00:00,Steroids,D04.808
18172066,2008-01-02T00:00:00,Testosterone,D04.808.054.079.429.824
18172066,2008-01-02T00:00:00,Testosterone,D06.472.334.851.968.984
18172738,2008-01-03T00:00:00,Adult,M01.060.116
18172738,2008-01-03T00:00:00,Advance Care Planning,N04.590.233.624.124
18172738,2008-01-03T00:00:00,African Americans,M01.686.508.100.100
18172738,2008-01-03T00:00:00,African Americans,M01.686.754.100
18172738,2008-01-03T00:00:00,Decision Making,F02.463.785.373
18172738,2008-01-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
18172738,2008-01-03T00:00:00,Hispanic Americans,M01.686.754.441
18172738,2008-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18172738,2008-01-03T00:00:00,Middle Aged,M01.060.116.630
18172738,2008-01-03T00:00:00,Questionnaires,E05.318.308.750
18172738,2008-01-03T00:00:00,Questionnaires,L01.280.800
18172738,2008-01-03T00:00:00,Questionnaires,N05.715.360.300.695
18172738,2008-01-03T00:00:00,Questionnaires,N06.850.520.308.750
18172738,2008-01-03T00:00:00,Risk Assessment,E05.318.740.600.800.715
18172738,2008-01-03T00:00:00,Risk Assessment,N04.452.871.715
18172738,2008-01-03T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18172738,2008-01-03T00:00:00,Risk Assessment,N06.850.505.715
18172738,2008-01-03T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18172738,2008-01-03T00:00:00,Terminal Care,E02.760.905
18172738,2008-01-03T00:00:00,Terminal Care,N02.421.585.905
18172738,2008-01-03T00:00:00,United States,Z01.107.567.875
18172769,2008-01-03T00:00:00,Adolescent,M01.060.057
18172769,2008-01-03T00:00:00,Child,M01.060.406
18172769,2008-01-03T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18172769,2008-01-03T00:00:00,Crime,I01.198.240
18172769,2008-01-03T00:00:00,Crime,I01.880.735.191
18172769,2008-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18172769,2008-01-03T00:00:00,Juvenile Delinquency,I01.880.735.479
18172769,2008-01-03T00:00:00,South Carolina,Z01.107.567.875.075.662
18172769,2008-01-03T00:00:00,South Carolina,Z01.107.567.875.750.700
18172769,2008-01-03T00:00:00,Substance-Related Disorders,C21.739
18172769,2008-01-03T00:00:00,Substance-Related Disorders,F03.900
18175214,2008-01-03T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18175214,2008-01-03T00:00:00,Child,M01.060.406
18175214,2008-01-03T00:00:00,Cognition Disorders,F03.087.250
18175214,2008-01-03T00:00:00,"Diagnosis, Differential",E01.171
18175214,2008-01-03T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18175214,2008-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18175214,2008-01-03T00:00:00,Inhibition (Psychology),F01.145.544
18175214,2008-01-03T00:00:00,Inhibition (Psychology),F02.463.425.475
18175214,2008-01-03T00:00:00,Inhibition (Psychology),F02.739.794.405
18175214,2008-01-03T00:00:00,Motivation,F01.658
18175214,2008-01-03T00:00:00,Motivation,F01.752.543.500.750
18175214,2008-01-03T00:00:00,Neuropsychological Tests,F04.711.513
18175214,2008-01-03T00:00:00,Personality Assessment,F04.513
18175214,2008-01-03T00:00:00,Psychometrics,F04.711.780
18175214,2008-01-03T00:00:00,Reaction Time,F02.830.650
18175214,2008-01-03T00:00:00,Reaction Time,F04.669.817
18175214,2008-01-03T00:00:00,Reaction Time,G11.561.677
18173221,2008-01-04T00:00:00,Computer Graphics,L01.224.108
18173221,2008-01-04T00:00:00,Computer Graphics,L01.296.110
18173221,2008-01-04T00:00:00,"Data Interpretation, Statistical",E05.245.380
18173221,2008-01-04T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18173221,2008-01-04T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18173221,2008-01-04T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18173221,2008-01-04T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18173221,2008-01-04T00:00:00,Proteomics,H01.158.201.843
18173221,2008-01-04T00:00:00,Proteomics,H01.158.273.180.350.700
18173221,2008-01-04T00:00:00,Proteomics,H01.158.273.343.350.700
18173221,2008-01-04T00:00:00,Proteomics,H01.181.122.738
18177920,2008-01-04T00:00:00,"Models, Chemical",E05.599.495
18177920,2008-01-04T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
18177920,2008-01-04T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
18177920,2008-01-04T00:00:00,Porosity,G01.374.710
18177920,2008-01-04T00:00:00,Surface Properties,G02.842.850
18178719,2008-01-04T00:00:00,Actins,D05.750.078.730.250
18178719,2008-01-04T00:00:00,Actins,D12.776.210.500.100
18178719,2008-01-04T00:00:00,Actins,D12.776.220.525.255
18178719,2008-01-04T00:00:00,Adult,M01.060.116
18178719,2008-01-04T00:00:00,Cardiomegaly,C14.280.195
18178719,2008-01-04T00:00:00,Cardiomegaly,C23.300.775.250
18178719,2008-01-04T00:00:00,DNA-Binding Proteins,D12.776.260
18178719,2008-01-04T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
18178719,2008-01-04T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
18178719,2008-01-04T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
18178719,2008-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18178719,2008-01-04T00:00:00,Microtubule-Associated Proteins,D12.776.220.600.450
18178719,2008-01-04T00:00:00,Microtubule-Associated Proteins,D12.776.641.560
18178719,2008-01-04T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18178719,2008-01-04T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18178719,2008-01-04T00:00:00,"Myocytes, Cardiac",A11.620.500
18178719,2008-01-04T00:00:00,Pulmonary Artery,A07.231.114.715
18178719,2008-01-04T00:00:00,"RNA, Messenger",D13.444.735.544
18178728,2008-01-04T00:00:00,Animals,B01.050
18178728,2008-01-04T00:00:00,Blood Pressure,E01.370.600.875.249
18178728,2008-01-04T00:00:00,Blood Pressure,G09.330.380.076
18178728,2008-01-04T00:00:00,Cardiomegaly,C14.280.195
18178728,2008-01-04T00:00:00,Cardiomegaly,C23.300.775.250
18178728,2008-01-04T00:00:00,Collagen,D05.750.078.280
18178728,2008-01-04T00:00:00,Collagen,D12.776.860.300.250
18178728,2008-01-04T00:00:00,Hypertension,C14.907.489
18178728,2008-01-04T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18178728,2008-01-04T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18178728,2008-01-04T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18178728,2008-01-04T00:00:00,"Microscopy, Confocal",E05.595.395
18178728,2008-01-04T00:00:00,Myocardium,A02.633.580
18178728,2008-01-04T00:00:00,Myocardium,A07.541.704
18178728,2008-01-04T00:00:00,Myocardium,A10.690.552.750
18178728,2008-01-04T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18178728,2008-01-04T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18178728,2008-01-04T00:00:00,"Myocytes, Cardiac",A11.620.500
18178728,2008-01-04T00:00:00,"RNA, Messenger",D13.444.735.544
18178728,2008-01-04T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18179696,2008-01-07T00:00:00,Animals,B01.050
18179696,2008-01-07T00:00:00,Database Management Systems,L01.224.900.280
18179696,2008-01-07T00:00:00,Database Management Systems,L01.700.508.300.680.110
18179696,2008-01-07T00:00:00,Database Management Systems,N04.452.515.110
18179696,2008-01-07T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
18179696,2008-01-07T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
18179696,2008-01-07T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
18179696,2008-01-07T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
18179696,2008-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18179696,2008-01-07T00:00:00,Information Dissemination,F01.145.209.364
18179696,2008-01-07T00:00:00,Information Dissemination,L01.143.443
18179696,2008-01-07T00:00:00,Internet,L01.224.230.110.500
18179696,2008-01-07T00:00:00,Proteomics,H01.158.201.843
18179696,2008-01-07T00:00:00,Proteomics,H01.158.273.180.350.700
18179696,2008-01-07T00:00:00,Proteomics,H01.158.273.343.350.700
18179696,2008-01-07T00:00:00,Proteomics,H01.181.122.738
18179696,2008-01-07T00:00:00,Research Design,E05.581.500
18179696,2008-01-07T00:00:00,Research Design,H01.770.644.728
18179696,2008-01-07T00:00:00,User-Computer Interface,L01.224.900.910
18190539,2008-01-07T00:00:00,Child,M01.060.406
18190539,2008-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18190539,2008-01-07T00:00:00,Membrane Transport Proteins,D12.776.157.530
18190539,2008-01-07T00:00:00,Membrane Transport Proteins,D12.776.543.585
18190539,2008-01-07T00:00:00,Mutation,G05.365.590
18190539,2008-01-07T00:00:00,Nerve Tissue Proteins,D12.776.641
18182498,2008-01-08T00:00:00,Animals,B01.050
18182498,2008-01-08T00:00:00,Astrocytes,A08.637.200
18182498,2008-01-08T00:00:00,Astrocytes,A11.650.200
18182498,2008-01-08T00:00:00,Cell Death,G04.299.139
18182498,2008-01-08T00:00:00,Gene Expression Regulation,G05.355.315
18182498,2008-01-08T00:00:00,Motor Neurons,A08.663.655.500
18182498,2008-01-08T00:00:00,Motor Neurons,A11.671.655.500
18182498,2008-01-08T00:00:00,Nerve Growth Factor,D12.644.276.860.437
18182498,2008-01-08T00:00:00,Nerve Growth Factor,D12.776.467.860.437
18182498,2008-01-08T00:00:00,Nerve Growth Factor,D12.776.641.600.437
18182498,2008-01-08T00:00:00,Nerve Growth Factor,D23.529.850.437
18182498,2008-01-08T00:00:00,Neurons,A08.663
18182498,2008-01-08T00:00:00,Neurons,A11.671
18182498,2008-01-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18182498,2008-01-08T00:00:00,"Receptors, Cell Surface",D12.776.543.750
18182498,2008-01-08T00:00:00,Sciatic Nerve,A08.800.800.720.450.760
18181651,2008-01-09T00:00:00,Alkanes,D02.455.326.146
18181651,2008-01-09T00:00:00,"Models, Chemical",E05.599.495
18181651,2008-01-09T00:00:00,Surface Plasmon Resonance,E05.196.890
18181651,2008-01-09T00:00:00,Surface Plasmon Resonance,E05.601.123.700
18181651,2008-01-09T00:00:00,Surface Properties,G02.842.850
18183036,2008-01-09T00:00:00,Adult,M01.060.116
18183036,2008-01-09T00:00:00,Aged,M01.060.116.100
18183036,2008-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18183036,2008-01-09T00:00:00,Liver,A03.620
18183036,2008-01-09T00:00:00,Middle Aged,M01.060.116.630
18183036,2008-01-09T00:00:00,"Models, Biological",E05.599.395
18183036,2008-01-09T00:00:00,Research Design,E05.581.500
18183036,2008-01-09T00:00:00,Research Design,H01.770.644.728
18184658,2008-01-09T00:00:00,Alzheimer Disease,C10.228.140.380.100
18184658,2008-01-09T00:00:00,Alzheimer Disease,C10.574.945.249
18184658,2008-01-09T00:00:00,Alzheimer Disease,F03.087.400.100
18184658,2008-01-09T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
18184658,2008-01-09T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
18184658,2008-01-09T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
18184658,2008-01-09T00:00:00,Animals,B01.050
18184658,2008-01-09T00:00:00,Cathepsin B,D08.811.277.656.224.125
18184658,2008-01-09T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
18184658,2008-01-09T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
18184658,2008-01-09T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18184658,2008-01-09T00:00:00,Gene Expression,G05.355.310
18184658,2008-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18184658,2008-01-09T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18184658,2008-01-09T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18187364,2008-01-09T00:00:00,Adult,M01.060.116
18187364,2008-01-09T00:00:00,Biological Markers,D23.101
18187364,2008-01-09T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
18187364,2008-01-09T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
18187364,2008-01-09T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
18187364,2008-01-09T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
18187364,2008-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18187364,2008-01-09T00:00:00,Hyaluronic Acid,D09.698.373.475
18187364,2008-01-09T00:00:00,Liver,A03.620
18187364,2008-01-09T00:00:00,Liver Cirrhosis,C06.552.630
18187364,2008-01-09T00:00:00,Middle Aged,M01.060.116.630
18187364,2008-01-09T00:00:00,Sensitivity and Specificity,E05.318.740.872
18187364,2008-01-09T00:00:00,Sensitivity and Specificity,E05.318.780.800
18187364,2008-01-09T00:00:00,Sensitivity and Specificity,G17.800
18187364,2008-01-09T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18187364,2008-01-09T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18187364,2008-01-09T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18187364,2008-01-09T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18187364,2008-01-09T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
18187469,2008-01-10T00:00:00,Animals,B01.050
18187469,2008-01-10T00:00:00,Calcium,D01.268.552.100
18187469,2008-01-10T00:00:00,Calcium,D01.552.539.288
18187469,2008-01-10T00:00:00,Calcium,D23.119.100
18187469,2008-01-10T00:00:00,Heart Atria,A07.541.358
18187469,2008-01-10T00:00:00,Heart Ventricles,A07.541.560
18187469,2008-01-10T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
18187469,2008-01-10T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
18187469,2008-01-10T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18187469,2008-01-10T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18187469,2008-01-10T00:00:00,"Myocytes, Cardiac",A11.620.500
18187469,2008-01-10T00:00:00,Nitric Oxide Synthase,D08.811.682.664.500.772
18187469,2008-01-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18187469,2008-01-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
18187469,2008-01-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
18187469,2008-01-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
18187469,2008-01-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
18187469,2008-01-10T00:00:00,Signal Transduction,G02.111.087.800
18187469,2008-01-10T00:00:00,Signal Transduction,G02.149.115.800
18187469,2008-01-10T00:00:00,Signal Transduction,G04.299.880
18187469,2008-01-10T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
18187469,2008-01-10T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
18312756,2008-01-10T00:00:00,Anticoagulants,D27.505.954.502.119
18312756,2008-01-10T00:00:00,Case-Control Studies,E05.318.760.500.500
18312756,2008-01-10T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18312756,2008-01-10T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18312756,2008-01-10T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18312756,2008-01-10T00:00:00,Coronary Angiography,E01.370.370.050.200
18312756,2008-01-10T00:00:00,Coronary Angiography,E01.370.370.380.200
18312756,2008-01-10T00:00:00,Coronary Circulation,G09.330.190.163.324
18312756,2008-01-10T00:00:00,Heparin,D09.698.373.400
18312756,2008-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18312756,2008-01-10T00:00:00,Middle Aged,M01.060.116.630
18312756,2008-01-10T00:00:00,Myocardial Infarction,C14.280.647.500
18312756,2008-01-10T00:00:00,Myocardial Infarction,C14.907.585.500
18312756,2008-01-10T00:00:00,Peptide Fragments,D12.644.541
18312756,2008-01-10T00:00:00,Recombinant Proteins,D12.776.828
18312756,2008-01-10T00:00:00,Thrombectomy,E04.100.814.842
18312756,2008-01-10T00:00:00,Treatment Outcome,E01.789.800
18312756,2008-01-10T00:00:00,Treatment Outcome,N04.761.559.590.800
18312756,2008-01-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18191373,2008-01-11T00:00:00,Animals,B01.050
18191373,2008-01-11T00:00:00,Cholesterol,D04.808.247.222.284
18191373,2008-01-11T00:00:00,Cholesterol,D04.808.247.808.197
18191373,2008-01-11T00:00:00,Cholesterol,D10.570.938.208
18191373,2008-01-11T00:00:00,Cholesterol,D10.851.208
18191373,2008-01-11T00:00:00,Fatty Acids,D10.251
18191373,2008-01-11T00:00:00,Gene Expression,G05.355.310
18191373,2008-01-11T00:00:00,Gene Expression Profiling,E05.393.332
18191373,2008-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18191373,2008-01-11T00:00:00,Insulin,D06.472.699.587.740.625
18191373,2008-01-11T00:00:00,Insulin,D12.644.548.586.740.625
18191373,2008-01-11T00:00:00,Marine Toxins,D23.946.580
18191373,2008-01-11T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18191373,2008-01-11T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18191373,2008-01-11T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18191373,2008-01-11T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18191373,2008-01-11T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18191373,2008-01-11T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18191373,2008-01-11T00:00:00,Signal Transduction,G02.111.087.800
18191373,2008-01-11T00:00:00,Signal Transduction,G02.149.115.800
18191373,2008-01-11T00:00:00,Signal Transduction,G04.299.880
18191373,2008-01-11T00:00:00,Spiro Compounds,D02.455.426.559.847.885
18191373,2008-01-11T00:00:00,Spiro Compounds,D04.615.885
18191373,2008-01-11T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18191373,2008-01-11T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18191373,2008-01-11T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18191373,2008-01-11T00:00:00,Wnt Proteins,D12.644.276.984
18191373,2008-01-11T00:00:00,Wnt Proteins,D12.776.467.984
18191373,2008-01-11T00:00:00,Wnt Proteins,D23.529.984
18205750,2008-01-12T00:00:00,Acetylcysteine,D02.886.030.230.259
18205750,2008-01-12T00:00:00,Acetylcysteine,D12.125.166.230.259
18205750,2008-01-12T00:00:00,Animals,B01.050
18205750,2008-01-12T00:00:00,"Animals, Newborn",B01.050.050.282
18205750,2008-01-12T00:00:00,Brain,A08.186.211
18205750,2008-01-12T00:00:00,Cell Differentiation,G04.299.151
18205750,2008-01-12T00:00:00,Cell Line,A11.251.210
18205750,2008-01-12T00:00:00,Down-Regulation,G02.111.087.225
18205750,2008-01-12T00:00:00,Down-Regulation,G02.149.115.225
18205750,2008-01-12T00:00:00,Down-Regulation,G05.355.315.200
18205750,2008-01-12T00:00:00,Down-Regulation,G07.690.812.230
18205750,2008-01-12T00:00:00,Down-Regulation,G07.700.680.230
18205750,2008-01-12T00:00:00,Encephalitis,C02.182.500
18205750,2008-01-12T00:00:00,Encephalitis,C10.228.140.430
18205750,2008-01-12T00:00:00,Encephalitis,C10.228.228.210.150
18205750,2008-01-12T00:00:00,Encephalitis,C10.228.228.245
18205750,2008-01-12T00:00:00,"Infectious Disease Transmission, Vertical",N06.850.310.425
18205750,2008-01-12T00:00:00,Lipopolysaccharides,D09.400.500
18205750,2008-01-12T00:00:00,Lipopolysaccharides,D09.698.718.450
18205750,2008-01-12T00:00:00,Lipopolysaccharides,D10.494
18205750,2008-01-12T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18205750,2008-01-12T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18205750,2008-01-12T00:00:00,Oligodendroglia,A08.637.600
18205750,2008-01-12T00:00:00,Oligodendroglia,A11.650.600
18205750,2008-01-12T00:00:00,Oxidative Stress,G03.495.710
18205750,2008-01-12T00:00:00,Oxidative Stress,G07.700.830.750
18205750,2008-01-12T00:00:00,Peroxisomes,A11.284.430.214.190.500.585.600
18205750,2008-01-12T00:00:00,Peroxisomes,A11.284.430.214.190.875.190.190.755.600
18205750,2008-01-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18205750,2008-01-12T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18205750,2008-01-12T00:00:00,Stem Cells,A11.872
18076114,2008-01-15T00:00:00,African Americans,M01.686.508.100.100
18076114,2008-01-15T00:00:00,African Americans,M01.686.754.100
18076114,2008-01-15T00:00:00,Attitude to Health,F01.100.150
18076114,2008-01-15T00:00:00,Attitude to Health,N05.300.150
18076114,2008-01-15T00:00:00,Breast Neoplasms,C04.588.180
18076114,2008-01-15T00:00:00,Breast Neoplasms,C17.800.090.500
18076114,2008-01-15T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
18076114,2008-01-15T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
18076114,2008-01-15T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
18076114,2008-01-15T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
18076114,2008-01-15T00:00:00,Genetic Counseling,H01.158.273.343.315.384
18076114,2008-01-15T00:00:00,Genetic Counseling,N02.421.308.400
18076114,2008-01-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18076114,2008-01-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
18076114,2008-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18076114,2008-01-15T00:00:00,Middle Aged,M01.060.116.630
18076114,2008-01-15T00:00:00,Ovarian Neoplasms,C04.588.322.455
18076114,2008-01-15T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
18076114,2008-01-15T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
18076114,2008-01-15T00:00:00,Ovarian Neoplasms,C19.344.410
18076114,2008-01-15T00:00:00,Ovarian Neoplasms,C19.391.630.705
18076114,2008-01-15T00:00:00,Retention (Psychology),F02.463.425.540.772
18076114,2008-01-15T00:00:00,Risk Factors,E05.318.740.600.800.725
18076114,2008-01-15T00:00:00,Risk Factors,N05.715.350.200.700
18076114,2008-01-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18076114,2008-01-15T00:00:00,Risk Factors,N06.850.490.625.750
18076114,2008-01-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18171241,2008-01-15T00:00:00,Adult,M01.060.116
18171241,2008-01-15T00:00:00,Aged,M01.060.116.100
18171241,2008-01-15T00:00:00,Cryptococcosis,C01.703.248
18171241,2008-01-15T00:00:00,Cryptococcus neoformans,B01.300.381.258.366
18171241,2008-01-15T00:00:00,Cryptococcus neoformans,B01.300.930.316.366
18171241,2008-01-15T00:00:00,Fungemia,C01.539.757.360
18171241,2008-01-15T00:00:00,Fungemia,C01.703.360
18171241,2008-01-15T00:00:00,Fungemia,C23.550.470.790.500.360
18171241,2008-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18171241,2008-01-15T00:00:00,Middle Aged,M01.060.116.630
18178409,2008-01-15T00:00:00,Adolescent,M01.060.057
18178409,2008-01-15T00:00:00,Adult,M01.060.116
18178409,2008-01-15T00:00:00,Aged,M01.060.116.100
18178409,2008-01-15T00:00:00,Albuminuria,C12.777.934.734.269
18178409,2008-01-15T00:00:00,Albuminuria,C13.351.968.934.734.269
18178409,2008-01-15T00:00:00,Albuminuria,C23.888.942.750.269
18178409,2008-01-15T00:00:00,Echocardiography,E01.370.350.850.220
18178409,2008-01-15T00:00:00,Echocardiography,E01.370.370.380.220
18178409,2008-01-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18178409,2008-01-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
18178409,2008-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18178409,2008-01-15T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
18178409,2008-01-15T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
18178409,2008-01-15T00:00:00,Middle Aged,M01.060.116.630
18178409,2008-01-15T00:00:00,Prevalence,E05.318.308.985.525.750
18178409,2008-01-15T00:00:00,Prevalence,L01.280.975.525.750
18178409,2008-01-15T00:00:00,Prevalence,N01.224.935.597.750
18178409,2008-01-15T00:00:00,Prevalence,N06.850.505.400.975.525.750
18178409,2008-01-15T00:00:00,Prevalence,N06.850.520.308.985.525.750
18178409,2008-01-15T00:00:00,United States,Z01.107.567.875
18178409,2008-01-15T00:00:00,Urinalysis,E01.370.390.810
18178409,2008-01-15T00:00:00,Urinalysis,E01.450.150.810
18178409,2008-01-15T00:00:00,Urinalysis,E01.450.890
18178863,2008-01-15T00:00:00,Animals,B01.050
18178863,2008-01-15T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
18178863,2008-01-15T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
18178863,2008-01-15T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
18178863,2008-01-15T00:00:00,Antigen-Antibody Complex,D23.050.101
18178863,2008-01-15T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18178863,2008-01-15T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18178863,2008-01-15T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18178863,2008-01-15T00:00:00,Autoimmune Diseases,C20.111
18178863,2008-01-15T00:00:00,Complement C3,D12.776.124.050.140
18178863,2008-01-15T00:00:00,Complement C3,D12.776.124.486.274.250
18178863,2008-01-15T00:00:00,Kidney,A05.810.453
18178863,2008-01-15T00:00:00,Kidney Diseases,C12.777.419
18178863,2008-01-15T00:00:00,Kidney Diseases,C13.351.968.419
18178863,2008-01-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18178863,2008-01-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18178863,2008-01-15T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
18178863,2008-01-15T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
18178863,2008-01-15T00:00:00,Lupus Nephritis,C17.300.480.680
18178863,2008-01-15T00:00:00,Lupus Nephritis,C20.111.590.560
18178863,2008-01-15T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
18178863,2008-01-15T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
18178863,2008-01-15T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
18178863,2008-01-15T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
18192903,2008-01-15T00:00:00,Graft Survival,G12.425.901.545.340
18192903,2008-01-15T00:00:00,Health Facilities,N02.278
18192903,2008-01-15T00:00:00,Health Status,I01.240.425
18192903,2008-01-15T00:00:00,Health Status,N01.224.425
18192903,2008-01-15T00:00:00,Health Status,N06.850.505.400.425
18192903,2008-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18192903,2008-01-15T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
18192903,2008-01-15T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
18192903,2008-01-15T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
18192903,2008-01-15T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
18192903,2008-01-15T00:00:00,Kidney Transplantation,E02.870.500
18192903,2008-01-15T00:00:00,Kidney Transplantation,E04.936.450.485
18192903,2008-01-15T00:00:00,Kidney Transplantation,E04.950.774.400
18192903,2008-01-15T00:00:00,Medicare,N03.219.521.346.506.564.663
18192903,2008-01-15T00:00:00,Medicare,N03.219.521.576.343.840
18192903,2008-01-15T00:00:00,Medicare,N03.706.615.696
18192903,2008-01-15T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18192903,2008-01-15T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18192903,2008-01-15T00:00:00,Patient Selection,E05.581.500.653
18192903,2008-01-15T00:00:00,Patient Selection,N04.590.731
18192903,2008-01-15T00:00:00,Quality of Life,I01.800
18192903,2008-01-15T00:00:00,Quality of Life,K01.752.400.750
18192903,2008-01-15T00:00:00,Treatment Outcome,E01.789.800
18192903,2008-01-15T00:00:00,Treatment Outcome,N04.761.559.590.800
18192903,2008-01-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18192903,2008-01-15T00:00:00,United States,Z01.107.567.875
18196245,2008-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18196245,2008-01-15T00:00:00,Middle Aged,M01.060.116.630
18196245,2008-01-15T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
18196245,2008-01-15T00:00:00,Sarcoidosis,C15.604.515.827
18198196,2008-01-15T00:00:00,Adult,M01.060.116
18198196,2008-01-15T00:00:00,African Americans,M01.686.508.100.100
18198196,2008-01-15T00:00:00,African Americans,M01.686.754.100
18198196,2008-01-15T00:00:00,Aged,M01.060.116.100
18198196,2008-01-15T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
18198196,2008-01-15T00:00:00,"Arthritis, Rheumatoid",C05.799.114
18198196,2008-01-15T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
18198196,2008-01-15T00:00:00,"Arthritis, Rheumatoid",C20.111.199
18198196,2008-01-15T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18198196,2008-01-15T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18198196,2008-01-15T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18198196,2008-01-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18198196,2008-01-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
18198196,2008-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18198196,2008-01-15T00:00:00,Middle Aged,M01.060.116.630
18198196,2008-01-15T00:00:00,Smoking,F01.145.466.753
18198196,2008-01-15T00:00:00,United States,Z01.107.567.875
18198344,2008-01-15T00:00:00,Animals,B01.050
18198344,2008-01-15T00:00:00,Cocaine,D02.145.074.722.388
18198344,2008-01-15T00:00:00,Cocaine,D03.132.889.354
18198344,2008-01-15T00:00:00,Cocaine,D03.605.869.388
18198344,2008-01-15T00:00:00,Cocaine,D04.075.080.875.099.722.388
18198344,2008-01-15T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
18198344,2008-01-15T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
18198344,2008-01-15T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
18198344,2008-01-15T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
18198344,2008-01-15T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18198344,2008-01-15T00:00:00,Protein Transport,G03.495.166.700
18198344,2008-01-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18198344,2008-01-15T00:00:00,Self Administration,E02.319.890
18198344,2008-01-15T00:00:00,Self Administration,E02.900.890
18198344,2008-01-15T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18198344,2008-01-15T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18199437,2008-01-15T00:00:00,"History, 20th Century",K01.400.504.968
18199437,2008-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18199437,2008-01-15T00:00:00,Pregnancy,G08.686.785.760.769
18199437,2008-01-15T00:00:00,"Pregnancy Complications, Neoplastic",C04.850
18199437,2008-01-15T00:00:00,"Pregnancy Complications, Neoplastic",C13.703.720
18199477,2008-01-15T00:00:00,Animals,B01.050
18199477,2008-01-15T00:00:00,Bioprosthesis,E07.695.100
18199477,2008-01-15T00:00:00,Enzymes,D08.811
18199477,2008-01-15T00:00:00,Glycosaminoglycans,D09.698.373
18199477,2008-01-15T00:00:00,Heart Valve Prosthesis,E07.695.310
18199477,2008-01-15T00:00:00,Swine,B01.050.150.900.649.077.880
18202112,2008-01-17T00:00:00,Helicobacter Infections,C01.252.400.466
18202112,2008-01-17T00:00:00,Helicobacter pylori,B03.440.500.550
18202112,2008-01-17T00:00:00,Helicobacter pylori,B03.660.150.280.550
18202112,2008-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18202112,2008-01-17T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
18202112,2008-01-17T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
18202112,2008-01-17T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
18202112,2008-01-17T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
18202112,2008-01-17T00:00:00,Molecular Sequence Data,L01.453.245.667
18202112,2008-01-17T00:00:00,Plasmids,G05.360.600
18202112,2008-01-17T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18202112,2008-01-17T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18202112,2008-01-17T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18202112,2008-01-17T00:00:00,Signal Transduction,G02.111.087.800
18202112,2008-01-17T00:00:00,Signal Transduction,G02.149.115.800
18202112,2008-01-17T00:00:00,Signal Transduction,G04.299.880
18202112,2008-01-17T00:00:00,Sodium-Potassium-Exchanging ATPase,D08.811.277.040.025.810
18202112,2008-01-17T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.162.780
18202112,2008-01-17T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.250.880
18202112,2008-01-17T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.162.800
18202112,2008-01-17T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.250.890
18202112,2008-01-17T00:00:00,Stomach Neoplasms,C04.588.274.476.767
18202112,2008-01-17T00:00:00,Stomach Neoplasms,C06.301.371.767
18202112,2008-01-17T00:00:00,Stomach Neoplasms,C06.405.249.767
18202112,2008-01-17T00:00:00,Stomach Neoplasms,C06.405.748.789
18202112,2008-01-17T00:00:00,"Transcription, Genetic",G02.111.087.847
18202112,2008-01-17T00:00:00,"Transcription, Genetic",G02.149.115.847
18202112,2008-01-17T00:00:00,"Transcription, Genetic",G05.355.310.700
18202432,2008-01-17T00:00:00,Adult,M01.060.116
18202432,2008-01-17T00:00:00,Amino Acid Sequence,G02.111.570.060
18202432,2008-01-17T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18202432,2008-01-17T00:00:00,Cardiovascular Diseases,C14
18202432,2008-01-17T00:00:00,"Cholesterol, HDL",D10.532.432.400
18202432,2008-01-17T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
18202432,2008-01-17T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
18202432,2008-01-17T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18202432,2008-01-17T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18202432,2008-01-17T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18202432,2008-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18202432,2008-01-17T00:00:00,Risk Factors,E05.318.740.600.800.725
18202432,2008-01-17T00:00:00,Risk Factors,N05.715.350.200.700
18202432,2008-01-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18202432,2008-01-17T00:00:00,Risk Factors,N06.850.490.625.750
18202432,2008-01-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18202432,2008-01-17T00:00:00,Sensitivity and Specificity,E05.318.740.872
18202432,2008-01-17T00:00:00,Sensitivity and Specificity,E05.318.780.800
18202432,2008-01-17T00:00:00,Sensitivity and Specificity,G17.800
18202432,2008-01-17T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18202432,2008-01-17T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18202432,2008-01-17T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18202432,2008-01-17T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18202859,2008-01-17T00:00:00,Adolescent,M01.060.057
18202859,2008-01-17T00:00:00,Biological Markers,D23.101
18202859,2008-01-17T00:00:00,Child,M01.060.406
18202859,2008-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18202859,2008-01-17T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
18202859,2008-01-17T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
18202859,2008-01-17T00:00:00,Lupus Nephritis,C17.300.480.680
18202859,2008-01-17T00:00:00,Lupus Nephritis,C20.111.590.560
18202859,2008-01-17T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
18239550,2008-01-17T00:00:00,"Adaptation, Psychological",F01.058
18239550,2008-01-17T00:00:00,Adult,M01.060.116
18239550,2008-01-17T00:00:00,Aged,M01.060.116.100
18239550,2008-01-17T00:00:00,Bariatric Surgery,E02.065.062
18239550,2008-01-17T00:00:00,Bariatric Surgery,E04.062
18239550,2008-01-17T00:00:00,Body Image,F02.463.593.112
18239550,2008-01-17T00:00:00,Body Mass Index,E01.370.600.115.100.125
18239550,2008-01-17T00:00:00,Body Mass Index,E05.041.124.125
18239550,2008-01-17T00:00:00,Body Mass Index,G07.100.100.125
18239550,2008-01-17T00:00:00,Body Mass Index,N06.850.505.200.100.175
18239550,2008-01-17T00:00:00,Depression,F01.145.126.350
18239550,2008-01-17T00:00:00,"Diet, Reducing",E02.642.249.285
18239550,2008-01-17T00:00:00,"Diet, Reducing",G07.610.240.285
18239550,2008-01-17T00:00:00,Feeding Behavior,F01.145.113.547
18239550,2008-01-17T00:00:00,Feeding Behavior,F01.145.407
18239550,2008-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18239550,2008-01-17T00:00:00,Middle Aged,M01.060.116.630
18239550,2008-01-17T00:00:00,Obesity,C18.654.726.500
18239550,2008-01-17T00:00:00,Obesity,C23.888.144.699.500
18239550,2008-01-17T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18239550,2008-01-17T00:00:00,Obesity,G07.100.100.160.120.699.500
18239550,2008-01-17T00:00:00,Quality of Life,I01.800
18239550,2008-01-17T00:00:00,Quality of Life,K01.752.400.750
18239550,2008-01-17T00:00:00,Questionnaires,E05.318.308.750
18239550,2008-01-17T00:00:00,Questionnaires,L01.280.800
18239550,2008-01-17T00:00:00,Questionnaires,N05.715.360.300.695
18239550,2008-01-17T00:00:00,Questionnaires,N06.850.520.308.750
18239550,2008-01-17T00:00:00,Self-Help Groups,N03.540.782
18239550,2008-01-17T00:00:00,"Stress, Psychological",F01.145.126.990
18239550,2008-01-17T00:00:00,"Stress, Psychological",F02.830.900
18239603,2008-01-17T00:00:00,Adult,M01.060.116
18239603,2008-01-17T00:00:00,Eating Disorders,F03.375
18239603,2008-01-17T00:00:00,Feeding Behavior,F01.145.113.547
18239603,2008-01-17T00:00:00,Feeding Behavior,F01.145.407
18239603,2008-01-17T00:00:00,Gastric Bypass,E02.065.062.249
18239603,2008-01-17T00:00:00,Gastric Bypass,E04.035.398.385
18239603,2008-01-17T00:00:00,Gastric Bypass,E04.062.249
18239603,2008-01-17T00:00:00,Gastric Bypass,E04.210.457.430
18239603,2008-01-17T00:00:00,Health Behavior,F01.145.488
18239603,2008-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18239603,2008-01-17T00:00:00,Middle Aged,M01.060.116.630
18239603,2008-01-17T00:00:00,Obesity,C18.654.726.500
18239603,2008-01-17T00:00:00,Obesity,C23.888.144.699.500
18239603,2008-01-17T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18239603,2008-01-17T00:00:00,Obesity,G07.100.100.160.120.699.500
18239603,2008-01-17T00:00:00,Questionnaires,E05.318.308.750
18239603,2008-01-17T00:00:00,Questionnaires,L01.280.800
18239603,2008-01-17T00:00:00,Questionnaires,N05.715.360.300.695
18239603,2008-01-17T00:00:00,Questionnaires,N06.850.520.308.750
18239603,2008-01-17T00:00:00,"Stress, Psychological",F01.145.126.990
18239603,2008-01-17T00:00:00,"Stress, Psychological",F02.830.900
18239603,2008-01-17T00:00:00,Treatment Outcome,E01.789.800
18239603,2008-01-17T00:00:00,Treatment Outcome,N04.761.559.590.800
18239603,2008-01-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18239603,2008-01-17T00:00:00,Weight Loss,C23.888.144.243.963
18239603,2008-01-17T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18313657,2008-01-17T00:00:00,Animals,B01.050
18313657,2008-01-17T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
18313657,2008-01-17T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
18313657,2008-01-17T00:00:00,Cell Adhesion Molecules,D23.050.301.350
18313657,2008-01-17T00:00:00,Embryonic Development,G07.700.320.500.325.180
18313657,2008-01-17T00:00:00,Embryonic Development,G08.686.785.760.170.104
18313657,2008-01-17T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
18313657,2008-01-17T00:00:00,Heart,A07.541
18313657,2008-01-17T00:00:00,Heart Valves,A07.541.510
18203815,2008-01-18T00:00:00,Actins,D05.750.078.730.250
18203815,2008-01-18T00:00:00,Actins,D12.776.210.500.100
18203815,2008-01-18T00:00:00,Actins,D12.776.220.525.255
18203815,2008-01-18T00:00:00,Animals,B01.050
18203815,2008-01-18T00:00:00,Apoptosis,G04.299.139.160
18203815,2008-01-18T00:00:00,Caveolin 1,D12.644.360.024.264
18203815,2008-01-18T00:00:00,Caveolin 1,D12.776.157.057.010
18203815,2008-01-18T00:00:00,Caveolin 1,D12.776.476.024.280
18203815,2008-01-18T00:00:00,Caveolin 1,D12.776.543.990.100.500
18203815,2008-01-18T00:00:00,Caveolin 1,D12.776.744.287
18203815,2008-01-18T00:00:00,Collagen,D05.750.078.280
18203815,2008-01-18T00:00:00,Collagen,D12.776.860.300.250
18203815,2008-01-18T00:00:00,Fibroblasts,A11.329.228
18203815,2008-01-18T00:00:00,Fibroblasts,A11.872.228
18203815,2008-01-18T00:00:00,Fibrosis,C23.550.355
18203815,2008-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18203815,2008-01-18T00:00:00,Lung,A04.411
18203815,2008-01-18T00:00:00,"Lung Diseases, Interstitial",C08.381.483
18203815,2008-01-18T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18203815,2008-01-18T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18203815,2008-01-18T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18203815,2008-01-18T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18203815,2008-01-18T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
18203815,2008-01-18T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
18203815,2008-01-18T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
18203815,2008-01-18T00:00:00,Peptide Fragments,D12.644.541
18203815,2008-01-18T00:00:00,"Scleroderma, Systemic",C17.300.799
18203815,2008-01-18T00:00:00,"Scleroderma, Systemic",C17.800.784
18207629,2008-01-18T00:00:00,Adolescent,M01.060.057
18207629,2008-01-18T00:00:00,Adult,M01.060.116
18207629,2008-01-18T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
18207629,2008-01-18T00:00:00,Child,M01.060.406
18207629,2008-01-18T00:00:00,Cognition Disorders,F03.087.250
18207629,2008-01-18T00:00:00,Heart Arrest,C14.280.383
18207629,2008-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18207629,2008-01-18T00:00:00,Neuropsychological Tests,F04.711.513
18207629,2008-01-18T00:00:00,Risk Factors,E05.318.740.600.800.725
18207629,2008-01-18T00:00:00,Risk Factors,N05.715.350.200.700
18207629,2008-01-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18207629,2008-01-18T00:00:00,Risk Factors,N06.850.490.625.750
18207629,2008-01-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18207629,2008-01-18T00:00:00,Treatment Outcome,E01.789.800
18207629,2008-01-18T00:00:00,Treatment Outcome,N04.761.559.590.800
18207629,2008-01-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18207629,2008-01-18T00:00:00,Wolff-Parkinson-White Syndrome,C14.280.067.780.977
18207629,2008-01-18T00:00:00,Wolff-Parkinson-White Syndrome,C16.131.240.400.980
18207691,2008-01-18T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18207691,2008-01-18T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18207691,2008-01-18T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18207691,2008-01-18T00:00:00,Evidence-Based Medicine,H02.249.750
18207691,2008-01-18T00:00:00,Evidence-Based Medicine,H02.403.200.400
18207691,2008-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18207691,2008-01-18T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18207691,2008-01-18T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18207691,2008-01-18T00:00:00,Middle Aged,M01.060.116.630
18207691,2008-01-18T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18207691,2008-01-18T00:00:00,Risk Factors,E05.318.740.600.800.725
18207691,2008-01-18T00:00:00,Risk Factors,N05.715.350.200.700
18207691,2008-01-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18207691,2008-01-18T00:00:00,Risk Factors,N06.850.490.625.750
18207691,2008-01-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18207691,2008-01-18T00:00:00,Stroke,C10.228.140.300.775
18207691,2008-01-18T00:00:00,Stroke,C14.907.253.855
18281192,2008-01-18T00:00:00,Adult,M01.060.116
18281192,2008-01-18T00:00:00,Affect,F01.470.047
18281192,2008-01-18T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18281192,2008-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18281192,2008-01-18T00:00:00,Life Change Events,F01.829.458.410
18281192,2008-01-18T00:00:00,Mass Screening,E01.370.500
18281192,2008-01-18T00:00:00,Mass Screening,E05.318.308.250.580
18281192,2008-01-18T00:00:00,Mass Screening,N02.421.143.827.233.443
18281192,2008-01-18T00:00:00,Mass Screening,N02.421.726.233.443
18281192,2008-01-18T00:00:00,Mass Screening,N05.715.360.300.375.500
18281192,2008-01-18T00:00:00,Mass Screening,N06.850.520.308.250.580
18281192,2008-01-18T00:00:00,Mass Screening,N06.850.780.500
18281192,2008-01-18T00:00:00,Questionnaires,E05.318.308.750
18281192,2008-01-18T00:00:00,Questionnaires,L01.280.800
18281192,2008-01-18T00:00:00,Questionnaires,N05.715.360.300.695
18281192,2008-01-18T00:00:00,Questionnaires,N06.850.520.308.750
18281192,2008-01-18T00:00:00,Risk Factors,E05.318.740.600.800.725
18281192,2008-01-18T00:00:00,Risk Factors,N05.715.350.200.700
18281192,2008-01-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18281192,2008-01-18T00:00:00,Risk Factors,N06.850.490.625.750
18281192,2008-01-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18281192,2008-01-18T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18329483,2008-01-18T00:00:00,Adenocarcinoma,C04.557.470.200.025
18329483,2008-01-18T00:00:00,Calmodulin,D12.644.360.381.249
18329483,2008-01-18T00:00:00,Calmodulin,D12.776.157.125.412.249
18329483,2008-01-18T00:00:00,Calmodulin,D12.776.476.387.249
18329483,2008-01-18T00:00:00,Gene Expression Profiling,E05.393.332
18329483,2008-01-18T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18329483,2008-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18329483,2008-01-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
18329483,2008-01-18T00:00:00,Lung Neoplasms,C08.381.540
18329483,2008-01-18T00:00:00,Lung Neoplasms,C08.785.520
18329483,2008-01-18T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18329483,2008-01-18T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18329483,2008-01-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18329483,2008-01-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18329483,2008-01-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18329483,2008-01-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18329483,2008-01-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18329483,2008-01-18T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18329483,2008-01-18T00:00:00,Pilot Projects,E05.318.760.750
18329483,2008-01-18T00:00:00,Pilot Projects,E05.337.737
18329483,2008-01-18T00:00:00,Pilot Projects,N05.715.360.775.625
18329483,2008-01-18T00:00:00,Pilot Projects,N06.850.520.450.720
18329483,2008-01-18T00:00:00,Probability,E05.318.740.600
18329483,2008-01-18T00:00:00,Probability,G17.680
18329483,2008-01-18T00:00:00,Probability,N05.715.360.750.625
18329483,2008-01-18T00:00:00,Probability,N06.850.520.830.600
18329483,2008-01-18T00:00:00,Sensitivity and Specificity,E05.318.740.872
18329483,2008-01-18T00:00:00,Sensitivity and Specificity,E05.318.780.800
18329483,2008-01-18T00:00:00,Sensitivity and Specificity,G17.800
18329483,2008-01-18T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18329483,2008-01-18T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18329483,2008-01-18T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18329483,2008-01-18T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18329483,2008-01-18T00:00:00,"Tumor Markers, Biological",D23.101.840
18342372,2008-01-18T00:00:00,Alzheimer Disease,C10.228.140.380.100
18342372,2008-01-18T00:00:00,Alzheimer Disease,C10.574.945.249
18342372,2008-01-18T00:00:00,Alzheimer Disease,F03.087.400.100
18342372,2008-01-18T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
18342372,2008-01-18T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
18342372,2008-01-18T00:00:00,Animals,B01.050
18342372,2008-01-18T00:00:00,Gene Expression Regulation,G05.355.315
18342372,2008-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18342372,2008-01-18T00:00:00,"Models, Biological",E05.599.395
18342372,2008-01-18T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18342372,2008-01-18T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18342372,2008-01-18T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18342372,2008-01-18T00:00:00,"Transcription, Genetic",G02.111.087.847
18342372,2008-01-18T00:00:00,"Transcription, Genetic",G02.149.115.847
18342372,2008-01-18T00:00:00,"Transcription, Genetic",G05.355.310.700
18204446,2008-01-20T00:00:00,Alleles,G05.360.340.024.340.030
18204446,2008-01-20T00:00:00,Case-Control Studies,E05.318.760.500.500
18204446,2008-01-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18204446,2008-01-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18204446,2008-01-20T00:00:00,"Chromosomes, Human, Pair 3",A11.284.187.520.300.235.250
18204446,2008-01-20T00:00:00,"Chromosomes, Human, Pair 3",G05.360.162.520.300.235.250
18204446,2008-01-20T00:00:00,European Continental Ancestry Group,M01.686.508.400
18204446,2008-01-20T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18204446,2008-01-20T00:00:00,Genetic Predisposition to Disease,G05.380.355
18204446,2008-01-20T00:00:00,Genetic Variation,G05.365
18204446,2008-01-20T00:00:00,HLA Antigens,D23.050.301.500.450
18204446,2008-01-20T00:00:00,HLA Antigens,D23.050.705.552.450
18204446,2008-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18204446,2008-01-20T00:00:00,Interferon Regulatory Factors,D12.644.360.024.302
18204446,2008-01-20T00:00:00,Interferon Regulatory Factors,D12.776.157.057.050
18204446,2008-01-20T00:00:00,Interferon Regulatory Factors,D12.776.260.504
18204446,2008-01-20T00:00:00,Interferon Regulatory Factors,D12.776.476.024.385
18204446,2008-01-20T00:00:00,Interferon Regulatory Factors,D12.776.930.332
18204446,2008-01-20T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18204446,2008-01-20T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18204446,2008-01-20T00:00:00,Linkage Disequilibrium,G05.540.500
18204446,2008-01-20T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18204446,2008-01-20T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18204446,2008-01-20T00:00:00,Nerve Tissue Proteins,D12.776.641
18204446,2008-01-20T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18204446,2008-01-20T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18204446,2008-01-20T00:00:00,Risk Factors,E05.318.740.600.800.725
18204446,2008-01-20T00:00:00,Risk Factors,N05.715.350.200.700
18204446,2008-01-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18204446,2008-01-20T00:00:00,Risk Factors,N06.850.490.625.750
18204446,2008-01-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18204448,2008-01-20T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
18204448,2008-01-20T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
18204448,2008-01-20T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
18204448,2008-01-20T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
18204448,2008-01-20T00:00:00,African Americans,M01.686.508.100.100
18204448,2008-01-20T00:00:00,African Americans,M01.686.754.100
18204448,2008-01-20T00:00:00,Alleles,G05.360.340.024.340.030
18204448,2008-01-20T00:00:00,Case-Control Studies,E05.318.760.500.500
18204448,2008-01-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18204448,2008-01-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18204448,2008-01-20T00:00:00,European Continental Ancestry Group,M01.686.508.400
18204448,2008-01-20T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18204448,2008-01-20T00:00:00,Genetic Predisposition to Disease,G05.380.355
18204448,2008-01-20T00:00:00,Genetic Variation,G05.365
18204448,2008-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18204448,2008-01-20T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18204448,2008-01-20T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18204448,2008-01-20T00:00:00,"Models, Genetic",E05.599.395.397
18204448,2008-01-20T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18204448,2008-01-20T00:00:00,Probability,E05.318.740.600
18204448,2008-01-20T00:00:00,Probability,G17.680
18204448,2008-01-20T00:00:00,Probability,N05.715.360.750.625
18204448,2008-01-20T00:00:00,Probability,N06.850.520.830.600
18204448,2008-01-20T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18204448,2008-01-20T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18204448,2008-01-20T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18204448,2008-01-20T00:00:00,Risk Factors,E05.318.740.600.800.725
18204448,2008-01-20T00:00:00,Risk Factors,N05.715.350.200.700
18204448,2008-01-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18204448,2008-01-20T00:00:00,Risk Factors,N06.850.490.625.750
18204448,2008-01-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18221378,2008-01-21T00:00:00,Animals,B01.050
18221378,2008-01-21T00:00:00,Central Nervous System Stimulants,D27.505.696.282
18221378,2008-01-21T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
18221378,2008-01-21T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
18221378,2008-01-21T00:00:00,Gene Expression Regulation,G05.355.315
18221378,2008-01-21T00:00:00,Signal Transduction,G02.111.087.800
18221378,2008-01-21T00:00:00,Signal Transduction,G02.149.115.800
18221378,2008-01-21T00:00:00,Signal Transduction,G04.299.880
18212329,2008-01-22T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
18212329,2008-01-22T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
18212329,2008-01-22T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
18212329,2008-01-22T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
18212329,2008-01-22T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
18212329,2008-01-22T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
18212329,2008-01-22T00:00:00,Cell Culture Techniques,E05.200.249.249
18212329,2008-01-22T00:00:00,Cell Division,G04.299.134.220
18212329,2008-01-22T00:00:00,Cell Division,G04.299.233.750.500
18212329,2008-01-22T00:00:00,Cell Division,G05.355.105
18212329,2008-01-22T00:00:00,Cell Division,G07.700.320.249.410.750.500
18212329,2008-01-22T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
18212329,2008-01-22T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
18212329,2008-01-22T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
18212329,2008-01-22T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
18212329,2008-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18212329,2008-01-22T00:00:00,Immediate-Early Proteins,D12.776.460
18212329,2008-01-22T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
18212329,2008-01-22T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18212329,2008-01-22T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18212329,2008-01-22T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18212329,2008-01-22T00:00:00,Kidney Neoplasms,C04.588.945.947.535
18212329,2008-01-22T00:00:00,Kidney Neoplasms,C12.758.820.750
18212329,2008-01-22T00:00:00,Kidney Neoplasms,C12.777.419.473
18212329,2008-01-22T00:00:00,Kidney Neoplasms,C13.351.937.820.535
18212329,2008-01-22T00:00:00,Kidney Neoplasms,C13.351.968.419.473
18212329,2008-01-22T00:00:00,Mutation,G05.365.590
18212329,2008-01-22T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
18212329,2008-01-22T00:00:00,RNA Interference,G05.355.315.203.374.790
18534546,2008-01-22T00:00:00,Aged,M01.060.116.100
18534546,2008-01-22T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
18534546,2008-01-22T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
18534546,2008-01-22T00:00:00,Computer Simulation,L01.224.160
18534546,2008-01-22T00:00:00,Fluoroscopy,E01.370.350.700.225
18534546,2008-01-22T00:00:00,Hip Joint,A02.835.583.411
18534546,2008-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18534546,2008-01-22T00:00:00,Middle Aged,M01.060.116.630
18534546,2008-01-22T00:00:00,"Surgery, Computer-Assisted",E02.950.875
18534546,2008-01-22T00:00:00,"Surgery, Computer-Assisted",E04.749
18534546,2008-01-22T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
18212316,2008-01-23T00:00:00,Adult,M01.060.116
18212316,2008-01-23T00:00:00,Blood Glucose,D09.546.359.448.500
18212316,2008-01-23T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18212316,2008-01-23T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18212316,2008-01-23T00:00:00,Exercise,G11.427.590.237
18212316,2008-01-23T00:00:00,Exercise,I03.350
18212316,2008-01-23T00:00:00,Gastroplasty,E02.065.062.750
18212316,2008-01-23T00:00:00,Gastroplasty,E04.062.750
18212316,2008-01-23T00:00:00,Gastroplasty,E04.210.485
18212316,2008-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18212316,2008-01-23T00:00:00,Laparoscopy,E01.370.388.250.520
18212316,2008-01-23T00:00:00,Laparoscopy,E04.800.250.520
18212316,2008-01-23T00:00:00,Middle Aged,M01.060.116.630
18212316,2008-01-23T00:00:00,Obesity,C18.654.726.500
18212316,2008-01-23T00:00:00,Obesity,C23.888.144.699.500
18212316,2008-01-23T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18212316,2008-01-23T00:00:00,Obesity,G07.100.100.160.120.699.500
18212316,2008-01-23T00:00:00,Remission Induction,E02.860
18212316,2008-01-23T00:00:00,Weight Loss,C23.888.144.243.963
18212316,2008-01-23T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18218715,2008-01-24T00:00:00,Biosensing Techniques,E05.601.123
18218715,2008-01-24T00:00:00,Elastin,D05.750.078.421
18218715,2008-01-24T00:00:00,Elastin,D12.776.860.300.350
18218715,2008-01-24T00:00:00,Fluorescent Dyes,D27.720.233.348
18218715,2008-01-24T00:00:00,Fluorescent Dyes,D27.720.470.330.348
18218715,2008-01-24T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
18218715,2008-01-24T00:00:00,Mutation,G05.365.590
18218715,2008-01-24T00:00:00,Peptides,D12.644
18218715,2008-01-24T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
18218715,2008-01-24T00:00:00,Temperature,G01.906.595
18218715,2008-01-24T00:00:00,Temperature,G16.500.275.063.725.710
18218715,2008-01-24T00:00:00,Temperature,G16.500.750.775.710
18218715,2008-01-24T00:00:00,Temperature,N06.230.150.450
18218715,2008-01-24T00:00:00,Temperature,N06.230.300.100.725.710
18218995,2008-01-24T00:00:00,Animals,B01.050
18218995,2008-01-24T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
18218995,2008-01-24T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
18218995,2008-01-24T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
18218995,2008-01-24T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
18218995,2008-01-24T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
18218995,2008-01-24T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18218995,2008-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18218995,2008-01-24T00:00:00,Lung Neoplasms,C04.588.894.797.520
18218995,2008-01-24T00:00:00,Lung Neoplasms,C08.381.540
18218995,2008-01-24T00:00:00,Lung Neoplasms,C08.785.520
18218995,2008-01-24T00:00:00,Mesothelioma,C04.557.470.035.510
18218995,2008-01-24T00:00:00,Mesothelioma,C04.557.470.660.510
18218995,2008-01-24T00:00:00,Phenotype,G05.695
18218995,2008-01-24T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
18218995,2008-01-24T00:00:00,RNA Interference,G05.355.315.203.374.790
18218995,2008-01-24T00:00:00,RNA-Binding Proteins,D12.776.157.725
18218995,2008-01-24T00:00:00,RNA-Binding Proteins,D12.776.664.962
18239580,2008-01-24T00:00:00,Adolescent,M01.060.057
18239580,2008-01-24T00:00:00,Adult,M01.060.116
18239580,2008-01-24T00:00:00,Aged,M01.060.116.100
18239580,2008-01-24T00:00:00,Aging,G07.700.320.124
18239580,2008-01-24T00:00:00,Body Mass Index,E01.370.600.115.100.125
18239580,2008-01-24T00:00:00,Body Mass Index,E05.041.124.125
18239580,2008-01-24T00:00:00,Body Mass Index,G07.100.100.125
18239580,2008-01-24T00:00:00,Body Mass Index,N06.850.505.200.100.175
18239580,2008-01-24T00:00:00,Cardiovascular Diseases,C14
18239580,2008-01-24T00:00:00,Child,M01.060.406
18239580,2008-01-24T00:00:00,"Child, Preschool",M01.060.406.448
18239580,2008-01-24T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18239580,2008-01-24T00:00:00,Genetic Predisposition to Disease,G05.380.355
18239580,2008-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18239580,2008-01-24T00:00:00,Middle Aged,M01.060.116.630
18239580,2008-01-24T00:00:00,Obesity,C18.654.726.500
18239580,2008-01-24T00:00:00,Obesity,C23.888.144.699.500
18239580,2008-01-24T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18239580,2008-01-24T00:00:00,Obesity,G07.100.100.160.120.699.500
18239580,2008-01-24T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18239580,2008-01-24T00:00:00,Proteins,D12.776
18219582,2008-01-25T00:00:00,Adult,M01.060.116
18219582,2008-01-25T00:00:00,African Americans,M01.686.508.100.100
18219582,2008-01-25T00:00:00,African Americans,M01.686.754.100
18219582,2008-01-25T00:00:00,Aged,M01.060.116.100
18219582,2008-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18219582,2008-01-25T00:00:00,Middle Aged,M01.060.116.630
18219582,2008-01-25T00:00:00,Neoplasms,C04
18219582,2008-01-25T00:00:00,Prevalence,E05.318.308.985.525.750
18219582,2008-01-25T00:00:00,Prevalence,L01.280.975.525.750
18219582,2008-01-25T00:00:00,Prevalence,N01.224.935.597.750
18219582,2008-01-25T00:00:00,Prevalence,N06.850.505.400.975.525.750
18219582,2008-01-25T00:00:00,Prevalence,N06.850.520.308.985.525.750
18219582,2008-01-25T00:00:00,United States,Z01.107.567.875
18219582,2008-01-25T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18223104,2008-01-25T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
18223104,2008-01-25T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
18223104,2008-01-25T00:00:00,Chlorine,D01.268.380.150
18223104,2008-01-25T00:00:00,Chlorine,D01.362.225
18223104,2008-01-25T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
18223104,2008-01-25T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
18223104,2008-01-25T00:00:00,Soil Pollutants,D27.888.284.756
18267125,2008-01-26T00:00:00,Angiotensin II,D06.472.699.094.078
18267125,2008-01-26T00:00:00,Angiotensin II,D12.644.400.070.078
18267125,2008-01-26T00:00:00,Angiotensin II,D12.644.456.073.041
18267125,2008-01-26T00:00:00,Angiotensin II,D12.644.548.058.078
18267125,2008-01-26T00:00:00,Angiotensin II,D12.776.641.650.070.078
18267125,2008-01-26T00:00:00,Angiotensin II,D23.469.050.050.050
18267125,2008-01-26T00:00:00,Animals,B01.050
18267125,2008-01-26T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
18267125,2008-01-26T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
18267125,2008-01-26T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
18267125,2008-01-26T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
18267125,2008-01-26T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
18267125,2008-01-26T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
18267125,2008-01-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18267125,2008-01-26T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
18267125,2008-01-26T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
18267125,2008-01-26T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
18267125,2008-01-26T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
18227104,2008-01-27T00:00:00,Animals,B01.050
18227104,2008-01-27T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18227104,2008-01-27T00:00:00,Apoptosis,G04.299.139.160
18227104,2008-01-27T00:00:00,Blood Pressure,E01.370.600.875.249
18227104,2008-01-27T00:00:00,Blood Pressure,G09.330.380.076
18227104,2008-01-27T00:00:00,Bradykinin,D12.644.276.812.169
18227104,2008-01-27T00:00:00,Bradykinin,D12.644.400.090
18227104,2008-01-27T00:00:00,Bradykinin,D12.644.456.193
18227104,2008-01-27T00:00:00,Bradykinin,D12.776.467.812.169
18227104,2008-01-27T00:00:00,Bradykinin,D12.776.641.650.090
18227104,2008-01-27T00:00:00,Bradykinin,D23.469.050.375.110
18227104,2008-01-27T00:00:00,Bradykinin,D23.529.812.169
18227104,2008-01-27T00:00:00,Collagen,D05.750.078.280
18227104,2008-01-27T00:00:00,Collagen,D12.776.860.300.250
18227104,2008-01-27T00:00:00,Gentamicins,D09.408.051.374
18227104,2008-01-27T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
18227104,2008-01-27T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
18227104,2008-01-27T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
18227104,2008-01-27T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
18227104,2008-01-27T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
18227104,2008-01-27T00:00:00,Kidney,A05.810.453
18227104,2008-01-27T00:00:00,"Nephritis, Interstitial",C12.777.419.570.643
18227104,2008-01-27T00:00:00,"Nephritis, Interstitial",C13.351.968.419.570.643
18227104,2008-01-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18227104,2008-01-27T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18227104,2008-01-27T00:00:00,Recovery of Function,G16.757
18227104,2008-01-27T00:00:00,Superoxides,D01.248.497.158.685.750.850
18227104,2008-01-27T00:00:00,Superoxides,D01.339.431.374.850
18227104,2008-01-27T00:00:00,Superoxides,D01.339.431.750
18227104,2008-01-27T00:00:00,Superoxides,D01.650.550.750.800
18227104,2008-01-27T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
18227104,2008-01-27T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
18227104,2008-01-27T00:00:00,Tissue Kallikreins,D23.101.840.870
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18227104,2008-01-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18227370,2008-01-28T00:00:00,African Continental Ancestry Group,M01.686.508.100
18227370,2008-01-28T00:00:00,Aged,M01.060.116.100
18227370,2008-01-28T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18227370,2008-01-28T00:00:00,European Continental Ancestry Group,M01.686.508.400
18227370,2008-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18227370,2008-01-28T00:00:00,Hypertension,C14.907.489
18227370,2008-01-28T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
18227370,2008-01-28T00:00:00,Metabolic Syndrome X,C18.452.625
18227370,2008-01-28T00:00:00,Middle Aged,M01.060.116.630
18227370,2008-01-28T00:00:00,Treatment Outcome,E01.789.800
18227370,2008-01-28T00:00:00,Treatment Outcome,N04.761.559.590.800
18227370,2008-01-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18248654,2008-01-28T00:00:00,Adolescent,M01.060.057
18248654,2008-01-28T00:00:00,Adult,M01.060.116
18248654,2008-01-28T00:00:00,Aged,M01.060.116.100
18248654,2008-01-28T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18248654,2008-01-28T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18248654,2008-01-28T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18248654,2008-01-28T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18248654,2008-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18248654,2008-01-28T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
18248654,2008-01-28T00:00:00,Length of Stay,E02.760.400.480
18248654,2008-01-28T00:00:00,Length of Stay,N02.421.585.400.480
18248654,2008-01-28T00:00:00,Middle Aged,M01.060.116.630
18248654,2008-01-28T00:00:00,Risk Factors,E05.318.740.600.800.725
18248654,2008-01-28T00:00:00,Risk Factors,N05.715.350.200.700
18248654,2008-01-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18248654,2008-01-28T00:00:00,Risk Factors,N06.850.490.625.750
18248654,2008-01-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18248654,2008-01-28T00:00:00,Secondary Prevention,N02.421.726.825
18248654,2008-01-28T00:00:00,Secondary Prevention,N06.850.780.750
18248654,2008-01-28T00:00:00,Treatment Outcome,E01.789.800
18248654,2008-01-28T00:00:00,Treatment Outcome,N04.761.559.590.800
18248654,2008-01-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18295132,2008-01-28T00:00:00,Adolescent,M01.060.057
18295132,2008-01-28T00:00:00,Adolescent Behavior,F01.145.022
18295132,2008-01-28T00:00:00,Adult,M01.060.116
18295132,2008-01-28T00:00:00,Child,M01.060.406
18295132,2008-01-28T00:00:00,Continental Population Groups,M01.686.508
18295132,2008-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18295132,2008-01-28T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18295132,2008-01-28T00:00:00,Pregnancy,G08.686.785.760.769
18295132,2008-01-28T00:00:00,Pregnancy in Adolescence,G08.686.785.760.769.494
18295132,2008-01-28T00:00:00,United States,Z01.107.567.875
18222360,2008-01-29T00:00:00,Animals,B01.050
18222360,2008-01-29T00:00:00,Calcium,D01.268.552.100
18222360,2008-01-29T00:00:00,Calcium,D01.552.539.288
18222360,2008-01-29T00:00:00,Calcium,D23.119.100
18222360,2008-01-29T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
18222360,2008-01-29T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
18222360,2008-01-29T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
18222360,2008-01-29T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18222360,2008-01-29T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18222360,2008-01-29T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
18222360,2008-01-29T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
18222360,2008-01-29T00:00:00,Mitral Valve Insufficiency,C14.280.484.461
18222360,2008-01-29T00:00:00,Myocardial Infarction,C14.280.647.500
18222360,2008-01-29T00:00:00,Myocardial Infarction,C14.907.585.500
18222360,2008-01-29T00:00:00,Stroke Volume,E01.370.370.380.150.700
18222360,2008-01-29T00:00:00,Stroke Volume,G09.330.380.124.882
18222360,2008-01-29T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18222360,2008-01-29T00:00:00,Ventricular Remodeling,C23.300.985
18222360,2008-01-29T00:00:00,Ventricular Remodeling,G09.330.190.962.975
18234350,2008-01-29T00:00:00,Adult,M01.060.116
18234350,2008-01-29T00:00:00,Anxiety Disorders,F03.080
18234350,2008-01-29T00:00:00,Bipolar Disorder,F03.600.150.150
18234350,2008-01-29T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18234350,2008-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18234350,2008-01-29T00:00:00,Obsessive-Compulsive Disorder,F03.080.600
18234350,2008-01-29T00:00:00,Panic Disorder,F03.080.700
18234350,2008-01-29T00:00:00,Prevalence,E05.318.308.985.525.750
18234350,2008-01-29T00:00:00,Prevalence,L01.280.975.525.750
18234350,2008-01-29T00:00:00,Prevalence,N01.224.935.597.750
18234350,2008-01-29T00:00:00,Prevalence,N06.850.505.400.975.525.750
18234350,2008-01-29T00:00:00,Prevalence,N06.850.520.308.985.525.750
18234350,2008-01-29T00:00:00,Psychiatric Status Rating Scales,F04.586
18234350,2008-01-29T00:00:00,Questionnaires,E05.318.308.750
18234350,2008-01-29T00:00:00,Questionnaires,L01.280.800
18234350,2008-01-29T00:00:00,Questionnaires,N05.715.360.300.695
18234350,2008-01-29T00:00:00,Questionnaires,N06.850.520.308.750
18234350,2008-01-29T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18234350,2008-01-29T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18234350,2008-01-29T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18234350,2008-01-29T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18234350,2008-01-29T00:00:00,Risk Factors,E05.318.740.600.800.725
18234350,2008-01-29T00:00:00,Risk Factors,N05.715.350.200.700
18234350,2008-01-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18234350,2008-01-29T00:00:00,Risk Factors,N06.850.490.625.750
18234350,2008-01-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18234350,2008-01-29T00:00:00,Substance-Related Disorders,C21.739
18234350,2008-01-29T00:00:00,Substance-Related Disorders,F03.900
18234554,2008-01-29T00:00:00,Aged,M01.060.116.100
18234554,2008-01-29T00:00:00,Angiotensin II,D06.472.699.094.078
18234554,2008-01-29T00:00:00,Angiotensin II,D12.644.400.070.078
18234554,2008-01-29T00:00:00,Angiotensin II,D12.644.456.073.041
18234554,2008-01-29T00:00:00,Angiotensin II,D12.644.548.058.078
18234554,2008-01-29T00:00:00,Angiotensin II,D12.776.641.650.070.078
18234554,2008-01-29T00:00:00,Angiotensin II,D23.469.050.050.050
18234554,2008-01-29T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
18234554,2008-01-29T00:00:00,Endothelin-1,D12.644.276.400.225
18234554,2008-01-29T00:00:00,Endothelin-1,D12.776.467.400.225
18234554,2008-01-29T00:00:00,Endothelin-1,D23.529.400.225
18234554,2008-01-29T00:00:00,Extracellular Matrix,A11.284.295.310
18234554,2008-01-29T00:00:00,Heart Failure,C14.280.434
18234554,2008-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18234554,2008-01-29T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
18234554,2008-01-29T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
18234554,2008-01-29T00:00:00,Middle Aged,M01.060.116.630
18234554,2008-01-29T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
18234681,2008-01-29T00:00:00,"Accidents, Traffic",N06.850.135.392
18234681,2008-01-29T00:00:00,Adult,M01.060.116
18234681,2008-01-29T00:00:00,Heart Ventricles,A07.541.560
18234681,2008-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18234681,2008-01-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18234681,2008-01-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18234681,2008-01-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18234681,2008-01-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18234681,2008-01-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18234681,2008-01-29T00:00:00,"Wounds, Nonpenetrating",C21.866.974
18235078,2008-01-30T00:00:00,Aged,M01.060.116.100
18235078,2008-01-30T00:00:00,"Constriction, Pathologic",C23.300.287
18235078,2008-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18235078,2008-01-30T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18235078,2008-01-30T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18235078,2008-01-30T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18235078,2008-01-30T00:00:00,Middle Aged,M01.060.116.630
18235078,2008-01-30T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
18235078,2008-01-30T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
18235078,2008-01-30T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18235078,2008-01-30T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18235078,2008-01-30T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18235078,2008-01-30T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18235078,2008-01-30T00:00:00,Risk Factors,E05.318.740.600.800.725
18235078,2008-01-30T00:00:00,Risk Factors,N05.715.350.200.700
18235078,2008-01-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18235078,2008-01-30T00:00:00,Risk Factors,N06.850.490.625.750
18235078,2008-01-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18235078,2008-01-30T00:00:00,Stents,E07.695.750
18235078,2008-01-30T00:00:00,Stroke,C10.228.140.300.775
18235078,2008-01-30T00:00:00,Stroke,C14.907.253.855
18235078,2008-01-30T00:00:00,Treatment Outcome,E01.789.800
18235078,2008-01-30T00:00:00,Treatment Outcome,N04.761.559.590.800
18235078,2008-01-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18235078,2008-01-30T00:00:00,United States,Z01.107.567.875
18239032,2008-01-31T00:00:00,Animals,B01.050
18239032,2008-01-31T00:00:00,Cell Differentiation,G04.299.151
18239032,2008-01-31T00:00:00,Cell Proliferation,G04.299.233.750
18239032,2008-01-31T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18239032,2008-01-31T00:00:00,Cholesterol,D04.808.247.222.284
18239032,2008-01-31T00:00:00,Cholesterol,D04.808.247.808.197
18239032,2008-01-31T00:00:00,Cholesterol,D10.570.938.208
18239032,2008-01-31T00:00:00,Cholesterol,D10.851.208
18239032,2008-01-31T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
18239032,2008-01-31T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
18239032,2008-01-31T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
18239032,2008-01-31T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
18239032,2008-01-31T00:00:00,Hydroxymethylglutaryl CoA Reductases,D08.811.682.047.385.415
18239032,2008-01-31T00:00:00,Inflammation,C23.550.470
18239032,2008-01-31T00:00:00,Lovastatin,D02.455.426.559.847.638.400
18239032,2008-01-31T00:00:00,Lovastatin,D04.615.638.400
18239032,2008-01-31T00:00:00,Mevalonic Acid,D02.241.511.579
18239032,2008-01-31T00:00:00,Neuroglia,A08.637
18239032,2008-01-31T00:00:00,Neuroglia,A11.650
18239032,2008-01-31T00:00:00,Oligodendroglia,A08.637.600
18239032,2008-01-31T00:00:00,Oligodendroglia,A11.650.600
18239032,2008-01-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18239032,2008-01-31T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18239032,2008-01-31T00:00:00,Spinal Cord,A08.186.854
18239032,2008-01-31T00:00:00,Wound Healing,G16.100.856.891
18239032,2008-01-31T00:00:00,rho GTP-Binding Proteins,D08.811.277.040.330.300.400.700
18239032,2008-01-31T00:00:00,rho GTP-Binding Proteins,D12.644.360.525.700
18239032,2008-01-31T00:00:00,rho GTP-Binding Proteins,D12.776.157.325.515.700
18239032,2008-01-31T00:00:00,rho GTP-Binding Proteins,D12.776.476.525.700
18239161,2008-01-31T00:00:00,Aged,M01.060.116.100
18239161,2008-01-31T00:00:00,Brain Ischemia,C10.228.140.300.150
18239161,2008-01-31T00:00:00,Brain Ischemia,C14.907.253.092
18239161,2008-01-31T00:00:00,"Constriction, Pathologic",C23.300.287
18239161,2008-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18239161,2008-01-31T00:00:00,Incidence,E05.318.308.985.525.375
18239161,2008-01-31T00:00:00,Incidence,L01.280.975.525.375
18239161,2008-01-31T00:00:00,Incidence,N01.224.935.597.500
18239161,2008-01-31T00:00:00,Incidence,N06.850.505.400.975.525.375
18239161,2008-01-31T00:00:00,Incidence,N06.850.520.308.985.525.375
18239161,2008-01-31T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18239161,2008-01-31T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18239161,2008-01-31T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18239161,2008-01-31T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
18239161,2008-01-31T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
18239161,2008-01-31T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
18239161,2008-01-31T00:00:00,Middle Aged,M01.060.116.630
18239161,2008-01-31T00:00:00,Prevalence,E05.318.308.985.525.750
18239161,2008-01-31T00:00:00,Prevalence,L01.280.975.525.750
18239161,2008-01-31T00:00:00,Prevalence,N01.224.935.597.750
18239161,2008-01-31T00:00:00,Prevalence,N06.850.505.400.975.525.750
18239161,2008-01-31T00:00:00,Prevalence,N06.850.520.308.985.525.750
18239161,2008-01-31T00:00:00,Risk Assessment,E05.318.740.600.800.715
18239161,2008-01-31T00:00:00,Risk Assessment,N04.452.871.715
18239161,2008-01-31T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18239161,2008-01-31T00:00:00,Risk Assessment,N06.850.505.715
18239161,2008-01-31T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18239161,2008-01-31T00:00:00,Stroke,C10.228.140.300.775
18239161,2008-01-31T00:00:00,Stroke,C14.907.253.855
18239574,2008-01-31T00:00:00,Adult,M01.060.116
18239574,2008-01-31T00:00:00,Body Mass Index,E01.370.600.115.100.125
18239574,2008-01-31T00:00:00,Body Mass Index,E05.041.124.125
18239574,2008-01-31T00:00:00,Body Mass Index,G07.100.100.125
18239574,2008-01-31T00:00:00,Body Mass Index,N06.850.505.200.100.175
18239574,2008-01-31T00:00:00,Case-Control Studies,E05.318.760.500.500
18239574,2008-01-31T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18239574,2008-01-31T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18239574,2008-01-31T00:00:00,Computational Biology,H01.158.273.180
18239574,2008-01-31T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18239574,2008-01-31T00:00:00,Genetic Predisposition to Disease,G05.380.355
18239574,2008-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18239574,2008-01-31T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18239574,2008-01-31T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18239574,2008-01-31T00:00:00,"Lipoproteins, HDL",D10.532.432
18239574,2008-01-31T00:00:00,"Lipoproteins, HDL",D12.776.521.479
18239574,2008-01-31T00:00:00,"Lipoproteins, LDL",D10.532.515
18239574,2008-01-31T00:00:00,"Lipoproteins, LDL",D12.776.521.550
18239574,2008-01-31T00:00:00,Membrane Proteins,D12.776.543
18239574,2008-01-31T00:00:00,Middle Aged,M01.060.116.630
18239574,2008-01-31T00:00:00,Obesity,C18.654.726.500
18239574,2008-01-31T00:00:00,Obesity,C23.888.144.699.500
18239574,2008-01-31T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18239574,2008-01-31T00:00:00,Obesity,G07.100.100.160.120.699.500
18239574,2008-01-31T00:00:00,Phenotype,G05.695
18239574,2008-01-31T00:00:00,"Polymorphism, Genetic",G05.365.795
18239574,2008-01-31T00:00:00,Risk Factors,E05.318.740.600.800.725
18239574,2008-01-31T00:00:00,Risk Factors,N05.715.350.200.700
18239574,2008-01-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18239574,2008-01-31T00:00:00,Risk Factors,N06.850.490.625.750
18239574,2008-01-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17668860,2008-02-01T00:00:00,Electrodes,E07.305.250
17668860,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17668860,2008-02-01T00:00:00,Resin Cements,D05.750.716.822.730
17668860,2008-02-01T00:00:00,Resin Cements,D25.339.291.750
17668860,2008-02-01T00:00:00,Resin Cements,D25.720.716.822.730
17668860,2008-02-01T00:00:00,Resin Cements,J01.637.051.339.291.750
17668860,2008-02-01T00:00:00,Resin Cements,J01.637.051.720.716.822.730
18083540,2008-02-01T00:00:00,Autistic Disorder,F03.550.325.125
18083540,2008-02-01T00:00:00,Child,M01.060.406
18083540,2008-02-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18083540,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18083540,2008-02-01T00:00:00,Population Surveillance,E05.318.308.250.700
18083540,2008-02-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
18083540,2008-02-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
18083540,2008-02-01T00:00:00,Population Surveillance,N06.850.780.675
18083540,2008-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18083540,2008-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18098270,2008-02-01T00:00:00,Animals,B01.050
18098270,2008-02-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18098270,2008-02-01T00:00:00,Apoptosis,G04.299.139.160
18098270,2008-02-01T00:00:00,Cell Differentiation,G04.299.151
18098270,2008-02-01T00:00:00,Central Nervous System Neoplasms,C04.588.614.250
18098270,2008-02-01T00:00:00,Central Nervous System Neoplasms,C10.551.240
18098270,2008-02-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
18098270,2008-02-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
18098270,2008-02-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
18098270,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18098270,2008-02-01T00:00:00,NF-kappa B,D12.776.260.600
18098270,2008-02-01T00:00:00,NF-kappa B,D12.776.660.600
18098270,2008-02-01T00:00:00,NF-kappa B,D12.776.930.600
18098270,2008-02-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18098270,2008-02-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18098270,2008-02-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18098270,2008-02-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
18098270,2008-02-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
18098270,2008-02-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
18098270,2008-02-01T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
18098270,2008-02-01T00:00:00,Telomerase,D12.776.157.725.500.921
18098270,2008-02-01T00:00:00,Telomerase,D12.776.664.962.500.921
18098270,2008-02-01T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
18098270,2008-02-01T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
18161058,2008-02-01T00:00:00,Animals,B01.050
18161058,2008-02-01T00:00:00,"Animals, Newborn",B01.050.050.282
18161058,2008-02-01T00:00:00,Down Syndrome,C10.597.606.643.220
18161058,2008-02-01T00:00:00,Down Syndrome,C16.131.077.327
18161058,2008-02-01T00:00:00,Down Syndrome,C16.131.260.260
18161058,2008-02-01T00:00:00,Down Syndrome,C16.320.180.260
18161058,2008-02-01T00:00:00,"Heart Defects, Congenital",C14.240.400
18161058,2008-02-01T00:00:00,"Heart Defects, Congenital",C14.280.400
18161058,2008-02-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18194071,2008-02-01T00:00:00,Biocompatible Materials,D25.130
18194071,2008-02-01T00:00:00,Biocompatible Materials,D27.720.102.130
18194071,2008-02-01T00:00:00,Biocompatible Materials,J01.637.051.130
18194071,2008-02-01T00:00:00,Bioreactors,E07.115
18194071,2008-02-01T00:00:00,Bioreactors,J01.897.120.115
18194071,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18194071,2008-02-01T00:00:00,Polyethylene Glycols,D02.033.455.250.700
18194071,2008-02-01T00:00:00,Polyethylene Glycols,D05.750.741
18194071,2008-02-01T00:00:00,Polyethylene Glycols,D25.720.741
18194071,2008-02-01T00:00:00,Polyethylene Glycols,J01.637.051.720.741
18194071,2008-02-01T00:00:00,Tissue Engineering,E05.200.249.750
18194071,2008-02-01T00:00:00,Tissue Scaffolds,E07.206.627
18194071,2008-02-01T00:00:00,Tissue Scaffolds,E07.695.825
18201647,2008-02-01T00:00:00,Curriculum,I02.158
18201647,2008-02-01T00:00:00,Health Personnel,M01.526.485
18201647,2008-02-01T00:00:00,Health Personnel,N02.360
18201647,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18201647,2008-02-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
18201647,2008-02-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
18201647,2008-02-01T00:00:00,Interdisciplinary Communication,L01.143.474
18201647,2008-02-01T00:00:00,Preventive Medicine,H02.403.720.750
18201647,2008-02-01T00:00:00,Teaching,I02.903
18201647,2008-02-01T00:00:00,United States,Z01.107.567.875
18203962,2008-02-01T00:00:00,Apoptosis,G04.299.139.160
18203962,2008-02-01T00:00:00,Brain,A08.186.211
18203962,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18203962,2008-02-01T00:00:00,"Immunity, Innate",G12.450.575
18203962,2008-02-01T00:00:00,Inflammation,C23.550.470
18203962,2008-02-01T00:00:00,Neurodegenerative Diseases,C10.574
18203962,2008-02-01T00:00:00,Neurons,A08.663
18203962,2008-02-01T00:00:00,Neurons,A11.671
18204334,2008-02-01T00:00:00,Adult,M01.060.116
18204334,2008-02-01T00:00:00,Aged,M01.060.116.100
18204334,2008-02-01T00:00:00,Alcoholism,C21.739.100.250
18204334,2008-02-01T00:00:00,Alcoholism,F03.900.100.350
18204334,2008-02-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18204334,2008-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18204334,2008-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18204334,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18204334,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18204334,2008-02-01T00:00:00,Piperazines,D03.383.606
18204334,2008-02-01T00:00:00,Quinolones,D03.438.810.835
18204334,2008-02-01T00:00:00,Treatment Outcome,E01.789.800
18204334,2008-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18204334,2008-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18216516,2008-02-01T00:00:00,Animals,B01.050
18216516,2008-02-01T00:00:00,"Electrodes, Implanted",E07.305.250.319
18216516,2008-02-01T00:00:00,Foreign-Body Reaction,C21.866.392.560
18216516,2008-02-01T00:00:00,Foreign-Body Reaction,C23.550.470.251
18216516,2008-02-01T00:00:00,Materials Testing,E05.570
18216516,2008-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18216516,2008-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18216516,2008-02-01T00:00:00,Wound Healing,G16.100.856.891
18220458,2008-02-01T00:00:00,Computer Simulation,L01.224.160
18220458,2008-02-01T00:00:00,DNA,D13.444.308
18220458,2008-02-01T00:00:00,"Models, Chemical",E05.599.495
18220458,2008-02-01T00:00:00,"Models, Molecular",E05.599.595
18220458,2008-02-01T00:00:00,Monte Carlo Method,E05.318.740.525
18220458,2008-02-01T00:00:00,Monte Carlo Method,L01.906.575.422
18220458,2008-02-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
18220458,2008-02-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
18220458,2008-02-01T00:00:00,Radiation Dosage,E05.799.513
18220458,2008-02-01T00:00:00,Radiation Dosage,G01.201.875.740
18220458,2008-02-01T00:00:00,Radiation Dosage,N06.850.810.250
18223140,2008-02-01T00:00:00,"History, 20th Century",K01.400.504.968
18223140,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18223140,2008-02-01T00:00:00,Vitamin D,D04.808.812.768
18225964,2008-02-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
18225964,2008-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18225964,2008-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18225964,2008-02-01T00:00:00,Heart Failure,C14.280.434
18225964,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18225964,2008-02-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
18225974,2008-02-01T00:00:00,Ambulatory Care,E02.760.106
18225974,2008-02-01T00:00:00,Ambulatory Care,N02.421.585.106
18225974,2008-02-01T00:00:00,Decision Making,F02.463.785.373
18225974,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18225974,2008-02-01T00:00:00,"Models, Organizational",E05.599.670
18225974,2008-02-01T00:00:00,"Models, Organizational",N04.452.534
18225974,2008-02-01T00:00:00,Needs Assessment,I02.594
18225974,2008-02-01T00:00:00,Needs Assessment,N03.349.380.565
18225974,2008-02-01T00:00:00,Needs Assessment,N05.300.537
18225974,2008-02-01T00:00:00,Pharmaceutical Services,N02.421.668
18225974,2008-02-01T00:00:00,Pharmacists,M01.526.485.780
18225974,2008-02-01T00:00:00,Pharmacists,N02.360.780
18225974,2008-02-01T00:00:00,Professional Competence,I02.399.630
18227537,2008-02-01T00:00:00,Adult,M01.060.116
18227537,2008-02-01T00:00:00,Aged,M01.060.116.100
18227537,2008-02-01T00:00:00,Breast Neoplasms,C04.588.180
18227537,2008-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
18227537,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18227537,2008-02-01T00:00:00,Mammography,E01.370.350.700.500
18227537,2008-02-01T00:00:00,Mass Screening,E01.370.500
18227537,2008-02-01T00:00:00,Mass Screening,E05.318.308.250.580
18227537,2008-02-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18227537,2008-02-01T00:00:00,Mass Screening,N02.421.726.233.443
18227537,2008-02-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18227537,2008-02-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18227537,2008-02-01T00:00:00,Mass Screening,N06.850.780.500
18227537,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18227537,2008-02-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
18227537,2008-02-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
18227537,2008-02-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
18227537,2008-02-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18227537,2008-02-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18227537,2008-02-01T00:00:00,Sensitivity and Specificity,G17.800
18227537,2008-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18227537,2008-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18227537,2008-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18227537,2008-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18227537,2008-02-01T00:00:00,United States,Z01.107.567.875
18231926,2008-02-01T00:00:00,Antigen Presentation,G12.425.107
18231926,2008-02-01T00:00:00,Antigen Presentation,G12.450.050.400.070
18231926,2008-02-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18231926,2008-02-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18231926,2008-02-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18231926,2008-02-01T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
18231926,2008-02-01T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
18231926,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18237871,2008-02-01T00:00:00,Aged,M01.060.116.100
18237871,2008-02-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
18237871,2008-02-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
18237871,2008-02-01T00:00:00,Colonoscopy,E04.210.240.250.160
18237871,2008-02-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
18237871,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18237871,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18237871,2008-02-01T00:00:00,Polyps,C23.300.825
18239025,2008-02-01T00:00:00,Adult,M01.060.116
18239025,2008-02-01T00:00:00,Fetal Diseases,C13.703.277
18239025,2008-02-01T00:00:00,Fetal Diseases,C16.300
18239025,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18239025,2008-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18239025,2008-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18239025,2008-02-01T00:00:00,Pregnancy,G08.686.785.760.769
18239025,2008-02-01T00:00:00,Prenatal Diagnosis,E01.370.378.630
18239278,2008-02-01T00:00:00,Adenosine Triphosphatases,D08.811.277.040.025
18239278,2008-02-01T00:00:00,Algorithms,G17.035
18239278,2008-02-01T00:00:00,Algorithms,L01.224.050
18239278,2008-02-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
18239278,2008-02-01T00:00:00,Blood-Brain Barrier,A07.035
18239278,2008-02-01T00:00:00,Blood-Brain Barrier,A08.186.211.035
18239278,2008-02-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
18239278,2008-02-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18239278,2008-02-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18239278,2008-02-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18239278,2008-02-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18239278,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18239278,2008-02-01T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
18239278,2008-02-01T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
18239278,2008-02-01T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
18239278,2008-02-01T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
18239278,2008-02-01T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
18239278,2008-02-01T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
18239278,2008-02-01T00:00:00,Sertraline,D02.092.705.800
18239278,2008-02-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
18239278,2008-02-01T00:00:00,Sertraline,D04.615.638.845.800
18240029,2008-02-01T00:00:00,Biotechnology,H01.158.550
18240029,2008-02-01T00:00:00,Biotechnology,J01.897.120
18240029,2008-02-01T00:00:00,Membrane Proteins,D12.776.543
18240029,2008-02-01T00:00:00,"Models, Theoretical",E05.599
18240029,2008-02-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
18240029,2008-02-01T00:00:00,Signal Transduction,G02.111.087.800
18240029,2008-02-01T00:00:00,Signal Transduction,G02.149.115.800
18240029,2008-02-01T00:00:00,Signal Transduction,G04.299.880
18240241,2008-02-01T00:00:00,Adult,M01.060.116
18240241,2008-02-01T00:00:00,African Americans,M01.686.508.100.100
18240241,2008-02-01T00:00:00,African Americans,M01.686.754.100
18240241,2008-02-01T00:00:00,Alleles,G05.360.340.024.340.030
18240241,2008-02-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
18240241,2008-02-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
18240241,2008-02-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
18240241,2008-02-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
18240241,2008-02-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18240241,2008-02-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18240241,2008-02-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18240241,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18240241,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18241820,2008-02-01T00:00:00,Adult,M01.060.116
18241820,2008-02-01T00:00:00,Blood Glucose,D09.546.359.448.500
18241820,2008-02-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18241820,2008-02-01T00:00:00,Diabetes Mellitus,C19.246
18241820,2008-02-01T00:00:00,"Diabetes, Gestational",C13.703.170
18241820,2008-02-01T00:00:00,"Diabetes, Gestational",C18.452.394.750.448
18241820,2008-02-01T00:00:00,"Diabetes, Gestational",C19.246.200
18241820,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18241820,2008-02-01T00:00:00,Mass Screening,E01.370.500
18241820,2008-02-01T00:00:00,Mass Screening,E05.318.308.250.580
18241820,2008-02-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18241820,2008-02-01T00:00:00,Mass Screening,N02.421.726.233.443
18241820,2008-02-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18241820,2008-02-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18241820,2008-02-01T00:00:00,Mass Screening,N06.850.780.500
18241820,2008-02-01T00:00:00,Pregnancy,G08.686.785.760.769
18241820,2008-02-01T00:00:00,Prevalence,E05.318.308.985.525.750
18241820,2008-02-01T00:00:00,Prevalence,L01.280.975.525.750
18241820,2008-02-01T00:00:00,Prevalence,N01.224.935.597.750
18241820,2008-02-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18241820,2008-02-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18242925,2008-02-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18242925,2008-02-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18242925,2008-02-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18242925,2008-02-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
18242925,2008-02-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
18242925,2008-02-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
18242925,2008-02-01T00:00:00,"Hospitals, Rural",N02.278.421.518
18242925,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18242925,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18242925,2008-02-01T00:00:00,Referral and Consultation,N04.452.758.849
18242925,2008-02-01T00:00:00,Stroke,C10.228.140.300.775
18242925,2008-02-01T00:00:00,Stroke,C14.907.253.855
18242925,2008-02-01T00:00:00,Telemedicine,H02.403.840
18242925,2008-02-01T00:00:00,Telemedicine,L01.178.847.652
18242925,2008-02-01T00:00:00,Telemedicine,N04.590.374.800
18242925,2008-02-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
18242925,2008-02-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
18242925,2008-02-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
18242925,2008-02-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
18250251,2008-02-01T00:00:00,Adult,M01.060.116
18250251,2008-02-01T00:00:00,Alcoholism,C21.739.100.250
18250251,2008-02-01T00:00:00,Alcoholism,F03.900.100.350
18250251,2008-02-01T00:00:00,Alleles,G05.360.340.024.340.030
18250251,2008-02-01T00:00:00,Cognitive Therapy,F04.754.137.428
18250251,2008-02-01T00:00:00,Combined Modality Therapy,E02.186
18250251,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18250251,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18250251,2008-02-01T00:00:00,Naltrexone,D03.132.577.249.706.550
18250251,2008-02-01T00:00:00,Naltrexone,D03.549.686.750.550
18250251,2008-02-01T00:00:00,Naltrexone,D03.605.497.750.550
18250251,2008-02-01T00:00:00,Naltrexone,D04.615.723.795.706.550
18250251,2008-02-01T00:00:00,Narcotic Antagonists,D27.505.696.543
18250251,2008-02-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
18250251,2008-02-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
18250251,2008-02-01T00:00:00,Pharmacogenetics,H01.158.273.343.750
18250251,2008-02-01T00:00:00,Pharmacogenetics,H01.158.703.052
18250251,2008-02-01T00:00:00,Pharmacogenetics,H02.628.479
18250251,2008-02-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18250251,2008-02-01T00:00:00,Taurine,D02.455.326.146.100.850
18250251,2008-02-01T00:00:00,Taurine,D02.886.645.600.055.850
18250251,2008-02-01T00:00:00,Treatment Outcome,E01.789.800
18250251,2008-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18250251,2008-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18251632,2008-02-01T00:00:00,"Education, Dental",I02.358.274
18251632,2008-02-01T00:00:00,"Faculty, Dental",I02.463.273
18251632,2008-02-01T00:00:00,"Faculty, Dental",M01.526.339.273
18251632,2008-02-01T00:00:00,"Faculty, Dental",M01.526.485.360
18251632,2008-02-01T00:00:00,"Faculty, Dental",N02.360.360
18251632,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18251632,2008-02-01T00:00:00,Internet,L01.224.230.110.500
18251632,2008-02-01T00:00:00,Interprofessional Relations,F01.829.401.205
18251632,2008-02-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18251632,2008-02-01T00:00:00,Referral and Consultation,N04.452.758.849
18251632,2008-02-01T00:00:00,United States,Z01.107.567.875
18251816,2008-02-01T00:00:00,Aged,M01.060.116.100
18251816,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18251816,2008-02-01T00:00:00,Pain Measurement,E01.370.376.550.600
18251816,2008-02-01T00:00:00,Questionnaires,E05.318.308.750
18251816,2008-02-01T00:00:00,Questionnaires,L01.280.800
18251816,2008-02-01T00:00:00,Questionnaires,N05.715.360.300.695
18251816,2008-02-01T00:00:00,Questionnaires,N06.850.520.308.750
18251816,2008-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18251816,2008-02-01T00:00:00,Risk Factors,N05.715.350.200.700
18251816,2008-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18251816,2008-02-01T00:00:00,Risk Factors,N06.850.490.625.750
18251816,2008-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18251816,2008-02-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18251816,2008-02-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18251816,2008-02-01T00:00:00,Sensitivity and Specificity,G17.800
18251816,2008-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18251816,2008-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18251816,2008-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18251816,2008-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18257886,2008-02-01T00:00:00,Adult,M01.060.116
18257886,2008-02-01T00:00:00,Botulism,C01.252.410.222.151
18257886,2008-02-01T00:00:00,Botulism,C10.668.758.200
18257886,2008-02-01T00:00:00,Botulism,C10.720.150
18257886,2008-02-01T00:00:00,Botulism,C21.613.415.151
18257886,2008-02-01T00:00:00,Escherichia coli Infections,C01.252.400.310.330
18257886,2008-02-01T00:00:00,Food Contamination,N06.850.460.400
18257886,2008-02-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18257886,2008-02-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18257886,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18257886,2008-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
18257886,2008-02-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
18257886,2008-02-01T00:00:00,Nurse's Role,N05.300.100.337
18257886,2008-02-01T00:00:00,Patient Education as Topic,I02.233.332.500
18257886,2008-02-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
18257886,2008-02-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
18257886,2008-02-01T00:00:00,Pregnancy,G08.686.785.760.769
18257886,2008-02-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
18257886,2008-02-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
18257886,2008-02-01T00:00:00,United States,Z01.107.567.875
18260793,2008-02-01T00:00:00,Adolescent,M01.060.057
18260793,2008-02-01T00:00:00,Adult,M01.060.116
18260793,2008-02-01T00:00:00,Aged,M01.060.116.100
18260793,2008-02-01T00:00:00,Anticoagulants,D27.505.954.502.119
18260793,2008-02-01T00:00:00,Heparin,D09.698.373.400
18260793,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18260793,2008-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18260793,2008-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18260793,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18260793,2008-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18260793,2008-02-01T00:00:00,Risk Factors,N05.715.350.200.700
18260793,2008-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18260793,2008-02-01T00:00:00,Risk Factors,N06.850.490.625.750
18260793,2008-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18260793,2008-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18260793,2008-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18260793,2008-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18260793,2008-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18260793,2008-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18260793,2008-02-01T00:00:00,Warfarin,D03.438.150.446.520.914
18260793,2008-02-01T00:00:00,Warfarin,D03.830.219.446.520.914
18277227,2008-02-01T00:00:00,Adolescent,M01.060.057
18277227,2008-02-01T00:00:00,Adult,M01.060.116
18277227,2008-02-01T00:00:00,Aged,M01.060.116.100
18277227,2008-02-01T00:00:00,Health Services Accessibility,N04.590.374.350
18277227,2008-02-01T00:00:00,Health Services Accessibility,N05.300.430
18277227,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18277227,2008-02-01T00:00:00,Mental Health Services,F04.408
18277227,2008-02-01T00:00:00,Mental Health Services,N02.421.461
18277227,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18277227,2008-02-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18277227,2008-02-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18277227,2008-02-01T00:00:00,Patient Satisfaction,N05.715.360.600
18277227,2008-02-01T00:00:00,Primary Health Care,N04.590.233.727
18277227,2008-02-01T00:00:00,Questionnaires,E05.318.308.750
18277227,2008-02-01T00:00:00,Questionnaires,L01.280.800
18277227,2008-02-01T00:00:00,Questionnaires,N05.715.360.300.695
18277227,2008-02-01T00:00:00,Questionnaires,N06.850.520.308.750
18277227,2008-02-01T00:00:00,Rural Population,N01.600.725
18277227,2008-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18277227,2008-02-01T00:00:00,Urban Population,N01.600.900
18279770,2008-02-01T00:00:00,Aged,M01.060.116.100
18279770,2008-02-01T00:00:00,Atrial Fibrillation,C14.280.067.198
18279770,2008-02-01T00:00:00,Atrial Fibrillation,C23.550.073.198
18279770,2008-02-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18279770,2008-02-01T00:00:00,Body Mass Index,E05.041.124.125
18279770,2008-02-01T00:00:00,Body Mass Index,G07.100.100.125
18279770,2008-02-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18279770,2008-02-01T00:00:00,Diabetic Angiopathies,C14.907.320
18279770,2008-02-01T00:00:00,Diabetic Angiopathies,C19.246.099.500
18279770,2008-02-01T00:00:00,Heart Failure,C14.280.434
18279770,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18279770,2008-02-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
18279770,2008-02-01T00:00:00,Stroke Volume,G09.330.380.124.882
18282113,2008-02-01T00:00:00,Adolescent,M01.060.057
18282113,2008-02-01T00:00:00,Adult,M01.060.116
18282113,2008-02-01T00:00:00,Aged,M01.060.116.100
18282113,2008-02-01T00:00:00,Aging,G07.700.320.124
18282113,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18282113,2008-02-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
18282113,2008-02-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
18282113,2008-02-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
18282113,2008-02-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
18282113,2008-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
18282113,2008-02-01T00:00:00,Leukocytes,A11.118.637
18282113,2008-02-01T00:00:00,Leukocytes,A15.145.229.637
18282113,2008-02-01T00:00:00,Leukocytes,A15.382.490
18282113,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18282113,2008-02-01T00:00:00,Pregnancy,G08.686.785.760.769
18282113,2008-02-01T00:00:00,Regression Analysis,E05.318.740.750
18282113,2008-02-01T00:00:00,Regression Analysis,N05.715.360.750.695
18282113,2008-02-01T00:00:00,Regression Analysis,N06.850.520.830.750
18282113,2008-02-01T00:00:00,Spermatozoa,A05.360.490.890
18282113,2008-02-01T00:00:00,Spermatozoa,A11.497.760
18284277,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18284277,2008-02-01T00:00:00,Observation,E05.581.249
18284277,2008-02-01T00:00:00,Physician's Practice Patterns,N04.590.748
18284277,2008-02-01T00:00:00,Physician's Practice Patterns,N05.300.625
18284277,2008-02-01T00:00:00,Psychotherapy,F04.754
18284277,2008-02-01T00:00:00,Research Design,E05.581.500
18284277,2008-02-01T00:00:00,Research Design,H01.770.644.728
18288936,2008-02-01T00:00:00,Activities of Daily Living,E02.831.067
18288936,2008-02-01T00:00:00,Activities of Daily Living,I03.050
18288936,2008-02-01T00:00:00,Activities of Daily Living,N02.421.784.110
18288936,2008-02-01T00:00:00,Aged,M01.060.116.100
18288936,2008-02-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18288936,2008-02-01T00:00:00,Alzheimer Disease,C10.574.945.249
18288936,2008-02-01T00:00:00,Alzheimer Disease,F03.087.400.100
18288936,2008-02-01T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
18288936,2008-02-01T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
18288936,2008-02-01T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
18288936,2008-02-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18288936,2008-02-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18288936,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18288936,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18288936,2008-02-01T00:00:00,Neuropsychological Tests,F04.711.513
18288936,2008-02-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18288936,2008-02-01T00:00:00,Treatment Outcome,E01.789.800
18288936,2008-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18288936,2008-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18298257,2008-02-01T00:00:00,Animals,B01.050
18298257,2008-02-01T00:00:00,"Behavior, Animal",F01.145.113
18298257,2008-02-01T00:00:00,Cocaine,D02.145.074.722.388
18298257,2008-02-01T00:00:00,Cocaine,D03.132.889.354
18298257,2008-02-01T00:00:00,Cocaine,D03.605.869.388
18298257,2008-02-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
18298257,2008-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
18298257,2008-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
18298257,2008-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
18298257,2008-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
18298257,2008-02-01T00:00:00,Motor Activity,F01.145.632
18298257,2008-02-01T00:00:00,Motor Activity,G11.427.590.530.698
18298257,2008-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18298257,2008-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18300379,2008-02-01T00:00:00,Adult,M01.060.116
18300379,2008-02-01T00:00:00,Bacterial Proteins,D12.776.097
18300379,2008-02-01T00:00:00,Chlamydia Infections,C01.252.400.210.210
18300379,2008-02-01T00:00:00,Chlamydia Infections,C01.252.810.301
18300379,2008-02-01T00:00:00,Chlamydia Infections,C01.539.778.281.301
18300379,2008-02-01T00:00:00,Chlamydia Infections,C12.294.668.281.301
18300379,2008-02-01T00:00:00,Chlamydia Infections,C13.351.500.711.281.301
18300379,2008-02-01T00:00:00,Chlamydia trachomatis,B03.440.190.190.190.750
18300379,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18300379,2008-02-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18300379,2008-02-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18300379,2008-02-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18300379,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18300379,2008-02-01T00:00:00,Pelvic Inflammatory Disease,C01.539.635.500
18300379,2008-02-01T00:00:00,Pelvic Inflammatory Disease,C13.351.500.056.750
18300379,2008-02-01T00:00:00,Pregnancy,G08.686.785.760.769
18300379,2008-02-01T00:00:00,Serologic Tests,E01.450.495.735
18300379,2008-02-01T00:00:00,Serologic Tests,E05.478.594.760
18300379,2008-02-01T00:00:00,United States,Z01.107.567.875
18308053,2008-02-01T00:00:00,Animals,B01.050
18308053,2008-02-01T00:00:00,Environmental Pollutants,D27.888.284
18308092,2008-02-01T00:00:00,Guideline Adherence,N04.761.337
18308092,2008-02-01T00:00:00,Guideline Adherence,N05.715.360.395
18308092,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18308092,2008-02-01T00:00:00,"Societies, Medical",N03.540.828.589
18308092,2008-02-01T00:00:00,United States,Z01.107.567.875
18308092,2008-02-01T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
18308092,2008-02-01T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
18308092,2008-02-01T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
18308092,2008-02-01T00:00:00,Urology,H02.403.810.860
18323114,2008-02-01T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
18323114,2008-02-01T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
18323114,2008-02-01T00:00:00,Ethylene Dibromide,D02.455.526.368.225
18323114,2008-02-01T00:00:00,Ethylene Dichlorides,D02.455.326.146.379.350
18323114,2008-02-01T00:00:00,Ethylene Dichlorides,D02.455.526.439.458
18323114,2008-02-01T00:00:00,Methane,D02.455.326.146.571
18323354,2008-02-01T00:00:00,Age Factors,N05.715.350.075
18323354,2008-02-01T00:00:00,Age Factors,N06.850.490.250
18323354,2008-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18323354,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18323354,2008-02-01T00:00:00,Infant,M01.060.703
18323354,2008-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
18323354,2008-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18323354,2008-02-01T00:00:00,Risk Factors,N05.715.350.200.700
18323354,2008-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18323354,2008-02-01T00:00:00,Risk Factors,N06.850.490.625.750
18323354,2008-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18366997,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18366997,2008-02-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
18366997,2008-02-01T00:00:00,Metabolic Syndrome X,C18.452.625
18366997,2008-02-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18366997,2008-02-01T00:00:00,Risk Assessment,N04.452.871.715
18366997,2008-02-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18366997,2008-02-01T00:00:00,Risk Assessment,N06.850.505.715
18366997,2008-02-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18366997,2008-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18366997,2008-02-01T00:00:00,Risk Factors,N05.715.350.200.700
18366997,2008-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18366997,2008-02-01T00:00:00,Risk Factors,N06.850.490.625.750
18366997,2008-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18366997,2008-02-01T00:00:00,Stroke,C10.228.140.300.775
18366997,2008-02-01T00:00:00,Stroke,C14.907.253.855
18396601,2008-02-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18396601,2008-02-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18396601,2008-02-01T00:00:00,Head and Neck Neoplasms,C04.588.443
18396601,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18396601,2008-02-01T00:00:00,Middle Aged,M01.060.116.630
18396601,2008-02-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18396601,2008-02-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18396601,2008-02-01T00:00:00,Salvage Therapy,E02.186.800
18396601,2008-02-01T00:00:00,Salvage Therapy,E02.895
18396601,2008-02-01T00:00:00,Treatment Outcome,E01.789.800
18396601,2008-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18396601,2008-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18660710,2008-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18660710,2008-02-01T00:00:00,Hyperglycemia,C18.452.394.952
18660710,2008-02-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18660710,2008-02-01T00:00:00,Pancreas Transplantation,E04.210.725
18660710,2008-02-01T00:00:00,Pancreas Transplantation,E04.936.450.650
18245776,2008-02-02T00:00:00,Animals,B01.050
18245776,2008-02-02T00:00:00,Copper,D01.268.556.195
18245776,2008-02-02T00:00:00,Copper,D01.268.956.170
18245776,2008-02-02T00:00:00,Copper,D01.552.544.195
18245776,2008-02-02T00:00:00,Fibroblasts,A11.329.228
18245776,2008-02-02T00:00:00,Fibroblasts,A11.872.228
18245776,2008-02-02T00:00:00,Gene Expression Regulation,G05.355.315
18245776,2008-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18245776,2008-02-02T00:00:00,Molecular Chaperones,D12.776.580
18245776,2008-02-02T00:00:00,Neoplasms,C04
18245776,2008-02-02T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18245776,2008-02-02T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18245776,2008-02-02T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18245776,2008-02-02T00:00:00,Transcription Factors,D12.776.930
18248608,2008-02-04T00:00:00,Animals,B01.050
18248608,2008-02-04T00:00:00,Astrocytes,A08.637.200
18248608,2008-02-04T00:00:00,Astrocytes,A11.650.200
18248608,2008-02-04T00:00:00,Cell Death,G04.299.139
18248608,2008-02-04T00:00:00,Down-Regulation,G02.111.087.225
18248608,2008-02-04T00:00:00,Down-Regulation,G02.149.115.225
18248608,2008-02-04T00:00:00,Down-Regulation,G05.355.315.200
18248608,2008-02-04T00:00:00,Down-Regulation,G07.690.812.230
18248608,2008-02-04T00:00:00,Down-Regulation,G07.700.680.230
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
18248608,2008-02-04T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
18248608,2008-02-04T00:00:00,Lipid Metabolism,G03.495.520
18248608,2008-02-04T00:00:00,Neural Pathways,A08.612
18248608,2008-02-04T00:00:00,Oligodendroglia,A08.637.600
18248608,2008-02-04T00:00:00,Oligodendroglia,A11.650.600
18248608,2008-02-04T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18248608,2008-02-04T00:00:00,Psychosine,D02.033.100.700.700
18248608,2008-02-04T00:00:00,Psychosine,D02.092.063.700.700
18248608,2008-02-04T00:00:00,Psychosine,D09.400.410.420.806
18248608,2008-02-04T00:00:00,Psychosine,D10.390.470.806
18248608,2008-02-04T00:00:00,Psychosine,D10.570.877.360.806
18248608,2008-02-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18252810,2008-02-05T00:00:00,Animals,B01.050
18252810,2008-02-05T00:00:00,Brain,A08.186.211
18252810,2008-02-05T00:00:00,Cocaine,D02.145.074.722.388
18252810,2008-02-05T00:00:00,Cocaine,D03.132.889.354
18252810,2008-02-05T00:00:00,Cocaine,D03.605.869.388
18252810,2008-02-05T00:00:00,Cocaine,D04.075.080.875.099.722.388
18252810,2008-02-05T00:00:00,Cocaine-Related Disorders,C21.739.300
18252810,2008-02-05T00:00:00,Cocaine-Related Disorders,F03.900.300
18252810,2008-02-05T00:00:00,Motor Activity,F01.145.632
18252810,2008-02-05T00:00:00,Motor Activity,G11.427.590.530.698
18252810,2008-02-05T00:00:00,Neurotensin,D12.644.400.550
18252810,2008-02-05T00:00:00,Neurotensin,D12.776.641.650.550
18252810,2008-02-05T00:00:00,Peptide Fragments,D12.644.541
18252810,2008-02-05T00:00:00,Pyrazoles,D03.383.129.539
18252810,2008-02-05T00:00:00,Quinolines,D03.438.810
18252810,2008-02-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18252810,2008-02-05T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18252810,2008-02-05T00:00:00,"Receptors, Neurotensin",D12.776.543.750.100.550
18252810,2008-02-05T00:00:00,"Receptors, Neurotensin",D12.776.543.750.720.600.560
18252810,2008-02-05T00:00:00,"Receptors, Neurotensin",D12.776.543.750.750.555.560
18252810,2008-02-05T00:00:00,Self Administration,E02.319.890
18252810,2008-02-05T00:00:00,Self Administration,E02.900.890
18252810,2008-02-05T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
18252810,2008-02-05T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
18266936,2008-02-05T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
18266936,2008-02-05T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
18266936,2008-02-05T00:00:00,Animals,B01.050
18266936,2008-02-05T00:00:00,Lovastatin,D02.455.426.559.847.638.400
18266936,2008-02-05T00:00:00,Lovastatin,D04.615.638.400
18266936,2008-02-05T00:00:00,Polyethylene Glycols,D02.033.455.250.700
18266936,2008-02-05T00:00:00,Polyethylene Glycols,D05.750.741
18266936,2008-02-05T00:00:00,Polyethylene Glycols,D25.720.741
18266936,2008-02-05T00:00:00,Polyethylene Glycols,J01.637.051.720.741
18266936,2008-02-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18266936,2008-02-05T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18258844,2008-02-07T00:00:00,Aged,M01.060.116.100
18258844,2008-02-07T00:00:00,Cognition,F02.463.188
18258844,2008-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18258844,2008-02-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18258844,2008-02-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18258844,2008-02-07T00:00:00,Middle Aged,M01.060.116.630
18258844,2008-02-07T00:00:00,Psychomotor Performance,F02.808
18258844,2008-02-07T00:00:00,Psychomotor Performance,G11.427.700
18258844,2008-02-07T00:00:00,Psychomotor Performance,G11.561.623
18261793,2008-02-07T00:00:00,Adult,M01.060.116
18261793,2008-02-07T00:00:00,Aged,M01.060.116.100
18261793,2008-02-07T00:00:00,Bone Marrow Transplantation,E04.936.580.040
18261793,2008-02-07T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
18261793,2008-02-07T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
18261793,2008-02-07T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
18261793,2008-02-07T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
18261793,2008-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18261793,2008-02-07T00:00:00,Incidence,E05.318.308.985.525.375
18261793,2008-02-07T00:00:00,Incidence,L01.280.975.525.375
18261793,2008-02-07T00:00:00,Incidence,N01.224.935.597.500
18261793,2008-02-07T00:00:00,Incidence,N06.850.505.400.975.525.375
18261793,2008-02-07T00:00:00,Incidence,N06.850.520.308.985.525.375
18261793,2008-02-07T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
18261793,2008-02-07T00:00:00,Middle Aged,M01.060.116.630
18261793,2008-02-07T00:00:00,Remission Induction,E02.860
18261793,2008-02-07T00:00:00,Risk Factors,E05.318.740.600.800.725
18261793,2008-02-07T00:00:00,Risk Factors,N05.715.350.200.700
18261793,2008-02-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18261793,2008-02-07T00:00:00,Risk Factors,N06.850.490.625.750
18261793,2008-02-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18261793,2008-02-07T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18261793,2008-02-07T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18261793,2008-02-07T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18261793,2008-02-07T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
18261793,2008-02-07T00:00:00,Transplantation Conditioning,E05.478.610.800
18261793,2008-02-07T00:00:00,Treatment Outcome,E01.789.800
18261793,2008-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
18261793,2008-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18337058,2008-02-07T00:00:00,Adolescent,M01.060.057
18337058,2008-02-07T00:00:00,Adult,M01.060.116
18337058,2008-02-07T00:00:00,Aged,M01.060.116.100
18337058,2008-02-07T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18337058,2008-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18337058,2008-02-07T00:00:00,Life Change Events,F01.829.458.410
18337058,2008-02-07T00:00:00,Middle Aged,M01.060.116.630
18337058,2008-02-07T00:00:00,Psychiatric Status Rating Scales,F04.586
18337058,2008-02-07T00:00:00,Psychometrics,F04.711.780
18337058,2008-02-07T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18346665,2008-02-07T00:00:00,Adolescent,M01.060.057
18346665,2008-02-07T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18346665,2008-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18346665,2008-02-07T00:00:00,Intervention Studies,E05.318.760.565
18346665,2008-02-07T00:00:00,Intervention Studies,N05.715.360.775.390
18346665,2008-02-07T00:00:00,Intervention Studies,N06.850.520.450.565
18346665,2008-02-07T00:00:00,Pregnancy,G08.686.785.760.769
18346665,2008-02-07T00:00:00,Pregnancy in Adolescence,G08.686.785.760.769.494
18346665,2008-02-07T00:00:00,Program Evaluation,E05.337.820
18346665,2008-02-07T00:00:00,Program Evaluation,N04.761.685
18346665,2008-02-07T00:00:00,Program Evaluation,N05.715.360.650
18266737,2008-02-08T00:00:00,"Models, Theoretical",E05.599
18266737,2008-02-08T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18329085,2008-02-08T00:00:00,Amphetamine-Related Disorders,C21.739.225
18329085,2008-02-08T00:00:00,Amphetamine-Related Disorders,F03.900.225
18329085,2008-02-08T00:00:00,Animals,B01.050
18329085,2008-02-08T00:00:00,Methamphetamine,D02.092.471.683.152.619
18329085,2008-02-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18329085,2008-02-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18329085,2008-02-08T00:00:00,Reinforcement (Psychology),F02.463.425.770
18329085,2008-02-08T00:00:00,Self Administration,E02.319.890
18329085,2008-02-08T00:00:00,Self Administration,E02.900.890
18264728,2008-02-09T00:00:00,Adolescent,M01.060.057
18264728,2008-02-09T00:00:00,Adult,M01.060.116
18264728,2008-02-09T00:00:00,Age of Onset,N05.715.350.075.100
18264728,2008-02-09T00:00:00,Age of Onset,N06.850.490.250.100
18264728,2008-02-09T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18264728,2008-02-09T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18264728,2008-02-09T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18264728,2008-02-09T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18264728,2008-02-09T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18264728,2008-02-09T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18264728,2008-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18264728,2008-02-09T00:00:00,Mass Screening,E01.370.500
18264728,2008-02-09T00:00:00,Mass Screening,E05.318.308.250.580
18264728,2008-02-09T00:00:00,Mass Screening,N02.421.143.827.233.443
18264728,2008-02-09T00:00:00,Mass Screening,N02.421.726.233.443
18264728,2008-02-09T00:00:00,Mass Screening,N05.715.360.300.375.500
18264728,2008-02-09T00:00:00,Mass Screening,N06.850.520.308.250.580
18264728,2008-02-09T00:00:00,Mass Screening,N06.850.780.500
18264728,2008-02-09T00:00:00,Middle Aged,M01.060.116.630
18264728,2008-02-09T00:00:00,Risk Factors,E05.318.740.600.800.725
18264728,2008-02-09T00:00:00,Risk Factors,N05.715.350.200.700
18264728,2008-02-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18264728,2008-02-09T00:00:00,Risk Factors,N06.850.490.625.750
18264728,2008-02-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18264728,2008-02-09T00:00:00,Smoking,F01.145.466.753
18264728,2008-02-09T00:00:00,Smoking Cessation,F01.145.940.700
18264728,2008-02-09T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
18264728,2008-02-09T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
19220624,2008-02-10T00:00:00,Adolescent,M01.060.057
19220624,2008-02-10T00:00:00,Age Factors,N05.715.350.075
19220624,2008-02-10T00:00:00,Age Factors,N06.850.490.250
19220624,2008-02-10T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19220624,2008-02-10T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
19220624,2008-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19220624,2008-02-10T00:00:00,Mental Disorders,F03
19220624,2008-02-10T00:00:00,Parents,F01.829.263.500.320
19220624,2008-02-10T00:00:00,Parents,I01.880.225.500.340
19220624,2008-02-10T00:00:00,Parents,M01.620
19220624,2008-02-10T00:00:00,Prevalence,E05.318.308.985.525.750
19220624,2008-02-10T00:00:00,Prevalence,L01.280.975.525.750
19220624,2008-02-10T00:00:00,Prevalence,N01.224.935.597.750
19220624,2008-02-10T00:00:00,Prevalence,N06.850.505.400.975.525.750
19220624,2008-02-10T00:00:00,Prevalence,N06.850.520.308.985.525.750
19220624,2008-02-10T00:00:00,Psychiatric Status Rating Scales,F04.586
19220624,2008-02-10T00:00:00,Questionnaires,E05.318.308.750
19220624,2008-02-10T00:00:00,Questionnaires,L01.280.800
19220624,2008-02-10T00:00:00,Questionnaires,N05.715.360.300.695
19220624,2008-02-10T00:00:00,Questionnaires,N06.850.520.308.750
19220624,2008-02-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19220624,2008-02-10T00:00:00,Risk Factors,N05.715.350.200.700
19220624,2008-02-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19220624,2008-02-10T00:00:00,Risk Factors,N06.850.490.625.750
19220624,2008-02-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19220624,2008-02-10T00:00:00,Sex Factors,N05.715.350.675
19220624,2008-02-10T00:00:00,Sex Factors,N06.850.490.875
19220624,2008-02-10T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19220624,2008-02-10T00:00:00,"Stress, Psychological",F01.145.126.990
19220624,2008-02-10T00:00:00,"Stress, Psychological",F02.830.900
19220624,2008-02-10T00:00:00,United States,Z01.107.567.875
19220624,2008-02-10T00:00:00,Violence,I01.198.240.856
19220624,2008-02-10T00:00:00,Violence,I01.880.735.900
18267976,2008-02-11T00:00:00,Animals,B01.050
18267976,2008-02-11T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
18267976,2008-02-11T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18267976,2008-02-11T00:00:00,Mitochondria,A11.284.835.626
18267976,2008-02-11T00:00:00,Oxygen Consumption,G03.730
18267976,2008-02-11T00:00:00,RNA-Binding Proteins,D12.776.157.725
18267976,2008-02-11T00:00:00,RNA-Binding Proteins,D12.776.664.962
18267976,2008-02-11T00:00:00,Rabbits,B01.050.150.900.649.521.700
18267976,2008-02-11T00:00:00,Transcription Factors,D12.776.930
18270318,2008-02-12T00:00:00,Adenosine Triphosphatases,D08.811.277.040.025
18270318,2008-02-12T00:00:00,Animals,B01.050
18270318,2008-02-12T00:00:00,Cell Differentiation,G04.299.151
18270318,2008-02-12T00:00:00,Epithelial Cells,A11.436
18270318,2008-02-12T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
18270318,2008-02-12T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
18270318,2008-02-12T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
18270318,2008-02-12T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
18270318,2008-02-12T00:00:00,Rabbits,B01.050.150.900.649.521.700
18270318,2008-02-12T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18270318,2008-02-12T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18270318,2008-02-12T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18270318,2008-02-12T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18275990,2008-02-13T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18275990,2008-02-13T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18275990,2008-02-13T00:00:00,Cervical Intraepithelial Neoplasia,C04.557.470.200.240.250
18275990,2008-02-13T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18275990,2008-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18275990,2008-02-13T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
18275990,2008-02-13T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
18275990,2008-02-13T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
18275990,2008-02-13T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
18282235,2008-02-13T00:00:00,African Americans,M01.686.508.100.100
18282235,2008-02-13T00:00:00,African Americans,M01.686.754.100
18282235,2008-02-13T00:00:00,Aged,M01.060.116.100
18282235,2008-02-13T00:00:00,Breast Neoplasms,C04.588.180
18282235,2008-02-13T00:00:00,Breast Neoplasms,C17.800.090.500
18282235,2008-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18282235,2008-02-13T00:00:00,Middle Aged,M01.060.116.630
18282235,2008-02-13T00:00:00,"Stress, Psychological",F01.145.126.990
18282235,2008-02-13T00:00:00,"Stress, Psychological",F02.830.900
18282235,2008-02-13T00:00:00,Weight Gain,C23.888.144.243.926
18282235,2008-02-13T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
18282235,2008-02-13T00:00:00,Weight Loss,C23.888.144.243.963
18282235,2008-02-13T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18342804,2008-02-13T00:00:00,Drug Design,E05.295.500
18342804,2008-02-13T00:00:00,Drug Design,H01.158.703.007.675.500
18342804,2008-02-13T00:00:00,Drug Design,H01.181.466.675.500
18342804,2008-02-13T00:00:00,Energy Metabolism,G03.495.335
18342804,2008-02-13T00:00:00,"Monitoring, Physiologic",E01.370.520
18342804,2008-02-13T00:00:00,Oxygen Consumption,G03.730
18276844,2008-02-14T00:00:00,Animals,B01.050
18276844,2008-02-14T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18276844,2008-02-14T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18276844,2008-02-14T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18276844,2008-02-14T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18276844,2008-02-14T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18276844,2008-02-14T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18276844,2008-02-14T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18276844,2008-02-14T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18276844,2008-02-14T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18276844,2008-02-14T00:00:00,Cell Differentiation,G04.299.151
18276844,2008-02-14T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18276844,2008-02-14T00:00:00,Flow Cytometry,E05.200.500.386.350
18276844,2008-02-14T00:00:00,Gene Expression,G05.355.310
18276844,2008-02-14T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
18276844,2008-02-14T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
18276844,2008-02-14T00:00:00,Interleukin-15,D12.644.276.374.465.515
18276844,2008-02-14T00:00:00,Interleukin-15,D12.776.467.374.465.515
18276844,2008-02-14T00:00:00,Interleukin-15,D23.529.374.465.515
18276844,2008-02-14T00:00:00,Interleukin-2,D12.644.276.374.465.502
18276844,2008-02-14T00:00:00,Interleukin-2,D12.644.276.374.480.372
18276844,2008-02-14T00:00:00,Interleukin-2,D12.776.467.374.465.502
18276844,2008-02-14T00:00:00,Interleukin-2,D12.776.467.374.480.372
18276844,2008-02-14T00:00:00,Interleukin-2,D23.529.374.465.502
18276844,2008-02-14T00:00:00,Interleukin-2,D23.529.374.480.372
18276844,2008-02-14T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18276844,2008-02-14T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18276844,2008-02-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18276844,2008-02-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18276844,2008-02-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18276844,2008-02-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18276844,2008-02-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18276844,2008-02-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18276844,2008-02-14T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18276844,2008-02-14T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18276844,2008-02-14T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18276844,2008-02-14T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18276844,2008-02-14T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18276844,2008-02-14T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18240194,2008-02-15T00:00:00,Child,M01.060.406
18240194,2008-02-15T00:00:00,Chronic Disease,C23.550.291.500
18240194,2008-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18240194,2008-02-15T00:00:00,Pilot Projects,E05.318.760.750
18240194,2008-02-15T00:00:00,Pilot Projects,E05.337.737
18240194,2008-02-15T00:00:00,Pilot Projects,N05.715.360.775.625
18240194,2008-02-15T00:00:00,Pilot Projects,N06.850.520.450.720
18240194,2008-02-15T00:00:00,Skin,A17.815
18274825,2008-02-15T00:00:00,Adult,M01.060.116
18274825,2008-02-15T00:00:00,Aged,M01.060.116.100
18274825,2008-02-15T00:00:00,Aging,G07.700.320.124
18274825,2008-02-15T00:00:00,Attention,F02.830.104.214
18274825,2008-02-15T00:00:00,Auditory Cortex,A08.186.211.730.885.287.500.863.297
18274825,2008-02-15T00:00:00,Gyrus Cinguli,A08.186.211.464.330
18274825,2008-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18274825,2008-02-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18274825,2008-02-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18274825,2008-02-15T00:00:00,Middle Aged,M01.060.116.630
18274825,2008-02-15T00:00:00,Speech Perception,F02.463.593.071.875
18279929,2008-02-15T00:00:00,Aged,M01.060.116.100
18279929,2008-02-15T00:00:00,Gonadotropin-Releasing Hormone,D06.472.699.327.740.320
18279929,2008-02-15T00:00:00,Gonadotropin-Releasing Hormone,D12.644.400.400.740.320
18279929,2008-02-15T00:00:00,Gonadotropin-Releasing Hormone,D12.644.456.460
18279929,2008-02-15T00:00:00,Gonadotropin-Releasing Hormone,D12.644.548.365.740.320
18279929,2008-02-15T00:00:00,Gonadotropin-Releasing Hormone,D12.776.641.650.405.740.320
18279929,2008-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18279929,2008-02-15T00:00:00,Middle Aged,M01.060.116.630
18279929,2008-02-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18279929,2008-02-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
18279929,2008-02-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
18279929,2008-02-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
18279929,2008-02-15T00:00:00,Testosterone,D04.808.054.079.429.824
18279929,2008-02-15T00:00:00,Testosterone,D06.472.334.851.968.984
18279932,2008-02-15T00:00:00,Animals,B01.050
18279932,2008-02-15T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
18279932,2008-02-15T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
18279932,2008-02-15T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
18279932,2008-02-15T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
18279932,2008-02-15T00:00:00,Gene Expression,G05.355.310
18279932,2008-02-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18279932,2008-02-15T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18279932,2008-02-15T00:00:00,Urinary Bladder,A05.810.890
18322569,2008-02-15T00:00:00,"Education, Pharmacy",I02.358.525
18322569,2008-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18322569,2008-02-15T00:00:00,"Internship, Nonmedical",I02.358.750
18322569,2008-02-15T00:00:00,"Pharmacy Service, Hospital",N02.278.354.422.603
18322569,2008-02-15T00:00:00,"Pharmacy Service, Hospital",N02.421.668.556
18322569,2008-02-15T00:00:00,"Pharmacy Service, Hospital",N04.452.442.422.603
18322569,2008-02-15T00:00:00,Professional Competence,I02.399.630
18322569,2008-02-15T00:00:00,Questionnaires,E05.318.308.750
18322569,2008-02-15T00:00:00,Questionnaires,L01.280.800
18322569,2008-02-15T00:00:00,Questionnaires,N05.715.360.300.695
18322569,2008-02-15T00:00:00,Questionnaires,N06.850.520.308.750
18322569,2008-02-15T00:00:00,Self Concept,F01.752.747.792
18322569,2008-02-15T00:00:00,"Students, Pharmacy",I02.851.686.768
18322569,2008-02-15T00:00:00,"Students, Pharmacy",M01.848.769.768
18322569,2008-02-15T00:00:00,United States,Z01.107.567.875
18322577,2008-02-15T00:00:00,Curriculum,I02.158
18322577,2008-02-15T00:00:00,"Education, Pharmacy",I02.358.525
18322577,2008-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18322577,2008-02-15T00:00:00,Learning,F02.463.425
18322577,2008-02-15T00:00:00,Learning,F02.784.629.529
18322577,2008-02-15T00:00:00,"Students, Pharmacy",I02.851.686.768
18322577,2008-02-15T00:00:00,"Students, Pharmacy",M01.848.769.768
18322577,2008-02-15T00:00:00,Teaching,I02.903
18285552,2008-02-19T00:00:00,African Continental Ancestry Group,M01.686.508.100
18285552,2008-02-19T00:00:00,Aged,M01.060.116.100
18285552,2008-02-19T00:00:00,Attitude to Health,F01.100.150
18285552,2008-02-19T00:00:00,Attitude to Health,N05.300.150
18285552,2008-02-19T00:00:00,Blood Glucose,D09.546.359.448.500
18285552,2008-02-19T00:00:00,Diabetes Mellitus,C18.452.394.750
18285552,2008-02-19T00:00:00,Diabetes Mellitus,C19.246
18285552,2008-02-19T00:00:00,European Continental Ancestry Group,M01.686.508.400
18285552,2008-02-19T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
18285552,2008-02-19T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
18285552,2008-02-19T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
18285552,2008-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18285552,2008-02-19T00:00:00,Middle Aged,M01.060.116.630
18285552,2008-02-19T00:00:00,Physician-Patient Relations,F01.829.401.650.675
18285552,2008-02-19T00:00:00,Physician-Patient Relations,N05.300.660.625
18285552,2008-02-19T00:00:00,"Physicians, Family",M01.526.485.810.770
18285552,2008-02-19T00:00:00,"Physicians, Family",N02.360.810.770
18285552,2008-02-19T00:00:00,United States,Z01.107.567.875
18285560,2008-02-19T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18285560,2008-02-19T00:00:00,Cross Infection,C01.539.248
18285560,2008-02-19T00:00:00,Health Care Costs,N03.219.151.400
18285560,2008-02-19T00:00:00,Health Care Costs,N05.300.375
18285560,2008-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18285560,2008-02-19T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
18285560,2008-02-19T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
18285560,2008-02-19T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
18285560,2008-02-19T00:00:00,Staphylococcal Infections,C01.252.410.868
18285560,2008-02-19T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
18285560,2008-02-19T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
18285560,2008-02-19T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
18285817,2008-02-19T00:00:00,Endoscopy,E01.370.388.250
18285817,2008-02-19T00:00:00,Endoscopy,E04.800.250
18285817,2008-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18285817,2008-02-19T00:00:00,Middle Aged,M01.060.116.630
18285817,2008-02-19T00:00:00,Treatment Outcome,E01.789.800
18285817,2008-02-19T00:00:00,Treatment Outcome,N04.761.559.590.800
18285817,2008-02-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18286311,2008-02-20T00:00:00,Adsorption,G02.149.047
18286311,2008-02-20T00:00:00,Adsorption,G02.149.767.029
18286311,2008-02-20T00:00:00,Adsorption,G02.842.750.029
18286311,2008-02-20T00:00:00,Computer Simulation,L01.224.160
18286311,2008-02-20T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
18286311,2008-02-20T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
18287310,2008-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18287310,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18287310,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18287310,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18287310,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18287310,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18287310,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18287310,2008-02-20T00:00:00,Staphylococcal Infections,C01.252.410.868
18287310,2008-02-20T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
18287310,2008-02-20T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
18287310,2008-02-20T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
18289390,2008-02-20T00:00:00,Adult,M01.060.116
18289390,2008-02-20T00:00:00,Aged,M01.060.116.100
18289390,2008-02-20T00:00:00,Bone Marrow Cells,A11.148
18289390,2008-02-20T00:00:00,Bone Marrow Cells,A15.378.316
18289390,2008-02-20T00:00:00,Breast Neoplasms,C04.588.180
18289390,2008-02-20T00:00:00,Breast Neoplasms,C17.800.090.500
18289390,2008-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18289390,2008-02-20T00:00:00,Lymph Nodes,A10.549.400
18289390,2008-02-20T00:00:00,Lymph Nodes,A15.382.520.604.412
18289390,2008-02-20T00:00:00,Middle Aged,M01.060.116.630
18289390,2008-02-20T00:00:00,Neoplasm Proteins,D12.776.624
18289390,2008-02-20T00:00:00,"RNA, Messenger",D13.444.735.544
18346726,2008-02-20T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
18346726,2008-02-20T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
18346726,2008-02-20T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
18346726,2008-02-20T00:00:00,Animals,B01.050
18346726,2008-02-20T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18346726,2008-02-20T00:00:00,Energy Metabolism,G03.495.335
18346726,2008-02-20T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18346726,2008-02-20T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18346726,2008-02-20T00:00:00,Gene Expression Profiling,E05.393.332
18346726,2008-02-20T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
18346726,2008-02-20T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18346726,2008-02-20T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18346726,2008-02-20T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18346726,2008-02-20T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18346726,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18346726,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18346726,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18346726,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18346726,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18346726,2008-02-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18346726,2008-02-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18346726,2008-02-20T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
18346726,2008-02-20T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
18346726,2008-02-20T00:00:00,"Transcription, Genetic",G02.111.087.847
18346726,2008-02-20T00:00:00,"Transcription, Genetic",G02.149.115.847
18346726,2008-02-20T00:00:00,"Transcription, Genetic",G05.355.310.700
18294225,2008-02-21T00:00:00,Animals,B01.050
18294225,2008-02-21T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
18294225,2008-02-21T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
18294225,2008-02-21T00:00:00,Cell Adhesion Molecules,D23.050.301.350
18294225,2008-02-21T00:00:00,"Embryo, Nonmammalian",A13.350
18294225,2008-02-21T00:00:00,"Embryo, Nonmammalian",A16.331
18294225,2008-02-21T00:00:00,Heart,A07.541
18294225,2008-02-21T00:00:00,Heart Valves,A07.541.510
18294225,2008-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18294225,2008-02-21T00:00:00,Pericardium,A07.541.795
18294225,2008-02-21T00:00:00,Pericardium,A10.615.789.470
18294804,2008-02-21T00:00:00,Adult,M01.060.116
18294804,2008-02-21T00:00:00,Community Mental Health Services,F04.408.307
18294804,2008-02-21T00:00:00,Community Mental Health Services,N02.421.143.183
18294804,2008-02-21T00:00:00,Community Mental Health Services,N02.421.461.232
18294804,2008-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18294804,2008-02-21T00:00:00,Middle Aged,M01.060.116.630
18294804,2008-02-21T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18294804,2008-02-21T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
18294804,2008-02-21T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
18294804,2008-02-21T00:00:00,Substance-Related Disorders,C21.739
18294804,2008-02-21T00:00:00,Substance-Related Disorders,F03.900
18294804,2008-02-21T00:00:00,Treatment Outcome,E01.789.800
18294804,2008-02-21T00:00:00,Treatment Outcome,N04.761.559.590.800
18294804,2008-02-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18343358,2008-02-21T00:00:00,Animals,B01.050
18343358,2008-02-21T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18343358,2008-02-21T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18343358,2008-02-21T00:00:00,Motor Activity,F01.145.632
18343358,2008-02-21T00:00:00,Motor Activity,G11.427.590.530.698
18343358,2008-02-21T00:00:00,Neuropeptides,D12.644.400
18343358,2008-02-21T00:00:00,Neuropeptides,D12.776.641.650
18343358,2008-02-21T00:00:00,Periodicity,G01.910.645
18343358,2008-02-21T00:00:00,Periodicity,G07.180.562
18343358,2008-02-21T00:00:00,Signal Transduction,G02.111.087.800
18343358,2008-02-21T00:00:00,Signal Transduction,G02.149.115.800
18343358,2008-02-21T00:00:00,Signal Transduction,G04.299.880
18343358,2008-02-21T00:00:00,Temperature,G01.906.595
18343358,2008-02-21T00:00:00,Temperature,G16.500.275.063.725.710
18343358,2008-02-21T00:00:00,Temperature,G16.500.750.775.710
18343358,2008-02-21T00:00:00,Temperature,N06.230.150.450
18343358,2008-02-21T00:00:00,Temperature,N06.230.300.100.725.710
18296617,2008-02-22T00:00:00,Animals,B01.050
18296617,2008-02-22T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
18296617,2008-02-22T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
18296617,2008-02-22T00:00:00,Cell Adhesion Molecules,D23.050.301.350
18296617,2008-02-22T00:00:00,Cell Differentiation,G04.299.151
18296617,2008-02-22T00:00:00,Cell Proliferation,G04.299.233.750
18296617,2008-02-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18296617,2008-02-22T00:00:00,Endocardium,A07.541.207
18296617,2008-02-22T00:00:00,Extracellular Matrix,A11.284.295.310
18296617,2008-02-22T00:00:00,Fibroblasts,A11.329.228
18296617,2008-02-22T00:00:00,Fibroblasts,A11.872.228
18296617,2008-02-22T00:00:00,Mesoderm,A16.504.660
18296617,2008-02-22T00:00:00,Myocardium,A02.633.580
18296617,2008-02-22T00:00:00,Myocardium,A07.541.704
18296617,2008-02-22T00:00:00,Myocardium,A10.690.552.750
18296617,2008-02-22T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18296617,2008-02-22T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18296617,2008-02-22T00:00:00,"Myocytes, Cardiac",A11.620.500
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18296617,2008-02-22T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18296659,2008-02-22T00:00:00,Animals,B01.050
18296659,2008-02-22T00:00:00,Carrier Proteins,D12.776.157
18296659,2008-02-22T00:00:00,Eye Proteins,D12.776.306
18296659,2008-02-22T00:00:00,Retinal Degeneration,C11.768.585
18296659,2008-02-22T00:00:00,Retinaldehyde,D02.047.850
18296659,2008-02-22T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
18296659,2008-02-22T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
18296659,2008-02-22T00:00:00,Retinaldehyde,D02.455.849.131.495.690
18296659,2008-02-22T00:00:00,Retinaldehyde,D23.767.261.700.690
18297428,2008-02-24T00:00:00,Azacitidine,D02.145.150
18297428,2008-02-24T00:00:00,Azacitidine,D03.383.742.680.245.217
18297428,2008-02-24T00:00:00,Azacitidine,D13.570.685.245.217
18297428,2008-02-24T00:00:00,Azacitidine,D13.570.800.286.300
18297428,2008-02-24T00:00:00,Breast Neoplasms,C04.588.180
18297428,2008-02-24T00:00:00,Breast Neoplasms,C17.800.090.500
18297428,2008-02-24T00:00:00,Carcinoma,C04.557.470.200
18297428,2008-02-24T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18297428,2008-02-24T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18297428,2008-02-24T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18297428,2008-02-24T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18297428,2008-02-24T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18297428,2008-02-24T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18297428,2008-02-24T00:00:00,DNA Methylation,G02.111.087.029.538.161
18297428,2008-02-24T00:00:00,DNA Methylation,G02.111.087.218
18297428,2008-02-24T00:00:00,DNA Methylation,G02.149.115.029.538.161
18297428,2008-02-24T00:00:00,DNA Methylation,G02.149.115.218
18297428,2008-02-24T00:00:00,DNA Methylation,G03.495.130.538.161
18297428,2008-02-24T00:00:00,DNA Methylation,G05.355.190
18297428,2008-02-24T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18297428,2008-02-24T00:00:00,"Genes, p53",G05.360.340.024.340.375.249.385
18297428,2008-02-24T00:00:00,"Genes, p53",G05.360.340.024.340.415.400.385
18297428,2008-02-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18297428,2008-02-24T00:00:00,Neoplasm Proteins,D12.776.624
18297428,2008-02-24T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18297428,2008-02-24T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18297428,2008-02-24T00:00:00,Prostatic Neoplasms,C12.294.260.750
18297428,2008-02-24T00:00:00,Prostatic Neoplasms,C12.294.565.625
18297428,2008-02-24T00:00:00,Prostatic Neoplasms,C12.758.409.750
18297428,2008-02-24T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18297428,2008-02-24T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
18297428,2008-02-24T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
18297428,2008-02-24T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
18297428,2008-02-24T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
18312399,2008-02-24T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
18312399,2008-02-24T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
18312399,2008-02-24T00:00:00,Chlorine,D01.268.380.150
18312399,2008-02-24T00:00:00,Chlorine,D01.362.225
18312399,2008-02-24T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
18312399,2008-02-24T00:00:00,Geologic Sediments,G01.311.500
18312399,2008-02-24T00:00:00,Geologic Sediments,G16.500.320
18312399,2008-02-24T00:00:00,Molecular Sequence Data,L01.453.245.667
18312399,2008-02-24T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
18312399,2008-02-24T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
18312399,2008-02-24T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18312399,2008-02-24T00:00:00,Rivers,G01.311.750
18312399,2008-02-24T00:00:00,Rivers,G16.500.275.280.500
18312399,2008-02-24T00:00:00,Rivers,N06.230.232.500
18312399,2008-02-24T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
18367789,2008-02-25T00:00:00,Algorithms,G17.035
18367789,2008-02-25T00:00:00,Algorithms,L01.224.050
18367789,2008-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18367789,2008-02-25T00:00:00,Melanoma,C04.557.465.625.650.510
18367789,2008-02-25T00:00:00,Melanoma,C04.557.580.625.650.510
18367789,2008-02-25T00:00:00,Melanoma,C04.557.665.510
18367789,2008-02-25T00:00:00,Monte Carlo Method,E05.318.740.525
18367789,2008-02-25T00:00:00,Monte Carlo Method,L01.906.575.422
18367789,2008-02-25T00:00:00,Monte Carlo Method,N05.715.360.750.540
18367789,2008-02-25T00:00:00,Monte Carlo Method,N06.850.520.830.525
18367789,2008-02-25T00:00:00,Protons,D01.248.497.300.459.700
18367789,2008-02-25T00:00:00,Protons,D01.435.550
18367789,2008-02-25T00:00:00,Protons,G01.249.765
18367789,2008-02-25T00:00:00,Radiation Dosage,E05.799.513
18367789,2008-02-25T00:00:00,Radiation Dosage,G01.201.875.740
18367789,2008-02-25T00:00:00,Radiation Dosage,N06.850.810.250
18367789,2008-02-25T00:00:00,Radiotherapy Dosage,E02.815.639
18367789,2008-02-25T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
18367789,2008-02-25T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
18367789,2008-02-25T00:00:00,Uveal Neoplasms,C04.588.364.978
18367789,2008-02-25T00:00:00,Uveal Neoplasms,C11.319.494
18367789,2008-02-25T00:00:00,Uveal Neoplasms,C11.941.855
18661045,2008-02-25T00:00:00,Animals,B01.050
18661045,2008-02-25T00:00:00,Heart,A07.541
18661045,2008-02-25T00:00:00,Retinoids,D02.455.326.271.665.202.495
18661045,2008-02-25T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
18661045,2008-02-25T00:00:00,Retinoids,D02.455.849.131.495
18661045,2008-02-25T00:00:00,Retinoids,D23.767.261.700
18661045,2008-02-25T00:00:00,Signal Transduction,G02.111.087.800
18661045,2008-02-25T00:00:00,Signal Transduction,G02.149.115.800
18661045,2008-02-25T00:00:00,Signal Transduction,G04.299.880
18299939,2008-02-26T00:00:00,Adult,M01.060.116
18299939,2008-02-26T00:00:00,African Americans,M01.686.508.100.100
18299939,2008-02-26T00:00:00,African Americans,M01.686.754.100
18299939,2008-02-26T00:00:00,Aged,M01.060.116.100
18299939,2008-02-26T00:00:00,Delivery of Health Care,N04.590.374
18299939,2008-02-26T00:00:00,Delivery of Health Care,N05.300
18299939,2008-02-26T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18299939,2008-02-26T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18299939,2008-02-26T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18299939,2008-02-26T00:00:00,European Continental Ancestry Group,M01.686.508.400
18299939,2008-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18299939,2008-02-26T00:00:00,Middle Aged,M01.060.116.630
18299939,2008-02-26T00:00:00,Patient Satisfaction,N04.452.822.360.600
18299939,2008-02-26T00:00:00,Patient Satisfaction,N05.300.150.600.630
18299939,2008-02-26T00:00:00,Patient Satisfaction,N05.715.360.600
18299939,2008-02-26T00:00:00,Primary Health Care,N04.590.233.727
18299939,2008-02-26T00:00:00,Quality of Health Care,N04.761
18299939,2008-02-26T00:00:00,Quality of Health Care,N05.715
18303083,2008-02-26T00:00:00,Aged,M01.060.116.100
18303083,2008-02-26T00:00:00,Gene Expression Profiling,E05.393.332
18303083,2008-02-26T00:00:00,Gene Expression Regulation,G05.355.315
18303083,2008-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18303083,2008-02-26T00:00:00,Myocardium,A02.633.580
18303083,2008-02-26T00:00:00,Myocardium,A07.541.704
18303083,2008-02-26T00:00:00,Myocardium,A10.690.552.750
18303083,2008-02-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18303083,2008-02-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18303083,2008-02-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18303083,2008-02-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18303083,2008-02-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18303083,2008-02-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18303083,2008-02-26T00:00:00,Sex Characteristics,G08.686.815
18377870,2008-02-26T00:00:00,Animals,B01.050
18377870,2008-02-26T00:00:00,Apoptosis,G04.299.139.160
18377870,2008-02-26T00:00:00,Cell Line,A11.251.210
18377870,2008-02-26T00:00:00,Cell Survival,G04.299.316
18377870,2008-02-26T00:00:00,Protein Kinases,D08.811.913.696.620.682
18377870,2008-02-26T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18377870,2008-02-26T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18377870,2008-02-26T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18377870,2008-02-26T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18377870,2008-02-26T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
18377870,2008-02-26T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
18377870,2008-02-26T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
18377870,2008-02-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18301984,2008-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18301984,2008-02-27T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
18301984,2008-02-27T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
18301984,2008-02-27T00:00:00,Middle Aged,M01.060.116.630
18301984,2008-02-27T00:00:00,Multiple Organ Failure,C23.550.835.525
18301984,2008-02-27T00:00:00,Pain,C10.597.617
18301984,2008-02-27T00:00:00,Pain,C23.888.592.612
18301984,2008-02-27T00:00:00,Pain,C23.888.646
18301984,2008-02-27T00:00:00,Pain,F02.830.816.444
18301984,2008-02-27T00:00:00,Pain,G11.561.600.810.444
18301984,2008-02-27T00:00:00,Palliative Care,E02.760.666
18301984,2008-02-27T00:00:00,Palliative Care,N02.421.585.666
18301984,2008-02-27T00:00:00,Radiation Dosage,E05.799.513
18301984,2008-02-27T00:00:00,Radiation Dosage,G01.201.875.740
18301984,2008-02-27T00:00:00,Radiation Dosage,N06.850.810.250
18301984,2008-02-27T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
18301984,2008-02-27T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
18301984,2008-02-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18301984,2008-02-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18301984,2008-02-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18301984,2008-02-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18301984,2008-02-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18301984,2008-02-27T00:00:00,Treatment Outcome,E01.789.800
18301984,2008-02-27T00:00:00,Treatment Outcome,N04.761.559.590.800
18301984,2008-02-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18305138,2008-02-27T00:00:00,Adult,M01.060.116
18305138,2008-02-27T00:00:00,African Americans,M01.686.508.100.100
18305138,2008-02-27T00:00:00,African Americans,M01.686.754.100
18305138,2008-02-27T00:00:00,"Cholesterol, HDL",D10.532.432.400
18305138,2008-02-27T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
18305138,2008-02-27T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
18305138,2008-02-27T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18305138,2008-02-27T00:00:00,Genetic Predisposition to Disease,G05.380.355
18305138,2008-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18305138,2008-02-27T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
18305138,2008-02-27T00:00:00,Metabolic Syndrome X,C18.452.625
18305138,2008-02-27T00:00:00,Middle Aged,M01.060.116.630
18305138,2008-02-27T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18305138,2008-02-27T00:00:00,United States,Z01.107.567.875
18306052,2008-02-28T00:00:00,Adult,M01.060.116
18306052,2008-02-28T00:00:00,Clinical Competence,I02.399.630.210
18306052,2008-02-28T00:00:00,Clinical Competence,N04.761.210
18306052,2008-02-28T00:00:00,Educational Measurement,I02.399
18306052,2008-02-28T00:00:00,Family Practice,H02.403.280
18306052,2008-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18306052,2008-02-28T00:00:00,Internship and Residency,I02.358.399.644
18306052,2008-02-28T00:00:00,Patient Satisfaction,N04.452.822.360.600
18306052,2008-02-28T00:00:00,Patient Satisfaction,N05.300.150.600.630
18306052,2008-02-28T00:00:00,Patient Satisfaction,N05.715.360.600
18306052,2008-02-28T00:00:00,Pilot Projects,E05.318.760.750
18306052,2008-02-28T00:00:00,Pilot Projects,E05.337.737
18306052,2008-02-28T00:00:00,Pilot Projects,N05.715.360.775.625
18306052,2008-02-28T00:00:00,Pilot Projects,N06.850.520.450.720
18306052,2008-02-28T00:00:00,Questionnaires,E05.318.308.750
18306052,2008-02-28T00:00:00,Questionnaires,L01.280.800
18306052,2008-02-28T00:00:00,Questionnaires,N05.715.360.300.695
18306052,2008-02-28T00:00:00,Questionnaires,N06.850.520.308.750
18306052,2008-02-28T00:00:00,Workplace,N01.824.245.925
18306052,2008-02-28T00:00:00,Workplace,N04.452.677.975
18308952,2008-02-28T00:00:00,Adolescent,M01.060.057
18308952,2008-02-28T00:00:00,Adult,M01.060.116
18308952,2008-02-28T00:00:00,Health Promotion,N02.370
18308952,2008-02-28T00:00:00,Health Promotion,N02.421.726.507
18308952,2008-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18308952,2008-02-28T00:00:00,Middle Aged,M01.060.116.630
18308952,2008-02-28T00:00:00,New York,Z01.107.567.875.075.437
18308952,2008-02-28T00:00:00,New York,Z01.107.567.875.350.530
18308952,2008-02-28T00:00:00,New York,Z01.107.567.875.500.530
18308952,2008-02-28T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18308952,2008-02-28T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18308952,2008-02-28T00:00:00,Postal Service,I01.451.617
18308952,2008-02-28T00:00:00,Smoking Cessation,F01.145.940.700
18307038,2008-02-29T00:00:00,Adult,M01.060.116
18307038,2008-02-29T00:00:00,Animals,B01.050
18307038,2008-02-29T00:00:00,Brain,A08.186.211
18307038,2008-02-29T00:00:00,Hippocampus,A08.186.211.464.405
18307038,2008-02-29T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
18307038,2008-02-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18307038,2008-02-29T00:00:00,Mental Disorders,F03
18307038,2008-02-29T00:00:00,Molecular Sequence Data,L01.453.245.667
18307038,2008-02-29T00:00:00,Proteome,D12.776.817
18307038,2008-02-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18307038,2008-02-29T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18307038,2008-02-29T00:00:00,"Stress, Psychological",F01.145.126.990
18307038,2008-02-29T00:00:00,"Stress, Psychological",F02.830.900
18312436,2008-02-29T00:00:00,Biological Markers,D23.101
18312436,2008-02-29T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18312436,2008-02-29T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18312436,2008-02-29T00:00:00,Down-Regulation,G02.111.087.225
18312436,2008-02-29T00:00:00,Down-Regulation,G02.149.115.225
18312436,2008-02-29T00:00:00,Down-Regulation,G05.355.315.200
18312436,2008-02-29T00:00:00,Down-Regulation,G07.690.812.230
18312436,2008-02-29T00:00:00,Down-Regulation,G07.700.680.230
18312436,2008-02-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18312436,2008-02-29T00:00:00,Skin,A17.815
18312436,2008-02-29T00:00:00,Skin Neoplasms,C04.588.805
18312436,2008-02-29T00:00:00,Skin Neoplasms,C17.800.882
18374917,2008-02-29T00:00:00,Apoptosis,G04.299.139.160
18374917,2008-02-29T00:00:00,Ceramides,D02.065.313
18374917,2008-02-29T00:00:00,Ceramides,D09.400.410.420.525.200
18374917,2008-02-29T00:00:00,Ceramides,D10.390.470.675.200
18374917,2008-02-29T00:00:00,Ceramides,D10.570.877.360.612.200
18374917,2008-02-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18374917,2008-02-29T00:00:00,Membrane Proteins,D12.776.543
18374917,2008-02-29T00:00:00,Nerve Tissue Proteins,D12.776.641
18374917,2008-02-29T00:00:00,Photosensitizing Agents,D27.505.696.750.710
18374917,2008-02-29T00:00:00,Photosensitizing Agents,D27.505.954.444.600
18374917,2008-02-29T00:00:00,RNA Interference,G05.355.315.203.374.790
17557363,2008-03-01T00:00:00,Contrast Media,D27.720.259
17557363,2008-03-01T00:00:00,Gadolinium DTPA,D01.632.400
17557363,2008-03-01T00:00:00,Gadolinium DTPA,D02.092.782.590.401
17557363,2008-03-01T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
17557363,2008-03-01T00:00:00,Gadolinium DTPA,D02.691.400
17557363,2008-03-01T00:00:00,Hemodynamics,G09.330.190.400
17557363,2008-03-01T00:00:00,Hemodynamics,G09.330.380
17557363,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17557363,2008-03-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17557363,2008-03-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17557363,2008-03-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17557363,2008-03-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17557363,2008-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17557363,2008-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17557363,2008-03-01T00:00:00,"Models, Theoretical",E05.599
17557363,2008-03-01T00:00:00,Spinal Cord,A08.186.854
17593426,2008-03-01T00:00:00,Adult,M01.060.116
17593426,2008-03-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
17593426,2008-03-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
17593426,2008-03-01T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
17593426,2008-03-01T00:00:00,Carotid Artery Diseases,C14.907.253.123
17593426,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17593426,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
17593426,2008-03-01T00:00:00,Polytetrafluoroethylene,D05.750.395.616
17593426,2008-03-01T00:00:00,Polytetrafluoroethylene,D25.720.395.616
17593426,2008-03-01T00:00:00,Polytetrafluoroethylene,J01.637.051.720.395.616
17593426,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17593426,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17593426,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17593426,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17593426,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17593426,2008-03-01T00:00:00,"Ultrasonography, Doppler, Color",E01.370.350.850.850.850.850
17786913,2008-03-01T00:00:00,Carbon,D01.268.150
17786913,2008-03-01T00:00:00,Computer Simulation,L01.224.160
17786913,2008-03-01T00:00:00,Hot Temperature,G01.906.595.543
17786913,2008-03-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
17786913,2008-03-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
17786913,2008-03-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
17786913,2008-03-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
17786913,2008-03-01T00:00:00,"Models, Chemical",E05.599.495
17786913,2008-03-01T00:00:00,Pressure,G01.374.715
17957708,2008-03-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
17957708,2008-03-01T00:00:00,Animals,B01.050
17957708,2008-03-01T00:00:00,Oogenesis,G04.299.151.650.249
17957708,2008-03-01T00:00:00,Oogenesis,G08.686.785.760.310.500
17957708,2008-03-01T00:00:00,Ovary,A05.360.319.114.630
17957708,2008-03-01T00:00:00,Ovary,A05.360.576.497
17957708,2008-03-01T00:00:00,Ovary,A06.407.312.497
18085433,2008-03-01T00:00:00,Child,M01.060.406
18085433,2008-03-01T00:00:00,Child Health Services,N02.421.143.130
18085433,2008-03-01T00:00:00,Community Mental Health Services,F04.408.307
18085433,2008-03-01T00:00:00,Community Mental Health Services,N02.421.143.183
18085433,2008-03-01T00:00:00,Community Mental Health Services,N02.421.461.232
18085433,2008-03-01T00:00:00,Diffusion of Innovation,L01.143.320
18085433,2008-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
18085433,2008-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18085433,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18085433,2008-03-01T00:00:00,Mental Disorders,F03
18085433,2008-03-01T00:00:00,United States,Z01.107.567.875
18223498,2008-03-01T00:00:00,Adolescent,M01.060.057
18223498,2008-03-01T00:00:00,Adult,M01.060.116
18223498,2008-03-01T00:00:00,Aged,M01.060.116.100
18223498,2008-03-01T00:00:00,Deglutition,G10.261.326.215
18223498,2008-03-01T00:00:00,Esophagus,A03.556.875.500
18223498,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18223498,2008-03-01T00:00:00,Manometry,E05.559
18223498,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18223498,2008-03-01T00:00:00,Pressure,G01.374.715
18246575,2008-03-01T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
18246575,2008-03-01T00:00:00,Microfluidic Analytical Techniques,E05.588.465
18246575,2008-03-01T00:00:00,Nanotechnology,H01.603
18246575,2008-03-01T00:00:00,Nanotechnology,J01.897.520.600
18269381,2008-03-01T00:00:00,Animals,B01.050
18269381,2008-03-01T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
18269381,2008-03-01T00:00:00,Naltrexone,D03.132.577.249.706.550
18269381,2008-03-01T00:00:00,Naltrexone,D03.549.686.750.550
18269381,2008-03-01T00:00:00,Naltrexone,D03.605.497.750.550
18269381,2008-03-01T00:00:00,Naltrexone,D04.615.723.795.706.550
18269381,2008-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18269381,2008-03-01T00:00:00,Taurine,D02.455.326.146.100.850
18269381,2008-03-01T00:00:00,Taurine,D02.886.645.600.055.850
18278988,2008-03-01T00:00:00,Adolescent,M01.060.057
18278988,2008-03-01T00:00:00,Adult,M01.060.116
18278988,2008-03-01T00:00:00,Aged,M01.060.116.100
18278988,2008-03-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18278988,2008-03-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
18278988,2008-03-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
18278988,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18278988,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18278988,2008-03-01T00:00:00,Psychiatric Status Rating Scales,F04.586
18278988,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
18278988,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18278988,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18281589,2008-03-01T00:00:00,Age Factors,N05.715.350.075
18281589,2008-03-01T00:00:00,Age Factors,N06.850.490.250
18281589,2008-03-01T00:00:00,Aging,G07.700.320.124
18281589,2008-03-01T00:00:00,Animals,B01.050
18281589,2008-03-01T00:00:00,Body Weight,C23.888.144
18281589,2008-03-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
18281589,2008-03-01T00:00:00,Body Weight,E05.041.124.160.750
18281589,2008-03-01T00:00:00,Body Weight,G07.100.100.160.120
18281589,2008-03-01T00:00:00,Body Weight,G07.700.320.249.314.120
18281589,2008-03-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18281589,2008-03-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18281589,2008-03-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
18281589,2008-03-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
18281589,2008-03-01T00:00:00,Poultry Diseases,C22.131.728
18281591,2008-03-01T00:00:00,Animals,B01.050
18281591,2008-03-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18281591,2008-03-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18281591,2008-03-01T00:00:00,Dietary Supplements,J02.500.456
18281591,2008-03-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
18281591,2008-03-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
18281591,2008-03-01T00:00:00,Poultry Diseases,C22.131.728
18287449,2008-03-01T00:00:00,Bias (Epidemiology),N05.715.350.150
18287449,2008-03-01T00:00:00,Bias (Epidemiology),N06.850.490.500
18287449,2008-03-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18287449,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18287449,2008-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18287449,2008-03-01T00:00:00,Lung Neoplasms,C08.381.540
18287449,2008-03-01T00:00:00,Lung Neoplasms,C08.785.520
18287449,2008-03-01T00:00:00,Mass Screening,E01.370.500
18287449,2008-03-01T00:00:00,Mass Screening,E05.318.308.250.580
18287449,2008-03-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18287449,2008-03-01T00:00:00,Mass Screening,N02.421.726.233.443
18287449,2008-03-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18287449,2008-03-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18287449,2008-03-01T00:00:00,Mass Screening,N06.850.780.500
18287449,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18287449,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18287449,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18287449,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18287449,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18287449,2008-03-01T00:00:00,United States,Z01.107.567.875
18294022,2008-03-01T00:00:00,Adolescent,M01.060.057
18294022,2008-03-01T00:00:00,Adult,M01.060.116
18294022,2008-03-01T00:00:00,Aged,M01.060.116.100
18294022,2008-03-01T00:00:00,Cognition Disorders,F03.087.250
18294022,2008-03-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18294022,2008-03-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18294022,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18294022,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18294022,2008-03-01T00:00:00,Neuropsychological Tests,F04.711.513
18294022,2008-03-01T00:00:00,Questionnaires,E05.318.308.750
18294022,2008-03-01T00:00:00,Questionnaires,L01.280.800
18294022,2008-03-01T00:00:00,Questionnaires,N05.715.360.300.695
18294022,2008-03-01T00:00:00,Questionnaires,N06.850.520.308.750
18294022,2008-03-01T00:00:00,Remission Induction,E02.860
18294022,2008-03-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
18294022,2008-03-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
18294022,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
18294022,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18294022,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18294512,2008-03-01T00:00:00,Animals,B01.050
18294512,2008-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18294512,2008-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18294512,2008-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18294512,2008-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18294512,2008-03-01T00:00:00,Esophagus,A03.556.875.500
18294512,2008-03-01T00:00:00,Pericardium,A07.541.795
18294512,2008-03-01T00:00:00,Pericardium,A10.615.789.470
18294512,2008-03-01T00:00:00,Pilot Projects,E05.318.760.750
18294512,2008-03-01T00:00:00,Pilot Projects,E05.337.737
18294512,2008-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
18294512,2008-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
18294512,2008-03-01T00:00:00,Swine,B01.050.150.900.649.077.880
18295078,2008-03-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
18295078,2008-03-01T00:00:00,Graft Rejection,G12.425.901.545.328
18295078,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18295078,2008-03-01T00:00:00,Kidney Diseases,C12.777.419
18295078,2008-03-01T00:00:00,Kidney Diseases,C13.351.968.419
18295078,2008-03-01T00:00:00,Kidney Transplantation,E02.870.500
18295078,2008-03-01T00:00:00,Kidney Transplantation,E04.936.450.485
18295078,2008-03-01T00:00:00,Kidney Transplantation,E04.950.774.400
18299428,2008-03-01T00:00:00,Animals,B01.050
18299428,2008-03-01T00:00:00,Gene Deletion,G05.355.600.800.320
18299428,2008-03-01T00:00:00,Gene Deletion,G05.365.590.762.320
18299428,2008-03-01T00:00:00,Insulin,D06.472.699.587.740.625
18299428,2008-03-01T00:00:00,Insulin,D12.644.548.586.740.625
18299428,2008-03-01T00:00:00,"Models, Animal",E05.598
18299428,2008-03-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18299428,2008-03-01T00:00:00,Peptide Fragments,D12.644.541
18299428,2008-03-01T00:00:00,Pregnancy,G08.686.785.760.769
18299428,2008-03-01T00:00:00,Proteins,D12.776
18299428,2008-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18299428,2008-03-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18299428,2008-03-01T00:00:00,Signal Transduction,G02.111.087.800
18299428,2008-03-01T00:00:00,Signal Transduction,G02.149.115.800
18299428,2008-03-01T00:00:00,Signal Transduction,G04.299.880
18299428,2008-03-01T00:00:00,Testis,A05.360.444.849
18299428,2008-03-01T00:00:00,Testis,A05.360.576.782
18299428,2008-03-01T00:00:00,Testis,A06.407.312.782
18299768,2008-03-01T00:00:00,Adolescent,M01.060.057
18299768,2008-03-01T00:00:00,Adult,M01.060.116
18299768,2008-03-01T00:00:00,Alcohol Drinking,F01.145.317.269
18299768,2008-03-01T00:00:00,Alcohol-Related Disorders,C21.739.100
18299768,2008-03-01T00:00:00,Alcohol-Related Disorders,F03.900.100
18299768,2008-03-01T00:00:00,Employment,N01.824.245
18299768,2008-03-01T00:00:00,Health Surveys,E05.318.308.250
18299768,2008-03-01T00:00:00,Health Surveys,N05.715.360.300.375
18299768,2008-03-01T00:00:00,Health Surveys,N06.850.520.308.250
18299768,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18299768,2008-03-01T00:00:00,Rural Population,N01.600.725
18299768,2008-03-01T00:00:00,United States,Z01.107.567.875
18299768,2008-03-01T00:00:00,Urban Population,N01.600.900
18301269,2008-03-01T00:00:00,Enteral Nutrition,E02.421.360
18301269,2008-03-01T00:00:00,Enteral Nutrition,E02.642.500.360
18301269,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18301269,2008-03-01T00:00:00,Malnutrition,C18.654.521
18301269,2008-03-01T00:00:00,Metabolic Diseases,C18.452
18301269,2008-03-01T00:00:00,Wound Healing,G16.100.856.891
18304055,2008-03-01T00:00:00,Animals,B01.050
18304055,2008-03-01T00:00:00,Brain Ischemia,C10.228.140.300.150
18304055,2008-03-01T00:00:00,Brain Ischemia,C14.907.253.092
18304055,2008-03-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
18304055,2008-03-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
18304055,2008-03-01T00:00:00,Nitric Oxide,D01.339.387
18304055,2008-03-01T00:00:00,Nitric Oxide,D01.625.550.500
18304055,2008-03-01T00:00:00,Nitric Oxide,D01.625.700.500
18304055,2008-03-01T00:00:00,Nitric Oxide,D01.650.550.587.600
18304055,2008-03-01T00:00:00,Oligopeptides,D12.644.456
18307624,2008-03-01T00:00:00,Animals,B01.050
18307624,2008-03-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
18307624,2008-03-01T00:00:00,Catheter Ablation,E02.148.110
18307624,2008-03-01T00:00:00,Catheter Ablation,E02.148.442.110
18307624,2008-03-01T00:00:00,Catheter Ablation,E02.154.402.110
18307624,2008-03-01T00:00:00,Catheter Ablation,E04.014.170.402.110
18307624,2008-03-01T00:00:00,Cryosurgery,E04.014.180
18307624,2008-03-01T00:00:00,Heart,A07.541
18307624,2008-03-01T00:00:00,Myocardium,A02.633.580
18307624,2008-03-01T00:00:00,Myocardium,A07.541.704
18307624,2008-03-01T00:00:00,Myocardium,A10.690.552.750
18307624,2008-03-01T00:00:00,Swine,B01.050.150.900.649.077.880
18308998,2008-03-01T00:00:00,Graft Rejection,G12.425.901.545.328
18308998,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18308998,2008-03-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18308998,2008-03-01T00:00:00,Kidney Transplantation,E02.870.500
18308998,2008-03-01T00:00:00,Kidney Transplantation,E04.936.450.485
18308998,2008-03-01T00:00:00,Kidney Transplantation,E04.950.774.400
18310704,2008-03-01T00:00:00,Adolescent,M01.060.057
18310704,2008-03-01T00:00:00,Disease Progression,C23.550.291.656
18310704,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18310704,2008-03-01T00:00:00,Radius,A02.835.232.087.090.700
18310704,2008-03-01T00:00:00,Scoliosis,C05.116.900.800.875
18314525,2008-03-01T00:00:00,Adult,M01.060.116
18314525,2008-03-01T00:00:00,Breast Neoplasms,C04.588.180
18314525,2008-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
18314525,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18314525,2008-03-01T00:00:00,Mammography,E01.370.350.700.500
18314525,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18314525,2008-03-01T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
18314525,2008-03-01T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
18317311,2008-03-01T00:00:00,Clinical Competence,I02.399.630.210
18317311,2008-03-01T00:00:00,Clinical Competence,N04.761.210
18317311,2008-03-01T00:00:00,"Education, Nursing, Baccalaureate",I02.358.462.316
18317311,2008-03-01T00:00:00,"Education, Nursing, Continuing",I02.358.212.450
18317311,2008-03-01T00:00:00,"Education, Nursing, Continuing",I02.358.462.399
18317311,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18317311,2008-03-01T00:00:00,Internet,L01.224.230.110.500
18317311,2008-03-01T00:00:00,Needs Assessment,I02.594
18317311,2008-03-01T00:00:00,Needs Assessment,N03.349.380.565
18317311,2008-03-01T00:00:00,Needs Assessment,N05.300.537
18317311,2008-03-01T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
18317311,2008-03-01T00:00:00,Social Support,I01.880.656.600
18317311,2008-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18317311,2008-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18321181,2008-03-01T00:00:00,Adult,M01.060.116
18321181,2008-03-01T00:00:00,Counseling,F02.784.176
18321181,2008-03-01T00:00:00,Counseling,F04.408.413
18321181,2008-03-01T00:00:00,Counseling,N02.421.143.303
18321181,2008-03-01T00:00:00,Counseling,N02.421.461.363
18321181,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18321181,2008-03-01T00:00:00,Nicotine,D03.132.760.570
18321181,2008-03-01T00:00:00,Nicotine,D03.383.725.518
18321181,2008-03-01T00:00:00,Pilot Projects,E05.318.760.750
18321181,2008-03-01T00:00:00,Pilot Projects,E05.337.737
18321181,2008-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
18321181,2008-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
18321181,2008-03-01T00:00:00,Smoking,F01.145.466.753
18321181,2008-03-01T00:00:00,Smoking Cessation,F01.145.940.700
18321181,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
18321181,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18321181,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18326598,2008-03-01T00:00:00,Adult,M01.060.116
18326598,2008-03-01T00:00:00,African Americans,M01.686.508.100.100
18326598,2008-03-01T00:00:00,African Americans,M01.686.754.100
18326598,2008-03-01T00:00:00,Aged,M01.060.116.100
18326598,2008-03-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18326598,2008-03-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18326598,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18326598,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18326598,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18326598,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18326598,2008-03-01T00:00:00,Ethnic Groups,M01.686.754
18326598,2008-03-01T00:00:00,Ethnic Groups,N01.224.317
18326598,2008-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18326598,2008-03-01T00:00:00,Health Status,I01.240.425
18326598,2008-03-01T00:00:00,Health Status,N01.224.425
18326598,2008-03-01T00:00:00,Health Status,N06.850.505.400.425
18326598,2008-03-01T00:00:00,Hispanic Americans,M01.686.754.441
18326598,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18326598,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18326598,2008-03-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18326598,2008-03-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18326598,2008-03-01T00:00:00,Prevalence,E05.318.308.985.525.750
18326598,2008-03-01T00:00:00,Prevalence,L01.280.975.525.750
18326598,2008-03-01T00:00:00,Prevalence,N01.224.935.597.750
18326598,2008-03-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18326598,2008-03-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18326598,2008-03-01T00:00:00,Vitamin D,D04.808.812.768
18326598,2008-03-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18327412,2008-03-01T00:00:00,Adult,M01.060.116
18327412,2008-03-01T00:00:00,Aged,M01.060.116.100
18327412,2008-03-01T00:00:00,Anticoagulants,D27.505.954.502.119
18327412,2008-03-01T00:00:00,Antithrombins,D12.644.822.750.060
18327412,2008-03-01T00:00:00,Antithrombins,D12.644.861.060
18327412,2008-03-01T00:00:00,Antithrombins,D12.776.645.750.060
18327412,2008-03-01T00:00:00,Antithrombins,D12.776.872.060
18327412,2008-03-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
18327412,2008-03-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
18327412,2008-03-01T00:00:00,Blood Coagulation,G09.188.124.560.150
18327412,2008-03-01T00:00:00,Cesarean Section,E04.520.252.500
18327412,2008-03-01T00:00:00,Heparin,D09.698.373.400
18327412,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18327412,2008-03-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
18327412,2008-03-01T00:00:00,Mammaplasty,E02.218.565
18327412,2008-03-01T00:00:00,Mammaplasty,E04.680.500
18327412,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18327412,2008-03-01T00:00:00,Recombinant Proteins,D12.776.828
18327412,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
18327412,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18327412,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18327412,2008-03-01T00:00:00,United States,Z01.107.567.875
18327412,2008-03-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
18332401,2008-03-01T00:00:00,Adult,M01.060.116
18332401,2008-03-01T00:00:00,Biological Markers,D23.101
18332401,2008-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18332401,2008-03-01T00:00:00,Body Mass Index,E05.041.124.125
18332401,2008-03-01T00:00:00,Body Mass Index,G07.100.100.125
18332401,2008-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18332401,2008-03-01T00:00:00,C-Reactive Protein,D12.776.034.145
18332401,2008-03-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
18332401,2008-03-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
18332401,2008-03-01T00:00:00,Dietary Supplements,J02.500.456
18332401,2008-03-01T00:00:00,Fibrinogen,D12.776.124.050.250
18332401,2008-03-01T00:00:00,Fibrinogen,D12.776.124.125.500
18332401,2008-03-01T00:00:00,Fibrinogen,D12.776.811.300
18332401,2008-03-01T00:00:00,Fibrinogen,D23.119.490
18332401,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18332401,2008-03-01T00:00:00,Inflammation,C23.550.470
18332401,2008-03-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
18332401,2008-03-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
18332401,2008-03-01T00:00:00,Interleukin-6,D23.529.374.465.506
18332401,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18332401,2008-03-01T00:00:00,Obesity,C18.654.726.500
18332401,2008-03-01T00:00:00,Obesity,C23.888.144.699.500
18332401,2008-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18332401,2008-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18332405,2008-03-01T00:00:00,Adult,M01.060.116
18332405,2008-03-01T00:00:00,Attitude to Health,F01.100.150
18332405,2008-03-01T00:00:00,Attitude to Health,N05.300.150
18332405,2008-03-01T00:00:00,Diabetes Complications,C19.246.099
18332405,2008-03-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18332405,2008-03-01T00:00:00,Diabetes Mellitus,C19.246
18332405,2008-03-01T00:00:00,Exercise,G11.427.590.237
18332405,2008-03-01T00:00:00,Exercise,I03.350
18332405,2008-03-01T00:00:00,Health Behavior,F01.145.488
18332405,2008-03-01T00:00:00,Health Services Accessibility,N04.590.374.350
18332405,2008-03-01T00:00:00,Health Services Accessibility,N05.300.430
18332405,2008-03-01T00:00:00,Hispanic Americans,M01.686.754.441
18332405,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18332405,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18332405,2008-03-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
18332405,2008-03-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
18332405,2008-03-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
18332405,2008-03-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
18332405,2008-03-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
18332405,2008-03-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
18332405,2008-03-01T00:00:00,Obesity,C18.654.726.500
18332405,2008-03-01T00:00:00,Obesity,C23.888.144.699.500
18332405,2008-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18332405,2008-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18332405,2008-03-01T00:00:00,Smoking,F01.145.466.753
18332405,2008-03-01T00:00:00,United States,Z01.107.567.875
18333793,2008-03-01T00:00:00,Animals,B01.050
18333793,2008-03-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18333793,2008-03-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18333793,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18333793,2008-03-01T00:00:00,Morphogenesis,G07.700.320.500
18333793,2008-03-01T00:00:00,Myocardium,A02.633.580
18333793,2008-03-01T00:00:00,Myocardium,A07.541.704
18333793,2008-03-01T00:00:00,Myocardium,A10.690.552.750
18333793,2008-03-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18333793,2008-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18333793,2008-03-01T00:00:00,"Spheroids, Cellular",A11.251.800
18333793,2008-03-01T00:00:00,Tissue Engineering,E05.200.249.750
18333793,2008-03-01T00:00:00,Tissue Scaffolds,E07.206.627
18333793,2008-03-01T00:00:00,Tissue Scaffolds,E07.695.825
18337393,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18337393,2008-03-01T00:00:00,Myocardial Ischemia,C14.280.647
18337393,2008-03-01T00:00:00,Myocardial Ischemia,C14.907.585
18337393,2008-03-01T00:00:00,Pilot Projects,E05.318.760.750
18337393,2008-03-01T00:00:00,Pilot Projects,E05.337.737
18337393,2008-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
18337393,2008-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
18337393,2008-03-01T00:00:00,Stroke,C10.228.140.300.775
18337393,2008-03-01T00:00:00,Stroke,C14.907.253.855
18337393,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
18337393,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18337393,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18337393,2008-03-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
18341490,2008-03-01T00:00:00,Deglutition,G10.261.326.215
18341490,2008-03-01T00:00:00,Deglutition Disorders,C06.405.117.119
18341490,2008-03-01T00:00:00,Deglutition Disorders,C09.775.174
18341490,2008-03-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
18341490,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18341490,2008-03-01T00:00:00,Manometry,E05.559
18341490,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18343860,2008-03-01T00:00:00,Adolescent,M01.060.057
18343860,2008-03-01T00:00:00,Adult,M01.060.116
18343860,2008-03-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18343860,2008-03-01T00:00:00,Attitude to Health,F01.100.150
18343860,2008-03-01T00:00:00,Attitude to Health,N05.300.150
18343860,2008-03-01T00:00:00,Hispanic Americans,M01.686.754.441
18343860,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18343860,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18343860,2008-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18343860,2008-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18344805,2008-03-01T00:00:00,Adolescent,M01.060.057
18344805,2008-03-01T00:00:00,Adult,M01.060.116
18344805,2008-03-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18344805,2008-03-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18344805,2008-03-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18344805,2008-03-01T00:00:00,Biological Markers,D23.101
18344805,2008-03-01T00:00:00,Calcinosis,C18.452.174.130
18344805,2008-03-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18344805,2008-03-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18344805,2008-03-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18344805,2008-03-01T00:00:00,Child,M01.060.406
18344805,2008-03-01T00:00:00,Exanthema,C17.800.257
18344805,2008-03-01T00:00:00,Fatty Liver,C06.552.241
18344805,2008-03-01T00:00:00,Forecasting,I01.320
18344805,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18344805,2008-03-01T00:00:00,Insulin Resistance,C18.452.394.968.500
18344805,2008-03-01T00:00:00,Insulin Resistance,G07.690.320.617
18344805,2008-03-01T00:00:00,Muscular Atrophy,C10.597.613.612
18344805,2008-03-01T00:00:00,Muscular Atrophy,C23.300.070.500
18344805,2008-03-01T00:00:00,Muscular Atrophy,C23.888.592.608.612
18344805,2008-03-01T00:00:00,Phenotype,G05.695
18351717,2008-03-01T00:00:00,Animals,B01.050
18351717,2008-03-01T00:00:00,"Behavior, Animal",F01.145.113
18351717,2008-03-01T00:00:00,Corticosterone,D04.808.745.745.654.237
18351717,2008-03-01T00:00:00,Corticosterone,D06.472.040.585.353.237
18351717,2008-03-01T00:00:00,Immune System,A15.382
18351717,2008-03-01T00:00:00,Social Isolation,F01.145.813.781
18351717,2008-03-01T00:00:00,Social Isolation,I01.880.683
18351717,2008-03-01T00:00:00,"Stress, Psychological",F01.145.126.990
18351717,2008-03-01T00:00:00,"Stress, Psychological",F02.830.900
18351717,2008-03-01T00:00:00,Weight Gain,C23.888.144.243.926
18351717,2008-03-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
18360200,2008-03-01T00:00:00,Adult,M01.060.116
18360200,2008-03-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18360200,2008-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18360200,2008-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18360200,2008-03-01T00:00:00,Benzodiazepines,D03.438.079.080
18360200,2008-03-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
18360200,2008-03-01T00:00:00,Cyclophosphamide,D02.705.670.243
18360200,2008-03-01T00:00:00,"Diagnosis, Differential",E01.171
18360200,2008-03-01T00:00:00,Drug Interactions,G07.690.812.240
18360200,2008-03-01T00:00:00,Drug Interactions,G07.700.680.240
18360200,2008-03-01T00:00:00,Enteral Nutrition,E02.421.360
18360200,2008-03-01T00:00:00,Enteral Nutrition,E02.642.500.360
18360200,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18360200,2008-03-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18360200,2008-03-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18360200,2008-03-01T00:00:00,Patient Care Team,N04.590.715
18360200,2008-03-01T00:00:00,Personality Assessment,F04.513
18360200,2008-03-01T00:00:00,Referral and Consultation,N04.452.758.849
18360200,2008-03-01T00:00:00,"Scleroderma, Systemic",C17.300.799
18360200,2008-03-01T00:00:00,"Scleroderma, Systemic",C17.800.784
18360200,2008-03-01T00:00:00,Weight Loss,C23.888.144.243.963
18360200,2008-03-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18362761,2008-03-01T00:00:00,Adolescent,M01.060.057
18362761,2008-03-01T00:00:00,Adult,M01.060.116
18362761,2008-03-01T00:00:00,Age Factors,N05.715.350.075
18362761,2008-03-01T00:00:00,Age Factors,N06.850.490.250
18362761,2008-03-01T00:00:00,Aged,M01.060.116.100
18362761,2008-03-01T00:00:00,Anxiety,F01.470.132
18362761,2008-03-01T00:00:00,Brain Injuries,C10.228.140.199
18362761,2008-03-01T00:00:00,Brain Injuries,C10.900.300.087
18362761,2008-03-01T00:00:00,Brain Injuries,C21.866.260.118
18362761,2008-03-01T00:00:00,Brain Injuries,C21.866.915.300.200
18362761,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18362761,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18362761,2008-03-01T00:00:00,Mood Disorders,F03.600
18362761,2008-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18362761,2008-03-01T00:00:00,Risk Factors,N05.715.350.200.700
18362761,2008-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18362761,2008-03-01T00:00:00,Risk Factors,N06.850.490.625.750
18362761,2008-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18362761,2008-03-01T00:00:00,Sex Factors,N05.715.350.675
18362761,2008-03-01T00:00:00,Sex Factors,N06.850.490.875
18362761,2008-03-01T00:00:00,Social Support,I01.880.656.600
18362766,2008-03-01T00:00:00,Adolescent,M01.060.057
18362766,2008-03-01T00:00:00,Adult,M01.060.116
18362766,2008-03-01T00:00:00,Aged,M01.060.116.100
18362766,2008-03-01T00:00:00,Brain Injuries,C10.228.140.199
18362766,2008-03-01T00:00:00,Brain Injuries,C10.900.300.087
18362766,2008-03-01T00:00:00,Brain Injuries,C21.866.260.118
18362766,2008-03-01T00:00:00,Brain Injuries,C21.866.915.300.200
18362766,2008-03-01T00:00:00,Child,M01.060.406
18362766,2008-03-01T00:00:00,"Child, Preschool",M01.060.406.448
18362766,2008-03-01T00:00:00,Hospitalization,E02.760.400
18362766,2008-03-01T00:00:00,Hospitalization,N02.421.585.400
18362766,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18362766,2008-03-01T00:00:00,Incidence,E05.318.308.985.525.375
18362766,2008-03-01T00:00:00,Incidence,L01.280.975.525.375
18362766,2008-03-01T00:00:00,Incidence,N01.224.935.597.500
18362766,2008-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18362766,2008-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18362766,2008-03-01T00:00:00,Infant,M01.060.703
18362766,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18362766,2008-03-01T00:00:00,United States,Z01.107.567.875
18367060,2008-03-01T00:00:00,Contrast Media,D27.720.259
18367060,2008-03-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18367060,2008-03-01T00:00:00,Coronary Angiography,E01.370.370.050.200
18367060,2008-03-01T00:00:00,Coronary Angiography,E01.370.370.380.200
18367060,2008-03-01T00:00:00,Coronary Disease,C14.280.647.250
18367060,2008-03-01T00:00:00,Coronary Disease,C14.907.585.250
18367060,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18367060,2008-03-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18367060,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18367060,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18367060,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18367060,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18367060,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18375575,2008-03-01T00:00:00,Adult,M01.060.116
18375575,2008-03-01T00:00:00,Animals,B01.050
18375575,2008-03-01T00:00:00,"Animals, Newborn",B01.050.050.282
18375575,2008-03-01T00:00:00,Cardiovascular System,A07
18375575,2008-03-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
18375575,2008-03-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
18375575,2008-03-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
18375575,2008-03-01T00:00:00,Cell Differentiation,G04.299.151
18375575,2008-03-01T00:00:00,Fibroblasts,A11.329.228
18375575,2008-03-01T00:00:00,Fibroblasts,A11.872.228
18375575,2008-03-01T00:00:00,Heart,A07.541
18375575,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18375575,2008-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
18375575,2008-03-01T00:00:00,Myocardium,A02.633.580
18375575,2008-03-01T00:00:00,Myocardium,A07.541.704
18375575,2008-03-01T00:00:00,Myocardium,A10.690.552.750
18375575,2008-03-01T00:00:00,Stem Cells,A11.872
18375577,2008-03-01T00:00:00,Animals,B01.050
18375577,2008-03-01T00:00:00,Calcium,D01.268.552.100
18375577,2008-03-01T00:00:00,Calcium,D01.552.539.288
18375577,2008-03-01T00:00:00,Calcium,D23.119.100
18375577,2008-03-01T00:00:00,Calcium Signaling,G02.111.087.800.800.100
18375577,2008-03-01T00:00:00,Calcium Signaling,G02.149.115.800.800.100
18375577,2008-03-01T00:00:00,Calcium Signaling,G03.495.166.500.100
18375577,2008-03-01T00:00:00,Calcium Signaling,G04.299.880.800.100
18375577,2008-03-01T00:00:00,Cyclosporine,D04.345.566.235.300
18375577,2008-03-01T00:00:00,Cyclosporine,D12.644.641.235.300
18375577,2008-03-01T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
18375577,2008-03-01T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
18375577,2008-03-01T00:00:00,Myocardial Contraction,G09.330.190.541
18375577,2008-03-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
18375577,2008-03-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18375577,2008-03-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18375577,2008-03-01T00:00:00,"Myocytes, Cardiac",A11.620.500
18375577,2008-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18375775,2008-03-01T00:00:00,Adult,M01.060.116
18375775,2008-03-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18375775,2008-03-01T00:00:00,Diabetes Mellitus,C19.246
18375775,2008-03-01T00:00:00,Health Status,I01.240.425
18375775,2008-03-01T00:00:00,Health Status,N01.224.425
18375775,2008-03-01T00:00:00,Health Status,N06.850.505.400.425
18375775,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18375775,2008-03-01T00:00:00,Patient Selection,E05.581.500.653
18375775,2008-03-01T00:00:00,Patient Selection,N04.590.731
18375775,2008-03-01T00:00:00,Quality of Life,I01.800
18375775,2008-03-01T00:00:00,Quality of Life,K01.752.400.750
18375775,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
18375775,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18375775,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18376297,2008-03-01T00:00:00,Animals,B01.050
18376297,2008-03-01T00:00:00,"Animals, Newborn",B01.050.050.282
18376297,2008-03-01T00:00:00,Cell Differentiation,G04.299.151
18376297,2008-03-01T00:00:00,Cord Blood Stem Cell Transplantation,E04.936.225.687.312
18376297,2008-03-01T00:00:00,Fetal Blood,A12.207.152.200
18376297,2008-03-01T00:00:00,Fetal Blood,A15.145.300
18376297,2008-03-01T00:00:00,Fetal Blood,A16.378.200
18376297,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18376297,2008-03-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
18376297,2008-03-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
18376297,2008-03-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
18376297,2008-03-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
18376297,2008-03-01T00:00:00,"RNA, Messenger",D13.444.735.544
18376297,2008-03-01T00:00:00,Stem Cells,A11.872
18376696,2008-03-01T00:00:00,Adrenal Glands,A06.407.071
18376696,2008-03-01T00:00:00,Adult,M01.060.116
18376696,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18376696,2008-03-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
18377099,2008-03-01T00:00:00,Cholecalciferol,D04.808.247.222.159
18377099,2008-03-01T00:00:00,Cholecalciferol,D04.808.247.808.146
18377099,2008-03-01T00:00:00,Cholecalciferol,D04.808.812.768.196
18377099,2008-03-01T00:00:00,Cholecalciferol,D10.570.938.146
18377099,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18377099,2008-03-01T00:00:00,Vitamin D,D04.808.812.768
18377099,2008-03-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18377141,2008-03-01T00:00:00,"Adaptation, Psychological",F01.058
18377141,2008-03-01T00:00:00,Adult,M01.060.116
18377141,2008-03-01T00:00:00,Aged,M01.060.116.100
18377141,2008-03-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
18377141,2008-03-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
18377141,2008-03-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
18377141,2008-03-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
18377141,2008-03-01T00:00:00,Culture,I01.076.201.450
18377141,2008-03-01T00:00:00,Culture,I01.880.143
18377141,2008-03-01T00:00:00,Disability Evaluation,E01.370.400
18377141,2008-03-01T00:00:00,Emotions,F01.470
18377141,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18377141,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18377141,2008-03-01T00:00:00,Questionnaires,E05.318.308.750
18377141,2008-03-01T00:00:00,Questionnaires,L01.280.800
18377141,2008-03-01T00:00:00,Questionnaires,N05.715.360.300.695
18377141,2008-03-01T00:00:00,Questionnaires,N06.850.520.308.750
18377141,2008-03-01T00:00:00,Spouses,F01.829.263.500.660
18377141,2008-03-01T00:00:00,Spouses,I01.880.225.500.670
18377141,2008-03-01T00:00:00,Spouses,M01.816
18380270,2008-03-01T00:00:00,Attitude of Health Personnel,F01.100.050
18380270,2008-03-01T00:00:00,Attitude of Health Personnel,N05.300.100
18380270,2008-03-01T00:00:00,Cooperative Behavior,F01.145.813.115
18380270,2008-03-01T00:00:00,"Education, Nursing, Graduate",I02.358.337.450
18380270,2008-03-01T00:00:00,"Education, Nursing, Graduate",I02.358.462.565
18380270,2008-03-01T00:00:00,Group Processes,F01.829.316
18380270,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18380270,2008-03-01T00:00:00,Interprofessional Relations,F01.829.401.205
18380270,2008-03-01T00:00:00,"Models, Educational",E05.599.545
18380270,2008-03-01T00:00:00,"Models, Educational",I02.903.302
18380270,2008-03-01T00:00:00,Program Evaluation,E05.337.820
18380270,2008-03-01T00:00:00,Program Evaluation,N04.761.685
18380270,2008-03-01T00:00:00,Program Evaluation,N05.715.360.650
18380270,2008-03-01T00:00:00,"Students, Nursing",I02.851.686.685
18380270,2008-03-01T00:00:00,"Students, Nursing",M01.848.769.685
18380270,2008-03-01T00:00:00,Teaching,I02.903
18382256,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18382256,2008-03-01T00:00:00,Lower Extremity,A01.378.610
18382256,2008-03-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
18382256,2008-03-01T00:00:00,Nurse's Role,N05.300.100.337
18382256,2008-03-01T00:00:00,Quality of Life,I01.800
18382256,2008-03-01T00:00:00,Quality of Life,K01.752.400.750
18382256,2008-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18382256,2008-03-01T00:00:00,Risk Factors,N05.715.350.200.700
18382256,2008-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18382256,2008-03-01T00:00:00,Risk Factors,N06.850.490.625.750
18382256,2008-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18382256,2008-03-01T00:00:00,Varicose Ulcer,C14.907.927.730
18382256,2008-03-01T00:00:00,Varicose Ulcer,C17.800.893.592.730
18382256,2008-03-01T00:00:00,Venous Insufficiency,C14.907.952
18382256,2008-03-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
18382257,2008-03-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
18382257,2008-03-01T00:00:00,"Diagnosis, Differential",E01.171
18382257,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18382257,2008-03-01T00:00:00,Intermittent Claudication,C14.907.137.126.669
18382257,2008-03-01T00:00:00,Intermittent Claudication,C23.888.531
18382257,2008-03-01T00:00:00,Leg,A01.378.610.500
18382257,2008-03-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
18382257,2008-03-01T00:00:00,Nurse's Role,N05.300.100.337
18382257,2008-03-01T00:00:00,Pain,C10.597.617
18382257,2008-03-01T00:00:00,Pain,C23.888.592.612
18382257,2008-03-01T00:00:00,Pain,C23.888.646
18382257,2008-03-01T00:00:00,Pain,F02.830.816.444
18382257,2008-03-01T00:00:00,Pain,G11.561.600.810.444
18382257,2008-03-01T00:00:00,Peripheral Vascular Diseases,C14.907.617
18382257,2008-03-01T00:00:00,Quality of Life,I01.800
18382257,2008-03-01T00:00:00,Quality of Life,K01.752.400.750
18382257,2008-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18382257,2008-03-01T00:00:00,Risk Assessment,N04.452.871.715
18382257,2008-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18382257,2008-03-01T00:00:00,Risk Assessment,N06.850.505.715
18382257,2008-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18382257,2008-03-01T00:00:00,United States,Z01.107.567.875
18382257,2008-03-01T00:00:00,Walking,G11.427.590.530.568.900
18382257,2008-03-01T00:00:00,Walking,G11.427.590.530.698.940
18382257,2008-03-01T00:00:00,Walking,I03.450.642.845.940
18390022,2008-03-01T00:00:00,African Americans,M01.686.508.100.100
18390022,2008-03-01T00:00:00,African Americans,M01.686.754.100
18390022,2008-03-01T00:00:00,Aged,M01.060.116.100
18390022,2008-03-01T00:00:00,Attitude to Health,F01.100.150
18390022,2008-03-01T00:00:00,Attitude to Health,N05.300.150
18390022,2008-03-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18390022,2008-03-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18390022,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18390022,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18390022,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18390022,2008-03-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18390022,2008-03-01T00:00:00,Ethnic Groups,M01.686.754
18390022,2008-03-01T00:00:00,Ethnic Groups,N01.224.317
18390022,2008-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18390022,2008-03-01T00:00:00,Hispanic Americans,M01.686.754.441
18390022,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18390022,2008-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18390022,2008-03-01T00:00:00,Lung Neoplasms,C08.381.540
18390022,2008-03-01T00:00:00,Lung Neoplasms,C08.785.520
18390022,2008-03-01T00:00:00,Mass Screening,E01.370.500
18390022,2008-03-01T00:00:00,Mass Screening,E05.318.308.250.580
18390022,2008-03-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18390022,2008-03-01T00:00:00,Mass Screening,N02.421.726.233.443
18390022,2008-03-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18390022,2008-03-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18390022,2008-03-01T00:00:00,Mass Screening,N06.850.780.500
18390022,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18390022,2008-03-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
18390022,2008-03-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
18390022,2008-03-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
18390022,2008-03-01T00:00:00,Ovarian Neoplasms,C19.344.410
18390022,2008-03-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
18390022,2008-03-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18390022,2008-03-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18390022,2008-03-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18390022,2008-03-01T00:00:00,Patient Satisfaction,N05.715.360.600
18390022,2008-03-01T00:00:00,Patient Selection,E05.581.500.653
18390022,2008-03-01T00:00:00,Patient Selection,N04.590.731
18390022,2008-03-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18390022,2008-03-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18390022,2008-03-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18390022,2008-03-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18390022,2008-03-01T00:00:00,United States,Z01.107.567.875
18391803,2008-03-01T00:00:00,Communication,F01.145.209
18391803,2008-03-01T00:00:00,Communication,L01.143
18391803,2008-03-01T00:00:00,Group Processes,F01.829.316
18391803,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18391803,2008-03-01T00:00:00,Interprofessional Relations,F01.829.401.205
18391803,2008-03-01T00:00:00,Leadership,F01.752.609
18391803,2008-03-01T00:00:00,Nurse Administrators,M01.526.070.670
18391803,2008-03-01T00:00:00,Nurse Administrators,M01.526.485.650.580
18391803,2008-03-01T00:00:00,Nurse Administrators,N02.360.650.580
18391803,2008-03-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
18391803,2008-03-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
18391803,2008-03-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
18391803,2008-03-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
18394088,2008-03-01T00:00:00,Dermatologic Agents,D27.505.954.444
18394088,2008-03-01T00:00:00,Dermatology,H02.403.225
18394088,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18394088,2008-03-01T00:00:00,Patient Selection,E05.581.500.653
18394088,2008-03-01T00:00:00,Patient Selection,N04.590.731
18394088,2008-03-01T00:00:00,Skin Diseases,C17.800
18394088,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
18394088,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18394088,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18396245,2008-03-01T00:00:00,Aged,M01.060.116.100
18396245,2008-03-01T00:00:00,Drug Prescriptions,E02.319.307
18396245,2008-03-01T00:00:00,Drug Prescriptions,N02.421.668.778.500
18396245,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18396245,2008-03-01T00:00:00,Medication Errors,E02.319.529
18396245,2008-03-01T00:00:00,Medication Errors,N02.421.450.500
18396245,2008-03-01T00:00:00,Physician's Practice Patterns,N04.590.748
18396245,2008-03-01T00:00:00,Physician's Practice Patterns,N05.300.625
18396245,2008-03-01T00:00:00,Primary Health Care,N04.590.233.727
18401214,2008-03-01T00:00:00,Aged,M01.060.116.100
18401214,2008-03-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
18401214,2008-03-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
18401214,2008-03-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
18401214,2008-03-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
18401214,2008-03-01T00:00:00,Disease Progression,C23.550.291.656
18401214,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18401214,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18401214,2008-03-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
18401214,2008-03-01T00:00:00,Stroke Volume,G09.330.380.124.882
18401214,2008-03-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18401214,2008-03-01T00:00:00,Ventricular Remodeling,C23.300.985
18401214,2008-03-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
18416974,2008-03-01T00:00:00,Cadaver,C23.550.260.224
18416974,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18416974,2008-03-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
18416974,2008-03-01T00:00:00,Paranasal Sinuses,A04.531.621
18416974,2008-03-01T00:00:00,Pilot Projects,E05.318.760.750
18416974,2008-03-01T00:00:00,Pilot Projects,E05.337.737
18416974,2008-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
18416974,2008-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
18416974,2008-03-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
18416974,2008-03-01T00:00:00,"Surgery, Computer-Assisted",E04.749
18416974,2008-03-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
18416974,2008-03-01T00:00:00,"Tomography Scanners, X-Ray Computed",E07.913
18416974,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18416974,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18416974,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18416974,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18416974,2008-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18424993,2008-03-01T00:00:00,Aged,M01.060.116.100
18424993,2008-03-01T00:00:00,Device Removal,E04.199
18424993,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18424993,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
18424993,2008-03-01T00:00:00,Prosthesis Implantation,E04.650
18424993,2008-03-01T00:00:00,Reconstructive Surgical Procedures,E04.680
18424993,2008-03-01T00:00:00,Surgical Flaps,A10.850.710
18424993,2008-03-01T00:00:00,Surgical Flaps,E07.862.710
18432047,2008-03-01T00:00:00,Bacterial Infections,C01.252
18432047,2008-03-01T00:00:00,Biological Markers,D23.101
18432047,2008-03-01T00:00:00,C-Reactive Protein,D12.776.034.145
18432047,2008-03-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
18432047,2008-03-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
18432047,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18432047,2008-03-01T00:00:00,Infant,M01.060.703
18432047,2008-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
18432047,2008-03-01T00:00:00,Urinalysis,E01.370.390.810
18432047,2008-03-01T00:00:00,Urinalysis,E01.450.150.810
18432047,2008-03-01T00:00:00,Urinalysis,E01.450.890
18438789,2008-03-01T00:00:00,Adolescent,M01.060.057
18438789,2008-03-01T00:00:00,Asthma,C08.127.108
18438789,2008-03-01T00:00:00,Asthma,C08.381.495.108
18438789,2008-03-01T00:00:00,Asthma,C08.674.095
18438789,2008-03-01T00:00:00,Asthma,C20.543.480.680.095
18438789,2008-03-01T00:00:00,Child,M01.060.406
18438789,2008-03-01T00:00:00,"Child, Preschool",M01.060.406.448
18438789,2008-03-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18438789,2008-03-01T00:00:00,Hospital Costs,N03.219.151.400.687
18438789,2008-03-01T00:00:00,Hospital Costs,N03.219.262.500
18438789,2008-03-01T00:00:00,Hospital Costs,N05.300.375.500
18438789,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18438789,2008-03-01T00:00:00,Infant,M01.060.703
18438789,2008-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
18438789,2008-03-01T00:00:00,Influenza Vaccines,D20.215.894.899.302
18438789,2008-03-01T00:00:00,"Influenza, Human",C02.782.620.365
18438789,2008-03-01T00:00:00,"Influenza, Human",C08.730.310
18438789,2008-03-01T00:00:00,Inpatients,M01.643.470
18438789,2008-03-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18438789,2008-03-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18438789,2008-03-01T00:00:00,Program Evaluation,E05.337.820
18438789,2008-03-01T00:00:00,Program Evaluation,N04.761.685
18438789,2008-03-01T00:00:00,Program Evaluation,N05.715.360.650
18438792,2008-03-01T00:00:00,Aged,M01.060.116.100
18438792,2008-03-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18438792,2008-03-01T00:00:00,Clostridium Infections,C01.252.410.222
18438792,2008-03-01T00:00:00,Clostridium difficile,B03.300.390.400.200.250
18438792,2008-03-01T00:00:00,Clostridium difficile,B03.510.415.400.200.250
18438792,2008-03-01T00:00:00,Cross Infection,C01.539.248
18438792,2008-03-01T00:00:00,Hospitalists,M01.526.485.630.490.400
18438792,2008-03-01T00:00:00,Hospitalists,M01.526.485.740.422.400
18438792,2008-03-01T00:00:00,Hospitalists,M01.526.485.810.580
18438792,2008-03-01T00:00:00,Hospitalists,N02.360.630.490.400
18438792,2008-03-01T00:00:00,Hospitalists,N02.360.740.422.400
18438792,2008-03-01T00:00:00,Hospitalists,N02.360.810.580
18438792,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18438792,2008-03-01T00:00:00,Physician's Practice Patterns,N04.590.748
18438792,2008-03-01T00:00:00,Physician's Practice Patterns,N05.300.625
18438792,2008-03-01T00:00:00,Secondary Prevention,N02.421.726.825
18438792,2008-03-01T00:00:00,Secondary Prevention,N06.850.780.750
18438792,2008-03-01T00:00:00,Vancomycin,D09.400.420.925
18438792,2008-03-01T00:00:00,Vancomycin,D12.644.233.925
18619381,2008-03-01T00:00:00,Diagnostic Imaging,E01.370.350
18619381,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18619381,2008-03-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
19034204,2008-03-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19034204,2008-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
19034204,2008-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
19034204,2008-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19034204,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034204,2008-03-01T00:00:00,Information Dissemination,F01.145.209.364
19034204,2008-03-01T00:00:00,Information Dissemination,L01.143.443
19034204,2008-03-01T00:00:00,United States,Z01.107.567.875
19034205,2008-03-01T00:00:00,Amines,D02.092
19034205,2008-03-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19034205,2008-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
19034205,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
19034205,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
19034205,2008-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
19034205,2008-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19034205,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034205,2008-03-01T00:00:00,Treatment Outcome,E01.789.800
19034205,2008-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19034205,2008-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19034205,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19034205,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19034206,2008-03-01T00:00:00,Amines,D02.092
19034206,2008-03-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19034206,2008-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
19034206,2008-03-01T00:00:00,Conflict of Interest,K01.316.130
19034206,2008-03-01T00:00:00,Conflict of Interest,N05.350.225
19034206,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
19034206,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
19034206,2008-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
19034206,2008-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19034206,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034206,2008-03-01T00:00:00,Research Design,E05.581.500
19034206,2008-03-01T00:00:00,Research Design,H01.770.644.728
19034206,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19034206,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19034207,2008-03-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19034207,2008-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
19034207,2008-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
19034207,2008-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19034207,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034207,2008-03-01T00:00:00,Information Dissemination,F01.145.209.364
19034207,2008-03-01T00:00:00,Information Dissemination,L01.143.443
19034207,2008-03-01T00:00:00,United States,Z01.107.567.875
19034208,2008-03-01T00:00:00,Adult,M01.060.116
19034208,2008-03-01T00:00:00,Amines,D02.092
19034208,2008-03-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19034208,2008-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
19034208,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
19034208,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
19034208,2008-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
19034208,2008-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19034208,2008-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19034208,2008-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19034208,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034208,2008-03-01T00:00:00,Information Dissemination,F01.145.209.364
19034208,2008-03-01T00:00:00,Information Dissemination,L01.143.443
19034208,2008-03-01T00:00:00,Middle Aged,M01.060.116.630
19034208,2008-03-01T00:00:00,Physician's Practice Patterns,N04.590.748
19034208,2008-03-01T00:00:00,Physician's Practice Patterns,N05.300.625
19034208,2008-03-01T00:00:00,Psychiatry,F04.096.544
19034208,2008-03-01T00:00:00,Psychiatry,H02.403.690
19034208,2008-03-01T00:00:00,United States,Z01.107.567.875
19034208,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19034208,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19034209,2008-03-01T00:00:00,Amines,D02.092
19034209,2008-03-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19034209,2008-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
19034209,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
19034209,2008-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
19034209,2008-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
19034209,2008-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19034209,2008-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034209,2008-03-01T00:00:00,Information Dissemination,F01.145.209.364
19034209,2008-03-01T00:00:00,Information Dissemination,L01.143.443
19034209,2008-03-01T00:00:00,"Models, Organizational",E05.599.670
19034209,2008-03-01T00:00:00,"Models, Organizational",N04.452.534
19034209,2008-03-01T00:00:00,United States,Z01.107.567.875
19034209,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
19034209,2008-03-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
19206573,2008-03-01T00:00:00,Animals,B01.050
19206573,2008-03-01T00:00:00,Contrast Media,D27.720.259
19206573,2008-03-01T00:00:00,Drug Delivery Systems,E02.319.300
19206573,2008-03-01T00:00:00,Gene Expression Profiling,E05.393.332
19206573,2008-03-01T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
19206573,2008-03-01T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
19206573,2008-03-01T00:00:00,Image Enhancement,E01.370.350.600.350
19206573,2008-03-01T00:00:00,Image Enhancement,L01.224.308.380
19206573,2008-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19206573,2008-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19206573,2008-03-01T00:00:00,Magnetics,H01.671.493
19206573,2008-03-01T00:00:00,Nanoparticles,J01.637.512.600
19206573,2008-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18311559,2008-03-03T00:00:00,Animals,B01.050
18311559,2008-03-03T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
18311559,2008-03-03T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
18311559,2008-03-03T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
18311559,2008-03-03T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
18311559,2008-03-03T00:00:00,Cocaine-Related Disorders,C21.739.300
18311559,2008-03-03T00:00:00,Cocaine-Related Disorders,F03.900.300
18311559,2008-03-03T00:00:00,Gene Expression Regulation,G05.355.315
18311559,2008-03-03T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18311559,2008-03-03T00:00:00,Motor Activity,F01.145.632
18311559,2008-03-03T00:00:00,Motor Activity,G11.427.590.530.698
18311559,2008-03-03T00:00:00,Nerve Tissue Proteins,D12.776.641
18311559,2008-03-03T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18311559,2008-03-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18311559,2008-03-03T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18311559,2008-03-03T00:00:00,Self Administration,E02.319.890
18311559,2008-03-03T00:00:00,Self Administration,E02.900.890
18311559,2008-03-03T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18311559,2008-03-03T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18312716,2008-03-03T00:00:00,Animals,B01.050
18312716,2008-03-03T00:00:00,"Animals, Newborn",B01.050.050.282
18312716,2008-03-03T00:00:00,Cell Adhesion,G04.299.117
18312716,2008-03-03T00:00:00,Cell Culture Techniques,E05.200.249.249
18312716,2008-03-03T00:00:00,Cell Movement,G04.299.283
18312716,2008-03-03T00:00:00,Cell Movement,G07.700.560.500.180
18312716,2008-03-03T00:00:00,Extracellular Matrix,A11.284.295.310
18312716,2008-03-03T00:00:00,Fibroblasts,A11.329.228
18312716,2008-03-03T00:00:00,Fibroblasts,A11.872.228
18312716,2008-03-03T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
18312716,2008-03-03T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
18312716,2008-03-03T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18312716,2008-03-03T00:00:00,"Microscopy, Confocal",E05.595.395
18312716,2008-03-03T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
18312716,2008-03-03T00:00:00,"Microscopy, Fluorescence",E05.595.458
18312716,2008-03-03T00:00:00,Myocardium,A02.633.580
18312716,2008-03-03T00:00:00,Myocardium,A07.541.704
18312716,2008-03-03T00:00:00,Myocardium,A10.690.552.750
18312716,2008-03-03T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18312716,2008-03-03T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18312716,2008-03-03T00:00:00,"Myocytes, Cardiac",A11.620.500
18312716,2008-03-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18313756,2008-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18313756,2008-03-03T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18313756,2008-03-03T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18313756,2008-03-03T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18313756,2008-03-03T00:00:00,Protein Engineering,E05.393.420.601
18313756,2008-03-03T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
18289664,2008-03-04T00:00:00,Animals,B01.050
18289664,2008-03-04T00:00:00,Bone Marrow Cells,A11.148
18289664,2008-03-04T00:00:00,Bone Marrow Cells,A15.378.316
18289664,2008-03-04T00:00:00,Calcium,D01.268.552.100
18289664,2008-03-04T00:00:00,Calcium,D01.552.539.288
18289664,2008-03-04T00:00:00,Calcium,D23.119.100
18289664,2008-03-04T00:00:00,Cell Culture Techniques,E05.200.249.249
18289664,2008-03-04T00:00:00,Cell Differentiation,G04.299.151
18289664,2008-03-04T00:00:00,Collagen Type I,D05.750.078.280.300.100
18289664,2008-03-04T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
18289664,2008-03-04T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
18289664,2008-03-04T00:00:00,Osteogenesis,G11.427.590.560.100.729
18289664,2008-03-04T00:00:00,Pericardium,A07.541.795
18289664,2008-03-04T00:00:00,Pericardium,A10.615.789.470
18289664,2008-03-04T00:00:00,"RNA, Messenger",D13.444.735.544
18289664,2008-03-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18289664,2008-03-04T00:00:00,Stromal Cells,A11.329.830
18289664,2008-03-04T00:00:00,Tissue Engineering,E05.200.249.750
18295916,2008-03-04T00:00:00,Adult,M01.060.116
18295916,2008-03-04T00:00:00,Collagen,D05.750.078.280
18295916,2008-03-04T00:00:00,Collagen,D12.776.860.300.250
18295916,2008-03-04T00:00:00,Extracellular Matrix,A11.284.295.310
18295916,2008-03-04T00:00:00,Fetus,A16.378
18295916,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18295916,2008-03-04T00:00:00,Inflammation,C23.550.470
18295916,2008-03-04T00:00:00,Protein Engineering,E05.393.420.601
18295916,2008-03-04T00:00:00,Skin,A17.815
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18295916,2008-03-04T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18295916,2008-03-04T00:00:00,Wound Healing,G16.100.856.891
18308158,2008-03-04T00:00:00,Aged,M01.060.116.100
18308158,2008-03-04T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
18308158,2008-03-04T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
18308158,2008-03-04T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
18308158,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18308158,2008-03-04T00:00:00,Stroke,C10.228.140.300.775
18308158,2008-03-04T00:00:00,Stroke,C14.907.253.855
18308158,2008-03-04T00:00:00,Thrombolytic Therapy,E02.319.913
18308158,2008-03-04T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
18308158,2008-03-04T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
18308158,2008-03-04T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
18308158,2008-03-04T00:00:00,Tissue Plasminogen Activator,D23.119.970
18308158,2008-03-04T00:00:00,Treatment Outcome,E01.789.800
18308158,2008-03-04T00:00:00,Treatment Outcome,N04.761.559.590.800
18308158,2008-03-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18308316,2008-03-04T00:00:00,Adolescent,M01.060.057
18308316,2008-03-04T00:00:00,Child,M01.060.406
18308316,2008-03-04T00:00:00,"Child, Preschool",M01.060.406.448
18308316,2008-03-04T00:00:00,Critical Illness,C23.550.291.625
18308316,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18308316,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18308316,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18308316,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18308316,2008-03-04T00:00:00,Enteral Nutrition,E02.421.360
18308316,2008-03-04T00:00:00,Enteral Nutrition,E02.642.500.360
18308316,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18308316,2008-03-04T00:00:00,Jejunostomy,E04.210.338.523
18308316,2008-03-04T00:00:00,Jejunostomy,E04.579.338.523
18316501,2008-03-04T00:00:00,Aged,M01.060.116.100
18316501,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18316501,2008-03-04T00:00:00,Myocardial Ischemia,C14.280.647
18316501,2008-03-04T00:00:00,Myocardial Ischemia,C14.907.585
18316501,2008-03-04T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
18316501,2008-03-04T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
18316501,2008-03-04T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
18316501,2008-03-04T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
18316501,2008-03-04T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
18317493,2008-03-04T00:00:00,Adult,M01.060.116
18317493,2008-03-04T00:00:00,Aged,M01.060.116.100
18317493,2008-03-04T00:00:00,Case-Control Studies,E05.318.760.500.500
18317493,2008-03-04T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18317493,2008-03-04T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18317493,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18317493,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18317493,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18317493,2008-03-04T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18317493,2008-03-04T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
18317493,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18317493,2008-03-04T00:00:00,Middle Aged,M01.060.116.630
18319310,2008-03-04T00:00:00,Adolescent,M01.060.057
18319310,2008-03-04T00:00:00,Adult,M01.060.116
18319310,2008-03-04T00:00:00,Albuminuria,C12.777.934.734.269
18319310,2008-03-04T00:00:00,Albuminuria,C13.351.968.934.734.269
18319310,2008-03-04T00:00:00,Albuminuria,C23.888.942.750.269
18319310,2008-03-04T00:00:00,Blood Pressure,E01.370.600.875.249
18319310,2008-03-04T00:00:00,Blood Pressure,G09.330.380.076
18319310,2008-03-04T00:00:00,Carotid Arteries,A07.231.114.186
18319310,2008-03-04T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
18319310,2008-03-04T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
18319310,2008-03-04T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
18319310,2008-03-04T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
18319310,2008-03-04T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18319310,2008-03-04T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18319310,2008-03-04T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18319310,2008-03-04T00:00:00,Diabetic Angiopathies,C14.907.320
18319310,2008-03-04T00:00:00,Diabetic Angiopathies,C19.246.099.500
18319310,2008-03-04T00:00:00,Diabetic Nephropathies,C12.777.419.192
18319310,2008-03-04T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
18319310,2008-03-04T00:00:00,Diabetic Nephropathies,C19.246.099.875
18319310,2008-03-04T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
18319310,2008-03-04T00:00:00,Glomerular Filtration Rate,G08.852.357
18319310,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18319310,2008-03-04T00:00:00,Immediate-Early Proteins,D12.776.460
18319310,2008-03-04T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
18319310,2008-03-04T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18319310,2008-03-04T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18319310,2008-03-04T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18319310,2008-03-04T00:00:00,Peptide Fragments,D12.644.541
18400537,2008-03-04T00:00:00,Ceramides,D02.065.313
18400537,2008-03-04T00:00:00,Ceramides,D09.400.410.420.525.200
18400537,2008-03-04T00:00:00,Ceramides,D10.390.470.675.200
18400537,2008-03-04T00:00:00,Ceramides,D10.570.877.360.612.200
18400537,2008-03-04T00:00:00,Gamma Rays,G01.201.875.750.400
18400537,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18400537,2008-03-04T00:00:00,Oxidoreductases,D08.811.682
18400537,2008-03-04T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
18400537,2008-03-04T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
18400537,2008-03-04T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
18400537,2008-03-04T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
18400537,2008-03-04T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
18400537,2008-03-04T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
18400538,2008-03-04T00:00:00,Animals,B01.050
18400538,2008-03-04T00:00:00,Anoxia,C23.888.852.079
18400538,2008-03-04T00:00:00,Ceramides,D02.065.313
18400538,2008-03-04T00:00:00,Ceramides,D09.400.410.420.525.200
18400538,2008-03-04T00:00:00,Ceramides,D10.390.470.675.200
18400538,2008-03-04T00:00:00,Ceramides,D10.570.877.360.612.200
18400538,2008-03-04T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
18400538,2008-03-04T00:00:00,"Heart Defects, Congenital",C14.240.400
18400538,2008-03-04T00:00:00,"Heart Defects, Congenital",C14.280.400
18400538,2008-03-04T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18400538,2008-03-04T00:00:00,Lipid Metabolism,G03.495.520
18400538,2008-03-04T00:00:00,Myocardium,A02.633.580
18400538,2008-03-04T00:00:00,Myocardium,A07.541.704
18400538,2008-03-04T00:00:00,Myocardium,A10.690.552.750
18400538,2008-03-04T00:00:00,Sphingosine,D02.033.100.700
18400538,2008-03-04T00:00:00,Sphingosine,D02.033.455.843
18400538,2008-03-04T00:00:00,Sphingosine,D02.092.063.700
18402828,2008-03-04T00:00:00,Adenocarcinoma,C04.557.470.200.025
18402828,2008-03-04T00:00:00,Cell Differentiation,G04.299.151
18402828,2008-03-04T00:00:00,Echocardiography,E01.370.350.850.220
18402828,2008-03-04T00:00:00,Echocardiography,E01.370.370.380.220
18402828,2008-03-04T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
18402828,2008-03-04T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
18402828,2008-03-04T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
18402828,2008-03-04T00:00:00,Heart Neoplasms,C04.588.894.309
18402828,2008-03-04T00:00:00,Heart Neoplasms,C14.280.459
18402828,2008-03-04T00:00:00,Heart Ventricles,A07.541.560
18402828,2008-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18402828,2008-03-04T00:00:00,Middle Aged,M01.060.116.630
18402828,2008-03-04T00:00:00,Neoplasm Invasiveness,C04.697.645
18402828,2008-03-04T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18402828,2008-03-04T00:00:00,Palliative Care,E02.760.666
18402828,2008-03-04T00:00:00,Palliative Care,N02.421.585.666
18402828,2008-03-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18402828,2008-03-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18402828,2008-03-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18402828,2008-03-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18402828,2008-03-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18320046,2008-03-05T00:00:00,Case-Control Studies,E05.318.760.500.500
18320046,2008-03-05T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18320046,2008-03-05T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18320046,2008-03-05T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18320046,2008-03-05T00:00:00,Genetic Predisposition to Disease,G05.380.355
18320046,2008-03-05T00:00:00,Genetic Variation,G05.365
18320046,2008-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18320046,2008-03-05T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18320046,2008-03-05T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18320046,2008-03-05T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18321521,2008-03-05T00:00:00,Nanotechnology,H01.603
18321521,2008-03-05T00:00:00,Nanotechnology,J01.897.520.600
18321521,2008-03-05T00:00:00,Software,L01.224.900
18321653,2008-03-05T00:00:00,Adult,M01.060.116
18321653,2008-03-05T00:00:00,Blood Pressure,E01.370.600.875.249
18321653,2008-03-05T00:00:00,Blood Pressure,G09.330.380.076
18321653,2008-03-05T00:00:00,Corticotropin-Releasing Hormone,D06.472.699.327.740.140
18321653,2008-03-05T00:00:00,Corticotropin-Releasing Hormone,D12.644.400.400.740.140
18321653,2008-03-05T00:00:00,Corticotropin-Releasing Hormone,D12.644.548.365.740.140
18321653,2008-03-05T00:00:00,Corticotropin-Releasing Hormone,D12.776.641.650.405.740.140
18321653,2008-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18321653,2008-03-05T00:00:00,Hydrocortisone,D04.808.745.745.654.600
18321653,2008-03-05T00:00:00,Hydrocortisone,D06.472.040.585.353.476
18321653,2008-03-05T00:00:00,Hydrocortisone,D06.472.040.585.478.392
18321653,2008-03-05T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
18321653,2008-03-05T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
18321653,2008-03-05T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
18321653,2008-03-05T00:00:00,Middle Aged,M01.060.116.630
18321653,2008-03-05T00:00:00,Pituitary-Adrenal System,A06.407.691
18321653,2008-03-05T00:00:00,Research Design,E05.581.500
18321653,2008-03-05T00:00:00,Research Design,H01.770.644.728
18321653,2008-03-05T00:00:00,Sex Characteristics,G08.686.815
18321653,2008-03-05T00:00:00,Sex Factors,N05.715.350.675
18321653,2008-03-05T00:00:00,Sex Factors,N06.850.490.875
18321653,2008-03-05T00:00:00,Smoking,F01.145.466.753
18321653,2008-03-05T00:00:00,"Stress, Physiological",G07.700.830
18321653,2008-03-05T00:00:00,"Stress, Psychological",F01.145.126.990
18321653,2008-03-05T00:00:00,"Stress, Psychological",F02.830.900
18321948,2008-03-05T00:00:00,Aortic Valve Stenosis,C14.280.484.150
18321948,2008-03-05T00:00:00,Aortic Valve Stenosis,C14.280.955.249
18321948,2008-03-05T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18321948,2008-03-05T00:00:00,Coronary Angiography,E01.370.370.050.200
18321948,2008-03-05T00:00:00,Coronary Angiography,E01.370.370.380.200
18321948,2008-03-05T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
18321948,2008-03-05T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
18321948,2008-03-05T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
18321948,2008-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18321948,2008-03-05T00:00:00,Incidental Findings,E01.410
18321948,2008-03-05T00:00:00,Middle Aged,M01.060.116.630
18321948,2008-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18321948,2008-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18321948,2008-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18321948,2008-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18321948,2008-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18322260,2008-03-05T00:00:00,Brain Ischemia,C10.228.140.300.150
18322260,2008-03-05T00:00:00,Brain Ischemia,C14.907.253.092
18322260,2008-03-05T00:00:00,Clinical Trials as Topic,E05.318.760.535
18322260,2008-03-05T00:00:00,Clinical Trials as Topic,E05.337.250
18322260,2008-03-05T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18322260,2008-03-05T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18322260,2008-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18322260,2008-03-05T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
18322260,2008-03-05T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
18322260,2008-03-05T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
18322260,2008-03-05T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18322260,2008-03-05T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18322260,2008-03-05T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18322260,2008-03-05T00:00:00,Secondary Prevention,N02.421.726.825
18322260,2008-03-05T00:00:00,Secondary Prevention,N06.850.780.750
18322260,2008-03-05T00:00:00,Stroke,C10.228.140.300.775
18322260,2008-03-05T00:00:00,Stroke,C14.907.253.855
18322260,2008-03-05T00:00:00,Ticlopidine,D02.886.778.834
18322260,2008-03-05T00:00:00,Ticlopidine,D03.383.903.834
18322462,2008-03-05T00:00:00,Brain,A08.186.211
18322462,2008-03-05T00:00:00,Brain Mapping,E01.370.350.086
18322462,2008-03-05T00:00:00,Brain Mapping,E01.370.376.149
18322462,2008-03-05T00:00:00,Brain Mapping,E05.132
18322462,2008-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18322462,2008-03-05T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18322462,2008-03-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18322462,2008-03-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18322462,2008-03-05T00:00:00,Photic Stimulation,E05.723.729
18322462,2008-03-05T00:00:00,Photography,E01.370.350.600
18322462,2008-03-05T00:00:00,Photography,E05.712
18322462,2008-03-05T00:00:00,Research Design,E05.581.500
18322462,2008-03-05T00:00:00,Research Design,H01.770.644.728
18322462,2008-03-05T00:00:00,Visual Perception,F02.463.593.932
18435953,2008-03-05T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
18435953,2008-03-05T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
18435953,2008-03-05T00:00:00,Coronary Disease,C14.280.647.250
18435953,2008-03-05T00:00:00,Coronary Disease,C14.907.585.250
18435953,2008-03-05T00:00:00,Diabetes Mellitus,C18.452.394.750
18435953,2008-03-05T00:00:00,Diabetes Mellitus,C19.246
18435953,2008-03-05T00:00:00,Drug-Eluting Stents,E07.695.750.500
18435953,2008-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18435953,2008-03-05T00:00:00,Insulin,D06.472.699.587.740.625
18435953,2008-03-05T00:00:00,Insulin,D12.644.548.586.740.625
18435953,2008-03-05T00:00:00,Middle Aged,M01.060.116.630
18435953,2008-03-05T00:00:00,Treatment Outcome,E01.789.800
18435953,2008-03-05T00:00:00,Treatment Outcome,N04.761.559.590.800
18435953,2008-03-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18323513,2008-03-06T00:00:00,Adult,M01.060.116
18323513,2008-03-06T00:00:00,African Continental Ancestry Group,M01.686.508.100
18323513,2008-03-06T00:00:00,Aged,M01.060.116.100
18323513,2008-03-06T00:00:00,Blood Pressure,E01.370.600.875.249
18323513,2008-03-06T00:00:00,Blood Pressure,G09.330.380.076
18323513,2008-03-06T00:00:00,European Continental Ancestry Group,M01.686.508.400
18323513,2008-03-06T00:00:00,Genomics,H01.158.273.180.350
18323513,2008-03-06T00:00:00,Genomics,H01.158.273.343.350
18323513,2008-03-06T00:00:00,Hispanic Americans,M01.686.754.441
18323513,2008-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18323513,2008-03-06T00:00:00,Middle Aged,M01.060.116.630
18323513,2008-03-06T00:00:00,Myocardial Infarction,C14.280.647.500
18323513,2008-03-06T00:00:00,Myocardial Infarction,C14.907.585.500
18323513,2008-03-06T00:00:00,Phenotype,G05.695
18323513,2008-03-06T00:00:00,Stroke,C10.228.140.300.775
18323513,2008-03-06T00:00:00,Stroke,C14.907.253.855
18323784,2008-03-06T00:00:00,Actins,D05.750.078.730.250
18323784,2008-03-06T00:00:00,Actins,D12.776.210.500.100
18323784,2008-03-06T00:00:00,Actins,D12.776.220.525.255
18323784,2008-03-06T00:00:00,Case-Control Studies,E05.318.760.500.500
18323784,2008-03-06T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18323784,2008-03-06T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18323784,2008-03-06T00:00:00,Collagen,D05.750.078.280
18323784,2008-03-06T00:00:00,Collagen,D12.776.860.300.250
18323784,2008-03-06T00:00:00,Collagen Type I,D05.750.078.280.300.100
18323784,2008-03-06T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
18323784,2008-03-06T00:00:00,Fibroblasts,A11.329.228
18323784,2008-03-06T00:00:00,Fibroblasts,A11.872.228
18323784,2008-03-06T00:00:00,Gene Expression Regulation,G05.355.315
18323784,2008-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18323784,2008-03-06T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
18323784,2008-03-06T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
18323784,2008-03-06T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
18323784,2008-03-06T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
18323784,2008-03-06T00:00:00,"Scleroderma, Systemic",C17.300.799
18323784,2008-03-06T00:00:00,"Scleroderma, Systemic",C17.800.784
18323784,2008-03-06T00:00:00,Skin,A17.815
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18323784,2008-03-06T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18326054,2008-03-06T00:00:00,"Child, Preschool",M01.060.406.448
18326054,2008-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18326054,2008-03-06T00:00:00,Physical Therapy Modalities,E02.779
18326054,2008-03-06T00:00:00,Spinal Cord Injuries,C10.228.854.770
18326054,2008-03-06T00:00:00,Spinal Cord Injuries,C10.900.850
18326054,2008-03-06T00:00:00,Spinal Cord Injuries,C21.866.819
18326054,2008-03-06T00:00:00,Treatment Outcome,E01.789.800
18326054,2008-03-06T00:00:00,Treatment Outcome,N04.761.559.590.800
18326054,2008-03-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18326054,2008-03-06T00:00:00,Walking,G11.427.590.530.568.900
18326054,2008-03-06T00:00:00,Walking,G11.427.590.530.698.940
18326054,2008-03-06T00:00:00,Walking,I03.450.642.845.940
18396063,2008-03-06T00:00:00,Adult,M01.060.116
18396063,2008-03-06T00:00:00,Brain Mapping,E01.370.350.086
18396063,2008-03-06T00:00:00,Brain Mapping,E01.370.376.149
18396063,2008-03-06T00:00:00,Brain Mapping,E05.132
18396063,2008-03-06T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18396063,2008-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18396063,2008-03-06T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
18396063,2008-03-06T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
18396063,2008-03-06T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
18396063,2008-03-06T00:00:00,Language,F01.145.209.399
18396063,2008-03-06T00:00:00,Language,L01.143.506
18396063,2008-03-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18396063,2008-03-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18396063,2008-03-06T00:00:00,Speech Perception,F02.463.593.071.875
18326857,2008-03-07T00:00:00,Cell Survival,G04.299.316
18326857,2008-03-07T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
18326857,2008-03-07T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
18326857,2008-03-07T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
18326857,2008-03-07T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
18326857,2008-03-07T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
18326857,2008-03-07T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18326857,2008-03-07T00:00:00,Epithelial Cells,A11.436
18326857,2008-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18326857,2008-03-07T00:00:00,Hyaluronic Acid,D09.698.373.475
18326857,2008-03-07T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18326857,2008-03-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18326857,2008-03-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18326857,2008-03-07T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
18326857,2008-03-07T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
18326857,2008-03-07T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
18326857,2008-03-07T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
18326857,2008-03-07T00:00:00,"Receptor, erbB-2",D23.101.840.642
18326857,2008-03-07T00:00:00,Signal Transduction,G02.111.087.800
18326857,2008-03-07T00:00:00,Signal Transduction,G02.149.115.800
18326857,2008-03-07T00:00:00,Signal Transduction,G04.299.880
18326857,2008-03-07T00:00:00,beta Catenin,D12.776.091.249
18326857,2008-03-07T00:00:00,beta Catenin,D12.776.220.145.500
18326857,2008-03-07T00:00:00,beta Catenin,D12.776.930.130
18329227,2008-03-07T00:00:00,Adult,M01.060.116
18329227,2008-03-07T00:00:00,Alcoholism,C21.739.100.250
18329227,2008-03-07T00:00:00,Alcoholism,F03.900.100.350
18329227,2008-03-07T00:00:00,Community Health Services,N02.421.143
18329227,2008-03-07T00:00:00,Data Collection,E05.318.308
18329227,2008-03-07T00:00:00,Data Collection,L01.280
18329227,2008-03-07T00:00:00,Data Collection,N05.715.360.300
18329227,2008-03-07T00:00:00,Data Collection,N06.850.520.308
18329227,2008-03-07T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18329227,2008-03-07T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18329227,2008-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18329227,2008-03-07T00:00:00,Inservice Training,I02.574
18329227,2008-03-07T00:00:00,Middle Aged,M01.060.116.630
18329227,2008-03-07T00:00:00,Naltrexone,D03.132.577.249.706.550
18329227,2008-03-07T00:00:00,Naltrexone,D03.549.686.750.550
18329227,2008-03-07T00:00:00,Naltrexone,D03.605.497.750.550
18329227,2008-03-07T00:00:00,Naltrexone,D04.615.723.795.706.550
18329227,2008-03-07T00:00:00,Narcotic Antagonists,D27.505.696.543
18329227,2008-03-07T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
18329227,2008-03-07T00:00:00,Narcotic Antagonists,D27.505.954.427.550
18329227,2008-03-07T00:00:00,Pilot Projects,E05.318.760.750
18329227,2008-03-07T00:00:00,Pilot Projects,E05.337.737
18329227,2008-03-07T00:00:00,Pilot Projects,N05.715.360.775.625
18329227,2008-03-07T00:00:00,Pilot Projects,N06.850.520.450.720
18329227,2008-03-07T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
18329227,2008-03-07T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
18331398,2008-03-07T00:00:00,Animals,B01.050
18331398,2008-03-07T00:00:00,Rabbits,B01.050.150.900.649.521.700
18331398,2008-03-07T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
18331398,2008-03-07T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
18331398,2008-03-07T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
18331398,2008-03-07T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
18331398,2008-03-07T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
18331398,2008-03-07T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
18331398,2008-03-07T00:00:00,Water,D01.455.900
18331398,2008-03-07T00:00:00,Water,D01.650.550.925
18164543,2008-03-08T00:00:00,Apoptosis,G04.299.139.160
18164543,2008-03-08T00:00:00,Caspases,D08.811.277.656.262.500.126
18164543,2008-03-08T00:00:00,Caspases,D08.811.277.656.300.200.126
18164543,2008-03-08T00:00:00,Caspases,D12.644.360.075.405
18164543,2008-03-08T00:00:00,Caspases,D12.776.476.075.405
18164543,2008-03-08T00:00:00,Cell Cycle,G04.299.134
18164543,2008-03-08T00:00:00,Cell Differentiation,G04.299.151
18164543,2008-03-08T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
18164543,2008-03-08T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
18164543,2008-03-08T00:00:00,Fenretinide,D02.455.849.131.495.270
18164543,2008-03-08T00:00:00,Fenretinide,D23.767.261.700.270
18164543,2008-03-08T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
18164543,2008-03-08T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
18164543,2008-03-08T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
18164543,2008-03-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.644.276.374.440.893
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.644.276.374.480.350
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.644.276.718.550
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.776.467.374.440.893
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.776.467.374.480.350
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
18164543,2008-03-08T00:00:00,Interferon-gamma,D12.776.467.718.550
18164543,2008-03-08T00:00:00,Interferon-gamma,D23.529.374.440.893
18164543,2008-03-08T00:00:00,Interferon-gamma,D23.529.374.480.350
18164543,2008-03-08T00:00:00,Interferon-gamma,D23.529.374.480.615.350
18164543,2008-03-08T00:00:00,Interferon-gamma,D23.529.718.550
18164543,2008-03-08T00:00:00,"Models, Biological",E05.599.395
18164543,2008-03-08T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
18164543,2008-03-08T00:00:00,Telomerase,D12.776.157.725.500.921
18164543,2008-03-08T00:00:00,Telomerase,D12.776.664.962.500.921
18327258,2008-03-09T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
18327258,2008-03-09T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
18327258,2008-03-09T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
18327258,2008-03-09T00:00:00,Amino Acid Sequence,G02.111.570.060
18327258,2008-03-09T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18327258,2008-03-09T00:00:00,Animals,B01.050
18327258,2008-03-09T00:00:00,Cilia,A11.284.180.165
18327258,2008-03-09T00:00:00,Ethylnitrosourea,D02.654.692.300
18327258,2008-03-09T00:00:00,Ethylnitrosourea,D02.948.594.310
18327258,2008-03-09T00:00:00,Fibroblasts,A11.329.228
18327258,2008-03-09T00:00:00,Fibroblasts,A11.872.228
18327258,2008-03-09T00:00:00,Molecular Sequence Data,L01.453.245.667
18327258,2008-03-09T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
18327258,2008-03-09T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
18327258,2008-03-09T00:00:00,Signal Transduction,G02.111.087.800
18327258,2008-03-09T00:00:00,Signal Transduction,G02.149.115.800
18327258,2008-03-09T00:00:00,Signal Transduction,G04.299.880
18327258,2008-03-09T00:00:00,Spinal Cord,A08.186.854
18327258,2008-03-09T00:00:00,Trans-Activators,D12.776.260.755
18327258,2008-03-09T00:00:00,Trans-Activators,D12.776.930.900
18327258,2008-03-09T00:00:00,Trans-Activators,D12.776.964.925.984
18327258,2008-03-09T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
18332155,2008-03-10T00:00:00,African Continental Ancestry Group,M01.686.508.100
18332155,2008-03-10T00:00:00,Aged,M01.060.116.100
18332155,2008-03-10T00:00:00,Awareness,F02.463.188.150
18332155,2008-03-10T00:00:00,Continental Population Groups,M01.686.508
18332155,2008-03-10T00:00:00,Depression,F01.145.126.350
18332155,2008-03-10T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18332155,2008-03-10T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18332155,2008-03-10T00:00:00,Employment,N01.824.245
18332155,2008-03-10T00:00:00,Ethnic Groups,M01.686.754
18332155,2008-03-10T00:00:00,Ethnic Groups,N01.224.317
18332155,2008-03-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
18332155,2008-03-10T00:00:00,Hispanic Americans,M01.686.754.441
18332155,2008-03-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18332155,2008-03-10T00:00:00,Middle Aged,M01.060.116.630
18332266,2008-03-10T00:00:00,Animals,B01.050
18332266,2008-03-10T00:00:00,Cell Movement,G04.299.283
18332266,2008-03-10T00:00:00,Cell Movement,G07.700.560.500.180
18332266,2008-03-10T00:00:00,"Embryo, Nonmammalian",A13.350
18332266,2008-03-10T00:00:00,"Embryo, Nonmammalian",A16.331
18332266,2008-03-10T00:00:00,Fibroblasts,A11.329.228
18332266,2008-03-10T00:00:00,Fibroblasts,A11.872.228
18332266,2008-03-10T00:00:00,Fibrosis,C23.550.355
18332266,2008-03-10T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18332266,2008-03-10T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18332266,2008-03-10T00:00:00,"Myocytes, Cardiac",A11.620.500
18332266,2008-03-10T00:00:00,Pericardium,A07.541.795
18332266,2008-03-10T00:00:00,Pericardium,A10.615.789.470
18358825,2008-03-10T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
18358825,2008-03-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18358825,2008-03-10T00:00:00,Peroxiredoxins,D08.811.682.732.850
18358825,2008-03-10T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
18358825,2008-03-10T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
18396207,2008-03-10T00:00:00,Adult,M01.060.116
18396207,2008-03-10T00:00:00,African Americans,M01.686.508.100.100
18396207,2008-03-10T00:00:00,African Americans,M01.686.754.100
18396207,2008-03-10T00:00:00,Alleles,G05.360.340.024.340.030
18396207,2008-03-10T00:00:00,Hepacivirus,B04.450.410
18396207,2008-03-10T00:00:00,Hepacivirus,B04.820.250.475
18396207,2008-03-10T00:00:00,Hepacivirus,B04.909.777.310.475
18396207,2008-03-10T00:00:00,Hepatitis C,C02.440.440
18396207,2008-03-10T00:00:00,Hepatitis C,C02.782.350.350
18396207,2008-03-10T00:00:00,Hepatitis C,C06.552.380.705.440
18396207,2008-03-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18396207,2008-03-10T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18396207,2008-03-10T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18396207,2008-03-10T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
18396207,2008-03-10T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
18396207,2008-03-10T00:00:00,Middle Aged,M01.060.116.630
18396207,2008-03-10T00:00:00,Phenotype,G05.695
18396207,2008-03-10T00:00:00,Serologic Tests,E01.450.495.735
18396207,2008-03-10T00:00:00,Serologic Tests,E05.478.594.760
18334599,2008-03-11T00:00:00,Animals,B01.050
18334599,2008-03-11T00:00:00,Apoptosis,G04.299.139.160
18334599,2008-03-11T00:00:00,Dendritic Cells,A11.066.270
18334599,2008-03-11T00:00:00,Dendritic Cells,A11.436.270
18334599,2008-03-11T00:00:00,Dendritic Cells,A15.382.066.270
18334599,2008-03-11T00:00:00,Dendritic Cells,A15.382.812.260
18334599,2008-03-11T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18334599,2008-03-11T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18334599,2008-03-11T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18334599,2008-03-11T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18334599,2008-03-11T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18334599,2008-03-11T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18334599,2008-03-11T00:00:00,Tetrachlorodibenzodioxin,D03.383.231.900
18336635,2008-03-11T00:00:00,Adult,M01.060.116
18336635,2008-03-11T00:00:00,Aged,M01.060.116.100
18336635,2008-03-11T00:00:00,Alcoholism,C21.739.100.250
18336635,2008-03-11T00:00:00,Alcoholism,F03.900.100.350
18336635,2008-03-11T00:00:00,Cognitive Therapy,F04.754.137.428
18336635,2008-03-11T00:00:00,"Data Interpretation, Statistical",E05.245.380
18336635,2008-03-11T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18336635,2008-03-11T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18336635,2008-03-11T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18336635,2008-03-11T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18336635,2008-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18336635,2008-03-11T00:00:00,Middle Aged,M01.060.116.630
18336635,2008-03-11T00:00:00,Naltrexone,D03.132.577.249.706.550
18336635,2008-03-11T00:00:00,Naltrexone,D03.549.686.750.550
18336635,2008-03-11T00:00:00,Naltrexone,D03.605.497.750.550
18336635,2008-03-11T00:00:00,Naltrexone,D04.615.723.795.706.550
18336635,2008-03-11T00:00:00,Narcotic Antagonists,D27.505.696.543
18336635,2008-03-11T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
18336635,2008-03-11T00:00:00,Narcotic Antagonists,D27.505.954.427.550
18336635,2008-03-11T00:00:00,Patient Compliance,F01.145.488.500
18336635,2008-03-11T00:00:00,Patient Compliance,N05.300.150.600.600
18336635,2008-03-11T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18336635,2008-03-11T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18336635,2008-03-11T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18336635,2008-03-11T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18336635,2008-03-11T00:00:00,Sex Factors,N05.715.350.675
18336635,2008-03-11T00:00:00,Sex Factors,N06.850.490.875
18336635,2008-03-11T00:00:00,Treatment Outcome,E01.789.800
18336635,2008-03-11T00:00:00,Treatment Outcome,N04.761.559.590.800
18336635,2008-03-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18335026,2008-03-12T00:00:00,Alleles,G05.360.340.024.340.030
18335026,2008-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18335026,2008-03-12T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18335026,2008-03-12T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18335026,2008-03-12T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18335026,2008-03-12T00:00:00,Sex Factors,N05.715.350.675
18335026,2008-03-12T00:00:00,Sex Factors,N06.850.490.875
18336038,2008-03-13T00:00:00,Ethers,D02.355
18336038,2008-03-13T00:00:00,Molecular Structure,G02.111.570
18336038,2008-03-13T00:00:00,Molecular Structure,G02.575
18336038,2008-03-13T00:00:00,Molecular Structure,G02.842.575
18336038,2008-03-13T00:00:00,Spiro Compounds,D02.455.426.559.847.885
18336038,2008-03-13T00:00:00,Spiro Compounds,D04.615.885
18339970,2008-03-13T00:00:00,Animals,B01.050
18339970,2008-03-13T00:00:00,Cyclosporine,D04.345.566.235.300
18339970,2008-03-13T00:00:00,Cyclosporine,D12.644.641.235.300
18339970,2008-03-13T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
18339970,2008-03-13T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
18339970,2008-03-13T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
18339970,2008-03-13T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
18339970,2008-03-13T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18339970,2008-03-13T00:00:00,Mitochondria,A11.284.835.626
18339970,2008-03-13T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
18339970,2008-03-13T00:00:00,Rabbits,B01.050.150.900.649.521.700
18341645,2008-03-13T00:00:00,Animals,B01.050
18341645,2008-03-13T00:00:00,Ethanol,D02.033.375
18341645,2008-03-13T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18341645,2008-03-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18341645,2008-03-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18341645,2008-03-13T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18341645,2008-03-13T00:00:00,Synaptic Transmission,G02.111.087.800.850
18341645,2008-03-13T00:00:00,Synaptic Transmission,G02.149.115.800.850
18341645,2008-03-13T00:00:00,Synaptic Transmission,G04.299.880.850
18341645,2008-03-13T00:00:00,Synaptic Transmission,G07.265.337.900
18341645,2008-03-13T00:00:00,Synaptic Transmission,G07.700.240.900
18341645,2008-03-13T00:00:00,Synaptic Transmission,G11.561.600.835
18344371,2008-03-14T00:00:00,Animals,B01.050
18344371,2008-03-14T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
18344371,2008-03-14T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
18344371,2008-03-14T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18344371,2008-03-14T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18344371,2008-03-14T00:00:00,Mutation,G05.365.590
18344371,2008-03-14T00:00:00,Myocardial Contraction,G09.330.190.541
18344371,2008-03-14T00:00:00,Myocardial Contraction,G11.427.590.540.570
18344371,2008-03-14T00:00:00,Myocardium,A02.633.580
18344371,2008-03-14T00:00:00,Myocardium,A07.541.704
18344371,2008-03-14T00:00:00,Myocardium,A10.690.552.750
18344371,2008-03-14T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18344371,2008-03-14T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18344371,2008-03-14T00:00:00,"Myocytes, Cardiac",A11.620.500
18344371,2008-03-14T00:00:00,Phenotype,G05.695
18344371,2008-03-14T00:00:00,Tubulin,D05.750.078.734.800
18344371,2008-03-14T00:00:00,Tubulin,D12.776.220.600.800
18344371,2008-03-14T00:00:00,Tubulin,D12.776.641.920
18344371,2008-03-14T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18339881,2008-03-15T00:00:00,Animals,B01.050
18339881,2008-03-15T00:00:00,Apoptosis,G04.299.139.160
18339881,2008-03-15T00:00:00,Bone Morphogenetic Proteins,D12.644.276.954.200
18339881,2008-03-15T00:00:00,Bone Morphogenetic Proteins,D12.776.467.942.200
18339881,2008-03-15T00:00:00,Bone Morphogenetic Proteins,D23.529.942.200
18339881,2008-03-15T00:00:00,Gene Expression Profiling,E05.393.332
18339881,2008-03-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18339881,2008-03-15T00:00:00,Homeodomain Proteins,D12.776.260.400
18339881,2008-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18339881,2008-03-15T00:00:00,Neoplasm Proteins,D12.776.624
18339881,2008-03-15T00:00:00,Nuclear Proteins,D12.776.660
18339881,2008-03-15T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18339881,2008-03-15T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18339881,2008-03-15T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18339881,2008-03-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18339881,2008-03-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
18339881,2008-03-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
18339881,2008-03-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
18339881,2008-03-15T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D08.811.913.696.620.682.725.400.900.500
18339881,2008-03-15T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D12.776.543.750.060.625.300
18339881,2008-03-15T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D12.776.543.750.750.400.630.300
18339881,2008-03-15T00:00:00,"Transcription, Genetic",G02.111.087.847
18339881,2008-03-15T00:00:00,"Transcription, Genetic",G02.149.115.847
18339881,2008-03-15T00:00:00,"Transcription, Genetic",G05.355.310.700
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18339881,2008-03-15T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18343923,2008-03-15T00:00:00,Antigen Presentation,G12.425.107
18343923,2008-03-15T00:00:00,Antigen Presentation,G12.450.050.400.070
18343923,2008-03-15T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18343923,2008-03-15T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18343923,2008-03-15T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18343923,2008-03-15T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18343923,2008-03-15T00:00:00,Flow Cytometry,E05.200.500.386.350
18343923,2008-03-15T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
18343923,2008-03-15T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
18343923,2008-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18343923,2008-03-15T00:00:00,Lymphocyte Activation,E01.450.495.482
18343923,2008-03-15T00:00:00,Lymphocyte Activation,E05.478.594.530
18343923,2008-03-15T00:00:00,Lymphocyte Activation,G12.425.747
18343923,2008-03-15T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18343923,2008-03-15T00:00:00,Melanoma,C04.557.465.625.650.510
18343923,2008-03-15T00:00:00,Melanoma,C04.557.580.625.650.510
18343923,2008-03-15T00:00:00,Melanoma,C04.557.665.510
18343923,2008-03-15T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18343923,2008-03-15T00:00:00,"Microscopy, Confocal",E05.595.395
18343923,2008-03-15T00:00:00,"RNA, Messenger",D13.444.735.544
18343923,2008-03-15T00:00:00,Skin Neoplasms,C04.588.805
18343923,2008-03-15T00:00:00,Skin Neoplasms,C17.800.882
18344547,2008-03-15T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18344547,2008-03-15T00:00:00,Daptomycin,D04.345.566.270
18344547,2008-03-15T00:00:00,Daptomycin,D10.477.500
18344547,2008-03-15T00:00:00,Daptomycin,D12.644.365.500
18344547,2008-03-15T00:00:00,Daptomycin,D12.644.641.270
18344547,2008-03-15T00:00:00,"Endocarditis, Bacterial",C01.252.300
18344547,2008-03-15T00:00:00,"Endocarditis, Bacterial",C01.539.190.249
18344547,2008-03-15T00:00:00,"Endocarditis, Bacterial",C14.260.249
18344547,2008-03-15T00:00:00,"Endocarditis, Bacterial",C14.280.282.407
18344547,2008-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18344547,2008-03-15T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
18344547,2008-03-15T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
18344547,2008-03-15T00:00:00,Middle Aged,M01.060.116.630
18344547,2008-03-15T00:00:00,Treatment Outcome,E01.789.800
18344547,2008-03-15T00:00:00,Treatment Outcome,N04.761.559.590.800
18344547,2008-03-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18347183,2008-03-15T00:00:00,Animals,B01.050
18347183,2008-03-15T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18347183,2008-03-15T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18347183,2008-03-15T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18347183,2008-03-15T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18347183,2008-03-15T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18347183,2008-03-15T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18347183,2008-03-15T00:00:00,Antineoplastic Agents,D27.505.954.248
18347183,2008-03-15T00:00:00,Drug Delivery Systems,E02.319.300
18347183,2008-03-15T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18347183,2008-03-15T00:00:00,Glioma,C04.557.465.625.600.380
18347183,2008-03-15T00:00:00,Glioma,C04.557.470.670.380
18347183,2008-03-15T00:00:00,Glioma,C04.557.580.625.600.380
18347183,2008-03-15T00:00:00,Hyaluronic Acid,D09.698.373.475
18347183,2008-03-15T00:00:00,Neoplastic Stem Cells,A11.872.650
18347183,2008-03-15T00:00:00,Polymers,D05.750
18347183,2008-03-15T00:00:00,Polymers,D25.720
18347183,2008-03-15T00:00:00,Polymers,J01.637.051.720
18347183,2008-03-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18347183,2008-03-15T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18381790,2008-03-15T00:00:00,Adolescent,M01.060.057
18381790,2008-03-15T00:00:00,Adult,M01.060.116
18381790,2008-03-15T00:00:00,African Americans,M01.686.508.100.100
18381790,2008-03-15T00:00:00,African Americans,M01.686.754.100
18381790,2008-03-15T00:00:00,Aged,M01.060.116.100
18381790,2008-03-15T00:00:00,Child,M01.060.406
18381790,2008-03-15T00:00:00,"Child, Preschool",M01.060.406.448
18381790,2008-03-15T00:00:00,European Continental Ancestry Group,M01.686.508.400
18381790,2008-03-15T00:00:00,Health Status Disparities,I01.240.425.675
18381790,2008-03-15T00:00:00,Health Status Disparities,N01.224.425.437
18381790,2008-03-15T00:00:00,Health Status Disparities,N06.850.505.400.425.675
18381790,2008-03-15T00:00:00,Hospital Mortality,E05.318.308.985.550.400
18381790,2008-03-15T00:00:00,Hospital Mortality,L01.280.975.550.400
18381790,2008-03-15T00:00:00,Hospital Mortality,N01.224.935.698.400
18381790,2008-03-15T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
18381790,2008-03-15T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
18381790,2008-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18381790,2008-03-15T00:00:00,Infant,M01.060.703
18381790,2008-03-15T00:00:00,"Infant, Newborn",M01.060.703.520
18381790,2008-03-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18381790,2008-03-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18381790,2008-03-15T00:00:00,Middle Aged,M01.060.116.630
18381790,2008-03-15T00:00:00,South Carolina,Z01.107.567.875.075.662
18381790,2008-03-15T00:00:00,South Carolina,Z01.107.567.875.750.700
18440244,2008-03-15T00:00:00,Adolescent,M01.060.057
18440244,2008-03-15T00:00:00,Adult,M01.060.116
18440244,2008-03-15T00:00:00,Aged,M01.060.116.100
18440244,2008-03-15T00:00:00,Brain Mapping,E01.370.350.086
18440244,2008-03-15T00:00:00,Brain Mapping,E01.370.376.149
18440244,2008-03-15T00:00:00,Brain Mapping,E05.132
18440244,2008-03-15T00:00:00,Child,M01.060.406
18440244,2008-03-15T00:00:00,Functional Laterality,F02.830.297.425
18440244,2008-03-15T00:00:00,Functional Laterality,G11.561.225.425
18440244,2008-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18440244,2008-03-15T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18440244,2008-03-15T00:00:00,Middle Aged,M01.060.116.630
18440244,2008-03-15T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
18423620,2008-03-16T00:00:00,Adult,M01.060.116
18423620,2008-03-16T00:00:00,Aged,M01.060.116.100
18423620,2008-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18423620,2008-03-16T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
18423620,2008-03-16T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
18423620,2008-03-16T00:00:00,Melanoma,C04.557.465.625.650.510
18423620,2008-03-16T00:00:00,Melanoma,C04.557.580.625.650.510
18423620,2008-03-16T00:00:00,Melanoma,C04.557.665.510
18423620,2008-03-16T00:00:00,Middle Aged,M01.060.116.630
18423620,2008-03-16T00:00:00,Neoplasm Proteins,D12.776.624
18423620,2008-03-16T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
18423620,2008-03-16T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
18423620,2008-03-16T00:00:00,"Tumor Markers, Biological",D23.101.840
18423620,2008-03-16T00:00:00,Uveal Neoplasms,C04.588.364.978
18423620,2008-03-16T00:00:00,Uveal Neoplasms,C11.319.494
18423620,2008-03-16T00:00:00,Uveal Neoplasms,C11.941.855
18342923,2008-03-17T00:00:00,Adult,M01.060.116
18342923,2008-03-17T00:00:00,Aged,M01.060.116.100
18342923,2008-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18342923,2008-03-17T00:00:00,Middle Aged,M01.060.116.630
18342923,2008-03-17T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
18342923,2008-03-17T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
18342923,2008-03-17T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
18345022,2008-03-17T00:00:00,Animals,B01.050
18345022,2008-03-17T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18345022,2008-03-17T00:00:00,"Behavior, Animal",F01.145.113
18345022,2008-03-17T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
18345022,2008-03-17T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
18345022,2008-03-17T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
18345022,2008-03-17T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
18345022,2008-03-17T00:00:00,Cocaine-Related Disorders,C21.739.300
18345022,2008-03-17T00:00:00,Cocaine-Related Disorders,F03.900.300
18345022,2008-03-17T00:00:00,Dopamine,D02.092.211.215.311.342
18345022,2008-03-17T00:00:00,Dopamine,D02.092.311.342
18345022,2008-03-17T00:00:00,Glutamic Acid,D12.125.067.750
18345022,2008-03-17T00:00:00,Glutamic Acid,D12.125.119.450
18345022,2008-03-17T00:00:00,Glutamic Acid,D12.125.427.300
18345022,2008-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18345022,2008-03-17T00:00:00,Limbic System,A08.186.211.464
18345022,2008-03-17T00:00:00,"Models, Animal",E05.598
18345022,2008-03-17T00:00:00,Neural Pathways,A08.612
18345022,2008-03-17T00:00:00,Neuronal Plasticity,G11.561.600.635
18345022,2008-03-17T00:00:00,Psychomotor Performance,F02.808
18345022,2008-03-17T00:00:00,Psychomotor Performance,G11.427.700
18345022,2008-03-17T00:00:00,Psychomotor Performance,G11.561.623
18345022,2008-03-17T00:00:00,Synaptic Transmission,G02.111.087.800.850
18345022,2008-03-17T00:00:00,Synaptic Transmission,G02.149.115.800.850
18345022,2008-03-17T00:00:00,Synaptic Transmission,G04.299.880.850
18345022,2008-03-17T00:00:00,Synaptic Transmission,G07.265.337.900
18345022,2008-03-17T00:00:00,Synaptic Transmission,G07.700.240.900
18345022,2008-03-17T00:00:00,Synaptic Transmission,G11.561.600.835
18346783,2008-03-17T00:00:00,Animals,B01.050
18346783,2008-03-17T00:00:00,Calcium,D01.268.552.100
18346783,2008-03-17T00:00:00,Calcium,D01.552.539.288
18346783,2008-03-17T00:00:00,Calcium,D23.119.100
18346783,2008-03-17T00:00:00,Protons,D01.248.497.300.459.700
18346783,2008-03-17T00:00:00,Protons,D01.435.550
18346783,2008-03-17T00:00:00,Protons,G01.249.765
18346783,2008-03-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18346939,2008-03-17T00:00:00,Epilepsy,C10.228.140.490
18346939,2008-03-17T00:00:00,Estradiol,D04.808.365.415.248
18346939,2008-03-17T00:00:00,Estradiol,D06.472.334.851.437.500
18346939,2008-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18346939,2008-03-17T00:00:00,Progesterone,D04.808.745.745.654.829
18346939,2008-03-17T00:00:00,Progesterone,D06.472.334.734.623
18346939,2008-03-17T00:00:00,Progesterone,D06.472.334.851.687.750
18471721,2008-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18471721,2008-03-17T00:00:00,Reoperation,E04.690
18471721,2008-03-17T00:00:00,Sphincter of Oddi Dysfunction,C06.130.120.250.098.800
18471721,2008-03-17T00:00:00,Stents,E07.695.750
18471721,2008-03-17T00:00:00,Treatment Outcome,E01.789.800
18471721,2008-03-17T00:00:00,Treatment Outcome,N04.761.559.590.800
18471721,2008-03-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18342224,2008-03-18T00:00:00,Adult,M01.060.116
18342224,2008-03-18T00:00:00,Aged,M01.060.116.100
18342224,2008-03-18T00:00:00,Heart Failure,C14.280.434
18342224,2008-03-18T00:00:00,Hemodynamics,G09.330.190.400
18342224,2008-03-18T00:00:00,Hemodynamics,G09.330.380
18342224,2008-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18342224,2008-03-18T00:00:00,Middle Aged,M01.060.116.630
18342224,2008-03-18T00:00:00,"Monitoring, Physiologic",E01.370.520
18342224,2008-03-18T00:00:00,Ventricular Pressure,G09.330.190.962.950
18342224,2008-03-18T00:00:00,Ventricular Pressure,G09.330.380.937
18349434,2008-03-18T00:00:00,Aged,M01.060.116.100
18349434,2008-03-18T00:00:00,Caregivers,M01.085
18349434,2008-03-18T00:00:00,Caregivers,M01.526.485.200
18349434,2008-03-18T00:00:00,Caregivers,N02.360.200
18349434,2008-03-18T00:00:00,Decision Making,F02.463.785.373
18349434,2008-03-18T00:00:00,Dementia,C10.228.140.380
18349434,2008-03-18T00:00:00,Dementia,F03.087.400
18349434,2008-03-18T00:00:00,Geriatric Assessment,E05.318.308.225
18349434,2008-03-18T00:00:00,Geriatric Assessment,I01.240.425.350
18349434,2008-03-18T00:00:00,Geriatric Assessment,L01.280.360
18349434,2008-03-18T00:00:00,Geriatric Assessment,N01.224.425.350
18349434,2008-03-18T00:00:00,Geriatric Assessment,N05.715.360.300.360
18349434,2008-03-18T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
18349434,2008-03-18T00:00:00,Geriatric Assessment,N06.850.520.308.225
18349434,2008-03-18T00:00:00,Health Status,I01.240.425
18349434,2008-03-18T00:00:00,Health Status,N01.224.425
18349434,2008-03-18T00:00:00,Health Status,N06.850.505.400.425
18349434,2008-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18349434,2008-03-18T00:00:00,Middle Aged,M01.060.116.630
18349434,2008-03-18T00:00:00,Psychiatric Status Rating Scales,F04.586
18353383,2008-03-18T00:00:00,Adult,M01.060.116
18353383,2008-03-18T00:00:00,Aged,M01.060.116.100
18353383,2008-03-18T00:00:00,Biological Markers,D23.101
18353383,2008-03-18T00:00:00,"Biopsy, Needle",E01.370.388.100.100
18353383,2008-03-18T00:00:00,"Biopsy, Needle",E01.450.230.100.100
18353383,2008-03-18T00:00:00,"Biopsy, Needle",E01.450.865.100.100
18353383,2008-03-18T00:00:00,"Biopsy, Needle",E01.450.865.632.100
18353383,2008-03-18T00:00:00,"Biopsy, Needle",E04.074.119
18353383,2008-03-18T00:00:00,Glycoproteins,D09.400.430
18353383,2008-03-18T00:00:00,Glycoproteins,D12.776.395
18353383,2008-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18353383,2008-03-18T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18353383,2008-03-18T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18353383,2008-03-18T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18353383,2008-03-18T00:00:00,Interleukin-6,D12.644.276.374.465.506
18353383,2008-03-18T00:00:00,Interleukin-6,D12.776.467.374.465.506
18353383,2008-03-18T00:00:00,Interleukin-6,D23.529.374.465.506
18353383,2008-03-18T00:00:00,Middle Aged,M01.060.116.630
18353383,2008-03-18T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18353383,2008-03-18T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18353383,2008-03-18T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18353383,2008-03-18T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18353383,2008-03-18T00:00:00,Ulcer,C23.550.891
18353383,2008-03-18T00:00:00,Urinary Bladder,A05.810.890
18417253,2008-03-18T00:00:00,Adult,M01.060.116
18417253,2008-03-18T00:00:00,Body Mass Index,E01.370.600.115.100.125
18417253,2008-03-18T00:00:00,Body Mass Index,E05.041.124.125
18417253,2008-03-18T00:00:00,Body Mass Index,G07.100.100.125
18417253,2008-03-18T00:00:00,Body Mass Index,N06.850.505.200.100.175
18417253,2008-03-18T00:00:00,Dietary Carbohydrates,D09.301
18417253,2008-03-18T00:00:00,Dietary Carbohydrates,J02.500.362
18417253,2008-03-18T00:00:00,Dietary Fats,D10.212.302
18417253,2008-03-18T00:00:00,Dietary Fats,J02.500.375
18417253,2008-03-18T00:00:00,Eating,G07.610.593.260
18417253,2008-03-18T00:00:00,Eating,G07.700.620.260
18417253,2008-03-18T00:00:00,Eating,G10.261.326.240
18417253,2008-03-18T00:00:00,Energy Intake,G07.610.240.340
18417253,2008-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18417253,2008-03-18T00:00:00,Obesity,C18.654.726.500
18417253,2008-03-18T00:00:00,Obesity,C23.888.144.699.500
18417253,2008-03-18T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18417253,2008-03-18T00:00:00,Obesity,G07.100.100.160.120.699.500
18417253,2008-03-18T00:00:00,Pilot Projects,E05.318.760.750
18417253,2008-03-18T00:00:00,Pilot Projects,E05.337.737
18417253,2008-03-18T00:00:00,Pilot Projects,N05.715.360.775.625
18417253,2008-03-18T00:00:00,Pilot Projects,N06.850.520.450.720
18417253,2008-03-18T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18417253,2008-03-18T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18417253,2008-03-18T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18417253,2008-03-18T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18417253,2008-03-18T00:00:00,Taste,F02.830.816.724
18417253,2008-03-18T00:00:00,Taste,G11.561.600.810.724
18348516,2008-03-19T00:00:00,Enzyme Inhibitors,D27.505.519.389
18348516,2008-03-19T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
18348516,2008-03-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18348516,2008-03-19T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
18354020,2008-03-19T00:00:00,Animals,B01.050
18354020,2008-03-19T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18354020,2008-03-19T00:00:00,"Behavior, Animal",F01.145.113
18354020,2008-03-19T00:00:00,Cues,F02.463.425.234
18354020,2008-03-19T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18354020,2008-03-19T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18354020,2008-03-19T00:00:00,Glutamic Acid,D12.125.067.750
18354020,2008-03-19T00:00:00,Glutamic Acid,D12.125.119.450
18354020,2008-03-19T00:00:00,Glutamic Acid,D12.125.427.300
18354020,2008-03-19T00:00:00,Narcotics,D27.505.696.277.600
18354020,2008-03-19T00:00:00,Narcotics,D27.505.696.663.850.014.760
18354020,2008-03-19T00:00:00,Narcotics,D27.505.954.427.040.550
18354020,2008-03-19T00:00:00,Narcotics,D27.505.954.427.210.600
18354020,2008-03-19T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18354020,2008-03-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18354020,2008-03-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18354020,2008-03-19T00:00:00,Self Administration,E02.319.890
18354020,2008-03-19T00:00:00,Self Administration,E02.900.890
18354038,2008-03-19T00:00:00,Animals,B01.050
18354038,2008-03-19T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18354038,2008-03-19T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18354038,2008-03-19T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18354038,2008-03-19T00:00:00,Interferon Type I,D12.644.276.374.440.890
18354038,2008-03-19T00:00:00,Interferon Type I,D12.644.276.718.500
18354038,2008-03-19T00:00:00,Interferon Type I,D12.776.467.374.440.890
18354038,2008-03-19T00:00:00,Interferon Type I,D12.776.467.718.500
18354038,2008-03-19T00:00:00,Interferon Type I,D23.529.374.440.890
18354038,2008-03-19T00:00:00,Interferon Type I,D23.529.718.500
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.644.276.374.440.893
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.644.276.374.480.350
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.644.276.718.550
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.776.467.374.440.893
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.776.467.374.480.350
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
18354038,2008-03-19T00:00:00,Interferon-gamma,D12.776.467.718.550
18354038,2008-03-19T00:00:00,Interferon-gamma,D23.529.374.440.893
18354038,2008-03-19T00:00:00,Interferon-gamma,D23.529.374.480.350
18354038,2008-03-19T00:00:00,Interferon-gamma,D23.529.374.480.615.350
18354038,2008-03-19T00:00:00,Interferon-gamma,D23.529.718.550
18354038,2008-03-19T00:00:00,Melanoma,C04.557.465.625.650.510
18354038,2008-03-19T00:00:00,Melanoma,C04.557.580.625.650.510
18354038,2008-03-19T00:00:00,Melanoma,C04.557.665.510
18354038,2008-03-19T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18354038,2008-03-19T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18354038,2008-03-19T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18354038,2008-03-19T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18354038,2008-03-19T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18354038,2008-03-19T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18354038,2008-03-19T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18354038,2008-03-19T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18356117,2008-03-20T00:00:00,Adult,M01.060.116
18356117,2008-03-20T00:00:00,Aged,M01.060.116.100
18356117,2008-03-20T00:00:00,"Education, Medical, Continuing",I02.358.212.350
18356117,2008-03-20T00:00:00,"Education, Medical, Continuing",I02.358.399.250
18356117,2008-03-20T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
18356117,2008-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18356117,2008-03-20T00:00:00,Incidence,E05.318.308.985.525.375
18356117,2008-03-20T00:00:00,Incidence,L01.280.975.525.375
18356117,2008-03-20T00:00:00,Incidence,N01.224.935.597.500
18356117,2008-03-20T00:00:00,Incidence,N06.850.505.400.975.525.375
18356117,2008-03-20T00:00:00,Incidence,N06.850.520.308.985.525.375
18356117,2008-03-20T00:00:00,Middle Aged,M01.060.116.630
18356117,2008-03-20T00:00:00,"Monitoring, Physiologic",E01.370.520
18356117,2008-03-20T00:00:00,Probability,E05.318.740.600
18356117,2008-03-20T00:00:00,Probability,G17.680
18356117,2008-03-20T00:00:00,Probability,N05.715.360.750.625
18356117,2008-03-20T00:00:00,Probability,N06.850.520.830.600
18356117,2008-03-20T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
18356117,2008-03-20T00:00:00,Risk Assessment,E05.318.740.600.800.715
18356117,2008-03-20T00:00:00,Risk Assessment,N04.452.871.715
18356117,2008-03-20T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18356117,2008-03-20T00:00:00,Risk Assessment,N06.850.505.715
18356117,2008-03-20T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18356534,2008-03-20T00:00:00,Animals,B01.050
18356534,2008-03-20T00:00:00,Blood Flow Velocity,E01.370.370.130
18356534,2008-03-20T00:00:00,Blood Flow Velocity,G09.330.380.630.080
18356534,2008-03-20T00:00:00,Liver Cirrhosis,C06.552.630
18358756,2008-03-20T00:00:00,Adult,M01.060.116
18358756,2008-03-20T00:00:00,Aged,M01.060.116.100
18358756,2008-03-20T00:00:00,Brain Injuries,C10.228.140.199
18358756,2008-03-20T00:00:00,Brain Injuries,C10.900.300.087
18358756,2008-03-20T00:00:00,Brain Injuries,C21.866.260.118
18358756,2008-03-20T00:00:00,Brain Injuries,C21.866.915.300.200
18358756,2008-03-20T00:00:00,Brain Mapping,E01.370.350.086
18358756,2008-03-20T00:00:00,Brain Mapping,E01.370.376.149
18358756,2008-03-20T00:00:00,Brain Mapping,E05.132
18358756,2008-03-20T00:00:00,Case-Control Studies,E05.318.760.500.500
18358756,2008-03-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18358756,2008-03-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18358756,2008-03-20T00:00:00,Dystonic Disorders,C10.228.662.300
18358756,2008-03-20T00:00:00,Functional Laterality,F02.830.297.425
18358756,2008-03-20T00:00:00,Functional Laterality,G11.561.225.425
18358756,2008-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18358756,2008-03-20T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
18358756,2008-03-20T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
18358756,2008-03-20T00:00:00,Middle Aged,M01.060.116.630
18358756,2008-03-20T00:00:00,Neural Pathways,A08.612
18358756,2008-03-20T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18359755,2008-03-20T00:00:00,DNA Damage,C21.111
18359755,2008-03-20T00:00:00,DNA Damage,G05.355.180
18359755,2008-03-20T00:00:00,Estradiol,D04.808.365.415.248
18359755,2008-03-20T00:00:00,Estradiol,D06.472.334.851.437.500
18359755,2008-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18359755,2008-03-20T00:00:00,Luteinizing Hormone,D06.472.699.322.576.463
18359755,2008-03-20T00:00:00,Luteinizing Hormone,D06.472.699.631.525.343.463
18359755,2008-03-20T00:00:00,Luteinizing Hormone,D12.644.548.691.525.343.463
18359755,2008-03-20T00:00:00,Spermatozoa,A05.360.490.890
18359755,2008-03-20T00:00:00,Spermatozoa,A11.497.760
18359755,2008-03-20T00:00:00,Testosterone,D04.808.054.079.429.824
18359755,2008-03-20T00:00:00,Testosterone,D06.472.334.851.968.984
18359764,2008-03-20T00:00:00,Animals,B01.050
18359764,2008-03-20T00:00:00,Cell Proliferation,G04.299.233.750
18359764,2008-03-20T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18359764,2008-03-20T00:00:00,Fluorocarbons,D02.455.526.510.435
18359764,2008-03-20T00:00:00,Lymphocytes,A11.118.637.555.567
18359764,2008-03-20T00:00:00,Lymphocytes,A15.145.229.637.555.567
18359764,2008-03-20T00:00:00,Lymphocytes,A15.382.490.555.567
18359764,2008-03-20T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
18359764,2008-03-20T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
18359764,2008-03-20T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
18359764,2008-03-20T00:00:00,Muramidase,D08.811.277.450.642
18455813,2008-03-20T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
18455813,2008-03-20T00:00:00,Animals,B01.050
18455813,2008-03-20T00:00:00,DNA-Binding Proteins,D12.776.260
18455813,2008-03-20T00:00:00,Environmental Exposure,N06.850.460.350
18455813,2008-03-20T00:00:00,Gene Expression Profiling,E05.393.332
18455813,2008-03-20T00:00:00,Gene Expression Regulation,G05.355.315
18455813,2008-03-20T00:00:00,Ovary,A05.360.319.114.630
18455813,2008-03-20T00:00:00,Ovary,A05.360.576.497
18455813,2008-03-20T00:00:00,Ovary,A06.407.312.497
18455813,2008-03-20T00:00:00,Testis,A05.360.444.849
18455813,2008-03-20T00:00:00,Testis,A05.360.576.782
18455813,2008-03-20T00:00:00,Testis,A06.407.312.782
18455813,2008-03-20T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18357521,2008-03-21T00:00:00,Apoptosis,G04.299.139.160
18357521,2008-03-21T00:00:00,Calcium,D01.268.552.100
18357521,2008-03-21T00:00:00,Calcium,D01.552.539.288
18357521,2008-03-21T00:00:00,Calcium,D23.119.100
18357521,2008-03-21T00:00:00,Calpain,D08.811.277.656.262.500.120
18357521,2008-03-21T00:00:00,Calpain,D08.811.277.656.300.200.120
18357521,2008-03-21T00:00:00,Down-Regulation,G02.111.087.225
18357521,2008-03-21T00:00:00,Down-Regulation,G02.149.115.225
18357521,2008-03-21T00:00:00,Down-Regulation,G05.355.315.200
18357521,2008-03-21T00:00:00,Down-Regulation,G07.690.812.230
18357521,2008-03-21T00:00:00,Down-Regulation,G07.700.680.230
18357521,2008-03-21T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
18357521,2008-03-21T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
18357521,2008-03-21T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
18357521,2008-03-21T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
18357521,2008-03-21T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
18357521,2008-03-21T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
18357521,2008-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18357521,2008-03-21T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
18357521,2008-03-21T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
18357521,2008-03-21T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
18358022,2008-03-22T00:00:00,Carbon Dioxide,D01.200.200
18358022,2008-03-22T00:00:00,Carbon Dioxide,D01.362.150
18358022,2008-03-22T00:00:00,Carbon Dioxide,D01.650.550.200
18358022,2008-03-22T00:00:00,Computer Simulation,L01.224.160
18358022,2008-03-22T00:00:00,"Models, Chemical",E05.599.495
18358022,2008-03-22T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
18358022,2008-03-22T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
18359942,2008-03-22T00:00:00,Animals,B01.050
18359942,2008-03-22T00:00:00,Ceramides,D02.065.313
18359942,2008-03-22T00:00:00,Ceramides,D09.400.410.420.525.200
18359942,2008-03-22T00:00:00,Ceramides,D10.390.470.675.200
18359942,2008-03-22T00:00:00,Ceramides,D10.570.877.360.612.200
18359942,2008-03-22T00:00:00,Dietary Fats,D10.212.302
18359942,2008-03-22T00:00:00,Dietary Fats,J02.500.375
18359942,2008-03-22T00:00:00,Fatty Acids,D10.251
18359942,2008-03-22T00:00:00,Insulin Resistance,C18.452.394.968.500
18359942,2008-03-22T00:00:00,Insulin Resistance,G07.690.320.617
18359942,2008-03-22T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18359942,2008-03-22T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18359942,2008-03-22T00:00:00,"Models, Biological",E05.599.395
18359942,2008-03-22T00:00:00,Obesity,C18.654.726.500
18359942,2008-03-22T00:00:00,Obesity,C23.888.144.699.500
18359942,2008-03-22T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18359942,2008-03-22T00:00:00,Obesity,G07.100.100.160.120.699.500
18359942,2008-03-22T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
18362056,2008-03-24T00:00:00,Adolescent,M01.060.057
18362056,2008-03-24T00:00:00,Autistic Disorder,F03.550.325.125
18362056,2008-03-24T00:00:00,Brain,A08.186.211
18362056,2008-03-24T00:00:00,Brain Mapping,E01.370.350.086
18362056,2008-03-24T00:00:00,Brain Mapping,E01.370.376.149
18362056,2008-03-24T00:00:00,Brain Mapping,E05.132
18362056,2008-03-24T00:00:00,Child,M01.060.406
18362056,2008-03-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18362056,2008-03-24T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18362056,2008-03-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18362056,2008-03-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18364404,2008-03-25T00:00:00,Adolescent,M01.060.057
18364404,2008-03-25T00:00:00,Adult,M01.060.116
18364404,2008-03-25T00:00:00,Aged,M01.060.116.100
18364404,2008-03-25T00:00:00,Animals,B01.050
18364404,2008-03-25T00:00:00,Brain Injuries,C10.228.140.199
18364404,2008-03-25T00:00:00,Brain Injuries,C10.900.300.087
18364404,2008-03-25T00:00:00,Brain Injuries,C21.866.260.118
18364404,2008-03-25T00:00:00,Brain Injuries,C21.866.915.300.200
18364404,2008-03-25T00:00:00,Critical Illness,C23.550.291.625
18364404,2008-03-25T00:00:00,Enteral Nutrition,E02.421.360
18364404,2008-03-25T00:00:00,Enteral Nutrition,E02.642.500.360
18364404,2008-03-25T00:00:00,Feeding Behavior,F01.145.113.547
18364404,2008-03-25T00:00:00,Feeding Behavior,F01.145.407
18364404,2008-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18364404,2008-03-25T00:00:00,Middle Aged,M01.060.116.630
18367755,2008-03-26T00:00:00,Adolescent,M01.060.057
18367755,2008-03-26T00:00:00,Behavior Therapy,F04.754.137
18367755,2008-03-26T00:00:00,Diffusion of Innovation,L01.143.320
18367755,2008-03-26T00:00:00,Evidence-Based Medicine,H02.249.750
18367755,2008-03-26T00:00:00,Evidence-Based Medicine,H02.403.200.400
18367755,2008-03-26T00:00:00,Health Promotion,N02.370
18367755,2008-03-26T00:00:00,Health Promotion,N02.421.726.507
18367755,2008-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18367755,2008-03-26T00:00:00,Juvenile Delinquency,I01.880.735.479
18367755,2008-03-26T00:00:00,Social Environment,I01.880.656
18373557,2008-03-26T00:00:00,Animals,B01.050
18373557,2008-03-26T00:00:00,Antioxidants,D27.505.519.217
18373557,2008-03-26T00:00:00,Antioxidants,D27.505.696.706.125
18373557,2008-03-26T00:00:00,Antioxidants,D27.720.799.047
18373557,2008-03-26T00:00:00,Apoptosis,G04.299.139.160
18373557,2008-03-26T00:00:00,Astrocytes,A08.637.200
18373557,2008-03-26T00:00:00,Astrocytes,A11.650.200
18373557,2008-03-26T00:00:00,Calcium,D01.268.552.100
18373557,2008-03-26T00:00:00,Calcium,D01.552.539.288
18373557,2008-03-26T00:00:00,Calcium,D23.119.100
18373557,2008-03-26T00:00:00,Cell Survival,G04.299.316
18373557,2008-03-26T00:00:00,Glutamic Acid,D12.125.067.750
18373557,2008-03-26T00:00:00,Glutamic Acid,D12.125.119.450
18373557,2008-03-26T00:00:00,Glutamic Acid,D12.125.427.300
18373557,2008-03-26T00:00:00,Oxidative Stress,G03.495.710
18373557,2008-03-26T00:00:00,Oxidative Stress,G07.700.830.750
18373557,2008-03-26T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
18373557,2008-03-26T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
18373557,2008-03-26T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
18373557,2008-03-26T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
18373557,2008-03-26T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
18534864,2008-03-26T00:00:00,Animals,B01.050
18534864,2008-03-26T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18534864,2008-03-26T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18534864,2008-03-26T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18534864,2008-03-26T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18534864,2008-03-26T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18534864,2008-03-26T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18534864,2008-03-26T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18534864,2008-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18534864,2008-03-26T00:00:00,Hyaluronic Acid,D09.698.373.475
18534864,2008-03-26T00:00:00,Neoplasms,C04
18534864,2008-03-26T00:00:00,Signal Transduction,G02.111.087.800
18534864,2008-03-26T00:00:00,Signal Transduction,G02.149.115.800
18534864,2008-03-26T00:00:00,Signal Transduction,G04.299.880
18368485,2008-03-27T00:00:00,Apoptosis,G04.299.139.160
18368485,2008-03-27T00:00:00,Calcium-Binding Proteins,D12.776.157.125
18368485,2008-03-27T00:00:00,Cell Differentiation,G04.299.151
18368485,2008-03-27T00:00:00,Down-Regulation,G02.111.087.225
18368485,2008-03-27T00:00:00,Down-Regulation,G02.149.115.225
18368485,2008-03-27T00:00:00,Down-Regulation,G05.355.315.200
18368485,2008-03-27T00:00:00,Down-Regulation,G07.690.812.230
18368485,2008-03-27T00:00:00,Down-Regulation,G07.700.680.230
18368485,2008-03-27T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
18368485,2008-03-27T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
18368485,2008-03-27T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
18368485,2008-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18368485,2008-03-27T00:00:00,Inflammation,C23.550.470
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.644.276.374.440.893
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.644.276.374.480.350
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.644.276.718.550
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.776.467.374.440.893
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.776.467.374.480.350
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
18368485,2008-03-27T00:00:00,Interferon-gamma,D12.776.467.718.550
18368485,2008-03-27T00:00:00,Interferon-gamma,D23.529.374.440.893
18368485,2008-03-27T00:00:00,Interferon-gamma,D23.529.374.480.350
18368485,2008-03-27T00:00:00,Interferon-gamma,D23.529.374.480.615.350
18368485,2008-03-27T00:00:00,Interferon-gamma,D23.529.718.550
18368485,2008-03-27T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18368485,2008-03-27T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18368485,2008-03-27T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18368485,2008-03-27T00:00:00,Mitochondria,A11.284.835.626
18368485,2008-03-27T00:00:00,Mitochondrial Proteins,D12.776.575
18368485,2008-03-27T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
18368485,2008-03-27T00:00:00,Retinoids,D02.455.326.271.665.202.495
18368485,2008-03-27T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
18368485,2008-03-27T00:00:00,Retinoids,D02.455.849.131.495
18368485,2008-03-27T00:00:00,Retinoids,D23.767.261.700
18368485,2008-03-27T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
18368485,2008-03-27T00:00:00,Telomerase,D12.776.157.725.500.921
18368485,2008-03-27T00:00:00,Telomerase,D12.776.664.962.500.921
18372326,2008-03-27T00:00:00,3T3 Cells,A11.251.210.700
18372326,2008-03-27T00:00:00,3T3 Cells,A11.329.228.900
18372326,2008-03-27T00:00:00,Animals,B01.050
18372326,2008-03-27T00:00:00,Calcium,D01.268.552.100
18372326,2008-03-27T00:00:00,Calcium,D01.552.539.288
18372326,2008-03-27T00:00:00,Calcium,D23.119.100
18372326,2008-03-27T00:00:00,Chromatin Immunoprecipitation,E05.393.170
18372326,2008-03-27T00:00:00,Chromatin Immunoprecipitation,E05.478.605.160
18372326,2008-03-27T00:00:00,Kidney,A05.810.453
18372326,2008-03-27T00:00:00,Vitamin D,D04.808.812.768
18372454,2008-03-27T00:00:00,Artifacts,E05.047
18372454,2008-03-27T00:00:00,Contrast Media,D27.720.259
18372454,2008-03-27T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18372454,2008-03-27T00:00:00,Coronary Angiography,E01.370.370.050.200
18372454,2008-03-27T00:00:00,Coronary Angiography,E01.370.370.380.200
18372454,2008-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18372454,2008-03-27T00:00:00,Middle Aged,M01.060.116.630
18372454,2008-03-27T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
18372454,2008-03-27T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
18372454,2008-03-27T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
18372454,2008-03-27T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
18372454,2008-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18372454,2008-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18372454,2008-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18372454,2008-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18372454,2008-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20633378,2008-03-28T00:00:00,Adult,M01.060.116
20633378,2008-03-28T00:00:00,Anxiety Disorders,F03.080
20633378,2008-03-28T00:00:00,Brain,A08.186.211
20633378,2008-03-28T00:00:00,Clinical Trials as Topic,E05.318.760.535
20633378,2008-03-28T00:00:00,Clinical Trials as Topic,E05.337.250
20633378,2008-03-28T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20633378,2008-03-28T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20633378,2008-03-28T00:00:00,Cognitive Therapy,F04.754.137.428
20633378,2008-03-28T00:00:00,Combined Modality Therapy,E02.186
20633378,2008-03-28T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20633378,2008-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633378,2008-03-28T00:00:00,Middle Aged,M01.060.116.630
20633378,2008-03-28T00:00:00,Obsessive-Compulsive Disorder,F03.080.600
20633378,2008-03-28T00:00:00,Panic Disorder,F03.080.700
20633378,2008-03-28T00:00:00,Pilot Projects,E05.318.760.750
20633378,2008-03-28T00:00:00,Pilot Projects,E05.337.737
20633378,2008-03-28T00:00:00,Pilot Projects,N05.715.360.775.625
20633378,2008-03-28T00:00:00,Pilot Projects,N06.850.520.450.720
20633378,2008-03-28T00:00:00,Psychiatric Status Rating Scales,F04.586
20633378,2008-03-28T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20633378,2008-03-28T00:00:00,Treatment Outcome,E01.789.800
20633378,2008-03-28T00:00:00,Treatment Outcome,N04.761.559.590.800
20633378,2008-03-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20633378,2008-03-28T00:00:00,Vagus Nerve Stimulation,E02.342.900
20633378,2008-03-28T00:00:00,Vagus Nerve Stimulation,E02.779.468.900
20633378,2008-03-28T00:00:00,Young Adult,M01.060.116.815
18378812,2008-03-31T00:00:00,Adult,M01.060.116
18378812,2008-03-31T00:00:00,Aged,M01.060.116.100
18378812,2008-03-31T00:00:00,Child,M01.060.406
18378812,2008-03-31T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
18378812,2008-03-31T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
18378812,2008-03-31T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
18378812,2008-03-31T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
18378812,2008-03-31T00:00:00,Child Welfare,I01.880.787.293
18378812,2008-03-31T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18378812,2008-03-31T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18378812,2008-03-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18378812,2008-03-31T00:00:00,Middle Aged,M01.060.116.630
18378812,2008-03-31T00:00:00,Parents,F01.829.263.500.320
18378812,2008-03-31T00:00:00,Parents,I01.880.225.500.340
18378812,2008-03-31T00:00:00,Parents,M01.620
18378812,2008-03-31T00:00:00,Primary Prevention,N02.421.726.758
18378812,2008-03-31T00:00:00,Primary Prevention,N06.850.780.680
18378812,2008-03-31T00:00:00,South Carolina,Z01.107.567.875.075.662
18378812,2008-03-31T00:00:00,South Carolina,Z01.107.567.875.750.700
17701335,2008-04-01T00:00:00,Adolescent,M01.060.057
17701335,2008-04-01T00:00:00,Adult,M01.060.116
17701335,2008-04-01T00:00:00,Attitude to Health,F01.100.150
17701335,2008-04-01T00:00:00,Attitude to Health,N05.300.150
17701335,2008-04-01T00:00:00,Demography,I01.240
17701335,2008-04-01T00:00:00,Demography,N01.224
17701335,2008-04-01T00:00:00,Demography,N06.850.505.400
17701335,2008-04-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
17701335,2008-04-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
17701335,2008-04-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
17701335,2008-04-01T00:00:00,Health Behavior,F01.145.488
17701335,2008-04-01T00:00:00,Health Promotion,N02.370
17701335,2008-04-01T00:00:00,Health Promotion,N02.421.726.507
17701335,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18074208,2008-04-01T00:00:00,Adult,M01.060.116
18074208,2008-04-01T00:00:00,African Americans,M01.686.508.100.100
18074208,2008-04-01T00:00:00,African Americans,M01.686.754.100
18074208,2008-04-01T00:00:00,Diet,E05.272
18074208,2008-04-01T00:00:00,Diet,G07.610.240
18074208,2008-04-01T00:00:00,Fruit,A18.024.500
18074208,2008-04-01T00:00:00,Fruit,J02.500.562
18074208,2008-04-01T00:00:00,Health Education,I02.233.332
18074208,2008-04-01T00:00:00,Health Education,N02.421.143.827.407
18074208,2008-04-01T00:00:00,Health Education,N02.421.726.407
18074208,2008-04-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18074208,2008-04-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18074208,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18074208,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18074208,2008-04-01T00:00:00,Self Efficacy,F01.752.747.792.700
18074208,2008-04-01T00:00:00,Social Support,I01.880.656.600
18200599,2008-04-01T00:00:00,Adult,M01.060.116
18200599,2008-04-01T00:00:00,African Americans,M01.686.508.100.100
18200599,2008-04-01T00:00:00,African Americans,M01.686.754.100
18200599,2008-04-01T00:00:00,Aged,M01.060.116.100
18200599,2008-04-01T00:00:00,Atherosclerosis,C14.907.137.126.307
18200599,2008-04-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
18200599,2008-04-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
18200599,2008-04-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
18200599,2008-04-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18200599,2008-04-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18200599,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18200599,2008-04-01T00:00:00,Markov Chains,E05.318.740.600.500
18200599,2008-04-01T00:00:00,Markov Chains,E05.318.740.996.500
18200599,2008-04-01T00:00:00,Markov Chains,G17.830.500
18200599,2008-04-01T00:00:00,Markov Chains,N05.715.360.750.625.500
18200599,2008-04-01T00:00:00,Markov Chains,N05.715.360.750.770.500
18200599,2008-04-01T00:00:00,Markov Chains,N06.850.520.830.600.500
18200599,2008-04-01T00:00:00,Markov Chains,N06.850.520.830.996.500
18200599,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18200599,2008-04-01T00:00:00,Monte Carlo Method,E05.318.740.525
18200599,2008-04-01T00:00:00,Monte Carlo Method,L01.906.575.422
18200599,2008-04-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
18200599,2008-04-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
18200599,2008-04-01T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
18200599,2008-04-01T00:00:00,United States,Z01.107.567.875
18278987,2008-04-01T00:00:00,Adolescent,M01.060.057
18278987,2008-04-01T00:00:00,Adult,M01.060.116
18278987,2008-04-01T00:00:00,Aged,M01.060.116.100
18278987,2008-04-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18278987,2008-04-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18278987,2008-04-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18278987,2008-04-01T00:00:00,Demography,I01.240
18278987,2008-04-01T00:00:00,Demography,N01.224
18278987,2008-04-01T00:00:00,Demography,N06.850.505.400
18278987,2008-04-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18278987,2008-04-01T00:00:00,Drug Resistance,G07.690.320
18278987,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18278987,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18278987,2008-04-01T00:00:00,Risperidone,D03.383.742.698.685
18278987,2008-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
18278987,2008-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
18278987,2008-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
18278987,2008-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
18278987,2008-04-01T00:00:00,Sertraline,D02.092.705.800
18278987,2008-04-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
18278987,2008-04-01T00:00:00,Sertraline,D04.615.638.845.800
18278987,2008-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18294026,2008-04-01T00:00:00,Anxiety Disorders,F03.080
18294026,2008-04-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18294026,2008-04-01T00:00:00,Disability Evaluation,E01.370.400
18294026,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18294026,2008-04-01T00:00:00,Prevalence,E05.318.308.985.525.750
18294026,2008-04-01T00:00:00,Prevalence,L01.280.975.525.750
18294026,2008-04-01T00:00:00,Prevalence,N01.224.935.597.750
18294026,2008-04-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18294026,2008-04-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18294026,2008-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18294026,2008-04-01T00:00:00,United States,Z01.107.567.875
18302623,2008-04-01T00:00:00,Animals,B01.050
18302623,2008-04-01T00:00:00,Cell Differentiation,G04.299.151
18302623,2008-04-01T00:00:00,Escherichia coli,B03.440.450.425.325.300
18302623,2008-04-01T00:00:00,Escherichia coli,B03.660.250.150.180.100
18302623,2008-04-01T00:00:00,Gene Expression,G05.355.310
18302623,2008-04-01T00:00:00,Lipopolysaccharides,D09.400.500
18302623,2008-04-01T00:00:00,Lipopolysaccharides,D09.698.718.450
18302623,2008-04-01T00:00:00,Lipopolysaccharides,D10.494
18302623,2008-04-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18302623,2008-04-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18302623,2008-04-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18302623,2008-04-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18302623,2008-04-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18302623,2008-04-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18302623,2008-04-01T00:00:00,Osteoclasts,A11.329.372.700
18302623,2008-04-01T00:00:00,Osteoclasts,A11.627.482.700
18302623,2008-04-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
18302623,2008-04-01T00:00:00,RANK Ligand,D12.644.276.972.562
18302623,2008-04-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
18302623,2008-04-01T00:00:00,RANK Ligand,D12.776.467.972.562
18302623,2008-04-01T00:00:00,RANK Ligand,D23.529.374.750.562
18302623,2008-04-01T00:00:00,RANK Ligand,D23.529.972.562
18302623,2008-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
18302623,2008-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
18302623,2008-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
18302623,2008-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
18330727,2008-04-01T00:00:00,Epithelial Cells,A11.436
18330727,2008-04-01T00:00:00,Gastrointestinal Tract,A03.556
18330727,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18330727,2008-04-01T00:00:00,Infant Nutritional Physiological Phenomena,G07.610.220.500
18330727,2008-04-01T00:00:00,"Infant, Newborn",M01.060.703.520
18330727,2008-04-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18330727,2008-04-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18330727,2008-04-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18330727,2008-04-01T00:00:00,"Milk, Human",A12.200.467
18330727,2008-04-01T00:00:00,"Milk, Human",J02.200.700.500
18330727,2008-04-01T00:00:00,"Milk, Human",J02.500.350.525.500
18339985,2008-04-01T00:00:00,Age Factors,N05.715.350.075
18339985,2008-04-01T00:00:00,Age Factors,N06.850.490.250
18339985,2008-04-01T00:00:00,Animals,B01.050
18339985,2008-04-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18339985,2008-04-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18339985,2008-04-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
18339985,2008-04-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
18339985,2008-04-01T00:00:00,Poultry Diseases,C22.131.728
18339985,2008-04-01T00:00:00,Respiratory Tract Diseases,C08
18339985,2008-04-01T00:00:00,Vaccination,E02.095.465.425.400.530.890
18339985,2008-04-01T00:00:00,Vaccination,E05.478.550.600.890
18339985,2008-04-01T00:00:00,Vaccination,N02.421.726.758.310.890
18339985,2008-04-01T00:00:00,Vaccination,N06.850.780.200.425.900
18339985,2008-04-01T00:00:00,Vaccination,N06.850.780.680.310.890
18340636,2008-04-01T00:00:00,Algorithms,G17.035
18340636,2008-04-01T00:00:00,Algorithms,L01.224.050
18340636,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18340636,2008-04-01T00:00:00,"Pattern Recognition, Automated",L01.725
18340636,2008-04-01T00:00:00,Proteome,D12.776.817
18340636,2008-04-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
18342767,2008-04-01T00:00:00,Adult,M01.060.116
18342767,2008-04-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18342767,2008-04-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18342767,2008-04-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18342767,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18342767,2008-04-01T00:00:00,Pulmonary Embolism,C08.381.746
18342767,2008-04-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
18342767,2008-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18342767,2008-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18342767,2008-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18342767,2008-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18342767,2008-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18348684,2008-04-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
18348684,2008-04-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
18348684,2008-04-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
18348684,2008-04-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
18348684,2008-04-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18348684,2008-04-01T00:00:00,Alzheimer Disease,C10.574.945.249
18348684,2008-04-01T00:00:00,Alzheimer Disease,F03.087.400.100
18348684,2008-04-01T00:00:00,Animals,B01.050
18348684,2008-04-01T00:00:00,Drug Delivery Systems,E02.319.300
18348684,2008-04-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18348684,2008-04-01T00:00:00,Gene Expression Regulation,G05.355.315
18348684,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18348684,2008-04-01T00:00:00,Neoplasms,C04
18348684,2008-04-01T00:00:00,Neoplastic Stem Cells,A11.872.650
18352828,2008-04-01T00:00:00,Animals,B01.050
18352828,2008-04-01T00:00:00,Bone Marrow Cells,A11.148
18352828,2008-04-01T00:00:00,Bone Marrow Cells,A15.378.316
18352828,2008-04-01T00:00:00,Cell Differentiation,G04.299.151
18352828,2008-04-01T00:00:00,Cell Lineage,G04.172
18352828,2008-04-01T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
18352828,2008-04-01T00:00:00,Cell Lineage,G08.686.155
18352828,2008-04-01T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
18352828,2008-04-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
18352828,2008-04-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
18352828,2008-04-01T00:00:00,Endothelial Cells,A11.436.275
18352828,2008-04-01T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
18352828,2008-04-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18352828,2008-04-01T00:00:00,Osteoblasts,A11.329.629
18352828,2008-04-01T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
18352828,2008-04-01T00:00:00,Osteogenesis,G11.427.590.560.100.729
18352828,2008-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18352828,2008-04-01T00:00:00,Stromal Cells,A11.329.830
18352828,2008-04-01T00:00:00,Tissue Scaffolds,E07.206.627
18352828,2008-04-01T00:00:00,Tissue Scaffolds,E07.695.825
18353705,2008-04-01T00:00:00,Animals,B01.050
18353705,2008-04-01T00:00:00,Apoptosis,G04.299.139.160
18353705,2008-04-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
18353705,2008-04-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
18353705,2008-04-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18353705,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18353705,2008-04-01T00:00:00,"Models, Biological",E05.599.395
18353705,2008-04-01T00:00:00,Neoplasms,C04
18353705,2008-04-01T00:00:00,Protein Biosynthesis,G02.111.087.675.871
18353705,2008-04-01T00:00:00,Protein Biosynthesis,G02.149.115.675.871
18353705,2008-04-01T00:00:00,Protein Biosynthesis,G03.495.770.871
18353705,2008-04-01T00:00:00,Protein Biosynthesis,G05.355.310.670
18353705,2008-04-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
18353705,2008-04-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
18353705,2008-04-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
18353705,2008-04-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
18353705,2008-04-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
18353705,2008-04-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
18353705,2008-04-01T00:00:00,Transcription Factors,D12.776.930
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18353705,2008-04-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18355128,2008-04-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
18355128,2008-04-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
18355128,2008-04-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
18355128,2008-04-01T00:00:00,Animals,B01.050
18355128,2008-04-01T00:00:00,Eye,A01.456.505.420
18355128,2008-04-01T00:00:00,Eye,A09.371
18355128,2008-04-01T00:00:00,Eye Diseases,C11
18355128,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18355128,2008-04-01T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
18355128,2008-04-01T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
18355128,2008-04-01T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
18355128,2008-04-01T00:00:00,Signal Transduction,G02.111.087.800
18355128,2008-04-01T00:00:00,Signal Transduction,G02.149.115.800
18355128,2008-04-01T00:00:00,Signal Transduction,G04.299.880
18360830,2008-04-01T00:00:00,Aged,M01.060.116.100
18360830,2008-04-01T00:00:00,Health Behavior,F01.145.488
18360830,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18360830,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18360830,2008-04-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18360830,2008-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18360830,2008-04-01T00:00:00,Risk Factors,N05.715.350.200.700
18360830,2008-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18360830,2008-04-01T00:00:00,Risk Factors,N06.850.490.625.750
18360830,2008-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18360830,2008-04-01T00:00:00,Stroke,C10.228.140.300.775
18360830,2008-04-01T00:00:00,Stroke,C14.907.253.855
18360830,2008-04-01T00:00:00,United States,Z01.107.567.875
18365824,2008-04-01T00:00:00,Adult,M01.060.116
18365824,2008-04-01T00:00:00,Contrast Media,D27.720.259
18365824,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18365824,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18365824,2008-04-01T00:00:00,Temperature,G01.906.595
18365824,2008-04-01T00:00:00,Temperature,G16.500.275.063.725.710
18365824,2008-04-01T00:00:00,Temperature,G16.500.750.775.710
18365824,2008-04-01T00:00:00,Temperature,N06.230.150.450
18365824,2008-04-01T00:00:00,Temperature,N06.230.300.100.725.710
18367695,2008-04-01T00:00:00,Adult,M01.060.116
18367695,2008-04-01T00:00:00,Aged,M01.060.116.100
18367695,2008-04-01T00:00:00,Aging,G07.700.320.124
18367695,2008-04-01T00:00:00,Auditory Threshold,F02.463.593.071.173
18367695,2008-04-01T00:00:00,Auditory Threshold,F02.463.593.710.190
18367695,2008-04-01T00:00:00,Hearing,F02.830.816.263
18367695,2008-04-01T00:00:00,Hearing,G11.561.600.810.263
18367695,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18367695,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18367695,2008-04-01T00:00:00,Noise,G01.595.907.567
18367695,2008-04-01T00:00:00,Noise,G16.500.275.600
18367695,2008-04-01T00:00:00,Noise,N06.230.400
18367695,2008-04-01T00:00:00,Noise,N06.850.460.610
18367695,2008-04-01T00:00:00,Normal Distribution,E05.318.740.994.500
18367695,2008-04-01T00:00:00,Normal Distribution,G17.820.500
18367695,2008-04-01T00:00:00,Normal Distribution,N05.715.360.750.750.565
18367695,2008-04-01T00:00:00,Normal Distribution,N06.850.520.830.994.500
18367695,2008-04-01T00:00:00,Perceptual Masking,F02.463.593.071.594
18367695,2008-04-01T00:00:00,Perceptual Masking,F02.463.593.932.733
18367695,2008-04-01T00:00:00,Speech Perception,F02.463.593.071.875
18367887,2008-04-01T00:00:00,Clinical Competence,I02.399.630.210
18367887,2008-04-01T00:00:00,Clinical Competence,N04.761.210
18367887,2008-04-01T00:00:00,Curriculum,I02.158
18367887,2008-04-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
18367887,2008-04-01T00:00:00,Evidence-Based Medicine,H02.249.750
18367887,2008-04-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18367887,2008-04-01T00:00:00,Health Policy,I01.880.604.825.608.400
18367887,2008-04-01T00:00:00,Health Policy,N03.706.825.608.428
18367887,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18367887,2008-04-01T00:00:00,"Schools, Medical",I02.783.660.552
18367887,2008-04-01T00:00:00,"Schools, Medical",N02.278.020.578
18367887,2008-04-01T00:00:00,United States,Z01.107.567.875
18372463,2008-04-01T00:00:00,Adult,M01.060.116
18372463,2008-04-01T00:00:00,Aged,M01.060.116.100
18372463,2008-04-01T00:00:00,Breast Neoplasms,C04.588.180
18372463,2008-04-01T00:00:00,Breast Neoplasms,C17.800.090.500
18372463,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18372463,2008-04-01T00:00:00,Mammography,E01.370.350.700.500
18372463,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18372463,2008-04-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
18372463,2008-04-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
18372463,2008-04-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
18372463,2008-04-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18372463,2008-04-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18372463,2008-04-01T00:00:00,Sensitivity and Specificity,G17.800
18372463,2008-04-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18372463,2008-04-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18372463,2008-04-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18372463,2008-04-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18379355,2008-04-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
18379355,2008-04-01T00:00:00,Adult,M01.060.116
18379355,2008-04-01T00:00:00,Aged,M01.060.116.100
18379355,2008-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
18379355,2008-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
18379355,2008-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
18379355,2008-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
18379355,2008-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
18379355,2008-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
18379355,2008-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18379355,2008-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18379355,2008-04-01T00:00:00,Disease-Free Survival,E01.789.200
18379355,2008-04-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
18379355,2008-04-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18379355,2008-04-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18379355,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18379355,2008-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18379355,2008-04-01T00:00:00,Lung Neoplasms,C08.381.540
18379355,2008-04-01T00:00:00,Lung Neoplasms,C08.785.520
18379355,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18379355,2008-04-01T00:00:00,Pyrazoles,D03.383.129.539
18379355,2008-04-01T00:00:00,Quinazolines,D03.438.786
18379363,2008-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
18379363,2008-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
18379363,2008-04-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
18379363,2008-04-01T00:00:00,Clinical Competence,I02.399.630.210
18379363,2008-04-01T00:00:00,Clinical Competence,N04.761.210
18379363,2008-04-01T00:00:00,Disease Progression,C23.550.291.656
18379363,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18379363,2008-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18379363,2008-04-01T00:00:00,Lung Neoplasms,C08.381.540
18379363,2008-04-01T00:00:00,Lung Neoplasms,C08.785.520
18379363,2008-04-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18379363,2008-04-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18379363,2008-04-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
18379363,2008-04-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
18379363,2008-04-01T00:00:00,Questionnaires,E05.318.308.750
18379363,2008-04-01T00:00:00,Questionnaires,L01.280.800
18379363,2008-04-01T00:00:00,Questionnaires,N05.715.360.300.695
18379363,2008-04-01T00:00:00,Questionnaires,N06.850.520.308.750
18379363,2008-04-01T00:00:00,Solitary Pulmonary Nodule,C04.588.894.797.520.966
18379363,2008-04-01T00:00:00,Solitary Pulmonary Nodule,C08.381.540.933
18379363,2008-04-01T00:00:00,Solitary Pulmonary Nodule,C08.381.884
18379363,2008-04-01T00:00:00,Solitary Pulmonary Nodule,C08.785.520.933
18381177,2008-04-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18381177,2008-04-01T00:00:00,Clinical Trials as Topic,E05.337.250
18381177,2008-04-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18381177,2008-04-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18381177,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18381177,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18381177,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18381177,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18381177,2008-04-01T00:00:00,Evidence-Based Medicine,H02.249.750
18381177,2008-04-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18381177,2008-04-01T00:00:00,Gastrointestinal Diseases,C06.405
18381177,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18381177,2008-04-01T00:00:00,Research Design,E05.581.500
18381177,2008-04-01T00:00:00,Research Design,H01.770.644.728
18381427,2008-04-01T00:00:00,Animals,B01.050
18381427,2008-04-01T00:00:00,Apoptosis,G04.299.139.160
18381427,2008-04-01T00:00:00,Cell Cycle Proteins,D12.776.167
18381427,2008-04-01T00:00:00,DNA Damage,C21.111
18381427,2008-04-01T00:00:00,DNA Damage,G05.355.180
18381427,2008-04-01T00:00:00,DNA-Binding Proteins,D12.776.260
18381427,2008-04-01T00:00:00,Keratinocytes,A11.436.397
18381427,2008-04-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18381427,2008-04-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18381427,2008-04-01T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18381427,2008-04-01T00:00:00,Reactive Oxygen Species,D01.339.431
18381427,2008-04-01T00:00:00,Reactive Oxygen Species,D01.650.775
18381427,2008-04-01T00:00:00,Signal Transduction,G02.111.087.800
18381427,2008-04-01T00:00:00,Signal Transduction,G02.149.115.800
18381427,2008-04-01T00:00:00,Signal Transduction,G04.299.880
18381427,2008-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
18381427,2008-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
18381427,2008-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
18381427,2008-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
18381427,2008-04-01T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
18381466,2008-04-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18381466,2008-04-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18381466,2008-04-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18381466,2008-04-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18381466,2008-04-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18381466,2008-04-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18381466,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18381466,2008-04-01T00:00:00,Mass Screening,E01.370.500
18381466,2008-04-01T00:00:00,Mass Screening,E05.318.308.250.580
18381466,2008-04-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18381466,2008-04-01T00:00:00,Mass Screening,N02.421.726.233.443
18381466,2008-04-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18381466,2008-04-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18381466,2008-04-01T00:00:00,Mass Screening,N06.850.780.500
18381472,2008-04-01T00:00:00,Aged,M01.060.116.100
18381472,2008-04-01T00:00:00,Biological Markers,D23.101
18381472,2008-04-01T00:00:00,Breast Neoplasms,C04.588.180
18381472,2008-04-01T00:00:00,Breast Neoplasms,C17.800.090.500
18381472,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18381472,2008-04-01T00:00:00,Mass Screening,E01.370.500
18381472,2008-04-01T00:00:00,Mass Screening,E05.318.308.250.580
18381472,2008-04-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18381472,2008-04-01T00:00:00,Mass Screening,N02.421.726.233.443
18381472,2008-04-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18381472,2008-04-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18381472,2008-04-01T00:00:00,Mass Screening,N06.850.780.500
18381472,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18381472,2008-04-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
18381472,2008-04-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
18381472,2008-04-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
18381472,2008-04-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
18381472,2008-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18381472,2008-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18381472,2008-04-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18381472,2008-04-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18381472,2008-04-01T00:00:00,Vitamin D,D04.808.812.768
18381498,2008-04-01T00:00:00,Adolescent,M01.060.057
18381498,2008-04-01T00:00:00,Adolescent Behavior,F01.145.022
18381498,2008-04-01T00:00:00,Age Factors,N05.715.350.075
18381498,2008-04-01T00:00:00,Age Factors,N06.850.490.250
18381498,2008-04-01T00:00:00,Alcohol-Related Disorders,C21.739.100
18381498,2008-04-01T00:00:00,Alcohol-Related Disorders,F03.900.100
18381498,2008-04-01T00:00:00,Evidence-Based Medicine,H02.249.750
18381498,2008-04-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18381498,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18382000,2008-04-01T00:00:00,Adolescent,M01.060.057
18382000,2008-04-01T00:00:00,Adult,M01.060.116
18382000,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18382000,2008-04-01T00:00:00,Immunization Schedule,E02.095.465.425.400.470
18382000,2008-04-01T00:00:00,Immunization Schedule,E05.478.550.545
18382000,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18382000,2008-04-01T00:00:00,Population Surveillance,E05.318.308.250.700
18382000,2008-04-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
18382000,2008-04-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
18382000,2008-04-01T00:00:00,Population Surveillance,N06.850.780.675
18382000,2008-04-01T00:00:00,Prevalence,E05.318.308.985.525.750
18382000,2008-04-01T00:00:00,Prevalence,L01.280.975.525.750
18382000,2008-04-01T00:00:00,Prevalence,N01.224.935.597.750
18382000,2008-04-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18382000,2008-04-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18382000,2008-04-01T00:00:00,Questionnaires,E05.318.308.750
18382000,2008-04-01T00:00:00,Questionnaires,L01.280.800
18382000,2008-04-01T00:00:00,Questionnaires,N05.715.360.300.695
18382000,2008-04-01T00:00:00,Questionnaires,N06.850.520.308.750
18382000,2008-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18382000,2008-04-01T00:00:00,Risk Factors,N05.715.350.200.700
18382000,2008-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18382000,2008-04-01T00:00:00,Risk Factors,N06.850.490.625.750
18382000,2008-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18382000,2008-04-01T00:00:00,United States,Z01.107.567.875
18391135,2008-04-01T00:00:00,Adult,M01.060.116
18391135,2008-04-01T00:00:00,Alcoholism,C21.739.100.250
18391135,2008-04-01T00:00:00,Alcoholism,F03.900.100.350
18391135,2008-04-01T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
18391135,2008-04-01T00:00:00,Cues,F02.463.425.234
18391135,2008-04-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18391135,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18391135,2008-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18391135,2008-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18391135,2008-04-01T00:00:00,Naltrexone,D03.132.577.249.706.550
18391135,2008-04-01T00:00:00,Naltrexone,D03.549.686.750.550
18391135,2008-04-01T00:00:00,Naltrexone,D03.605.497.750.550
18391135,2008-04-01T00:00:00,Naltrexone,D04.615.723.795.706.550
18391135,2008-04-01T00:00:00,Narcotics,D27.505.696.277.600
18391135,2008-04-01T00:00:00,Narcotics,D27.505.696.663.850.014.760
18391135,2008-04-01T00:00:00,Narcotics,D27.505.954.427.040.550
18391135,2008-04-01T00:00:00,Narcotics,D27.505.954.427.210.600
18391135,2008-04-01T00:00:00,Oxygen,D01.268.185.550
18391135,2008-04-01T00:00:00,Oxygen,D01.362.670
18391135,2008-04-01T00:00:00,Photic Stimulation,E05.723.729
18391168,2008-04-01T00:00:00,Adipokines,D06.472.699.042
18391168,2008-04-01T00:00:00,Adipokines,D12.644.276.024
18391168,2008-04-01T00:00:00,Adipokines,D12.644.548.011
18391168,2008-04-01T00:00:00,Adipokines,D12.776.467.024
18391168,2008-04-01T00:00:00,Adipokines,D23.529.024
18391168,2008-04-01T00:00:00,Animals,B01.050
18391168,2008-04-01T00:00:00,Heart,A07.541
18391168,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18391168,2008-04-01T00:00:00,Myocardium,A02.633.580
18391168,2008-04-01T00:00:00,Myocardium,A07.541.704
18391168,2008-04-01T00:00:00,Myocardium,A10.690.552.750
18391168,2008-04-01T00:00:00,Obesity,C18.654.726.500
18391168,2008-04-01T00:00:00,Obesity,C23.888.144.699.500
18391168,2008-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18391168,2008-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18391168,2008-04-01T00:00:00,Ventricular Remodeling,C23.300.985
18391168,2008-04-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
18393861,2008-04-01T00:00:00,Algorithms,G17.035
18393861,2008-04-01T00:00:00,Algorithms,L01.224.050
18393861,2008-04-01T00:00:00,Amino Acid Sequence,G02.111.570.060
18393861,2008-04-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18393861,2008-04-01T00:00:00,Binding Sites,G02.111.570.120
18393861,2008-04-01T00:00:00,"Models, Chemical",E05.599.495
18393861,2008-04-01T00:00:00,"Models, Molecular",E05.599.595
18393861,2008-04-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18393861,2008-04-01T00:00:00,Protein Conformation,G02.111.570.790.709
18393861,2008-04-01T00:00:00,Protein Interaction Mapping,E05.601.690
18393861,2008-04-01T00:00:00,Proteins,D12.776
18393865,2008-04-01T00:00:00,Algorithms,G17.035
18393865,2008-04-01T00:00:00,Algorithms,L01.224.050
18393865,2008-04-01T00:00:00,Amino Acid Sequence,G02.111.570.060
18393865,2008-04-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18393865,2008-04-01T00:00:00,Binding Sites,G02.111.570.120
18393865,2008-04-01T00:00:00,Drug Design,E05.295.500
18393865,2008-04-01T00:00:00,Drug Design,H01.158.703.007.675.500
18393865,2008-04-01T00:00:00,Drug Design,H01.181.466.675.500
18393865,2008-04-01T00:00:00,Energy Transfer,G01.154.100.240
18393865,2008-04-01T00:00:00,Energy Transfer,G01.595.100.240
18393865,2008-04-01T00:00:00,Energy Transfer,G02.111.087.242
18393865,2008-04-01T00:00:00,Energy Transfer,G02.149.115.242
18393865,2008-04-01T00:00:00,Energy Transfer,G02.149.767.580
18393865,2008-04-01T00:00:00,Energy Transfer,G02.842.750.580
18393865,2008-04-01T00:00:00,"Models, Chemical",E05.599.495
18393865,2008-04-01T00:00:00,"Models, Molecular",E05.599.595
18393865,2008-04-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18393865,2008-04-01T00:00:00,Pharmaceutical Preparations,D26
18393865,2008-04-01T00:00:00,Protein Conformation,G02.111.570.790.709
18393865,2008-04-01T00:00:00,Protein Interaction Mapping,E05.601.690
18393865,2008-04-01T00:00:00,Proteins,D12.776
18393868,2008-04-01T00:00:00,Algorithms,G17.035
18393868,2008-04-01T00:00:00,Algorithms,L01.224.050
18393868,2008-04-01T00:00:00,Amino Acid Sequence,G02.111.570.060
18393868,2008-04-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18393868,2008-04-01T00:00:00,Binding Sites,G02.111.570.120
18393868,2008-04-01T00:00:00,"Models, Chemical",E05.599.495
18393868,2008-04-01T00:00:00,"Models, Molecular",E05.599.595
18393868,2008-04-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18393868,2008-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18393868,2008-04-01T00:00:00,Protein Conformation,G02.111.570.790.709
18393868,2008-04-01T00:00:00,Protein Interaction Mapping,E05.601.690
18393868,2008-04-01T00:00:00,Proteins,D12.776
18393868,2008-04-01T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
18397425,2008-04-01T00:00:00,Aged,M01.060.116.100
18397425,2008-04-01T00:00:00,Dementia,C10.228.140.380
18397425,2008-04-01T00:00:00,Dementia,F03.087.400
18397425,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18397425,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18397425,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18397425,2008-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18397425,2008-04-01T00:00:00,Gastrostomy,E04.210.496
18397425,2008-04-01T00:00:00,Gastrostomy,E04.579.408
18397425,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18397425,2008-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18397425,2008-04-01T00:00:00,Risk Factors,N05.715.350.200.700
18397425,2008-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18397425,2008-04-01T00:00:00,Risk Factors,N06.850.490.625.750
18397425,2008-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18398113,2008-04-01T00:00:00,Aircraft,J01.937.285.100
18398113,2008-04-01T00:00:00,Altitude,G16.500.275.058
18398113,2008-04-01T00:00:00,Altitude,N06.230.058
18398113,2008-04-01T00:00:00,Anoxia,C23.888.852.079
18398113,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18398113,2008-04-01T00:00:00,Lung Diseases,C08.381
18398113,2008-04-01T00:00:00,Oxygen,D01.268.185.550
18398113,2008-04-01T00:00:00,Oxygen,D01.362.670
18398113,2008-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18398113,2008-04-01T00:00:00,Risk Factors,N05.715.350.200.700
18398113,2008-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18398113,2008-04-01T00:00:00,Risk Factors,N06.850.490.625.750
18398113,2008-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18400191,2008-04-01T00:00:00,Animals,B01.050
18400191,2008-04-01T00:00:00,Cell Differentiation,G04.299.151
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
18400191,2008-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
18400191,2008-04-01T00:00:00,Signal Transduction,G02.111.087.800
18400191,2008-04-01T00:00:00,Signal Transduction,G02.149.115.800
18400191,2008-04-01T00:00:00,Signal Transduction,G04.299.880
18400191,2008-04-01T00:00:00,Stem Cells,A11.872
18403635,2008-04-01T00:00:00,Actins,D05.750.078.730.250
18403635,2008-04-01T00:00:00,Actins,D12.776.210.500.100
18403635,2008-04-01T00:00:00,Actins,D12.776.220.525.255
18403635,2008-04-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
18403635,2008-04-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
18403635,2008-04-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
18403635,2008-04-01T00:00:00,Animals,B01.050
18403635,2008-04-01T00:00:00,Cell Movement,G04.299.283
18403635,2008-04-01T00:00:00,Cell Movement,G07.700.560.500.180
18403635,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18403635,2008-04-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
18403635,2008-04-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
18403635,2008-04-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
18403635,2008-04-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
18403635,2008-04-01T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
18403635,2008-04-01T00:00:00,Nuclear Proteins,D12.776.660
18403635,2008-04-01T00:00:00,Proto-Oncogene Proteins pp60(c-src),D08.811.913.696.620.682.725.800.630
18403635,2008-04-01T00:00:00,Proto-Oncogene Proteins pp60(c-src),D12.776.624.664.700.202
18403635,2008-04-01T00:00:00,Signal Transduction,G02.111.087.800
18403635,2008-04-01T00:00:00,Signal Transduction,G02.149.115.800
18403635,2008-04-01T00:00:00,Signal Transduction,G04.299.880
18403635,2008-04-01T00:00:00,cdc42 GTP-Binding Protein,D08.811.277.040.330.300.400.700.050
18403635,2008-04-01T00:00:00,cdc42 GTP-Binding Protein,D12.644.360.525.700.050
18403635,2008-04-01T00:00:00,cdc42 GTP-Binding Protein,D12.776.157.325.515.700.050
18403635,2008-04-01T00:00:00,cdc42 GTP-Binding Protein,D12.776.476.525.700.050
18403635,2008-04-01T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
18408653,2008-04-01T00:00:00,Alcohol-Related Disorders,C21.739.100
18408653,2008-04-01T00:00:00,Alcohol-Related Disorders,F03.900.100
18408653,2008-04-01T00:00:00,Anxiety Disorders,F03.080
18408653,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18408653,2008-04-01T00:00:00,Mood Disorders,F03.600
18408653,2008-04-01T00:00:00,Substance-Related Disorders,C21.739
18408653,2008-04-01T00:00:00,Substance-Related Disorders,F03.900
18413791,2008-04-01T00:00:00,Animals,B01.050
18413791,2008-04-01T00:00:00,Cell Cycle,G04.299.134
18413791,2008-04-01T00:00:00,Cell Proliferation,G04.299.233.750
18413791,2008-04-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18413791,2008-04-01T00:00:00,Cell Survival,G04.299.316
18413791,2008-04-01T00:00:00,Chlorambucil,D02.455.526.728.650.156
18413791,2008-04-01T00:00:00,Histones,D12.776.660.470
18413791,2008-04-01T00:00:00,Histones,D12.776.664.469
18413791,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18413791,2008-04-01T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
18413791,2008-04-01T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
18413791,2008-04-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18413791,2008-04-01T00:00:00,Nylons,D05.750.716.392
18413791,2008-04-01T00:00:00,Nylons,D25.720.716.392
18413791,2008-04-01T00:00:00,Nylons,J01.576.885.800.600
18413791,2008-04-01T00:00:00,Nylons,J01.637.051.720.716.392
18413791,2008-04-01T00:00:00,Nylons,J01.637.548
18413791,2008-04-01T00:00:00,Pyrroles,D03.383.129.578
18413791,2008-04-01T00:00:00,"RNA, Messenger",D13.444.735.544
18414135,2008-04-01T00:00:00,Adult,M01.060.116
18414135,2008-04-01T00:00:00,Brain,A08.186.211
18414135,2008-04-01T00:00:00,Brain Injuries,C10.228.140.199
18414135,2008-04-01T00:00:00,Brain Injuries,C10.900.300.087
18414135,2008-04-01T00:00:00,Brain Injuries,C21.866.260.118
18414135,2008-04-01T00:00:00,Brain Injuries,C21.866.915.300.200
18414135,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18414135,2008-04-01T00:00:00,Oxygen Consumption,G03.730
18425029,2008-04-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
18425029,2008-04-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18425029,2008-04-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18425029,2008-04-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18425029,2008-04-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18425029,2008-04-01T00:00:00,Documentation,L01.453.245
18425029,2008-04-01T00:00:00,Monte Carlo Method,E05.318.740.525
18425029,2008-04-01T00:00:00,Monte Carlo Method,L01.906.575.422
18425029,2008-04-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
18425029,2008-04-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
18425029,2008-04-01T00:00:00,Quality of Health Care,N04.761
18425029,2008-04-01T00:00:00,Quality of Health Care,N05.715
18427286,2008-04-01T00:00:00,Aprotinin,D12.776.083
18427286,2008-04-01T00:00:00,"Blood Loss, Surgical",C23.550.414.300
18427286,2008-04-01T00:00:00,"Blood Loss, Surgical",C23.550.505.300
18427286,2008-04-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
18427286,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18427286,2008-04-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
18427286,2008-04-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
18427286,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18427286,2008-04-01T00:00:00,Postoperative Complications,C23.550.767
18427286,2008-04-01T00:00:00,Serine Proteinase Inhibitors,D27.505.519.389.745.800
18430269,2008-04-01T00:00:00,Autoimmune Diseases,C20.111
18430269,2008-04-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18430269,2008-04-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18430269,2008-04-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18430269,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18430269,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18430269,2008-04-01T00:00:00,Multiple Sclerosis,C10.114.375.500
18430269,2008-04-01T00:00:00,Multiple Sclerosis,C10.314.350.500
18430269,2008-04-01T00:00:00,Multiple Sclerosis,C20.111.258.250.500
18430269,2008-04-01T00:00:00,Prevalence,E05.318.308.985.525.750
18430269,2008-04-01T00:00:00,Prevalence,L01.280.975.525.750
18430269,2008-04-01T00:00:00,Prevalence,N01.224.935.597.750
18430269,2008-04-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18430269,2008-04-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18430269,2008-04-01T00:00:00,"Scleroderma, Systemic",C17.300.799
18430269,2008-04-01T00:00:00,"Scleroderma, Systemic",C17.800.784
18430269,2008-04-01T00:00:00,United States,Z01.107.567.875
18436132,2008-04-01T00:00:00,Adult,M01.060.116
18436132,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18436132,2008-04-01T00:00:00,Military Personnel,M01.526.625
18436132,2008-04-01T00:00:00,United States,Z01.107.567.875
18436132,2008-04-01T00:00:00,Upper Extremity,A01.378.800
18436132,2008-04-01T00:00:00,Wounds and Injuries,C21.866
18480503,2008-04-01T00:00:00,Aged,M01.060.116.100
18480503,2008-04-01T00:00:00,Chronic Disease,C23.550.291.500
18480503,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18480503,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18480503,2008-04-01T00:00:00,"Monitoring, Physiologic",E01.370.520
18480503,2008-04-01T00:00:00,Skin Temperature,G07.110.753
18480503,2008-04-01T00:00:00,Skin Temperature,G13.750.844
18486967,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18486967,2008-04-01T00:00:00,Middle Aged,M01.060.116.630
18486967,2008-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18486967,2008-04-01T00:00:00,Smoking,F01.145.466.753
18557320,2008-04-01T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
18557320,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18557320,2008-04-01T00:00:00,Particulate Matter,D20.633
18557320,2008-04-01T00:00:00,Pilot Projects,E05.318.760.750
18557320,2008-04-01T00:00:00,Pilot Projects,E05.337.737
18557320,2008-04-01T00:00:00,Pilot Projects,N05.715.360.775.625
18557320,2008-04-01T00:00:00,Pilot Projects,N06.850.520.450.720
18557320,2008-04-01T00:00:00,Smoking,F01.145.466.753
18557320,2008-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18557320,2008-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19317017,2008-04-01T00:00:00,Alcohol-Related Disorders,C21.739.100
19317017,2008-04-01T00:00:00,Alcohol-Related Disorders,F03.900.100
19317017,2008-04-01T00:00:00,Alcoholism,C21.739.100.250
19317017,2008-04-01T00:00:00,Alcoholism,F03.900.100.350
19317017,2008-04-01T00:00:00,Anxiety Disorders,F03.080
19317017,2008-04-01T00:00:00,Evidence-Based Medicine,H02.249.750
19317017,2008-04-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19317017,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19317017,2008-04-01T00:00:00,Mood Disorders,F03.600
19317017,2008-04-01T00:00:00,Phobic Disorders,F03.080.725
19317017,2008-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19759838,2008-04-01T00:00:00,Adult,M01.060.116
19759838,2008-04-01T00:00:00,Analgesia,E03.091
19759838,2008-04-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
19759838,2008-04-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
19759838,2008-04-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
19759838,2008-04-01T00:00:00,Gastric Bypass,E02.065.062.249
19759838,2008-04-01T00:00:00,Gastric Bypass,E04.035.398.385
19759838,2008-04-01T00:00:00,Gastric Bypass,E04.062.249
19759838,2008-04-01T00:00:00,Gastric Bypass,E04.210.457.430
19759838,2008-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19759838,2008-04-01T00:00:00,Morphine,D03.132.577.249.547
19759838,2008-04-01T00:00:00,Morphine,D03.549.686.575
19759838,2008-04-01T00:00:00,Morphine,D03.605.497.575
19759838,2008-04-01T00:00:00,Morphine,D04.615.723.795.547
19759838,2008-04-01T00:00:00,Pain Measurement,E01.370.376.550.600
19759838,2008-04-01T00:00:00,"Pain, Postoperative",C23.550.767.700
19759838,2008-04-01T00:00:00,"Pain, Postoperative",C23.888.646.530
19759838,2008-04-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19759838,2008-04-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19759838,2008-04-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19759838,2008-04-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19759838,2008-04-01T00:00:00,Treatment Outcome,E01.789.800
19759838,2008-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19759838,2008-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18382470,2008-04-02T00:00:00,Atherosclerosis,C14.907.137.126.307
18382470,2008-04-02T00:00:00,Biological Markers,D23.101
18382470,2008-04-02T00:00:00,Blood Platelets,A11.118.188
18382470,2008-04-02T00:00:00,Blood Platelets,A15.145.229.188
18382470,2008-04-02T00:00:00,Case-Control Studies,E05.318.760.500.500
18382470,2008-04-02T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18382470,2008-04-02T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18382470,2008-04-02T00:00:00,"Diagnosis, Differential",E01.171
18382470,2008-04-02T00:00:00,Embolism,C14.907.355.350
18382470,2008-04-02T00:00:00,Gene Expression Profiling,E05.393.332
18382470,2008-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18382470,2008-04-02T00:00:00,Monocytes,A11.118.637.555.652
18382470,2008-04-02T00:00:00,Monocytes,A11.148.580
18382470,2008-04-02T00:00:00,Monocytes,A11.627.624
18382470,2008-04-02T00:00:00,Monocytes,A11.733.547
18382470,2008-04-02T00:00:00,Monocytes,A15.145.229.637.555.652
18382470,2008-04-02T00:00:00,Monocytes,A15.378.316.580
18382470,2008-04-02T00:00:00,Monocytes,A15.382.490.555.652
18382470,2008-04-02T00:00:00,Monocytes,A15.382.680.547
18382470,2008-04-02T00:00:00,Monocytes,A15.382.812.547
18382470,2008-04-02T00:00:00,Neutrophils,A11.118.637.415.583
18382470,2008-04-02T00:00:00,Neutrophils,A11.627.340.583
18382470,2008-04-02T00:00:00,Neutrophils,A11.733.689
18382470,2008-04-02T00:00:00,Neutrophils,A15.145.229.637.415.583
18382470,2008-04-02T00:00:00,Neutrophils,A15.382.490.315.583
18382470,2008-04-02T00:00:00,Neutrophils,A15.382.680.689
18382470,2008-04-02T00:00:00,Sensitivity and Specificity,E05.318.740.872
18382470,2008-04-02T00:00:00,Sensitivity and Specificity,E05.318.780.800
18382470,2008-04-02T00:00:00,Sensitivity and Specificity,G17.800
18382470,2008-04-02T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18382470,2008-04-02T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18382470,2008-04-02T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18382470,2008-04-02T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18382470,2008-04-02T00:00:00,Stroke,C10.228.140.300.775
18382470,2008-04-02T00:00:00,Stroke,C14.907.253.855
18387661,2008-04-02T00:00:00,Adult,M01.060.116
18387661,2008-04-02T00:00:00,Aged,M01.060.116.100
18387661,2008-04-02T00:00:00,DNA Methylation,G02.111.087.029.538.161
18387661,2008-04-02T00:00:00,DNA Methylation,G02.111.087.218
18387661,2008-04-02T00:00:00,DNA Methylation,G02.149.115.029.538.161
18387661,2008-04-02T00:00:00,DNA Methylation,G02.149.115.218
18387661,2008-04-02T00:00:00,DNA Methylation,G03.495.130.538.161
18387661,2008-04-02T00:00:00,DNA Methylation,G05.355.190
18387661,2008-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18387661,2008-04-02T00:00:00,Middle Aged,M01.060.116.630
18387661,2008-04-02T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18387661,2008-04-02T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18387661,2008-04-02T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18387661,2008-04-02T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
18387661,2008-04-02T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
18387661,2008-04-02T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
18387661,2008-04-02T00:00:00,Prostate-Specific Antigen,D23.050.285.625
18387661,2008-04-02T00:00:00,Prostate-Specific Antigen,D23.101.840.625
18387661,2008-04-02T00:00:00,Prostatectomy,E04.950.774.860.625
18387661,2008-04-02T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18387661,2008-04-02T00:00:00,Prostatic Neoplasms,C12.294.260.750
18387661,2008-04-02T00:00:00,Prostatic Neoplasms,C12.294.565.625
18387661,2008-04-02T00:00:00,Prostatic Neoplasms,C12.758.409.750
18388209,2008-04-03T00:00:00,Adult,M01.060.116
18388209,2008-04-03T00:00:00,Aged,M01.060.116.100
18388209,2008-04-03T00:00:00,Blood Vessel Prosthesis,E07.695.110
18388209,2008-04-03T00:00:00,"Constriction, Pathologic",C23.300.287
18388209,2008-04-03T00:00:00,Equipment Failure Analysis,E05.325.192
18388209,2008-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18388209,2008-04-03T00:00:00,Incidence,E05.318.308.985.525.375
18388209,2008-04-03T00:00:00,Incidence,L01.280.975.525.375
18388209,2008-04-03T00:00:00,Incidence,N01.224.935.597.500
18388209,2008-04-03T00:00:00,Incidence,N06.850.505.400.975.525.375
18388209,2008-04-03T00:00:00,Incidence,N06.850.520.308.985.525.375
18388209,2008-04-03T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18388209,2008-04-03T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18388209,2008-04-03T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18388209,2008-04-03T00:00:00,Middle Aged,M01.060.116.630
18388209,2008-04-03T00:00:00,Prosthesis Design,E05.320.550
18388209,2008-04-03T00:00:00,Prosthesis Design,E07.695.680
18388209,2008-04-03T00:00:00,Risk Assessment,E05.318.740.600.800.715
18388209,2008-04-03T00:00:00,Risk Assessment,N04.452.871.715
18388209,2008-04-03T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18388209,2008-04-03T00:00:00,Risk Assessment,N06.850.505.715
18388209,2008-04-03T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18388209,2008-04-03T00:00:00,Risk Factors,E05.318.740.600.800.725
18388209,2008-04-03T00:00:00,Risk Factors,N05.715.350.200.700
18388209,2008-04-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18388209,2008-04-03T00:00:00,Risk Factors,N06.850.490.625.750
18388209,2008-04-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18388209,2008-04-03T00:00:00,Stents,E07.695.750
18388209,2008-04-03T00:00:00,Treatment Outcome,E01.789.800
18388209,2008-04-03T00:00:00,Treatment Outcome,N04.761.559.590.800
18388209,2008-04-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18388209,2008-04-03T00:00:00,United States,Z01.107.567.875
18388242,2008-04-03T00:00:00,Animals,B01.050
18388242,2008-04-03T00:00:00,Apoptosis,G04.299.139.160
18388242,2008-04-03T00:00:00,Arachidonic Acids,D10.251.355.096
18388242,2008-04-03T00:00:00,Arachidonic Acids,D10.251.355.255.100
18388242,2008-04-03T00:00:00,Arachidonic Acids,D10.251.355.310.166
18388242,2008-04-03T00:00:00,Chemokines,D12.644.276.374.200
18388242,2008-04-03T00:00:00,Chemokines,D12.776.467.374.200
18388242,2008-04-03T00:00:00,Chemokines,D23.125.300
18388242,2008-04-03T00:00:00,Chemokines,D23.469.200
18388242,2008-04-03T00:00:00,Chemokines,D23.529.374.200
18388242,2008-04-03T00:00:00,Cytokines,D12.644.276.374
18388242,2008-04-03T00:00:00,Cytokines,D12.776.467.374
18388242,2008-04-03T00:00:00,Cytokines,D23.529.374
18388242,2008-04-03T00:00:00,"Hepatitis, Autoimmune",C06.552.380.350.050
18388242,2008-04-03T00:00:00,"Hepatitis, Autoimmune",C20.111.567
18388242,2008-04-03T00:00:00,Hepatocytes,A11.436.348
18388242,2008-04-03T00:00:00,Leukocytes,A11.118.637
18388242,2008-04-03T00:00:00,Leukocytes,A15.145.229.637
18388242,2008-04-03T00:00:00,Leukocytes,A15.382.490
18388242,2008-04-03T00:00:00,Liver,A03.620
18388242,2008-04-03T00:00:00,Polyunsaturated Alkamides,D02.065.160
18388242,2008-04-03T00:00:00,Polyunsaturated Alkamides,D02.455.326.271.060
18388242,2008-04-03T00:00:00,Polyunsaturated Alkamides,D02.455.326.397.675
18388242,2008-04-03T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
18388242,2008-04-03T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
18388242,2008-04-03T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
18388242,2008-04-03T00:00:00,Treatment Outcome,E01.789.800
18388242,2008-04-03T00:00:00,Treatment Outcome,N04.761.559.590.800
18388242,2008-04-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18388297,2008-04-03T00:00:00,Animals,B01.050
18388297,2008-04-03T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18388297,2008-04-03T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18388297,2008-04-03T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18388297,2008-04-03T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18388297,2008-04-03T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18388297,2008-04-03T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18388297,2008-04-03T00:00:00,Bone Marrow Cells,A11.148
18388297,2008-04-03T00:00:00,Bone Marrow Cells,A15.378.316
18388297,2008-04-03T00:00:00,Cell Differentiation,G04.299.151
18388297,2008-04-03T00:00:00,Cell Proliferation,G04.299.233.750
18388297,2008-04-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18388297,2008-04-03T00:00:00,Cytokines,D12.644.276.374
18388297,2008-04-03T00:00:00,Cytokines,D12.776.467.374
18388297,2008-04-03T00:00:00,Cytokines,D23.529.374
18388297,2008-04-03T00:00:00,Dendritic Cells,A11.066.270
18388297,2008-04-03T00:00:00,Dendritic Cells,A11.436.270
18388297,2008-04-03T00:00:00,Dendritic Cells,A15.382.066.270
18388297,2008-04-03T00:00:00,Dendritic Cells,A15.382.812.260
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.644.276.374.440.893
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.644.276.374.480.350
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.644.276.718.550
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.776.467.374.440.893
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.776.467.374.480.350
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
18388297,2008-04-03T00:00:00,Interferon-gamma,D12.776.467.718.550
18388297,2008-04-03T00:00:00,Interferon-gamma,D23.529.374.440.893
18388297,2008-04-03T00:00:00,Interferon-gamma,D23.529.374.480.350
18388297,2008-04-03T00:00:00,Interferon-gamma,D23.529.374.480.615.350
18388297,2008-04-03T00:00:00,Interferon-gamma,D23.529.718.550
18388297,2008-04-03T00:00:00,Interleukin-2,D12.644.276.374.465.502
18388297,2008-04-03T00:00:00,Interleukin-2,D12.644.276.374.480.372
18388297,2008-04-03T00:00:00,Interleukin-2,D12.776.467.374.465.502
18388297,2008-04-03T00:00:00,Interleukin-2,D12.776.467.374.480.372
18388297,2008-04-03T00:00:00,Interleukin-2,D23.529.374.465.502
18388297,2008-04-03T00:00:00,Interleukin-2,D23.529.374.480.372
18388297,2008-04-03T00:00:00,Lymphocyte Activation,E01.450.495.482
18388297,2008-04-03T00:00:00,Lymphocyte Activation,E05.478.594.530
18388297,2008-04-03T00:00:00,Lymphocyte Activation,G12.425.747
18388297,2008-04-03T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18388297,2008-04-03T00:00:00,Protein Transport,G03.495.166.700
18388297,2008-04-03T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18388297,2008-04-03T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18388297,2008-04-03T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18388336,2008-04-03T00:00:00,Adult,M01.060.116
18388336,2008-04-03T00:00:00,African Continental Ancestry Group,M01.686.508.100
18388336,2008-04-03T00:00:00,Aged,M01.060.116.100
18388336,2008-04-03T00:00:00,Diabetes Mellitus,C18.452.394.750
18388336,2008-04-03T00:00:00,Diabetes Mellitus,C19.246
18388336,2008-04-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
18388336,2008-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18388336,2008-04-03T00:00:00,Hyperglycemia,C18.452.394.952
18388336,2008-04-03T00:00:00,Incidence,E05.318.308.985.525.375
18388336,2008-04-03T00:00:00,Incidence,L01.280.975.525.375
18388336,2008-04-03T00:00:00,Incidence,N01.224.935.597.500
18388336,2008-04-03T00:00:00,Incidence,N06.850.505.400.975.525.375
18388336,2008-04-03T00:00:00,Incidence,N06.850.520.308.985.525.375
18388336,2008-04-03T00:00:00,Middle Aged,M01.060.116.630
18388336,2008-04-03T00:00:00,Prevalence,E05.318.308.985.525.750
18388336,2008-04-03T00:00:00,Prevalence,L01.280.975.525.750
18388336,2008-04-03T00:00:00,Prevalence,N01.224.935.597.750
18388336,2008-04-03T00:00:00,Prevalence,N06.850.505.400.975.525.750
18388336,2008-04-03T00:00:00,Prevalence,N06.850.520.308.985.525.750
18388336,2008-04-03T00:00:00,Risk Factors,E05.318.740.600.800.725
18388336,2008-04-03T00:00:00,Risk Factors,N05.715.350.200.700
18388336,2008-04-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18388336,2008-04-03T00:00:00,Risk Factors,N06.850.490.625.750
18388336,2008-04-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18388336,2008-04-03T00:00:00,Stroke,C10.228.140.300.775
18388336,2008-04-03T00:00:00,Stroke,C14.907.253.855
18388336,2008-04-03T00:00:00,United States,Z01.107.567.875
18388342,2008-04-03T00:00:00,Ambulatory Care,E02.760.106
18388342,2008-04-03T00:00:00,Ambulatory Care,N02.421.585.106
18388342,2008-04-03T00:00:00,Cardiovascular Diseases,C14
18388342,2008-04-03T00:00:00,Counseling,F02.784.176
18388342,2008-04-03T00:00:00,Counseling,F04.408.413
18388342,2008-04-03T00:00:00,Counseling,N02.421.143.303
18388342,2008-04-03T00:00:00,Counseling,N02.421.461.363
18388342,2008-04-03T00:00:00,Data Collection,E05.318.308
18388342,2008-04-03T00:00:00,Data Collection,L01.280
18388342,2008-04-03T00:00:00,Data Collection,N05.715.360.300
18388342,2008-04-03T00:00:00,Data Collection,N06.850.520.308
18388342,2008-04-03T00:00:00,Hospitalization,E02.760.400
18388342,2008-04-03T00:00:00,Hospitalization,N02.421.585.400
18388342,2008-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18388342,2008-04-03T00:00:00,Outpatients,M01.643.630
18388342,2008-04-03T00:00:00,Patient Compliance,F01.145.488.500
18388342,2008-04-03T00:00:00,Patient Compliance,N05.300.150.600.600
18388342,2008-04-03T00:00:00,Physician's Practice Patterns,N04.590.748
18388342,2008-04-03T00:00:00,Physician's Practice Patterns,N05.300.625
18388342,2008-04-03T00:00:00,Physician-Patient Relations,F01.829.401.650.675
18388342,2008-04-03T00:00:00,Physician-Patient Relations,N05.300.660.625
18388342,2008-04-03T00:00:00,Stroke,C10.228.140.300.775
18388342,2008-04-03T00:00:00,Stroke,C14.907.253.855
18388342,2008-04-03T00:00:00,United States,Z01.107.567.875
18391098,2008-04-07T00:00:00,Animals,B01.050
18391098,2008-04-07T00:00:00,Antioxidants,D27.505.519.217
18391098,2008-04-07T00:00:00,Antioxidants,D27.505.696.706.125
18391098,2008-04-07T00:00:00,Antioxidants,D27.720.799.047
18391098,2008-04-07T00:00:00,Collagen,D05.750.078.280
18391098,2008-04-07T00:00:00,Collagen,D12.776.860.300.250
18391098,2008-04-07T00:00:00,Fibrosis,C23.550.355
18391098,2008-04-07T00:00:00,Inflammation,C23.550.470
18391098,2008-04-07T00:00:00,Kidney Diseases,C12.777.419
18391098,2008-04-07T00:00:00,Kidney Diseases,C13.351.968.419
18391098,2008-04-07T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
18391098,2008-04-07T00:00:00,Mesangial Cells,A05.810.453.324.359.620
18391098,2008-04-07T00:00:00,Mesangial Cells,A05.810.453.736.520.620
18391098,2008-04-07T00:00:00,Mesangial Cells,A11.329.228.950
18391098,2008-04-07T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
18391098,2008-04-07T00:00:00,Nitrogen Oxides,D01.362.635
18391098,2008-04-07T00:00:00,Nitrogen Oxides,D01.625.550
18391098,2008-04-07T00:00:00,Nitrogen Oxides,D01.650.550.587
18391098,2008-04-07T00:00:00,Oxidative Stress,G03.495.710
18391098,2008-04-07T00:00:00,Oxidative Stress,G07.700.830.750
18391098,2008-04-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18391098,2008-04-07T00:00:00,Reactive Oxygen Species,D01.339.431
18391098,2008-04-07T00:00:00,Reactive Oxygen Species,D01.650.775
18391098,2008-04-07T00:00:00,Serpins,D12.644.822.750
18391098,2008-04-07T00:00:00,Serpins,D12.644.861
18391098,2008-04-07T00:00:00,Serpins,D12.776.645.750
18391098,2008-04-07T00:00:00,Serpins,D12.776.872
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
18391098,2008-04-07T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
18391098,2008-04-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
18391098,2008-04-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
18391098,2008-04-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
18391098,2008-04-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
20633371,2008-04-07T00:00:00,Brain,A08.186.211
20633371,2008-04-07T00:00:00,Clinical Trials as Topic,E05.318.760.535
20633371,2008-04-07T00:00:00,Clinical Trials as Topic,E05.337.250
20633371,2008-04-07T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20633371,2008-04-07T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20633371,2008-04-07T00:00:00,"Diagnostic Techniques, Neurological",E01.370.376
20633371,2008-04-07T00:00:00,Electroconvulsive Therapy,F04.570.200.583
20633371,2008-04-07T00:00:00,Electroconvulsive Therapy,F04.669.224.300
20633371,2008-04-07T00:00:00,Evoked Potentials,G07.265.500
20633371,2008-04-07T00:00:00,Evoked Potentials,G11.561.270
20633371,2008-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633371,2008-04-07T00:00:00,Physical Stimulation,E05.723
18398221,2008-04-08T00:00:00,Animals,B01.050
18398221,2008-04-08T00:00:00,Apoptosis,G04.299.139.160
18398221,2008-04-08T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
18398221,2008-04-08T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18398221,2008-04-08T00:00:00,Mitochondria,A11.284.835.626
18398221,2008-04-08T00:00:00,Phospholipids,D10.570.755
18398221,2008-04-08T00:00:00,Phospholipids,D10.695
18398221,2008-04-08T00:00:00,RNA Interference,G05.355.315.203.374.790
18398221,2008-04-08T00:00:00,Rabbits,B01.050.150.900.649.521.700
18442884,2008-04-08T00:00:00,Adult,M01.060.116
18442884,2008-04-08T00:00:00,Crime Victims,M01.135
18442884,2008-04-08T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18442884,2008-04-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18442884,2008-04-08T00:00:00,Life Change Events,F01.829.458.410
18442884,2008-04-08T00:00:00,Sex Factors,N05.715.350.675
18442884,2008-04-08T00:00:00,Sex Factors,N06.850.490.875
18442884,2008-04-08T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18442884,2008-04-08T00:00:00,Substance-Related Disorders,C21.739
18442884,2008-04-08T00:00:00,Substance-Related Disorders,F03.900
18442884,2008-04-08T00:00:00,Tobacco Use Disorder,C21.739.912
18442884,2008-04-08T00:00:00,Tobacco Use Disorder,F03.900.912
18398659,2008-04-09T00:00:00,African Americans,M01.686.508.100.100
18398659,2008-04-09T00:00:00,African Americans,M01.686.754.100
18398659,2008-04-09T00:00:00,Aged,M01.060.116.100
18398659,2008-04-09T00:00:00,Breast Neoplasms,C04.588.180
18398659,2008-04-09T00:00:00,Breast Neoplasms,C17.800.090.500
18398659,2008-04-09T00:00:00,European Continental Ancestry Group,M01.686.508.400
18398659,2008-04-09T00:00:00,Forecasting,I01.320
18398659,2008-04-09T00:00:00,Healthcare Disparities,N04.590.374.380
18398659,2008-04-09T00:00:00,Healthcare Disparities,N05.300.493
18398659,2008-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18398659,2008-04-09T00:00:00,Middle Aged,M01.060.116.630
18398659,2008-04-09T00:00:00,Rural Population,N01.600.725
18398659,2008-04-09T00:00:00,South Carolina,Z01.107.567.875.075.662
18398659,2008-04-09T00:00:00,South Carolina,Z01.107.567.875.750.700
18398659,2008-04-09T00:00:00,Urban Population,N01.600.900
18399918,2008-04-09T00:00:00,Amino Acid Sequence,G02.111.570.060
18399918,2008-04-09T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18399918,2008-04-09T00:00:00,Animals,B01.050
18399918,2008-04-09T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18399918,2008-04-09T00:00:00,"Models, Molecular",E05.599.595
18399918,2008-04-09T00:00:00,Molecular Sequence Data,L01.453.245.667
18399918,2008-04-09T00:00:00,Protein Conformation,G02.111.570.790.709
18399918,2008-04-09T00:00:00,Rhodopsin,D12.776.543.750.100.955
18399918,2008-04-09T00:00:00,Rhodopsin,D23.767.930.750.500.500
18400200,2008-04-09T00:00:00,Adult,M01.060.116
18400200,2008-04-09T00:00:00,Aged,M01.060.116.100
18400200,2008-04-09T00:00:00,Conscious Sedation,E03.250
18400200,2008-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18400200,2008-04-09T00:00:00,Middle Aged,M01.060.116.630
18400200,2008-04-09T00:00:00,Ophthalmologic Surgical Procedures,E04.540
18400200,2008-04-09T00:00:00,Propofol,D02.755.773
18400900,2008-04-09T00:00:00,Animals,B01.050
18400900,2008-04-09T00:00:00,Carrier Proteins,D12.776.157
18400900,2008-04-09T00:00:00,Eye Proteins,D12.776.306
18400900,2008-04-09T00:00:00,Membrane Proteins,D12.776.543
18400900,2008-04-09T00:00:00,Protein Isoforms,D12.776.800
18400900,2008-04-09T00:00:00,Protein Transport,G03.495.166.700
18400900,2008-04-09T00:00:00,"Receptors, Cell Surface",D12.776.543.750
18400900,2008-04-09T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
18400900,2008-04-09T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
18400900,2008-04-09T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
18400900,2008-04-09T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
18400900,2008-04-09T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
18400900,2008-04-09T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
18400900,2008-04-09T00:00:00,Retinaldehyde,D02.047.850
18400900,2008-04-09T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
18400900,2008-04-09T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
18400900,2008-04-09T00:00:00,Retinaldehyde,D02.455.849.131.495.690
18400900,2008-04-09T00:00:00,Retinaldehyde,D23.767.261.700.690
18400900,2008-04-09T00:00:00,"Vision, Ocular",F02.830.816.964
18400900,2008-04-09T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
18400900,2008-04-09T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
18400900,2008-04-09T00:00:00,"Vision, Ocular",G04.299.880.480.900
18400900,2008-04-09T00:00:00,"Vision, Ocular",G11.561.600.810.964
18400900,2008-04-09T00:00:00,"Vision, Ocular",G14.640.816
18403134,2008-04-09T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
18403134,2008-04-09T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
18403134,2008-04-09T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
18403134,2008-04-09T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
18403134,2008-04-09T00:00:00,Adult,M01.060.116
18403134,2008-04-09T00:00:00,Alcohol Drinking,F01.145.317.269
18403134,2008-04-09T00:00:00,Alcohol-Related Disorders,C21.739.100
18403134,2008-04-09T00:00:00,Alcohol-Related Disorders,F03.900.100
18403134,2008-04-09T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18403134,2008-04-09T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18403134,2008-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18403134,2008-04-09T00:00:00,Propylamines,D02.092.831
18403134,2008-04-09T00:00:00,Psychiatric Status Rating Scales,F04.586
18403134,2008-04-09T00:00:00,Treatment Outcome,E01.789.800
18403134,2008-04-09T00:00:00,Treatment Outcome,N04.761.559.590.800
18403134,2008-04-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18402997,2008-04-10T00:00:00,Animals,B01.050
18402997,2008-04-10T00:00:00,Antigen Presentation,G12.425.107
18402997,2008-04-10T00:00:00,Antigen Presentation,G12.450.050.400.070
18402997,2008-04-10T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18402997,2008-04-10T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18402997,2008-04-10T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18402997,2008-04-10T00:00:00,"Epitopes, T-Lymphocyte",D23.050.550.402
18402997,2008-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18402997,2008-04-10T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18402997,2008-04-10T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18403590,2008-04-10T00:00:00,Alzheimer Disease,C10.228.140.380.100
18403590,2008-04-10T00:00:00,Alzheimer Disease,C10.574.945.249
18403590,2008-04-10T00:00:00,Alzheimer Disease,F03.087.400.100
18403590,2008-04-10T00:00:00,Animals,B01.050
18403590,2008-04-10T00:00:00,Brain,A08.186.211
18403590,2008-04-10T00:00:00,Cell Line,A11.251.210
18403590,2008-04-10T00:00:00,Gene Transfer Techniques,E05.393.350
18403590,2008-04-10T00:00:00,Genetic Vectors,G05.360.337
18403590,2008-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18403590,2008-04-10T00:00:00,Lentivirus,B04.820.650.589
18403590,2008-04-10T00:00:00,Lentivirus,B04.909.777.731.589
18403590,2008-04-10T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18403590,2008-04-10T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18403590,2008-04-10T00:00:00,Oxidative Stress,G03.495.710
18403590,2008-04-10T00:00:00,Oxidative Stress,G07.700.830.750
18455875,2008-04-10T00:00:00,Animals,B01.050
18455875,2008-04-10T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
18455875,2008-04-10T00:00:00,Cocaine,D02.145.074.722.388
18455875,2008-04-10T00:00:00,Cocaine,D03.132.889.354
18455875,2008-04-10T00:00:00,Cocaine,D03.605.869.388
18455875,2008-04-10T00:00:00,Cocaine,D04.075.080.875.099.722.388
18455875,2008-04-10T00:00:00,Cocaine-Related Disorders,C21.739.300
18455875,2008-04-10T00:00:00,Cocaine-Related Disorders,F03.900.300
18455875,2008-04-10T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
18455875,2008-04-10T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
18455875,2008-04-10T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
18455875,2008-04-10T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
18455875,2008-04-10T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18455875,2008-04-10T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18455875,2008-04-10T00:00:00,Glutamic Acid,D12.125.067.750
18455875,2008-04-10T00:00:00,Glutamic Acid,D12.125.119.450
18455875,2008-04-10T00:00:00,Glutamic Acid,D12.125.427.300
18455875,2008-04-10T00:00:00,Neural Pathways,A08.612
18455875,2008-04-10T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18455875,2008-04-10T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18455875,2008-04-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18455875,2008-04-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18455875,2008-04-10T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
18455875,2008-04-10T00:00:00,Synaptic Transmission,G02.111.087.800.850
18455875,2008-04-10T00:00:00,Synaptic Transmission,G02.149.115.800.850
18455875,2008-04-10T00:00:00,Synaptic Transmission,G04.299.880.850
18455875,2008-04-10T00:00:00,Synaptic Transmission,G07.265.337.900
18455875,2008-04-10T00:00:00,Synaptic Transmission,G07.700.240.900
18455875,2008-04-10T00:00:00,Synaptic Transmission,G11.561.600.835
18455875,2008-04-10T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
18455875,2008-04-10T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
18402443,2008-04-11T00:00:00,Calcium,D01.268.552.100
18402443,2008-04-11T00:00:00,Calcium,D01.552.539.288
18402443,2008-04-11T00:00:00,Calcium,D23.119.100
18402443,2008-04-11T00:00:00,Calmodulin,D12.644.360.381.249
18402443,2008-04-11T00:00:00,Calmodulin,D12.776.157.125.412.249
18402443,2008-04-11T00:00:00,Calmodulin,D12.776.476.387.249
18402443,2008-04-11T00:00:00,Metal Nanoparticles,J01.637.512.600.500
18402443,2008-04-11T00:00:00,Nanotechnology,H01.603
18402443,2008-04-11T00:00:00,Nanotechnology,J01.897.520.600
18402443,2008-04-11T00:00:00,Protein Conformation,G02.111.570.790.709
18402443,2008-04-11T00:00:00,Silver,D01.268.556.812
18402443,2008-04-11T00:00:00,Silver,D01.268.956.843
18402443,2008-04-11T00:00:00,Silver,D01.552.544.812
18402443,2008-04-11T00:00:00,Surface Plasmon Resonance,E05.196.890
18402443,2008-04-11T00:00:00,Surface Plasmon Resonance,E05.601.123.700
18408982,2008-04-12T00:00:00,Adult,M01.060.116
18408982,2008-04-12T00:00:00,Exercise,G11.427.590.237
18408982,2008-04-12T00:00:00,Exercise,I03.350
18408982,2008-04-12T00:00:00,Feeding Behavior,F01.145.113.547
18408982,2008-04-12T00:00:00,Feeding Behavior,F01.145.407
18408982,2008-04-12T00:00:00,Gastroplasty,E02.065.062.750
18408982,2008-04-12T00:00:00,Gastroplasty,E04.062.750
18408982,2008-04-12T00:00:00,Gastroplasty,E04.210.485
18408982,2008-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18408982,2008-04-12T00:00:00,Laparoscopy,E01.370.388.250.520
18408982,2008-04-12T00:00:00,Laparoscopy,E04.800.250.520
18408982,2008-04-12T00:00:00,Middle Aged,M01.060.116.630
18408982,2008-04-12T00:00:00,"Obesity, Morbid",C18.654.726.500.700
18408982,2008-04-12T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
18408982,2008-04-12T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
18408982,2008-04-12T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
18408982,2008-04-12T00:00:00,Treatment Outcome,E01.789.800
18408982,2008-04-12T00:00:00,Treatment Outcome,N04.761.559.590.800
18408982,2008-04-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18408982,2008-04-12T00:00:00,Weight Loss,C23.888.144.243.963
18408982,2008-04-12T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18513726,2008-04-12T00:00:00,Animals,B01.050
18513726,2008-04-12T00:00:00,Atherosclerosis,C14.907.137.126.307
18513726,2008-04-12T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18513726,2008-04-12T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18513726,2008-04-12T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18513726,2008-04-12T00:00:00,Chemokines,D12.644.276.374.200
18513726,2008-04-12T00:00:00,Chemokines,D12.776.467.374.200
18513726,2008-04-12T00:00:00,Chemokines,D23.125.300
18513726,2008-04-12T00:00:00,Chemokines,D23.469.200
18513726,2008-04-12T00:00:00,Chemokines,D23.529.374.200
18513726,2008-04-12T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
18513726,2008-04-12T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
18513726,2008-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18513726,2008-04-12T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18513726,2008-04-12T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18513726,2008-04-12T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18513726,2008-04-12T00:00:00,Inflammation,C23.550.470
18513726,2008-04-12T00:00:00,Lipoproteins,D10.532
18513726,2008-04-12T00:00:00,Lipoproteins,D12.776.521
18513726,2008-04-12T00:00:00,"Lipoproteins, LDL",D10.532.515
18513726,2008-04-12T00:00:00,"Lipoproteins, LDL",D12.776.521.550
18513726,2008-04-12T00:00:00,"T-Lymphocytes, Helper-Inducer",A11.118.637.555.567.569.200.400
18513726,2008-04-12T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.145.229.637.555.567.569.200.400
18513726,2008-04-12T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.382.490.555.567.569.200.400
18414384,2008-04-14T00:00:00,Animals,B01.050
18414384,2008-04-14T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18414384,2008-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18414384,2008-04-14T00:00:00,Neural Pathways,A08.612
18414384,2008-04-14T00:00:00,Pharmacogenetics,H01.158.273.343.750
18414384,2008-04-14T00:00:00,Pharmacogenetics,H01.158.703.052
18414384,2008-04-14T00:00:00,Pharmacogenetics,H02.628.479
18414384,2008-04-14T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18414384,2008-04-14T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18414384,2008-04-14T00:00:00,Substance-Related Disorders,C21.739
18414384,2008-04-14T00:00:00,Substance-Related Disorders,F03.900
18417966,2008-04-14T00:00:00,African Americans,M01.686.508.100.100
18417966,2008-04-14T00:00:00,African Americans,M01.686.754.100
18417966,2008-04-14T00:00:00,Attitude to Health,F01.100.150
18417966,2008-04-14T00:00:00,Attitude to Health,N05.300.150
18417966,2008-04-14T00:00:00,Breast Neoplasms,C04.588.180
18417966,2008-04-14T00:00:00,Breast Neoplasms,C17.800.090.500
18417966,2008-04-14T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
18417966,2008-04-14T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
18417966,2008-04-14T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
18417966,2008-04-14T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
18417966,2008-04-14T00:00:00,Genetic Counseling,H01.158.273.343.315.384
18417966,2008-04-14T00:00:00,Genetic Counseling,N02.421.308.400
18417966,2008-04-14T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18417966,2008-04-14T00:00:00,Genetic Predisposition to Disease,G05.380.355
18417966,2008-04-14T00:00:00,Genetic Testing,E01.370.427
18417966,2008-04-14T00:00:00,Genetic Testing,E05.393.435
18417966,2008-04-14T00:00:00,Genetic Testing,N02.421.143.827.233.221
18417966,2008-04-14T00:00:00,Genetic Testing,N02.421.308.430
18417966,2008-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18417966,2008-04-14T00:00:00,Middle Aged,M01.060.116.630
18417966,2008-04-14T00:00:00,Mutation,G05.365.590
18417966,2008-04-14T00:00:00,Ovarian Neoplasms,C04.588.322.455
18417966,2008-04-14T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
18417966,2008-04-14T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
18417966,2008-04-14T00:00:00,Ovarian Neoplasms,C19.344.410
18417966,2008-04-14T00:00:00,Ovarian Neoplasms,C19.391.630.705
18417966,2008-04-14T00:00:00,Risk Factors,E05.318.740.600.800.725
18417966,2008-04-14T00:00:00,Risk Factors,N05.715.350.200.700
18417966,2008-04-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18417966,2008-04-14T00:00:00,Risk Factors,N06.850.490.625.750
18417966,2008-04-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18501524,2008-04-14T00:00:00,Adult,M01.060.116
18501524,2008-04-14T00:00:00,Crime Victims,M01.135
18501524,2008-04-14T00:00:00,Depressive Disorder,F03.600.300
18501524,2008-04-14T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18501524,2008-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18501524,2008-04-14T00:00:00,Psychometrics,F04.711.780
18501524,2008-04-14T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18501524,2008-04-14T00:00:00,Substance-Related Disorders,C21.739
18501524,2008-04-14T00:00:00,Substance-Related Disorders,F03.900
18534438,2008-04-14T00:00:00,Aged,M01.060.116.100
18534438,2008-04-14T00:00:00,Anticoagulants,D27.505.954.502.119
18534438,2008-04-14T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
18534438,2008-04-14T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
18534438,2008-04-14T00:00:00,Benzimidazoles,D03.438.103
18534438,2008-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18534438,2008-04-14T00:00:00,Middle Aged,M01.060.116.630
18534438,2008-04-14T00:00:00,North America,Z01.107.567
18534438,2008-04-14T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18534438,2008-04-14T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18534438,2008-04-14T00:00:00,Risk Factors,E05.318.740.600.800.725
18534438,2008-04-14T00:00:00,Risk Factors,N05.715.350.200.700
18534438,2008-04-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18534438,2008-04-14T00:00:00,Risk Factors,N06.850.490.625.750
18534438,2008-04-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18534438,2008-04-14T00:00:00,Thrombin,D08.811.277.656.300.760.855
18534438,2008-04-14T00:00:00,Thrombin,D08.811.277.656.959.350.855
18534438,2008-04-14T00:00:00,Thrombin,D12.776.124.125.890
18534438,2008-04-14T00:00:00,Thrombin,D23.119.960
18534438,2008-04-14T00:00:00,Venous Thromboembolism,C14.907.355.590.700
18534438,2008-04-14T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
17891780,2008-04-15T00:00:00,Bone Marrow Cells,A11.148
17891780,2008-04-15T00:00:00,Bone Marrow Cells,A15.378.316
17891780,2008-04-15T00:00:00,Eye Proteins,D12.776.306
17891780,2008-04-15T00:00:00,Gene Expression Regulation,G05.355.315
17891780,2008-04-15T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
17891780,2008-04-15T00:00:00,Heat-Shock Proteins,D12.776.580.216
17891780,2008-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17891780,2008-04-15T00:00:00,Osteoblasts,A11.329.629
17891780,2008-04-15T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17891780,2008-04-15T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17891780,2008-04-15T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17891780,2008-04-15T00:00:00,RANK Ligand,D12.644.276.374.750.562
17891780,2008-04-15T00:00:00,RANK Ligand,D12.644.276.972.562
17891780,2008-04-15T00:00:00,RANK Ligand,D12.776.467.374.750.562
17891780,2008-04-15T00:00:00,RANK Ligand,D12.776.467.972.562
17891780,2008-04-15T00:00:00,RANK Ligand,D23.529.374.750.562
17891780,2008-04-15T00:00:00,RANK Ligand,D23.529.972.562
17891780,2008-04-15T00:00:00,Stromal Cells,A11.329.830
17891780,2008-04-15T00:00:00,Transcription Factors,D12.776.930
18383420,2008-04-15T00:00:00,Adolescent,M01.060.057
18383420,2008-04-15T00:00:00,Adult,M01.060.116
18383420,2008-04-15T00:00:00,Aged,M01.060.116.100
18383420,2008-04-15T00:00:00,Case-Control Studies,E05.318.760.500.500
18383420,2008-04-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18383420,2008-04-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18383420,2008-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18383420,2008-04-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18383420,2008-04-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18383420,2008-04-15T00:00:00,Middle Aged,M01.060.116.630
18383420,2008-04-15T00:00:00,Quality of Life,I01.800
18383420,2008-04-15T00:00:00,Quality of Life,K01.752.400.750
18390713,2008-04-15T00:00:00,Animals,B01.050
18390713,2008-04-15T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18390713,2008-04-15T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18390713,2008-04-15T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18390713,2008-04-15T00:00:00,Cell Proliferation,G04.299.233.750
18390713,2008-04-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18390713,2008-04-15T00:00:00,Homeostasis,G07.700.360
18390713,2008-04-15T00:00:00,Interleukin-15,D12.644.276.374.465.515
18390713,2008-04-15T00:00:00,Interleukin-15,D12.776.467.374.465.515
18390713,2008-04-15T00:00:00,Interleukin-15,D23.529.374.465.515
18390713,2008-04-15T00:00:00,Interleukin-2,D12.644.276.374.465.502
18390713,2008-04-15T00:00:00,Interleukin-2,D12.644.276.374.480.372
18390713,2008-04-15T00:00:00,Interleukin-2,D12.776.467.374.465.502
18390713,2008-04-15T00:00:00,Interleukin-2,D12.776.467.374.480.372
18390713,2008-04-15T00:00:00,Interleukin-2,D23.529.374.465.502
18390713,2008-04-15T00:00:00,Interleukin-2,D23.529.374.480.372
18390713,2008-04-15T00:00:00,Lymphocyte Activation,E01.450.495.482
18390713,2008-04-15T00:00:00,Lymphocyte Activation,E05.478.594.530
18390713,2008-04-15T00:00:00,Lymphocyte Activation,G12.425.747
18390713,2008-04-15T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18390713,2008-04-15T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18390713,2008-04-15T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18413755,2008-04-15T00:00:00,Antineoplastic Agents,D27.505.954.248
18413755,2008-04-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
18413755,2008-04-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
18413755,2008-04-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
18413755,2008-04-15T00:00:00,Cell Survival,G04.299.316
18413755,2008-04-15T00:00:00,Cisplatin,D01.210.375
18413755,2008-04-15T00:00:00,Cisplatin,D01.625.125
18413755,2008-04-15T00:00:00,Cisplatin,D01.710.100
18413755,2008-04-15T00:00:00,Glutathione,D12.644.456.448
18413755,2008-04-15T00:00:00,Glutathione Disulfide,D12.644.456.448.500
18413755,2008-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18413755,2008-04-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
18413755,2008-04-15T00:00:00,Lung Neoplasms,C08.381.540
18413755,2008-04-15T00:00:00,Lung Neoplasms,C08.785.520
18413767,2008-04-15T00:00:00,Animals,B01.050
18413767,2008-04-15T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18413767,2008-04-15T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18413767,2008-04-15T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18413767,2008-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18413767,2008-04-15T00:00:00,Melanoma,C04.557.465.625.650.510
18413767,2008-04-15T00:00:00,Melanoma,C04.557.580.625.650.510
18413767,2008-04-15T00:00:00,Melanoma,C04.557.665.510
18413767,2008-04-15T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18413767,2008-04-15T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18413767,2008-04-15T00:00:00,Neoplasms,C04
18413767,2008-04-15T00:00:00,Pancreatic Neoplasms,C04.588.274.761
18413767,2008-04-15T00:00:00,Pancreatic Neoplasms,C04.588.322.421
18413767,2008-04-15T00:00:00,Pancreatic Neoplasms,C06.301.761
18413767,2008-04-15T00:00:00,Pancreatic Neoplasms,C06.689.667
18413767,2008-04-15T00:00:00,Pancreatic Neoplasms,C19.344.421
18413845,2008-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18413845,2008-04-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
18413845,2008-04-15T00:00:00,Lung Neoplasms,C08.381.540
18413845,2008-04-15T00:00:00,Lung Neoplasms,C08.785.520
18483594,2008-04-15T00:00:00,Career Choice,F02.463.785.373.346.400
18483594,2008-04-15T00:00:00,Curriculum,I02.158
18483594,2008-04-15T00:00:00,Data Collection,E05.318.308
18483594,2008-04-15T00:00:00,Data Collection,L01.280
18483594,2008-04-15T00:00:00,Data Collection,N05.715.360.300
18483594,2008-04-15T00:00:00,Data Collection,N06.850.520.308
18483594,2008-04-15T00:00:00,"Education, Graduate",I02.358.337
18483594,2008-04-15T00:00:00,Educational Measurement,I02.399
18483594,2008-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18483594,2008-04-15T00:00:00,Salaries and Fringe Benefits,N01.824.417.700
18483594,2008-04-15T00:00:00,Salaries and Fringe Benefits,N04.452.677.800
18483594,2008-04-15T00:00:00,"Schools, Pharmacy",I02.783.660.694
18483594,2008-04-15T00:00:00,South Carolina,Z01.107.567.875.075.662
18483594,2008-04-15T00:00:00,South Carolina,Z01.107.567.875.750.700
18483594,2008-04-15T00:00:00,"Students, Pharmacy",I02.851.686.768
18483594,2008-04-15T00:00:00,"Students, Pharmacy",M01.848.769.768
18413179,2008-04-16T00:00:00,Adolescent,M01.060.057
18413179,2008-04-16T00:00:00,Adult,M01.060.116
18413179,2008-04-16T00:00:00,African Continental Ancestry Group,M01.686.508.100
18413179,2008-04-16T00:00:00,Aged,M01.060.116.100
18413179,2008-04-16T00:00:00,Continental Population Groups,M01.686.508
18413179,2008-04-16T00:00:00,Diabetes Mellitus,C18.452.394.750
18413179,2008-04-16T00:00:00,Diabetes Mellitus,C19.246
18413179,2008-04-16T00:00:00,Ethnic Groups,M01.686.754
18413179,2008-04-16T00:00:00,Ethnic Groups,N01.224.317
18413179,2008-04-16T00:00:00,European Continental Ancestry Group,M01.686.508.400
18413179,2008-04-16T00:00:00,Health Behavior,F01.145.488
18413179,2008-04-16T00:00:00,Hispanic Americans,M01.686.754.441
18413179,2008-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18413179,2008-04-16T00:00:00,Middle Aged,M01.060.116.630
18413179,2008-04-16T00:00:00,Patient Compliance,F01.145.488.500
18413179,2008-04-16T00:00:00,Patient Compliance,N05.300.150.600.600
18413179,2008-04-16T00:00:00,Patient Education as Topic,I02.233.332.500
18413179,2008-04-16T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
18413179,2008-04-16T00:00:00,Patient Education as Topic,N02.421.726.407.680
18413179,2008-04-16T00:00:00,Regression Analysis,E05.318.740.750
18413179,2008-04-16T00:00:00,Regression Analysis,N05.715.360.750.695
18413179,2008-04-16T00:00:00,Regression Analysis,N06.850.520.830.750
18413179,2008-04-16T00:00:00,Self Care,E02.900
18413179,2008-04-16T00:00:00,Self Care,N02.421.784.680
18413179,2008-04-16T00:00:00,Young Adult,M01.060.116.815
18413218,2008-04-16T00:00:00,Adult,M01.060.116
18413218,2008-04-16T00:00:00,C-Reactive Protein,D12.776.034.145
18413218,2008-04-16T00:00:00,C-Reactive Protein,D12.776.124.050.120
18413218,2008-04-16T00:00:00,C-Reactive Protein,D12.776.124.486.157
18413218,2008-04-16T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18413218,2008-04-16T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18413218,2008-04-16T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18413218,2008-04-16T00:00:00,Diabetic Angiopathies,C14.907.320
18413218,2008-04-16T00:00:00,Diabetic Angiopathies,C19.246.099.500
18413218,2008-04-16T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
18413218,2008-04-16T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
18413218,2008-04-16T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
18413218,2008-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18413218,2008-04-16T00:00:00,Hypertension,C14.907.489
18413218,2008-04-16T00:00:00,Lipids,D10
18413218,2008-04-16T00:00:00,Risk Factors,E05.318.740.600.800.725
18413218,2008-04-16T00:00:00,Risk Factors,N05.715.350.200.700
18413218,2008-04-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18413218,2008-04-16T00:00:00,Risk Factors,N06.850.490.625.750
18413218,2008-04-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18413218,2008-04-16T00:00:00,Sex Characteristics,G08.686.815
18415653,2008-04-16T00:00:00,Adult,M01.060.116
18415653,2008-04-16T00:00:00,Aged,M01.060.116.100
18415653,2008-04-16T00:00:00,Delivery of Health Care,N04.590.374
18415653,2008-04-16T00:00:00,Delivery of Health Care,N05.300
18415653,2008-04-16T00:00:00,Health Facilities,N02.278
18415653,2008-04-16T00:00:00,Health Personnel,M01.526.485
18415653,2008-04-16T00:00:00,Health Personnel,N02.360
18415653,2008-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18415653,2008-04-16T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.576.343.480
18415653,2008-04-16T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.710
18415653,2008-04-16T00:00:00,Middle Aged,M01.060.116.630
18415653,2008-04-16T00:00:00,Patient Satisfaction,N04.452.822.360.600
18415653,2008-04-16T00:00:00,Patient Satisfaction,N05.300.150.600.630
18415653,2008-04-16T00:00:00,Patient Satisfaction,N05.715.360.600
18415653,2008-04-16T00:00:00,Psychometrics,F04.711.780
18415653,2008-04-16T00:00:00,Quality of Health Care,N04.761
18415653,2008-04-16T00:00:00,Quality of Health Care,N05.715
18415653,2008-04-16T00:00:00,Questionnaires,E05.318.308.750
18415653,2008-04-16T00:00:00,Questionnaires,L01.280.800
18415653,2008-04-16T00:00:00,Questionnaires,N05.715.360.300.695
18415653,2008-04-16T00:00:00,Questionnaires,N06.850.520.308.750
18415653,2008-04-16T00:00:00,United States,Z01.107.567.875
18417691,2008-04-16T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
18417691,2008-04-16T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
18417691,2008-04-16T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
18417691,2008-04-16T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
18417691,2008-04-16T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
18417691,2008-04-16T00:00:00,Animals,B01.050
18417691,2008-04-16T00:00:00,Antioxidants,D27.505.519.217
18417691,2008-04-16T00:00:00,Antioxidants,D27.505.696.706.125
18417691,2008-04-16T00:00:00,Antioxidants,D27.720.799.047
18417691,2008-04-16T00:00:00,Astrocytes,A08.637.200
18417691,2008-04-16T00:00:00,Astrocytes,A11.650.200
18417691,2008-04-16T00:00:00,Drug Delivery Systems,E02.319.300
18417691,2008-04-16T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18417691,2008-04-16T00:00:00,Mitochondria,A11.284.835.626
18417691,2008-04-16T00:00:00,Motor Neurons,A08.663.655.500
18417691,2008-04-16T00:00:00,Motor Neurons,A11.671.655.500
18417691,2008-04-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18417691,2008-04-16T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18417691,2008-04-16T00:00:00,Superoxide Dismutase,D08.811.682.881
18422825,2008-04-16T00:00:00,Alcoholism,C21.739.100.250
18422825,2008-04-16T00:00:00,Alcoholism,F03.900.100.350
18422825,2008-04-16T00:00:00,Algorithms,G17.035
18422825,2008-04-16T00:00:00,Algorithms,L01.224.050
18422825,2008-04-16T00:00:00,Counseling,F02.784.176
18422825,2008-04-16T00:00:00,Counseling,F04.408.413
18422825,2008-04-16T00:00:00,Counseling,N02.421.143.303
18422825,2008-04-16T00:00:00,Counseling,N02.421.461.363
18422825,2008-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18422825,2008-04-16T00:00:00,Hypertension,C14.907.489
18422825,2008-04-16T00:00:00,Middle Aged,M01.060.116.630
18422825,2008-04-16T00:00:00,Physician's Practice Patterns,N04.590.748
18422825,2008-04-16T00:00:00,Physician's Practice Patterns,N05.300.625
18422825,2008-04-16T00:00:00,Primary Health Care,N04.590.233.727
18422825,2008-04-16T00:00:00,Risk Assessment,E05.318.740.600.800.715
18422825,2008-04-16T00:00:00,Risk Assessment,N04.452.871.715
18422825,2008-04-16T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18422825,2008-04-16T00:00:00,Risk Assessment,N06.850.505.715
18422825,2008-04-16T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18422825,2008-04-16T00:00:00,United States,Z01.107.567.875
18418604,2008-04-17T00:00:00,Adult,M01.060.116
18418604,2008-04-17T00:00:00,Aged,M01.060.116.100
18418604,2008-04-17T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18418604,2008-04-17T00:00:00,Coronary Angiography,E01.370.370.050.200
18418604,2008-04-17T00:00:00,Coronary Angiography,E01.370.370.380.200
18418604,2008-04-17T00:00:00,Heart Transplantation,E04.100.376.475
18418604,2008-04-17T00:00:00,Heart Transplantation,E04.928.220.390
18418604,2008-04-17T00:00:00,Heart Transplantation,E04.936.450.475
18418604,2008-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18418604,2008-04-17T00:00:00,Middle Aged,M01.060.116.630
18418604,2008-04-17T00:00:00,Sensitivity and Specificity,E05.318.740.872
18418604,2008-04-17T00:00:00,Sensitivity and Specificity,E05.318.780.800
18418604,2008-04-17T00:00:00,Sensitivity and Specificity,G17.800
18418604,2008-04-17T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18418604,2008-04-17T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18418604,2008-04-17T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18418604,2008-04-17T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18418604,2008-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18418604,2008-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18418604,2008-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18418604,2008-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18418604,2008-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18394850,2008-04-18T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
18394850,2008-04-18T00:00:00,"Diagnosis, Differential",E01.171
18394850,2008-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18394850,2008-04-18T00:00:00,Middle Aged,M01.060.116.630
18394850,2008-04-18T00:00:00,Seizures,C10.228.140.490.631
18394850,2008-04-18T00:00:00,Seizures,C10.597.742
18394850,2008-04-18T00:00:00,Seizures,C23.888.592.742
18394850,2008-04-18T00:00:00,Stomach Rupture,C06.405.748.824
18394850,2008-04-18T00:00:00,Stomach Rupture,C21.866.017.809
18394850,2008-04-18T00:00:00,Stomach Rupture,C21.866.761.684
18394850,2008-04-18T00:00:00,Vomiting,C23.888.821.937
18421538,2008-04-18T00:00:00,Adult,M01.060.116
18421538,2008-04-18T00:00:00,Aged,M01.060.116.100
18421538,2008-04-18T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18421538,2008-04-18T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
18421538,2008-04-18T00:00:00,"Arthroplasty, Replacement",E04.650.110
18421538,2008-04-18T00:00:00,Debridement,E04.176
18421538,2008-04-18T00:00:00,Disease-Free Survival,E01.789.200
18421538,2008-04-18T00:00:00,Disease-Free Survival,E05.318.740.998.300
18421538,2008-04-18T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18421538,2008-04-18T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18421538,2008-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18421538,2008-04-18T00:00:00,Joint Prosthesis,E07.695.400
18421538,2008-04-18T00:00:00,Middle Aged,M01.060.116.630
18421538,2008-04-18T00:00:00,Prosthesis-Related Infections,C01.539.685
18421538,2008-04-18T00:00:00,Prosthesis-Related Infections,C23.550.767.868
18421538,2008-04-18T00:00:00,Reoperation,E04.690
18421538,2008-04-18T00:00:00,Risk Factors,E05.318.740.600.800.725
18421538,2008-04-18T00:00:00,Risk Factors,N05.715.350.200.700
18421538,2008-04-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18421538,2008-04-18T00:00:00,Risk Factors,N06.850.490.625.750
18421538,2008-04-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18421538,2008-04-18T00:00:00,Treatment Outcome,E01.789.800
18421538,2008-04-18T00:00:00,Treatment Outcome,N04.761.559.590.800
18421538,2008-04-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18423615,2008-04-18T00:00:00,Child,M01.060.406
18423615,2008-04-18T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
18423615,2008-04-18T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
18423615,2008-04-18T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
18423615,2008-04-18T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
18423615,2008-04-18T00:00:00,Crime Victims,M01.135
18423615,2008-04-18T00:00:00,Delivery of Health Care,N04.590.374
18423615,2008-04-18T00:00:00,Delivery of Health Care,N05.300
18423615,2008-04-18T00:00:00,Health Status,I01.240.425
18423615,2008-04-18T00:00:00,Health Status,N01.224.425
18423615,2008-04-18T00:00:00,Health Status,N06.850.505.400.425
18423615,2008-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18423615,2008-04-18T00:00:00,Life Change Events,F01.829.458.410
18423615,2008-04-18T00:00:00,Mental Disorders,F03
18423615,2008-04-18T00:00:00,Middle Aged,M01.060.116.630
18423615,2008-04-18T00:00:00,Prevalence,E05.318.308.985.525.750
18423615,2008-04-18T00:00:00,Prevalence,L01.280.975.525.750
18423615,2008-04-18T00:00:00,Prevalence,N01.224.935.597.750
18423615,2008-04-18T00:00:00,Prevalence,N06.850.505.400.975.525.750
18423615,2008-04-18T00:00:00,Prevalence,N06.850.520.308.985.525.750
18423615,2008-04-18T00:00:00,Primary Health Care,N04.590.233.727
18423615,2008-04-18T00:00:00,Sex Factors,N05.715.350.675
18423615,2008-04-18T00:00:00,Sex Factors,N06.850.490.875
18423615,2008-04-18T00:00:00,Sex Offenses,I01.198.240.748
18423615,2008-04-18T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18423615,2008-04-18T00:00:00,United States,Z01.107.567.875
18423615,2008-04-18T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
18423615,2008-04-18T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
18423615,2008-04-18T00:00:00,Veterans,M01.930
18489931,2008-04-18T00:00:00,Aged,M01.060.116.100
18489931,2008-04-18T00:00:00,Biological Markers,D23.101
18489931,2008-04-18T00:00:00,Coronary Disease,C14.280.647.250
18489931,2008-04-18T00:00:00,Coronary Disease,C14.907.585.250
18489931,2008-04-18T00:00:00,Creatinine,D03.383.129.308.207
18489931,2008-04-18T00:00:00,Diabetes Complications,C19.246.099
18489931,2008-04-18T00:00:00,Hospital Mortality,E05.318.308.985.550.400
18489931,2008-04-18T00:00:00,Hospital Mortality,L01.280.975.550.400
18489931,2008-04-18T00:00:00,Hospital Mortality,N01.224.935.698.400
18489931,2008-04-18T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
18489931,2008-04-18T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
18489931,2008-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18489931,2008-04-18T00:00:00,Incidence,E05.318.308.985.525.375
18489931,2008-04-18T00:00:00,Incidence,L01.280.975.525.375
18489931,2008-04-18T00:00:00,Incidence,N01.224.935.597.500
18489931,2008-04-18T00:00:00,Incidence,N06.850.505.400.975.525.375
18489931,2008-04-18T00:00:00,Incidence,N06.850.520.308.985.525.375
18489931,2008-04-18T00:00:00,Kidney Diseases,C12.777.419
18489931,2008-04-18T00:00:00,Kidney Diseases,C13.351.968.419
18489931,2008-04-18T00:00:00,Middle Aged,M01.060.116.630
18489931,2008-04-18T00:00:00,Regression Analysis,E05.318.740.750
18489931,2008-04-18T00:00:00,Regression Analysis,N05.715.360.750.695
18489931,2008-04-18T00:00:00,Regression Analysis,N06.850.520.830.750
18489931,2008-04-18T00:00:00,Risk Assessment,E05.318.740.600.800.715
18489931,2008-04-18T00:00:00,Risk Assessment,N04.452.871.715
18489931,2008-04-18T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18489931,2008-04-18T00:00:00,Risk Assessment,N06.850.505.715
18489931,2008-04-18T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18489931,2008-04-18T00:00:00,Risk Factors,E05.318.740.600.800.725
18489931,2008-04-18T00:00:00,Risk Factors,N05.715.350.200.700
18489931,2008-04-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18489931,2008-04-18T00:00:00,Risk Factors,N06.850.490.625.750
18489931,2008-04-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18489931,2008-04-18T00:00:00,Treatment Outcome,E01.789.800
18489931,2008-04-18T00:00:00,Treatment Outcome,N04.761.559.590.800
18489931,2008-04-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18534414,2008-04-18T00:00:00,Aged,M01.060.116.100
18534414,2008-04-18T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
18534414,2008-04-18T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
18534414,2008-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18534414,2008-04-18T00:00:00,Middle Aged,M01.060.116.630
18534414,2008-04-18T00:00:00,North America,Z01.107.567
18534414,2008-04-18T00:00:00,"Osteoarthritis, Knee",C05.550.114.606.500
18534414,2008-04-18T00:00:00,"Osteoarthritis, Knee",C05.799.613.500
18534414,2008-04-18T00:00:00,"Stress, Mechanical",G01.374.676.830
18534414,2008-04-18T00:00:00,"Stress, Mechanical",G01.595.540.830
18534414,2008-04-18T00:00:00,Weight-Bearing,G01.374.676.965
18534414,2008-04-18T00:00:00,Weight-Bearing,G01.595.540.965
18490286,2008-04-19T00:00:00,Aged,M01.060.116.100
18490286,2008-04-19T00:00:00,Heart Failure,C14.280.434
18490286,2008-04-19T00:00:00,Heart Ventricles,A07.541.560
18490286,2008-04-19T00:00:00,Hemodynamics,G09.330.190.400
18490286,2008-04-19T00:00:00,Hemodynamics,G09.330.380
18490286,2008-04-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18490286,2008-04-19T00:00:00,Middle Aged,M01.060.116.630
18490286,2008-04-19T00:00:00,Stroke Volume,E01.370.370.380.150.700
18490286,2008-04-19T00:00:00,Stroke Volume,G09.330.380.124.882
18490286,2008-04-19T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18490286,2008-04-19T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
18423666,2008-04-20T00:00:00,Animals,B01.050
18423666,2008-04-20T00:00:00,Biocompatible Materials,D25.130
18423666,2008-04-20T00:00:00,Biocompatible Materials,D27.720.102.130
18423666,2008-04-20T00:00:00,Biocompatible Materials,J01.637.051.130
18423666,2008-04-20T00:00:00,Biomedical Engineering,H02.070
18423666,2008-04-20T00:00:00,Biomedical Engineering,J01.293.140
18423666,2008-04-20T00:00:00,Blood Vessels,A07.231
18423666,2008-04-20T00:00:00,Cell Culture Techniques,E05.200.249.249
18423666,2008-04-20T00:00:00,Collagen,D05.750.078.280
18423666,2008-04-20T00:00:00,Collagen,D12.776.860.300.250
18423666,2008-04-20T00:00:00,Elastin,D05.750.078.421
18423666,2008-04-20T00:00:00,Elastin,D12.776.860.300.350
18423666,2008-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18423666,2008-04-20T00:00:00,Magnetics,H01.671.493
18423666,2008-04-20T00:00:00,Nanoparticles,J01.637.512.600
18423666,2008-04-20T00:00:00,Nanostructures,J01.637.512
18423666,2008-04-20T00:00:00,Nanotechnology,H01.603
18423666,2008-04-20T00:00:00,Nanotechnology,J01.897.520.600
18423666,2008-04-20T00:00:00,Tissue Engineering,E05.200.249.750
18511057,2008-04-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
18511057,2008-04-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
18511057,2008-04-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
18511057,2008-04-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
18511057,2008-04-20T00:00:00,Atherosclerosis,C14.907.137.126.307
18511057,2008-04-20T00:00:00,Cholesterol,D04.808.247.222.284
18511057,2008-04-20T00:00:00,Cholesterol,D04.808.247.808.197
18511057,2008-04-20T00:00:00,Cholesterol,D10.570.938.208
18511057,2008-04-20T00:00:00,Cholesterol,D10.851.208
18511057,2008-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18511057,2008-04-20T00:00:00,Lentivirus,B04.820.650.589
18511057,2008-04-20T00:00:00,Lentivirus,B04.909.777.731.589
18511057,2008-04-20T00:00:00,Lipid Metabolism,G03.495.520
18511057,2008-04-20T00:00:00,Lipids,D10
18511057,2008-04-20T00:00:00,"Lipoproteins, LDL",D10.532.515
18511057,2008-04-20T00:00:00,"Lipoproteins, LDL",D12.776.521.550
18511057,2008-04-20T00:00:00,Macrophages,A11.329.372
18511057,2008-04-20T00:00:00,Macrophages,A11.627.482
18511057,2008-04-20T00:00:00,Macrophages,A11.733.397
18511057,2008-04-20T00:00:00,Macrophages,A15.382.680.397
18511057,2008-04-20T00:00:00,Macrophages,A15.382.812.522
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18511057,2008-04-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18426800,2008-04-21T00:00:00,Apoptosis,G04.299.139.160
18426800,2008-04-21T00:00:00,Cell Survival,G04.299.316
18426800,2008-04-21T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18426800,2008-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18426800,2008-04-21T00:00:00,"Models, Biological",E05.599.395
18426800,2008-04-21T00:00:00,NF-kappa B,D12.776.260.600
18426800,2008-04-21T00:00:00,NF-kappa B,D12.776.660.600
18426800,2008-04-21T00:00:00,NF-kappa B,D12.776.930.600
18426800,2008-04-21T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18426800,2008-04-21T00:00:00,Prostatic Neoplasms,C12.294.260.750
18426800,2008-04-21T00:00:00,Prostatic Neoplasms,C12.294.565.625
18426800,2008-04-21T00:00:00,Prostatic Neoplasms,C12.758.409.750
18426800,2008-04-21T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
18426800,2008-04-21T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
18426800,2008-04-21T00:00:00,"Transcription, Genetic",G02.111.087.847
18426800,2008-04-21T00:00:00,"Transcription, Genetic",G02.149.115.847
18426800,2008-04-21T00:00:00,"Transcription, Genetic",G05.355.310.700
18430794,2008-04-22T00:00:00,Adult,M01.060.116
18430794,2008-04-22T00:00:00,"Diagnosis, Differential",E01.171
18430794,2008-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18430794,2008-04-22T00:00:00,Probability,E05.318.740.600
18430794,2008-04-22T00:00:00,Probability,G17.680
18430794,2008-04-22T00:00:00,Probability,N05.715.360.750.625
18430794,2008-04-22T00:00:00,Probability,N06.850.520.830.600
18431576,2008-04-23T00:00:00,Adolescent,M01.060.057
18431576,2008-04-23T00:00:00,Adult,M01.060.116
18431576,2008-04-23T00:00:00,Aged,M01.060.116.100
18431576,2008-04-23T00:00:00,Algorithms,G17.035
18431576,2008-04-23T00:00:00,Algorithms,L01.224.050
18431576,2008-04-23T00:00:00,Blood Flow Velocity,E01.370.370.130
18431576,2008-04-23T00:00:00,Blood Flow Velocity,G09.330.380.630.080
18431576,2008-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18431576,2008-04-23T00:00:00,Middle Aged,M01.060.116.630
18431576,2008-04-23T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
18431576,2008-04-23T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
18431576,2008-04-23T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
18431576,2008-04-23T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
18431576,2008-04-23T00:00:00,Sensitivity and Specificity,E05.318.740.872
18431576,2008-04-23T00:00:00,Sensitivity and Specificity,E05.318.780.800
18431576,2008-04-23T00:00:00,Sensitivity and Specificity,G17.800
18431576,2008-04-23T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18431576,2008-04-23T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18431576,2008-04-23T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18431576,2008-04-23T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18431576,2008-04-23T00:00:00,Software,L01.224.900
18431576,2008-04-23T00:00:00,Spinal Cord,A08.186.854
18431576,2008-04-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18431576,2008-04-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18431576,2008-04-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18431576,2008-04-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18431576,2008-04-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18431576,2008-04-23T00:00:00,Young Adult,M01.060.116.815
18431612,2008-04-23T00:00:00,Adolescent,M01.060.057
18431612,2008-04-23T00:00:00,Adult,M01.060.116
18431612,2008-04-23T00:00:00,Aged,M01.060.116.100
18431612,2008-04-23T00:00:00,Gastroplasty,E02.065.062.750
18431612,2008-04-23T00:00:00,Gastroplasty,E04.062.750
18431612,2008-04-23T00:00:00,Gastroplasty,E04.210.485
18431612,2008-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18431612,2008-04-23T00:00:00,Incidence,E05.318.308.985.525.375
18431612,2008-04-23T00:00:00,Incidence,L01.280.975.525.375
18431612,2008-04-23T00:00:00,Incidence,N01.224.935.597.500
18431612,2008-04-23T00:00:00,Incidence,N06.850.505.400.975.525.375
18431612,2008-04-23T00:00:00,Incidence,N06.850.520.308.985.525.375
18431612,2008-04-23T00:00:00,Laparoscopy,E01.370.388.250.520
18431612,2008-04-23T00:00:00,Laparoscopy,E04.800.250.520
18431612,2008-04-23T00:00:00,Middle Aged,M01.060.116.630
18431612,2008-04-23T00:00:00,"Obesity, Morbid",C18.654.726.500.700
18431612,2008-04-23T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
18431612,2008-04-23T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
18431612,2008-04-23T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
18431612,2008-04-23T00:00:00,Reoperation,E04.690
18431612,2008-04-23T00:00:00,Treatment Outcome,E01.789.800
18431612,2008-04-23T00:00:00,Treatment Outcome,N04.761.559.590.800
18431612,2008-04-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18431612,2008-04-23T00:00:00,Young Adult,M01.060.116.815
18434386,2008-04-23T00:00:00,Cell Line,A11.251.210
18434386,2008-04-23T00:00:00,Cell Proliferation,G04.299.233.750
18434386,2008-04-23T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18434386,2008-04-23T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.644.360.225.600
18434386,2008-04-23T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.167.187.600
18434386,2008-04-23T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.476.225.600
18434386,2008-04-23T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.624.776.355.600
18434386,2008-04-23T00:00:00,Epithelial Cells,A11.436
18434386,2008-04-23T00:00:00,Kidney,A05.810.453
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
18434386,2008-04-23T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
18434386,2008-04-23T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18434386,2008-04-23T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18434386,2008-04-23T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18434386,2008-04-23T00:00:00,Quinolines,D03.438.810
18434386,2008-04-23T00:00:00,Signal Transduction,G02.111.087.800
18434386,2008-04-23T00:00:00,Signal Transduction,G02.149.115.800
18434386,2008-04-23T00:00:00,Signal Transduction,G04.299.880
18434386,2008-04-23T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
18434745,2008-04-23T00:00:00,Animals,B01.050
18434745,2008-04-23T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
18434745,2008-04-23T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
18434745,2008-04-23T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
18434745,2008-04-23T00:00:00,Gene Expression Profiling,E05.393.332
18434745,2008-04-23T00:00:00,Signal Transduction,G02.111.087.800
18434745,2008-04-23T00:00:00,Signal Transduction,G02.149.115.800
18434745,2008-04-23T00:00:00,Signal Transduction,G04.299.880
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18434745,2008-04-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18436229,2008-04-23T00:00:00,Adult,M01.060.116
18436229,2008-04-23T00:00:00,Exercise Test,E01.370.370.380.250
18436229,2008-04-23T00:00:00,Exercise Test,E01.370.386.700.250
18436229,2008-04-23T00:00:00,Exercise Test,E05.333.250
18436229,2008-04-23T00:00:00,Gait,E01.370.600.250
18436229,2008-04-23T00:00:00,Gait,G11.427.590.530.389
18436229,2008-04-23T00:00:00,Hemiplegia,C10.597.622.295
18436229,2008-04-23T00:00:00,Hemiplegia,C23.888.592.636.312
18436229,2008-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18436229,2008-04-23T00:00:00,Walking,G11.427.590.530.568.900
18436229,2008-04-23T00:00:00,Walking,G11.427.590.530.698.940
18436229,2008-04-23T00:00:00,Walking,I03.450.642.845.940
18440950,2008-04-24T00:00:00,Animals,B01.050
18440950,2008-04-24T00:00:00,Brain,A08.186.211
18440950,2008-04-24T00:00:00,Functional Laterality,F02.830.297.425
18440950,2008-04-24T00:00:00,Functional Laterality,G11.561.225.425
18440950,2008-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18440950,2008-04-24T00:00:00,Phenotype,G05.695
18440950,2008-04-24T00:00:00,Postmortem Changes,C23.550.260.224.617
18440950,2008-04-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18440950,2008-04-24T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18440950,2008-04-24T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18440950,2008-04-24T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18440950,2008-04-24T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18440950,2008-04-24T00:00:00,Sex Characteristics,G08.686.815
18443564,2008-04-24T00:00:00,Adolescent,M01.060.057
18443564,2008-04-24T00:00:00,African Americans,M01.686.508.100.100
18443564,2008-04-24T00:00:00,African Americans,M01.686.754.100
18443564,2008-04-24T00:00:00,Body Mass Index,E01.370.600.115.100.125
18443564,2008-04-24T00:00:00,Body Mass Index,E05.041.124.125
18443564,2008-04-24T00:00:00,Body Mass Index,G07.100.100.125
18443564,2008-04-24T00:00:00,Body Mass Index,N06.850.505.200.100.175
18443564,2008-04-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
18443564,2008-04-24T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
18443564,2008-04-24T00:00:00,Heart Ventricles,A07.541.560
18443564,2008-04-24T00:00:00,Hemodynamics,G09.330.190.400
18443564,2008-04-24T00:00:00,Hemodynamics,G09.330.380
18443564,2008-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18443564,2008-04-24T00:00:00,"Models, Cardiovascular",E05.599.395.161
18443564,2008-04-24T00:00:00,"Models, Genetic",E05.599.395.397
18443564,2008-04-24T00:00:00,Sex Factors,N05.715.350.675
18443564,2008-04-24T00:00:00,Sex Factors,N06.850.490.875
18768437,2008-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18768437,2008-04-24T00:00:00,Internet,L01.224.230.110.500
18768437,2008-04-24T00:00:00,Terminology as Topic,L01.143.506.598.400
18437539,2008-04-25T00:00:00,Animals,B01.050
18437539,2008-04-25T00:00:00,Breast Neoplasms,C04.588.180
18437539,2008-04-25T00:00:00,Breast Neoplasms,C17.800.090.500
18437539,2008-04-25T00:00:00,Disease Progression,C23.550.291.656
18437539,2008-04-25T00:00:00,Drug Delivery Systems,E02.319.300
18437539,2008-04-25T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18437539,2008-04-25T00:00:00,Glycoproteins,D09.400.430
18437539,2008-04-25T00:00:00,Glycoproteins,D12.776.395
18437539,2008-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18437539,2008-04-25T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18437539,2008-04-25T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18437539,2008-04-25T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18437539,2008-04-25T00:00:00,Neoplasm Invasiveness,C04.697.645
18437539,2008-04-25T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18437539,2008-04-25T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18437539,2008-04-25T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18437539,2008-04-25T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18437539,2008-04-25T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18437539,2008-04-25T00:00:00,Transcriptional Activation,G05.355.315.800
18445110,2008-04-26T00:00:00,Aging,G07.700.320.124
18445110,2008-04-26T00:00:00,Animals,B01.050
18445110,2008-04-26T00:00:00,"Animals, Newborn",B01.050.050.282
18445110,2008-04-26T00:00:00,Ethanol,D02.033.375
18445110,2008-04-26T00:00:00,Hippocampus,A08.186.211.464.405
18445110,2008-04-26T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
18445110,2008-04-26T00:00:00,Piperidines,D03.383.621
18445110,2008-04-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18445110,2008-04-26T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18445110,2008-04-26T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18445110,2008-04-26T00:00:00,Sex Characteristics,G08.686.815
18445110,2008-04-26T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18445110,2008-04-26T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18445116,2008-04-26T00:00:00,Cell Line,A11.251.210
18445116,2008-04-26T00:00:00,Ethanol,D02.033.375
18445116,2008-04-26T00:00:00,Gene Expression,G05.355.310
18445116,2008-04-26T00:00:00,Glutamic Acid,D12.125.067.750
18445116,2008-04-26T00:00:00,Glutamic Acid,D12.125.119.450
18445116,2008-04-26T00:00:00,Glutamic Acid,D12.125.427.300
18445116,2008-04-26T00:00:00,Glycine,D12.125.481
18445116,2008-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18445116,2008-04-26T00:00:00,Kidney,A05.810.453
18445116,2008-04-26T00:00:00,Patch-Clamp Techniques,E05.200.500.800
18445116,2008-04-26T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18445116,2008-04-26T00:00:00,Recombinant Proteins,D12.776.828
18443217,2008-04-28T00:00:00,Animals,B01.050
18443217,2008-04-28T00:00:00,Calcium-Binding Proteins,D12.776.157.125
18443217,2008-04-28T00:00:00,Cell Cycle,G04.299.134
18443217,2008-04-28T00:00:00,Cell Cycle Proteins,D12.776.167
18443217,2008-04-28T00:00:00,"Chromosomal Proteins, Non-Histone",D12.776.660.235
18443217,2008-04-28T00:00:00,"Chromosomal Proteins, Non-Histone",D12.776.664.235
18443217,2008-04-28T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
18443217,2008-04-28T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
18443217,2008-04-28T00:00:00,Protein Isoforms,D12.776.800
18443217,2008-04-28T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18443217,2008-04-28T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
18443217,2008-04-28T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
18445095,2008-04-28T00:00:00,Adolescent,M01.060.057
18445095,2008-04-28T00:00:00,Adult,M01.060.116
18445095,2008-04-28T00:00:00,Aged,M01.060.116.100
18445095,2008-04-28T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
18445095,2008-04-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18445095,2008-04-28T00:00:00,Middle Aged,M01.060.116.630
18445095,2008-04-28T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
18445095,2008-04-28T00:00:00,Risk Factors,E05.318.740.600.800.725
18445095,2008-04-28T00:00:00,Risk Factors,N05.715.350.200.700
18445095,2008-04-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18445095,2008-04-28T00:00:00,Risk Factors,N06.850.490.625.750
18445095,2008-04-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18445095,2008-04-28T00:00:00,Treatment Outcome,E01.789.800
18445095,2008-04-28T00:00:00,Treatment Outcome,N04.761.559.590.800
18445095,2008-04-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18445824,2008-04-29T00:00:00,Androgens,D27.505.696.399.472.161
18445824,2008-04-29T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
18445824,2008-04-29T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
18445824,2008-04-29T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
18445824,2008-04-29T00:00:00,Disease-Free Survival,E01.789.200
18445824,2008-04-29T00:00:00,Disease-Free Survival,E05.318.740.998.300
18445824,2008-04-29T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18445824,2008-04-29T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18445824,2008-04-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18445824,2008-04-29T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18445824,2008-04-29T00:00:00,Prostatic Neoplasms,C12.294.260.750
18445824,2008-04-29T00:00:00,Prostatic Neoplasms,C12.294.565.625
18445824,2008-04-29T00:00:00,Prostatic Neoplasms,C12.758.409.750
18445824,2008-04-29T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18445824,2008-04-29T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18445824,2008-04-29T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18445824,2008-04-29T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18445824,2008-04-29T00:00:00,Treatment Outcome,E01.789.800
18445824,2008-04-29T00:00:00,Treatment Outcome,N04.761.559.590.800
18445824,2008-04-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17708511,2008-04-30T00:00:00,Bayes Theorem,E05.318.740.600.200
17708511,2008-04-30T00:00:00,Bayes Theorem,N05.715.360.750.625.150
17708511,2008-04-30T00:00:00,Bayes Theorem,N06.850.520.830.600.200
17708511,2008-04-30T00:00:00,Biometry,E05.318.740.225
17708511,2008-04-30T00:00:00,Biometry,N06.850.505.200
17708511,2008-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17708511,2008-04-30T00:00:00,"Models, Statistical",E05.318.740.500
17708511,2008-04-30T00:00:00,"Models, Statistical",E05.599.835
17708511,2008-04-30T00:00:00,"Models, Statistical",N05.715.360.750.530
17708511,2008-04-30T00:00:00,"Models, Statistical",N06.850.520.830.500
17708511,2008-04-30T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17708511,2008-04-30T00:00:00,Prostatic Neoplasms,C12.294.260.750
17708511,2008-04-30T00:00:00,Prostatic Neoplasms,C12.294.565.625
17708511,2008-04-30T00:00:00,Prostatic Neoplasms,C12.758.409.750
17708511,2008-04-30T00:00:00,South Carolina,Z01.107.567.875.075.662
17708511,2008-04-30T00:00:00,South Carolina,Z01.107.567.875.750.700
18446337,2008-04-30T00:00:00,Adult,M01.060.116
18446337,2008-04-30T00:00:00,Aged,M01.060.116.100
18446337,2008-04-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
18446337,2008-04-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
18446337,2008-04-30T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
18446337,2008-04-30T00:00:00,Breast Neoplasms,C04.588.180
18446337,2008-04-30T00:00:00,Breast Neoplasms,C17.800.090.500
18446337,2008-04-30T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
18446337,2008-04-30T00:00:00,Cyclophosphamide,D02.705.670.243
18446337,2008-04-30T00:00:00,Disease Progression,C23.550.291.656
18446337,2008-04-30T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
18446337,2008-04-30T00:00:00,Doxorubicin,D04.615.562.050.200.175
18446337,2008-04-30T00:00:00,Doxorubicin,D09.408.051.059.200.175
18446337,2008-04-30T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18446337,2008-04-30T00:00:00,Flow Cytometry,E05.200.500.386.350
18446337,2008-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18446337,2008-04-30T00:00:00,Middle Aged,M01.060.116.630
18446337,2008-04-30T00:00:00,Myeloid Cells,A11.627
18098190,2008-05-01T00:00:00,Ethanol,D02.033.375
18098190,2008-05-01T00:00:00,Lactic Acid,D02.241.511.459.450
18098190,2008-05-01T00:00:00,"Membranes, Artificial",D25.479
18098190,2008-05-01T00:00:00,"Membranes, Artificial",J01.637.051.479
18098190,2008-05-01T00:00:00,"Membranes, Artificial",J01.637.087.500
18098190,2008-05-01T00:00:00,Photochemistry,H01.181.529.711
18098190,2008-05-01T00:00:00,Polymers,D05.750
18098190,2008-05-01T00:00:00,Polymers,D25.720
18098190,2008-05-01T00:00:00,Polymers,J01.637.051.720
18098190,2008-05-01T00:00:00,Solvents,D27.720.844
18098190,2008-05-01T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
18098190,2008-05-01T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
18098190,2008-05-01T00:00:00,Surface Properties,G02.842.850
18098190,2008-05-01T00:00:00,Water,D01.455.900
18098190,2008-05-01T00:00:00,Water,D01.650.550.925
18213695,2008-05-01T00:00:00,Anticoagulants,D27.505.954.502.119
18213695,2008-05-01T00:00:00,Gastroenteritis,C06.405.205
18213695,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18213695,2008-05-01T00:00:00,Infant,M01.060.703
18213695,2008-05-01T00:00:00,Polysaccharides,D09.698
18213695,2008-05-01T00:00:00,Thrombosis,C14.907.355.830
18364586,2008-05-01T00:00:00,Esophagus,A03.556.875.500
18364586,2008-05-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
18364586,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18382764,2008-05-01T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
18382764,2008-05-01T00:00:00,Animals,B01.050
18382764,2008-05-01T00:00:00,Autoimmunity,G12.450.192
18382764,2008-05-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
18382764,2008-05-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
18382764,2008-05-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
18382764,2008-05-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
18382764,2008-05-01T00:00:00,Gene Expression Regulation,G05.355.315
18382764,2008-05-01T00:00:00,Inflammation,C23.550.470
18382764,2008-05-01T00:00:00,Interferon Type I,D12.644.276.374.440.890
18382764,2008-05-01T00:00:00,Interferon Type I,D12.644.276.718.500
18382764,2008-05-01T00:00:00,Interferon Type I,D12.776.467.374.440.890
18382764,2008-05-01T00:00:00,Interferon Type I,D12.776.467.718.500
18382764,2008-05-01T00:00:00,Interferon Type I,D23.529.374.440.890
18382764,2008-05-01T00:00:00,Interferon Type I,D23.529.718.500
18382764,2008-05-01T00:00:00,Multiple Sclerosis,C10.114.375.500
18382764,2008-05-01T00:00:00,Multiple Sclerosis,C10.314.350.500
18382764,2008-05-01T00:00:00,Multiple Sclerosis,C20.111.258.250.500
18382764,2008-05-01T00:00:00,Signal Transduction,G02.111.087.800
18382764,2008-05-01T00:00:00,Signal Transduction,G02.149.115.800
18382764,2008-05-01T00:00:00,Signal Transduction,G04.299.880
18382764,2008-05-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18382764,2008-05-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18382764,2008-05-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18382764,2008-05-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18382764,2008-05-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18382764,2008-05-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18382764,2008-05-01T00:00:00,"T-Lymphocytes, Helper-Inducer",A11.118.637.555.567.569.200.400
18382764,2008-05-01T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.145.229.637.555.567.569.200.400
18382764,2008-05-01T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.382.490.555.567.569.200.400
18392662,2008-05-01T00:00:00,African Americans,M01.686.508.100.100
18392662,2008-05-01T00:00:00,African Americans,M01.686.754.100
18392662,2008-05-01T00:00:00,Ethnic Groups,M01.686.754
18392662,2008-05-01T00:00:00,Ethnic Groups,N01.224.317
18392662,2008-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18392662,2008-05-01T00:00:00,Evidence-Based Medicine,H02.249.750
18392662,2008-05-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18392662,2008-05-01T00:00:00,Health Policy,I01.880.604.825.608.400
18392662,2008-05-01T00:00:00,Health Policy,N03.706.825.608.428
18392662,2008-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
18392662,2008-05-01T00:00:00,Health Services Accessibility,N05.300.430
18392662,2008-05-01T00:00:00,Healthcare Disparities,N04.590.374.380
18392662,2008-05-01T00:00:00,Healthcare Disparities,N05.300.493
18392662,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18392662,2008-05-01T00:00:00,Quality of Health Care,N04.761
18392662,2008-05-01T00:00:00,Quality of Health Care,N05.715
18392662,2008-05-01T00:00:00,United States,Z01.107.567.875
18408210,2008-05-01T00:00:00,Adolescent,M01.060.057
18408210,2008-05-01T00:00:00,Child,M01.060.406
18408210,2008-05-01T00:00:00,Child Behavior Disorders,F03.550.300
18408210,2008-05-01T00:00:00,Combined Modality Therapy,E02.186
18408210,2008-05-01T00:00:00,Community Mental Health Services,F04.408.307
18408210,2008-05-01T00:00:00,Community Mental Health Services,N02.421.143.183
18408210,2008-05-01T00:00:00,Community Mental Health Services,N02.421.461.232
18408210,2008-05-01T00:00:00,Family Therapy,F04.754.864.581.273
18408210,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18408210,2008-05-01T00:00:00,Juvenile Delinquency,I01.880.735.479
18408210,2008-05-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18408210,2008-05-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18408210,2008-05-01T00:00:00,Secondary Prevention,N02.421.726.825
18408210,2008-05-01T00:00:00,Secondary Prevention,N06.850.780.750
18408210,2008-05-01T00:00:00,Sex Offenses,I01.198.240.748
18408210,2008-05-01T00:00:00,Sexual Behavior,F01.145.802
18410568,2008-05-01T00:00:00,Altitude,G16.500.275.058
18410568,2008-05-01T00:00:00,Altitude,N06.230.058
18410568,2008-05-01T00:00:00,Anoxia,C23.888.852.079
18410568,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18410568,2008-05-01T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
18410568,2008-05-01T00:00:00,Transcriptional Activation,G05.355.315.800
18419361,2008-05-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18419361,2008-05-01T00:00:00,Bacteremia,C01.252.100
18419361,2008-05-01T00:00:00,Bacteremia,C01.539.757.100
18419361,2008-05-01T00:00:00,Bacteremia,C23.550.470.790.500.100
18419361,2008-05-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18419361,2008-05-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18419361,2008-05-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18419361,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18419361,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18419361,2008-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18419361,2008-05-01T00:00:00,Risk Assessment,N04.452.871.715
18419361,2008-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18419361,2008-05-01T00:00:00,Risk Assessment,N06.850.505.715
18419361,2008-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18419361,2008-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18419361,2008-05-01T00:00:00,Risk Factors,N05.715.350.200.700
18419361,2008-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18419361,2008-05-01T00:00:00,Risk Factors,N06.850.490.625.750
18419361,2008-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18419361,2008-05-01T00:00:00,Vancomycin,D09.400.420.925
18419361,2008-05-01T00:00:00,Vancomycin,D12.644.233.925
18420113,2008-05-01T00:00:00,Amino Acids,D12.125
18420113,2008-05-01T00:00:00,Animals,B01.050
18420113,2008-05-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D02.455.426.100.080.085
18420113,2008-05-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.438.260
18420113,2008-05-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.605.084
18420113,2008-05-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D04.075.080.875
18420113,2008-05-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
18420113,2008-05-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
18420113,2008-05-01T00:00:00,Ethanol,D02.033.375
18420113,2008-05-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18420113,2008-05-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18420113,2008-05-01T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
18420113,2008-05-01T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
18420847,2008-05-01T00:00:00,Aortic Diseases,C14.907.109
18420847,2008-05-01T00:00:00,Atherosclerosis,C14.907.137.126.307
18420847,2008-05-01T00:00:00,Clinical Competence,I02.399.630.210
18420847,2008-05-01T00:00:00,Clinical Competence,N04.761.210
18420847,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18420847,2008-05-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
18420847,2008-05-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
18420847,2008-05-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
18420847,2008-05-01T00:00:00,Patient Selection,E05.581.500.653
18420847,2008-05-01T00:00:00,Patient Selection,N04.590.731
18420847,2008-05-01T00:00:00,Transducers,E07.305.812
18420847,2008-05-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
18423670,2008-05-01T00:00:00,Adult,M01.060.116
18423670,2008-05-01T00:00:00,Aged,M01.060.116.100
18423670,2008-05-01T00:00:00,Automobile Driving,I03.125
18423670,2008-05-01T00:00:00,Cognition,F02.463.188
18423670,2008-05-01T00:00:00,Head and Neck Neoplasms,C04.588.443
18423670,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18423670,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18423670,2008-05-01T00:00:00,Radiation Dosage,E05.799.513
18423670,2008-05-01T00:00:00,Radiation Dosage,G01.201.875.740
18423670,2008-05-01T00:00:00,Radiation Dosage,N06.850.810.250
18423670,2008-05-01T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
18430837,2008-05-01T00:00:00,Adolescent,M01.060.057
18430837,2008-05-01T00:00:00,Angiography,E01.370.350.700.060
18430837,2008-05-01T00:00:00,Angiography,E01.370.370.050
18430837,2008-05-01T00:00:00,Artifacts,E05.047
18430837,2008-05-01T00:00:00,Body Weight,C23.888.144
18430837,2008-05-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
18430837,2008-05-01T00:00:00,Body Weight,E05.041.124.160.750
18430837,2008-05-01T00:00:00,Body Weight,G07.100.100.160.120
18430837,2008-05-01T00:00:00,Body Weight,G07.700.320.249.314.120
18430837,2008-05-01T00:00:00,Child,M01.060.406
18430837,2008-05-01T00:00:00,"Child, Preschool",M01.060.406.448
18430837,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18430837,2008-05-01T00:00:00,Infant,M01.060.703
18430837,2008-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
18430837,2008-05-01T00:00:00,Radiation Dosage,E05.799.513
18430837,2008-05-01T00:00:00,Radiation Dosage,G01.201.875.740
18430837,2008-05-01T00:00:00,Radiation Dosage,N06.850.810.250
18430837,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18430837,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18430837,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18430837,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18430837,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18430874,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18430874,2008-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18430874,2008-05-01T00:00:00,Lung Neoplasms,C08.381.540
18430874,2008-05-01T00:00:00,Lung Neoplasms,C08.785.520
18430874,2008-05-01T00:00:00,"Phantoms, Imaging",E07.671
18430874,2008-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
18430874,2008-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
18430874,2008-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
18430874,2008-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
18430874,2008-05-01T00:00:00,Solitary Pulmonary Nodule,C04.588.894.797.520.966
18430874,2008-05-01T00:00:00,Solitary Pulmonary Nodule,C08.381.540.933
18430874,2008-05-01T00:00:00,Solitary Pulmonary Nodule,C08.381.884
18430874,2008-05-01T00:00:00,Solitary Pulmonary Nodule,C08.785.520.933
18430874,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18430874,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18430874,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18430874,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18430874,2008-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18436156,2008-05-01T00:00:00,Adult,M01.060.116
18436156,2008-05-01T00:00:00,Aged,M01.060.116.100
18436156,2008-05-01T00:00:00,Bilirubin,D03.383.129.578.840.249.184
18436156,2008-05-01T00:00:00,Bilirubin,D03.549.909.249.184
18436156,2008-05-01T00:00:00,Bilirubin,D04.345.783.249.184
18436156,2008-05-01T00:00:00,Bilirubin,D23.767.193.184
18436156,2008-05-01T00:00:00,Biological Markers,D23.101
18436156,2008-05-01T00:00:00,Brain Ischemia,C10.228.140.300.150
18436156,2008-05-01T00:00:00,Brain Ischemia,C14.907.253.092
18436156,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18436156,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18436156,2008-05-01T00:00:00,Oxidative Stress,G03.495.710
18436156,2008-05-01T00:00:00,Oxidative Stress,G07.700.830.750
18436156,2008-05-01T00:00:00,Patient Admission,E02.760.400.600
18436156,2008-05-01T00:00:00,Patient Admission,N02.421.585.400.600
18436156,2008-05-01T00:00:00,Patient Discharge,E02.760.400.610
18436156,2008-05-01T00:00:00,Patient Discharge,N02.421.585.400.610
18436156,2008-05-01T00:00:00,Pilot Projects,E05.318.760.750
18436156,2008-05-01T00:00:00,Pilot Projects,E05.337.737
18436156,2008-05-01T00:00:00,Pilot Projects,N05.715.360.775.625
18436156,2008-05-01T00:00:00,Pilot Projects,N06.850.520.450.720
18436156,2008-05-01T00:00:00,Recovery of Function,G16.757
18436156,2008-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18436156,2008-05-01T00:00:00,Risk Assessment,N04.452.871.715
18436156,2008-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18436156,2008-05-01T00:00:00,Risk Assessment,N06.850.505.715
18436156,2008-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18436156,2008-05-01T00:00:00,Stroke,C10.228.140.300.775
18436156,2008-05-01T00:00:00,Stroke,C14.907.253.855
18436156,2008-05-01T00:00:00,Treatment Outcome,E01.789.800
18436156,2008-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18436156,2008-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18438839,2008-05-01T00:00:00,Adult,M01.060.116
18438839,2008-05-01T00:00:00,African Americans,M01.686.508.100.100
18438839,2008-05-01T00:00:00,African Americans,M01.686.754.100
18438839,2008-05-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18438839,2008-05-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18438839,2008-05-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18438839,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18438839,2008-05-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18438839,2008-05-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18438839,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18438839,2008-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18438839,2008-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18442563,2008-05-01T00:00:00,Adult,M01.060.116
18442563,2008-05-01T00:00:00,Aged,M01.060.116.100
18442563,2008-05-01T00:00:00,Aortic Diseases,C14.907.109
18442563,2008-05-01T00:00:00,Factor VIIa,D08.811.277.656.300.760.300
18442563,2008-05-01T00:00:00,Factor VIIa,D08.811.277.656.959.350.300
18442563,2008-05-01T00:00:00,Factor VIIa,D12.776.124.125.325.300
18442563,2008-05-01T00:00:00,Factor VIIa,D23.119.325.300
18442563,2008-05-01T00:00:00,Heart Diseases,C14.280
18442563,2008-05-01T00:00:00,Heart Transplantation,E04.100.376.475
18442563,2008-05-01T00:00:00,Heart Transplantation,E04.928.220.390
18442563,2008-05-01T00:00:00,Heart Transplantation,E04.936.450.475
18442563,2008-05-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
18442563,2008-05-01T00:00:00,Hospital Mortality,L01.280.975.550.400
18442563,2008-05-01T00:00:00,Hospital Mortality,N01.224.935.698.400
18442563,2008-05-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
18442563,2008-05-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
18442563,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18442563,2008-05-01T00:00:00,Intensive Care Units,N02.278.388.493
18442563,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18442563,2008-05-01T00:00:00,Recombinant Proteins,D12.776.828
18442563,2008-05-01T00:00:00,Reoperation,E04.690
18442563,2008-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18442563,2008-05-01T00:00:00,Risk Factors,N05.715.350.200.700
18442563,2008-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18442563,2008-05-01T00:00:00,Risk Factors,N06.850.490.625.750
18442563,2008-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18442563,2008-05-01T00:00:00,Thrombosis,C14.907.355.830
18442772,2008-05-01T00:00:00,Critical Care,E02.760.190
18442772,2008-05-01T00:00:00,Critical Care,N02.421.585.190
18442772,2008-05-01T00:00:00,Data Collection,E05.318.308
18442772,2008-05-01T00:00:00,Data Collection,L01.280
18442772,2008-05-01T00:00:00,Data Collection,N05.715.360.300
18442772,2008-05-01T00:00:00,Data Collection,N06.850.520.308
18442772,2008-05-01T00:00:00,Diagnostic Imaging,E01.370.350
18442772,2008-05-01T00:00:00,Internship and Residency,I02.358.399.644
18442772,2008-05-01T00:00:00,Patient Transfer,E02.760.400.630
18442772,2008-05-01T00:00:00,Patient Transfer,N02.421.585.400.630
18442772,2008-05-01T00:00:00,Radiology,H02.403.740
18442772,2008-05-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
18442772,2008-05-01T00:00:00,Trauma Centers,N02.421.297.195.480
18442772,2008-05-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
18442772,2008-05-01T00:00:00,United States,Z01.107.567.875
18442772,2008-05-01T00:00:00,Workload,N04.452.677.950
18443955,2008-05-01T00:00:00,Apoptosis,G04.299.139.160
18443955,2008-05-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
18443955,2008-05-01T00:00:00,Brain Neoplasms,C10.228.140.211
18443955,2008-05-01T00:00:00,Brain Neoplasms,C10.551.240.250
18443955,2008-05-01T00:00:00,Calpain,D08.811.277.656.262.500.120
18443955,2008-05-01T00:00:00,Calpain,D08.811.277.656.300.200.120
18443955,2008-05-01T00:00:00,Caspases,D08.811.277.656.262.500.126
18443955,2008-05-01T00:00:00,Caspases,D08.811.277.656.300.200.126
18443955,2008-05-01T00:00:00,Caspases,D12.644.360.075.405
18443955,2008-05-01T00:00:00,Caspases,D12.776.476.075.405
18443955,2008-05-01T00:00:00,Dexamethasone,D04.808.745.432.769.344
18443955,2008-05-01T00:00:00,Dexamethasone,D04.808.908.238
18443955,2008-05-01T00:00:00,Drug Interactions,G07.690.812.240
18443955,2008-05-01T00:00:00,Drug Interactions,G07.700.680.240
18443955,2008-05-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
18443955,2008-05-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
18443955,2008-05-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
18443955,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18443955,2008-05-01T00:00:00,Inflammation,C23.550.470
18443955,2008-05-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18443955,2008-05-01T00:00:00,Mitochondria,A11.284.835.626
18443955,2008-05-01T00:00:00,NF-kappa B,D12.776.260.600
18443955,2008-05-01T00:00:00,NF-kappa B,D12.776.660.600
18443955,2008-05-01T00:00:00,NF-kappa B,D12.776.930.600
18443955,2008-05-01T00:00:00,Neoplasm Proteins,D12.776.624
18443955,2008-05-01T00:00:00,"RNA, Messenger",D13.444.735.544
18443955,2008-05-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18443955,2008-05-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18443955,2008-05-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18449604,2008-05-01T00:00:00,Animals,B01.050
18449604,2008-05-01T00:00:00,Cell Death,G04.299.139
18449604,2008-05-01T00:00:00,Cell Differentiation,G04.299.151
18449604,2008-05-01T00:00:00,Cochlea,A09.246.631.246
18449604,2008-05-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
18449604,2008-05-01T00:00:00,Gerbillinae,B01.050.150.900.649.865.635.300
18449604,2008-05-01T00:00:00,Graft Survival,G12.425.901.545.340
18449604,2008-05-01T00:00:00,"Hearing Loss, Sensorineural",C09.218.458.341.887
18449604,2008-05-01T00:00:00,"Hearing Loss, Sensorineural",C10.597.751.418.341.887
18449604,2008-05-01T00:00:00,"Hearing Loss, Sensorineural",C23.888.592.763.393.341.887
18449604,2008-05-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18449604,2008-05-01T00:00:00,Neuroglia,A08.637
18449604,2008-05-01T00:00:00,Neuroglia,A11.650
18449604,2008-05-01T00:00:00,Spiral Ganglion,A08.340.390.800
18449604,2008-05-01T00:00:00,Spiral Ganglion,A08.800.350.800
18449604,2008-05-01T00:00:00,Spiral Ganglion,A08.800.800.120.910.120.800
18449604,2008-05-01T00:00:00,Spiral Ganglion,A09.246.631.246.900
18450958,2008-05-01T00:00:00,Animals,B01.050
18450958,2008-05-01T00:00:00,Brain,A08.186.211
18450958,2008-05-01T00:00:00,Carrier Proteins,D12.776.157
18450958,2008-05-01T00:00:00,Energy Metabolism,G03.495.335
18450958,2008-05-01T00:00:00,Homeostasis,G07.700.360
18450958,2008-05-01T00:00:00,Obesity,C18.654.726.500
18450958,2008-05-01T00:00:00,Obesity,C23.888.144.699.500
18450958,2008-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18450958,2008-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18450958,2008-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18451158,2008-05-01T00:00:00,Breast Neoplasms,C04.588.180
18451158,2008-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
18451158,2008-05-01T00:00:00,Cell Proliferation,G04.299.233.750
18451158,2008-05-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18451158,2008-05-01T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
18451158,2008-05-01T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
18451158,2008-05-01T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
18451158,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18451158,2008-05-01T00:00:00,Piperazines,D03.383.606
18451158,2008-05-01T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
18451158,2008-05-01T00:00:00,Proto-Oncogene Proteins c-met,D08.811.913.696.620.682.725.400.075
18451158,2008-05-01T00:00:00,Proto-Oncogene Proteins c-met,D12.776.543.750.060.186
18451158,2008-05-01T00:00:00,Proto-Oncogene Proteins c-met,D12.776.543.750.750.400.100
18451158,2008-05-01T00:00:00,Proto-Oncogene Proteins c-met,D12.776.624.664.700.186
18451158,2008-05-01T00:00:00,Proto-Oncogene Proteins pp60(c-src),D08.811.913.696.620.682.725.800.630
18451158,2008-05-01T00:00:00,Proto-Oncogene Proteins pp60(c-src),D12.776.624.664.700.202
18451158,2008-05-01T00:00:00,Quinazolines,D03.438.786
18451158,2008-05-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18451158,2008-05-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18451158,2008-05-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18451158,2008-05-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18463996,2008-05-01T00:00:00,Adolescent,M01.060.057
18463996,2008-05-01T00:00:00,Adult,M01.060.116
18463996,2008-05-01T00:00:00,Alcoholism,C21.739.100.250
18463996,2008-05-01T00:00:00,Alcoholism,F03.900.100.350
18463996,2008-05-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18463996,2008-05-01T00:00:00,Health Surveys,E05.318.308.250
18463996,2008-05-01T00:00:00,Health Surveys,N05.715.360.300.375
18463996,2008-05-01T00:00:00,Health Surveys,N06.850.520.308.250
18463996,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18463996,2008-05-01T00:00:00,Marijuana Abuse,C21.739.635
18463996,2008-05-01T00:00:00,Marijuana Abuse,F03.900.635
18463996,2008-05-01T00:00:00,Smoking,F01.145.466.753
18463996,2008-05-01T00:00:00,Tobacco Use Disorder,C21.739.912
18463996,2008-05-01T00:00:00,Tobacco Use Disorder,F03.900.912
18463996,2008-05-01T00:00:00,United States,Z01.107.567.875
18467528,2008-05-01T00:00:00,Aged,M01.060.116.100
18467528,2008-05-01T00:00:00,Asthma,C08.127.108
18467528,2008-05-01T00:00:00,Asthma,C08.381.495.108
18467528,2008-05-01T00:00:00,Asthma,C08.674.095
18467528,2008-05-01T00:00:00,Asthma,C20.543.480.680.095
18467528,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18467528,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18467528,2008-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18467528,2008-05-01T00:00:00,Risk Factors,N05.715.350.200.700
18467528,2008-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18467528,2008-05-01T00:00:00,Risk Factors,N06.850.490.625.750
18467528,2008-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18467528,2008-05-01T00:00:00,Stroke,C10.228.140.300.775
18467528,2008-05-01T00:00:00,Stroke,C14.907.253.855
18469667,2008-05-01T00:00:00,Carotid Artery Injuries,C10.228.140.300.200.345
18469667,2008-05-01T00:00:00,Carotid Artery Injuries,C10.228.140.300.350.500
18469667,2008-05-01T00:00:00,Carotid Artery Injuries,C10.900.250.300
18469667,2008-05-01T00:00:00,Carotid Artery Injuries,C14.907.253.123.345
18469667,2008-05-01T00:00:00,Carotid Artery Injuries,C14.907.253.535.500
18469667,2008-05-01T00:00:00,Carotid Artery Injuries,C21.866.915.200.200
18469667,2008-05-01T00:00:00,Esophagus,A03.556.875.500
18469667,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18469667,2008-05-01T00:00:00,Neck Injuries,C21.866.700
18469667,2008-05-01T00:00:00,"Wounds, Penetrating",C21.866.986
18474300,2008-05-01T00:00:00,Aged,M01.060.116.100
18474300,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18474300,2008-05-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
18474300,2008-05-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
18474300,2008-05-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
18474300,2008-05-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
18496103,2008-05-01T00:00:00,Adult,M01.060.116
18496103,2008-05-01T00:00:00,Health Behavior,F01.145.488
18496103,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18496103,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18496103,2008-05-01T00:00:00,Questionnaires,E05.318.308.750
18496103,2008-05-01T00:00:00,Questionnaires,L01.280.800
18496103,2008-05-01T00:00:00,Questionnaires,N05.715.360.300.695
18496103,2008-05-01T00:00:00,Questionnaires,N06.850.520.308.750
18496103,2008-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18496103,2008-05-01T00:00:00,Risk Factors,N05.715.350.200.700
18496103,2008-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18496103,2008-05-01T00:00:00,Risk Factors,N06.850.490.625.750
18496103,2008-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18496103,2008-05-01T00:00:00,Sex Offenses,I01.198.240.748
18496103,2008-05-01T00:00:00,Social Support,I01.880.656.600
18496103,2008-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18496103,2008-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18496112,2008-05-01T00:00:00,Clinical Competence,I02.399.630.210
18496112,2008-05-01T00:00:00,Clinical Competence,N04.761.210
18496112,2008-05-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18496112,2008-05-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18496112,2008-05-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18496112,2008-05-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
18496112,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18496112,2008-05-01T00:00:00,"Intubation, Intratracheal",E05.497.578
18496112,2008-05-01T00:00:00,Pediatrics,H02.403.670
18496112,2008-05-01T00:00:00,Questionnaires,E05.318.308.750
18496112,2008-05-01T00:00:00,Questionnaires,L01.280.800
18496112,2008-05-01T00:00:00,Questionnaires,N05.715.360.300.695
18496112,2008-05-01T00:00:00,Questionnaires,N06.850.520.308.750
18496112,2008-05-01T00:00:00,Specialization,H02.811
18508603,2008-05-01T00:00:00,"Gene Expression Regulation, Viral",G05.355.315.385
18508603,2008-05-01T00:00:00,Hepatitis B virus,B04.280.375.650.425
18508603,2008-05-01T00:00:00,Hepatitis B virus,B04.450.390.650.425
18508603,2008-05-01T00:00:00,Hepatitis B virus,B04.909.204.340.650.425
18508603,2008-05-01T00:00:00,"RNA Processing, Post-Transcriptional",G02.111.087.750
18508603,2008-05-01T00:00:00,"RNA Processing, Post-Transcriptional",G02.149.115.750
18508603,2008-05-01T00:00:00,"RNA Processing, Post-Transcriptional",G03.495.839
18508603,2008-05-01T00:00:00,"RNA Processing, Post-Transcriptional",G05.355.315.700
18508603,2008-05-01T00:00:00,"RNA, Viral",D13.444.735.828
18514826,2008-05-01T00:00:00,Brain Injuries,C10.228.140.199
18514826,2008-05-01T00:00:00,Brain Injuries,C10.900.300.087
18514826,2008-05-01T00:00:00,Brain Injuries,C21.866.260.118
18514826,2008-05-01T00:00:00,Brain Injuries,C21.866.915.300.200
18514826,2008-05-01T00:00:00,Critical Care,E02.760.190
18514826,2008-05-01T00:00:00,Critical Care,N02.421.585.190
18514826,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18514826,2008-05-01T00:00:00,"Respiration, Artificial",E02.365.647.729
18514826,2008-05-01T00:00:00,"Respiration, Artificial",E02.880.820
18520783,2008-05-01T00:00:00,Adolescent,M01.060.057
18520783,2008-05-01T00:00:00,Alcohol Drinking,F01.145.317.269
18520783,2008-05-01T00:00:00,Alcoholism,C21.739.100.250
18520783,2008-05-01T00:00:00,Alcoholism,F03.900.100.350
18520783,2008-05-01T00:00:00,Child,M01.060.406
18520783,2008-05-01T00:00:00,Counseling,F02.784.176
18520783,2008-05-01T00:00:00,Counseling,F04.408.413
18520783,2008-05-01T00:00:00,Counseling,N02.421.143.303
18520783,2008-05-01T00:00:00,Counseling,N02.421.461.363
18520783,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18520783,2008-05-01T00:00:00,Marijuana Abuse,C21.739.635
18520783,2008-05-01T00:00:00,Marijuana Abuse,F03.900.635
18520783,2008-05-01T00:00:00,Mass Screening,E01.370.500
18520783,2008-05-01T00:00:00,Mass Screening,E05.318.308.250.580
18520783,2008-05-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18520783,2008-05-01T00:00:00,Mass Screening,N02.421.726.233.443
18520783,2008-05-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18520783,2008-05-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18520783,2008-05-01T00:00:00,Mass Screening,N06.850.780.500
18520783,2008-05-01T00:00:00,Mental Disorders,F03
18520783,2008-05-01T00:00:00,Patient Education as Topic,I02.233.332.500
18520783,2008-05-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
18520783,2008-05-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
18520783,2008-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18520783,2008-05-01T00:00:00,Risk Factors,N05.715.350.200.700
18520783,2008-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18520783,2008-05-01T00:00:00,Risk Factors,N06.850.490.625.750
18520783,2008-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18520783,2008-05-01T00:00:00,Sleep Initiation and Maintenance Disorders,C10.886.425.800.800
18520783,2008-05-01T00:00:00,Sleep Initiation and Maintenance Disorders,F03.870.400.800.800
18520783,2008-05-01T00:00:00,Substance-Related Disorders,C21.739
18520783,2008-05-01T00:00:00,Substance-Related Disorders,F03.900
18572636,2008-05-01T00:00:00,Animals,B01.050
18572636,2008-05-01T00:00:00,Endocytosis,G04.299.482
18572636,2008-05-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18572636,2008-05-01T00:00:00,Flow Cytometry,E05.200.500.386.350
18572636,2008-05-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18572636,2008-05-01T00:00:00,"Microscopy, Confocal",E05.595.395
18572636,2008-05-01T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
18572636,2008-05-01T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
18572636,2008-05-01T00:00:00,Polyethylene Glycols,D02.033.455.250.700
18572636,2008-05-01T00:00:00,Polyethylene Glycols,D05.750.741
18572636,2008-05-01T00:00:00,Polyethylene Glycols,D25.720.741
18572636,2008-05-01T00:00:00,Polyethylene Glycols,J01.637.051.720.741
18572636,2008-05-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18572636,2008-05-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18572636,2008-05-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18588763,2008-05-01T00:00:00,Adult,M01.060.116
18588763,2008-05-01T00:00:00,Chronic Disease,C23.550.291.500
18588763,2008-05-01T00:00:00,Endoscopy,E01.370.388.250
18588763,2008-05-01T00:00:00,Endoscopy,E04.800.250
18588763,2008-05-01T00:00:00,Headache,C10.597.617.470
18588763,2008-05-01T00:00:00,Headache,C23.888.592.612.441
18588763,2008-05-01T00:00:00,Headache,C23.888.646.487
18588763,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18588763,2008-05-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
18588763,2008-05-01T00:00:00,Pain Measurement,E01.370.376.550.600
18588763,2008-05-01T00:00:00,Quality of Life,I01.800
18588763,2008-05-01T00:00:00,Quality of Life,K01.752.400.750
18588763,2008-05-01T00:00:00,Rhinitis,C08.460.799
18588763,2008-05-01T00:00:00,Rhinitis,C08.730.674
18588763,2008-05-01T00:00:00,Rhinitis,C09.603.799
18588763,2008-05-01T00:00:00,Sinusitis,C08.460.692.752
18588763,2008-05-01T00:00:00,Sinusitis,C08.730.749
18588763,2008-05-01T00:00:00,Sinusitis,C09.603.692.752
18588763,2008-05-01T00:00:00,Treatment Outcome,E01.789.800
18588763,2008-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18588763,2008-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18650414,2008-05-01T00:00:00,Adult,M01.060.116
18650414,2008-05-01T00:00:00,Health Policy,I01.880.604.825.608.400
18650414,2008-05-01T00:00:00,Health Policy,N03.706.825.608.428
18650414,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18650414,2008-05-01T00:00:00,Insurance Claim Reporting,N03.219.521.576.210
18650414,2008-05-01T00:00:00,Intensive Care,E02.760.190.400
18650414,2008-05-01T00:00:00,Intensive Care,N02.421.585.190.400
18650414,2008-05-01T00:00:00,Length of Stay,E02.760.400.480
18650414,2008-05-01T00:00:00,Length of Stay,N02.421.585.400.480
18650414,2008-05-01T00:00:00,Medicare,N03.219.521.346.506.564.663
18650414,2008-05-01T00:00:00,Medicare,N03.219.521.576.343.840
18650414,2008-05-01T00:00:00,Medicare,N03.706.615.696
18650414,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18650414,2008-05-01T00:00:00,"Models, Economic",E05.318.740.500.600
18650414,2008-05-01T00:00:00,"Models, Economic",E05.599.835.890
18650414,2008-05-01T00:00:00,"Models, Economic",N05.715.360.750.530.500
18650414,2008-05-01T00:00:00,"Models, Economic",N06.850.520.830.500.600
18650414,2008-05-01T00:00:00,North Carolina,Z01.107.567.875.075.475
18650414,2008-05-01T00:00:00,North Carolina,Z01.107.567.875.750.530
18650414,2008-05-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
18650414,2008-05-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
18650414,2008-05-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
18650414,2008-05-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
18650414,2008-05-01T00:00:00,United States,Z01.107.567.875
18650414,2008-05-01T00:00:00,Workload,N04.452.677.950
18686266,2008-05-01T00:00:00,Adolescent,M01.060.057
18686266,2008-05-01T00:00:00,Adult,M01.060.116
18686266,2008-05-01T00:00:00,Bayes Theorem,E05.318.740.600.200
18686266,2008-05-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
18686266,2008-05-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
18686266,2008-05-01T00:00:00,Demography,I01.240
18686266,2008-05-01T00:00:00,Demography,N01.224
18686266,2008-05-01T00:00:00,Demography,N06.850.505.400
18686266,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18686266,2008-05-01T00:00:00,Pregnancy,G08.686.785.760.769
18686266,2008-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18686266,2008-05-01T00:00:00,Risk Assessment,N04.452.871.715
18686266,2008-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18686266,2008-05-01T00:00:00,Risk Assessment,N06.850.505.715
18686266,2008-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18686266,2008-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18686266,2008-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18686266,2008-05-01T00:00:00,United States,Z01.107.567.875
18706007,2008-05-01T00:00:00,Adolescent,M01.060.057
18706007,2008-05-01T00:00:00,Adult,M01.060.116
18706007,2008-05-01T00:00:00,Aged,M01.060.116.100
18706007,2008-05-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
18706007,2008-05-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
18706007,2008-05-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
18706007,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18706007,2008-05-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
18706007,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
18706007,2008-05-01T00:00:00,Patient Selection,E05.581.500.653
18706007,2008-05-01T00:00:00,Patient Selection,N04.590.731
18706007,2008-05-01T00:00:00,Pilot Projects,E05.318.760.750
18706007,2008-05-01T00:00:00,Pilot Projects,E05.337.737
18706007,2008-05-01T00:00:00,Pilot Projects,N05.715.360.775.625
18706007,2008-05-01T00:00:00,Pilot Projects,N06.850.520.450.720
18706007,2008-05-01T00:00:00,Stroke,C10.228.140.300.775
18706007,2008-05-01T00:00:00,Stroke,C14.907.253.855
18706007,2008-05-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
18706007,2008-05-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
18706007,2008-05-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
18706007,2008-05-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
18706008,2008-05-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18706008,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18706008,2008-05-01T00:00:00,Quality of Life,I01.800
18706008,2008-05-01T00:00:00,Quality of Life,K01.752.400.750
18706008,2008-05-01T00:00:00,Stroke,C10.228.140.300.775
18706008,2008-05-01T00:00:00,Stroke,C14.907.253.855
18706008,2008-05-01T00:00:00,United States,Z01.107.567.875
20614324,2008-05-01T00:00:00,Adult,M01.060.116
20614324,2008-05-01T00:00:00,Age Factors,N05.715.350.075
20614324,2008-05-01T00:00:00,Age Factors,N06.850.490.250
20614324,2008-05-01T00:00:00,Aged,M01.060.116.100
20614324,2008-05-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
20614324,2008-05-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
20614324,2008-05-01T00:00:00,"Hospitals, University",N02.278.020.300.310
20614324,2008-05-01T00:00:00,"Hospitals, University",N02.278.421.639.725
20614324,2008-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20614324,2008-05-01T00:00:00,Incidence,E05.318.308.985.525.375
20614324,2008-05-01T00:00:00,Incidence,L01.280.975.525.375
20614324,2008-05-01T00:00:00,Incidence,N01.224.935.597.500
20614324,2008-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20614324,2008-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20614324,2008-05-01T00:00:00,Middle Aged,M01.060.116.630
20614324,2008-05-01T00:00:00,Mouth Neoplasms,C04.588.443.591
20614324,2008-05-01T00:00:00,Mouth Neoplasms,C07.465.565
18462274,2008-05-02T00:00:00,Adult,M01.060.116
18462274,2008-05-02T00:00:00,African Americans,M01.686.508.100.100
18462274,2008-05-02T00:00:00,African Americans,M01.686.754.100
18462274,2008-05-02T00:00:00,Aged,M01.060.116.100
18462274,2008-05-02T00:00:00,Aging,G07.700.320.124
18462274,2008-05-02T00:00:00,Body Mass Index,E01.370.600.115.100.125
18462274,2008-05-02T00:00:00,Body Mass Index,E05.041.124.125
18462274,2008-05-02T00:00:00,Body Mass Index,G07.100.100.125
18462274,2008-05-02T00:00:00,Body Mass Index,N06.850.505.200.100.175
18462274,2008-05-02T00:00:00,European Continental Ancestry Group,M01.686.508.400
18462274,2008-05-02T00:00:00,Heart,A07.541
18462274,2008-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18462274,2008-05-02T00:00:00,Leukocytes,A11.118.637
18462274,2008-05-02T00:00:00,Leukocytes,A15.145.229.637
18462274,2008-05-02T00:00:00,Leukocytes,A15.382.490
18462274,2008-05-02T00:00:00,Middle Aged,M01.060.116.630
18462274,2008-05-02T00:00:00,Sex Characteristics,G08.686.815
18462274,2008-05-02T00:00:00,United States,Z01.107.567.875
18538758,2008-05-03T00:00:00,Animals,B01.050
18538758,2008-05-03T00:00:00,Calcium-Binding Proteins,D12.776.157.125
18538758,2008-05-03T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
18538758,2008-05-03T00:00:00,Fetal Heart,A07.541.278
18538758,2008-05-03T00:00:00,Fetal Heart,A16.378.303
18538758,2008-05-03T00:00:00,Heart Ventricles,A07.541.560
18538758,2008-05-03T00:00:00,Morphogenesis,G07.700.320.500
18538758,2008-05-03T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18538758,2008-05-03T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
18454177,2008-05-05T00:00:00,Antineoplastic Agents,D27.505.954.248
18454177,2008-05-05T00:00:00,Cell Cycle Proteins,D12.776.167
18454177,2008-05-05T00:00:00,Cell Proliferation,G04.299.233.750
18454177,2008-05-05T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18454177,2008-05-05T00:00:00,Cisplatin,D01.210.375
18454177,2008-05-05T00:00:00,Cisplatin,D01.625.125
18454177,2008-05-05T00:00:00,Cisplatin,D01.710.100
18454177,2008-05-05T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18454177,2008-05-05T00:00:00,Flow Cytometry,E05.200.500.386.350
18454177,2008-05-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18454177,2008-05-05T00:00:00,Oxidoreductases,D08.811.682
18454177,2008-05-05T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18454177,2008-05-05T00:00:00,Signal Transduction,G02.111.087.800
18454177,2008-05-05T00:00:00,Signal Transduction,G02.149.115.800
18454177,2008-05-05T00:00:00,Signal Transduction,G04.299.880
18457661,2008-05-05T00:00:00,Animals,B01.050
18457661,2008-05-05T00:00:00,Calpain,D08.811.277.656.262.500.120
18457661,2008-05-05T00:00:00,Calpain,D08.811.277.656.300.200.120
18457661,2008-05-05T00:00:00,Cell Line,A11.251.210
18457661,2008-05-05T00:00:00,Oligopeptides,D12.644.456
18457661,2008-05-05T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
18457661,2008-05-05T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
18457661,2008-05-05T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
18457661,2008-05-05T00:00:00,Rabbits,B01.050.150.900.649.521.700
18457661,2008-05-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18459748,2008-05-07T00:00:00,Fluorenes,D02.455.426.559.847.389
18459748,2008-05-07T00:00:00,Fluorenes,D04.615.389
18459748,2008-05-07T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
18459748,2008-05-07T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
18459748,2008-05-07T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
18459748,2008-05-07T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
18459748,2008-05-07T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
18459748,2008-05-07T00:00:00,Nanoparticles,J01.637.512.600
18459748,2008-05-07T00:00:00,Polymers,D05.750
18459748,2008-05-07T00:00:00,Polymers,D25.720
18459748,2008-05-07T00:00:00,Polymers,J01.637.051.720
18463229,2008-05-07T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
18463229,2008-05-07T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
18463229,2008-05-07T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
18463229,2008-05-07T00:00:00,Animals,B01.050
18463229,2008-05-07T00:00:00,"Animals, Newborn",B01.050.050.282
18463229,2008-05-07T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.260.103.625.750
18463229,2008-05-07T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.930.125.625.750
18463229,2008-05-07T00:00:00,Lactic Acid,D02.241.511.459.450
18463229,2008-05-07T00:00:00,Myocardial Contraction,G09.330.190.541
18463229,2008-05-07T00:00:00,Myocardial Contraction,G11.427.590.540.570
18463229,2008-05-07T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18463229,2008-05-07T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18463229,2008-05-07T00:00:00,"Myocytes, Cardiac",A11.620.500
18463229,2008-05-07T00:00:00,Oxygen Consumption,G03.730
18463229,2008-05-07T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
18463229,2008-05-07T00:00:00,Signal Transduction,G02.111.087.800
18463229,2008-05-07T00:00:00,Signal Transduction,G02.149.115.800
18463229,2008-05-07T00:00:00,Signal Transduction,G04.299.880
18463399,2008-05-07T00:00:00,African Americans,M01.686.508.100.100
18463399,2008-05-07T00:00:00,African Americans,M01.686.754.100
18463399,2008-05-07T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18463399,2008-05-07T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18463399,2008-05-07T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18463399,2008-05-07T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18463399,2008-05-07T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18463399,2008-05-07T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18463399,2008-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18463399,2008-05-07T00:00:00,Lung Neoplasms,C04.588.894.797.520
18463399,2008-05-07T00:00:00,Lung Neoplasms,C08.381.540
18463399,2008-05-07T00:00:00,Lung Neoplasms,C08.785.520
18463399,2008-05-07T00:00:00,Mass Screening,E01.370.500
18463399,2008-05-07T00:00:00,Mass Screening,E05.318.308.250.580
18463399,2008-05-07T00:00:00,Mass Screening,N02.421.143.827.233.443
18463399,2008-05-07T00:00:00,Mass Screening,N02.421.726.233.443
18463399,2008-05-07T00:00:00,Mass Screening,N05.715.360.300.375.500
18463399,2008-05-07T00:00:00,Mass Screening,N06.850.520.308.250.580
18463399,2008-05-07T00:00:00,Mass Screening,N06.850.780.500
18463399,2008-05-07T00:00:00,Middle Aged,M01.060.116.630
18463399,2008-05-07T00:00:00,Patient Compliance,F01.145.488.500
18463399,2008-05-07T00:00:00,Patient Compliance,N05.300.150.600.600
18463399,2008-05-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18463399,2008-05-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
18463399,2008-05-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
18463399,2008-05-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
18463399,2008-05-07T00:00:00,Risk Factors,E05.318.740.600.800.725
18463399,2008-05-07T00:00:00,Risk Factors,N05.715.350.200.700
18463399,2008-05-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18463399,2008-05-07T00:00:00,Risk Factors,N06.850.490.625.750
18463399,2008-05-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18511119,2008-05-07T00:00:00,Animals,B01.050
18511119,2008-05-07T00:00:00,Molecular Sequence Data,L01.453.245.667
18511119,2008-05-07T00:00:00,Mutation,G05.365.590
18511119,2008-05-07T00:00:00,Transcription Factors,D12.776.930
18511119,2008-05-07T00:00:00,Transcriptional Activation,G05.355.315.800
19154868,2008-05-07T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19154868,2008-05-07T00:00:00,Coronary Angiography,E01.370.370.050.200
19154868,2008-05-07T00:00:00,Coronary Angiography,E01.370.370.380.200
19154868,2008-05-07T00:00:00,Heart Failure,C14.280.434
19154868,2008-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19154868,2008-05-07T00:00:00,Middle Aged,M01.060.116.630
19154868,2008-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19154868,2008-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19154868,2008-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19154868,2008-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19154868,2008-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18583925,2008-05-08T00:00:00,Bronchoscopy,E01.370.386.105
18583925,2008-05-08T00:00:00,Bronchoscopy,E01.370.388.250.100
18583925,2008-05-08T00:00:00,Bronchoscopy,E04.800.250.100
18583925,2008-05-08T00:00:00,Bronchoscopy,E04.928.600.080
18583925,2008-05-08T00:00:00,Clinical Competence,I02.399.630.210
18583925,2008-05-08T00:00:00,Clinical Competence,N04.761.210
18583925,2008-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18583925,2008-05-08T00:00:00,Internship and Residency,I02.358.399.644
18583925,2008-05-08T00:00:00,Pulmonary Medicine,H02.403.429.675
18467817,2008-05-09T00:00:00,Aged,M01.060.116.100
18467817,2008-05-09T00:00:00,Deglutition,G10.261.326.215
18467817,2008-05-09T00:00:00,Disease-Free Survival,E01.789.200
18467817,2008-05-09T00:00:00,Disease-Free Survival,E05.318.740.998.300
18467817,2008-05-09T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18467817,2008-05-09T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18467817,2008-05-09T00:00:00,Esophageal Stenosis,C06.405.117.544
18467817,2008-05-09T00:00:00,Head and Neck Neoplasms,C04.588.443
18467817,2008-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18467817,2008-05-09T00:00:00,Incidence,E05.318.308.985.525.375
18467817,2008-05-09T00:00:00,Incidence,L01.280.975.525.375
18467817,2008-05-09T00:00:00,Incidence,N01.224.935.597.500
18467817,2008-05-09T00:00:00,Incidence,N06.850.505.400.975.525.375
18467817,2008-05-09T00:00:00,Incidence,N06.850.520.308.985.525.375
18467817,2008-05-09T00:00:00,Middle Aged,M01.060.116.630
18467817,2008-05-09T00:00:00,South Carolina,Z01.107.567.875.075.662
18467817,2008-05-09T00:00:00,South Carolina,Z01.107.567.875.750.700
18474423,2008-05-12T00:00:00,Carbon Dioxide,D01.200.200
18474423,2008-05-12T00:00:00,Carbon Dioxide,D01.362.150
18474423,2008-05-12T00:00:00,Carbon Dioxide,D01.650.550.200
18474423,2008-05-12T00:00:00,"Fatty Acids, Monounsaturated",D10.251.355.325
18474423,2008-05-12T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
18474423,2008-05-12T00:00:00,"Models, Chemical",E05.599.495
18558465,2008-05-13T00:00:00,Adult,M01.060.116
18558465,2008-05-13T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18558465,2008-05-13T00:00:00,"Child, Preschool",M01.060.406.448
18558465,2008-05-13T00:00:00,Cocaine-Related Disorders,C21.739.300
18558465,2008-05-13T00:00:00,Cocaine-Related Disorders,F03.900.300
18558465,2008-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18558465,2008-05-13T00:00:00,Impulsive Behavior,F01.145.527
18558465,2008-05-13T00:00:00,Opioid-Related Disorders,C21.739.675
18558465,2008-05-13T00:00:00,Opioid-Related Disorders,F03.900.675
18558465,2008-05-13T00:00:00,Prevalence,E05.318.308.985.525.750
18558465,2008-05-13T00:00:00,Prevalence,L01.280.975.525.750
18558465,2008-05-13T00:00:00,Prevalence,N01.224.935.597.750
18558465,2008-05-13T00:00:00,Prevalence,N06.850.505.400.975.525.750
18558465,2008-05-13T00:00:00,Prevalence,N06.850.520.308.985.525.750
18558465,2008-05-13T00:00:00,Regression Analysis,E05.318.740.750
18558465,2008-05-13T00:00:00,Regression Analysis,N05.715.360.750.695
18558465,2008-05-13T00:00:00,Regression Analysis,N06.850.520.830.750
18477782,2008-05-14T00:00:00,Adult,M01.060.116
18477782,2008-05-14T00:00:00,Aged,M01.060.116.100
18477782,2008-05-14T00:00:00,Breast Neoplasms,C04.588.180
18477782,2008-05-14T00:00:00,Breast Neoplasms,C17.800.090.500
18477782,2008-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18477782,2008-05-14T00:00:00,Mammography,E01.370.350.700.500
18477782,2008-05-14T00:00:00,Mass Screening,E01.370.500
18477782,2008-05-14T00:00:00,Mass Screening,E05.318.308.250.580
18477782,2008-05-14T00:00:00,Mass Screening,N02.421.143.827.233.443
18477782,2008-05-14T00:00:00,Mass Screening,N02.421.726.233.443
18477782,2008-05-14T00:00:00,Mass Screening,N05.715.360.300.375.500
18477782,2008-05-14T00:00:00,Mass Screening,N06.850.520.308.250.580
18477782,2008-05-14T00:00:00,Mass Screening,N06.850.780.500
18477782,2008-05-14T00:00:00,Middle Aged,M01.060.116.630
18477782,2008-05-14T00:00:00,Risk Factors,E05.318.740.600.800.725
18477782,2008-05-14T00:00:00,Risk Factors,N05.715.350.200.700
18477782,2008-05-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18477782,2008-05-14T00:00:00,Risk Factors,N06.850.490.625.750
18477782,2008-05-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18477782,2008-05-14T00:00:00,Sensitivity and Specificity,E05.318.740.872
18477782,2008-05-14T00:00:00,Sensitivity and Specificity,E05.318.780.800
18477782,2008-05-14T00:00:00,Sensitivity and Specificity,G17.800
18477782,2008-05-14T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18477782,2008-05-14T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18477782,2008-05-14T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18477782,2008-05-14T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18477782,2008-05-14T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
18477782,2008-05-14T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
18453575,2008-05-15T00:00:00,Animals,B01.050
18453575,2008-05-15T00:00:00,Antigen Presentation,G12.425.107
18453575,2008-05-15T00:00:00,Antigen Presentation,G12.450.050.400.070
18453575,2008-05-15T00:00:00,"Antigens, CD",D23.050.301.264.035
18453575,2008-05-15T00:00:00,"Antigens, CD",D23.101.100.110
18453575,2008-05-15T00:00:00,Dendritic Cells,A11.066.270
18453575,2008-05-15T00:00:00,Dendritic Cells,A11.436.270
18453575,2008-05-15T00:00:00,Dendritic Cells,A15.382.066.270
18453575,2008-05-15T00:00:00,Dendritic Cells,A15.382.812.260
18453575,2008-05-15T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18453575,2008-05-15T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18453575,2008-05-15T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18453575,2008-05-15T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18453575,2008-05-15T00:00:00,Flow Cytometry,E05.200.500.386.350
18453575,2008-05-15T00:00:00,Interleukin-10,D12.644.276.374.465.510
18453575,2008-05-15T00:00:00,Interleukin-10,D12.776.467.374.465.510
18453575,2008-05-15T00:00:00,Interleukin-10,D23.529.374.465.510
18453575,2008-05-15T00:00:00,Lymphocyte Activation,E01.450.495.482
18453575,2008-05-15T00:00:00,Lymphocyte Activation,E05.478.594.530
18453575,2008-05-15T00:00:00,Lymphocyte Activation,G12.425.747
18453575,2008-05-15T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18453575,2008-05-15T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18453575,2008-05-15T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18453575,2008-05-15T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18453575,2008-05-15T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18453575,2008-05-15T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18453575,2008-05-15T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18453575,2008-05-15T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
18453575,2008-05-15T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
18453575,2008-05-15T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18453575,2008-05-15T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18475191,2008-05-15T00:00:00,Animals,B01.050
18475191,2008-05-15T00:00:00,Bilirubin,D03.383.129.578.840.249.184
18475191,2008-05-15T00:00:00,Bilirubin,D03.549.909.249.184
18475191,2008-05-15T00:00:00,Bilirubin,D04.345.783.249.184
18475191,2008-05-15T00:00:00,Bilirubin,D23.767.193.184
18475191,2008-05-15T00:00:00,Liver Transplantation,E04.210.650
18475191,2008-05-15T00:00:00,Liver Transplantation,E04.936.450.490
18475191,2008-05-15T00:00:00,Liver Transplantation,E04.936.580.490
18475191,2008-05-15T00:00:00,"Models, Animal",E05.598
18475191,2008-05-15T00:00:00,Portal Vein,A07.231.908.670.567
18475191,2008-05-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18479530,2008-05-15T00:00:00,Adult,M01.060.116
18479530,2008-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18479530,2008-05-15T00:00:00,Piperazines,D03.383.606
18479530,2008-05-15T00:00:00,Pyrimidines,D03.383.742
18483187,2008-05-15T00:00:00,Adult,M01.060.116
18483187,2008-05-15T00:00:00,Blood Flow Velocity,E01.370.370.130
18483187,2008-05-15T00:00:00,Blood Flow Velocity,G09.330.380.630.080
18483187,2008-05-15T00:00:00,Blood Glucose,D09.546.359.448.500
18483187,2008-05-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18483187,2008-05-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18483187,2008-05-15T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
18483187,2008-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18483187,2008-05-15T00:00:00,Middle Aged,M01.060.116.630
18483187,2008-05-15T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18483187,2008-05-15T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18483187,2008-05-15T00:00:00,Pilot Projects,E05.318.760.750
18483187,2008-05-15T00:00:00,Pilot Projects,E05.337.737
18483187,2008-05-15T00:00:00,Pilot Projects,N05.715.360.775.625
18483187,2008-05-15T00:00:00,Pilot Projects,N06.850.520.450.720
18483187,2008-05-15T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18483187,2008-05-15T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18483187,2008-05-15T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18483187,2008-05-15T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18483187,2008-05-15T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18483187,2008-05-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18483187,2008-05-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18483187,2008-05-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18483187,2008-05-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18483187,2008-05-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18483232,2008-05-15T00:00:00,Adolescent,M01.060.057
18483232,2008-05-15T00:00:00,Adult,M01.060.116
18483232,2008-05-15T00:00:00,Aged,M01.060.116.100
18483232,2008-05-15T00:00:00,Contrast Media,D27.720.259
18483232,2008-05-15T00:00:00,Creatinine,D03.383.129.308.207
18483232,2008-05-15T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
18483232,2008-05-15T00:00:00,Glomerular Filtration Rate,G08.852.357
18483232,2008-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18483232,2008-05-15T00:00:00,Kidney Diseases,C12.777.419
18483232,2008-05-15T00:00:00,Kidney Diseases,C13.351.968.419
18483232,2008-05-15T00:00:00,Middle Aged,M01.060.116.630
18483282,2008-05-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18483282,2008-05-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18483282,2008-05-15T00:00:00,Cell Proliferation,G04.299.233.750
18483282,2008-05-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18483282,2008-05-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18483282,2008-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
18483282,2008-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
18483282,2008-05-15T00:00:00,"Models, Biological",E05.599.395
18483282,2008-05-15T00:00:00,Neoplasm Invasiveness,C04.697.645
18483282,2008-05-15T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18483282,2008-05-15T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
18483282,2008-05-15T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
18483282,2008-05-15T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
18483282,2008-05-15T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
18483282,2008-05-15T00:00:00,Phenotype,G05.695
18483282,2008-05-15T00:00:00,Treatment Outcome,E01.789.800
18483282,2008-05-15T00:00:00,Treatment Outcome,N04.761.559.590.800
18483282,2008-05-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18483374,2008-05-15T00:00:00,Adult,M01.060.116
18483374,2008-05-15T00:00:00,Aged,M01.060.116.100
18483374,2008-05-15T00:00:00,Antineoplastic Agents,D27.505.954.248
18483374,2008-05-15T00:00:00,Disease-Free Survival,E01.789.200
18483374,2008-05-15T00:00:00,Disease-Free Survival,E05.318.740.998.300
18483374,2008-05-15T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18483374,2008-05-15T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18483374,2008-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18483374,2008-05-15T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
18483374,2008-05-15T00:00:00,Middle Aged,M01.060.116.630
18483374,2008-05-15T00:00:00,Quinolones,D03.438.810.835
18483374,2008-05-15T00:00:00,Remission Induction,E02.860
18483374,2008-05-15T00:00:00,Risk Factors,E05.318.740.600.800.725
18483374,2008-05-15T00:00:00,Risk Factors,N05.715.350.200.700
18483374,2008-05-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18483374,2008-05-15T00:00:00,Risk Factors,N06.850.490.625.750
18483374,2008-05-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18483374,2008-05-15T00:00:00,Treatment Outcome,E01.789.800
18483374,2008-05-15T00:00:00,Treatment Outcome,N04.761.559.590.800
18483374,2008-05-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18485328,2008-05-15T00:00:00,Alleles,G05.360.340.024.340.030
18485328,2008-05-15T00:00:00,Catalytic Domain,G02.111.570.120.704
18485328,2008-05-15T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
18485328,2008-05-15T00:00:00,Cell Line,A11.251.210
18485328,2008-05-15T00:00:00,Central Nervous System Stimulants,D27.505.696.282
18485328,2008-05-15T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
18485328,2008-05-15T00:00:00,Continental Population Groups,M01.686.508
18485328,2008-05-15T00:00:00,Ethnic Groups,M01.686.754
18485328,2008-05-15T00:00:00,Ethnic Groups,N01.224.317
18485328,2008-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18485328,2008-05-15T00:00:00,Methylphenidate,D02.241.223.601.600
18485328,2008-05-15T00:00:00,Methylphenidate,D03.383.621.460
18485328,2008-05-15T00:00:00,Mutation,G05.365.590
18485328,2008-05-15T00:00:00,Pharmacogenetics,H01.158.273.343.750
18485328,2008-05-15T00:00:00,Pharmacogenetics,H01.158.703.052
18485328,2008-05-15T00:00:00,Pharmacogenetics,H02.628.479
18485328,2008-05-15T00:00:00,Point Mutation,G05.365.590.675
18485328,2008-05-15T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18485328,2008-05-15T00:00:00,Substrate Specificity,G02.111.835
18485369,2008-05-15T00:00:00,Adolescent,M01.060.057
18485369,2008-05-15T00:00:00,Adult,M01.060.116
18485369,2008-05-15T00:00:00,Aged,M01.060.116.100
18485369,2008-05-15T00:00:00,Complementary Therapies,E02.190
18485369,2008-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18485369,2008-05-15T00:00:00,Middle Aged,M01.060.116.630
18485369,2008-05-15T00:00:00,Stroke,C10.228.140.300.775
18485369,2008-05-15T00:00:00,Stroke,C14.907.253.855
18485369,2008-05-15T00:00:00,United States,Z01.107.567.875
18487434,2008-05-16T00:00:00,Animals,B01.050
18487434,2008-05-16T00:00:00,Apoptosis,G04.299.139.160
18487434,2008-05-16T00:00:00,Calpain,D08.811.277.656.262.500.120
18487434,2008-05-16T00:00:00,Calpain,D08.811.277.656.300.200.120
18487434,2008-05-16T00:00:00,Cardiomegaly,C14.280.195
18487434,2008-05-16T00:00:00,Cardiomegaly,C23.300.775.250
18487434,2008-05-16T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
18487434,2008-05-16T00:00:00,Heart Failure,C14.280.434
18487434,2008-05-16T00:00:00,Histones,D12.776.660.470
18487434,2008-05-16T00:00:00,Histones,D12.776.664.469
18487434,2008-05-16T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18487434,2008-05-16T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18487434,2008-05-16T00:00:00,"Myocytes, Cardiac",A11.620.500
18487434,2008-05-16T00:00:00,Pulmonary Artery,A07.231.114.715
18487473,2008-05-16T00:00:00,Adult,M01.060.116
18487473,2008-05-16T00:00:00,Aged,M01.060.116.100
18487473,2008-05-16T00:00:00,Body Mass Index,E01.370.600.115.100.125
18487473,2008-05-16T00:00:00,Body Mass Index,E05.041.124.125
18487473,2008-05-16T00:00:00,Body Mass Index,G07.100.100.125
18487473,2008-05-16T00:00:00,Body Mass Index,N06.850.505.200.100.175
18487473,2008-05-16T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18487473,2008-05-16T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18487473,2008-05-16T00:00:00,Genetic Variation,G05.365
18487473,2008-05-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18487473,2008-05-16T00:00:00,Middle Aged,M01.060.116.630
18487473,2008-05-16T00:00:00,Obesity,C18.654.726.500
18487473,2008-05-16T00:00:00,Obesity,C23.888.144.699.500
18487473,2008-05-16T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18487473,2008-05-16T00:00:00,Obesity,G07.100.100.160.120.699.500
18487473,2008-05-16T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18487473,2008-05-16T00:00:00,Sex Characteristics,G08.686.815
18488248,2008-05-17T00:00:00,Animals,B01.050
18488248,2008-05-17T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18488248,2008-05-17T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18488248,2008-05-17T00:00:00,Cocaine,D02.145.074.722.388
18488248,2008-05-17T00:00:00,Cocaine,D03.132.889.354
18488248,2008-05-17T00:00:00,Cocaine,D03.605.869.388
18488248,2008-05-17T00:00:00,Cocaine,D04.075.080.875.099.722.388
18488248,2008-05-17T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
18488248,2008-05-17T00:00:00,Gene Expression,G05.355.310
18488248,2008-05-17T00:00:00,Gene Expression Profiling,E05.393.332
18488248,2008-05-17T00:00:00,Nerve Tissue Proteins,D12.776.641
18488248,2008-05-17T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18488248,2008-05-17T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.260.108.765
18488248,2008-05-17T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.624.664.700.179
18488248,2008-05-17T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.660.760
18488248,2008-05-17T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.930.127.765
18488248,2008-05-17T00:00:00,"RNA, Messenger",D13.444.735.544
18488248,2008-05-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18488248,2008-05-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18488248,2008-05-17T00:00:00,Self Administration,E02.319.890
18488248,2008-05-17T00:00:00,Self Administration,E02.900.890
18488248,2008-05-17T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18488248,2008-05-17T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18721674,2008-05-17T00:00:00,Animals,B01.050
18721674,2008-05-17T00:00:00,"Colony Count, Microbial",E05.200.875.220
18721674,2008-05-17T00:00:00,Food Contamination,N06.850.460.400
18721674,2008-05-17T00:00:00,Hot Temperature,G01.906.595.543
18721674,2008-05-17T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
18721674,2008-05-17T00:00:00,Hot Temperature,G16.500.750.775.710.380
18721674,2008-05-17T00:00:00,Hot Temperature,N06.230.300.100.725.232
18721674,2008-05-17T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
18721674,2008-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18721674,2008-05-17T00:00:00,Muramidase,D08.811.277.450.642
18490190,2008-05-19T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
18490190,2008-05-19T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
18490190,2008-05-19T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
18490190,2008-05-19T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
18490190,2008-05-19T00:00:00,"Antigens, CD147",D12.776.395.550.045
18490190,2008-05-19T00:00:00,"Antigens, CD147",D12.776.543.550.188
18490190,2008-05-19T00:00:00,"Antigens, CD147",D23.050.285.040
18490190,2008-05-19T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
18490190,2008-05-19T00:00:00,"Antigens, CD147",D23.101.100.110.247
18490190,2008-05-19T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18490190,2008-05-19T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18490190,2008-05-19T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18490190,2008-05-19T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18490190,2008-05-19T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18490190,2008-05-19T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18490190,2008-05-19T00:00:00,Antineoplastic Agents,D27.505.954.248
18490190,2008-05-19T00:00:00,Apoptosis,G04.299.139.160
18490190,2008-05-19T00:00:00,Cell Membrane,A11.284.149
18490190,2008-05-19T00:00:00,Cell Survival,G04.299.316
18490190,2008-05-19T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18490190,2008-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18490190,2008-05-19T00:00:00,Hyaluronic Acid,D09.698.373.475
18490190,2008-05-19T00:00:00,Neoplasms,C04
18490190,2008-05-19T00:00:00,Phenotype,G05.695
18490190,2008-05-19T00:00:00,Signal Transduction,G02.111.087.800
18490190,2008-05-19T00:00:00,Signal Transduction,G02.149.115.800
18490190,2008-05-19T00:00:00,Signal Transduction,G04.299.880
18490702,2008-05-19T00:00:00,Adult,M01.060.116
18490702,2008-05-19T00:00:00,Health Status,I01.240.425
18490702,2008-05-19T00:00:00,Health Status,N01.224.425
18490702,2008-05-19T00:00:00,Health Status,N06.850.505.400.425
18490702,2008-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18490702,2008-05-19T00:00:00,Questionnaires,E05.318.308.750
18490702,2008-05-19T00:00:00,Questionnaires,L01.280.800
18490702,2008-05-19T00:00:00,Questionnaires,N05.715.360.300.695
18490702,2008-05-19T00:00:00,Questionnaires,N06.850.520.308.750
18805287,2008-05-19T00:00:00,Adult,M01.060.116
18805287,2008-05-19T00:00:00,Aged,M01.060.116.100
18805287,2008-05-19T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18805287,2008-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18805287,2008-05-19T00:00:00,"Intubation, Intratracheal",E05.497.578
18805287,2008-05-19T00:00:00,Wounds and Injuries,C21.866
18954638,2008-05-19T00:00:00,Cardiac Surgical Procedures,E04.100.376
18954638,2008-05-19T00:00:00,Cardiac Surgical Procedures,E04.928.220
18954638,2008-05-19T00:00:00,Heart Ventricles,A07.541.560
18954638,2008-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18954638,2008-05-19T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
18954638,2008-05-19T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
18954638,2008-05-19T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
18954638,2008-05-19T00:00:00,"Infant, Newborn",M01.060.703.520
18954638,2008-05-19T00:00:00,Postoperative Complications,C23.550.767
18954638,2008-05-19T00:00:00,Pulmonary Artery,A07.231.114.715
18954638,2008-05-19T00:00:00,Pulmonary Circulation,G09.330.190.163.770
18954638,2008-05-19T00:00:00,Pulmonary Circulation,G09.772.770.690
18954638,2008-05-19T00:00:00,Research Design,E05.581.500
18954638,2008-05-19T00:00:00,Research Design,H01.770.644.728
18954638,2008-05-19T00:00:00,Risk Assessment,E05.318.740.600.800.715
18954638,2008-05-19T00:00:00,Risk Assessment,N04.452.871.715
18954638,2008-05-19T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18954638,2008-05-19T00:00:00,Risk Assessment,N06.850.505.715
18954638,2008-05-19T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18954638,2008-05-19T00:00:00,Treatment Outcome,E01.789.800
18954638,2008-05-19T00:00:00,Treatment Outcome,N04.761.559.590.800
18954638,2008-05-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18364571,2008-05-20T00:00:00,Aged,M01.060.116.100
18364571,2008-05-20T00:00:00,Alleles,G05.360.340.024.340.030
18364571,2008-05-20T00:00:00,DNA-Binding Proteins,D12.776.260
18364571,2008-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18364571,2008-05-20T00:00:00,Middle Aged,M01.060.116.630
18364571,2008-05-20T00:00:00,Mutation,G05.365.590
18364571,2008-05-20T00:00:00,Risk Factors,E05.318.740.600.800.725
18364571,2008-05-20T00:00:00,Risk Factors,N05.715.350.200.700
18364571,2008-05-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18364571,2008-05-20T00:00:00,Risk Factors,N06.850.490.625.750
18364571,2008-05-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18364571,2008-05-20T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
18364571,2008-05-20T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
18364571,2008-05-20T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
18364571,2008-05-20T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
18364571,2008-05-20T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
18491100,2008-05-20T00:00:00,Adult,M01.060.116
18491100,2008-05-20T00:00:00,Aged,M01.060.116.100
18491100,2008-05-20T00:00:00,Heart Transplantation,E04.100.376.475
18491100,2008-05-20T00:00:00,Heart Transplantation,E04.928.220.390
18491100,2008-05-20T00:00:00,Heart Transplantation,E04.936.450.475
18491100,2008-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18491100,2008-05-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18491100,2008-05-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18491100,2008-05-20T00:00:00,Pilot Projects,E05.318.760.750
18491100,2008-05-20T00:00:00,Pilot Projects,E05.337.737
18491100,2008-05-20T00:00:00,Pilot Projects,N05.715.360.775.625
18491100,2008-05-20T00:00:00,Pilot Projects,N06.850.520.450.720
18491100,2008-05-20T00:00:00,Sensitivity and Specificity,E05.318.740.872
18491100,2008-05-20T00:00:00,Sensitivity and Specificity,E05.318.780.800
18491100,2008-05-20T00:00:00,Sensitivity and Specificity,G17.800
18491100,2008-05-20T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18491100,2008-05-20T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18491100,2008-05-20T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18491100,2008-05-20T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18491100,2008-05-20T00:00:00,Stroke Volume,E01.370.370.380.150.700
18491100,2008-05-20T00:00:00,Stroke Volume,G09.330.380.124.882
18491100,2008-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18491100,2008-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18491100,2008-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18491100,2008-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18491100,2008-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18491100,2008-05-20T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18493865,2008-05-21T00:00:00,Activities of Daily Living,E02.831.067
18493865,2008-05-21T00:00:00,Activities of Daily Living,I03.050
18493865,2008-05-21T00:00:00,Activities of Daily Living,N02.421.784.110
18493865,2008-05-21T00:00:00,Aged,M01.060.116.100
18493865,2008-05-21T00:00:00,Health Status,I01.240.425
18493865,2008-05-21T00:00:00,Health Status,N01.224.425
18493865,2008-05-21T00:00:00,Health Status,N06.850.505.400.425
18493865,2008-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18493865,2008-05-21T00:00:00,Middle Aged,M01.060.116.630
18493865,2008-05-21T00:00:00,Neoplasms,C04
18493865,2008-05-21T00:00:00,Social Support,I01.880.656.600
18572239,2008-05-21T00:00:00,Algorithms,G17.035
18572239,2008-05-21T00:00:00,Algorithms,L01.224.050
18572239,2008-05-21T00:00:00,Amino Acid Sequence,G02.111.570.060
18572239,2008-05-21T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18572239,2008-05-21T00:00:00,Computational Biology,H01.158.273.180
18572239,2008-05-21T00:00:00,"Databases, Genetic",L01.470.750.750.325
18572239,2008-05-21T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
18572239,2008-05-21T00:00:00,"Models, Molecular",E05.599.595
18572239,2008-05-21T00:00:00,Multiprotein Complexes,D05.500
18572239,2008-05-21T00:00:00,Protein Conformation,G02.111.570.790.709
18499697,2008-05-22T00:00:00,Algorithms,G17.035
18499697,2008-05-22T00:00:00,Algorithms,L01.224.050
18499697,2008-05-22T00:00:00,Bayes Theorem,E05.318.740.600.200
18499697,2008-05-22T00:00:00,Bayes Theorem,N05.715.360.750.625.150
18499697,2008-05-22T00:00:00,Bayes Theorem,N06.850.520.830.600.200
18499697,2008-05-22T00:00:00,Binding Sites,G02.111.570.120
18499697,2008-05-22T00:00:00,"Data Interpretation, Statistical",E05.245.380
18499697,2008-05-22T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18499697,2008-05-22T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18499697,2008-05-22T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18499697,2008-05-22T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18499697,2008-05-22T00:00:00,"Models, Statistical",E05.318.740.500
18499697,2008-05-22T00:00:00,"Models, Statistical",E05.599.835
18499697,2008-05-22T00:00:00,"Models, Statistical",N05.715.360.750.530
18499697,2008-05-22T00:00:00,"Models, Statistical",N06.850.520.830.500
18499697,2008-05-22T00:00:00,Protein Interaction Mapping,E05.601.690
18499697,2008-05-22T00:00:00,Proteins,D12.776
18499697,2008-05-22T00:00:00,Software,L01.224.900
18501327,2008-05-23T00:00:00,"Brain Diseases, Metabolic",C10.228.140.163
18501327,2008-05-23T00:00:00,"Brain Diseases, Metabolic",C18.452.132
18501327,2008-05-23T00:00:00,Fetal Diseases,C13.703.277
18501327,2008-05-23T00:00:00,Fetal Diseases,C16.300
18501327,2008-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18501327,2008-05-23T00:00:00,"Infant, Newborn",M01.060.703.520
18501327,2008-05-23T00:00:00,"Models, Statistical",E05.318.740.500
18501327,2008-05-23T00:00:00,"Models, Statistical",E05.599.835
18501327,2008-05-23T00:00:00,"Models, Statistical",N05.715.360.750.530
18501327,2008-05-23T00:00:00,"Models, Statistical",N06.850.520.830.500
18501327,2008-05-23T00:00:00,Pregnancy,G08.686.785.760.769
18501327,2008-05-23T00:00:00,Pregnancy Complications,C13.703
18501327,2008-05-23T00:00:00,Risk Factors,E05.318.740.600.800.725
18501327,2008-05-23T00:00:00,Risk Factors,N05.715.350.200.700
18501327,2008-05-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18501327,2008-05-23T00:00:00,Risk Factors,N06.850.490.625.750
18501327,2008-05-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18503034,2008-05-23T00:00:00,Aged,M01.060.116.100
18503034,2008-05-23T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
18503034,2008-05-23T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
18503034,2008-05-23T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
18503034,2008-05-23T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
18503034,2008-05-23T00:00:00,Cholesterol,D04.808.247.222.284
18503034,2008-05-23T00:00:00,Cholesterol,D04.808.247.808.197
18503034,2008-05-23T00:00:00,Cholesterol,D10.570.938.208
18503034,2008-05-23T00:00:00,Cholesterol,D10.851.208
18503034,2008-05-23T00:00:00,Cognition Disorders,F03.087.250
18503034,2008-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18503034,2008-05-23T00:00:00,Middle Aged,M01.060.116.630
18503034,2008-05-23T00:00:00,Motor Activity,F01.145.632
18503034,2008-05-23T00:00:00,Motor Activity,G11.427.590.530.698
18503034,2008-05-23T00:00:00,Neuropsychological Tests,F04.711.513
18503034,2008-05-23T00:00:00,Psychometrics,F04.711.780
18597958,2008-05-23T00:00:00,Acoustic Stimulation,E02.037
18597958,2008-05-23T00:00:00,Acoustic Stimulation,E02.190.888.030
18597958,2008-05-23T00:00:00,Acoustic Stimulation,E05.723.136
18597958,2008-05-23T00:00:00,Adolescent,M01.060.057
18597958,2008-05-23T00:00:00,Adult,M01.060.116
18597958,2008-05-23T00:00:00,Aged,M01.060.116.100
18597958,2008-05-23T00:00:00,Aging,G07.700.320.124
18597958,2008-05-23T00:00:00,Auditory Cortex,A08.186.211.730.885.287.500.863.297
18597958,2008-05-23T00:00:00,Auditory Threshold,F02.463.593.071.173
18597958,2008-05-23T00:00:00,Auditory Threshold,F02.463.593.710.190
18597958,2008-05-23T00:00:00,Electroencephalography,E01.370.376.300
18597958,2008-05-23T00:00:00,Electroencephalography,E01.370.405.245
18597958,2008-05-23T00:00:00,"Evoked Potentials, Auditory",G07.265.500.370
18597958,2008-05-23T00:00:00,"Evoked Potentials, Auditory",G11.561.270.370
18597958,2008-05-23T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G07.265.500.370.300
18597958,2008-05-23T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G11.561.270.370.300
18597958,2008-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18602532,2008-05-24T00:00:00,Avidin,D12.776.034.614.300
18602532,2008-05-24T00:00:00,Avidin,D12.776.256.317.663.300
18602532,2008-05-24T00:00:00,Avidin,D12.776.290.663.100
18602532,2008-05-24T00:00:00,Avidin,D12.776.395.175
18602532,2008-05-24T00:00:00,Binding Sites,G02.111.570.120
18602532,2008-05-24T00:00:00,Biological Assay,E05.091
18602532,2008-05-24T00:00:00,Carbon,D01.268.150
18602532,2008-05-24T00:00:00,Electrodes,E07.305.250
18602532,2008-05-24T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18602532,2008-05-24T00:00:00,"Microscopy, Confocal",E05.595.395
18602532,2008-05-24T00:00:00,Porosity,G01.374.710
18602532,2008-05-24T00:00:00,Sepharose,D09.698.813
18678306,2008-05-24T00:00:00,Diastole,G09.330.190.541.295
18678306,2008-05-24T00:00:00,Diastole,G11.427.590.540.554.250
18678306,2008-05-24T00:00:00,Diastole,G11.427.590.540.570.295
18678306,2008-05-24T00:00:00,Echocardiography,E01.370.350.850.220
18678306,2008-05-24T00:00:00,Echocardiography,E01.370.370.380.220
18678306,2008-05-24T00:00:00,Heart Failure,C14.280.434
18678306,2008-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18678306,2008-05-24T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
18678306,2008-05-24T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
18678306,2008-05-24T00:00:00,Risk Factors,E05.318.740.600.800.725
18678306,2008-05-24T00:00:00,Risk Factors,N05.715.350.200.700
18678306,2008-05-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18678306,2008-05-24T00:00:00,Risk Factors,N06.850.490.625.750
18678306,2008-05-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18678306,2008-05-24T00:00:00,Stroke Volume,E01.370.370.380.150.700
18678306,2008-05-24T00:00:00,Stroke Volume,G09.330.380.124.882
18497693,2008-05-27T00:00:00,Animals,B01.050
18497693,2008-05-27T00:00:00,Apoptosis,G04.299.139.160
18497693,2008-05-27T00:00:00,Intracellular Membranes,A11.284.149.450
18497693,2008-05-27T00:00:00,Intracellular Membranes,A11.284.835.514
18497693,2008-05-27T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
18497693,2008-05-27T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
18497693,2008-05-27T00:00:00,Reperfusion Injury,C14.907.725
18497693,2008-05-27T00:00:00,Reperfusion Injury,C23.550.767.877
18504541,2008-05-27T00:00:00,Amino Acid Sequence,G02.111.570.060
18504541,2008-05-27T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18504541,2008-05-27T00:00:00,Molecular Sequence Data,L01.453.245.667
18504541,2008-05-27T00:00:00,Phylogeny,G05.697
18504541,2008-05-27T00:00:00,Phylogeny,G16.100.275.605
18504541,2008-05-27T00:00:00,Phylogeny,L01.100.697
18504541,2008-05-27T00:00:00,Plant Proteins,D12.776.765
18504541,2008-05-27T00:00:00,Plasmids,G05.360.600
18504541,2008-05-27T00:00:00,"RNA, Messenger",D13.444.735.544
18504541,2008-05-27T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
18505967,2008-05-27T00:00:00,Aged,M01.060.116.100
18505967,2008-05-27T00:00:00,Case-Control Studies,E05.318.760.500.500
18505967,2008-05-27T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18505967,2008-05-27T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18505967,2008-05-27T00:00:00,Clinical Trials as Topic,E05.318.760.535
18505967,2008-05-27T00:00:00,Clinical Trials as Topic,E05.337.250
18505967,2008-05-27T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18505967,2008-05-27T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18505967,2008-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18505967,2008-05-27T00:00:00,Incidence,E05.318.308.985.525.375
18505967,2008-05-27T00:00:00,Incidence,L01.280.975.525.375
18505967,2008-05-27T00:00:00,Incidence,N01.224.935.597.500
18505967,2008-05-27T00:00:00,Incidence,N06.850.505.400.975.525.375
18505967,2008-05-27T00:00:00,Incidence,N06.850.520.308.985.525.375
18505967,2008-05-27T00:00:00,Mass Screening,E01.370.500
18505967,2008-05-27T00:00:00,Mass Screening,E05.318.308.250.580
18505967,2008-05-27T00:00:00,Mass Screening,N02.421.143.827.233.443
18505967,2008-05-27T00:00:00,Mass Screening,N02.421.726.233.443
18505967,2008-05-27T00:00:00,Mass Screening,N05.715.360.300.375.500
18505967,2008-05-27T00:00:00,Mass Screening,N06.850.520.308.250.580
18505967,2008-05-27T00:00:00,Mass Screening,N06.850.780.500
18505967,2008-05-27T00:00:00,Middle Aged,M01.060.116.630
18505967,2008-05-27T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18505967,2008-05-27T00:00:00,Prostatic Neoplasms,C12.294.260.750
18505967,2008-05-27T00:00:00,Prostatic Neoplasms,C12.294.565.625
18505967,2008-05-27T00:00:00,Prostatic Neoplasms,C12.758.409.750
18505967,2008-05-27T00:00:00,Risk Assessment,E05.318.740.600.800.715
18505967,2008-05-27T00:00:00,Risk Assessment,N04.452.871.715
18505967,2008-05-27T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18505967,2008-05-27T00:00:00,Risk Assessment,N06.850.505.715
18505967,2008-05-27T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18505967,2008-05-27T00:00:00,Risk Factors,E05.318.740.600.800.725
18505967,2008-05-27T00:00:00,Risk Factors,N05.715.350.200.700
18505967,2008-05-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18505967,2008-05-27T00:00:00,Risk Factors,N06.850.490.625.750
18505967,2008-05-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18505967,2008-05-27T00:00:00,United States,Z01.107.567.875
18505967,2008-05-27T00:00:00,Vitamin D,D04.808.812.768
18506145,2008-05-27T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18506145,2008-05-27T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18506145,2008-05-27T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18506145,2008-05-27T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18506145,2008-05-27T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18506145,2008-05-27T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18506145,2008-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18506145,2008-05-27T00:00:00,"RNA, Messenger",D13.444.735.544
18509146,2008-05-28T00:00:00,Continuity of Patient Care,N04.590.233.727.210
18509146,2008-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18509146,2008-05-28T00:00:00,Internship and Residency,I02.358.399.644
18509146,2008-05-28T00:00:00,Pediatrics,H02.403.670
18509146,2008-05-28T00:00:00,South Carolina,Z01.107.567.875.075.662
18509146,2008-05-28T00:00:00,South Carolina,Z01.107.567.875.750.700
18509146,2008-05-28T00:00:00,Workload,N04.452.677.950
18597759,2008-05-28T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
18597759,2008-05-28T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
18597759,2008-05-28T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
18597759,2008-05-28T00:00:00,Antigen-Antibody Complex,D23.050.101
18597759,2008-05-28T00:00:00,Cell Survival,G04.299.316
18597759,2008-05-28T00:00:00,Gene Expression Profiling,E05.393.332
18597759,2008-05-28T00:00:00,Gene Expression Regulation,G05.355.315
18597759,2008-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18597759,2008-05-28T00:00:00,"Lipoproteins, LDL",D10.532.515
18597759,2008-05-28T00:00:00,"Lipoproteins, LDL",D12.776.521.550
18597759,2008-05-28T00:00:00,Monocytes,A11.118.637.555.652
18597759,2008-05-28T00:00:00,Monocytes,A11.148.580
18597759,2008-05-28T00:00:00,Monocytes,A11.627.624
18597759,2008-05-28T00:00:00,Monocytes,A11.733.547
18597759,2008-05-28T00:00:00,Monocytes,A15.145.229.637.555.652
18597759,2008-05-28T00:00:00,Monocytes,A15.378.316.580
18597759,2008-05-28T00:00:00,Monocytes,A15.382.490.555.652
18597759,2008-05-28T00:00:00,Monocytes,A15.382.680.547
18597759,2008-05-28T00:00:00,Monocytes,A15.382.812.547
18597759,2008-05-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18597759,2008-05-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18597759,2008-05-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18597759,2008-05-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18597759,2008-05-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18597759,2008-05-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18602514,2008-05-28T00:00:00,Anticoagulants,D27.505.954.502.119
18602514,2008-05-28T00:00:00,Hemorrhage,C23.550.414
18602514,2008-05-28T00:00:00,Heparin,D09.698.373.400
18602514,2008-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18602514,2008-05-28T00:00:00,Middle Aged,M01.060.116.630
18602514,2008-05-28T00:00:00,Peptide Fragments,D12.644.541
18602514,2008-05-28T00:00:00,Postoperative Complications,C23.550.767
18602514,2008-05-28T00:00:00,Recombinant Proteins,D12.776.828
18602514,2008-05-28T00:00:00,Risk Assessment,E05.318.740.600.800.715
18602514,2008-05-28T00:00:00,Risk Assessment,N04.452.871.715
18602514,2008-05-28T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18602514,2008-05-28T00:00:00,Risk Assessment,N06.850.505.715
18602514,2008-05-28T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18602514,2008-05-28T00:00:00,Risk Factors,E05.318.740.600.800.725
18602514,2008-05-28T00:00:00,Risk Factors,N05.715.350.200.700
18602514,2008-05-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18602514,2008-05-28T00:00:00,Risk Factors,N06.850.490.625.750
18602514,2008-05-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18602514,2008-05-28T00:00:00,Treatment Outcome,E01.789.800
18602514,2008-05-28T00:00:00,Treatment Outcome,N04.761.559.590.800
18602514,2008-05-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18638589,2008-05-28T00:00:00,Aged,M01.060.116.100
18638589,2008-05-28T00:00:00,Coronary Disease,C14.280.647.250
18638589,2008-05-28T00:00:00,Coronary Disease,C14.907.585.250
18638589,2008-05-28T00:00:00,Drug-Eluting Stents,E07.695.750.500
18638589,2008-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18638589,2008-05-28T00:00:00,Treatment Outcome,E01.789.800
18638589,2008-05-28T00:00:00,Treatment Outcome,N04.761.559.590.800
18638589,2008-05-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18507411,2008-05-29T00:00:00,Adsorption,G02.149.047
18507411,2008-05-29T00:00:00,Adsorption,G02.149.767.029
18507411,2008-05-29T00:00:00,Adsorption,G02.842.750.029
18507411,2008-05-29T00:00:00,Peptides,D12.644
18507411,2008-05-29T00:00:00,Proteins,D12.776
18507411,2008-05-29T00:00:00,Surface Plasmon Resonance,E05.196.890
18507411,2008-05-29T00:00:00,Surface Plasmon Resonance,E05.601.123.700
18507411,2008-05-29T00:00:00,Surface Properties,G02.842.850
18511031,2008-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18511031,2008-05-29T00:00:00,Lung Neoplasms,C04.588.894.797.520
18511031,2008-05-29T00:00:00,Lung Neoplasms,C08.381.540
18511031,2008-05-29T00:00:00,Lung Neoplasms,C08.785.520
18511031,2008-05-29T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18511031,2008-05-29T00:00:00,Water Supply,N06.850.860.510.915
18514033,2008-05-29T00:00:00,Animals,B01.050
18514033,2008-05-29T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18514033,2008-05-29T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18514033,2008-05-29T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18514033,2008-05-29T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
18514033,2008-05-29T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
18514033,2008-05-29T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
18514033,2008-05-29T00:00:00,Kidney,A05.810.453
18514033,2008-05-29T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18514033,2008-05-29T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18514033,2008-05-29T00:00:00,Proteinuria,C12.777.934.734
18514033,2008-05-29T00:00:00,Proteinuria,C13.351.968.934.734
18514033,2008-05-29T00:00:00,Proteinuria,C23.888.942.750
18514033,2008-05-29T00:00:00,Signal Transduction,G02.111.087.800
18514033,2008-05-29T00:00:00,Signal Transduction,G02.149.115.800
18514033,2008-05-29T00:00:00,Signal Transduction,G04.299.880
18638588,2008-05-29T00:00:00,Anticoagulants,D27.505.954.502.119
18638588,2008-05-29T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18638588,2008-05-29T00:00:00,Coronary Angiography,E01.370.370.050.200
18638588,2008-05-29T00:00:00,Coronary Angiography,E01.370.370.380.200
18638588,2008-05-29T00:00:00,Heparin,D09.698.373.400
18638588,2008-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18638588,2008-05-29T00:00:00,Integrin beta3,D12.776.543.750.705.408.200.750
18638588,2008-05-29T00:00:00,Integrin beta3,D23.050.301.264.035.302
18638588,2008-05-29T00:00:00,Integrin beta3,D23.101.100.110.299
18638588,2008-05-29T00:00:00,Middle Aged,M01.060.116.630
18638588,2008-05-29T00:00:00,Myocardial Infarction,C14.280.647.500
18638588,2008-05-29T00:00:00,Myocardial Infarction,C14.907.585.500
18638588,2008-05-29T00:00:00,Peptide Fragments,D12.644.541
18638588,2008-05-29T00:00:00,Recombinant Proteins,D12.776.828
18638588,2008-05-29T00:00:00,"Shock, Cardiogenic",C14.280.647.500.750
18638588,2008-05-29T00:00:00,"Shock, Cardiogenic",C14.907.585.500.750
18638588,2008-05-29T00:00:00,"Shock, Cardiogenic",C23.550.835.550
18638588,2008-05-29T00:00:00,Treatment Outcome,E01.789.800
18638588,2008-05-29T00:00:00,Treatment Outcome,N04.761.559.590.800
18638588,2008-05-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18638590,2008-05-29T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
18638590,2008-05-29T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
18638590,2008-05-29T00:00:00,Diabetes Complications,C19.246.099
18638590,2008-05-29T00:00:00,Drug-Eluting Stents,E07.695.750.500
18638590,2008-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18638590,2008-05-29T00:00:00,Middle Aged,M01.060.116.630
18638590,2008-05-29T00:00:00,Myocardial Infarction,C14.280.647.500
18638590,2008-05-29T00:00:00,Myocardial Infarction,C14.907.585.500
18512096,2008-05-30T00:00:00,Aminoglycosides,D09.408.051
18512096,2008-05-30T00:00:00,Animals,B01.050
18512096,2008-05-30T00:00:00,Apoptosis,G04.299.139.160
18512096,2008-05-30T00:00:00,DNA-Binding Proteins,D12.776.260
18512096,2008-05-30T00:00:00,Gentamicins,D09.408.051.374
18512096,2008-05-30T00:00:00,"Models, Animal",E05.598
18512096,2008-05-30T00:00:00,Neomycin,D09.408.051.623
18512096,2008-05-30T00:00:00,Transcription Factors,D12.776.930
18513393,2008-05-30T00:00:00,Adolescent,M01.060.057
18513393,2008-05-30T00:00:00,Blood Platelets,A11.118.188
18513393,2008-05-30T00:00:00,Blood Platelets,A15.145.229.188
18513393,2008-05-30T00:00:00,Chernobyl Nuclear Accident,K01.400.504.968.150
18513393,2008-05-30T00:00:00,Chernobyl Nuclear Accident,N06.850.135.848.500
18513393,2008-05-30T00:00:00,Child,M01.060.406
18513393,2008-05-30T00:00:00,"Child, Preschool",M01.060.406.448
18513393,2008-05-30T00:00:00,Environmental Exposure,N06.850.460.350
18513393,2008-05-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18513393,2008-05-30T00:00:00,Infant,M01.060.703
18513393,2008-05-30T00:00:00,"Infant, Newborn",M01.060.703.520
18513393,2008-05-30T00:00:00,Leukocytes,A11.118.637
18513393,2008-05-30T00:00:00,Leukocytes,A15.145.229.637
18513393,2008-05-30T00:00:00,Leukocytes,A15.382.490
18412277,2008-06-01T00:00:00,Adolescent,M01.060.057
18412277,2008-06-01T00:00:00,Adult,M01.060.116
18412277,2008-06-01T00:00:00,Cerebellum,A08.186.211.132.810.428.200
18412277,2008-06-01T00:00:00,Cerebellum,A08.186.211.865.428.200
18412277,2008-06-01T00:00:00,Child,M01.060.406
18412277,2008-06-01T00:00:00,"Child, Preschool",M01.060.406.448
18412277,2008-06-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
18412277,2008-06-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
18412277,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18412277,2008-06-01T00:00:00,Infant,M01.060.703
18412277,2008-06-01T00:00:00,"Infant, Newborn",M01.060.703.520
18412277,2008-06-01T00:00:00,Syndrome,C23.550.288.500
18446120,2008-06-01T00:00:00,Adult,M01.060.116
18446120,2008-06-01T00:00:00,Aged,M01.060.116.100
18446120,2008-06-01T00:00:00,Amputation,E04.555.080
18446120,2008-06-01T00:00:00,Angiography,E01.370.350.700.060
18446120,2008-06-01T00:00:00,Angiography,E01.370.370.050
18446120,2008-06-01T00:00:00,Anticoagulants,D27.505.954.502.119
18446120,2008-06-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
18446120,2008-06-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
18446120,2008-06-01T00:00:00,"Catheterization, Central Venous",E02.148.167
18446120,2008-06-01T00:00:00,Contrast Media,D27.720.259
18446120,2008-06-01T00:00:00,Device Removal,E04.199
18446120,2008-06-01T00:00:00,Femoral Artery,A07.231.114.351
18446120,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18446120,2008-06-01T00:00:00,Leg,A01.378.610.500
18446120,2008-06-01T00:00:00,Thrombocytopenia,C15.378.140.855
18446120,2008-06-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
18462068,2008-06-01T00:00:00,Adult,M01.060.116
18462068,2008-06-01T00:00:00,Aged,M01.060.116.100
18462068,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18462068,2008-06-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
18462068,2008-06-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
18462068,2008-06-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
18462068,2008-06-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
18462068,2008-06-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
18462068,2008-06-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
18462068,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18462068,2008-06-01T00:00:00,"Muscle, Smooth",A02.633.570
18462068,2008-06-01T00:00:00,"Muscle, Smooth",A10.690.467
18462068,2008-06-01T00:00:00,Protein Transport,G03.495.166.700
18473696,2008-06-01T00:00:00,Adult,M01.060.116
18473696,2008-06-01T00:00:00,Attitude to Health,F01.100.150
18473696,2008-06-01T00:00:00,Attitude to Health,N05.300.150
18473696,2008-06-01T00:00:00,Depression,F01.145.126.350
18473696,2008-06-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18473696,2008-06-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18473696,2008-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18473696,2008-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18473696,2008-06-01T00:00:00,"Hospitals, University",N02.278.020.300.310
18473696,2008-06-01T00:00:00,"Hospitals, University",N02.278.421.639.725
18473696,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18473696,2008-06-01T00:00:00,Incidence,E05.318.308.985.525.375
18473696,2008-06-01T00:00:00,Incidence,L01.280.975.525.375
18473696,2008-06-01T00:00:00,Incidence,N01.224.935.597.500
18473696,2008-06-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18473696,2008-06-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18473696,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18473696,2008-06-01T00:00:00,Patient Compliance,F01.145.488.500
18473696,2008-06-01T00:00:00,Patient Compliance,N05.300.150.600.600
18473696,2008-06-01T00:00:00,Self Care,E02.900
18473696,2008-06-01T00:00:00,Self Care,N02.421.784.680
18473696,2008-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18473696,2008-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18475070,2008-06-01T00:00:00,Aging,G07.700.320.124
18475070,2008-06-01T00:00:00,Deglutition,G10.261.326.215
18475070,2008-06-01T00:00:00,Deglutition Disorders,C06.405.117.119
18475070,2008-06-01T00:00:00,Deglutition Disorders,C09.775.174
18475070,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18475070,2008-06-01T00:00:00,Quality of Life,I01.800
18475070,2008-06-01T00:00:00,Quality of Life,K01.752.400.750
18480675,2008-06-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18480675,2008-06-01T00:00:00,Child,M01.060.406
18480675,2008-06-01T00:00:00,Child Behavior Disorders,F03.550.300
18480675,2008-06-01T00:00:00,Cognition Disorders,F03.087.250
18480675,2008-06-01T00:00:00,Combined Modality Therapy,E02.186
18480675,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18480675,2008-06-01T00:00:00,Patient Care Team,N04.590.715
18480678,2008-06-01T00:00:00,Adolescent,M01.060.057
18480678,2008-06-01T00:00:00,Adult,M01.060.116
18480678,2008-06-01T00:00:00,Animals,B01.050
18480678,2008-06-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18480678,2008-06-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
18480678,2008-06-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
18480678,2008-06-01T00:00:00,Child,M01.060.406
18480678,2008-06-01T00:00:00,"Child, Preschool",M01.060.406.448
18480678,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18480678,2008-06-01T00:00:00,Methylphenidate,D02.241.223.601.600
18480678,2008-06-01T00:00:00,Methylphenidate,D03.383.621.460
18482610,2008-06-01T00:00:00,Animals,B01.050
18482610,2008-06-01T00:00:00,Brain,A08.186.211
18482610,2008-06-01T00:00:00,Norepinephrine,D02.033.100.291.502
18482610,2008-06-01T00:00:00,Norepinephrine,D02.092.063.480
18482610,2008-06-01T00:00:00,Norepinephrine,D02.092.211.215.311.560
18482610,2008-06-01T00:00:00,Norepinephrine,D02.092.311.461.484
18482610,2008-06-01T00:00:00,Research,H01.770.644
18482610,2008-06-01T00:00:00,Substance-Related Disorders,C21.739
18482610,2008-06-01T00:00:00,Substance-Related Disorders,F03.900
18482612,2008-06-01T00:00:00,Biometry,E05.318.740.225
18482612,2008-06-01T00:00:00,Biometry,N06.850.505.200
18482612,2008-06-01T00:00:00,Fetal Growth Retardation,C13.703.277.370
18482612,2008-06-01T00:00:00,Fetal Growth Retardation,C16.300.390
18482612,2008-06-01T00:00:00,Fetal Growth Retardation,C23.550.393.450
18482612,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18482612,2008-06-01T00:00:00,Pregnancy,G08.686.785.760.769
18482612,2008-06-01T00:00:00,"Pregnancy, Multiple",G08.686.710
18482612,2008-06-01T00:00:00,"Pregnancy, Multiple",G08.686.785.760.769.525
18482612,2008-06-01T00:00:00,"Ultrasonography, Prenatal",E01.370.350.850.865
18482612,2008-06-01T00:00:00,"Ultrasonography, Prenatal",E01.370.378.630.865
18492886,2008-06-01T00:00:00,Contrast Media,D27.720.259
18492886,2008-06-01T00:00:00,"History, 20th Century",K01.400.504.968
18492886,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18493000,2008-06-01T00:00:00,Animals,B01.050
18493000,2008-06-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18493000,2008-06-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18493000,2008-06-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
18493000,2008-06-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
18494541,2008-06-01T00:00:00,Bayes Theorem,E05.318.740.600.200
18494541,2008-06-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
18494541,2008-06-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
18494541,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18494541,2008-06-01T00:00:00,"Models, Statistical",E05.318.740.500
18494541,2008-06-01T00:00:00,"Models, Statistical",E05.599.835
18494541,2008-06-01T00:00:00,"Models, Statistical",N05.715.360.750.530
18494541,2008-06-01T00:00:00,"Models, Statistical",N06.850.520.830.500
18494541,2008-06-01T00:00:00,"Models, Theoretical",E05.599
18494541,2008-06-01T00:00:00,Monte Carlo Method,E05.318.740.525
18494541,2008-06-01T00:00:00,Monte Carlo Method,L01.906.575.422
18494541,2008-06-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
18494541,2008-06-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
18494541,2008-06-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
18494541,2008-06-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
18494541,2008-06-01T00:00:00,Radiation Dosage,E05.799.513
18494541,2008-06-01T00:00:00,Radiation Dosage,G01.201.875.740
18494541,2008-06-01T00:00:00,Radiation Dosage,N06.850.810.250
18494541,2008-06-01T00:00:00,Regression Analysis,E05.318.740.750
18494541,2008-06-01T00:00:00,Regression Analysis,N05.715.360.750.695
18494541,2008-06-01T00:00:00,Regression Analysis,N06.850.520.830.750
18494541,2008-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18494541,2008-06-01T00:00:00,Risk Assessment,N04.452.871.715
18494541,2008-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18494541,2008-06-01T00:00:00,Risk Assessment,N06.850.505.715
18494541,2008-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18497851,2008-06-01T00:00:00,Biosensing Techniques,E05.601.123
18497851,2008-06-01T00:00:00,Metal Nanoparticles,J01.637.512.600.500
18497851,2008-06-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18497851,2008-06-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18497851,2008-06-01T00:00:00,Sensitivity and Specificity,G17.800
18497851,2008-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18497851,2008-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18497851,2008-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18497851,2008-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18497851,2008-06-01T00:00:00,Surface Plasmon Resonance,E05.196.890
18497851,2008-06-01T00:00:00,Surface Plasmon Resonance,E05.601.123.700
18503406,2008-06-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
18503406,2008-06-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
18503406,2008-06-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
18503406,2008-06-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
18503406,2008-06-01T00:00:00,Cardiovascular System,A07
18503406,2008-06-01T00:00:00,Chronic Disease,C23.550.291.500
18503406,2008-06-01T00:00:00,Fibromyalgia,C05.651.324
18503406,2008-06-01T00:00:00,Fibromyalgia,C05.799.321
18503406,2008-06-01T00:00:00,Fibromyalgia,C10.668.491.425
18503406,2008-06-01T00:00:00,Gastrointestinal Tract,A03.556
18503406,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18503406,2008-06-01T00:00:00,Low Back Pain,C10.597.617.152.400
18503406,2008-06-01T00:00:00,Low Back Pain,C23.888.592.612.107.400
18503406,2008-06-01T00:00:00,Low Back Pain,C23.888.646.172.500
18503406,2008-06-01T00:00:00,Pain,C10.597.617
18503406,2008-06-01T00:00:00,Pain,C23.888.592.612
18503406,2008-06-01T00:00:00,Pain,C23.888.646
18503406,2008-06-01T00:00:00,Pain,F02.830.816.444
18503406,2008-06-01T00:00:00,Pain,G11.561.600.810.444
18503406,2008-06-01T00:00:00,Peripheral Nervous System Diseases,C10.668.829
18503841,2008-06-01T00:00:00,Adult,M01.060.116
18503841,2008-06-01T00:00:00,Aged,M01.060.116.100
18503841,2008-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
18503841,2008-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
18503841,2008-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
18503841,2008-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
18503841,2008-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
18503841,2008-06-01T00:00:00,Endoscopy,E01.370.388.250
18503841,2008-06-01T00:00:00,Endoscopy,E04.800.250
18503841,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18503841,2008-06-01T00:00:00,Intracranial Hypertension,C10.228.140.631
18503841,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18503841,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18503841,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18503841,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18506052,2008-06-01T00:00:00,Adolescent,M01.060.057
18506052,2008-06-01T00:00:00,Adult,M01.060.116
18506052,2008-06-01T00:00:00,Auditory Threshold,F02.463.593.071.173
18506052,2008-06-01T00:00:00,Auditory Threshold,F02.463.593.710.190
18506052,2008-06-01T00:00:00,Hearing Aids,E07.814.458
18506052,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18506052,2008-06-01T00:00:00,Noise,G01.595.907.567
18506052,2008-06-01T00:00:00,Noise,G16.500.275.600
18506052,2008-06-01T00:00:00,Noise,N06.230.400
18506052,2008-06-01T00:00:00,Noise,N06.850.460.610
18506052,2008-06-01T00:00:00,Speech Perception,F02.463.593.071.875
18506659,2008-06-01T00:00:00,Combined Modality Therapy,E02.186
18506659,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18506659,2008-06-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18506659,2008-06-01T00:00:00,Lung Neoplasms,C08.381.540
18506659,2008-06-01T00:00:00,Lung Neoplasms,C08.785.520
18506659,2008-06-01T00:00:00,Mass Screening,E01.370.500
18506659,2008-06-01T00:00:00,Mass Screening,E05.318.308.250.580
18506659,2008-06-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18506659,2008-06-01T00:00:00,Mass Screening,N02.421.726.233.443
18506659,2008-06-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18506659,2008-06-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18506659,2008-06-01T00:00:00,Mass Screening,N06.850.780.500
18506660,2008-06-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18506660,2008-06-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18506660,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18506660,2008-06-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18506660,2008-06-01T00:00:00,Lung Neoplasms,C08.381.540
18506660,2008-06-01T00:00:00,Lung Neoplasms,C08.785.520
18506660,2008-06-01T00:00:00,"Models, Biological",E05.599.395
18506660,2008-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18506660,2008-06-01T00:00:00,Risk Assessment,N04.452.871.715
18506660,2008-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18506660,2008-06-01T00:00:00,Risk Assessment,N06.850.505.715
18506660,2008-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18506660,2008-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18506660,2008-06-01T00:00:00,Risk Factors,N05.715.350.200.700
18506660,2008-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18506660,2008-06-01T00:00:00,Risk Factors,N06.850.490.625.750
18506660,2008-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18506660,2008-06-01T00:00:00,Sex Factors,N05.715.350.675
18506660,2008-06-01T00:00:00,Sex Factors,N06.850.490.875
18506660,2008-06-01T00:00:00,Smoking,F01.145.466.753
18506664,2008-06-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
18506664,2008-06-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
18506664,2008-06-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
18506664,2008-06-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
18506664,2008-06-01T00:00:00,"Biopsy, Needle",E04.074.119
18506664,2008-06-01T00:00:00,Bronchoscopy,E01.370.386.105
18506664,2008-06-01T00:00:00,Bronchoscopy,E01.370.388.250.100
18506664,2008-06-01T00:00:00,Bronchoscopy,E04.800.250.100
18506664,2008-06-01T00:00:00,Bronchoscopy,E04.928.600.080
18506664,2008-06-01T00:00:00,Endosonography,E01.370.350.850.280
18506664,2008-06-01T00:00:00,Fluoroscopy,E01.370.350.700.225
18506664,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18506664,2008-06-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18506664,2008-06-01T00:00:00,Lung Neoplasms,C08.381.540
18506664,2008-06-01T00:00:00,Lung Neoplasms,C08.785.520
18512816,2008-06-01T00:00:00,Adult,M01.060.116
18512816,2008-06-01T00:00:00,Aged,M01.060.116.100
18512816,2008-06-01T00:00:00,Animals,B01.050
18512816,2008-06-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18512816,2008-06-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
18512816,2008-06-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
18512816,2008-06-01T00:00:00,Disease Progression,C23.550.291.656
18512816,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18512816,2008-06-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18512816,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18512816,2008-06-01T00:00:00,"Scleroderma, Diffuse",C17.300.799.602
18512816,2008-06-01T00:00:00,"Scleroderma, Diffuse",C17.800.784.602
18512816,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18512816,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18512816,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18515595,2008-06-01T00:00:00,Adult,M01.060.116
18515595,2008-06-01T00:00:00,African Americans,M01.686.508.100.100
18515595,2008-06-01T00:00:00,African Americans,M01.686.754.100
18515595,2008-06-01T00:00:00,Aged,M01.060.116.100
18515595,2008-06-01T00:00:00,Aging,G07.700.320.124
18515595,2008-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18515595,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18515595,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18515595,2008-06-01T00:00:00,Sex Characteristics,G08.686.815
18515595,2008-06-01T00:00:00,"Tomography, Optical Coherence",E01.370.350.825.805.500
18518710,2008-06-01T00:00:00,Adolescent,M01.060.057
18518710,2008-06-01T00:00:00,Adult,M01.060.116
18518710,2008-06-01T00:00:00,Aged,M01.060.116.100
18518710,2008-06-01T00:00:00,Angioplasty,E02.148.050
18518710,2008-06-01T00:00:00,Angioplasty,E04.100.814.050
18518710,2008-06-01T00:00:00,Child,M01.060.406
18518710,2008-06-01T00:00:00,"Embolization, Therapeutic",E02.520.360
18518710,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18518710,2008-06-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
18518710,2008-06-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
18518710,2008-06-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
18518710,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18518710,2008-06-01T00:00:00,Stents,E07.695.750
18518710,2008-06-01T00:00:00,Stroke,C10.228.140.300.775
18518710,2008-06-01T00:00:00,Stroke,C14.907.253.855
18518763,2008-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18518763,2008-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
18518763,2008-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18518763,2008-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18518763,2008-06-01T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
18518763,2008-06-01T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
18518763,2008-06-01T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
18518763,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18518841,2008-06-01T00:00:00,Alcoholism,C21.739.100.250
18518841,2008-06-01T00:00:00,Alcoholism,F03.900.100.350
18518841,2008-06-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18518841,2008-06-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18518841,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18518841,2008-06-01T00:00:00,Naltrexone,D03.132.577.249.706.550
18518841,2008-06-01T00:00:00,Naltrexone,D03.549.686.750.550
18518841,2008-06-01T00:00:00,Naltrexone,D03.605.497.750.550
18518841,2008-06-01T00:00:00,Naltrexone,D04.615.723.795.706.550
18518841,2008-06-01T00:00:00,Narcotic Antagonists,D27.505.696.543
18518841,2008-06-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
18518841,2008-06-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
18518841,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18518841,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18518841,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18519540,2008-06-01T00:00:00,Combat Disorders,F03.080.931.249
18519540,2008-06-01T00:00:00,Health Surveys,E05.318.308.250
18519540,2008-06-01T00:00:00,Health Surveys,N05.715.360.300.375
18519540,2008-06-01T00:00:00,Health Surveys,N06.850.520.308.250
18519540,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18519540,2008-06-01T00:00:00,Mass Screening,E01.370.500
18519540,2008-06-01T00:00:00,Mass Screening,E05.318.308.250.580
18519540,2008-06-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18519540,2008-06-01T00:00:00,Mass Screening,N02.421.726.233.443
18519540,2008-06-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18519540,2008-06-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18519540,2008-06-01T00:00:00,Mass Screening,N06.850.780.500
18519540,2008-06-01T00:00:00,Military Personnel,M01.526.625
18519668,2008-06-01T00:00:00,Animals,B01.050
18519668,2008-06-01T00:00:00,Cell Division,G04.299.134.220
18519668,2008-06-01T00:00:00,Cell Division,G04.299.233.750.500
18519668,2008-06-01T00:00:00,Cell Division,G05.355.105
18519668,2008-06-01T00:00:00,Cell Division,G07.700.320.249.410.750.500
18519668,2008-06-01T00:00:00,Cell Movement,G04.299.283
18519668,2008-06-01T00:00:00,Cell Movement,G07.700.560.500.180
18519668,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18519668,2008-06-01T00:00:00,Neoplasm Invasiveness,C04.697.645
18519668,2008-06-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18519668,2008-06-01T00:00:00,Protein Isoforms,D12.776.800
18519668,2008-06-01T00:00:00,"Receptors, Thromboxane",D12.776.543.750.075.800
18519668,2008-06-01T00:00:00,"Receptors, Thromboxane",D12.776.543.750.100.200.800
18519668,2008-06-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
18519668,2008-06-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
18519668,2008-06-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
18519668,2008-06-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
18519668,2008-06-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
18519707,2008-06-01T00:00:00,Adult,M01.060.116
18519707,2008-06-01T00:00:00,Aged,M01.060.116.100
18519707,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18519707,2008-06-01T00:00:00,Immunoglobulin Allotypes,D12.776.124.486.485.114.606
18519707,2008-06-01T00:00:00,Immunoglobulin Allotypes,D12.776.124.790.651.114.606
18519707,2008-06-01T00:00:00,Immunoglobulin Allotypes,D12.776.377.715.548.114.606
18519707,2008-06-01T00:00:00,Immunoglobulin Allotypes,G12.500.400
18519707,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18519707,2008-06-01T00:00:00,Stomach Neoplasms,C04.588.274.476.767
18519707,2008-06-01T00:00:00,Stomach Neoplasms,C06.301.371.767
18519707,2008-06-01T00:00:00,Stomach Neoplasms,C06.405.249.767
18519707,2008-06-01T00:00:00,Stomach Neoplasms,C06.405.748.789
18533284,2008-06-01T00:00:00,Adult,M01.060.116
18533284,2008-06-01T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
18533284,2008-06-01T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
18533284,2008-06-01T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
18533284,2008-06-01T00:00:00,Antigen-Antibody Complex,D23.050.101
18533284,2008-06-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18533284,2008-06-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18533284,2008-06-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18533284,2008-06-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18533284,2008-06-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18533284,2008-06-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18533284,2008-06-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18533284,2008-06-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18533284,2008-06-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18533284,2008-06-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
18533284,2008-06-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
18533284,2008-06-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
18533284,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18533284,2008-06-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18533284,2008-06-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18533284,2008-06-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18533284,2008-06-01T00:00:00,"Lipoproteins, LDL",D10.532.515
18533284,2008-06-01T00:00:00,"Lipoproteins, LDL",D12.776.521.550
18533284,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18533284,2008-06-01T00:00:00,Pilot Projects,E05.318.760.750
18533284,2008-06-01T00:00:00,Pilot Projects,E05.337.737
18533284,2008-06-01T00:00:00,Pilot Projects,N05.715.360.775.625
18533284,2008-06-01T00:00:00,Pilot Projects,N06.850.520.450.720
18533807,2008-06-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18533807,2008-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
18533807,2008-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
18533807,2008-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18533807,2008-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
18533807,2008-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18533807,2008-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18533807,2008-06-01T00:00:00,Combined Modality Therapy,E02.186
18533807,2008-06-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
18533807,2008-06-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
18533807,2008-06-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
18533807,2008-06-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
18533807,2008-06-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
18533807,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18533807,2008-06-01T00:00:00,Liver Neoplasms,C04.588.274.623
18533807,2008-06-01T00:00:00,Liver Neoplasms,C06.301.623
18533807,2008-06-01T00:00:00,Liver Neoplasms,C06.552.697
18533807,2008-06-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
18533807,2008-06-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
18533807,2008-06-01T00:00:00,Pancreatic Neoplasms,C06.301.761
18533807,2008-06-01T00:00:00,Pancreatic Neoplasms,C06.689.667
18533807,2008-06-01T00:00:00,Pancreatic Neoplasms,C19.344.421
18533807,2008-06-01T00:00:00,Stomach Neoplasms,C04.588.274.476.767
18533807,2008-06-01T00:00:00,Stomach Neoplasms,C06.301.371.767
18533807,2008-06-01T00:00:00,Stomach Neoplasms,C06.405.249.767
18533807,2008-06-01T00:00:00,Stomach Neoplasms,C06.405.748.789
18533807,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18533807,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18533807,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18533807,2008-06-01T00:00:00,United States,Z01.107.567.875
18541563,2008-06-01T00:00:00,Cholecalciferol,D04.808.247.222.159
18541563,2008-06-01T00:00:00,Cholecalciferol,D04.808.247.808.146
18541563,2008-06-01T00:00:00,Cholecalciferol,D04.808.812.768.196
18541563,2008-06-01T00:00:00,Cholecalciferol,D10.570.938.146
18541563,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18541563,2008-06-01T00:00:00,Light,G01.201.875.770.578
18541563,2008-06-01T00:00:00,Light,G01.590.540
18541563,2008-06-01T00:00:00,Vitamin D,D04.808.812.768
18541793,2008-06-01T00:00:00,"Constriction, Pathologic",C23.300.287
18541793,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18541793,2008-06-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18541793,2008-06-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18541793,2008-06-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18541793,2008-06-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18541793,2008-06-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18541793,2008-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18541793,2008-06-01T00:00:00,Risk Factors,N05.715.350.200.700
18541793,2008-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18541793,2008-06-01T00:00:00,Risk Factors,N06.850.490.625.750
18541793,2008-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18541793,2008-06-01T00:00:00,Stroke,C10.228.140.300.775
18541793,2008-06-01T00:00:00,Stroke,C14.907.253.855
18545046,2008-06-01T00:00:00,Alveolar Ridge Augmentation,E04.545.550.100
18545046,2008-06-01T00:00:00,Alveolar Ridge Augmentation,E06.645.550.100
18545046,2008-06-01T00:00:00,Bone Transplantation,E04.555.130
18545046,2008-06-01T00:00:00,Bone Transplantation,E04.936.450.050
18545046,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18545046,2008-06-01T00:00:00,Maxilla,A02.835.232.781.324.502.645
18545046,2008-06-01T00:00:00,Maxilla,A14.521.645
18545046,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18545046,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18545046,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18545046,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18545049,2008-06-01T00:00:00,Aged,M01.060.116.100
18545049,2008-06-01T00:00:00,Bone Substitutes,D25.130.325
18545049,2008-06-01T00:00:00,Bone Substitutes,J01.637.051.130.325
18545049,2008-06-01T00:00:00,Bone Transplantation,E04.555.130
18545049,2008-06-01T00:00:00,Bone Transplantation,E04.936.450.050
18545049,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18545049,2008-06-01T00:00:00,"Membranes, Artificial",D25.479
18545049,2008-06-01T00:00:00,"Membranes, Artificial",J01.637.051.479
18545049,2008-06-01T00:00:00,"Membranes, Artificial",J01.637.087.500
18545049,2008-06-01T00:00:00,Molar,A14.549.167.860.525
18546544,2008-06-01T00:00:00,Bias (Epidemiology),N05.715.350.150
18546544,2008-06-01T00:00:00,Bias (Epidemiology),N06.850.490.500
18546544,2008-06-01T00:00:00,Health Services Research,N03.349.380
18546544,2008-06-01T00:00:00,Health Services Research,N05.425
18546544,2008-06-01T00:00:00,United States,Z01.107.567.875
18549754,2008-06-01T00:00:00,Aged,M01.060.116.100
18549754,2008-06-01T00:00:00,Ankle Joint,A02.835.583.378.062
18549754,2008-06-01T00:00:00,Bone Plates,E07.695.125
18549754,2008-06-01T00:00:00,Bone Plates,E07.858.442.660.110
18549754,2008-06-01T00:00:00,Bone Plates,E07.858.690.650.110
18549754,2008-06-01T00:00:00,Bone Screws,E07.695.130
18549754,2008-06-01T00:00:00,Bone Screws,E07.858.442.660.115
18549754,2008-06-01T00:00:00,Bone Screws,E07.858.690.650.115
18549754,2008-06-01T00:00:00,Cadaver,C23.550.260.224
18549754,2008-06-01T00:00:00,Equipment Failure Analysis,E05.325.192
18549754,2008-06-01T00:00:00,"Fracture Fixation, Intramedullary",E04.555.300.300.300
18549754,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18549754,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18549754,2008-06-01T00:00:00,Pliability,G01.374.705
18549754,2008-06-01T00:00:00,Subtalar Joint,A02.835.583.378.831.780
18549754,2008-06-01T00:00:00,Weight-Bearing,G01.374.676.965
18549754,2008-06-01T00:00:00,Weight-Bearing,G01.595.540.965
18556992,2008-06-01T00:00:00,Adolescent,M01.060.057
18556992,2008-06-01T00:00:00,Adult,M01.060.116
18556992,2008-06-01T00:00:00,Aged,M01.060.116.100
18556992,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18556992,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18556992,2008-06-01T00:00:00,Pancreaticojejunostomy,E04.035.703
18556992,2008-06-01T00:00:00,Pancreaticojejunostomy,E04.210.762
18556992,2008-06-01T00:00:00,"Pancreatitis, Alcoholic",C06.689.750.660
18556992,2008-06-01T00:00:00,"Pancreatitis, Alcoholic",C21.739.100.087.730
18556992,2008-06-01T00:00:00,Postoperative Complications,C23.550.767
18556992,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18556992,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18556992,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18558177,2008-06-01T00:00:00,Bacterial Infections,C01.252
18558177,2008-06-01T00:00:00,"Catheterization, Central Venous",E02.148.167
18558177,2008-06-01T00:00:00,"Catheters, Indwelling",E07.150
18558177,2008-06-01T00:00:00,"Child, Preschool",M01.060.406.448
18558177,2008-06-01T00:00:00,Ethanol,D02.033.375
18558177,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18558177,2008-06-01T00:00:00,Infant,M01.060.703
18558177,2008-06-01T00:00:00,Parenteral Nutrition,E02.421.505
18558177,2008-06-01T00:00:00,Parenteral Nutrition,E02.642.500.505
18558177,2008-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18558177,2008-06-01T00:00:00,Risk Assessment,N04.452.871.715
18558177,2008-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18558177,2008-06-01T00:00:00,Risk Assessment,N06.850.505.715
18558177,2008-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18558177,2008-06-01T00:00:00,Short Bowel Syndrome,C06.405.469.637.832
18558177,2008-06-01T00:00:00,Short Bowel Syndrome,C23.550.767.882
18558177,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18558177,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18558177,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18558178,2008-06-01T00:00:00,Adolescent,M01.060.057
18558178,2008-06-01T00:00:00,"Catheterization, Central Venous",E02.148.167
18558178,2008-06-01T00:00:00,"Catheters, Indwelling",E07.150
18558178,2008-06-01T00:00:00,Child,M01.060.406
18558178,2008-06-01T00:00:00,Device Removal,E04.199
18558178,2008-06-01T00:00:00,Equipment Failure,E05.325
18558178,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18558178,2008-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18558178,2008-06-01T00:00:00,Risk Assessment,N04.452.871.715
18558178,2008-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18558178,2008-06-01T00:00:00,Risk Assessment,N06.850.505.715
18558178,2008-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18558178,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18558178,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18558178,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18558200,2008-06-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
18558200,2008-06-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
18558200,2008-06-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
18558200,2008-06-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
18558200,2008-06-01T00:00:00,"Biopsy, Needle",E04.074.119
18558200,2008-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
18558200,2008-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
18558200,2008-06-01T00:00:00,Child,M01.060.406
18558200,2008-06-01T00:00:00,"Child, Preschool",M01.060.406.448
18558200,2008-06-01T00:00:00,"Diagnosis, Differential",E01.171
18558200,2008-06-01T00:00:00,Diagnostic Errors,E01.354
18558200,2008-06-01T00:00:00,Diagnostic Errors,N02.421.450.280
18558200,2008-06-01T00:00:00,Disease-Free Survival,E01.789.200
18558200,2008-06-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
18558200,2008-06-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18558200,2008-06-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18558200,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18558200,2008-06-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
18558200,2008-06-01T00:00:00,Kidney Neoplasms,C12.758.820.750
18558200,2008-06-01T00:00:00,Kidney Neoplasms,C12.777.419.473
18558200,2008-06-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
18558200,2008-06-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
18558200,2008-06-01T00:00:00,Nephrectomy,E04.950.774.435
18558200,2008-06-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
18558200,2008-06-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
18558200,2008-06-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
18558200,2008-06-01T00:00:00,Preoperative Care,E02.760.795
18558200,2008-06-01T00:00:00,Preoperative Care,E04.641
18558200,2008-06-01T00:00:00,Preoperative Care,N02.421.585.795
18558200,2008-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18558200,2008-06-01T00:00:00,Risk Assessment,N04.452.871.715
18558200,2008-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18558200,2008-06-01T00:00:00,Risk Assessment,N06.850.505.715
18558200,2008-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18558200,2008-06-01T00:00:00,Treatment Outcome,E01.789.800
18558200,2008-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18558200,2008-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18558200,2008-06-01T00:00:00,Wilms Tumor,C04.557.435.595
18558200,2008-06-01T00:00:00,Wilms Tumor,C04.588.945.947.535.585
18558200,2008-06-01T00:00:00,Wilms Tumor,C04.700.635
18558200,2008-06-01T00:00:00,Wilms Tumor,C12.758.820.750.585
18558200,2008-06-01T00:00:00,Wilms Tumor,C12.777.419.473.585
18558200,2008-06-01T00:00:00,Wilms Tumor,C13.351.937.820.535.585
18558200,2008-06-01T00:00:00,Wilms Tumor,C13.351.968.419.473.585
18558200,2008-06-01T00:00:00,Wilms Tumor,C16.320.700.642
18560126,2008-06-01T00:00:00,Age Factors,N05.715.350.075
18560126,2008-06-01T00:00:00,Age Factors,N06.850.490.250
18560126,2008-06-01T00:00:00,Animals,B01.050
18560126,2008-06-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18560126,2008-06-01T00:00:00,Cholesterol,D04.808.247.222.284
18560126,2008-06-01T00:00:00,Cholesterol,D04.808.247.808.197
18560126,2008-06-01T00:00:00,Cholesterol,D10.570.938.208
18560126,2008-06-01T00:00:00,Cholesterol,D10.851.208
18560126,2008-06-01T00:00:00,"Cholesterol, HDL",D10.532.432.400
18560126,2008-06-01T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
18560126,2008-06-01T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
18560126,2008-06-01T00:00:00,Cues,F02.463.425.234
18560126,2008-06-01T00:00:00,Dietary Fats,D10.212.302
18560126,2008-06-01T00:00:00,Dietary Fats,J02.500.375
18560126,2008-06-01T00:00:00,Fatty Acids,D10.251
18560126,2008-06-01T00:00:00,Hippocampus,A08.186.211.464.405
18560126,2008-06-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
18560126,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18560126,2008-06-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18560126,2008-06-01T00:00:00,"Memory, Short-Term",F02.463.425.540.407
18560126,2008-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18560126,2008-06-01T00:00:00,Retention (Psychology),F02.463.425.540.772
18562879,2008-06-01T00:00:00,Accidental Falls,N06.850.135.122
18562879,2008-06-01T00:00:00,Bronchoscopy,E01.370.386.105
18562879,2008-06-01T00:00:00,Bronchoscopy,E01.370.388.250.100
18562879,2008-06-01T00:00:00,Bronchoscopy,E04.800.250.100
18562879,2008-06-01T00:00:00,Bronchoscopy,E04.928.600.080
18562879,2008-06-01T00:00:00,Child,M01.060.406
18562879,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18562879,2008-06-01T00:00:00,Laryngoscopy,E01.370.386.460
18562879,2008-06-01T00:00:00,Laryngoscopy,E01.370.388.250.525
18562879,2008-06-01T00:00:00,Laryngoscopy,E04.580.373
18562879,2008-06-01T00:00:00,Laryngoscopy,E04.800.250.525
18562879,2008-06-01T00:00:00,Microsurgery,E04.494
18562879,2008-06-01T00:00:00,Microsurgery,E05.591.580
18562879,2008-06-01T00:00:00,Neck Injuries,C21.866.700
18562879,2008-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18562879,2008-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18562879,2008-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18562879,2008-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18562879,2008-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18562879,2008-06-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
18562888,2008-06-01T00:00:00,Child,M01.060.406
18562888,2008-06-01T00:00:00,"Diagnosis, Differential",E01.171
18562888,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18562888,2008-06-01T00:00:00,Ophthalmologic Surgical Procedures,E04.540
18562888,2008-06-01T00:00:00,Prevalence,E05.318.308.985.525.750
18562888,2008-06-01T00:00:00,Prevalence,L01.280.975.525.750
18562888,2008-06-01T00:00:00,Prevalence,N01.224.935.597.750
18562888,2008-06-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18562888,2008-06-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18562888,2008-06-01T00:00:00,United States,Z01.107.567.875
18570593,2008-06-01T00:00:00,Hepacivirus,B04.450.410
18570593,2008-06-01T00:00:00,Hepacivirus,B04.820.250.475
18570593,2008-06-01T00:00:00,Hepacivirus,B04.909.777.310.475
18570593,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18570593,2008-06-01T00:00:00,Viral Core Proteins,D12.776.964.970.600.850
18577011,2008-06-01T00:00:00,Adult,M01.060.116
18577011,2008-06-01T00:00:00,Demography,I01.240
18577011,2008-06-01T00:00:00,Demography,N01.224
18577011,2008-06-01T00:00:00,Demography,N06.850.505.400
18577011,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18577011,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18577011,2008-06-01T00:00:00,Taste,F02.830.816.724
18577011,2008-06-01T00:00:00,Taste,G11.561.600.810.724
18577011,2008-06-01T00:00:00,United States,Z01.107.567.875
18580552,2008-06-01T00:00:00,Depressive Disorder,F03.600.300
18580552,2008-06-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
18580552,2008-06-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
18580552,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18580552,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18580552,2008-06-01T00:00:00,Seizures,C10.228.140.490.631
18580552,2008-06-01T00:00:00,Seizures,C10.597.742
18580552,2008-06-01T00:00:00,Seizures,C23.888.592.742
18580553,2008-06-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
18580553,2008-06-01T00:00:00,Depressive Disorder,F03.600.300
18580553,2008-06-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
18580553,2008-06-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
18580553,2008-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18580553,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18580553,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18580553,2008-06-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18580553,2008-06-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18595858,2008-06-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
18595858,2008-06-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
18595858,2008-06-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
18595858,2008-06-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
18595858,2008-06-01T00:00:00,Adult,M01.060.116
18595858,2008-06-01T00:00:00,Autonomic Nervous System,A08.800.050
18595858,2008-06-01T00:00:00,Combined Modality Therapy,E02.186
18595858,2008-06-01T00:00:00,"Diagnosis, Differential",E01.171
18595858,2008-06-01T00:00:00,Environment,G16.500.275
18595858,2008-06-01T00:00:00,Environment,N06.230
18595858,2008-06-01T00:00:00,Gastrointestinal Tract,A03.556
18595858,2008-06-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18595858,2008-06-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18595858,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18595858,2008-06-01T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
18595858,2008-06-01T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
18595858,2008-06-01T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
18595858,2008-06-01T00:00:00,Nortriptyline,D02.455.426.559.847.181.384.535
18595858,2008-06-01T00:00:00,Nortriptyline,D04.615.181.384.535
18595858,2008-06-01T00:00:00,Pituitary-Adrenal System,A06.407.691
18595858,2008-06-01T00:00:00,Prevalence,E05.318.308.985.525.750
18595858,2008-06-01T00:00:00,Prevalence,L01.280.975.525.750
18595858,2008-06-01T00:00:00,Prevalence,N01.224.935.597.750
18595858,2008-06-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18595858,2008-06-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18627294,2008-06-01T00:00:00,Animals,B01.050
18627294,2008-06-01T00:00:00,Collagen,D05.750.078.280
18627294,2008-06-01T00:00:00,Collagen,D12.776.860.300.250
18627294,2008-06-01T00:00:00,Hemoglobins,D12.776.124.400
18627294,2008-06-01T00:00:00,Hemoglobins,D12.776.422.316.762
18627294,2008-06-01T00:00:00,Ischemia,C23.550.513
18627294,2008-06-01T00:00:00,Kinins,D12.644.276.812
18627294,2008-06-01T00:00:00,Kinins,D12.776.467.812
18627294,2008-06-01T00:00:00,Kinins,D23.469.050.375
18627294,2008-06-01T00:00:00,Kinins,D23.529.812
18627294,2008-06-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18627294,2008-06-01T00:00:00,Peptides,D12.644
18627294,2008-06-01T00:00:00,Perfusion,E05.680
18627294,2008-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18627294,2008-06-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
18627294,2008-06-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
18627294,2008-06-01T00:00:00,Tissue Kallikreins,D23.101.840.870
18650180,2008-06-01T00:00:00,Aged,M01.060.116.100
18650180,2008-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18650180,2008-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18650180,2008-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18650180,2008-06-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18650180,2008-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
18650180,2008-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
18650180,2008-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
18650180,2008-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
18650180,2008-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
18650180,2008-06-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
18650180,2008-06-01T00:00:00,Cyclophosphamide,D02.705.670.243
18650180,2008-06-01T00:00:00,Disease-Free Survival,E01.789.200
18650180,2008-06-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
18650180,2008-06-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18650180,2008-06-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18650180,2008-06-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
18650180,2008-06-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
18650180,2008-06-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
18650180,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18650180,2008-06-01T00:00:00,"Models, Biological",E05.599.395
18650180,2008-06-01T00:00:00,Remission Induction,E02.860
18650180,2008-06-01T00:00:00,United States,Z01.107.567.875
18661853,2008-06-01T00:00:00,Antiviral Agents,D27.505.954.122.388
18661853,2008-06-01T00:00:00,Delivery of Health Care,N04.590.374
18661853,2008-06-01T00:00:00,Delivery of Health Care,N05.300
18661853,2008-06-01T00:00:00,Disaster Planning,N06.230.100.035
18661853,2008-06-01T00:00:00,Disease Outbreaks,N06.850.290
18661853,2008-06-01T00:00:00,Health Manpower,N02.350
18661853,2008-06-01T00:00:00,Health Manpower,N05.300.420.400
18661853,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18661853,2008-06-01T00:00:00,"Influenza, Human",C02.782.620.365
18661853,2008-06-01T00:00:00,"Influenza, Human",C08.730.310
18663823,2008-06-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18663823,2008-06-01T00:00:00,Alzheimer Disease,C10.574.945.249
18663823,2008-06-01T00:00:00,Alzheimer Disease,F03.087.400.100
18663823,2008-06-01T00:00:00,Animals,B01.050
18663823,2008-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18663823,2008-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18663823,2008-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18663823,2008-06-01T00:00:00,Brain,A08.186.211
18663823,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18663823,2008-06-01T00:00:00,Peptide Fragments,D12.644.541
18664036,2008-06-01T00:00:00,Age Factors,N05.715.350.075
18664036,2008-06-01T00:00:00,Age Factors,N06.850.490.250
18664036,2008-06-01T00:00:00,Aged,M01.060.116.100
18664036,2008-06-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18664036,2008-06-01T00:00:00,Body Mass Index,E05.041.124.125
18664036,2008-06-01T00:00:00,Body Mass Index,G07.100.100.125
18664036,2008-06-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18664036,2008-06-01T00:00:00,Health Status,I01.240.425
18664036,2008-06-01T00:00:00,Health Status,N01.224.425
18664036,2008-06-01T00:00:00,Health Status,N06.850.505.400.425
18664036,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18664036,2008-06-01T00:00:00,Middle Aged,M01.060.116.630
18664036,2008-06-01T00:00:00,Motor Activity,F01.145.632
18664036,2008-06-01T00:00:00,Motor Activity,G11.427.590.530.698
18664036,2008-06-01T00:00:00,Questionnaires,E05.318.308.750
18664036,2008-06-01T00:00:00,Questionnaires,L01.280.800
18664036,2008-06-01T00:00:00,Questionnaires,N05.715.360.300.695
18664036,2008-06-01T00:00:00,Questionnaires,N06.850.520.308.750
18664036,2008-06-01T00:00:00,Walking,G11.427.590.530.568.900
18664036,2008-06-01T00:00:00,Walking,G11.427.590.530.698.940
18664036,2008-06-01T00:00:00,Walking,I03.450.642.845.940
18673211,2008-06-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18673211,2008-06-01T00:00:00,Alzheimer Disease,C10.574.945.249
18673211,2008-06-01T00:00:00,Alzheimer Disease,F03.087.400.100
18673211,2008-06-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
18673211,2008-06-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
18673211,2008-06-01T00:00:00,Animals,B01.050
18673211,2008-06-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
18673211,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18673211,2008-06-01T00:00:00,"Models, Biological",E05.599.395
18673212,2008-06-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18673212,2008-06-01T00:00:00,Alzheimer Disease,C10.574.945.249
18673212,2008-06-01T00:00:00,Alzheimer Disease,F03.087.400.100
18673212,2008-06-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
18673212,2008-06-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
18673212,2008-06-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
18673212,2008-06-01T00:00:00,Animals,B01.050
18673212,2008-06-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
18673212,2008-06-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
18673212,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18673212,2008-06-01T00:00:00,"Models, Biological",E05.599.395
18673214,2008-06-01T00:00:00,Animals,B01.050
18673214,2008-06-01T00:00:00,Calpain,D08.811.277.656.262.500.120
18673214,2008-06-01T00:00:00,Calpain,D08.811.277.656.300.200.120
18673214,2008-06-01T00:00:00,Glycoproteins,D09.400.430
18673214,2008-06-01T00:00:00,Glycoproteins,D12.776.395
18673214,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18673214,2008-06-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
18673214,2008-06-01T00:00:00,Parkinson Disease,C10.228.662.600.400
18673214,2008-06-01T00:00:00,Parkinson Disease,C10.574.812
18673215,2008-06-01T00:00:00,Animals,B01.050
18673215,2008-06-01T00:00:00,Calpain,D08.811.277.656.262.500.120
18673215,2008-06-01T00:00:00,Calpain,D08.811.277.656.300.200.120
18673215,2008-06-01T00:00:00,Demyelinating Diseases,C10.314
18673215,2008-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18673215,2008-06-01T00:00:00,Multiple Sclerosis,C10.114.375.500
18673215,2008-06-01T00:00:00,Multiple Sclerosis,C10.314.350.500
18673215,2008-06-01T00:00:00,Multiple Sclerosis,C20.111.258.250.500
18673215,2008-06-01T00:00:00,Signal Transduction,G02.111.087.800
18673215,2008-06-01T00:00:00,Signal Transduction,G02.149.115.800
18673215,2008-06-01T00:00:00,Signal Transduction,G04.299.880
18514228,2008-06-02T00:00:00,Albuminuria,C12.777.934.734.269
18514228,2008-06-02T00:00:00,Albuminuria,C13.351.968.934.734.269
18514228,2008-06-02T00:00:00,Albuminuria,C23.888.942.750.269
18514228,2008-06-02T00:00:00,Animals,B01.050
18514228,2008-06-02T00:00:00,Cardiovascular Diseases,C14
18514228,2008-06-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18514228,2008-06-02T00:00:00,Risk Factors,E05.318.740.600.800.725
18514228,2008-06-02T00:00:00,Risk Factors,N05.715.350.200.700
18514228,2008-06-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18514228,2008-06-02T00:00:00,Risk Factors,N06.850.490.625.750
18514228,2008-06-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19776626,2008-06-02T00:00:00,Aged,M01.060.116.100
19776626,2008-06-02T00:00:00,Alcohol Drinking,F01.145.317.269
19776626,2008-06-02T00:00:00,Carcinoma,C04.557.470.200
19776626,2008-06-02T00:00:00,Case-Control Studies,E05.318.760.500.500
19776626,2008-06-02T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19776626,2008-06-02T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19776626,2008-06-02T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19776626,2008-06-02T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19776626,2008-06-02T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19776626,2008-06-02T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19776626,2008-06-02T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19776626,2008-06-02T00:00:00,Eating,G07.610.593.260
19776626,2008-06-02T00:00:00,Eating,G07.700.620.260
19776626,2008-06-02T00:00:00,Eating,G10.261.326.240
19776626,2008-06-02T00:00:00,Folic Acid,D03.438.733.631.400
19776626,2008-06-02T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19776626,2008-06-02T00:00:00,Genetic Predisposition to Disease,G05.380.355
19776626,2008-06-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19776626,2008-06-02T00:00:00,Middle Aged,M01.060.116.630
19776626,2008-06-02T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19776626,2008-06-02T00:00:00,Risk Factors,E05.318.740.600.800.725
19776626,2008-06-02T00:00:00,Risk Factors,N05.715.350.200.700
19776626,2008-06-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19776626,2008-06-02T00:00:00,Risk Factors,N06.850.490.625.750
19776626,2008-06-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18522752,2008-06-03T00:00:00,Clinical Trials as Topic,E05.318.760.535
18522752,2008-06-03T00:00:00,Clinical Trials as Topic,E05.337.250
18522752,2008-06-03T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18522752,2008-06-03T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18522752,2008-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18522752,2008-06-03T00:00:00,"Models, Statistical",E05.318.740.500
18522752,2008-06-03T00:00:00,"Models, Statistical",E05.599.835
18522752,2008-06-03T00:00:00,"Models, Statistical",N05.715.360.750.530
18522752,2008-06-03T00:00:00,"Models, Statistical",N06.850.520.830.500
18522752,2008-06-03T00:00:00,Monte Carlo Method,E05.318.740.525
18522752,2008-06-03T00:00:00,Monte Carlo Method,L01.906.575.422
18522752,2008-06-03T00:00:00,Monte Carlo Method,N05.715.360.750.540
18522752,2008-06-03T00:00:00,Monte Carlo Method,N06.850.520.830.525
18522752,2008-06-03T00:00:00,Research Design,E05.581.500
18522752,2008-06-03T00:00:00,Research Design,H01.770.644.728
18522752,2008-06-03T00:00:00,Substance-Related Disorders,C21.739
18522752,2008-06-03T00:00:00,Substance-Related Disorders,F03.900
18523011,2008-06-03T00:00:00,Animals,B01.050
18523011,2008-06-03T00:00:00,Autoimmunity,G12.450.192
18523011,2008-06-03T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18523011,2008-06-03T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18523011,2008-06-03T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18523011,2008-06-03T00:00:00,Eye,A01.456.505.420
18523011,2008-06-03T00:00:00,Eye,A09.371
18523011,2008-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18523011,2008-06-03T00:00:00,Neoplasms,C04
18523140,2008-06-03T00:00:00,Animals,B01.050
18523140,2008-06-03T00:00:00,Cell Adhesion,G04.299.117
18523140,2008-06-03T00:00:00,Cell Movement,G04.299.283
18523140,2008-06-03T00:00:00,Cell Movement,G07.700.560.500.180
18523140,2008-06-03T00:00:00,Cell Proliferation,G04.299.233.750
18523140,2008-06-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18523140,2008-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18523140,2008-06-03T00:00:00,Neoplasm Invasiveness,C04.697.645
18523140,2008-06-03T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18523140,2008-06-03T00:00:00,Phenotype,G05.695
18523140,2008-06-03T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18523140,2008-06-03T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18523140,2008-06-03T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18523140,2008-06-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18523140,2008-06-03T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
18523140,2008-06-03T00:00:00,Signal Transduction,G02.111.087.800
18523140,2008-06-03T00:00:00,Signal Transduction,G02.149.115.800
18523140,2008-06-03T00:00:00,Signal Transduction,G04.299.880
18523456,2008-06-04T00:00:00,Adolescent,M01.060.057
18523456,2008-06-04T00:00:00,Adult,M01.060.116
18523456,2008-06-04T00:00:00,Aged,M01.060.116.100
18523456,2008-06-04T00:00:00,Blood Pressure,E01.370.600.875.249
18523456,2008-06-04T00:00:00,Blood Pressure,G09.330.380.076
18523456,2008-06-04T00:00:00,Child,M01.060.406
18523456,2008-06-04T00:00:00,Genome-Wide Association Study,E05.318.416.249
18523456,2008-06-04T00:00:00,Genome-Wide Association Study,E05.318.780.392
18523456,2008-06-04T00:00:00,Genome-Wide Association Study,E05.393.385.500
18523456,2008-06-04T00:00:00,Genome-Wide Association Study,E05.393.522.500
18523456,2008-06-04T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
18523456,2008-06-04T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
18523456,2008-06-04T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
18523456,2008-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18523456,2008-06-04T00:00:00,Hypertension,C14.907.489
18523456,2008-06-04T00:00:00,Middle Aged,M01.060.116.630
18523456,2008-06-04T00:00:00,Young Adult,M01.060.116.815
18523782,2008-06-04T00:00:00,Algorithms,G17.035
18523782,2008-06-04T00:00:00,Algorithms,L01.224.050
18523782,2008-06-04T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18523782,2008-06-04T00:00:00,Coronary Angiography,E01.370.370.050.200
18523782,2008-06-04T00:00:00,Coronary Angiography,E01.370.370.380.200
18523782,2008-06-04T00:00:00,Coronary Stenosis,C14.280.647.250.285
18523782,2008-06-04T00:00:00,Coronary Stenosis,C14.907.585.250.285
18523782,2008-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18523782,2008-06-04T00:00:00,Middle Aged,M01.060.116.630
18523782,2008-06-04T00:00:00,Myocardial Ischemia,C14.280.647
18523782,2008-06-04T00:00:00,Myocardial Ischemia,C14.907.585
18523782,2008-06-04T00:00:00,Pilot Projects,E05.318.760.750
18523782,2008-06-04T00:00:00,Pilot Projects,E05.337.737
18523782,2008-06-04T00:00:00,Pilot Projects,N05.715.360.775.625
18523782,2008-06-04T00:00:00,Pilot Projects,N06.850.520.450.720
18523782,2008-06-04T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
18523782,2008-06-04T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
18523782,2008-06-04T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
18523782,2008-06-04T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
18523782,2008-06-04T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
18523782,2008-06-04T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
18523782,2008-06-04T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
18523782,2008-06-04T00:00:00,Sensitivity and Specificity,E05.318.740.872
18523782,2008-06-04T00:00:00,Sensitivity and Specificity,E05.318.780.800
18523782,2008-06-04T00:00:00,Sensitivity and Specificity,G17.800
18523782,2008-06-04T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18523782,2008-06-04T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18523782,2008-06-04T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18523782,2008-06-04T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18523782,2008-06-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18523782,2008-06-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18523782,2008-06-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18523782,2008-06-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18523782,2008-06-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18523882,2008-06-04T00:00:00,"Adaptation, Psychological",F01.058
18523882,2008-06-04T00:00:00,Adolescent,M01.060.057
18523882,2008-06-04T00:00:00,Adult,M01.060.116
18523882,2008-06-04T00:00:00,Child,M01.060.406
18523882,2008-06-04T00:00:00,"Child, Preschool",M01.060.406.448
18523882,2008-06-04T00:00:00,Conflict (Psychology),F01.658.209
18523882,2008-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18523882,2008-06-04T00:00:00,Infant,M01.060.703
18523882,2008-06-04T00:00:00,"Infant, Newborn",M01.060.703.520
18523882,2008-06-04T00:00:00,Parenting,F01.829.263.370.310
18523882,2008-06-04T00:00:00,Prevalence,E05.318.308.985.525.750
18523882,2008-06-04T00:00:00,Prevalence,L01.280.975.525.750
18523882,2008-06-04T00:00:00,Prevalence,N01.224.935.597.750
18523882,2008-06-04T00:00:00,Prevalence,N06.850.505.400.975.525.750
18523882,2008-06-04T00:00:00,Prevalence,N06.850.520.308.985.525.750
18523882,2008-06-04T00:00:00,"Stress, Psychological",F01.145.126.990
18523882,2008-06-04T00:00:00,"Stress, Psychological",F02.830.900
18523882,2008-06-04T00:00:00,United States,Z01.107.567.875
18523882,2008-06-04T00:00:00,Young Adult,M01.060.116.815
18524868,2008-06-04T00:00:00,Animals,B01.050
18524868,2008-06-04T00:00:00,"Endothelium, Vascular",A07.231.330
18524868,2008-06-04T00:00:00,"Endothelium, Vascular",A10.272.491.355
18524868,2008-06-04T00:00:00,Heat-Shock Proteins,D12.776.580.216
18524868,2008-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18524868,2008-06-04T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18524868,2008-06-04T00:00:00,Mitochondria,A11.284.835.626
18524868,2008-06-04T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18524868,2008-06-04T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18524868,2008-06-04T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18524868,2008-06-04T00:00:00,Transcription Factors,D12.776.930
18524868,2008-06-04T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18524868,2008-06-04T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18524868,2008-06-04T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18524910,2008-06-04T00:00:00,Animals,B01.050
18524910,2008-06-04T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18524910,2008-06-04T00:00:00,Cocaine,D02.145.074.722.388
18524910,2008-06-04T00:00:00,Cocaine,D03.132.889.354
18524910,2008-06-04T00:00:00,Cocaine,D03.605.869.388
18524910,2008-06-04T00:00:00,Cocaine,D04.075.080.875.099.722.388
18524910,2008-06-04T00:00:00,"Extinction, Psychological",F02.463.425.770.232
18524910,2008-06-04T00:00:00,Limbic System,A08.186.211.464
18524910,2008-06-04T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18524910,2008-06-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18524910,2008-06-04T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18533119,2008-06-04T00:00:00,Aged,M01.060.116.100
18533119,2008-06-04T00:00:00,Algorithms,G17.035
18533119,2008-06-04T00:00:00,Algorithms,L01.224.050
18533119,2008-06-04T00:00:00,Case-Control Studies,E05.318.760.500.500
18533119,2008-06-04T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18533119,2008-06-04T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18533119,2008-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18533119,2008-06-04T00:00:00,Middle Aged,M01.060.116.630
18533119,2008-06-04T00:00:00,Neural Networks (Computer),G17.485
18533119,2008-06-04T00:00:00,Neural Networks (Computer),L01.224.065.605
18533119,2008-06-04T00:00:00,Neural Networks (Computer),L01.725.500
18533119,2008-06-04T00:00:00,Sensitivity and Specificity,E05.318.740.872
18533119,2008-06-04T00:00:00,Sensitivity and Specificity,E05.318.780.800
18533119,2008-06-04T00:00:00,Sensitivity and Specificity,G17.800
18533119,2008-06-04T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18533119,2008-06-04T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18533119,2008-06-04T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18533119,2008-06-04T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18533119,2008-06-04T00:00:00,Uterine Prolapse,C13.351.500.852.833
18533119,2008-06-04T00:00:00,Uterine Prolapse,C23.300.842.500.750
18528406,2008-06-05T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18528406,2008-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18528406,2008-06-05T00:00:00,Hypertension,C14.907.489
18528406,2008-06-05T00:00:00,Multiple Organ Failure,C23.550.835.525
18528406,2008-06-05T00:00:00,Risk Assessment,E05.318.740.600.800.715
18528406,2008-06-05T00:00:00,Risk Assessment,N04.452.871.715
18528406,2008-06-05T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18528406,2008-06-05T00:00:00,Risk Assessment,N06.850.505.715
18528406,2008-06-05T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18528406,2008-06-05T00:00:00,Risk Factors,E05.318.740.600.800.725
18528406,2008-06-05T00:00:00,Risk Factors,N05.715.350.200.700
18528406,2008-06-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18528406,2008-06-05T00:00:00,Risk Factors,N06.850.490.625.750
18528406,2008-06-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18528406,2008-06-05T00:00:00,United States,Z01.107.567.875
18534807,2008-06-05T00:00:00,Alcoholism,C21.739.100.250
18534807,2008-06-05T00:00:00,Alcoholism,F03.900.100.350
18534807,2008-06-05T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18534807,2008-06-05T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18534807,2008-06-05T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18534807,2008-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18534807,2008-06-05T00:00:00,Mass Screening,E01.370.500
18534807,2008-06-05T00:00:00,Mass Screening,E05.318.308.250.580
18534807,2008-06-05T00:00:00,Mass Screening,N02.421.143.827.233.443
18534807,2008-06-05T00:00:00,Mass Screening,N02.421.726.233.443
18534807,2008-06-05T00:00:00,Mass Screening,N05.715.360.300.375.500
18534807,2008-06-05T00:00:00,Mass Screening,N06.850.520.308.250.580
18534807,2008-06-05T00:00:00,Mass Screening,N06.850.780.500
18534807,2008-06-05T00:00:00,Prevalence,E05.318.308.985.525.750
18534807,2008-06-05T00:00:00,Prevalence,L01.280.975.525.750
18534807,2008-06-05T00:00:00,Prevalence,N01.224.935.597.750
18534807,2008-06-05T00:00:00,Prevalence,N06.850.505.400.975.525.750
18534807,2008-06-05T00:00:00,Prevalence,N06.850.520.308.985.525.750
18534807,2008-06-05T00:00:00,Questionnaires,E05.318.308.750
18534807,2008-06-05T00:00:00,Questionnaires,L01.280.800
18534807,2008-06-05T00:00:00,Questionnaires,N05.715.360.300.695
18534807,2008-06-05T00:00:00,Questionnaires,N06.850.520.308.750
18534807,2008-06-05T00:00:00,Risk Factors,E05.318.740.600.800.725
18534807,2008-06-05T00:00:00,Risk Factors,N05.715.350.200.700
18534807,2008-06-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18534807,2008-06-05T00:00:00,Risk Factors,N06.850.490.625.750
18534807,2008-06-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18534807,2008-06-05T00:00:00,Sensitivity and Specificity,E05.318.740.872
18534807,2008-06-05T00:00:00,Sensitivity and Specificity,E05.318.780.800
18534807,2008-06-05T00:00:00,Sensitivity and Specificity,G17.800
18534807,2008-06-05T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18534807,2008-06-05T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18534807,2008-06-05T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18534807,2008-06-05T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18534807,2008-06-05T00:00:00,South Carolina,Z01.107.567.875.075.662
18534807,2008-06-05T00:00:00,South Carolina,Z01.107.567.875.750.700
18535110,2008-06-05T00:00:00,Animals,B01.050
18535110,2008-06-05T00:00:00,Colitis,C06.405.205.265
18535110,2008-06-05T00:00:00,Colitis,C06.405.469.158.188
18535110,2008-06-05T00:00:00,Colon,A03.556.124.526.356
18535110,2008-06-05T00:00:00,Colon,A03.556.249.249.356
18535110,2008-06-05T00:00:00,Cytokines,D12.644.276.374
18535110,2008-06-05T00:00:00,Cytokines,D12.776.467.374
18535110,2008-06-05T00:00:00,Cytokines,D23.529.374
18535110,2008-06-05T00:00:00,Gastroenteritis,C06.405.205
18535110,2008-06-05T00:00:00,Gene Expression,G05.355.310
18535110,2008-06-05T00:00:00,Homeostasis,G07.700.360
18535110,2008-06-05T00:00:00,Kidney,A05.810.453
18535110,2008-06-05T00:00:00,"RNA, Messenger",D13.444.735.544
18535110,2008-06-05T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
18535110,2008-06-05T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18535548,2008-06-05T00:00:00,Adult,M01.060.116
18535548,2008-06-05T00:00:00,Beverages,J02.200
18535548,2008-06-05T00:00:00,Body Mass Index,E01.370.600.115.100.125
18535548,2008-06-05T00:00:00,Body Mass Index,E05.041.124.125
18535548,2008-06-05T00:00:00,Body Mass Index,G07.100.100.125
18535548,2008-06-05T00:00:00,Body Mass Index,N06.850.505.200.100.175
18535548,2008-06-05T00:00:00,Body Weight,C23.888.144
18535548,2008-06-05T00:00:00,Body Weight,E01.370.600.115.100.160.120
18535548,2008-06-05T00:00:00,Body Weight,E05.041.124.160.750
18535548,2008-06-05T00:00:00,Body Weight,G07.100.100.160.120
18535548,2008-06-05T00:00:00,Body Weight,G07.700.320.249.314.120
18535548,2008-06-05T00:00:00,European Continental Ancestry Group,M01.686.508.400
18535548,2008-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18535548,2008-06-05T00:00:00,Incidence,E05.318.308.985.525.375
18535548,2008-06-05T00:00:00,Incidence,L01.280.975.525.375
18535548,2008-06-05T00:00:00,Incidence,N01.224.935.597.500
18535548,2008-06-05T00:00:00,Incidence,N06.850.505.400.975.525.375
18535548,2008-06-05T00:00:00,Incidence,N06.850.520.308.985.525.375
18535548,2008-06-05T00:00:00,Mexican Americans,M01.686.754.441.500
18535548,2008-06-05T00:00:00,Middle Aged,M01.060.116.630
18535548,2008-06-05T00:00:00,Obesity,C18.654.726.500
18535548,2008-06-05T00:00:00,Obesity,C23.888.144.699.500
18535548,2008-06-05T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18535548,2008-06-05T00:00:00,Obesity,G07.100.100.160.120.699.500
18535548,2008-06-05T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18535548,2008-06-05T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18535548,2008-06-05T00:00:00,Risk Factors,E05.318.740.600.800.725
18535548,2008-06-05T00:00:00,Risk Factors,N05.715.350.200.700
18535548,2008-06-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18535548,2008-06-05T00:00:00,Risk Factors,N06.850.490.625.750
18535548,2008-06-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18535548,2008-06-05T00:00:00,Sweetening Agents,D27.720.364.609
18535548,2008-06-05T00:00:00,Sweetening Agents,D27.720.888
18535548,2008-06-05T00:00:00,Sweetening Agents,J02.500.512.400.700
18535548,2008-06-05T00:00:00,Weight Gain,C23.888.144.243.926
18535548,2008-06-05T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
18535839,2008-06-06T00:00:00,Animals,B01.050
18535839,2008-06-06T00:00:00,Dendrites,A08.663.256
18535839,2008-06-06T00:00:00,Dendrites,A11.284.180.225
18535839,2008-06-06T00:00:00,Dendrites,A11.671.240
18535839,2008-06-06T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
18535839,2008-06-06T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
18535839,2008-06-06T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18535839,2008-06-06T00:00:00,"Microscopy, Confocal",E05.595.395
18535839,2008-06-06T00:00:00,Neurons,A08.663
18535839,2008-06-06T00:00:00,Neurons,A11.671
18535839,2008-06-06T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18535839,2008-06-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18535839,2008-06-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18538375,2008-06-06T00:00:00,Child,M01.060.406
18538375,2008-06-06T00:00:00,"Child, Preschool",M01.060.406.448
18538375,2008-06-06T00:00:00,Developmental Disabilities,F03.550.362
18538375,2008-06-06T00:00:00,Fetus,A16.378
18538375,2008-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18538375,2008-06-06T00:00:00,Infant,M01.060.703
18538375,2008-06-06T00:00:00,Metals,D01.552
18538375,2008-06-06T00:00:00,Pregnancy,G08.686.785.760.769
18538375,2008-06-06T00:00:00,Soil Pollutants,D27.888.284.756
18538375,2008-06-06T00:00:00,South Carolina,Z01.107.567.875.075.662
18538375,2008-06-06T00:00:00,South Carolina,Z01.107.567.875.750.700
18539619,2008-06-06T00:00:00,"Adaptation, Psychological",F01.058
18539619,2008-06-06T00:00:00,Adolescent,M01.060.057
18539619,2008-06-06T00:00:00,Child,M01.060.406
18539619,2008-06-06T00:00:00,Depression,F01.145.126.350
18539619,2008-06-06T00:00:00,Epilepsy,C10.228.140.490
18539619,2008-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18539619,2008-06-06T00:00:00,Intelligence,F01.752.543
18539619,2008-06-06T00:00:00,Motivation,F01.658
18539619,2008-06-06T00:00:00,Motivation,F01.752.543.500.750
18539619,2008-06-06T00:00:00,Personality Inventory,F04.711.647.513
18539619,2008-06-06T00:00:00,Psychometrics,F04.711.780
18539619,2008-06-06T00:00:00,Self Efficacy,F01.752.747.792.700
18583044,2008-06-06T00:00:00,Animals,B01.050
18583044,2008-06-06T00:00:00,Cell Death,G04.299.139
18583044,2008-06-06T00:00:00,Heptanoic Acids,D10.251.450
18583044,2008-06-06T00:00:00,Hippocampus,A08.186.211.464.405
18583044,2008-06-06T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
18583044,2008-06-06T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
18583044,2008-06-06T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
18583044,2008-06-06T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
18583044,2008-06-06T00:00:00,Inflammation,C23.550.470
18583044,2008-06-06T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
18583044,2008-06-06T00:00:00,Pyrroles,D03.383.129.578
18583044,2008-06-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18583044,2008-06-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18583044,2008-06-06T00:00:00,Seizures,C10.228.140.490.631
18583044,2008-06-06T00:00:00,Seizures,C10.597.742
18583044,2008-06-06T00:00:00,Seizures,C23.888.592.742
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18583044,2008-06-06T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C10.314.400.250
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
18540993,2008-06-07T00:00:00,Adrenoleukodystrophy,C19.053.500.270
18540993,2008-06-07T00:00:00,Animals,B01.050
18540993,2008-06-07T00:00:00,Child,M01.060.406
18540993,2008-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18540993,2008-06-07T00:00:00,Lovastatin,D02.455.426.559.847.638.400
18540993,2008-06-07T00:00:00,Lovastatin,D04.615.638.400
18540993,2008-06-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18540993,2008-06-07T00:00:00,Reactive Oxygen Species,D01.339.431
18540993,2008-06-07T00:00:00,Reactive Oxygen Species,D01.650.775
18541825,2008-06-09T00:00:00,Adult,M01.060.116
18541825,2008-06-09T00:00:00,Aged,M01.060.116.100
18541825,2008-06-09T00:00:00,Case-Control Studies,E05.318.760.500.500
18541825,2008-06-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18541825,2008-06-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18541825,2008-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18541825,2008-06-09T00:00:00,Middle Aged,M01.060.116.630
18541825,2008-06-09T00:00:00,Myocardial Infarction,C14.280.647.500
18541825,2008-06-09T00:00:00,Myocardial Infarction,C14.907.585.500
18541825,2008-06-09T00:00:00,Questionnaires,E05.318.308.750
18541825,2008-06-09T00:00:00,Questionnaires,L01.280.800
18541825,2008-06-09T00:00:00,Questionnaires,N05.715.360.300.695
18541825,2008-06-09T00:00:00,Questionnaires,N06.850.520.308.750
18541825,2008-06-09T00:00:00,Risk Factors,E05.318.740.600.800.725
18541825,2008-06-09T00:00:00,Risk Factors,N05.715.350.200.700
18541825,2008-06-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18541825,2008-06-09T00:00:00,Risk Factors,N06.850.490.625.750
18541825,2008-06-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18541825,2008-06-09T00:00:00,Vitamin D,D04.808.812.768
18541827,2008-06-09T00:00:00,Alcoholism,C21.739.100.250
18541827,2008-06-09T00:00:00,Alcoholism,F03.900.100.350
18541827,2008-06-09T00:00:00,Fructose,D09.546.359.250
18541827,2008-06-09T00:00:00,Fructose,D09.546.465.354
18541827,2008-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18541827,2008-06-09T00:00:00,Middle Aged,M01.060.116.630
18541827,2008-06-09T00:00:00,Quality of Life,I01.800
18541827,2008-06-09T00:00:00,Quality of Life,K01.752.400.750
18541827,2008-06-09T00:00:00,Treatment Outcome,E01.789.800
18541827,2008-06-09T00:00:00,Treatment Outcome,N04.761.559.590.800
18541827,2008-06-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18541827,2008-06-09T00:00:00,United States,Z01.107.567.875
18545617,2008-06-09T00:00:00,Algorithms,G17.035
18545617,2008-06-09T00:00:00,Algorithms,L01.224.050
18545617,2008-06-09T00:00:00,Materials Testing,E05.570
18545617,2008-06-09T00:00:00,Paper,J01.576.154.600
18545617,2008-06-09T00:00:00,Paper,J01.637.650
18545617,2008-06-09T00:00:00,Sensitivity and Specificity,E05.318.740.872
18545617,2008-06-09T00:00:00,Sensitivity and Specificity,E05.318.780.800
18545617,2008-06-09T00:00:00,Sensitivity and Specificity,G17.800
18545617,2008-06-09T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18545617,2008-06-09T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18545617,2008-06-09T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18545617,2008-06-09T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18545617,2008-06-09T00:00:00,Water,D01.455.900
18545617,2008-06-09T00:00:00,Water,D01.650.550.925
18547394,2008-06-10T00:00:00,Ceramides,D02.065.313
18547394,2008-06-10T00:00:00,Ceramides,D09.400.410.420.525.200
18547394,2008-06-10T00:00:00,Ceramides,D10.390.470.675.200
18547394,2008-06-10T00:00:00,Ceramides,D10.570.877.360.612.200
18547394,2008-06-10T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
18547394,2008-06-10T00:00:00,Gene Expression,G05.355.310
18547394,2008-06-10T00:00:00,"Genes, Plant",G05.360.340.024.340.393
18547394,2008-06-10T00:00:00,"Genes, Plant",G05.360.340.365.500
18547394,2008-06-10T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
18547394,2008-06-10T00:00:00,Phylogeny,G05.697
18547394,2008-06-10T00:00:00,Phylogeny,G16.100.275.605
18547394,2008-06-10T00:00:00,Phylogeny,L01.100.697
18547394,2008-06-10T00:00:00,Plant Proteins,D12.776.765
18547394,2008-06-10T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
18547394,2008-06-10T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
18547394,2008-06-10T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
18547394,2008-06-10T00:00:00,Sphingolipids,D10.570.877
18547394,2008-06-10T00:00:00,Sphingolipids,D10.808
18547394,2008-06-10T00:00:00,Substrate Specificity,G02.111.835
18602645,2008-06-10T00:00:00,Bacterial Proteins,D12.776.097
18602645,2008-06-10T00:00:00,Binding Sites,G02.111.570.120
18602645,2008-06-10T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
18602645,2008-06-10T00:00:00,Escherichia coli,B03.440.450.425.325.300
18602645,2008-06-10T00:00:00,Escherichia coli,B03.660.250.150.180.100
18602645,2008-06-10T00:00:00,"Models, Biological",E05.599.395
18602645,2008-06-10T00:00:00,"Models, Molecular",E05.599.595
18602645,2008-06-10T00:00:00,Molecular Structure,G02.111.570
18602645,2008-06-10T00:00:00,Molecular Structure,G02.575
18602645,2008-06-10T00:00:00,Molecular Structure,G02.842.575
18602645,2008-06-10T00:00:00,Penicillin-Binding Proteins,D08.811.710
18602645,2008-06-10T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
18602645,2008-06-10T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
18602645,2008-06-10T00:00:00,Substrate Specificity,G02.111.835
18546049,2008-06-11T00:00:00,Aged,M01.060.116.100
18546049,2008-06-11T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
18546049,2008-06-11T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
18546049,2008-06-11T00:00:00,Disease-Free Survival,E01.789.200
18546049,2008-06-11T00:00:00,Disease-Free Survival,E05.318.740.998.300
18546049,2008-06-11T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18546049,2008-06-11T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18546049,2008-06-11T00:00:00,Drug Delivery Systems,E02.319.300
18546049,2008-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18546049,2008-06-11T00:00:00,Middle Aged,M01.060.116.630
18546049,2008-06-11T00:00:00,Piperazines,D03.383.606
18546049,2008-06-11T00:00:00,Probability,E05.318.740.600
18546049,2008-06-11T00:00:00,Probability,G17.680
18546049,2008-06-11T00:00:00,Probability,N05.715.360.750.625
18546049,2008-06-11T00:00:00,Probability,N06.850.520.830.600
18546049,2008-06-11T00:00:00,Pyrimidines,D03.383.742
18546049,2008-06-11T00:00:00,Risk Assessment,E05.318.740.600.800.715
18546049,2008-06-11T00:00:00,Risk Assessment,N04.452.871.715
18546049,2008-06-11T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18546049,2008-06-11T00:00:00,Risk Assessment,N06.850.505.715
18546049,2008-06-11T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18546049,2008-06-11T00:00:00,Treatment Outcome,E01.789.800
18546049,2008-06-11T00:00:00,Treatment Outcome,N04.761.559.590.800
18546049,2008-06-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18550115,2008-06-11T00:00:00,"History, 19th Century",K01.400.504.937
18550115,2008-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18550115,2008-06-11T00:00:00,"Schools, Medical",I02.783.660.552
18550115,2008-06-11T00:00:00,"Schools, Medical",N02.278.020.578
18550115,2008-06-11T00:00:00,South Carolina,Z01.107.567.875.075.662
18550115,2008-06-11T00:00:00,South Carolina,Z01.107.567.875.750.700
18550115,2008-06-11T00:00:00,Urology,H02.403.810.860
18550555,2008-06-11T00:00:00,Aged,M01.060.116.100
18550555,2008-06-11T00:00:00,Case-Control Studies,E05.318.760.500.500
18550555,2008-06-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18550555,2008-06-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18550555,2008-06-11T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18550555,2008-06-11T00:00:00,Coronary Angiography,E01.370.370.050.200
18550555,2008-06-11T00:00:00,Coronary Angiography,E01.370.370.380.200
18550555,2008-06-11T00:00:00,Coronary Artery Disease,C14.280.647.250.260
18550555,2008-06-11T00:00:00,Coronary Artery Disease,C14.907.137.126.339
18550555,2008-06-11T00:00:00,Coronary Artery Disease,C14.907.585.250.260
18550555,2008-06-11T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
18550555,2008-06-11T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
18550555,2008-06-11T00:00:00,Drug-Eluting Stents,E07.695.750.500
18550555,2008-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18550555,2008-06-11T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18550555,2008-06-11T00:00:00,Treatment Outcome,E01.789.800
18550555,2008-06-11T00:00:00,Treatment Outcome,N04.761.559.590.800
18550555,2008-06-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18550555,2008-06-11T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
18550444,2008-06-12T00:00:00,Affect,F01.470.047
18550444,2008-06-12T00:00:00,Aged,M01.060.116.100
18550444,2008-06-12T00:00:00,Attention,F02.830.104.214
18550444,2008-06-12T00:00:00,Awareness,F02.463.188.150
18550444,2008-06-12T00:00:00,Chronic Disease,C23.550.291.500
18550444,2008-06-12T00:00:00,Complementary Therapies,E02.190
18550444,2008-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18550444,2008-06-12T00:00:00,Low Back Pain,C10.597.617.152.400
18550444,2008-06-12T00:00:00,Low Back Pain,C23.888.592.612.107.400
18550444,2008-06-12T00:00:00,Low Back Pain,C23.888.646.172.500
18550444,2008-06-12T00:00:00,Meditation,E02.190.525.374
18550444,2008-06-12T00:00:00,Meditation,E02.190.901.455
18550444,2008-06-12T00:00:00,Meditation,F04.754.137.750.500
18550444,2008-06-12T00:00:00,Pain Measurement,E01.370.376.550.600
18550444,2008-06-12T00:00:00,Quality of Life,I01.800
18550444,2008-06-12T00:00:00,Quality of Life,K01.752.400.750
18550444,2008-06-12T00:00:00,Questionnaires,E05.318.308.750
18550444,2008-06-12T00:00:00,Questionnaires,L01.280.800
18550444,2008-06-12T00:00:00,Questionnaires,N05.715.360.300.695
18550444,2008-06-12T00:00:00,Questionnaires,N06.850.520.308.750
18550444,2008-06-12T00:00:00,Sleep,F02.830.855
18550444,2008-06-12T00:00:00,Sleep,G11.561.600.815
18550444,2008-06-12T00:00:00,"Stress, Psychological",F01.145.126.990
18550444,2008-06-12T00:00:00,"Stress, Psychological",F02.830.900
18550444,2008-06-12T00:00:00,Treatment Outcome,E01.789.800
18550444,2008-06-12T00:00:00,Treatment Outcome,N04.761.559.590.800
18550444,2008-06-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18556587,2008-06-12T00:00:00,Aged,M01.060.116.100
18556587,2008-06-12T00:00:00,Brain Ischemia,C10.228.140.300.150
18556587,2008-06-12T00:00:00,Brain Ischemia,C14.907.253.092
18556587,2008-06-12T00:00:00,Emergency Medical Services,N02.421.297
18556587,2008-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18556587,2008-06-12T00:00:00,Middle Aged,M01.060.116.630
18556587,2008-06-12T00:00:00,Movement,G07.700.560
18556587,2008-06-12T00:00:00,Movement,G11.427.590.530
18556587,2008-06-12T00:00:00,Muscle Contraction,G11.427.590.540
18556587,2008-06-12T00:00:00,Neurologic Examination,E01.370.376.550
18556587,2008-06-12T00:00:00,Neurologic Examination,E01.370.600.550
18556587,2008-06-12T00:00:00,Sensitivity and Specificity,E05.318.740.872
18556587,2008-06-12T00:00:00,Sensitivity and Specificity,E05.318.780.800
18556587,2008-06-12T00:00:00,Sensitivity and Specificity,G17.800
18556587,2008-06-12T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18556587,2008-06-12T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18556587,2008-06-12T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18556587,2008-06-12T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18556587,2008-06-12T00:00:00,Stroke,C10.228.140.300.775
18556587,2008-06-12T00:00:00,Stroke,C14.907.253.855
18602522,2008-06-12T00:00:00,Aged,M01.060.116.100
18602522,2008-06-12T00:00:00,Exercise Test,E01.370.370.380.250
18602522,2008-06-12T00:00:00,Exercise Test,E01.370.386.700.250
18602522,2008-06-12T00:00:00,Exercise Test,E05.333.250
18602522,2008-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18602522,2008-06-12T00:00:00,Middle Aged,M01.060.116.630
18602522,2008-06-12T00:00:00,Oxygen Consumption,G03.730
18602522,2008-06-12T00:00:00,Stroke Volume,E01.370.370.380.150.700
18602522,2008-06-12T00:00:00,Stroke Volume,G09.330.380.124.882
19302964,2008-06-12T00:00:00,Adult,M01.060.116
19302964,2008-06-12T00:00:00,Gingival Diseases,C07.465.714.258
19302964,2008-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19302964,2008-06-12T00:00:00,Inflammation,C23.550.470
18555656,2008-06-13T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
18555656,2008-06-13T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
18555656,2008-06-13T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
18555656,2008-06-13T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
18555656,2008-06-13T00:00:00,Hemorrhage,C23.550.414
18555656,2008-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18555656,2008-06-13T00:00:00,Postoperative Complications,C23.550.767
18555656,2008-06-13T00:00:00,Venous Thromboembolism,C14.907.355.590.700
18555656,2008-06-13T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
18555656,2008-06-13T00:00:00,Warfarin,D03.438.150.446.520.914
18555656,2008-06-13T00:00:00,Warfarin,D03.830.219.446.520.914
18553907,2008-06-14T00:00:00,Antioxidants,D27.505.519.217
18553907,2008-06-14T00:00:00,Antioxidants,D27.505.696.706.125
18553907,2008-06-14T00:00:00,Antioxidants,D27.720.799.047
18553907,2008-06-14T00:00:00,DNA Damage,C21.111
18553907,2008-06-14T00:00:00,DNA Damage,G05.355.180
18553907,2008-06-14T00:00:00,Hydrogen Bonding,G02.149.767.620
18553907,2008-06-14T00:00:00,Hydrogen Bonding,G02.842.750.620
18553907,2008-06-14T00:00:00,Iron,D01.268.556.412
18553907,2008-06-14T00:00:00,Iron,D01.268.956.287
18553907,2008-06-14T00:00:00,Iron,D01.552.544.412
18553907,2008-06-14T00:00:00,Molecular Structure,G02.111.570
18553907,2008-06-14T00:00:00,Molecular Structure,G02.575
18553907,2008-06-14T00:00:00,Molecular Structure,G02.842.575
18183633,2008-06-15T00:00:00,Animals,B01.050
18183633,2008-06-15T00:00:00,Anti-Infective Agents,D27.505.954.122
18183633,2008-06-15T00:00:00,Drug Delivery Systems,E02.319.300
18183633,2008-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18183633,2008-06-15T00:00:00,Molecular Weight,G02.842.580
18183633,2008-06-15T00:00:00,Muramidase,D08.811.277.450.642
18183633,2008-06-15T00:00:00,Nanoparticles,J01.637.512.600
18183633,2008-06-15T00:00:00,Polyethylene Glycols,D02.033.455.250.700
18183633,2008-06-15T00:00:00,Polyethylene Glycols,D05.750.741
18183633,2008-06-15T00:00:00,Polyethylene Glycols,D25.720.741
18183633,2008-06-15T00:00:00,Polyethylene Glycols,J01.637.051.720.741
18183633,2008-06-15T00:00:00,Proteins,D12.776
18183633,2008-06-15T00:00:00,Static Electricity,G01.201.249.820
18605550,2008-06-15T00:00:00,California,Z01.107.567.875.580.200
18605550,2008-06-15T00:00:00,California,Z01.107.567.875.760.200
18605550,2008-06-15T00:00:00,Environmental Pollutants,D27.888.284
18605550,2008-06-15T00:00:00,Trichloroethylene,D02.455.526.439.939
18698392,2008-06-15T00:00:00,Biomedical Research,H01.770.644.145
18698392,2008-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18698392,2008-06-15T00:00:00,Periodicals as Topic,L01.178.682.829.678
18698392,2008-06-15T00:00:00,Professional Competence,I02.399.630
18558437,2008-06-16T00:00:00,Adult,M01.060.116
18558437,2008-06-16T00:00:00,Depression,F01.145.126.350
18558437,2008-06-16T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18558437,2008-06-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18558437,2008-06-16T00:00:00,Panic Disorder,F03.080.700
18558437,2008-06-16T00:00:00,Prevalence,E05.318.308.985.525.750
18558437,2008-06-16T00:00:00,Prevalence,L01.280.975.525.750
18558437,2008-06-16T00:00:00,Prevalence,N01.224.935.597.750
18558437,2008-06-16T00:00:00,Prevalence,N06.850.505.400.975.525.750
18558437,2008-06-16T00:00:00,Prevalence,N06.850.520.308.985.525.750
18558437,2008-06-16T00:00:00,Psychiatric Status Rating Scales,F04.586
18558437,2008-06-16T00:00:00,Questionnaires,E05.318.308.750
18558437,2008-06-16T00:00:00,Questionnaires,L01.280.800
18558437,2008-06-16T00:00:00,Questionnaires,N05.715.360.300.695
18558437,2008-06-16T00:00:00,Questionnaires,N06.850.520.308.750
18558437,2008-06-16T00:00:00,Risk Factors,E05.318.740.600.800.725
18558437,2008-06-16T00:00:00,Risk Factors,N05.715.350.200.700
18558437,2008-06-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18558437,2008-06-16T00:00:00,Risk Factors,N06.850.490.625.750
18558437,2008-06-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18558437,2008-06-16T00:00:00,Sleep Disorders,C10.886
18558437,2008-06-16T00:00:00,Sleep Disorders,C23.888.592.796
18558437,2008-06-16T00:00:00,Sleep Disorders,F03.870
18558437,2008-06-16T00:00:00,Sleep Initiation and Maintenance Disorders,C10.886.425.800.800
18558437,2008-06-16T00:00:00,Sleep Initiation and Maintenance Disorders,F03.870.400.800.800
19027513,2008-06-16T00:00:00,Adult,M01.060.116
19027513,2008-06-16T00:00:00,"Blood Loss, Surgical",C23.550.414.300
19027513,2008-06-16T00:00:00,"Blood Loss, Surgical",C23.550.505.300
19027513,2008-06-16T00:00:00,Endoscopy,E01.370.388.250
19027513,2008-06-16T00:00:00,Endoscopy,E04.800.250
19027513,2008-06-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19027513,2008-06-16T00:00:00,Middle Aged,M01.060.116.630
19027513,2008-06-16T00:00:00,Patient Satisfaction,N04.452.822.360.600
19027513,2008-06-16T00:00:00,Patient Satisfaction,N05.300.150.600.630
19027513,2008-06-16T00:00:00,Patient Satisfaction,N05.715.360.600
19027513,2008-06-16T00:00:00,Risk Assessment,E05.318.740.600.800.715
19027513,2008-06-16T00:00:00,Risk Assessment,N04.452.871.715
19027513,2008-06-16T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19027513,2008-06-16T00:00:00,Risk Assessment,N06.850.505.715
19027513,2008-06-16T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19027513,2008-06-16T00:00:00,Sensitivity and Specificity,E05.318.740.872
19027513,2008-06-16T00:00:00,Sensitivity and Specificity,E05.318.780.800
19027513,2008-06-16T00:00:00,Sensitivity and Specificity,G17.800
19027513,2008-06-16T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19027513,2008-06-16T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19027513,2008-06-16T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19027513,2008-06-16T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19027513,2008-06-16T00:00:00,Thrombin,D08.811.277.656.300.760.855
19027513,2008-06-16T00:00:00,Thrombin,D08.811.277.656.959.350.855
19027513,2008-06-16T00:00:00,Thrombin,D12.776.124.125.890
19027513,2008-06-16T00:00:00,Thrombin,D23.119.960
19027513,2008-06-16T00:00:00,Treatment Outcome,E01.789.800
19027513,2008-06-16T00:00:00,Treatment Outcome,N04.761.559.590.800
19027513,2008-06-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18560212,2008-06-17T00:00:00,Animals,B01.050
18560212,2008-06-17T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18560212,2008-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18560212,2008-06-17T00:00:00,Hypertension,C14.907.489
18560212,2008-06-17T00:00:00,Hypoglycemic Agents,D27.505.696.422
18560212,2008-06-17T00:00:00,Insulin Resistance,C18.452.394.968.500
18560212,2008-06-17T00:00:00,Insulin Resistance,G07.690.320.617
18560212,2008-06-17T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18560212,2008-06-17T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18560212,2008-06-17T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
18560212,2008-06-17T00:00:00,Metabolic Syndrome X,C18.452.625
18560212,2008-06-17T00:00:00,Obesity,C18.654.726.500
18560212,2008-06-17T00:00:00,Obesity,C23.888.144.699.500
18560212,2008-06-17T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18560212,2008-06-17T00:00:00,Obesity,G07.100.100.160.120.699.500
18560212,2008-06-17T00:00:00,Renin-Angiotensin System,G03.495.805
18560212,2008-06-17T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
18560212,2008-06-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
18560212,2008-06-17T00:00:00,Risk Assessment,N04.452.871.715
18560212,2008-06-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18560212,2008-06-17T00:00:00,Risk Assessment,N06.850.505.715
18560212,2008-06-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18560212,2008-06-17T00:00:00,Risk Factors,E05.318.740.600.800.725
18560212,2008-06-17T00:00:00,Risk Factors,N05.715.350.200.700
18560212,2008-06-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18560212,2008-06-17T00:00:00,Risk Factors,N06.850.490.625.750
18560212,2008-06-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18560212,2008-06-17T00:00:00,Stroke,C10.228.140.300.775
18560212,2008-06-17T00:00:00,Stroke,C14.907.253.855
18561019,2008-06-17T00:00:00,Adolescent,M01.060.057
18561019,2008-06-17T00:00:00,Adult,M01.060.116
18561019,2008-06-17T00:00:00,Caregivers,M01.085
18561019,2008-06-17T00:00:00,Caregivers,M01.526.485.200
18561019,2008-06-17T00:00:00,Caregivers,N02.360.200
18561019,2008-06-17T00:00:00,Combined Modality Therapy,E02.186
18561019,2008-06-17T00:00:00,Conduct Disorder,F03.550.150.300
18561019,2008-06-17T00:00:00,Evidence-Based Medicine,H02.249.750
18561019,2008-06-17T00:00:00,Evidence-Based Medicine,H02.403.200.400
18561019,2008-06-17T00:00:00,Health Personnel,M01.526.485
18561019,2008-06-17T00:00:00,Health Personnel,N02.360
18561019,2008-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18562151,2008-06-17T00:00:00,Animals,B01.050
18562151,2008-06-17T00:00:00,"Animals, Newborn",B01.050.050.282
18562151,2008-06-17T00:00:00,Cell Line,A11.251.210
18562151,2008-06-17T00:00:00,Ethanol,D02.033.375
18562151,2008-06-17T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18562151,2008-06-17T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18562151,2008-06-17T00:00:00,Glutamic Acid,D12.125.067.750
18562151,2008-06-17T00:00:00,Glutamic Acid,D12.125.119.450
18562151,2008-06-17T00:00:00,Glutamic Acid,D12.125.427.300
18562151,2008-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18562151,2008-06-17T00:00:00,Neurons,A08.663
18562151,2008-06-17T00:00:00,Neurons,A11.671
18562151,2008-06-17T00:00:00,Patch-Clamp Techniques,E05.200.500.800
18562151,2008-06-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18562151,2008-06-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18562151,2008-06-17T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18562151,2008-06-17T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
18562151,2008-06-17T00:00:00,Recombinant Proteins,D12.776.828
18563509,2008-06-18T00:00:00,Anticoagulants,D27.505.954.502.119
18563509,2008-06-18T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
18563509,2008-06-18T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
18563509,2008-06-18T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
18563509,2008-06-18T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
18563509,2008-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18563509,2008-06-18T00:00:00,Polysaccharides,D09.698
18563509,2008-06-18T00:00:00,Pulmonary Embolism,C08.381.746
18563509,2008-06-18T00:00:00,Pulmonary Embolism,C14.907.355.350.700
18563509,2008-06-18T00:00:00,Research Design,E05.581.500
18563509,2008-06-18T00:00:00,Research Design,H01.770.644.728
18563509,2008-06-18T00:00:00,Thiophenes,D02.886.778
18563509,2008-06-18T00:00:00,Thiophenes,D03.383.903
18563509,2008-06-18T00:00:00,Venous Thrombosis,C14.907.355.830.925
18721524,2008-06-18T00:00:00,Adult,M01.060.116
18721524,2008-06-18T00:00:00,Aged,M01.060.116.100
18721524,2008-06-18T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
18721524,2008-06-18T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
18721524,2008-06-18T00:00:00,Ethanol,D02.033.375
18721524,2008-06-18T00:00:00,Heart Septum,A07.541.459
18721524,2008-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18721524,2008-06-18T00:00:00,Middle Aged,M01.060.116.630
18721524,2008-06-18T00:00:00,Solvents,D27.720.844
18721524,2008-06-18T00:00:00,Treatment Outcome,E01.789.800
18721524,2008-06-18T00:00:00,Treatment Outcome,N04.761.559.590.800
18721524,2008-06-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18563917,2008-06-19T00:00:00,Animals,B01.050
18563917,2008-06-19T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18563917,2008-06-19T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
18563917,2008-06-19T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
18563917,2008-06-19T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
18563917,2008-06-19T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
18563917,2008-06-19T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
18563917,2008-06-19T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
18563917,2008-06-19T00:00:00,Retinaldehyde,D02.047.850
18563917,2008-06-19T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
18563917,2008-06-19T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
18563917,2008-06-19T00:00:00,Retinaldehyde,D02.455.849.131.495.690
18563917,2008-06-19T00:00:00,Retinaldehyde,D23.767.261.700.690
18563917,2008-06-19T00:00:00,Rhodopsin,D12.776.543.750.100.955
18563917,2008-06-19T00:00:00,Rhodopsin,D23.767.930.750.500.500
18563917,2008-06-19T00:00:00,Transducin,D08.811.277.040.330.300.200.800
18563917,2008-06-19T00:00:00,Transducin,D12.644.360.375.940
18563917,2008-06-19T00:00:00,Transducin,D12.776.157.325.332.940
18563917,2008-06-19T00:00:00,Transducin,D12.776.476.375.940
18563917,2008-06-19T00:00:00,Transducin,D12.776.543.325.800
18563917,2008-06-19T00:00:00,"Vision, Ocular",F02.830.816.964
18563917,2008-06-19T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
18563917,2008-06-19T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
18563917,2008-06-19T00:00:00,"Vision, Ocular",G04.299.880.480.900
18563917,2008-06-19T00:00:00,"Vision, Ocular",G11.561.600.810.964
18563917,2008-06-19T00:00:00,"Vision, Ocular",G14.640.816
18566340,2008-06-19T00:00:00,Adolescent,M01.060.057
18566340,2008-06-19T00:00:00,Behavior Therapy,F04.754.137
18566340,2008-06-19T00:00:00,Child,M01.060.406
18566340,2008-06-19T00:00:00,Combined Modality Therapy,E02.186
18566340,2008-06-19T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18566340,2008-06-19T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18566340,2008-06-19T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18566340,2008-06-19T00:00:00,Diabetic Ketoacidosis,C18.452.076.176.390
18566340,2008-06-19T00:00:00,Diabetic Ketoacidosis,C18.452.394.750.535
18566340,2008-06-19T00:00:00,Diabetic Ketoacidosis,C19.246.099.812
18566340,2008-06-19T00:00:00,Hospitalization,E02.760.400
18566340,2008-06-19T00:00:00,Hospitalization,N02.421.585.400
18566340,2008-06-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18566340,2008-06-19T00:00:00,Hypoglycemic Agents,D27.505.696.422
18566340,2008-06-19T00:00:00,Insulin,D06.472.699.587.740.625
18566340,2008-06-19T00:00:00,Insulin,D12.644.548.586.740.625
18566340,2008-06-19T00:00:00,Parents,F01.829.263.500.320
18566340,2008-06-19T00:00:00,Parents,I01.880.225.500.340
18566340,2008-06-19T00:00:00,Parents,M01.620
18566340,2008-06-19T00:00:00,Treatment Outcome,E01.789.800
18566340,2008-06-19T00:00:00,Treatment Outcome,N04.761.559.590.800
18566340,2008-06-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18566450,2008-06-19T00:00:00,Animals,B01.050
18566450,2008-06-19T00:00:00,Carrier Proteins,D12.776.157
18566450,2008-06-19T00:00:00,Cell Membrane,A11.284.149
18566450,2008-06-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18566450,2008-06-19T00:00:00,Membrane Proteins,D12.776.543
18566450,2008-06-19T00:00:00,Protein Transport,G03.495.166.700
18566450,2008-06-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18468795,2008-06-20T00:00:00,Animals,B01.050
18468795,2008-06-20T00:00:00,Apoptosis,G04.299.139.160
18468795,2008-06-20T00:00:00,Astrocytes,A08.637.200
18468795,2008-06-20T00:00:00,Astrocytes,A11.650.200
18468795,2008-06-20T00:00:00,Nerve Regeneration,G11.561.600.615
18468795,2008-06-20T00:00:00,Nerve Regeneration,G16.100.856.611
18468795,2008-06-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18468795,2008-06-20T00:00:00,Spinal Cord,A08.186.854
18468795,2008-06-20T00:00:00,Spinal Cord Injuries,C10.228.854.770
18468795,2008-06-20T00:00:00,Spinal Cord Injuries,C10.900.850
18468795,2008-06-20T00:00:00,Spinal Cord Injuries,C21.866.819
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18468795,2008-06-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18468795,2008-06-20T00:00:00,Wound Healing,G16.100.856.891
18565488,2008-06-20T00:00:00,Adenocarcinoma,C04.557.470.200.025
18565488,2008-06-20T00:00:00,Adult,M01.060.116
18565488,2008-06-20T00:00:00,African Americans,M01.686.508.100.100
18565488,2008-06-20T00:00:00,African Americans,M01.686.754.100
18565488,2008-06-20T00:00:00,Body Weight,C23.888.144
18565488,2008-06-20T00:00:00,Body Weight,E01.370.600.115.100.160.120
18565488,2008-06-20T00:00:00,Body Weight,E05.041.124.160.750
18565488,2008-06-20T00:00:00,Body Weight,G07.100.100.160.120
18565488,2008-06-20T00:00:00,Body Weight,G07.700.320.249.314.120
18565488,2008-06-20T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18565488,2008-06-20T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18565488,2008-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18565488,2008-06-20T00:00:00,Hypertension,C14.907.489
18565488,2008-06-20T00:00:00,Hysterectomy,E04.950.300.399
18565488,2008-06-20T00:00:00,Middle Aged,M01.060.116.630
18565488,2008-06-20T00:00:00,Neoplasm Invasiveness,C04.697.645
18565488,2008-06-20T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18565488,2008-06-20T00:00:00,Stromal Cells,A11.329.830
18565488,2008-06-20T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
18565488,2008-06-20T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
18565488,2008-06-20T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
18565488,2008-06-20T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
18565885,2008-06-20T00:00:00,Adult,M01.060.116
18565885,2008-06-20T00:00:00,Aged,M01.060.116.100
18565885,2008-06-20T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18565885,2008-06-20T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18565885,2008-06-20T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18565885,2008-06-20T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18565885,2008-06-20T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18565885,2008-06-20T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18565885,2008-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18565885,2008-06-20T00:00:00,Middle Aged,M01.060.116.630
18565885,2008-06-20T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18565885,2008-06-20T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18565885,2008-06-20T00:00:00,Vitamin D,D04.808.812.768
18566905,2008-06-20T00:00:00,Chemical Fractionation,E05.196.155
18566905,2008-06-20T00:00:00,Disinfection,N06.850.780.200.450.850.375
18566905,2008-06-20T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18566905,2008-06-20T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
18566905,2008-06-20T00:00:00,Water Purification,N06.850.860.510.900.900
18566905,2008-06-20T00:00:00,Water Purification,N06.850.860.510.915.900
18567620,2008-06-20T00:00:00,Animals,B01.050
18567620,2008-06-20T00:00:00,Antioxidants,D27.505.519.217
18567620,2008-06-20T00:00:00,Antioxidants,D27.505.696.706.125
18567620,2008-06-20T00:00:00,Antioxidants,D27.720.799.047
18567620,2008-06-20T00:00:00,Apoptosis,G04.299.139.160
18567620,2008-06-20T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18567620,2008-06-20T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18567620,2008-06-20T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18567620,2008-06-20T00:00:00,Colitis,C06.405.205.265
18567620,2008-06-20T00:00:00,Colitis,C06.405.469.158.188
18567620,2008-06-20T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18567620,2008-06-20T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18567620,2008-06-20T00:00:00,Flow Cytometry,E05.200.500.386.350
18567620,2008-06-20T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
18567620,2008-06-20T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
18567620,2008-06-20T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
18567620,2008-06-20T00:00:00,Inflammation,C23.550.470
18567620,2008-06-20T00:00:00,Macrophages,A11.329.372
18567620,2008-06-20T00:00:00,Macrophages,A11.627.482
18567620,2008-06-20T00:00:00,Macrophages,A11.733.397
18567620,2008-06-20T00:00:00,Macrophages,A15.382.680.397
18567620,2008-06-20T00:00:00,Macrophages,A15.382.812.522
18567620,2008-06-20T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
18567620,2008-06-20T00:00:00,Plant Extracts,D20.215.784.500
18567620,2008-06-20T00:00:00,Plant Extracts,D26.667
18567620,2008-06-20T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
18567620,2008-06-20T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
18567620,2008-06-20T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
18571356,2008-06-20T00:00:00,Adolescent,M01.060.057
18571356,2008-06-20T00:00:00,Adult,M01.060.116
18571356,2008-06-20T00:00:00,Aged,M01.060.116.100
18571356,2008-06-20T00:00:00,"Diagnosis, Differential",E01.171
18571356,2008-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18571356,2008-06-20T00:00:00,Middle Aged,M01.060.116.630
18571356,2008-06-20T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
18571356,2008-06-20T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
18571356,2008-06-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18571356,2008-06-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18571356,2008-06-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18571356,2008-06-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18571356,2008-06-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18571356,2008-06-20T00:00:00,Young Adult,M01.060.116.815
18601915,2008-06-20T00:00:00,Actins,D05.750.078.730.250
18601915,2008-06-20T00:00:00,Actins,D12.776.210.500.100
18601915,2008-06-20T00:00:00,Actins,D12.776.220.525.255
18601915,2008-06-20T00:00:00,Animals,B01.050
18601915,2008-06-20T00:00:00,Cell Adhesion,G04.299.117
18601915,2008-06-20T00:00:00,Cell Differentiation,G04.299.151
18601915,2008-06-20T00:00:00,Chick Embryo,A13.350.150
18601915,2008-06-20T00:00:00,Chick Embryo,A16.331.200
18601915,2008-06-20T00:00:00,Extremities,A01.378
18601915,2008-06-20T00:00:00,Fibroblast Growth Factor 8,D12.644.276.624.180
18601915,2008-06-20T00:00:00,Fibroblast Growth Factor 8,D12.776.467.624.180
18601915,2008-06-20T00:00:00,Fibroblast Growth Factor 8,D23.529.624.180
18601915,2008-06-20T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
18601915,2008-06-20T00:00:00,Mesoderm,A16.504.660
18601915,2008-06-20T00:00:00,Phenotype,G05.695
18675460,2008-06-20T00:00:00,Antioxidants,D27.505.519.217
18675460,2008-06-20T00:00:00,Antioxidants,D27.505.696.706.125
18675460,2008-06-20T00:00:00,Antioxidants,D27.720.799.047
18675460,2008-06-20T00:00:00,Copper,D01.268.556.195
18675460,2008-06-20T00:00:00,Copper,D01.268.956.170
18675460,2008-06-20T00:00:00,Copper,D01.552.544.195
18675460,2008-06-20T00:00:00,DNA Damage,C21.111
18675460,2008-06-20T00:00:00,DNA Damage,G05.355.180
18675460,2008-06-20T00:00:00,Glutathione,D12.644.456.448
18675460,2008-06-20T00:00:00,Iron,D01.268.556.412
18675460,2008-06-20T00:00:00,Iron,D01.268.956.287
18675460,2008-06-20T00:00:00,Iron,D01.552.544.412
18675460,2008-06-20T00:00:00,Sulfur,D01.268.185.900
18602901,2008-06-21T00:00:00,Antineoplastic Agents,D27.505.954.248
18602901,2008-06-21T00:00:00,Apoptosis,G04.299.139.160
18602901,2008-06-21T00:00:00,Astrocytes,A08.637.200
18602901,2008-06-21T00:00:00,Astrocytes,A11.650.200
18602901,2008-06-21T00:00:00,Brain Neoplasms,C04.588.614.250.195
18602901,2008-06-21T00:00:00,Brain Neoplasms,C10.228.140.211
18602901,2008-06-21T00:00:00,Brain Neoplasms,C10.551.240.250
18602901,2008-06-21T00:00:00,Calpain,D08.811.277.656.262.500.120
18602901,2008-06-21T00:00:00,Calpain,D08.811.277.656.300.200.120
18602901,2008-06-21T00:00:00,Cell Differentiation,G04.299.151
18602901,2008-06-21T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
18602901,2008-06-21T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
18602901,2008-06-21T00:00:00,Fenretinide,D02.455.849.131.495.270
18602901,2008-06-21T00:00:00,Fenretinide,D23.767.261.700.270
18602901,2008-06-21T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
18602901,2008-06-21T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
18602901,2008-06-21T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
18602901,2008-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18602901,2008-06-21T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18602901,2008-06-21T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18602901,2008-06-21T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18602901,2008-06-21T00:00:00,Mitochondria,A11.284.835.626
18602901,2008-06-21T00:00:00,Mitochondrial Proteins,D12.776.575
18602901,2008-06-21T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
18602901,2008-06-21T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
18602901,2008-06-21T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
18602901,2008-06-21T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
18602901,2008-06-21T00:00:00,Telomerase,D12.776.157.725.500.921
18602901,2008-06-21T00:00:00,Telomerase,D12.776.664.962.500.921
18602901,2008-06-21T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
18602901,2008-06-21T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
18602885,2008-06-24T00:00:00,Animals,B01.050
18602885,2008-06-24T00:00:00,Cytokines,D12.644.276.374
18602885,2008-06-24T00:00:00,Cytokines,D12.776.467.374
18602885,2008-06-24T00:00:00,Cytokines,D23.529.374
18602885,2008-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
18602885,2008-06-24T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
18602885,2008-06-24T00:00:00,Liver,A03.620
18602885,2008-06-24T00:00:00,Peroxisomes,A11.284.430.214.190.500.585.600
18602885,2008-06-24T00:00:00,Peroxisomes,A11.284.430.214.190.875.190.190.755.600
18602885,2008-06-24T00:00:00,Psychosine,D02.033.100.700.700
18602885,2008-06-24T00:00:00,Psychosine,D02.092.063.700.700
18602885,2008-06-24T00:00:00,Psychosine,D09.400.410.420.806
18602885,2008-06-24T00:00:00,Psychosine,D10.390.470.806
18602885,2008-06-24T00:00:00,Psychosine,D10.570.877.360.806
18653310,2008-06-24T00:00:00,Adolescent,M01.060.057
18653310,2008-06-24T00:00:00,Anxiety Disorders,F03.080
18653310,2008-06-24T00:00:00,Child,M01.060.406
18653310,2008-06-24T00:00:00,Cognitive Therapy,F04.754.137.428
18653310,2008-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18575910,2008-06-25T00:00:00,Aortic Diseases,C14.907.109
18575910,2008-06-25T00:00:00,Hematoma,C23.550.414.838
18575910,2008-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18575910,2008-06-25T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18575910,2008-06-25T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18575910,2008-06-25T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18575910,2008-06-25T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18575910,2008-06-25T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18575910,2008-06-25T00:00:00,Ulcer,C23.550.891
18579687,2008-06-25T00:00:00,Breast Neoplasms,C04.588.180
18579687,2008-06-25T00:00:00,Breast Neoplasms,C17.800.090.500
18579687,2008-06-25T00:00:00,Cell Movement,G04.299.283
18579687,2008-06-25T00:00:00,Cell Movement,G07.700.560.500.180
18579687,2008-06-25T00:00:00,Gene Expression Profiling,E05.393.332
18579687,2008-06-25T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18579687,2008-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18579687,2008-06-25T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
18579687,2008-06-25T00:00:00,"Microscopy, Fluorescence",E05.595.458
18579687,2008-06-25T00:00:00,"Models, Biological",E05.599.395
18579687,2008-06-25T00:00:00,Neoplasm Invasiveness,C04.697.645
18579687,2008-06-25T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18579687,2008-06-25T00:00:00,Neoplasms,C04
18579687,2008-06-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18579687,2008-06-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18579687,2008-06-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18579687,2008-06-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18579687,2008-06-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18579687,2008-06-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18579687,2008-06-25T00:00:00,Phenotype,G05.695
18579687,2008-06-25T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
18579687,2008-06-25T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
18579687,2008-06-25T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
18582900,2008-06-25T00:00:00,Adult,M01.060.116
18582900,2008-06-25T00:00:00,Aged,M01.060.116.100
18582900,2008-06-25T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
18582900,2008-06-25T00:00:00,Bipolar Disorder,F03.600.150.150
18582900,2008-06-25T00:00:00,Brain,A08.186.211
18582900,2008-06-25T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18582900,2008-06-25T00:00:00,Depression,F01.145.126.350
18582900,2008-06-25T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
18582900,2008-06-25T00:00:00,Glucose,D09.546.359.448
18582900,2008-06-25T00:00:00,Gyrus Cinguli,A08.186.211.464.330
18582900,2008-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18582900,2008-06-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18582900,2008-06-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18582900,2008-06-25T00:00:00,Middle Aged,M01.060.116.630
18582900,2008-06-25T00:00:00,Outpatients,M01.643.630
18582900,2008-06-25T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18582900,2008-06-25T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18582900,2008-06-25T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18582900,2008-06-25T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18582900,2008-06-25T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18582900,2008-06-25T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18582900,2008-06-25T00:00:00,Psychiatric Status Rating Scales,F04.586
18582900,2008-06-25T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
18582900,2008-06-25T00:00:00,Young Adult,M01.060.116.815
18578521,2008-06-26T00:00:00,Amino Acid Sequence,G02.111.570.060
18578521,2008-06-26T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18578521,2008-06-26T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
18578521,2008-06-26T00:00:00,Enzymes,D08.811
18578521,2008-06-26T00:00:00,Gene Expression Profiling,E05.393.332
18578521,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18578521,2008-06-26T00:00:00,"Models, Statistical",E05.318.740.500
18578521,2008-06-26T00:00:00,"Models, Statistical",E05.599.835
18578521,2008-06-26T00:00:00,"Models, Statistical",N05.715.360.750.530
18578521,2008-06-26T00:00:00,"Models, Statistical",N06.850.520.830.500
18578521,2008-06-26T00:00:00,Molecular Sequence Data,L01.453.245.667
18578521,2008-06-26T00:00:00,Protein Biosynthesis,G02.111.087.675.871
18578521,2008-06-26T00:00:00,Protein Biosynthesis,G02.149.115.675.871
18578521,2008-06-26T00:00:00,Protein Biosynthesis,G03.495.770.871
18578521,2008-06-26T00:00:00,Protein Biosynthesis,G05.355.310.670
18578521,2008-06-26T00:00:00,Protein Folding,G01.154.100.640
18578521,2008-06-26T00:00:00,Protein Folding,G01.595.100.640
18578521,2008-06-26T00:00:00,Protein Folding,G02.111.087.690
18578521,2008-06-26T00:00:00,Protein Folding,G02.149.115.690
18578521,2008-06-26T00:00:00,Proteins,D12.776
18578521,2008-06-26T00:00:00,"Serum Albumin, Bovine",D12.776.034.841.540
18578521,2008-06-26T00:00:00,"Serum Albumin, Bovine",D12.776.124.727.540
18578521,2008-06-26T00:00:00,Software,L01.224.900
18579811,2008-06-26T00:00:00,Adolescent,M01.060.057
18579811,2008-06-26T00:00:00,Adult,M01.060.116
18579811,2008-06-26T00:00:00,Aged,M01.060.116.100
18579811,2008-06-26T00:00:00,Anticoagulants,D27.505.954.502.119
18579811,2008-06-26T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
18579811,2008-06-26T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
18579811,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18579811,2008-06-26T00:00:00,Middle Aged,M01.060.116.630
18579811,2008-06-26T00:00:00,Pulmonary Embolism,C08.381.746
18579811,2008-06-26T00:00:00,Pulmonary Embolism,C14.907.355.350.700
18579811,2008-06-26T00:00:00,Thiophenes,D02.886.778
18579811,2008-06-26T00:00:00,Thiophenes,D03.383.903
18579811,2008-06-26T00:00:00,Venous Thromboembolism,C14.907.355.590.700
18579811,2008-06-26T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
18579811,2008-06-26T00:00:00,Venous Thrombosis,C14.907.355.830.925
18581225,2008-06-26T00:00:00,Adolescent,M01.060.057
18581225,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18581225,2008-06-26T00:00:00,Mental Health Services,F04.408
18581225,2008-06-26T00:00:00,Mental Health Services,N02.421.461
18581225,2008-06-26T00:00:00,School Health Services,N02.421.143.827.809
18581225,2008-06-26T00:00:00,School Health Services,N02.421.726.809
18581225,2008-06-26T00:00:00,Social Support,I01.880.656.600
18583560,2008-06-26T00:00:00,Aged,M01.060.116.100
18583560,2008-06-26T00:00:00,Brain Ischemia,C10.228.140.300.150
18583560,2008-06-26T00:00:00,Brain Ischemia,C14.907.253.092
18583560,2008-06-26T00:00:00,Calcium,D01.268.552.100
18583560,2008-06-26T00:00:00,Calcium,D01.552.539.288
18583560,2008-06-26T00:00:00,Calcium,D23.119.100
18583560,2008-06-26T00:00:00,Disease Progression,C23.550.291.656
18583560,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18583560,2008-06-26T00:00:00,Middle Aged,M01.060.116.630
18583560,2008-06-26T00:00:00,Stroke,C10.228.140.300.775
18583560,2008-06-26T00:00:00,Stroke,C14.907.253.855
18583984,2008-06-26T00:00:00,Adolescent,M01.060.057
18583984,2008-06-26T00:00:00,Alleles,G05.360.340.024.340.030
18583984,2008-06-26T00:00:00,Continental Population Groups,M01.686.508
18583984,2008-06-26T00:00:00,Genetic Variation,G05.365
18583984,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18583984,2008-06-26T00:00:00,Hypertension,C14.907.489
18627775,2008-06-26T00:00:00,Adolescent,M01.060.057
18627775,2008-06-26T00:00:00,Adult,M01.060.116
18627775,2008-06-26T00:00:00,Affect,F01.470.047
18627775,2008-06-26T00:00:00,Blood Pressure,E01.370.600.875.249
18627775,2008-06-26T00:00:00,Blood Pressure,G09.330.380.076
18627775,2008-06-26T00:00:00,"Data Interpretation, Statistical",E05.245.380
18627775,2008-06-26T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18627775,2008-06-26T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18627775,2008-06-26T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18627775,2008-06-26T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18627775,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18627775,2008-06-26T00:00:00,Marijuana Abuse,C21.739.635
18627775,2008-06-26T00:00:00,Marijuana Abuse,F03.900.635
18627775,2008-06-26T00:00:00,Psychomotor Performance,F02.808
18627775,2008-06-26T00:00:00,Psychomotor Performance,G11.427.700
18627775,2008-06-26T00:00:00,Psychomotor Performance,G11.561.623
18721507,2008-06-26T00:00:00,Aged,M01.060.116.100
18721507,2008-06-26T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
18721507,2008-06-26T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
18721507,2008-06-26T00:00:00,"Coated Materials, Biocompatible",D25.130.420
18721507,2008-06-26T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
18721507,2008-06-26T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18721507,2008-06-26T00:00:00,Coronary Angiography,E01.370.370.050.200
18721507,2008-06-26T00:00:00,Coronary Angiography,E01.370.370.380.200
18721507,2008-06-26T00:00:00,"Creatine Kinase, MB Form",D08.811.913.696.640.150.625
18721507,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18721507,2008-06-26T00:00:00,Metals,D01.552
18721507,2008-06-26T00:00:00,Myocardial Infarction,C14.280.647.500
18721507,2008-06-26T00:00:00,Myocardial Infarction,C14.907.585.500
18721507,2008-06-26T00:00:00,Stents,E07.695.750
18721507,2008-06-26T00:00:00,Treatment Outcome,E01.789.800
18721507,2008-06-26T00:00:00,Treatment Outcome,N04.761.559.590.800
18721507,2008-06-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18721508,2008-06-26T00:00:00,Aged,M01.060.116.100
18721508,2008-06-26T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18721508,2008-06-26T00:00:00,Coronary Angiography,E01.370.370.050.200
18721508,2008-06-26T00:00:00,Coronary Angiography,E01.370.370.380.200
18721508,2008-06-26T00:00:00,Coronary Disease,C14.280.647.250
18721508,2008-06-26T00:00:00,Coronary Disease,C14.907.585.250
18721508,2008-06-26T00:00:00,Creatine,D02.078.370.280
18721508,2008-06-26T00:00:00,Creatine,D12.125.373
18721508,2008-06-26T00:00:00,Disease Progression,C23.550.291.656
18721508,2008-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18721508,2008-06-26T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
18721508,2008-06-26T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
18721508,2008-06-26T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
18721508,2008-06-26T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
18721508,2008-06-26T00:00:00,Middle Aged,M01.060.116.630
18721508,2008-06-26T00:00:00,Renal Dialysis,E02.870.300
18721508,2008-06-26T00:00:00,Renal Dialysis,E02.912.800
18721508,2008-06-26T00:00:00,Thrombolytic Therapy,E02.319.913
18721508,2008-06-26T00:00:00,Treatment Outcome,E01.789.800
18721508,2008-06-26T00:00:00,Treatment Outcome,N04.761.559.590.800
18721508,2008-06-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18585962,2008-06-27T00:00:00,Adolescent,M01.060.057
18585962,2008-06-27T00:00:00,Adult,M01.060.116
18585962,2008-06-27T00:00:00,Aged,M01.060.116.100
18585962,2008-06-27T00:00:00,Epilepsy,C10.228.140.490
18585962,2008-06-27T00:00:00,Health Behavior,F01.145.488
18585962,2008-06-27T00:00:00,Health Services Accessibility,N04.590.374.350
18585962,2008-06-27T00:00:00,Health Services Accessibility,N05.300.430
18585962,2008-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18585962,2008-06-27T00:00:00,Middle Aged,M01.060.116.630
18585962,2008-06-27T00:00:00,Prevalence,E05.318.308.985.525.750
18585962,2008-06-27T00:00:00,Prevalence,L01.280.975.525.750
18585962,2008-06-27T00:00:00,Prevalence,N01.224.935.597.750
18585962,2008-06-27T00:00:00,Prevalence,N06.850.505.400.975.525.750
18585962,2008-06-27T00:00:00,Prevalence,N06.850.520.308.985.525.750
18585962,2008-06-27T00:00:00,Quality of Life,I01.800
18585962,2008-06-27T00:00:00,Quality of Life,K01.752.400.750
18585962,2008-06-27T00:00:00,Self Concept,F01.752.747.792
18585962,2008-06-27T00:00:00,South Carolina,Z01.107.567.875.075.662
18585962,2008-06-27T00:00:00,South Carolina,Z01.107.567.875.750.700
18585962,2008-06-27T00:00:00,Young Adult,M01.060.116.815
18585975,2008-06-27T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
18585975,2008-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18612371,2008-06-27T00:00:00,Animals,B01.050
18612371,2008-06-27T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
18612371,2008-06-27T00:00:00,Integrins,D12.776.543.750.705.408
18612371,2008-06-27T00:00:00,"Models, Biological",E05.599.395
18612371,2008-06-27T00:00:00,Myocardium,A02.633.580
18612371,2008-06-27T00:00:00,Myocardium,A07.541.704
18612371,2008-06-27T00:00:00,Myocardium,A10.690.552.750
18612371,2008-06-27T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18612371,2008-06-27T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18612371,2008-06-27T00:00:00,"Myocytes, Cardiac",A11.620.500
18612371,2008-06-27T00:00:00,Pressure,G01.374.715
18612371,2008-06-27T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
18612371,2008-06-27T00:00:00,Signal Transduction,G02.111.087.800
18612371,2008-06-27T00:00:00,Signal Transduction,G02.149.115.800
18612371,2008-06-27T00:00:00,Signal Transduction,G04.299.880
20633399,2008-06-27T00:00:00,Anxiety Disorders,F03.080
20633399,2008-06-27T00:00:00,Bipolar Disorder,F03.600.150.150
20633399,2008-06-27T00:00:00,Clinical Trials as Topic,E05.318.760.535
20633399,2008-06-27T00:00:00,Clinical Trials as Topic,E05.337.250
20633399,2008-06-27T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20633399,2008-06-27T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20633399,2008-06-27T00:00:00,Depressive Disorder,F03.600.300
20633399,2008-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633399,2008-06-27T00:00:00,Schizophrenia,F03.700.750
20633399,2008-06-27T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633399,2008-06-27T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
18564161,2008-06-28T00:00:00,Adult,M01.060.116
18564161,2008-06-28T00:00:00,Aged,M01.060.116.100
18564161,2008-06-28T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
18564161,2008-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18564161,2008-06-28T00:00:00,Manometry,E05.559
18564161,2008-06-28T00:00:00,Middle Aged,M01.060.116.630
18564161,2008-06-28T00:00:00,Probability,E05.318.740.600
18564161,2008-06-28T00:00:00,Probability,G17.680
18564161,2008-06-28T00:00:00,Probability,N05.715.360.750.625
18564161,2008-06-28T00:00:00,Probability,N06.850.520.830.600
18564161,2008-06-28T00:00:00,Risk Assessment,E05.318.740.600.800.715
18564161,2008-06-28T00:00:00,Risk Assessment,N04.452.871.715
18564161,2008-06-28T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18564161,2008-06-28T00:00:00,Risk Assessment,N06.850.505.715
18564161,2008-06-28T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18564161,2008-06-28T00:00:00,Sensitivity and Specificity,E05.318.740.872
18564161,2008-06-28T00:00:00,Sensitivity and Specificity,E05.318.780.800
18564161,2008-06-28T00:00:00,Sensitivity and Specificity,G17.800
18564161,2008-06-28T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18564161,2008-06-28T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18564161,2008-06-28T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18564161,2008-06-28T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18564369,2008-06-28T00:00:00,Autoantigens,D23.050.422
18564369,2008-06-28T00:00:00,Binding Sites,G02.111.570.120
18564369,2008-06-28T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
18564369,2008-06-28T00:00:00,Hela Cells,A11.251.210.190.400
18564369,2008-06-28T00:00:00,Hela Cells,A11.251.860.180.400
18564369,2008-06-28T00:00:00,Hela Cells,A11.436.340
18564369,2008-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18564369,2008-06-28T00:00:00,Membrane Proteins,D12.776.543
18564369,2008-06-28T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
18564369,2008-06-28T00:00:00,"Microscopy, Fluorescence",E05.595.458
18564369,2008-06-28T00:00:00,Peptide Fragments,D12.644.541
18564369,2008-06-28T00:00:00,Protein Transport,G03.495.166.700
18564369,2008-06-28T00:00:00,Vesicular Transport Proteins,D12.776.543.990
18639563,2008-06-29T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
18639563,2008-06-29T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
18639563,2008-06-29T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
18639563,2008-06-29T00:00:00,Animals,B01.050
18639563,2008-06-29T00:00:00,Central Nervous System Depressants,D27.505.696.277
18639563,2008-06-29T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
18639563,2008-06-29T00:00:00,Ethanol,D02.033.375
18639563,2008-06-29T00:00:00,Mutation,G05.365.590
18639563,2008-06-29T00:00:00,Patch-Clamp Techniques,E05.200.500.800
18639563,2008-06-29T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
18586252,2008-06-30T00:00:00,Atherosclerosis,C14.907.137.126.307
18586252,2008-06-30T00:00:00,Diabetic Angiopathies,C14.907.320
18586252,2008-06-30T00:00:00,Diabetic Angiopathies,C19.246.099.500
18586252,2008-06-30T00:00:00,Glucose,D09.546.359.448
18586252,2008-06-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18586252,2008-06-30T00:00:00,Hyperglycemia,C18.452.394.952
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.644.276.374.440.893
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.644.276.374.480.350
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.644.276.718.550
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.776.467.374.440.893
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.776.467.374.480.350
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
18586252,2008-06-30T00:00:00,Interferon-gamma,D12.776.467.718.550
18586252,2008-06-30T00:00:00,Interferon-gamma,D23.529.374.440.893
18586252,2008-06-30T00:00:00,Interferon-gamma,D23.529.374.480.350
18586252,2008-06-30T00:00:00,Interferon-gamma,D23.529.374.480.615.350
18586252,2008-06-30T00:00:00,Interferon-gamma,D23.529.718.550
18586252,2008-06-30T00:00:00,Macrophages,A11.329.372
18586252,2008-06-30T00:00:00,Macrophages,A11.627.482
18586252,2008-06-30T00:00:00,Macrophages,A11.733.397
18586252,2008-06-30T00:00:00,Macrophages,A15.382.680.397
18586252,2008-06-30T00:00:00,Macrophages,A15.382.812.522
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
18586252,2008-06-30T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
18586252,2008-06-30T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
18586252,2008-06-30T00:00:00,Signal Transduction,G02.111.087.800
18586252,2008-06-30T00:00:00,Signal Transduction,G02.149.115.800
18586252,2008-06-30T00:00:00,Signal Transduction,G04.299.880
18586252,2008-06-30T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
18586572,2008-06-30T00:00:00,Adolescent,M01.060.057
18586572,2008-06-30T00:00:00,Adult,M01.060.116
18586572,2008-06-30T00:00:00,Aged,M01.060.116.100
18586572,2008-06-30T00:00:00,Body Weight,C23.888.144
18586572,2008-06-30T00:00:00,Body Weight,E01.370.600.115.100.160.120
18586572,2008-06-30T00:00:00,Body Weight,E05.041.124.160.750
18586572,2008-06-30T00:00:00,Body Weight,G07.100.100.160.120
18586572,2008-06-30T00:00:00,Body Weight,G07.700.320.249.314.120
18586572,2008-06-30T00:00:00,Gastric Bypass,E02.065.062.249
18586572,2008-06-30T00:00:00,Gastric Bypass,E04.035.398.385
18586572,2008-06-30T00:00:00,Gastric Bypass,E04.062.249
18586572,2008-06-30T00:00:00,Gastric Bypass,E04.210.457.430
18586572,2008-06-30T00:00:00,Health Status,I01.240.425
18586572,2008-06-30T00:00:00,Health Status,N01.224.425
18586572,2008-06-30T00:00:00,Health Status,N06.850.505.400.425
18586572,2008-06-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18586572,2008-06-30T00:00:00,Middle Aged,M01.060.116.630
18586572,2008-06-30T00:00:00,"Obesity, Morbid",C18.654.726.500.700
18586572,2008-06-30T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
18586572,2008-06-30T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
18586572,2008-06-30T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
18586572,2008-06-30T00:00:00,Quality of Life,I01.800
18586572,2008-06-30T00:00:00,Quality of Life,K01.752.400.750
18586572,2008-06-30T00:00:00,Questionnaires,E05.318.308.750
18586572,2008-06-30T00:00:00,Questionnaires,L01.280.800
18586572,2008-06-30T00:00:00,Questionnaires,N05.715.360.300.695
18586572,2008-06-30T00:00:00,Questionnaires,N06.850.520.308.750
18586572,2008-06-30T00:00:00,Sex Factors,N05.715.350.675
18586572,2008-06-30T00:00:00,Sex Factors,N06.850.490.875
18586572,2008-06-30T00:00:00,United States,Z01.107.567.875
18586572,2008-06-30T00:00:00,Young Adult,M01.060.116.815
17514035,2008-07-01T00:00:00,"Accidents, Traffic",N06.850.135.392
17514035,2008-07-01T00:00:00,Adult,M01.060.116
17514035,2008-07-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
17514035,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17514035,2008-07-01T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
17514035,2008-07-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
18058097,2008-07-01T00:00:00,Animals,B01.050
18058097,2008-07-01T00:00:00,Cell Proliferation,G04.299.233.750
18058097,2008-07-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18058097,2008-07-01T00:00:00,Cytokines,D12.644.276.374
18058097,2008-07-01T00:00:00,Cytokines,D12.776.467.374
18058097,2008-07-01T00:00:00,Cytokines,D23.529.374
18058097,2008-07-01T00:00:00,Endothelial Cells,A11.436.275
18058097,2008-07-01T00:00:00,Macrophages,A11.329.372
18058097,2008-07-01T00:00:00,Macrophages,A11.627.482
18058097,2008-07-01T00:00:00,Macrophages,A11.733.397
18058097,2008-07-01T00:00:00,Macrophages,A15.382.680.397
18058097,2008-07-01T00:00:00,Macrophages,A15.382.812.522
18058097,2008-07-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18058097,2008-07-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18058097,2008-07-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18348201,2008-07-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
18348201,2008-07-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
18348201,2008-07-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
18348201,2008-07-01T00:00:00,Animals,B01.050
18348201,2008-07-01T00:00:00,Bone Resorption,C05.116.264
18348201,2008-07-01T00:00:00,Bone Resorption,G11.427.590.195.150
18348201,2008-07-01T00:00:00,Cell Differentiation,G04.299.151
18348201,2008-07-01T00:00:00,Gene Expression Regulation,G05.355.315
18348201,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18348201,2008-07-01T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
18348201,2008-07-01T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
18348201,2008-07-01T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
18348201,2008-07-01T00:00:00,Measles virus,B04.820.455.600.650.500.500
18348201,2008-07-01T00:00:00,Measles virus,B04.909.777.455.600.650.500.500
18348201,2008-07-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18348201,2008-07-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18348201,2008-07-01T00:00:00,Osteitis Deformans,C05.116.692
18348201,2008-07-01T00:00:00,Osteoclasts,A11.329.372.700
18348201,2008-07-01T00:00:00,Osteoclasts,A11.627.482.700
18348201,2008-07-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
18348201,2008-07-01T00:00:00,RANK Ligand,D12.644.276.972.562
18348201,2008-07-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
18348201,2008-07-01T00:00:00,RANK Ligand,D12.776.467.972.562
18348201,2008-07-01T00:00:00,RANK Ligand,D23.529.374.750.562
18348201,2008-07-01T00:00:00,RANK Ligand,D23.529.972.562
18348201,2008-07-01T00:00:00,Transcription Factors,D12.776.930
18385920,2008-07-01T00:00:00,"Anastomosis, Surgical",E04.035
18385920,2008-07-01T00:00:00,Animals,B01.050
18385920,2008-07-01T00:00:00,Fontan Procedure,E04.035.410.295
18385920,2008-07-01T00:00:00,Fontan Procedure,E04.100.376.410.295
18385920,2008-07-01T00:00:00,Fontan Procedure,E04.928.220.370.295
18385920,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18385920,2008-07-01T00:00:00,"Infant, Newborn",M01.060.703.520
18385920,2008-07-01T00:00:00,Pulmonary Artery,A07.231.114.715
18385920,2008-07-01T00:00:00,"Vena Cava, Superior",A07.231.908.949.815
18410513,2008-07-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18410513,2008-07-01T00:00:00,Alzheimer Disease,C10.574.945.249
18410513,2008-07-01T00:00:00,Alzheimer Disease,F03.087.400.100
18410513,2008-07-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
18410513,2008-07-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
18410513,2008-07-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
18410513,2008-07-01T00:00:00,Animals,B01.050
18410513,2008-07-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
18410513,2008-07-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
18410513,2008-07-01T00:00:00,Brain,A08.186.211
18410513,2008-07-01T00:00:00,Cholesterol,D04.808.247.222.284
18410513,2008-07-01T00:00:00,Cholesterol,D04.808.247.808.197
18410513,2008-07-01T00:00:00,Cholesterol,D10.570.938.208
18410513,2008-07-01T00:00:00,Cholesterol,D10.851.208
18410513,2008-07-01T00:00:00,Cytokines,D12.644.276.374
18410513,2008-07-01T00:00:00,Cytokines,D12.776.467.374
18410513,2008-07-01T00:00:00,Cytokines,D23.529.374
18410513,2008-07-01T00:00:00,Dietary Fats,D10.212.302
18410513,2008-07-01T00:00:00,Dietary Fats,J02.500.375
18410513,2008-07-01T00:00:00,Encephalitis,C02.182.500
18410513,2008-07-01T00:00:00,Encephalitis,C10.228.140.430
18410513,2008-07-01T00:00:00,Encephalitis,C10.228.228.210.150
18410513,2008-07-01T00:00:00,Encephalitis,C10.228.228.245
18410513,2008-07-01T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
18410513,2008-07-01T00:00:00,Memory Disorders,C10.597.606.525
18410513,2008-07-01T00:00:00,Memory Disorders,C23.888.592.604.529
18410513,2008-07-01T00:00:00,Memory Disorders,F01.700.625
18410513,2008-07-01T00:00:00,"Memory, Short-Term",F02.463.425.540.407
18410513,2008-07-01T00:00:00,Neurons,A08.663
18410513,2008-07-01T00:00:00,Neurons,A11.671
18410513,2008-07-01T00:00:00,Peptide Fragments,D12.644.541
18412133,2008-07-01T00:00:00,Adult,M01.060.116
18412133,2008-07-01T00:00:00,Auditory Cortex,A08.186.211.730.885.287.500.863.297
18412133,2008-07-01T00:00:00,Brain Mapping,E01.370.350.086
18412133,2008-07-01T00:00:00,Brain Mapping,E01.370.376.149
18412133,2008-07-01T00:00:00,Brain Mapping,E05.132
18412133,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18412133,2008-07-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18412133,2008-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18412133,2008-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18412133,2008-07-01T00:00:00,Neural Pathways,A08.612
18412133,2008-07-01T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
18431464,2008-07-01T00:00:00,Animals,B01.050
18431464,2008-07-01T00:00:00,Endotoxins,D23.946.123.329
18431464,2008-07-01T00:00:00,Inflammation,C23.550.470
18431464,2008-07-01T00:00:00,Lipopolysaccharides,D09.400.500
18431464,2008-07-01T00:00:00,Lipopolysaccharides,D09.698.718.450
18431464,2008-07-01T00:00:00,Lipopolysaccharides,D10.494
18431464,2008-07-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18431464,2008-07-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18431464,2008-07-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
18431464,2008-07-01T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
18431464,2008-07-01T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
18431464,2008-07-01T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
18431464,2008-07-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
18431464,2008-07-01T00:00:00,Signal Transduction,G02.111.087.800
18431464,2008-07-01T00:00:00,Signal Transduction,G02.149.115.800
18431464,2008-07-01T00:00:00,Signal Transduction,G04.299.880
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18431464,2008-07-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18475213,2008-07-01T00:00:00,Adult,M01.060.116
18475213,2008-07-01T00:00:00,Aged,M01.060.116.100
18475213,2008-07-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
18475213,2008-07-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
18475213,2008-07-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
18475213,2008-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18475213,2008-07-01T00:00:00,Body Mass Index,E05.041.124.125
18475213,2008-07-01T00:00:00,Body Mass Index,G07.100.100.125
18475213,2008-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18475213,2008-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18475213,2008-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18475213,2008-07-01T00:00:00,Cisplatin,D01.210.375
18475213,2008-07-01T00:00:00,Cisplatin,D01.625.125
18475213,2008-07-01T00:00:00,Cisplatin,D01.710.100
18475213,2008-07-01T00:00:00,Combined Modality Therapy,E02.186
18475213,2008-07-01T00:00:00,Enteral Nutrition,E02.421.360
18475213,2008-07-01T00:00:00,Enteral Nutrition,E02.642.500.360
18475213,2008-07-01T00:00:00,Gastrostomy,E04.210.496
18475213,2008-07-01T00:00:00,Gastrostomy,E04.579.408
18475213,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18475213,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18475213,2008-07-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18475213,2008-07-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18475213,2008-07-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
18475213,2008-07-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
18475213,2008-07-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
18475213,2008-07-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
18475213,2008-07-01T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
18475213,2008-07-01T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
18496394,2008-07-01T00:00:00,Adolescent,M01.060.057
18496394,2008-07-01T00:00:00,Adult,M01.060.116
18496394,2008-07-01T00:00:00,Aged,M01.060.116.100
18496394,2008-07-01T00:00:00,Drug Tolerance,G07.690.812.260
18496394,2008-07-01T00:00:00,Drug Tolerance,G07.700.680.260
18496394,2008-07-01T00:00:00,Gastric Acid,A12.200.307.603
18496394,2008-07-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
18496394,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18496394,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18496394,2008-07-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
18506881,2008-07-01T00:00:00,Antigen Presentation,G12.425.107
18506881,2008-07-01T00:00:00,Antigen Presentation,G12.450.050.400.070
18506881,2008-07-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
18506881,2008-07-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
18506881,2008-07-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
18506881,2008-07-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
18506881,2008-07-01T00:00:00,Autoantigens,D23.050.422
18506881,2008-07-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18506881,2008-07-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18506881,2008-07-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18506881,2008-07-01T00:00:00,Cell Line,A11.251.210
18506881,2008-07-01T00:00:00,HLA-D Antigens,D23.050.301.500.410.400
18506881,2008-07-01T00:00:00,HLA-D Antigens,D23.050.301.500.450.400
18506881,2008-07-01T00:00:00,HLA-D Antigens,D23.050.705.552.410.400
18506881,2008-07-01T00:00:00,HLA-D Antigens,D23.050.705.552.450.400
18506881,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18506881,2008-07-01T00:00:00,Peptide Fragments,D12.644.541
18520962,2008-07-01T00:00:00,Adolescent,M01.060.057
18520962,2008-07-01T00:00:00,Aggression,F01.145.126.125
18520962,2008-07-01T00:00:00,Aggression,F01.145.813.045
18520962,2008-07-01T00:00:00,Alcoholism,C21.739.100.250
18520962,2008-07-01T00:00:00,Alcoholism,F03.900.100.350
18520962,2008-07-01T00:00:00,Child,M01.060.406
18520962,2008-07-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18520962,2008-07-01T00:00:00,Health Surveys,E05.318.308.250
18520962,2008-07-01T00:00:00,Health Surveys,N05.715.360.300.375
18520962,2008-07-01T00:00:00,Health Surveys,N06.850.520.308.250
18520962,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18520962,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18520962,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18520962,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18520962,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18520962,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18520962,2008-07-01T00:00:00,Sex Offenses,I01.198.240.748
18520962,2008-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18520962,2008-07-01T00:00:00,Substance-Related Disorders,C21.739
18520962,2008-07-01T00:00:00,Substance-Related Disorders,F03.900
18520962,2008-07-01T00:00:00,United States,Z01.107.567.875
18520962,2008-07-01T00:00:00,Violence,I01.198.240.856
18520962,2008-07-01T00:00:00,Violence,I01.880.735.900
18541186,2008-07-01T00:00:00,Community-Institutional Relations,N04.452.822.210
18541186,2008-07-01T00:00:00,Evidence-Based Medicine,H02.249.750
18541186,2008-07-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18541186,2008-07-01T00:00:00,Health Promotion,N02.370
18541186,2008-07-01T00:00:00,Health Promotion,N02.421.726.507
18541186,2008-07-01T00:00:00,Health Services Accessibility,N04.590.374.350
18541186,2008-07-01T00:00:00,Health Services Accessibility,N05.300.430
18541186,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18541186,2008-07-01T00:00:00,Mass Screening,E01.370.500
18541186,2008-07-01T00:00:00,Mass Screening,E05.318.308.250.580
18541186,2008-07-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18541186,2008-07-01T00:00:00,Mass Screening,N02.421.726.233.443
18541186,2008-07-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18541186,2008-07-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18541186,2008-07-01T00:00:00,Mass Screening,N06.850.780.500
18541186,2008-07-01T00:00:00,Neoplasms,C04
18541186,2008-07-01T00:00:00,United States,Z01.107.567.875
18549343,2008-07-01T00:00:00,Animals,B01.050
18549343,2008-07-01T00:00:00,Cisplatin,D01.210.375
18549343,2008-07-01T00:00:00,Cisplatin,D01.625.125
18549343,2008-07-01T00:00:00,Cisplatin,D01.710.100
18549343,2008-07-01T00:00:00,Drug Tolerance,G07.690.812.260
18549343,2008-07-01T00:00:00,Drug Tolerance,G07.700.680.260
18549343,2008-07-01T00:00:00,Glutathione Disulfide,D12.644.456.448.500
18549343,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18549343,2008-07-01T00:00:00,Molecular Structure,G02.111.570
18549343,2008-07-01T00:00:00,Molecular Structure,G02.575
18549343,2008-07-01T00:00:00,Molecular Structure,G02.842.575
18551011,2008-07-01T00:00:00,Adult,M01.060.116
18551011,2008-07-01T00:00:00,African Americans,M01.686.508.100.100
18551011,2008-07-01T00:00:00,African Americans,M01.686.754.100
18551011,2008-07-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18551011,2008-07-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18551011,2008-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18551011,2008-07-01T00:00:00,Heart Diseases,C14.280
18551011,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18551011,2008-07-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
18551011,2008-07-01T00:00:00,Metabolic Syndrome X,C18.452.625
18551011,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18551011,2008-07-01T00:00:00,Phenotype,G05.695
18551011,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18551011,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18551011,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18551011,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18551011,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18558283,2008-07-01T00:00:00,Cytokines,D12.644.276.374
18558283,2008-07-01T00:00:00,Cytokines,D12.776.467.374
18558283,2008-07-01T00:00:00,Cytokines,D23.529.374
18558283,2008-07-01T00:00:00,DNA,D13.444.308
18558283,2008-07-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18558283,2008-07-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18558283,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18558283,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18558283,2008-07-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18558283,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18558283,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18558283,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18558283,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18558283,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18558283,2008-07-01T00:00:00,Smoking,F01.145.466.753
18558283,2008-07-01T00:00:00,Treatment Outcome,E01.789.800
18558283,2008-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18558283,2008-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18558283,2008-07-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
18558283,2008-07-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
18558283,2008-07-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
18558283,2008-07-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
18558283,2008-07-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
18562717,2008-07-01T00:00:00,Contrast Media,D27.720.259
18562717,2008-07-01T00:00:00,Proteins,D12.776
18562717,2008-07-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
18562717,2008-07-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
18562717,2008-07-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
18562717,2008-07-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
18573421,2008-07-01T00:00:00,"Anastomosis, Surgical",E04.035
18573421,2008-07-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
18573421,2008-07-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
18573421,2008-07-01T00:00:00,"Heart Defects, Congenital",C14.240.400
18573421,2008-07-01T00:00:00,"Heart Defects, Congenital",C14.280.400
18573421,2008-07-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18573421,2008-07-01T00:00:00,Heart Ventricles,A07.541.560
18573421,2008-07-01T00:00:00,Hemodynamics,G09.330.190.400
18573421,2008-07-01T00:00:00,Hemodynamics,G09.330.380
18573421,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18573421,2008-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
18573421,2008-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
18573421,2008-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
18573421,2008-07-01T00:00:00,Infant,M01.060.703
18573421,2008-07-01T00:00:00,"Infant, Newborn",M01.060.703.520
18573421,2008-07-01T00:00:00,Oxygen Consumption,G03.730
18573421,2008-07-01T00:00:00,Palliative Care,E02.760.666
18573421,2008-07-01T00:00:00,Palliative Care,N02.421.585.666
18573421,2008-07-01T00:00:00,Pulmonary Artery,A07.231.114.715
18573421,2008-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18573421,2008-07-01T00:00:00,Risk Assessment,N04.452.871.715
18573421,2008-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18573421,2008-07-01T00:00:00,Risk Assessment,N06.850.505.715
18573421,2008-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18573421,2008-07-01T00:00:00,Treatment Outcome,E01.789.800
18573421,2008-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18573421,2008-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18573427,2008-07-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
18573427,2008-07-01T00:00:00,Aged,M01.060.116.100
18573427,2008-07-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
18573427,2008-07-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
18573427,2008-07-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
18573427,2008-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18573427,2008-07-01T00:00:00,Healthcare Disparities,N04.590.374.380
18573427,2008-07-01T00:00:00,Healthcare Disparities,N05.300.493
18573427,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18573427,2008-07-01T00:00:00,Incidence,E05.318.308.985.525.375
18573427,2008-07-01T00:00:00,Incidence,L01.280.975.525.375
18573427,2008-07-01T00:00:00,Incidence,N01.224.935.597.500
18573427,2008-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18573427,2008-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18573427,2008-07-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18573427,2008-07-01T00:00:00,Lung Neoplasms,C08.381.540
18573427,2008-07-01T00:00:00,Lung Neoplasms,C08.785.520
18573427,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18573427,2008-07-01T00:00:00,Pneumonectomy,E04.928.600.600
18573427,2008-07-01T00:00:00,Probability,E05.318.740.600
18573427,2008-07-01T00:00:00,Probability,G17.680
18573427,2008-07-01T00:00:00,Probability,N05.715.360.750.625
18573427,2008-07-01T00:00:00,Probability,N06.850.520.830.600
18573427,2008-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18573427,2008-07-01T00:00:00,Risk Assessment,N04.452.871.715
18573427,2008-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18573427,2008-07-01T00:00:00,Risk Assessment,N06.850.505.715
18573427,2008-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18573427,2008-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18573427,2008-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18574022,2008-07-01T00:00:00,Acute Coronary Syndrome,C14.280.647.124
18574022,2008-07-01T00:00:00,Acute Coronary Syndrome,C14.907.585.124
18574022,2008-07-01T00:00:00,Drug Therapy,E02.319
18574022,2008-07-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
18574022,2008-07-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
18574022,2008-07-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
18574022,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18574022,2008-07-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18574022,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18574022,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18574022,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18574022,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18574022,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18574022,2008-07-01T00:00:00,Stents,E07.695.750
18576896,2008-07-01T00:00:00,"Education, Pharmacy",I02.358.525
18576896,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18576896,2008-07-01T00:00:00,"Internship, Nonmedical",I02.358.750
18577616,2008-07-01T00:00:00,Animals,B01.050
18577616,2008-07-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18577616,2008-07-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18577616,2008-07-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
18577616,2008-07-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
18577616,2008-07-01T00:00:00,Poultry Diseases,C22.131.728
18580719,2008-07-01T00:00:00,Animals,B01.050
18580719,2008-07-01T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
18580719,2008-07-01T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
18580719,2008-07-01T00:00:00,Borrelia burgdorferi,B03.440.425.410.711.193.150.125
18580719,2008-07-01T00:00:00,Borrelia burgdorferi,B03.851.595.193.150.125
18580719,2008-07-01T00:00:00,Erythema Chronicum Migrans,C01.252.400.155.569.200
18580719,2008-07-01T00:00:00,Erythema Chronicum Migrans,C01.252.400.825.480.400
18580719,2008-07-01T00:00:00,Erythema Chronicum Migrans,C01.252.825.310
18580719,2008-07-01T00:00:00,Erythema Chronicum Migrans,C01.252.847.193.569.200
18580719,2008-07-01T00:00:00,Erythema Chronicum Migrans,C01.539.800.720.310
18580719,2008-07-01T00:00:00,Erythema Chronicum Migrans,C17.800.229.200
18580719,2008-07-01T00:00:00,Erythema Chronicum Migrans,C17.800.838.765.310
18580719,2008-07-01T00:00:00,Exanthema,C17.800.257
18580719,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18580719,2008-07-01T00:00:00,Insect Bites and Stings,C21.613.127.441
18580719,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18580719,2008-07-01T00:00:00,Serologic Tests,E01.450.495.735
18580719,2008-07-01T00:00:00,Serologic Tests,E05.478.594.760
18580719,2008-07-01T00:00:00,Ticks,B01.050.500.131.166.132.832
18580740,2008-07-01T00:00:00,Adult,M01.060.116
18580740,2008-07-01T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
18580740,2008-07-01T00:00:00,"Arthroplasty, Replacement",E04.650.110
18580740,2008-07-01T00:00:00,Diskectomy,E04.555.200
18580740,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18580740,2008-07-01T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
18580740,2008-07-01T00:00:00,Pain Measurement,E01.370.376.550.600
18580740,2008-07-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18580740,2008-07-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18580740,2008-07-01T00:00:00,Patient Satisfaction,N05.715.360.600
18580740,2008-07-01T00:00:00,Questionnaires,E05.318.308.750
18580740,2008-07-01T00:00:00,Questionnaires,L01.280.800
18580740,2008-07-01T00:00:00,Questionnaires,N05.715.360.300.695
18580740,2008-07-01T00:00:00,Questionnaires,N06.850.520.308.750
18580740,2008-07-01T00:00:00,Reoperation,E04.690
18580740,2008-07-01T00:00:00,Treatment Outcome,E01.789.800
18580740,2008-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18580740,2008-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18582635,2008-07-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
18582635,2008-07-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
18582635,2008-07-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
18582635,2008-07-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
18582635,2008-07-01T00:00:00,"Child, Preschool",M01.060.406.448
18582635,2008-07-01T00:00:00,Fontan Procedure,E04.035.410.295
18582635,2008-07-01T00:00:00,Fontan Procedure,E04.100.376.410.295
18582635,2008-07-01T00:00:00,Fontan Procedure,E04.928.220.370.295
18582635,2008-07-01T00:00:00,Heart Ventricles,A07.541.560
18582635,2008-07-01T00:00:00,Hemodynamics,G09.330.190.400
18582635,2008-07-01T00:00:00,Hemodynamics,G09.330.380
18582635,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18582635,2008-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
18582635,2008-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
18582635,2008-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
18582635,2008-07-01T00:00:00,Infant,M01.060.703
18582635,2008-07-01T00:00:00,Intensive Care Units,N02.278.388.493
18582635,2008-07-01T00:00:00,Length of Stay,E02.760.400.480
18582635,2008-07-01T00:00:00,Length of Stay,N02.421.585.400.480
18582635,2008-07-01T00:00:00,Pulmonary Artery,A07.231.114.715
18582635,2008-07-01T00:00:00,Vascular Surgical Procedures,E04.100.814
18585576,2008-07-01T00:00:00,Adult,M01.060.116
18585576,2008-07-01T00:00:00,Cadaver,C23.550.260.224
18585576,2008-07-01T00:00:00,Drug Delivery Systems,E02.319.300
18585576,2008-07-01T00:00:00,Endoscopy,E01.370.388.250
18585576,2008-07-01T00:00:00,Endoscopy,E04.800.250
18585576,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18585576,2008-07-01T00:00:00,Paranasal Sinuses,A04.531.621
18585576,2008-07-01T00:00:00,Sinusitis,C08.460.692.752
18585576,2008-07-01T00:00:00,Sinusitis,C08.730.749
18585576,2008-07-01T00:00:00,Sinusitis,C09.603.692.752
18586990,2008-07-01T00:00:00,Adolescent,M01.060.057
18586990,2008-07-01T00:00:00,Adult,M01.060.116
18586990,2008-07-01T00:00:00,Child,M01.060.406
18586990,2008-07-01T00:00:00,Child Health Services,N02.421.143.130
18586990,2008-07-01T00:00:00,Community Mental Health Services,F04.408.307
18586990,2008-07-01T00:00:00,Community Mental Health Services,N02.421.143.183
18586990,2008-07-01T00:00:00,Community Mental Health Services,N02.421.461.232
18586990,2008-07-01T00:00:00,Evidence-Based Medicine,H02.249.750
18586990,2008-07-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18586990,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18586990,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18586990,2008-07-01T00:00:00,Process Assessment (Health Care),N04.761.559.650
18586990,2008-07-01T00:00:00,Process Assessment (Health Care),N05.715.360.575.625
18586990,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18586990,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18586990,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18586990,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18588360,2008-07-01T00:00:00,Adult,M01.060.116
18588360,2008-07-01T00:00:00,Anxiety Disorders,F03.080
18588360,2008-07-01T00:00:00,Bipolar Disorder,F03.600.150.150
18588360,2008-07-01T00:00:00,Child,M01.060.406
18588360,2008-07-01T00:00:00,Child Abuse,I01.198.240.856.350.250
18588360,2008-07-01T00:00:00,Child Abuse,I01.880.735.900.350.250
18588360,2008-07-01T00:00:00,Child Abuse,I01.880.787.293.292
18588360,2008-07-01T00:00:00,Demography,I01.240
18588360,2008-07-01T00:00:00,Demography,N01.224
18588360,2008-07-01T00:00:00,Demography,N06.850.505.400
18588360,2008-07-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18588360,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18588360,2008-07-01T00:00:00,Incidence,E05.318.308.985.525.375
18588360,2008-07-01T00:00:00,Incidence,L01.280.975.525.375
18588360,2008-07-01T00:00:00,Incidence,N01.224.935.597.500
18588360,2008-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18588360,2008-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18588360,2008-07-01T00:00:00,Panic Disorder,F03.080.700
18588360,2008-07-01T00:00:00,Periodicity,G01.910.645
18588360,2008-07-01T00:00:00,Periodicity,G07.180.562
18588360,2008-07-01T00:00:00,Prevalence,E05.318.308.985.525.750
18588360,2008-07-01T00:00:00,Prevalence,L01.280.975.525.750
18588360,2008-07-01T00:00:00,Prevalence,N01.224.935.597.750
18588360,2008-07-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18588360,2008-07-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18588360,2008-07-01T00:00:00,Questionnaires,E05.318.308.750
18588360,2008-07-01T00:00:00,Questionnaires,L01.280.800
18588360,2008-07-01T00:00:00,Questionnaires,N05.715.360.300.695
18588360,2008-07-01T00:00:00,Questionnaires,N06.850.520.308.750
18588360,2008-07-01T00:00:00,Substance-Related Disorders,C21.739
18588360,2008-07-01T00:00:00,Substance-Related Disorders,F03.900
18589334,2008-07-01T00:00:00,Atherosclerosis,C14.907.137.126.307
18589334,2008-07-01T00:00:00,Atrial Fibrillation,C14.280.067.198
18589334,2008-07-01T00:00:00,Atrial Fibrillation,C23.550.073.198
18589334,2008-07-01T00:00:00,Coronary Disease,C14.280.647.250
18589334,2008-07-01T00:00:00,Coronary Disease,C14.907.585.250
18589334,2008-07-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18589334,2008-07-01T00:00:00,Diabetes Mellitus,C19.246
18589334,2008-07-01T00:00:00,Headache,C10.597.617.470
18589334,2008-07-01T00:00:00,Headache,C23.888.592.612.441
18589334,2008-07-01T00:00:00,Headache,C23.888.646.487
18589334,2008-07-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
18589334,2008-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
18589334,2008-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
18589334,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18589334,2008-07-01T00:00:00,Hypertension,C14.907.489
18589334,2008-07-01T00:00:00,Incidence,E05.318.308.985.525.375
18589334,2008-07-01T00:00:00,Incidence,L01.280.975.525.375
18589334,2008-07-01T00:00:00,Incidence,N01.224.935.597.500
18589334,2008-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18589334,2008-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18589334,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18589334,2008-07-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
18589334,2008-07-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
18589334,2008-07-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
18589334,2008-07-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
18589334,2008-07-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
18589334,2008-07-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
18589334,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18589334,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18589334,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18589334,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18589334,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18589334,2008-07-01T00:00:00,Stroke,C10.228.140.300.775
18589334,2008-07-01T00:00:00,Stroke,C14.907.253.855
18589334,2008-07-01T00:00:00,United States,Z01.107.567.875
18593937,2008-07-01T00:00:00,Binding Sites,G02.111.570.120
18593937,2008-07-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.644.360.225.600
18593937,2008-07-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.167.187.600
18593937,2008-07-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.476.225.600
18593937,2008-07-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.624.776.355.600
18593937,2008-07-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18593937,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18593937,2008-07-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18593937,2008-07-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18593937,2008-07-01T00:00:00,Nerve Tissue Proteins,D12.776.641
18593937,2008-07-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18593937,2008-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18593937,2008-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18593937,2008-07-01T00:00:00,"RNA, Messenger",D13.444.735.544
18595807,2008-07-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
18595807,2008-07-01T00:00:00,Catheter Ablation,E02.148.110
18595807,2008-07-01T00:00:00,Catheter Ablation,E02.148.442.110
18595807,2008-07-01T00:00:00,Catheter Ablation,E02.154.402.110
18595807,2008-07-01T00:00:00,Catheter Ablation,E04.014.170.402.110
18595807,2008-07-01T00:00:00,Computer Simulation,L01.224.160
18595807,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18595807,2008-07-01T00:00:00,"Models, Biological",E05.599.395
18595807,2008-07-01T00:00:00,Neoplasms,C04
18595807,2008-07-01T00:00:00,Skin,A17.815
18612732,2008-07-01T00:00:00,Adult,M01.060.116
18612732,2008-07-01T00:00:00,Clinical Clerkship,I02.358.399.450.110
18612732,2008-07-01T00:00:00,Curriculum,I02.158
18612732,2008-07-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
18612732,2008-07-01T00:00:00,Educational Measurement,I02.399
18612732,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18612732,2008-07-01T00:00:00,"Licensure, Medical",N03.706.110.510.410
18612732,2008-07-01T00:00:00,"Licensure, Medical",N05.700.200.450.500
18613809,2008-07-01T00:00:00,Alcoholism,C21.739.100.250
18613809,2008-07-01T00:00:00,Alcoholism,F03.900.100.350
18613809,2008-07-01T00:00:00,Cocaine-Related Disorders,C21.739.300
18613809,2008-07-01T00:00:00,Cocaine-Related Disorders,F03.900.300
18613809,2008-07-01T00:00:00,Disulfiram,D02.241.081.251.869.220.250
18613809,2008-07-01T00:00:00,Disulfiram,D02.886.520.150.175
18613809,2008-07-01T00:00:00,Disulfiram,D02.886.706.200.200
18613809,2008-07-01T00:00:00,Drug Interactions,G07.690.812.240
18613809,2008-07-01T00:00:00,Drug Interactions,G07.700.680.240
18613809,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18613809,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18613809,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18613809,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18613809,2008-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18613809,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18613809,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18613809,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18613809,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18613809,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18614733,2008-07-01T00:00:00,African Americans,M01.686.508.100.100
18614733,2008-07-01T00:00:00,African Americans,M01.686.754.100
18614733,2008-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18614733,2008-07-01T00:00:00,Body Mass Index,E05.041.124.125
18614733,2008-07-01T00:00:00,Body Mass Index,G07.100.100.125
18614733,2008-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18614733,2008-07-01T00:00:00,Breast Neoplasms,C04.588.180
18614733,2008-07-01T00:00:00,Breast Neoplasms,C17.800.090.500
18614733,2008-07-01T00:00:00,Ethnic Groups,M01.686.754
18614733,2008-07-01T00:00:00,Ethnic Groups,N01.224.317
18614733,2008-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18614733,2008-07-01T00:00:00,Hispanic Americans,M01.686.754.441
18614733,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18614733,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18614733,2008-07-01T00:00:00,Prevalence,E05.318.308.985.525.750
18614733,2008-07-01T00:00:00,Prevalence,L01.280.975.525.750
18614733,2008-07-01T00:00:00,Prevalence,N01.224.935.597.750
18614733,2008-07-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18614733,2008-07-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18614733,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18614733,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18614733,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18614733,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18614733,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18614733,2008-07-01T00:00:00,Vitamin D,D04.808.812.768
18614733,2008-07-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18625584,2008-07-01T00:00:00,Animals,B01.050
18625584,2008-07-01T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
18625584,2008-07-01T00:00:00,Cytokines,D12.644.276.374
18625584,2008-07-01T00:00:00,Cytokines,D12.776.467.374
18625584,2008-07-01T00:00:00,Cytokines,D23.529.374
18625584,2008-07-01T00:00:00,Lung Diseases,C08.381
18625584,2008-07-01T00:00:00,"Models, Animal",E05.598
18625584,2008-07-01T00:00:00,Phospholipids,D10.570.755
18625584,2008-07-01T00:00:00,Phospholipids,D10.695
18625584,2008-07-01T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
18625584,2008-07-01T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
18625584,2008-07-01T00:00:00,Surface-Active Agents,D27.720.877
18625584,2008-07-01T00:00:00,Weight Loss,C23.888.144.243.963
18625584,2008-07-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18625861,2008-07-01T00:00:00,Aged,M01.060.116.100
18625861,2008-07-01T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
18625861,2008-07-01T00:00:00,Glomerular Filtration Rate,G08.852.357
18625861,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18625861,2008-07-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
18625861,2008-07-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
18625861,2008-07-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
18625861,2008-07-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
18625861,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18625861,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18625861,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
18625861,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18625861,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
18625861,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18625861,2008-07-01T00:00:00,Stroke,C10.228.140.300.775
18625861,2008-07-01T00:00:00,Stroke,C14.907.253.855
18629721,2008-07-01T00:00:00,Adult,M01.060.116
18629721,2008-07-01T00:00:00,Health Behavior,F01.145.488
18629721,2008-07-01T00:00:00,Health Services Accessibility,N04.590.374.350
18629721,2008-07-01T00:00:00,Health Services Accessibility,N05.300.430
18629721,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18629721,2008-07-01T00:00:00,Pregnancy,G08.686.785.760.769
18629721,2008-07-01T00:00:00,Primary Prevention,N02.421.726.758
18629721,2008-07-01T00:00:00,Primary Prevention,N06.850.780.680
18629721,2008-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18629721,2008-07-01T00:00:00,Risk Assessment,N04.452.871.715
18629721,2008-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18629721,2008-07-01T00:00:00,Risk Assessment,N06.850.505.715
18629721,2008-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18629721,2008-07-01T00:00:00,Smoking,F01.145.466.753
18629721,2008-07-01T00:00:00,United States,Z01.107.567.875
18629731,2008-07-01T00:00:00,Adolescent,M01.060.057
18629731,2008-07-01T00:00:00,Adolescent Behavior,F01.145.022
18629731,2008-07-01T00:00:00,Adult,M01.060.116
18629731,2008-07-01T00:00:00,Age Factors,N05.715.350.075
18629731,2008-07-01T00:00:00,Age Factors,N06.850.490.250
18629731,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18629731,2008-07-01T00:00:00,Smoking,F01.145.466.753
18629731,2008-07-01T00:00:00,United States,Z01.107.567.875
18638341,2008-07-01T00:00:00,Herpes Simplex,C02.256.466.382
18638341,2008-07-01T00:00:00,Herpes Simplex,C02.825.320
18638341,2008-07-01T00:00:00,Herpes Simplex,C17.800.838.790.320
18638341,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18638341,2008-07-01T00:00:00,"Infant, Newborn",M01.060.703.520
18641504,2008-07-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
18641504,2008-07-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18641504,2008-07-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18641504,2008-07-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18641504,2008-07-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18641504,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18641504,2008-07-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18641504,2008-07-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18641504,2008-07-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
18641504,2008-07-01T00:00:00,"Quality Assurance, Health Care",N05.700
18645758,2008-07-01T00:00:00,Adolescent,M01.060.057
18645758,2008-07-01T00:00:00,Adult,M01.060.116
18645758,2008-07-01T00:00:00,Cognitive Therapy,F04.754.137.428
18645758,2008-07-01T00:00:00,Community Mental Health Services,F04.408.307
18645758,2008-07-01T00:00:00,Community Mental Health Services,N02.421.143.183
18645758,2008-07-01T00:00:00,Community Mental Health Services,N02.421.461.232
18645758,2008-07-01T00:00:00,Evidence-Based Medicine,H02.249.750
18645758,2008-07-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18645758,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18645758,2008-07-01T00:00:00,Inservice Training,I02.574
18645758,2008-07-01T00:00:00,Marijuana Abuse,C21.739.635
18645758,2008-07-01T00:00:00,Marijuana Abuse,F03.900.635
18645758,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18645758,2008-07-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
18645758,2008-07-01T00:00:00,"Quality Assurance, Health Care",N05.700
18677869,2008-07-01T00:00:00,Adolescent,M01.060.057
18677869,2008-07-01T00:00:00,Adult,M01.060.116
18677869,2008-07-01T00:00:00,Aged,M01.060.116.100
18677869,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18677869,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18677869,2008-07-01T00:00:00,Pilot Projects,E05.318.760.750
18677869,2008-07-01T00:00:00,Pilot Projects,E05.337.737
18677869,2008-07-01T00:00:00,Pilot Projects,N05.715.360.775.625
18677869,2008-07-01T00:00:00,Pilot Projects,N06.850.520.450.720
18677869,2008-07-01T00:00:00,Primary Health Care,N04.590.233.727
18677869,2008-07-01T00:00:00,Quality of Health Care,N04.761
18677869,2008-07-01T00:00:00,Quality of Health Care,N05.715
18680925,2008-07-01T00:00:00,Academic Medical Centers,N02.278.020
18680925,2008-07-01T00:00:00,Anxiety Disorders,F03.080
18680925,2008-07-01T00:00:00,Behavioral Medicine,F04.096.080
18680925,2008-07-01T00:00:00,Behavioral Medicine,H02.403.090
18680925,2008-07-01T00:00:00,Child,M01.060.406
18680925,2008-07-01T00:00:00,Data Collection,E05.318.308
18680925,2008-07-01T00:00:00,Data Collection,L01.280
18680925,2008-07-01T00:00:00,Data Collection,N05.715.360.300
18680925,2008-07-01T00:00:00,Data Collection,N06.850.520.308
18680925,2008-07-01T00:00:00,Evidence-Based Medicine,H02.249.750
18680925,2008-07-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18680925,2008-07-01T00:00:00,Health Services Research,N03.349.380
18680925,2008-07-01T00:00:00,Health Services Research,N05.425
18680925,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18680925,2008-07-01T00:00:00,Mental Health Services,F04.408
18680925,2008-07-01T00:00:00,Mental Health Services,N02.421.461
18680925,2008-07-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18680925,2008-07-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18680925,2008-07-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.035.380
18680925,2008-07-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.354.422.527
18680925,2008-07-01T00:00:00,"Outpatient Clinics, Hospital",N04.452.442.422.527
18680925,2008-07-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18680925,2008-07-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18680925,2008-07-01T00:00:00,Patient Satisfaction,N05.715.360.600
18680925,2008-07-01T00:00:00,Software,L01.224.900
18680925,2008-07-01T00:00:00,Total Quality Management,N04.452.955
18680925,2008-07-01T00:00:00,Total Quality Management,N04.761.700.675
18680925,2008-07-01T00:00:00,Total Quality Management,N05.700.792
18702911,2008-07-01T00:00:00,Adult,M01.060.116
18702911,2008-07-01T00:00:00,Chronic Disease,C23.550.291.500
18702911,2008-07-01T00:00:00,Endoscopy,E01.370.388.250
18702911,2008-07-01T00:00:00,Endoscopy,E04.800.250
18702911,2008-07-01T00:00:00,Fibromyalgia,C05.651.324
18702911,2008-07-01T00:00:00,Fibromyalgia,C05.799.321
18702911,2008-07-01T00:00:00,Fibromyalgia,C10.668.491.425
18702911,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18702911,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18702911,2008-07-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
18702911,2008-07-01T00:00:00,Pain Measurement,E01.370.376.550.600
18702911,2008-07-01T00:00:00,Quality of Life,I01.800
18702911,2008-07-01T00:00:00,Quality of Life,K01.752.400.750
18702911,2008-07-01T00:00:00,Rhinitis,C08.460.799
18702911,2008-07-01T00:00:00,Rhinitis,C08.730.674
18702911,2008-07-01T00:00:00,Rhinitis,C09.603.799
18702911,2008-07-01T00:00:00,Sinusitis,C08.460.692.752
18702911,2008-07-01T00:00:00,Sinusitis,C08.730.749
18702911,2008-07-01T00:00:00,Sinusitis,C09.603.692.752
18702911,2008-07-01T00:00:00,Treatment Outcome,E01.789.800
18702911,2008-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18702911,2008-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18707603,2008-07-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
18707603,2008-07-01T00:00:00,Adult,M01.060.116
18707603,2008-07-01T00:00:00,"Bile Ducts, Intrahepatic",A03.159.183.158
18707603,2008-07-01T00:00:00,"Bile Ducts, Intrahepatic",A03.620.150
18707603,2008-07-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
18707603,2008-07-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
18707603,2008-07-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
18707603,2008-07-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
18707603,2008-07-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
18707603,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18707603,2008-07-01T00:00:00,Neoplasm Invasiveness,C04.697.645
18707603,2008-07-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18707603,2008-07-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
18707603,2008-07-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
18707603,2008-07-01T00:00:00,Pancreatic Neoplasms,C06.301.761
18707603,2008-07-01T00:00:00,Pancreatic Neoplasms,C06.689.667
18707603,2008-07-01T00:00:00,Pancreatic Neoplasms,C19.344.421
18707603,2008-07-01T00:00:00,Portal Vein,A07.231.908.670.567
18707603,2008-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18707603,2008-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18707603,2008-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18707603,2008-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18707603,2008-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18728565,2008-07-01T00:00:00,Aged,M01.060.116.100
18728565,2008-07-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
18728565,2008-07-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
18728565,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18728565,2008-07-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18728565,2008-07-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18728565,2008-07-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18728565,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18728565,2008-07-01T00:00:00,Stents,E07.695.750
18751558,2008-07-01T00:00:00,Brain,A08.186.211
18751558,2008-07-01T00:00:00,Electric Stimulation,E05.723.402
18751558,2008-07-01T00:00:00,Electroencephalography,E01.370.376.300
18751558,2008-07-01T00:00:00,Electroencephalography,E01.370.405.245
18751558,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18751558,2008-07-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
18751558,2008-07-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
18751561,2008-07-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
18751561,2008-07-01T00:00:00,Depressive Disorder,F03.600.300
18751561,2008-07-01T00:00:00,Electroencephalography,E01.370.376.300
18751561,2008-07-01T00:00:00,Electroencephalography,E01.370.405.245
18751561,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18751561,2008-07-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18751561,2008-07-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
18751561,2008-07-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
18751561,2008-07-01T00:00:00,Treatment Outcome,E01.789.800
18751561,2008-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18751561,2008-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18753117,2008-07-01T00:00:00,Adolescent,M01.060.057
18753117,2008-07-01T00:00:00,Adult,M01.060.116
18753117,2008-07-01T00:00:00,Aged,M01.060.116.100
18753117,2008-07-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18753117,2008-07-01T00:00:00,Clinical Trials as Topic,E05.337.250
18753117,2008-07-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18753117,2008-07-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18753117,2008-07-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18753117,2008-07-01T00:00:00,HIV Infections,C02.782.815.616.400
18753117,2008-07-01T00:00:00,HIV Infections,C02.800.801.400
18753117,2008-07-01T00:00:00,HIV Infections,C20.673.480
18753117,2008-07-01T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
18753117,2008-07-01T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
18753117,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18753117,2008-07-01T00:00:00,Markov Chains,E05.318.740.600.500
18753117,2008-07-01T00:00:00,Markov Chains,E05.318.740.996.500
18753117,2008-07-01T00:00:00,Markov Chains,G17.830.500
18753117,2008-07-01T00:00:00,Markov Chains,N05.715.360.750.625.500
18753117,2008-07-01T00:00:00,Markov Chains,N05.715.360.750.770.500
18753117,2008-07-01T00:00:00,Markov Chains,N06.850.520.830.600.500
18753117,2008-07-01T00:00:00,Markov Chains,N06.850.520.830.996.500
18753117,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18753117,2008-07-01T00:00:00,Ritonavir,D02.886.675.653
18753117,2008-07-01T00:00:00,Ritonavir,D03.383.129.708.653
18753117,2008-07-01T00:00:00,United States,Z01.107.567.875
18756693,2008-07-01T00:00:00,Animals,B01.050
18756693,2008-07-01T00:00:00,Cell Adhesion,G04.299.117
18756693,2008-07-01T00:00:00,Computer Simulation,L01.224.160
18756693,2008-07-01T00:00:00,Hardness,G01.374.647
18756693,2008-07-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
18756693,2008-07-01T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
18756693,2008-07-01T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
18756693,2008-07-01T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
18756693,2008-07-01T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
18756693,2008-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18756693,2008-07-01T00:00:00,"Stress, Mechanical",G01.374.676.830
18756693,2008-07-01T00:00:00,"Stress, Mechanical",G01.595.540.830
18763414,2008-07-01T00:00:00,Adolescent,M01.060.057
18763414,2008-07-01T00:00:00,Adult,M01.060.116
18763414,2008-07-01T00:00:00,Aged,M01.060.116.100
18763414,2008-07-01T00:00:00,Continental Population Groups,M01.686.508
18763414,2008-07-01T00:00:00,Ethnic Groups,M01.686.754
18763414,2008-07-01T00:00:00,Ethnic Groups,N01.224.317
18763414,2008-07-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18763414,2008-07-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18763414,2008-07-01T00:00:00,Health Status Disparities,I01.240.425.675
18763414,2008-07-01T00:00:00,Health Status Disparities,N01.224.425.437
18763414,2008-07-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
18763414,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18763414,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
18763414,2008-07-01T00:00:00,Stroke,C10.228.140.300.775
18763414,2008-07-01T00:00:00,Stroke,C14.907.253.855
18763414,2008-07-01T00:00:00,United States,Z01.107.567.875
18765128,2008-07-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.519.625.050.200.100
18765128,2008-07-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.696.577.050.200.100
18765128,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18765128,2008-07-01T00:00:00,Prostatic Hyperplasia,C12.294.565.500
18828322,2008-07-01T00:00:00,Biomedical Research,H01.770.644.145
18828322,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18828322,2008-07-01T00:00:00,Neoplasms,C04
18828322,2008-07-01T00:00:00,North Carolina,Z01.107.567.875.075.475
18828322,2008-07-01T00:00:00,North Carolina,Z01.107.567.875.750.530
19123750,2008-07-01T00:00:00,Adolescent,M01.060.057
19123750,2008-07-01T00:00:00,Adolescent Behavior,F01.145.022
19123750,2008-07-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19123750,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19123750,2008-07-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19123750,2008-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19123750,2008-07-01T00:00:00,Risk Factors,N05.715.350.200.700
19123750,2008-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19123750,2008-07-01T00:00:00,Risk Factors,N06.850.490.625.750
19123750,2008-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19123750,2008-07-01T00:00:00,Sex Factors,N05.715.350.675
19123750,2008-07-01T00:00:00,Sex Factors,N06.850.490.875
19123750,2008-07-01T00:00:00,Sex Offenses,I01.198.240.748
19123750,2008-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19123750,2008-07-01T00:00:00,Violence,I01.198.240.856
19123750,2008-07-01T00:00:00,Violence,I01.880.735.900
19149463,2008-07-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
19149463,2008-07-01T00:00:00,Alzheimer Disease,C10.574.945.249
19149463,2008-07-01T00:00:00,Alzheimer Disease,F03.087.400.100
19149463,2008-07-01T00:00:00,Animals,B01.050
19149463,2008-07-01T00:00:00,Blood-Brain Barrier,A07.035
19149463,2008-07-01T00:00:00,Blood-Brain Barrier,A08.186.211.035
19149463,2008-07-01T00:00:00,Contrast Media,D27.720.259
19149463,2008-07-01T00:00:00,Drug Delivery Systems,E02.319.300
19149463,2008-07-01T00:00:00,Gadolinium DTPA,D01.632.400
19149463,2008-07-01T00:00:00,Gadolinium DTPA,D02.092.782.590.401
19149463,2008-07-01T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
19149463,2008-07-01T00:00:00,Gadolinium DTPA,D02.691.400
19149463,2008-07-01T00:00:00,Hippocampus,A08.186.211.464.405
19149463,2008-07-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
19149463,2008-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19149463,2008-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19149463,2008-07-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
19149463,2008-07-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
19149463,2008-07-01T00:00:00,Phospholipids,D10.570.755
19149463,2008-07-01T00:00:00,Phospholipids,D10.695
19181153,2008-07-01T00:00:00,"Diagnosis, Differential",E01.171
19181153,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19181153,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
19181153,2008-07-01T00:00:00,Nurse Practitioners,M01.526.485.650.640
19181153,2008-07-01T00:00:00,Nurse Practitioners,N02.360.650.640
19181153,2008-07-01T00:00:00,Primary Health Care,N04.590.233.727
19808518,2008-07-01T00:00:00,Atrial Fibrillation,C14.280.067.198
19808518,2008-07-01T00:00:00,Atrial Fibrillation,C23.550.073.198
19808518,2008-07-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19808518,2008-07-01T00:00:00,Catheter Ablation,E02.148.110
19808518,2008-07-01T00:00:00,Catheter Ablation,E02.148.442.110
19808518,2008-07-01T00:00:00,Catheter Ablation,E02.154.402.110
19808518,2008-07-01T00:00:00,Catheter Ablation,E04.014.170.402.110
19808518,2008-07-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
19808518,2008-07-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
19808518,2008-07-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
19808518,2008-07-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
19808518,2008-07-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
19808518,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19808518,2008-07-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19808518,2008-07-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19808518,2008-07-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19808518,2008-07-01T00:00:00,Middle Aged,M01.060.116.630
19808518,2008-07-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
20021382,2008-07-01T00:00:00,Affect,F01.470.047
20021382,2008-07-01T00:00:00,Age Factors,N05.715.350.075
20021382,2008-07-01T00:00:00,Age Factors,N06.850.490.250
20021382,2008-07-01T00:00:00,Aging,G07.700.320.124
20021382,2008-07-01T00:00:00,Animals,B01.050
20021382,2008-07-01T00:00:00,Brain,A08.186.211
20021382,2008-07-01T00:00:00,Cognition Disorders,F03.087.250
20021382,2008-07-01T00:00:00,Depression,F01.145.126.350
20021382,2008-07-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20021382,2008-07-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20021382,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20021382,2008-07-01T00:00:00,Locomotion,G07.700.560.500
20021382,2008-07-01T00:00:00,Locomotion,G11.427.590.530.568
20021382,2008-07-01T00:00:00,"Models, Animal",E05.598
20021382,2008-07-01T00:00:00,Neurodegenerative Diseases,C10.574
20633380,2008-07-01T00:00:00,Brain,A08.186.211
20633380,2008-07-01T00:00:00,Electric Stimulation,E05.723.402
20633380,2008-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633380,2008-07-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
18596045,2008-07-02T00:00:00,Animals,B01.050
18596045,2008-07-02T00:00:00,Calcium,D01.268.552.100
18596045,2008-07-02T00:00:00,Calcium,D01.552.539.288
18596045,2008-07-02T00:00:00,Calcium,D23.119.100
18596045,2008-07-02T00:00:00,Cell Death,G04.299.139
18596045,2008-07-02T00:00:00,Ceramides,D02.065.313
18596045,2008-07-02T00:00:00,Ceramides,D09.400.410.420.525.200
18596045,2008-07-02T00:00:00,Ceramides,D10.390.470.675.200
18596045,2008-07-02T00:00:00,Ceramides,D10.570.877.360.612.200
18596045,2008-07-02T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
18596045,2008-07-02T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
18596045,2008-07-02T00:00:00,Oxidative Stress,G03.495.710
18596045,2008-07-02T00:00:00,Oxidative Stress,G07.700.830.750
18596045,2008-07-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18596045,2008-07-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18596045,2008-07-02T00:00:00,Sphingolipids,D10.570.877
18596045,2008-07-02T00:00:00,Sphingolipids,D10.808
18596684,2008-07-02T00:00:00,Animals,B01.050
18596684,2008-07-02T00:00:00,Dopamine,D02.092.211.215.311.342
18596684,2008-07-02T00:00:00,Dopamine,D02.092.311.342
18596684,2008-07-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
18596684,2008-07-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
18596684,2008-07-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
18596684,2008-07-02T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
18596684,2008-07-02T00:00:00,Ethanol,D02.033.375
18596684,2008-07-02T00:00:00,Glutamic Acid,D12.125.067.750
18596684,2008-07-02T00:00:00,Glutamic Acid,D12.125.119.450
18596684,2008-07-02T00:00:00,Glutamic Acid,D12.125.427.300
18596684,2008-07-02T00:00:00,Neurons,A08.663
18596684,2008-07-02T00:00:00,Neurons,A11.671
18596684,2008-07-02T00:00:00,Piperazines,D03.383.606
18596684,2008-07-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18596684,2008-07-02T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
18596684,2008-07-02T00:00:00,Synaptic Transmission,G02.111.087.800.850
18596684,2008-07-02T00:00:00,Synaptic Transmission,G02.149.115.800.850
18596684,2008-07-02T00:00:00,Synaptic Transmission,G04.299.880.850
18596684,2008-07-02T00:00:00,Synaptic Transmission,G07.265.337.900
18596684,2008-07-02T00:00:00,Synaptic Transmission,G07.700.240.900
18596684,2008-07-02T00:00:00,Synaptic Transmission,G11.561.600.835
18596684,2008-07-02T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
18596684,2008-07-02T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
18602156,2008-07-03T00:00:00,Animals,B01.050
18602156,2008-07-03T00:00:00,Biocompatible Materials,D25.130
18602156,2008-07-03T00:00:00,Biocompatible Materials,D27.720.102.130
18602156,2008-07-03T00:00:00,Biocompatible Materials,J01.637.051.130
18602156,2008-07-03T00:00:00,Cell Proliferation,G04.299.233.750
18602156,2008-07-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18602156,2008-07-03T00:00:00,Materials Testing,E05.570
18602156,2008-07-03T00:00:00,Molecular Structure,G02.111.570
18602156,2008-07-03T00:00:00,Molecular Structure,G02.575
18602156,2008-07-03T00:00:00,Molecular Structure,G02.842.575
18602156,2008-07-03T00:00:00,Printing,L01.737.787
18602156,2008-07-03T00:00:00,Swine,B01.050.150.900.649.077.880
18602156,2008-07-03T00:00:00,Tissue Engineering,E05.200.249.750
18602156,2008-07-03T00:00:00,Tissue Scaffolds,E07.206.627
18602156,2008-07-03T00:00:00,Tissue Scaffolds,E07.695.825
18627438,2008-07-03T00:00:00,Adult,M01.060.116
18627438,2008-07-03T00:00:00,Aged,M01.060.116.100
18627438,2008-07-03T00:00:00,Case-Control Studies,E05.318.760.500.500
18627438,2008-07-03T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18627438,2008-07-03T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18627438,2008-07-03T00:00:00,Diabetes Complications,C19.246.099
18627438,2008-07-03T00:00:00,Gingival Crevicular Fluid,A12.383.500
18627438,2008-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18627438,2008-07-03T00:00:00,Interleukin-6,D12.644.276.374.465.506
18627438,2008-07-03T00:00:00,Interleukin-6,D12.776.467.374.465.506
18627438,2008-07-03T00:00:00,Interleukin-6,D23.529.374.465.506
18627438,2008-07-03T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
18627438,2008-07-03T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
18627438,2008-07-03T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
18627438,2008-07-03T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
18627438,2008-07-03T00:00:00,Middle Aged,M01.060.116.630
18627438,2008-07-03T00:00:00,Periodontal Diseases,C07.465.714
18627438,2008-07-03T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18627438,2008-07-03T00:00:00,RNA,D13.444.735
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18627438,2008-07-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18627438,2008-07-03T00:00:00,Young Adult,M01.060.116.815
19057706,2008-07-03T00:00:00,Agriculture,J01.040
19057706,2008-07-03T00:00:00,Animals,B01.050
19057706,2008-07-03T00:00:00,Estradiol,D04.808.365.415.248
19057706,2008-07-03T00:00:00,Estradiol,D06.472.334.851.437.500
19057706,2008-07-03T00:00:00,Gonads,A05.360.576
19057706,2008-07-03T00:00:00,Gonads,A06.407.312
19057706,2008-07-03T00:00:00,Testosterone,D04.808.054.079.429.824
19057706,2008-07-03T00:00:00,Testosterone,D06.472.334.851.968.984
18655797,2008-07-04T00:00:00,Animals,B01.050
18655797,2008-07-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18655797,2008-07-04T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18655797,2008-07-04T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18655797,2008-07-04T00:00:00,Neurons,A08.663
18655797,2008-07-04T00:00:00,Neurons,A11.671
18655797,2008-07-04T00:00:00,Neuropeptides,D12.644.400
18655797,2008-07-04T00:00:00,Neuropeptides,D12.776.641.650
18655797,2008-07-04T00:00:00,Substance-Related Disorders,C21.739
18655797,2008-07-04T00:00:00,Substance-Related Disorders,F03.900
18606400,2008-07-07T00:00:00,Adult,M01.060.116
18606400,2008-07-07T00:00:00,Aged,M01.060.116.100
18606400,2008-07-07T00:00:00,Blood Pressure,E01.370.600.875.249
18606400,2008-07-07T00:00:00,Blood Pressure,G09.330.380.076
18606400,2008-07-07T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
18606400,2008-07-07T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
18606400,2008-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18606400,2008-07-07T00:00:00,Hypertension,C14.907.489
18606400,2008-07-07T00:00:00,Middle Aged,M01.060.116.630
18606400,2008-07-07T00:00:00,Nutrition Surveys,E05.318.308.250.600
18606400,2008-07-07T00:00:00,Nutrition Surveys,E05.318.308.585.550
18606400,2008-07-07T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
18606400,2008-07-07T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
18606400,2008-07-07T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
18606400,2008-07-07T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
18606400,2008-07-07T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
18606400,2008-07-07T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
18606400,2008-07-07T00:00:00,Sensitivity and Specificity,E05.318.740.872
18606400,2008-07-07T00:00:00,Sensitivity and Specificity,E05.318.780.800
18606400,2008-07-07T00:00:00,Sensitivity and Specificity,G17.800
18606400,2008-07-07T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18606400,2008-07-07T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18606400,2008-07-07T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18606400,2008-07-07T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18606613,2008-07-07T00:00:00,Adolescent,M01.060.057
18606613,2008-07-07T00:00:00,Coronary Aneurysm,C14.280.647.250.250
18606613,2008-07-07T00:00:00,Coronary Aneurysm,C14.907.055.395
18606613,2008-07-07T00:00:00,Coronary Aneurysm,C14.907.585.250.250
18606613,2008-07-07T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18606613,2008-07-07T00:00:00,Coronary Angiography,E01.370.370.050.200
18606613,2008-07-07T00:00:00,Coronary Angiography,E01.370.370.380.200
18606613,2008-07-07T00:00:00,Coronary Artery Bypass,E04.100.376.719.332
18606613,2008-07-07T00:00:00,Coronary Artery Bypass,E04.928.220.520.220
18606613,2008-07-07T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
18606613,2008-07-07T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
18606613,2008-07-07T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
18606613,2008-07-07T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
18606613,2008-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18606613,2008-07-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18606613,2008-07-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18606613,2008-07-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18606613,2008-07-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18606613,2008-07-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18606817,2008-07-07T00:00:00,Cell Movement,G04.299.283
18606817,2008-07-07T00:00:00,Cell Movement,G07.700.560.500.180
18606817,2008-07-07T00:00:00,Endothelial Cells,A11.436.275
18606817,2008-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18606817,2008-07-07T00:00:00,"Lipoproteins, HDL",D10.532.432
18606817,2008-07-07T00:00:00,"Lipoproteins, HDL",D12.776.521.479
18606817,2008-07-07T00:00:00,Lysophospholipids,D10.570.755.375.760.550
18606817,2008-07-07T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18606817,2008-07-07T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18606817,2008-07-07T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18606817,2008-07-07T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
18606817,2008-07-07T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
18606817,2008-07-07T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18606817,2008-07-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18606817,2008-07-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18606817,2008-07-07T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
18606817,2008-07-07T00:00:00,Sphingosine,D02.033.100.700
18606817,2008-07-07T00:00:00,Sphingosine,D02.033.455.843
18606817,2008-07-07T00:00:00,Sphingosine,D02.092.063.700
18598886,2008-07-08T00:00:00,Adolescent,M01.060.057
18598886,2008-07-08T00:00:00,Age Factors,N05.715.350.075
18598886,2008-07-08T00:00:00,Age Factors,N06.850.490.250
18598886,2008-07-08T00:00:00,Child,M01.060.406
18598886,2008-07-08T00:00:00,"Child, Preschool",M01.060.406.448
18598886,2008-07-08T00:00:00,Exercise,G11.427.590.237
18598886,2008-07-08T00:00:00,Exercise,I03.350
18598886,2008-07-08T00:00:00,Fontan Procedure,E04.035.410.295
18598886,2008-07-08T00:00:00,Fontan Procedure,E04.100.376.410.295
18598886,2008-07-08T00:00:00,Fontan Procedure,E04.928.220.370.295
18598886,2008-07-08T00:00:00,Health Status,I01.240.425
18598886,2008-07-08T00:00:00,Health Status,N01.224.425
18598886,2008-07-08T00:00:00,Health Status,N06.850.505.400.425
18598886,2008-07-08T00:00:00,Heart,A07.541
18598886,2008-07-08T00:00:00,"Heart Defects, Congenital",C14.240.400
18598886,2008-07-08T00:00:00,"Heart Defects, Congenital",C14.280.400
18598886,2008-07-08T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18598886,2008-07-08T00:00:00,Heart Ventricles,A07.541.560
18598886,2008-07-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18598886,2008-07-08T00:00:00,Sex Factors,N05.715.350.675
18598886,2008-07-08T00:00:00,Sex Factors,N06.850.490.875
18598886,2008-07-08T00:00:00,Treatment Outcome,E01.789.800
18598886,2008-07-08T00:00:00,Treatment Outcome,N04.761.559.590.800
18598886,2008-07-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18612598,2008-07-09T00:00:00,"Colony Count, Microbial",E05.200.875.220
18612598,2008-07-09T00:00:00,Escherichia coli,B03.440.450.425.325.300
18612598,2008-07-09T00:00:00,Escherichia coli,B03.660.250.150.180.100
18612598,2008-07-09T00:00:00,Gene Expression Profiling,E05.393.332
18612598,2008-07-09T00:00:00,Recombinant Proteins,D12.776.828
18612598,2008-07-09T00:00:00,Serine,D12.125.154.800
18612598,2008-07-09T00:00:00,Serine,D12.125.837
18614141,2008-07-09T00:00:00,Adult,M01.060.116
18614141,2008-07-09T00:00:00,Aged,M01.060.116.100
18614141,2008-07-09T00:00:00,Breast Neoplasms,C04.588.180
18614141,2008-07-09T00:00:00,Breast Neoplasms,C17.800.090.500
18614141,2008-07-09T00:00:00,Decision Making,F02.463.785.373
18614141,2008-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18614141,2008-07-09T00:00:00,Middle Aged,M01.060.116.630
18614141,2008-07-09T00:00:00,"Quality Indicators, Health Care",N04.761.789
17968859,2008-07-10T00:00:00,Environmental Pollutants,D27.888.284
17968859,2008-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17968859,2008-07-10T00:00:00,Lung Neoplasms,C04.588.894.797.520
17968859,2008-07-10T00:00:00,Lung Neoplasms,C08.381.540
17968859,2008-07-10T00:00:00,Lung Neoplasms,C08.785.520
17968859,2008-07-10T00:00:00,"Models, Statistical",E05.318.740.500
17968859,2008-07-10T00:00:00,"Models, Statistical",E05.599.835
17968859,2008-07-10T00:00:00,"Models, Statistical",N05.715.360.750.530
17968859,2008-07-10T00:00:00,"Models, Statistical",N06.850.520.830.500
17968859,2008-07-10T00:00:00,Regression Analysis,E05.318.740.750
17968859,2008-07-10T00:00:00,Regression Analysis,N05.715.360.750.695
17968859,2008-07-10T00:00:00,Regression Analysis,N06.850.520.830.750
17968859,2008-07-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
17968859,2008-07-10T00:00:00,Risk Assessment,N04.452.871.715
17968859,2008-07-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17968859,2008-07-10T00:00:00,Risk Assessment,N06.850.505.715
17968859,2008-07-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17968859,2008-07-10T00:00:00,South Carolina,Z01.107.567.875.075.662
17968859,2008-07-10T00:00:00,South Carolina,Z01.107.567.875.750.700
18648136,2008-07-10T00:00:00,Aged,M01.060.116.100
18648136,2008-07-10T00:00:00,"Blood Loss, Surgical",C23.550.414.300
18648136,2008-07-10T00:00:00,"Blood Loss, Surgical",C23.550.505.300
18648136,2008-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18648136,2008-07-10T00:00:00,Kidney Neoplasms,C04.588.945.947.535
18648136,2008-07-10T00:00:00,Kidney Neoplasms,C12.758.820.750
18648136,2008-07-10T00:00:00,Kidney Neoplasms,C12.777.419.473
18648136,2008-07-10T00:00:00,Kidney Neoplasms,C13.351.937.820.535
18648136,2008-07-10T00:00:00,Kidney Neoplasms,C13.351.968.419.473
18648136,2008-07-10T00:00:00,Middle Aged,M01.060.116.630
18648136,2008-07-10T00:00:00,Nephrectomy,E04.950.774.435
18648136,2008-07-10T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18648136,2008-07-10T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18648136,2008-07-10T00:00:00,Pancreaticoduodenectomy,E04.210.760
18648136,2008-07-10T00:00:00,Patient Selection,E05.581.500.653
18648136,2008-07-10T00:00:00,Patient Selection,N04.590.731
18648136,2008-07-10T00:00:00,Retroperitoneal Neoplasms,C04.588.033.731
18620566,2008-07-11T00:00:00,Animals,B01.050
18620566,2008-07-11T00:00:00,Blood Vessels,A07.231
18620566,2008-07-11T00:00:00,Catheter Ablation,E01.370.370.380.410.200
18620566,2008-07-11T00:00:00,Catheter Ablation,E02.148.110
18620566,2008-07-11T00:00:00,Catheter Ablation,E02.148.442.110
18620566,2008-07-11T00:00:00,Catheter Ablation,E02.154.402.110
18620566,2008-07-11T00:00:00,Catheter Ablation,E04.014.170.402.110
18620566,2008-07-11T00:00:00,Computer Simulation,L01.224.160
18620566,2008-07-11T00:00:00,Energy Transfer,G01.154.100.240
18620566,2008-07-11T00:00:00,Energy Transfer,G01.595.100.240
18620566,2008-07-11T00:00:00,Energy Transfer,G02.111.087.242
18620566,2008-07-11T00:00:00,Energy Transfer,G02.149.115.242
18620566,2008-07-11T00:00:00,Energy Transfer,G02.149.767.580
18620566,2008-07-11T00:00:00,Energy Transfer,G02.842.750.580
18620566,2008-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18620566,2008-07-11T00:00:00,"Models, Biological",E05.599.395
18620566,2008-07-11T00:00:00,Neoplasms,C04
18620566,2008-07-11T00:00:00,Temperature,G01.906.595
18620566,2008-07-11T00:00:00,Temperature,G16.500.275.063.725.710
18620566,2008-07-11T00:00:00,Temperature,G16.500.750.775.710
18620566,2008-07-11T00:00:00,Temperature,N06.230.150.450
18620566,2008-07-11T00:00:00,Temperature,N06.230.300.100.725.710
18637139,2008-07-11T00:00:00,Chronic Disease,C23.550.291.500
18637139,2008-07-11T00:00:00,Decision Support Techniques,E05.245
18637139,2008-07-11T00:00:00,Decision Support Techniques,L01.700.508.190
18637139,2008-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18637139,2008-07-11T00:00:00,Internet,L01.224.230.110.500
18637139,2008-07-11T00:00:00,Mass Screening,E01.370.500
18637139,2008-07-11T00:00:00,Mass Screening,E05.318.308.250.580
18637139,2008-07-11T00:00:00,Mass Screening,N02.421.143.827.233.443
18637139,2008-07-11T00:00:00,Mass Screening,N02.421.726.233.443
18637139,2008-07-11T00:00:00,Mass Screening,N05.715.360.300.375.500
18637139,2008-07-11T00:00:00,Mass Screening,N06.850.520.308.250.580
18637139,2008-07-11T00:00:00,Mass Screening,N06.850.780.500
18637139,2008-07-11T00:00:00,Middle Aged,M01.060.116.630
18637139,2008-07-11T00:00:00,Patient Preference,N04.452.822.360.600.500
18637139,2008-07-11T00:00:00,Patient Preference,N05.300.150.600.630.500
18637139,2008-07-11T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
18637139,2008-07-11T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
18637139,2008-07-11T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
18637139,2008-07-11T00:00:00,Prostate-Specific Antigen,D23.050.285.625
18637139,2008-07-11T00:00:00,Prostate-Specific Antigen,D23.101.840.625
18637139,2008-07-11T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18637139,2008-07-11T00:00:00,Prostatic Neoplasms,C12.294.260.750
18637139,2008-07-11T00:00:00,Prostatic Neoplasms,C12.294.565.625
18637139,2008-07-11T00:00:00,Prostatic Neoplasms,C12.758.409.750
18637139,2008-07-11T00:00:00,Quality of Life,I01.800
18637139,2008-07-11T00:00:00,Quality of Life,K01.752.400.750
18620382,2008-07-12T00:00:00,Animals,B01.050
18620382,2008-07-12T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
18620382,2008-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18620382,2008-07-12T00:00:00,"Models, Molecular",E05.599.595
18620382,2008-07-12T00:00:00,Molecular Structure,G02.111.570
18620382,2008-07-12T00:00:00,Molecular Structure,G02.575
18620382,2008-07-12T00:00:00,Molecular Structure,G02.842.575
18620382,2008-07-12T00:00:00,Neoplasms,C04
18620382,2008-07-12T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
18620382,2008-07-12T00:00:00,Pyrimidines,D03.383.742
18622703,2008-07-12T00:00:00,Animals,B01.050
18622703,2008-07-12T00:00:00,Collagen,D05.750.078.280
18622703,2008-07-12T00:00:00,Collagen,D12.776.860.300.250
18622703,2008-07-12T00:00:00,Elastin,D05.750.078.421
18622703,2008-07-12T00:00:00,Elastin,D12.776.860.300.350
18622703,2008-07-12T00:00:00,"Muscle, Smooth",A02.633.570
18622703,2008-07-12T00:00:00,"Muscle, Smooth",A10.690.467
18622703,2008-07-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18622703,2008-07-12T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18622703,2008-07-12T00:00:00,Spinal Cord Injuries,C10.228.854.770
18622703,2008-07-12T00:00:00,Spinal Cord Injuries,C10.900.850
18622703,2008-07-12T00:00:00,Spinal Cord Injuries,C21.866.819
18622703,2008-07-12T00:00:00,"Stress, Mechanical",G01.374.676.830
18622703,2008-07-12T00:00:00,"Stress, Mechanical",G01.595.540.830
18622703,2008-07-12T00:00:00,Urinary Bladder,A05.810.890
18637086,2008-07-12T00:00:00,Adult,M01.060.116
18637086,2008-07-12T00:00:00,Catheterization,E02.148
18637086,2008-07-12T00:00:00,Catheterization,E05.157
18637086,2008-07-12T00:00:00,Deglutition,G10.261.326.215
18637086,2008-07-12T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
18637086,2008-07-12T00:00:00,Fluoroscopy,E01.370.350.700.225
18637086,2008-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18637086,2008-07-12T00:00:00,Manometry,E05.559
18637086,2008-07-12T00:00:00,Middle Aged,M01.060.116.630
18625544,2008-07-14T00:00:00,Animals,B01.050
18625544,2008-07-14T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
18625544,2008-07-14T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
18625544,2008-07-14T00:00:00,Cell Adhesion Molecules,D23.050.301.350
18625544,2008-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18625544,2008-07-14T00:00:00,Lung Neoplasms,C04.588.894.797.520
18625544,2008-07-14T00:00:00,Lung Neoplasms,C08.381.540
18625544,2008-07-14T00:00:00,Lung Neoplasms,C08.785.520
18625544,2008-07-14T00:00:00,Nerve Tissue Proteins,D12.776.641
18625544,2008-07-14T00:00:00,Semaphorins,D12.644.276.923
18625544,2008-07-14T00:00:00,Semaphorins,D12.776.467.923
18625544,2008-07-14T00:00:00,Semaphorins,D23.529.923
18625544,2008-07-14T00:00:00,Signal Transduction,G02.111.087.800
18625544,2008-07-14T00:00:00,Signal Transduction,G02.149.115.800
18625544,2008-07-14T00:00:00,Signal Transduction,G04.299.880
18625914,2008-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18625914,2008-07-14T00:00:00,Lipopolysaccharides,D09.400.500
18625914,2008-07-14T00:00:00,Lipopolysaccharides,D09.698.718.450
18625914,2008-07-14T00:00:00,Lipopolysaccharides,D10.494
18625914,2008-07-14T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18625914,2008-07-14T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18625914,2008-07-14T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
18625914,2008-07-14T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
18625914,2008-07-14T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
18625914,2008-07-14T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
18625914,2008-07-14T00:00:00,Neoplasm Proteins,D12.776.624
18625914,2008-07-14T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18625914,2008-07-14T00:00:00,Transcription Factors,D12.776.930
18457330,2008-07-15T00:00:00,Adolescent,M01.060.057
18457330,2008-07-15T00:00:00,Adult,M01.060.116
18457330,2008-07-15T00:00:00,Aged,M01.060.116.100
18457330,2008-07-15T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
18457330,2008-07-15T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
18457330,2008-07-15T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
18457330,2008-07-15T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
18457330,2008-07-15T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
18457330,2008-07-15T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
18457330,2008-07-15T00:00:00,Child,M01.060.406
18457330,2008-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18457330,2008-07-15T00:00:00,Interleukin-2,D12.644.276.374.465.502
18457330,2008-07-15T00:00:00,Interleukin-2,D12.644.276.374.480.372
18457330,2008-07-15T00:00:00,Interleukin-2,D12.776.467.374.465.502
18457330,2008-07-15T00:00:00,Interleukin-2,D12.776.467.374.480.372
18457330,2008-07-15T00:00:00,Interleukin-2,D23.529.374.465.502
18457330,2008-07-15T00:00:00,Interleukin-2,D23.529.374.480.372
18457330,2008-07-15T00:00:00,Middle Aged,M01.060.116.630
18457330,2008-07-15T00:00:00,United States,Z01.107.567.875
18606658,2008-07-15T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18606658,2008-07-15T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18606658,2008-07-15T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18606658,2008-07-15T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18606658,2008-07-15T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18606658,2008-07-15T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18606658,2008-07-15T00:00:00,Cytokines,D12.644.276.374
18606658,2008-07-15T00:00:00,Cytokines,D12.776.467.374
18606658,2008-07-15T00:00:00,Cytokines,D23.529.374
18606658,2008-07-15T00:00:00,Genetic Vectors,G05.360.337
18606658,2008-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18606658,2008-07-15T00:00:00,Melanoma,C04.557.465.625.650.510
18606658,2008-07-15T00:00:00,Melanoma,C04.557.580.625.650.510
18606658,2008-07-15T00:00:00,Melanoma,C04.557.665.510
18606658,2008-07-15T00:00:00,Neoplasm Proteins,D12.776.624
18606658,2008-07-15T00:00:00,"Receptors, Antigen, T-Cell",D12.776.543.750.705.816.824
18628568,2008-07-15T00:00:00,Adult,M01.060.116
18628568,2008-07-15T00:00:00,Albuminuria,C12.777.934.734.269
18628568,2008-07-15T00:00:00,Albuminuria,C13.351.968.934.734.269
18628568,2008-07-15T00:00:00,Albuminuria,C23.888.942.750.269
18628568,2008-07-15T00:00:00,Biological Markers,D23.101
18628568,2008-07-15T00:00:00,C-Reactive Protein,D12.776.034.145
18628568,2008-07-15T00:00:00,C-Reactive Protein,D12.776.124.050.120
18628568,2008-07-15T00:00:00,C-Reactive Protein,D12.776.124.486.157
18628568,2008-07-15T00:00:00,Carotid Arteries,A07.231.114.186
18628568,2008-07-15T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18628568,2008-07-15T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18628568,2008-07-15T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18628568,2008-07-15T00:00:00,Diabetic Angiopathies,C14.907.320
18628568,2008-07-15T00:00:00,Diabetic Angiopathies,C19.246.099.500
18628568,2008-07-15T00:00:00,Diabetic Nephropathies,C12.777.419.192
18628568,2008-07-15T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
18628568,2008-07-15T00:00:00,Diabetic Nephropathies,C19.246.099.875
18628568,2008-07-15T00:00:00,"Endothelium, Vascular",A07.231.330
18628568,2008-07-15T00:00:00,"Endothelium, Vascular",A10.272.491.355
18628568,2008-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18628568,2008-07-15T00:00:00,Inflammation,C23.550.470
18628568,2008-07-15T00:00:00,Middle Aged,M01.060.116.630
18628568,2008-07-15T00:00:00,"Models, Statistical",E05.318.740.500
18628568,2008-07-15T00:00:00,"Models, Statistical",E05.599.835
18628568,2008-07-15T00:00:00,"Models, Statistical",N05.715.360.750.530
18628568,2008-07-15T00:00:00,"Models, Statistical",N06.850.520.830.500
18628568,2008-07-15T00:00:00,Regression Analysis,E05.318.740.750
18628568,2008-07-15T00:00:00,Regression Analysis,N05.715.360.750.695
18628568,2008-07-15T00:00:00,Regression Analysis,N06.850.520.830.750
18628568,2008-07-15T00:00:00,Risk Factors,E05.318.740.600.800.725
18628568,2008-07-15T00:00:00,Risk Factors,N05.715.350.200.700
18628568,2008-07-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18628568,2008-07-15T00:00:00,Risk Factors,N06.850.490.625.750
18628568,2008-07-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18632158,2008-07-15T00:00:00,Aged,M01.060.116.100
18632158,2008-07-15T00:00:00,Body Mass Index,E01.370.600.115.100.125
18632158,2008-07-15T00:00:00,Body Mass Index,E05.041.124.125
18632158,2008-07-15T00:00:00,Body Mass Index,G07.100.100.125
18632158,2008-07-15T00:00:00,Body Mass Index,N06.850.505.200.100.175
18632158,2008-07-15T00:00:00,Case-Control Studies,E05.318.760.500.500
18632158,2008-07-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18632158,2008-07-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18632158,2008-07-15T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18632158,2008-07-15T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18632158,2008-07-15T00:00:00,Hispanic Americans,M01.686.754.441
18632158,2008-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18632158,2008-07-15T00:00:00,Immunoglobulin Allotypes,D12.776.124.486.485.114.606
18632158,2008-07-15T00:00:00,Immunoglobulin Allotypes,D12.776.124.790.651.114.606
18632158,2008-07-15T00:00:00,Immunoglobulin Allotypes,D12.776.377.715.548.114.606
18632158,2008-07-15T00:00:00,Immunoglobulin Allotypes,G12.500.400
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
18632158,2008-07-15T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
18632158,2008-07-15T00:00:00,Middle Aged,M01.060.116.630
18632158,2008-07-15T00:00:00,Obesity,C18.654.726.500
18632158,2008-07-15T00:00:00,Obesity,C23.888.144.699.500
18632158,2008-07-15T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18632158,2008-07-15T00:00:00,Obesity,G07.100.100.160.120.699.500
18632158,2008-07-15T00:00:00,United States,Z01.107.567.875
18596607,2008-07-16T00:00:00,Adult,M01.060.116
18596607,2008-07-16T00:00:00,Brain,A08.186.211
18596607,2008-07-16T00:00:00,Cognition,F02.463.188
18596607,2008-07-16T00:00:00,Functional Laterality,F02.830.297.425
18596607,2008-07-16T00:00:00,Functional Laterality,G11.561.225.425
18596607,2008-07-16T00:00:00,Gyrus Cinguli,A08.186.211.464.330
18596607,2008-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18596607,2008-07-16T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18596607,2008-07-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18596607,2008-07-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18596607,2008-07-16T00:00:00,Mathematics,H01.548
18596607,2008-07-16T00:00:00,Neural Pathways,A08.612
18596607,2008-07-16T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
18596607,2008-07-16T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18632797,2008-07-16T00:00:00,Animals,B01.050
18632797,2008-07-16T00:00:00,Bradykinin,D12.644.276.812.169
18632797,2008-07-16T00:00:00,Bradykinin,D12.644.400.090
18632797,2008-07-16T00:00:00,Bradykinin,D12.644.456.193
18632797,2008-07-16T00:00:00,Bradykinin,D12.776.467.812.169
18632797,2008-07-16T00:00:00,Bradykinin,D12.776.641.650.090
18632797,2008-07-16T00:00:00,Bradykinin,D23.469.050.375.110
18632797,2008-07-16T00:00:00,Bradykinin,D23.529.812.169
18632797,2008-07-16T00:00:00,Kinins,D12.644.276.812
18632797,2008-07-16T00:00:00,Kinins,D12.776.467.812
18632797,2008-07-16T00:00:00,Kinins,D23.469.050.375
18632797,2008-07-16T00:00:00,Kinins,D23.529.812
18632797,2008-07-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18632797,2008-07-16T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18632797,2008-07-16T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
18632797,2008-07-16T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
18632797,2008-07-16T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
18632797,2008-07-16T00:00:00,Renal Circulation,G08.852.796.700
18632797,2008-07-16T00:00:00,Renal Circulation,G09.330.190.163.812
18632797,2008-07-16T00:00:00,Sodium,D01.268.549.750
18632797,2008-07-16T00:00:00,Sodium,D01.552.528.850
18675832,2008-07-16T00:00:00,Animals,B01.050
18675832,2008-07-16T00:00:00,Glutamic Acid,D12.125.067.750
18675832,2008-07-16T00:00:00,Glutamic Acid,D12.125.119.450
18675832,2008-07-16T00:00:00,Glutamic Acid,D12.125.427.300
18675832,2008-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18675832,2008-07-16T00:00:00,Substance-Related Disorders,C21.739
18675832,2008-07-16T00:00:00,Substance-Related Disorders,F03.900
18675832,2008-07-16T00:00:00,Synaptic Transmission,G02.111.087.800.850
18675832,2008-07-16T00:00:00,Synaptic Transmission,G02.149.115.800.850
18675832,2008-07-16T00:00:00,Synaptic Transmission,G04.299.880.850
18675832,2008-07-16T00:00:00,Synaptic Transmission,G07.265.337.900
18675832,2008-07-16T00:00:00,Synaptic Transmission,G07.700.240.900
18675832,2008-07-16T00:00:00,Synaptic Transmission,G11.561.600.835
18635653,2008-07-17T00:00:00,Animals,B01.050
18635653,2008-07-17T00:00:00,"Evolution, Molecular",G05.355.265.250
18635653,2008-07-17T00:00:00,"Evolution, Molecular",G16.100.275.250
18635653,2008-07-17T00:00:00,Fishes,B01.050.150.900.493
18635653,2008-07-17T00:00:00,Molecular Sequence Data,L01.453.245.667
18635653,2008-07-17T00:00:00,Phylogeny,G05.697
18635653,2008-07-17T00:00:00,Phylogeny,G16.100.275.605
18635653,2008-07-17T00:00:00,Phylogeny,L01.100.697
18635653,2008-07-17T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
18635653,2008-07-17T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
18635653,2008-07-17T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
18635653,2008-07-17T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
18635653,2008-07-17T00:00:00,"Transcription, Genetic",G02.111.087.847
18635653,2008-07-17T00:00:00,"Transcription, Genetic",G02.149.115.847
18635653,2008-07-17T00:00:00,"Transcription, Genetic",G05.355.310.700
18639205,2008-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18639205,2008-07-17T00:00:00,Incidence,E05.318.308.985.525.375
18639205,2008-07-17T00:00:00,Incidence,L01.280.975.525.375
18639205,2008-07-17T00:00:00,Incidence,N01.224.935.597.500
18639205,2008-07-17T00:00:00,Incidence,N06.850.505.400.975.525.375
18639205,2008-07-17T00:00:00,Incidence,N06.850.520.308.985.525.375
18639205,2008-07-17T00:00:00,Pregnancy,G08.686.785.760.769
18639205,2008-07-17T00:00:00,Probability,E05.318.740.600
18639205,2008-07-17T00:00:00,Probability,G17.680
18639205,2008-07-17T00:00:00,Probability,N05.715.360.750.625
18639205,2008-07-17T00:00:00,Probability,N06.850.520.830.600
18639205,2008-07-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
18639205,2008-07-17T00:00:00,Risk Assessment,N04.452.871.715
18639205,2008-07-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18639205,2008-07-17T00:00:00,Risk Assessment,N06.850.505.715
18639205,2008-07-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18639205,2008-07-17T00:00:00,Sensitivity and Specificity,E05.318.740.872
18639205,2008-07-17T00:00:00,Sensitivity and Specificity,E05.318.780.800
18639205,2008-07-17T00:00:00,Sensitivity and Specificity,G17.800
18639205,2008-07-17T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18639205,2008-07-17T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18639205,2008-07-17T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18639205,2008-07-17T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18639205,2008-07-17T00:00:00,Suture Techniques,E04.901
18639297,2008-07-17T00:00:00,Adrenergic alpha-Antagonists,D27.505.519.625.050.200.100
18639297,2008-07-17T00:00:00,Adrenergic alpha-Antagonists,D27.505.696.577.050.200.100
18639297,2008-07-17T00:00:00,Adult,M01.060.116
18639297,2008-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18639297,2008-07-17T00:00:00,Middle Aged,M01.060.116.630
18639297,2008-07-17T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
18639297,2008-07-17T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
18639297,2008-07-17T00:00:00,Patient Satisfaction,N04.452.822.360.600
18639297,2008-07-17T00:00:00,Patient Satisfaction,N05.300.150.600.630
18639297,2008-07-17T00:00:00,Patient Satisfaction,N05.715.360.600
18639297,2008-07-17T00:00:00,Prostatic Hyperplasia,C12.294.565.500
18639297,2008-07-17T00:00:00,Questionnaires,E05.318.308.750
18639297,2008-07-17T00:00:00,Questionnaires,L01.280.800
18639297,2008-07-17T00:00:00,Questionnaires,N05.715.360.300.695
18639297,2008-07-17T00:00:00,Questionnaires,N06.850.520.308.750
18639297,2008-07-17T00:00:00,Treatment Outcome,E01.789.800
18639297,2008-07-17T00:00:00,Treatment Outcome,N04.761.559.590.800
18639297,2008-07-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18639297,2008-07-17T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
18639297,2008-07-17T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
18639297,2008-07-17T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
18639327,2008-07-17T00:00:00,Aged,M01.060.116.100
18639327,2008-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18639327,2008-07-17T00:00:00,Middle Aged,M01.060.116.630
18639327,2008-07-17T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
18639327,2008-07-17T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
18639327,2008-07-17T00:00:00,Treatment Outcome,E01.789.800
18639327,2008-07-17T00:00:00,Treatment Outcome,N04.761.559.590.800
18639327,2008-07-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18639327,2008-07-17T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
18639327,2008-07-17T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
18639327,2008-07-17T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
18639327,2008-07-17T00:00:00,Urinary Incontinence,C12.777.934.852
18639327,2008-07-17T00:00:00,Urinary Incontinence,C13.351.968.934.814
18639327,2008-07-17T00:00:00,Urinary Incontinence,C23.888.942.800
18639448,2008-07-17T00:00:00,Animals,B01.050
18639448,2008-07-17T00:00:00,Bone and Bones,A02.835.232
18639448,2008-07-17T00:00:00,Bone and Bones,A10.165.265
18641105,2008-07-18T00:00:00,Adult,M01.060.116
18641105,2008-07-18T00:00:00,Aged,M01.060.116.100
18641105,2008-07-18T00:00:00,Bronchoscopy,E01.370.386.105
18641105,2008-07-18T00:00:00,Bronchoscopy,E01.370.388.250.100
18641105,2008-07-18T00:00:00,Bronchoscopy,E04.800.250.100
18641105,2008-07-18T00:00:00,Bronchoscopy,E04.928.600.080
18641105,2008-07-18T00:00:00,Conscious Sedation,E03.250
18641105,2008-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18641105,2008-07-18T00:00:00,Middle Aged,M01.060.116.630
18641105,2008-07-18T00:00:00,Patient Satisfaction,N04.452.822.360.600
18641105,2008-07-18T00:00:00,Patient Satisfaction,N05.300.150.600.630
18641105,2008-07-18T00:00:00,Patient Satisfaction,N05.715.360.600
18641105,2008-07-18T00:00:00,Propofol,D02.755.773
18641105,2008-07-18T00:00:00,Treatment Outcome,E01.789.800
18641105,2008-07-18T00:00:00,Treatment Outcome,N04.761.559.590.800
18641105,2008-07-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18641105,2008-07-18T00:00:00,Young Adult,M01.060.116.815
18687355,2008-07-18T00:00:00,Adolescent,M01.060.057
18687355,2008-07-18T00:00:00,Adult,M01.060.116
18687355,2008-07-18T00:00:00,Aged,M01.060.116.100
18687355,2008-07-18T00:00:00,Community Networks,I01.880.656.300
18687355,2008-07-18T00:00:00,Community Networks,L01.700.508.300.184
18687355,2008-07-18T00:00:00,Community Networks,N02.421.143.202
18687355,2008-07-18T00:00:00,Health Policy,I01.880.604.825.608.400
18687355,2008-07-18T00:00:00,Health Policy,N03.706.825.608.428
18687355,2008-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18687355,2008-07-18T00:00:00,Middle Aged,M01.060.116.630
18687355,2008-07-18T00:00:00,New York City,Z01.107.567.875.350.530.530
18687355,2008-07-18T00:00:00,New York City,Z01.107.567.875.500.530.530
18687355,2008-07-18T00:00:00,New York City,Z01.433.741
18687355,2008-07-18T00:00:00,Program Evaluation,E05.337.820
18687355,2008-07-18T00:00:00,Program Evaluation,N04.761.685
18687355,2008-07-18T00:00:00,Program Evaluation,N05.715.360.650
18687355,2008-07-18T00:00:00,Smoking,F01.145.466.753
18687355,2008-07-18T00:00:00,Smoking Cessation,F01.145.940.700
18687355,2008-07-18T00:00:00,Young Adult,M01.060.116.815
18692156,2008-07-19T00:00:00,Animals,B01.050
18692156,2008-07-19T00:00:00,Skin Neoplasms,C04.588.805
18692156,2008-07-19T00:00:00,Skin Neoplasms,C17.800.882
18189338,2008-07-20T00:00:00,Algorithms,G17.035
18189338,2008-07-20T00:00:00,Algorithms,L01.224.050
18189338,2008-07-20T00:00:00,Clinical Trials as Topic,E05.318.760.535
18189338,2008-07-20T00:00:00,Clinical Trials as Topic,E05.337.250
18189338,2008-07-20T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18189338,2008-07-20T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18189338,2008-07-20T00:00:00,Computer Simulation,L01.224.160
18189338,2008-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18189338,2008-07-20T00:00:00,"Models, Statistical",E05.318.740.500
18189338,2008-07-20T00:00:00,"Models, Statistical",E05.599.835
18189338,2008-07-20T00:00:00,"Models, Statistical",N05.715.360.750.530
18189338,2008-07-20T00:00:00,"Models, Statistical",N06.850.520.830.500
18189338,2008-07-20T00:00:00,Parkinson Disease,C10.228.140.079.862.500
18189338,2008-07-20T00:00:00,Parkinson Disease,C10.228.662.600.400
18189338,2008-07-20T00:00:00,Parkinson Disease,C10.574.812
18189338,2008-07-20T00:00:00,Poisson Distribution,E05.318.740.994.750
18189338,2008-07-20T00:00:00,Poisson Distribution,G17.820.750
18189338,2008-07-20T00:00:00,Poisson Distribution,N05.715.360.750.750.620
18189338,2008-07-20T00:00:00,Poisson Distribution,N06.850.520.830.994.750
18189338,2008-07-20T00:00:00,Research Design,E05.581.500
18189338,2008-07-20T00:00:00,Research Design,H01.770.644.728
18645184,2008-07-21T00:00:00,Animals,B01.050
18645184,2008-07-21T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18645184,2008-07-21T00:00:00,Electroencephalography,E01.370.376.300
18645184,2008-07-21T00:00:00,Electroencephalography,E01.370.405.245
18645184,2008-07-21T00:00:00,Neurons,A08.663
18645184,2008-07-21T00:00:00,Neurons,A11.671
18645184,2008-07-21T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.260.108.765
18645184,2008-07-21T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.624.664.700.179
18645184,2008-07-21T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.660.760
18645184,2008-07-21T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.930.127.765
18645184,2008-07-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18645184,2008-07-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18645184,2008-07-21T00:00:00,Sleep,F02.830.855
18645184,2008-07-21T00:00:00,Sleep,G11.561.600.815
18645184,2008-07-21T00:00:00,Wakefulness,F02.830.104.821
18645184,2008-07-21T00:00:00,Wakefulness,G11.561.600.042.738
18648075,2008-07-22T00:00:00,Adolescent,M01.060.057
18648075,2008-07-22T00:00:00,Body Weight,C23.888.144
18648075,2008-07-22T00:00:00,Body Weight,E01.370.600.115.100.160.120
18648075,2008-07-22T00:00:00,Body Weight,E05.041.124.160.750
18648075,2008-07-22T00:00:00,Body Weight,G07.100.100.160.120
18648075,2008-07-22T00:00:00,Body Weight,G07.700.320.249.314.120
18648075,2008-07-22T00:00:00,Child,M01.060.406
18648075,2008-07-22T00:00:00,"Child, Preschool",M01.060.406.448
18648075,2008-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18648075,2008-07-22T00:00:00,Infant,M01.060.703
18648075,2008-07-22T00:00:00,"Infant, Newborn",M01.060.703.520
18649928,2008-07-23T00:00:00,Aged,M01.060.116.100
18649928,2008-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18649928,2008-07-23T00:00:00,Lymph Nodes,A10.549.400
18649928,2008-07-23T00:00:00,Lymph Nodes,A15.382.520.604.412
18649928,2008-07-23T00:00:00,Prostatectomy,E04.950.774.860.625
18649928,2008-07-23T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18649928,2008-07-23T00:00:00,Prostatic Neoplasms,C12.294.260.750
18649928,2008-07-23T00:00:00,Prostatic Neoplasms,C12.294.565.625
18649928,2008-07-23T00:00:00,Prostatic Neoplasms,C12.758.409.750
18649928,2008-07-23T00:00:00,Regression Analysis,E05.318.740.750
18649928,2008-07-23T00:00:00,Regression Analysis,N05.715.360.750.695
18649928,2008-07-23T00:00:00,Regression Analysis,N06.850.520.830.750
18649928,2008-07-23T00:00:00,Treatment Outcome,E01.789.800
18649928,2008-07-23T00:00:00,Treatment Outcome,N04.761.559.590.800
18649928,2008-07-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18649928,2008-07-23T00:00:00,Urologic Surgical Procedures,E04.950.774
18649928,2008-07-23T00:00:00,Urology,H02.403.810.860
18650065,2008-07-23T00:00:00,Animals,B01.050
18650065,2008-07-23T00:00:00,Autoimmunity,G12.450.192
18650065,2008-07-23T00:00:00,Disease Progression,C23.550.291.656
18650065,2008-07-23T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18650065,2008-07-23T00:00:00,Flow Cytometry,E05.200.500.386.350
18650065,2008-07-23T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
18650065,2008-07-23T00:00:00,Immunologic Factors,D27.505.696.477
18650065,2008-07-23T00:00:00,Kidney,A05.810.453
18650065,2008-07-23T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18650065,2008-07-23T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18650065,2008-07-23T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
18650065,2008-07-23T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
18650065,2008-07-23T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
18760879,2008-07-23T00:00:00,Adolescent,M01.060.057
18760879,2008-07-23T00:00:00,Adult,M01.060.116
18760879,2008-07-23T00:00:00,Alcohol Drinking,F01.145.317.269
18760879,2008-07-23T00:00:00,Crime Victims,M01.135
18760879,2008-07-23T00:00:00,Ethanol,D02.033.375
18760879,2008-07-23T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18760879,2008-07-23T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18760879,2008-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18760879,2008-07-23T00:00:00,Questionnaires,E05.318.308.750
18760879,2008-07-23T00:00:00,Questionnaires,L01.280.800
18760879,2008-07-23T00:00:00,Questionnaires,N05.715.360.300.695
18760879,2008-07-23T00:00:00,Questionnaires,N06.850.520.308.750
18760879,2008-07-23T00:00:00,Rape,I01.198.240.748.640
18760879,2008-07-23T00:00:00,Sexual Behavior,F01.145.802
18760879,2008-07-23T00:00:00,Social Perception,F02.463.593.752
18760879,2008-07-23T00:00:00,Students,I02.233.748
18760879,2008-07-23T00:00:00,Students,I02.851
18760879,2008-07-23T00:00:00,Students,M01.848
18760879,2008-07-23T00:00:00,Universities,I02.783.850
18760879,2008-07-23T00:00:00,Young Adult,M01.060.116.815
18651175,2008-07-24T00:00:00,Amygdala,A08.186.211.464.090
18651175,2008-07-24T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
18651175,2008-07-24T00:00:00,Animals,B01.050
18651175,2008-07-24T00:00:00,Anxiety,F01.470.132
18651175,2008-07-24T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18651175,2008-07-24T00:00:00,Corticotropin-Releasing Hormone,D06.472.699.327.740.140
18651175,2008-07-24T00:00:00,Corticotropin-Releasing Hormone,D12.644.400.400.740.140
18651175,2008-07-24T00:00:00,Corticotropin-Releasing Hormone,D12.644.548.365.740.140
18651175,2008-07-24T00:00:00,Corticotropin-Releasing Hormone,D12.776.641.650.405.740.140
18651175,2008-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18651175,2008-07-24T00:00:00,Norepinephrine,D02.033.100.291.502
18651175,2008-07-24T00:00:00,Norepinephrine,D02.092.063.480
18651175,2008-07-24T00:00:00,Norepinephrine,D02.092.211.215.311.560
18651175,2008-07-24T00:00:00,Norepinephrine,D02.092.311.461.484
18651175,2008-07-24T00:00:00,"Stress, Psychological",F01.145.126.990
18651175,2008-07-24T00:00:00,"Stress, Psychological",F02.830.900
18651175,2008-07-24T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18651175,2008-07-24T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18656447,2008-07-24T00:00:00,Aged,M01.060.116.100
18656447,2008-07-24T00:00:00,Blood Glucose,D09.546.359.448.500
18656447,2008-07-24T00:00:00,Case-Control Studies,E05.318.760.500.500
18656447,2008-07-24T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18656447,2008-07-24T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18656447,2008-07-24T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18656447,2008-07-24T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18656447,2008-07-24T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18656447,2008-07-24T00:00:00,Genetic Predisposition to Disease,G05.380.355
18656447,2008-07-24T00:00:00,Heterotrimeric GTP-Binding Proteins,D08.811.277.040.330.300.200
18656447,2008-07-24T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.644.360.375
18656447,2008-07-24T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.157.325.332
18656447,2008-07-24T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.476.375
18656447,2008-07-24T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.543.325
18656447,2008-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18656447,2008-07-24T00:00:00,Middle Aged,M01.060.116.630
18656447,2008-07-24T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19026791,2008-07-24T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
19026791,2008-07-24T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.055.239.075
19026791,2008-07-24T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.109.139.075
19026791,2008-07-24T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
19026791,2008-07-24T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
19026791,2008-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18645492,2008-07-27T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
18645492,2008-07-27T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
18645492,2008-07-27T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
18645492,2008-07-27T00:00:00,Animals,B01.050
18645492,2008-07-27T00:00:00,Fatty Liver,C06.552.241
18645492,2008-07-27T00:00:00,Liver,A03.620
18645492,2008-07-27T00:00:00,Liver Transplantation,E04.210.650
18645492,2008-07-27T00:00:00,Liver Transplantation,E04.936.450.490
18645492,2008-07-27T00:00:00,Liver Transplantation,E04.936.580.490
18645492,2008-07-27T00:00:00,Reperfusion Injury,C14.907.725
18645492,2008-07-27T00:00:00,Reperfusion Injury,C23.550.767.877
18671679,2008-07-28T00:00:00,Animals,B01.050
18671679,2008-07-28T00:00:00,Apoptosis,G04.299.139.160
18671679,2008-07-28T00:00:00,Liver Transplantation,E04.210.650
18671679,2008-07-28T00:00:00,Liver Transplantation,E04.936.450.490
18671679,2008-07-28T00:00:00,Liver Transplantation,E04.936.580.490
18671679,2008-07-28T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18671679,2008-07-28T00:00:00,Mitochondria,A11.284.835.626
18671679,2008-07-28T00:00:00,Reperfusion Injury,C14.907.725
18671679,2008-07-28T00:00:00,Reperfusion Injury,C23.550.767.877
18680227,2008-07-28T00:00:00,Adult,M01.060.116
18680227,2008-07-28T00:00:00,Aged,M01.060.116.100
18680227,2008-07-28T00:00:00,Alcohol Drinking,F01.145.317.269
18680227,2008-07-28T00:00:00,Carrier Proteins,D12.776.157
18680227,2008-07-28T00:00:00,Case-Control Studies,E05.318.760.500.500
18680227,2008-07-28T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18680227,2008-07-28T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18680227,2008-07-28T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18680227,2008-07-28T00:00:00,Genetic Predisposition to Disease,G05.380.355
18680227,2008-07-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18680227,2008-07-28T00:00:00,Middle Aged,M01.060.116.630
18680227,2008-07-28T00:00:00,Mutation,G05.365.590
18680227,2008-07-28T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
18680227,2008-07-28T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18680227,2008-07-28T00:00:00,Risk Factors,E05.318.740.600.800.725
18680227,2008-07-28T00:00:00,Risk Factors,N05.715.350.200.700
18680227,2008-07-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18680227,2008-07-28T00:00:00,Risk Factors,N06.850.490.625.750
18680227,2008-07-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18680227,2008-07-28T00:00:00,United States,Z01.107.567.875
18512751,2008-07-30T00:00:00,Aged,M01.060.116.100
18512751,2008-07-30T00:00:00,Antiparkinson Agents,D27.505.954.427.090.050
18512751,2008-07-30T00:00:00,Drug Monitoring,E01.370.520.200
18512751,2008-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18512751,2008-07-30T00:00:00,Middle Aged,M01.060.116.630
18512751,2008-07-30T00:00:00,Parkinson Disease,C10.228.140.079.862.500
18512751,2008-07-30T00:00:00,Parkinson Disease,C10.228.662.600.400
18512751,2008-07-30T00:00:00,Parkinson Disease,C10.574.812
18512751,2008-07-30T00:00:00,Psychomotor Performance,F02.808
18512751,2008-07-30T00:00:00,Psychomotor Performance,G11.427.700
18512751,2008-07-30T00:00:00,Psychomotor Performance,G11.561.623
18512751,2008-07-30T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18512751,2008-07-30T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18512751,2008-07-30T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18512751,2008-07-30T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18512751,2008-07-30T00:00:00,Self Care,E02.900
18512751,2008-07-30T00:00:00,Self Care,N02.421.784.680
18512751,2008-07-30T00:00:00,Videotape Recording,J01.897.280.500.846.734
18512751,2008-07-30T00:00:00,Videotape Recording,J01.897.280.500.898.840
18512751,2008-07-30T00:00:00,Videotape Recording,L01.178.590.875.840
18512751,2008-07-30T00:00:00,Videotape Recording,L01.178.820.090.846.734
18512751,2008-07-30T00:00:00,Videotape Recording,L01.178.820.090.898.840
18512751,2008-07-30T00:00:00,Videotape Recording,L01.240.940.840
18512751,2008-07-30T00:00:00,Videotape Recording,L01.240.960.880
18668134,2008-07-31T00:00:00,Adult,M01.060.116
18668134,2008-07-31T00:00:00,Aged,M01.060.116.100
18668134,2008-07-31T00:00:00,Gene Expression Profiling,E05.393.332
18668134,2008-07-31T00:00:00,Homeodomain Proteins,D12.776.260.400
18668134,2008-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18668134,2008-07-31T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
18668134,2008-07-31T00:00:00,Middle Aged,M01.060.116.630
18668134,2008-07-31T00:00:00,Mutation,G05.365.590
18668134,2008-07-31T00:00:00,Neoplasm Proteins,D12.776.624
18668134,2008-07-31T00:00:00,Nuclear Proteins,D12.776.660
18668134,2008-07-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18668134,2008-07-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18668134,2008-07-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18668134,2008-07-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18668134,2008-07-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18668134,2008-07-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18668134,2008-07-31T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
18668134,2008-07-31T00:00:00,"RNA, Messenger",D13.444.735.544
18668134,2008-07-31T00:00:00,Repressor Proteins,D12.776.260.703
18668134,2008-07-31T00:00:00,Repressor Proteins,D12.776.930.700
18668134,2008-07-31T00:00:00,Young Adult,M01.060.116.815
18668224,2008-07-31T00:00:00,Adenocarcinoma,C04.557.470.200.025
18668224,2008-07-31T00:00:00,Alcohol Drinking,F01.145.317.269
18668224,2008-07-31T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18668224,2008-07-31T00:00:00,Genetic Predisposition to Disease,G05.380.355
18668224,2008-07-31T00:00:00,Glutathione Transferase,D08.811.913.225.500
18668224,2008-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18668224,2008-07-31T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18668224,2008-07-31T00:00:00,Prostatic Neoplasms,C12.294.260.750
18668224,2008-07-31T00:00:00,Prostatic Neoplasms,C12.294.565.625
18668224,2008-07-31T00:00:00,Prostatic Neoplasms,C12.758.409.750
18668224,2008-07-31T00:00:00,Risk Factors,E05.318.740.600.800.725
18668224,2008-07-31T00:00:00,Risk Factors,N05.715.350.200.700
18668224,2008-07-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18668224,2008-07-31T00:00:00,Risk Factors,N06.850.490.625.750
18668224,2008-07-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18668224,2008-07-31T00:00:00,Smoking,F01.145.466.753
18668224,2008-07-31T00:00:00,Tobacco,B01.650.388.100.905.900
18668339,2008-07-31T00:00:00,Alzheimer Disease,C10.228.140.380.100
18668339,2008-07-31T00:00:00,Alzheimer Disease,C10.574.945.249
18668339,2008-07-31T00:00:00,Alzheimer Disease,F03.087.400.100
18668339,2008-07-31T00:00:00,Environment,G16.500.275
18668339,2008-07-31T00:00:00,Environment,N06.230
18668339,2008-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18668339,2008-07-31T00:00:00,"Models, Biological",E05.599.395
18668339,2008-07-31T00:00:00,Risk Factors,E05.318.740.600.800.725
18668339,2008-07-31T00:00:00,Risk Factors,N05.715.350.200.700
18668339,2008-07-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18668339,2008-07-31T00:00:00,Risk Factors,N06.850.490.625.750
18668339,2008-07-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18721901,2008-07-31T00:00:00,Adolescent,M01.060.057
18721901,2008-07-31T00:00:00,Adult,M01.060.116
18721901,2008-07-31T00:00:00,Aged,M01.060.116.100
18721901,2008-07-31T00:00:00,Community-Based Participatory Research,N05.425.104
18721901,2008-07-31T00:00:00,Health Services Accessibility,N04.590.374.350
18721901,2008-07-31T00:00:00,Health Services Accessibility,N05.300.430
18721901,2008-07-31T00:00:00,Health Status Disparities,I01.240.425.675
18721901,2008-07-31T00:00:00,Health Status Disparities,N01.224.425.437
18721901,2008-07-31T00:00:00,Health Status Disparities,N06.850.505.400.425.675
18721901,2008-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18721901,2008-07-31T00:00:00,Middle Aged,M01.060.116.630
18721901,2008-07-31T00:00:00,Minority Groups,I01.880.371
18721901,2008-07-31T00:00:00,Patient Selection,E05.581.500.653
18721901,2008-07-31T00:00:00,Patient Selection,N04.590.731
18721901,2008-07-31T00:00:00,Questionnaires,E05.318.308.750
18721901,2008-07-31T00:00:00,Questionnaires,L01.280.800
18721901,2008-07-31T00:00:00,Questionnaires,N05.715.360.300.695
18721901,2008-07-31T00:00:00,Questionnaires,N06.850.520.308.750
18721901,2008-07-31T00:00:00,United States,Z01.107.567.875
18721901,2008-07-31T00:00:00,Young Adult,M01.060.116.815
18929699,2008-07-31T00:00:00,Contrast Media,D27.720.259
18929699,2008-07-31T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18929699,2008-07-31T00:00:00,Coronary Angiography,E01.370.370.050.200
18929699,2008-07-31T00:00:00,Coronary Angiography,E01.370.370.380.200
18929699,2008-07-31T00:00:00,Coronary Stenosis,C14.280.647.250.285
18929699,2008-07-31T00:00:00,Coronary Stenosis,C14.907.585.250.285
18929699,2008-07-31T00:00:00,"Diagnosis, Differential",E01.171
18929699,2008-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18929699,2008-07-31T00:00:00,Middle Aged,M01.060.116.630
18929699,2008-07-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18929699,2008-07-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18929699,2008-07-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18929699,2008-07-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18929699,2008-07-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18929699,2008-07-31T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
18277884,2008-08-01T00:00:00,Adult,M01.060.116
18277884,2008-08-01T00:00:00,Anemia,C15.378.071
18277884,2008-08-01T00:00:00,Capsule Endoscopy,E01.370.388.250.250.250.140
18277884,2008-08-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
18277884,2008-08-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
18277884,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18277884,2008-08-01T00:00:00,"Hypertension, Portal",C06.552.494
18277884,2008-08-01T00:00:00,Liver Cirrhosis,C06.552.630
18277884,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18360293,2008-08-01T00:00:00,Adolescent,M01.060.057
18360293,2008-08-01T00:00:00,Adult,M01.060.116
18360293,2008-08-01T00:00:00,Aged,M01.060.116.100
18360293,2008-08-01T00:00:00,Deglutition,G10.261.326.215
18360293,2008-08-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
18360293,2008-08-01T00:00:00,Esophagus,A03.556.875.500
18360293,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18360293,2008-08-01T00:00:00,Manometry,E05.559
18360293,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18458643,2008-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18458643,2008-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18458643,2008-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18458643,2008-08-01T00:00:00,Glomerulonephritis,C12.777.419.570.363
18458643,2008-08-01T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
18458643,2008-08-01T00:00:00,"Hepatitis, Autoimmune",C06.552.380.350.050
18458643,2008-08-01T00:00:00,"Hepatitis, Autoimmune",C20.111.567
18458643,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18458643,2008-08-01T00:00:00,Immunologic Factors,D27.505.696.477
18458643,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18458643,2008-08-01T00:00:00,Renal Insufficiency,C12.777.419.780
18458643,2008-08-01T00:00:00,Renal Insufficiency,C13.351.968.419.780
18458643,2008-08-01T00:00:00,Treatment Outcome,E01.789.800
18458643,2008-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18458643,2008-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18538188,2008-08-01T00:00:00,Anti-Arrhythmia Agents,D27.505.954.411.097
18538188,2008-08-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
18538188,2008-08-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
18538188,2008-08-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
18538188,2008-08-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
18538188,2008-08-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
18538188,2008-08-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
18538188,2008-08-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
18538188,2008-08-01T00:00:00,"Defibrillators, Implantable",E07.695.175
18538188,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18538188,2008-08-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
18538188,2008-08-01T00:00:00,Stroke Volume,G09.330.380.124.882
18538188,2008-08-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18538188,2008-08-01T00:00:00,Ventricular Fibrillation,C14.280.067.922
18538188,2008-08-01T00:00:00,Ventricular Fibrillation,C23.550.073.922
18554097,2008-08-01T00:00:00,Animals,B01.050
18554097,2008-08-01T00:00:00,Apoptosis,G04.299.139.160
18554097,2008-08-01T00:00:00,Gene Expression,G05.355.310
18554097,2008-08-01T00:00:00,Gene Transfer Techniques,E05.393.350
18554097,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18554097,2008-08-01T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
18554097,2008-08-01T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
18554097,2008-08-01T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
18554097,2008-08-01T00:00:00,Inflammation,C23.550.470
18554097,2008-08-01T00:00:00,Kidney,A05.810.453
18554097,2008-08-01T00:00:00,Kinins,D12.644.276.812
18554097,2008-08-01T00:00:00,Kinins,D12.776.467.812
18554097,2008-08-01T00:00:00,Kinins,D23.469.050.375
18554097,2008-08-01T00:00:00,Kinins,D23.529.812
18554097,2008-08-01T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
18554097,2008-08-01T00:00:00,Nitric Oxide,D01.339.387
18554097,2008-08-01T00:00:00,Nitric Oxide,D01.625.550.500
18554097,2008-08-01T00:00:00,Nitric Oxide,D01.625.700.500
18554097,2008-08-01T00:00:00,Nitric Oxide,D01.650.550.587.600
18554097,2008-08-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
18554097,2008-08-01T00:00:00,Oxidative Stress,G03.495.710
18554097,2008-08-01T00:00:00,Oxidative Stress,G07.700.830.750
18554097,2008-08-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18554097,2008-08-01T00:00:00,Reactive Oxygen Species,D01.339.431
18554097,2008-08-01T00:00:00,Reactive Oxygen Species,D01.650.775
18554097,2008-08-01T00:00:00,Recombinant Proteins,D12.776.828
18554097,2008-08-01T00:00:00,Reperfusion Injury,C14.907.725
18554097,2008-08-01T00:00:00,Reperfusion Injury,C23.550.767.877
18554097,2008-08-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
18554097,2008-08-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
18554097,2008-08-01T00:00:00,Tissue Kallikreins,D23.101.840.870
18625648,2008-08-01T00:00:00,Adolescent,M01.060.057
18625648,2008-08-01T00:00:00,Adult,M01.060.116
18625648,2008-08-01T00:00:00,Agriculture,J01.040
18625648,2008-08-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18625648,2008-08-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18625648,2008-08-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18625648,2008-08-01T00:00:00,Child,M01.060.406
18625648,2008-08-01T00:00:00,Environmental Exposure,N06.850.460.350
18625648,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18625648,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18625648,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18625648,2008-08-01T00:00:00,Occupational Exposure,N06.850.460.350.600
18625648,2008-08-01T00:00:00,Paper,J01.576.154.600
18625648,2008-08-01T00:00:00,Paper,J01.637.650
18625652,2008-08-01T00:00:00,"Anemia, Hemolytic",C15.378.071.141
18625652,2008-08-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18625652,2008-08-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18625652,2008-08-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18625652,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18625652,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18625652,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18626281,2008-08-01T00:00:00,Adult,M01.060.116
18626281,2008-08-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18626281,2008-08-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18626281,2008-08-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18626281,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18626281,2008-08-01T00:00:00,Mental Disorders,F03
18626281,2008-08-01T00:00:00,Piperazines,D03.383.606
18626281,2008-08-01T00:00:00,Quinolones,D03.438.810.835
18626281,2008-08-01T00:00:00,Substance-Related Disorders,C21.739
18626281,2008-08-01T00:00:00,Substance-Related Disorders,F03.900
18626281,2008-08-01T00:00:00,Weight Gain,C23.888.144.243.926
18626281,2008-08-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
18629867,2008-08-01T00:00:00,Animals,B01.050
18629867,2008-08-01T00:00:00,Cilia,A11.284.180.165
18629867,2008-08-01T00:00:00,Estradiol,D04.808.365.415.248
18629867,2008-08-01T00:00:00,Estradiol,D06.472.334.851.437.500
18629867,2008-08-01T00:00:00,Estrous Cycle,G08.686.195
18629867,2008-08-01T00:00:00,Granulosa Cells,A05.360.319.114.630.535.200
18629867,2008-08-01T00:00:00,Granulosa Cells,A06.407.312.497.535.300
18629867,2008-08-01T00:00:00,Granulosa Cells,A11.382.812
18629867,2008-08-01T00:00:00,Granulosa Cells,A11.436.329
18629867,2008-08-01T00:00:00,Homeodomain Proteins,D12.776.260.400
18629867,2008-08-01T00:00:00,Phenotype,G05.695
18629867,2008-08-01T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
18636020,2008-08-01T00:00:00,Academic Medical Centers,N02.278.020
18636020,2008-08-01T00:00:00,Adult,M01.060.116
18636020,2008-08-01T00:00:00,Antirheumatic Agents,D27.505.954.329
18636020,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18636020,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18636020,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18636020,2008-08-01T00:00:00,Medication Adherence,F01.145.488.500.500
18636020,2008-08-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
18636020,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18636020,2008-08-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.035.380
18636020,2008-08-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.354.422.527
18636020,2008-08-01T00:00:00,"Outpatient Clinics, Hospital",N04.452.442.422.527
18636020,2008-08-01T00:00:00,Young Adult,M01.060.116.815
18640296,2008-08-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
18640296,2008-08-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
18640296,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18640296,2008-08-01T00:00:00,Informed Consent,I01.880.604.473.650.718
18640296,2008-08-01T00:00:00,Informed Consent,I01.880.604.583.427
18640296,2008-08-01T00:00:00,Informed Consent,N03.706.437.650.312
18640296,2008-08-01T00:00:00,Informed Consent,N03.706.535.489
18640296,2008-08-01T00:00:00,Physicians,M01.526.485.810
18640296,2008-08-01T00:00:00,Physicians,N02.360.810
18640296,2008-08-01T00:00:00,"Stress, Psychological",F01.145.126.990
18640296,2008-08-01T00:00:00,"Stress, Psychological",F02.830.900
18640296,2008-08-01T00:00:00,Teaching,I02.903
18640296,2008-08-01T00:00:00,Thoracic Surgery,H02.403.810.803
18640296,2008-08-01T00:00:00,Thoracic Surgical Procedures,E04.928
18640296,2008-08-01T00:00:00,Videotape Recording,J01.897.280.500.846.734
18640296,2008-08-01T00:00:00,Videotape Recording,J01.897.280.500.898.840
18640296,2008-08-01T00:00:00,Videotape Recording,L01.178.590.875.840
18640296,2008-08-01T00:00:00,Videotape Recording,L01.178.820.090.846.734
18640296,2008-08-01T00:00:00,Videotape Recording,L01.178.820.090.898.840
18640296,2008-08-01T00:00:00,Videotape Recording,L01.240.940.840
18640296,2008-08-01T00:00:00,Videotape Recording,L01.240.960.880
18640335,2008-08-01T00:00:00,Animals,B01.050
18640335,2008-08-01T00:00:00,Aprotinin,D12.776.083
18640335,2008-08-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
18640335,2008-08-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
18640335,2008-08-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18640335,2008-08-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
18640335,2008-08-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
18640335,2008-08-01T00:00:00,Interleukin-6,D23.529.374.465.506
18640335,2008-08-01T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
18640335,2008-08-01T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
18640335,2008-08-01T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
18640335,2008-08-01T00:00:00,Myocardial Contraction,G09.330.190.541
18640335,2008-08-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
18640335,2008-08-01T00:00:00,Myocardial Reperfusion Injury,C14.280.238.615
18640335,2008-08-01T00:00:00,Myocardial Reperfusion Injury,C14.280.647.625
18640335,2008-08-01T00:00:00,Myocardial Reperfusion Injury,C14.907.585.625
18640335,2008-08-01T00:00:00,Myocardial Reperfusion Injury,C14.907.725.600
18640335,2008-08-01T00:00:00,Myocardial Reperfusion Injury,C23.550.767.877.500
18640335,2008-08-01T00:00:00,Myocardium,A02.633.580
18640335,2008-08-01T00:00:00,Myocardium,A07.541.704
18640335,2008-08-01T00:00:00,Myocardium,A10.690.552.750
18640335,2008-08-01T00:00:00,Oxidative Stress,G03.495.710
18640335,2008-08-01T00:00:00,Oxidative Stress,G07.700.830.750
18640335,2008-08-01T00:00:00,Serine Proteinase Inhibitors,D27.505.519.389.745.800
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18640335,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18640335,2008-08-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18641261,2008-08-01T00:00:00,Adult,M01.060.116
18641261,2008-08-01T00:00:00,Aged,M01.060.116.100
18641261,2008-08-01T00:00:00,Breast Neoplasms,C04.588.180
18641261,2008-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
18641261,2008-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18641261,2008-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
18641261,2008-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18641261,2008-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18641261,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18641261,2008-08-01T00:00:00,Mammography,E01.370.350.700.500
18641261,2008-08-01T00:00:00,Mass Screening,E01.370.500
18641261,2008-08-01T00:00:00,Mass Screening,E05.318.308.250.580
18641261,2008-08-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18641261,2008-08-01T00:00:00,Mass Screening,N02.421.726.233.443
18641261,2008-08-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18641261,2008-08-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18641261,2008-08-01T00:00:00,Mass Screening,N06.850.780.500
18641261,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18641261,2008-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
18641261,2008-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
18641261,2008-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
18641261,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18641261,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18641261,2008-08-01T00:00:00,Sensitivity and Specificity,G17.800
18641261,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18641261,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18641261,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18641261,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18641261,2008-08-01T00:00:00,United States,Z01.107.567.875
18641262,2008-08-01T00:00:00,Adult,M01.060.116
18641262,2008-08-01T00:00:00,Aged,M01.060.116.100
18641262,2008-08-01T00:00:00,Breast Neoplasms,C04.588.180
18641262,2008-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
18641262,2008-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18641262,2008-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
18641262,2008-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18641262,2008-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18641262,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18641262,2008-08-01T00:00:00,Mammography,E01.370.350.700.500
18641262,2008-08-01T00:00:00,Mass Screening,E01.370.500
18641262,2008-08-01T00:00:00,Mass Screening,E05.318.308.250.580
18641262,2008-08-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18641262,2008-08-01T00:00:00,Mass Screening,N02.421.726.233.443
18641262,2008-08-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18641262,2008-08-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18641262,2008-08-01T00:00:00,Mass Screening,N06.850.780.500
18641262,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18641262,2008-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
18641262,2008-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
18641262,2008-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
18641262,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18641262,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18641262,2008-08-01T00:00:00,Sensitivity and Specificity,G17.800
18641262,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18641262,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18641262,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18641262,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18641262,2008-08-01T00:00:00,United States,Z01.107.567.875
18641300,2008-08-01T00:00:00,Animals,B01.050
18641300,2008-08-01T00:00:00,B-Lymphocytes,A11.063.438
18641300,2008-08-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
18641300,2008-08-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
18641300,2008-08-01T00:00:00,B-Lymphocytes,A15.382.032.438
18641300,2008-08-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
18641300,2008-08-01T00:00:00,Cell Differentiation,G04.299.151
18641300,2008-08-01T00:00:00,Cell Proliferation,G04.299.233.750
18641300,2008-08-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18641300,2008-08-01T00:00:00,Gene Expression Regulation,G05.355.315
18641300,2008-08-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18641300,2008-08-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18641300,2008-08-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18641300,2008-08-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18641300,2008-08-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18641300,2008-08-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
18641300,2008-08-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
18641300,2008-08-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
18641300,2008-08-01T00:00:00,Signal Transduction,G02.111.087.800
18641300,2008-08-01T00:00:00,Signal Transduction,G02.149.115.800
18641300,2008-08-01T00:00:00,Signal Transduction,G04.299.880
18647916,2008-08-01T00:00:00,Contrast Media,D27.720.259
18647916,2008-08-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18647916,2008-08-01T00:00:00,Coronary Angiography,E01.370.370.050.200
18647916,2008-08-01T00:00:00,Coronary Angiography,E01.370.370.380.200
18647916,2008-08-01T00:00:00,Heart Transplantation,E04.100.376.475
18647916,2008-08-01T00:00:00,Heart Transplantation,E04.928.220.390
18647916,2008-08-01T00:00:00,Heart Transplantation,E04.936.450.475
18647916,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18647916,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18647916,2008-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
18647916,2008-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
18647916,2008-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
18647916,2008-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
18647916,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18647916,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18647916,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18647916,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18647916,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18655915,2008-08-01T00:00:00,Atrial Fibrillation,C14.280.067.198
18655915,2008-08-01T00:00:00,Atrial Fibrillation,C23.550.073.198
18655915,2008-08-01T00:00:00,Brain,A08.186.211
18655915,2008-08-01T00:00:00,Carotid Arteries,A07.231.114.186
18655915,2008-08-01T00:00:00,Clinical Laboratory Techniques,E05.200
18655915,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18655915,2008-08-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18655915,2008-08-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18655915,2008-08-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
18655915,2008-08-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
18655915,2008-08-01T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
18655915,2008-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18655915,2008-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18655915,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18655915,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18655915,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18655915,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18655915,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18655915,2008-08-01T00:00:00,Urinalysis,E01.370.390.810
18655915,2008-08-01T00:00:00,Urinalysis,E01.450.150.810
18655915,2008-08-01T00:00:00,Urinalysis,E01.450.890
18656594,2008-08-01T00:00:00,Cause of Death,E05.318.308.985.550.250
18656594,2008-08-01T00:00:00,Cause of Death,L01.280.975.550.250
18656594,2008-08-01T00:00:00,Cause of Death,N01.224.935.698.100
18656594,2008-08-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
18656594,2008-08-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
18656594,2008-08-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
18656594,2008-08-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
18656594,2008-08-01T00:00:00,Gastrostomy,E04.210.496
18656594,2008-08-01T00:00:00,Gastrostomy,E04.579.408
18656594,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18656594,2008-08-01T00:00:00,Informed Consent,I01.880.604.473.650.718
18656594,2008-08-01T00:00:00,Informed Consent,I01.880.604.583.427
18656594,2008-08-01T00:00:00,Informed Consent,N03.706.437.650.312
18656594,2008-08-01T00:00:00,Informed Consent,N03.706.535.489
18656594,2008-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18656594,2008-08-01T00:00:00,Risk Assessment,N04.452.871.715
18656594,2008-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18656594,2008-08-01T00:00:00,Risk Assessment,N06.850.505.715
18656594,2008-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18657013,2008-08-01T00:00:00,Adult,M01.060.116
18657013,2008-08-01T00:00:00,Aged,M01.060.116.100
18657013,2008-08-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
18657013,2008-08-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
18657013,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18657013,2008-08-01T00:00:00,Intensive Care Units,N02.278.388.493
18657013,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18657013,2008-08-01T00:00:00,Patient Discharge,E02.760.400.610
18657013,2008-08-01T00:00:00,Patient Discharge,N02.421.585.400.610
18657013,2008-08-01T00:00:00,Peptic Ulcer,C06.405.469.275.800
18657013,2008-08-01T00:00:00,Peptic Ulcer,C06.405.608
18657013,2008-08-01T00:00:00,Peptic Ulcer,C06.405.748.586
18657013,2008-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18657013,2008-08-01T00:00:00,Risk Factors,N05.715.350.200.700
18657013,2008-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18657013,2008-08-01T00:00:00,Risk Factors,N06.850.490.625.750
18657013,2008-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18657013,2008-08-01T00:00:00,"Stress, Psychological",F01.145.126.990
18657013,2008-08-01T00:00:00,"Stress, Psychological",F02.830.900
18657013,2008-08-01T00:00:00,"Surgical Procedures, Operative",E04
18660473,2008-08-01T00:00:00,"Abnormalities, Multiple",C16.131.077
18660473,2008-08-01T00:00:00,Adolescent,M01.060.057
18660473,2008-08-01T00:00:00,Adult,M01.060.116
18660473,2008-08-01T00:00:00,Aged,M01.060.116.100
18660473,2008-08-01T00:00:00,Brain,A08.186.211
18660473,2008-08-01T00:00:00,Child,M01.060.406
18660473,2008-08-01T00:00:00,Chromosome Aberrations,C23.550.210
18660473,2008-08-01T00:00:00,Chromosome Aberrations,G05.365.590.175
18660473,2008-08-01T00:00:00,Connexin 43,D12.776.543.585.250.200
18660473,2008-08-01T00:00:00,Craniofacial Abnormalities,C05.660.207
18660473,2008-08-01T00:00:00,Craniofacial Abnormalities,C16.131.621.207
18660473,2008-08-01T00:00:00,"Gait Disorders, Neurologic",C10.597.404
18660473,2008-08-01T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
18660473,2008-08-01T00:00:00,Genetic Counseling,H01.158.273.343.315.384
18660473,2008-08-01T00:00:00,Genetic Counseling,N02.421.308.400
18660473,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18660473,2008-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18660473,2008-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18660473,2008-08-01T00:00:00,"Mutation, Missense",G05.365.590.650
18660473,2008-08-01T00:00:00,Neurologic Examination,E01.370.376.550
18660473,2008-08-01T00:00:00,Neurologic Examination,E01.370.600.550
18660473,2008-08-01T00:00:00,Phenotype,G05.695
18660473,2008-08-01T00:00:00,Quadriplegia,C10.597.622.760
18660473,2008-08-01T00:00:00,Quadriplegia,C23.888.592.636.786
18660473,2008-08-01T00:00:00,Spinal Cord,A08.186.854
18662506,2008-08-01T00:00:00,Animals,B01.050
18662506,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18662506,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18662506,2008-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18662506,2008-08-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18662506,2008-08-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18664760,2008-08-01T00:00:00,Caregivers,M01.085
18664760,2008-08-01T00:00:00,Caregivers,M01.526.485.200
18664760,2008-08-01T00:00:00,Caregivers,N02.360.200
18664760,2008-08-01T00:00:00,Dementia,C10.228.140.380
18664760,2008-08-01T00:00:00,Dementia,F03.087.400
18664760,2008-08-01T00:00:00,Feeding Behavior,F01.145.113.547
18664760,2008-08-01T00:00:00,Feeding Behavior,F01.145.407
18664760,2008-08-01T00:00:00,Geriatric Assessment,E05.318.308.225
18664760,2008-08-01T00:00:00,Geriatric Assessment,I01.240.425.350
18664760,2008-08-01T00:00:00,Geriatric Assessment,L01.280.360
18664760,2008-08-01T00:00:00,Geriatric Assessment,N01.224.425.350
18664760,2008-08-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
18664760,2008-08-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
18664760,2008-08-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
18664760,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18664760,2008-08-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
18664760,2008-08-01T00:00:00,Nurse's Role,N05.300.100.337
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.350.500.100
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.350.825.500.100
18665075,2008-08-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.372.207
18665075,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18665075,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18665075,2008-08-01T00:00:00,Pancreatitis,C06.689.750
18665075,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18665075,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18665075,2008-08-01T00:00:00,Sensitivity and Specificity,G17.800
18665075,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18665075,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18665075,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18665075,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18665685,2008-08-01T00:00:00,Adolescent,M01.060.057
18665685,2008-08-01T00:00:00,Attitude of Health Personnel,F01.100.050
18665685,2008-08-01T00:00:00,Attitude of Health Personnel,N05.300.100
18665685,2008-08-01T00:00:00,Cognitive Therapy,F04.754.137.428
18665685,2008-08-01T00:00:00,Community Mental Health Services,F04.408.307
18665685,2008-08-01T00:00:00,Community Mental Health Services,N02.421.143.183
18665685,2008-08-01T00:00:00,Community Mental Health Services,N02.421.461.232
18665685,2008-08-01T00:00:00,Education,I02
18665685,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18665685,2008-08-01T00:00:00,Motivation,F01.658
18665685,2008-08-01T00:00:00,Motivation,F01.752.543.500.750
18665685,2008-08-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18665685,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18665685,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18665685,2008-08-01T00:00:00,Substance-Related Disorders,C21.739
18665685,2008-08-01T00:00:00,Substance-Related Disorders,F03.900
18665691,2008-08-01T00:00:00,Adolescent,M01.060.057
18665691,2008-08-01T00:00:00,Adult,M01.060.116
18665691,2008-08-01T00:00:00,Aged,M01.060.116.100
18665691,2008-08-01T00:00:00,Crime Victims,M01.135
18665691,2008-08-01T00:00:00,Depressive Disorder,F03.600.300
18665691,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18665691,2008-08-01T00:00:00,Life Change Events,F01.829.458.410
18665691,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18665691,2008-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18665691,2008-08-01T00:00:00,Risk Factors,N05.715.350.200.700
18665691,2008-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18665691,2008-08-01T00:00:00,Risk Factors,N06.850.490.625.750
18665691,2008-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18665691,2008-08-01T00:00:00,Sex Offenses,I01.198.240.748
18665691,2008-08-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18665691,2008-08-01T00:00:00,Substance-Related Disorders,C21.739
18665691,2008-08-01T00:00:00,Substance-Related Disorders,F03.900
18665691,2008-08-01T00:00:00,Violence,I01.198.240.856
18665691,2008-08-01T00:00:00,Violence,I01.880.735.900
18665691,2008-08-01T00:00:00,Young Adult,M01.060.116.815
18665807,2008-08-01T00:00:00,Animals,B01.050
18665807,2008-08-01T00:00:00,Intraocular Pressure,G14.440
18665807,2008-08-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
18665807,2008-08-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
18665807,2008-08-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18665807,2008-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18671462,2008-08-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18671462,2008-08-01T00:00:00,Diagnostic Imaging,E01.370.350
18671462,2008-08-01T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
18671462,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18671462,2008-08-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
18671462,2008-08-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
18671462,2008-08-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
18671462,2008-08-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18671462,2008-08-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18671462,2008-08-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18671462,2008-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18671462,2008-08-01T00:00:00,Risk Factors,N05.715.350.200.700
18671462,2008-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18671462,2008-08-01T00:00:00,Risk Factors,N06.850.490.625.750
18671462,2008-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18671462,2008-08-01T00:00:00,Stroke,C10.228.140.300.775
18671462,2008-08-01T00:00:00,Stroke,C14.907.253.855
18671659,2008-08-01T00:00:00,Anticoagulants,D27.505.954.502.119
18671659,2008-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18671659,2008-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
18671659,2008-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18671659,2008-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18671659,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18671659,2008-08-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
18671659,2008-08-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
18671659,2008-08-01T00:00:00,Stroke,C10.228.140.300.775
18671659,2008-08-01T00:00:00,Stroke,C14.907.253.855
18674751,2008-08-01T00:00:00,"Abnormalities, Multiple",C16.131.077
18674751,2008-08-01T00:00:00,Animals,B01.050
18674751,2008-08-01T00:00:00,Cilia,A11.284.180.165
18674751,2008-08-01T00:00:00,Computational Biology,H01.158.273.180
18674751,2008-08-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18674751,2008-08-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18674751,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18674751,2008-08-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18674751,2008-08-01T00:00:00,Mutation,G05.365.590
18674751,2008-08-01T00:00:00,Neurons,A08.663
18674751,2008-08-01T00:00:00,Neurons,A11.671
18674751,2008-08-01T00:00:00,Syndrome,C23.550.288.500
18674751,2008-08-01T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
18674983,2008-08-01T00:00:00,Adult,M01.060.116
18674983,2008-08-01T00:00:00,Age of Onset,N05.715.350.075.100
18674983,2008-08-01T00:00:00,Age of Onset,N06.850.490.250.100
18674983,2008-08-01T00:00:00,Employment,N01.824.245
18674983,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18674983,2008-08-01T00:00:00,Income,N01.824.417
18674983,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18674983,2008-08-01T00:00:00,Questionnaires,E05.318.308.750
18674983,2008-08-01T00:00:00,Questionnaires,L01.280.800
18674983,2008-08-01T00:00:00,Questionnaires,N05.715.360.300.695
18674983,2008-08-01T00:00:00,Questionnaires,N06.850.520.308.750
18674983,2008-08-01T00:00:00,Recovery of Function,G16.757
18674983,2008-08-01T00:00:00,"Rehabilitation, Vocational",E02.831.782
18674983,2008-08-01T00:00:00,"Rehabilitation, Vocational",N02.421.784.644
18674983,2008-08-01T00:00:00,Sex Factors,N05.715.350.675
18674983,2008-08-01T00:00:00,Sex Factors,N06.850.490.875
18674983,2008-08-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
18674983,2008-08-01T00:00:00,Spinal Cord Injuries,C10.900.850
18674983,2008-08-01T00:00:00,Spinal Cord Injuries,C21.866.819
18674984,2008-08-01T00:00:00,Adult,M01.060.116
18674984,2008-08-01T00:00:00,Aged,M01.060.116.100
18674984,2008-08-01T00:00:00,Amputation,E04.555.080
18674984,2008-08-01T00:00:00,Cause of Death,E05.318.308.985.550.250
18674984,2008-08-01T00:00:00,Cause of Death,L01.280.975.550.250
18674984,2008-08-01T00:00:00,Cause of Death,N01.224.935.698.100
18674984,2008-08-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
18674984,2008-08-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
18674984,2008-08-01T00:00:00,Health Status,I01.240.425
18674984,2008-08-01T00:00:00,Health Status,N01.224.425
18674984,2008-08-01T00:00:00,Health Status,N06.850.505.400.425
18674984,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18674984,2008-08-01T00:00:00,Length of Stay,E02.760.400.480
18674984,2008-08-01T00:00:00,Length of Stay,N02.421.585.400.480
18674984,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18674984,2008-08-01T00:00:00,"Models, Statistical",E05.318.740.500
18674984,2008-08-01T00:00:00,"Models, Statistical",E05.599.835
18674984,2008-08-01T00:00:00,"Models, Statistical",N05.715.360.750.530
18674984,2008-08-01T00:00:00,"Models, Statistical",N06.850.520.830.500
18674984,2008-08-01T00:00:00,Pressure Ulcer,C17.800.893.665
18674984,2008-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18674984,2008-08-01T00:00:00,Risk Factors,N05.715.350.200.700
18674984,2008-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18674984,2008-08-01T00:00:00,Risk Factors,N06.850.490.625.750
18674984,2008-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18674984,2008-08-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
18674984,2008-08-01T00:00:00,Spinal Cord Injuries,C10.900.850
18674984,2008-08-01T00:00:00,Spinal Cord Injuries,C21.866.819
18674991,2008-08-01T00:00:00,Aged,M01.060.116.100
18674991,2008-08-01T00:00:00,Disability Evaluation,E01.370.400
18674991,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18674991,2008-08-01T00:00:00,Movement,G07.700.560
18674991,2008-08-01T00:00:00,Movement,G11.427.590.530
18674991,2008-08-01T00:00:00,Posture,G11.427.695
18674991,2008-08-01T00:00:00,Recovery of Function,G16.757
18674991,2008-08-01T00:00:00,Shoulder,A01.378.800.750
18674991,2008-08-01T00:00:00,Stroke,C10.228.140.300.775
18674991,2008-08-01T00:00:00,Stroke,C14.907.253.855
18675624,2008-08-01T00:00:00,"Child, Preschool",M01.060.406.448
18675624,2008-08-01T00:00:00,Foreign Bodies,C21.866.392
18675624,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18675624,2008-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18675624,2008-08-01T00:00:00,Risk Assessment,N04.452.871.715
18675624,2008-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18675624,2008-08-01T00:00:00,Risk Assessment,N06.850.505.715
18675624,2008-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18675624,2008-08-01T00:00:00,Thoracic Injuries,C21.866.891
18675624,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18675624,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18675624,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18675624,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18675624,2008-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18675624,2008-08-01T00:00:00,Treatment Outcome,E01.789.800
18675624,2008-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18675624,2008-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18675624,2008-08-01T00:00:00,"Wounds, Penetrating",C21.866.986
18676372,2008-08-01T00:00:00,Apoptosis,G04.299.139.160
18676372,2008-08-01T00:00:00,Cell Line,A11.251.210
18676372,2008-08-01T00:00:00,Ceramides,D02.065.313
18676372,2008-08-01T00:00:00,Ceramides,D09.400.410.420.525.200
18676372,2008-08-01T00:00:00,Ceramides,D10.390.470.675.200
18676372,2008-08-01T00:00:00,Ceramides,D10.570.877.360.612.200
18676372,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18676372,2008-08-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18676372,2008-08-01T00:00:00,Mitochondria,A11.284.835.626
18676372,2008-08-01T00:00:00,Mitochondrial Proteins,D12.776.575
18676372,2008-08-01T00:00:00,Oxidoreductases,D08.811.682
18676372,2008-08-01T00:00:00,Protein Transport,G03.495.166.700
18676372,2008-08-01T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
18676372,2008-08-01T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
18676372,2008-08-01T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
18676372,2008-08-01T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
18676875,2008-08-01T00:00:00,Cell Culture Techniques,E05.200.249.249
18676875,2008-08-01T00:00:00,Cell Movement,G04.299.283
18676875,2008-08-01T00:00:00,Cell Movement,G07.700.560.500.180
18676875,2008-08-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
18676875,2008-08-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
18676875,2008-08-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
18676875,2008-08-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
18676875,2008-08-01T00:00:00,Down-Regulation,G02.111.087.225
18676875,2008-08-01T00:00:00,Down-Regulation,G02.149.115.225
18676875,2008-08-01T00:00:00,Down-Regulation,G05.355.315.200
18676875,2008-08-01T00:00:00,Down-Regulation,G07.690.812.230
18676875,2008-08-01T00:00:00,Down-Regulation,G07.700.680.230
18676875,2008-08-01T00:00:00,Fibroblasts,A11.329.228
18676875,2008-08-01T00:00:00,Fibroblasts,A11.872.228
18676875,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18676875,2008-08-01T00:00:00,Immediate-Early Proteins,D12.776.460
18676875,2008-08-01T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
18676875,2008-08-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18676875,2008-08-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18676875,2008-08-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18676875,2008-08-01T00:00:00,Lung,A04.411
18676875,2008-08-01T00:00:00,Proteomics,H01.158.201.843
18676875,2008-08-01T00:00:00,Proteomics,H01.158.273.180.350.700
18676875,2008-08-01T00:00:00,Proteomics,H01.158.273.343.350.700
18676875,2008-08-01T00:00:00,Proteomics,H01.181.122.738
18676875,2008-08-01T00:00:00,"Scleroderma, Systemic",C17.300.799
18676875,2008-08-01T00:00:00,"Scleroderma, Systemic",C17.800.784
18676875,2008-08-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
18676875,2008-08-01T00:00:00,Wound Healing,G16.100.856.891
18689373,2008-08-01T00:00:00,Adult,M01.060.116
18689373,2008-08-01T00:00:00,Aged,M01.060.116.100
18689373,2008-08-01T00:00:00,Diet,E05.272
18689373,2008-08-01T00:00:00,Diet,G07.610.240
18689373,2008-08-01T00:00:00,Dietary Supplements,J02.500.456
18689373,2008-08-01T00:00:00,Fruit,A18.024.500
18689373,2008-08-01T00:00:00,Fruit,J02.500.562
18689373,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18689373,2008-08-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18689373,2008-08-01T00:00:00,Lung Neoplasms,C08.381.540
18689373,2008-08-01T00:00:00,Lung Neoplasms,C08.785.520
18689373,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18689373,2008-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18689373,2008-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18689373,2008-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18689373,2008-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18689373,2008-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18689373,2008-08-01T00:00:00,Risk Factors,N05.715.350.200.700
18689373,2008-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18689373,2008-08-01T00:00:00,Risk Factors,N06.850.490.625.750
18689373,2008-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18689373,2008-08-01T00:00:00,Smoking,F01.145.466.753
18689391,2008-08-01T00:00:00,Clinical Laboratory Techniques,E05.200
18689391,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18689391,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18689391,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18689391,2008-08-01T00:00:00,Sensitivity and Specificity,G17.800
18689391,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18689391,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18689391,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18689391,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18689391,2008-08-01T00:00:00,Vitamin D,D04.808.812.768
18689391,2008-08-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18689401,2008-08-01T00:00:00,Clinical Laboratory Techniques,E05.200
18689401,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18689401,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18689401,2008-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18689401,2008-08-01T00:00:00,Sensitivity and Specificity,G17.800
18689401,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18689401,2008-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18689401,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18689401,2008-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18689401,2008-08-01T00:00:00,United States,Z01.107.567.875
18689401,2008-08-01T00:00:00,Vitamin D,D04.808.812.768
18690835,2008-08-01T00:00:00,Age Factors,N05.715.350.075
18690835,2008-08-01T00:00:00,Age Factors,N06.850.490.250
18690835,2008-08-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18690835,2008-08-01T00:00:00,Alzheimer Disease,C10.574.945.249
18690835,2008-08-01T00:00:00,Alzheimer Disease,F03.087.400.100
18690835,2008-08-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
18690835,2008-08-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
18690835,2008-08-01T00:00:00,Animals,B01.050
18690835,2008-08-01T00:00:00,Discrimination Learning,F02.463.425.280
18690835,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18690835,2008-08-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18690835,2008-08-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18690835,2008-08-01T00:00:00,Peptide Fragments,D12.644.541
18690835,2008-08-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18691012,2008-08-01T00:00:00,Animals,B01.050
18691012,2008-08-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18691012,2008-08-01T00:00:00,Ceramides,D02.065.313
18691012,2008-08-01T00:00:00,Ceramides,D09.400.410.420.525.200
18691012,2008-08-01T00:00:00,Ceramides,D10.390.470.675.200
18691012,2008-08-01T00:00:00,Ceramides,D10.570.877.360.612.200
18691012,2008-08-01T00:00:00,Drug Delivery Systems,E02.319.300
18691012,2008-08-01T00:00:00,Drug Design,E05.295.500
18691012,2008-08-01T00:00:00,Drug Design,H01.158.703.007.675.500
18691012,2008-08-01T00:00:00,Drug Design,H01.181.466.675.500
18691012,2008-08-01T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
18691012,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18691012,2008-08-01T00:00:00,Lipid Metabolism,G03.495.520
18691012,2008-08-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
18691012,2008-08-01T00:00:00,Neoplasms,C04
18691012,2008-08-01T00:00:00,Sphingosine,D02.033.100.700
18691012,2008-08-01T00:00:00,Sphingosine,D02.033.455.843
18691012,2008-08-01T00:00:00,Sphingosine,D02.092.063.700
18691085,2008-08-01T00:00:00,Animals,B01.050
18691085,2008-08-01T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18691085,2008-08-01T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18691085,2008-08-01T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18691085,2008-08-01T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18691085,2008-08-01T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18691085,2008-08-01T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18691085,2008-08-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18691085,2008-08-01T00:00:00,Apoptosis,G04.299.139.160
18691085,2008-08-01T00:00:00,Cell Proliferation,G04.299.233.750
18691085,2008-08-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18691085,2008-08-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18691085,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18691085,2008-08-01T00:00:00,Hyaluronic Acid,D09.698.373.475
18691085,2008-08-01T00:00:00,Neoplasms,C04
18692626,2008-08-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
18692626,2008-08-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
18692626,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18692626,2008-08-01T00:00:00,"Surgical Procedures, Operative",E04
18692626,2008-08-01T00:00:00,Video Recording,L01.240.960
18695055,2008-08-01T00:00:00,African Americans,M01.686.508.100.100
18695055,2008-08-01T00:00:00,African Americans,M01.686.754.100
18695055,2008-08-01T00:00:00,Aged,M01.060.116.100
18695055,2008-08-01T00:00:00,Aging,G07.700.320.124
18695055,2008-08-01T00:00:00,Brain,A08.186.211
18695055,2008-08-01T00:00:00,Dementia,C10.228.140.380
18695055,2008-08-01T00:00:00,Dementia,F03.087.400
18695055,2008-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18695055,2008-08-01T00:00:00,Hispanic Americans,M01.686.754.441
18695055,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18695055,2008-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18695055,2008-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18695055,2008-08-01T00:00:00,New York City,Z01.107.567.875.350.530.530
18695055,2008-08-01T00:00:00,New York City,Z01.107.567.875.500.530.530
18695055,2008-08-01T00:00:00,New York City,Z01.433.741
18695055,2008-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18695055,2008-08-01T00:00:00,Risk Factors,N05.715.350.200.700
18695055,2008-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18695055,2008-08-01T00:00:00,Risk Factors,N06.850.490.625.750
18695055,2008-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18705575,2008-08-01T00:00:00,Adult,M01.060.116
18705575,2008-08-01T00:00:00,Gastric Bypass,E02.065.062.249
18705575,2008-08-01T00:00:00,Gastric Bypass,E04.035.398.385
18705575,2008-08-01T00:00:00,Gastric Bypass,E04.062.249
18705575,2008-08-01T00:00:00,Gastric Bypass,E04.210.457.430
18705575,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18705575,2008-08-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
18705575,2008-08-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
18705575,2008-08-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
18705575,2008-08-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
18705575,2008-08-01T00:00:00,Pancreatectomy,E04.210.752
18705575,2008-08-01T00:00:00,Postoperative Complications,C23.550.767
18705575,2008-08-01T00:00:00,Treatment Outcome,E01.789.800
18705575,2008-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18705575,2008-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18705576,2008-08-01T00:00:00,Adult,M01.060.116
18705576,2008-08-01T00:00:00,Chronic Disease,C23.550.291.500
18705576,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18705576,2008-08-01T00:00:00,Islets of Langerhans Transplantation,E04.270.550
18705576,2008-08-01T00:00:00,Islets of Langerhans Transplantation,E04.936.225.375
18705576,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18705576,2008-08-01T00:00:00,Pancreatectomy,E04.210.752
18705576,2008-08-01T00:00:00,Pancreatitis,C06.689.750
18705576,2008-08-01T00:00:00,Reoperation,E04.690
18705576,2008-08-01T00:00:00,Treatment Outcome,E01.789.800
18705576,2008-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18705576,2008-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18714602,2008-08-01T00:00:00,Aged,M01.060.116.100
18714602,2008-08-01T00:00:00,Depressive Disorder,F03.600.300
18714602,2008-08-01T00:00:00,Home Care Services,N02.421.143.524
18714602,2008-08-01T00:00:00,Home Care Services,N02.421.539.089
18714602,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18714602,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18714602,2008-08-01T00:00:00,New York,Z01.107.567.875.075.437
18714602,2008-08-01T00:00:00,New York,Z01.107.567.875.350.530
18714602,2008-08-01T00:00:00,New York,Z01.107.567.875.500.530
18714602,2008-08-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18714602,2008-08-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18714602,2008-08-01T00:00:00,Patient Satisfaction,N05.715.360.600
18714602,2008-08-01T00:00:00,Pilot Projects,E05.318.760.750
18714602,2008-08-01T00:00:00,Pilot Projects,E05.337.737
18714602,2008-08-01T00:00:00,Pilot Projects,N05.715.360.775.625
18714602,2008-08-01T00:00:00,Pilot Projects,N06.850.520.450.720
18714602,2008-08-01T00:00:00,Religion,K01.844
18717125,2008-08-01T00:00:00,Acclimatization,G07.700.062.133
18717125,2008-08-01T00:00:00,Acclimatization,G16.100.057.500.133
18717125,2008-08-01T00:00:00,Adult,M01.060.116
18717125,2008-08-01T00:00:00,Altitude,G16.500.275.058
18717125,2008-08-01T00:00:00,Altitude,N06.230.058
18717125,2008-08-01T00:00:00,Anoxia,C23.888.852.079
18717125,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18717863,2008-08-01T00:00:00,Adult,M01.060.116
18717863,2008-08-01T00:00:00,Antifungal Agents,D27.505.954.122.136
18717863,2008-08-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
18717863,2008-08-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
18717863,2008-08-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
18717863,2008-08-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
18717863,2008-08-01T00:00:00,"Biopsy, Needle",E04.074.119
18717863,2008-08-01T00:00:00,"Diagnosis, Differential",E01.171
18717863,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18717863,2008-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18717863,2008-08-01T00:00:00,Risk Assessment,N04.452.871.715
18717863,2008-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18717863,2008-08-01T00:00:00,Risk Assessment,N06.850.505.715
18717863,2008-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18717863,2008-08-01T00:00:00,Treatment Outcome,E01.789.800
18717863,2008-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18717863,2008-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18776700,2008-08-01T00:00:00,Aged,M01.060.116.100
18776700,2008-08-01T00:00:00,Alcohol Drinking,F01.145.317.269
18776700,2008-08-01T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
18776700,2008-08-01T00:00:00,"Cholesterol, LDL",D10.532.515.500
18776700,2008-08-01T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
18776700,2008-08-01T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
18776700,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18776700,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18776700,2008-08-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18776700,2008-08-01T00:00:00,Population Surveillance,E05.318.308.250.700
18776700,2008-08-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
18776700,2008-08-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
18776700,2008-08-01T00:00:00,Population Surveillance,N06.850.780.675
18777906,2008-08-01T00:00:00,Algorithms,G17.035
18777906,2008-08-01T00:00:00,Algorithms,L01.224.050
18777906,2008-08-01T00:00:00,Blood Flow Velocity,E01.370.370.130
18777906,2008-08-01T00:00:00,Blood Flow Velocity,G09.330.380.630.080
18777906,2008-08-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
18777906,2008-08-01T00:00:00,Catheter Ablation,E02.148.110
18777906,2008-08-01T00:00:00,Catheter Ablation,E02.148.442.110
18777906,2008-08-01T00:00:00,Catheter Ablation,E02.154.402.110
18777906,2008-08-01T00:00:00,Catheter Ablation,E04.014.170.402.110
18777906,2008-08-01T00:00:00,Computer Simulation,L01.224.160
18777906,2008-08-01T00:00:00,Electrodes,E07.305.250
18777906,2008-08-01T00:00:00,Finite Element Analysis,E05.355
18777906,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18777906,2008-08-01T00:00:00,Liver Neoplasms,C04.588.274.623
18777906,2008-08-01T00:00:00,Liver Neoplasms,C06.301.623
18777906,2008-08-01T00:00:00,Liver Neoplasms,C06.552.697
18777906,2008-08-01T00:00:00,"Models, Biological",E05.599.395
18777906,2008-08-01T00:00:00,Neoplasms,C04
18777906,2008-08-01T00:00:00,Perfusion,E05.680
18777906,2008-08-01T00:00:00,Temperature,G01.906.595
18777906,2008-08-01T00:00:00,Temperature,G16.500.275.063.725.710
18777906,2008-08-01T00:00:00,Temperature,G16.500.750.775.710
18777906,2008-08-01T00:00:00,Temperature,N06.230.150.450
18777906,2008-08-01T00:00:00,Temperature,N06.230.300.100.725.710
18786015,2008-08-01T00:00:00,Evidence-Based Nursing,H02.249.875
18786015,2008-08-01T00:00:00,Evidence-Based Nursing,H02.478.197
18786015,2008-08-01T00:00:00,Health Behavior,F01.145.488
18786015,2008-08-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18786015,2008-08-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18786015,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18786015,2008-08-01T00:00:00,Motivation,F01.658
18786015,2008-08-01T00:00:00,Motivation,F01.752.543.500.750
18786015,2008-08-01T00:00:00,Nurse Practitioners,M01.526.485.650.640
18786015,2008-08-01T00:00:00,Nurse Practitioners,N02.360.650.640
18786015,2008-08-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
18786015,2008-08-01T00:00:00,Nurse's Role,N05.300.100.337
18786015,2008-08-01T00:00:00,Patient Compliance,F01.145.488.500
18786015,2008-08-01T00:00:00,Patient Compliance,N05.300.150.600.600
18786015,2008-08-01T00:00:00,Patient Education as Topic,I02.233.332.500
18786015,2008-08-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
18786015,2008-08-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
18786015,2008-08-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
18786015,2008-08-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
18786015,2008-08-01T00:00:00,Self Efficacy,F01.752.747.792.700
18786015,2008-08-01T00:00:00,Self-Help Groups,N03.540.782
18786015,2008-08-01T00:00:00,Smoking,F01.145.466.753
18786015,2008-08-01T00:00:00,Smoking Cessation,F01.145.940.700
18786015,2008-08-01T00:00:00,Social Support,I01.880.656.600
18786015,2008-08-01T00:00:00,Thinking,F02.463.785
18803996,2008-08-01T00:00:00,Adult,M01.060.116
18803996,2008-08-01T00:00:00,Aged,M01.060.116.100
18803996,2008-08-01T00:00:00,Data Collection,E05.318.308
18803996,2008-08-01T00:00:00,Data Collection,L01.280
18803996,2008-08-01T00:00:00,Data Collection,N05.715.360.300
18803996,2008-08-01T00:00:00,Data Collection,N06.850.520.308
18803996,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18803996,2008-08-01T00:00:00,Middle Aged,M01.060.116.630
18803996,2008-08-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
18803996,2008-08-01T00:00:00,Parkinson Disease,C10.228.662.600.400
18803996,2008-08-01T00:00:00,Parkinson Disease,C10.574.812
18935889,2008-08-01T00:00:00,Adolescent,M01.060.057
18935889,2008-08-01T00:00:00,Child,M01.060.406
18935889,2008-08-01T00:00:00,Child Welfare,I01.880.787.293
18935889,2008-08-01T00:00:00,"Child, Preschool",M01.060.406.448
18935889,2008-08-01T00:00:00,Evidence-Based Medicine,H02.249.750
18935889,2008-08-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18935889,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18935889,2008-08-01T00:00:00,Infant,M01.060.703
18935889,2008-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
18935889,2008-08-01T00:00:00,Pediatrics,H02.403.670
18935889,2008-08-01T00:00:00,Physician's Practice Patterns,N04.590.748
18935889,2008-08-01T00:00:00,Physician's Practice Patterns,N05.300.625
18935889,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18935889,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18935890,2008-08-01T00:00:00,Adolescent,M01.060.057
18935890,2008-08-01T00:00:00,Child,M01.060.406
18935890,2008-08-01T00:00:00,Child Welfare,I01.880.787.293
18935890,2008-08-01T00:00:00,"Child, Preschool",M01.060.406.448
18935890,2008-08-01T00:00:00,Data Collection,E05.318.308
18935890,2008-08-01T00:00:00,Data Collection,L01.280
18935890,2008-08-01T00:00:00,Data Collection,N05.715.360.300
18935890,2008-08-01T00:00:00,Data Collection,N06.850.520.308
18935890,2008-08-01T00:00:00,Evidence-Based Medicine,H02.249.750
18935890,2008-08-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18935890,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18935890,2008-08-01T00:00:00,Infant,M01.060.703
18935890,2008-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
18935890,2008-08-01T00:00:00,Pediatrics,H02.403.670
18935890,2008-08-01T00:00:00,Physician's Practice Patterns,N04.590.748
18935890,2008-08-01T00:00:00,Physician's Practice Patterns,N05.300.625
18935890,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18935890,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18935891,2008-08-01T00:00:00,Age Factors,N05.715.350.075
18935891,2008-08-01T00:00:00,Age Factors,N06.850.490.250
18935891,2008-08-01T00:00:00,Child,M01.060.406
18935891,2008-08-01T00:00:00,Child Behavior Disorders,F03.550.300
18935891,2008-08-01T00:00:00,"Child, Preschool",M01.060.406.448
18935891,2008-08-01T00:00:00,Data Collection,E05.318.308
18935891,2008-08-01T00:00:00,Data Collection,L01.280
18935891,2008-08-01T00:00:00,Data Collection,N05.715.360.300
18935891,2008-08-01T00:00:00,Data Collection,N06.850.520.308
18935891,2008-08-01T00:00:00,Developmental Disabilities,F03.550.362
18935891,2008-08-01T00:00:00,Disabled Children,M01.150.200
18935891,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18935891,2008-08-01T00:00:00,Infant,M01.060.703
18935891,2008-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
18935891,2008-08-01T00:00:00,Pediatrics,H02.403.670
18935891,2008-08-01T00:00:00,Physician's Practice Patterns,N04.590.748
18935891,2008-08-01T00:00:00,Physician's Practice Patterns,N05.300.625
18935891,2008-08-01T00:00:00,Pilot Projects,E05.318.760.750
18935891,2008-08-01T00:00:00,Pilot Projects,E05.337.737
18935891,2008-08-01T00:00:00,Pilot Projects,N05.715.360.775.625
18935891,2008-08-01T00:00:00,Pilot Projects,N06.850.520.450.720
18935892,2008-08-01T00:00:00,Adolescent,M01.060.057
18935892,2008-08-01T00:00:00,Age Factors,N05.715.350.075
18935892,2008-08-01T00:00:00,Age Factors,N06.850.490.250
18935892,2008-08-01T00:00:00,Analgesics,D27.505.696.663.850.014
18935892,2008-08-01T00:00:00,Analgesics,D27.505.954.427.040
18935892,2008-08-01T00:00:00,Child,M01.060.406
18935892,2008-08-01T00:00:00,"Child, Preschool",M01.060.406.448
18935892,2008-08-01T00:00:00,Headache,C10.597.617.470
18935892,2008-08-01T00:00:00,Headache,C23.888.592.612.441
18935892,2008-08-01T00:00:00,Headache,C23.888.646.487
18935892,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18935892,2008-08-01T00:00:00,Ibuprofen,D02.241.223.701.430
18935892,2008-08-01T00:00:00,Prevalence,E05.318.308.985.525.750
18935892,2008-08-01T00:00:00,Prevalence,L01.280.975.525.750
18935892,2008-08-01T00:00:00,Prevalence,N01.224.935.597.750
18935892,2008-08-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18935892,2008-08-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18935892,2008-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18935892,2008-08-01T00:00:00,Risk Factors,N05.715.350.200.700
18935892,2008-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18935892,2008-08-01T00:00:00,Risk Factors,N06.850.490.625.750
18935892,2008-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18935892,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18935892,2008-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18935892,2008-08-01T00:00:00,United States,Z01.107.567.875
18935893,2008-08-01T00:00:00,Child,M01.060.406
18935893,2008-08-01T00:00:00,Child Welfare,I01.880.787.293
18935893,2008-08-01T00:00:00,"Child, Preschool",M01.060.406.448
18935893,2008-08-01T00:00:00,Health Insurance Portability and Accountability Act,N03.219.521.576.343.349
18935893,2008-08-01T00:00:00,Health Insurance Portability and Accountability Act,N03.706.615.273
18935893,2008-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18935893,2008-08-01T00:00:00,Immunization,E02.095.465.425.400
18935893,2008-08-01T00:00:00,Immunization,E05.478.550
18935893,2008-08-01T00:00:00,Immunization,N02.421.726.758.310
18935893,2008-08-01T00:00:00,Immunization,N06.850.780.200.425
18935893,2008-08-01T00:00:00,Immunization,N06.850.780.680.310
18935893,2008-08-01T00:00:00,Infant,M01.060.703
18935893,2008-08-01T00:00:00,Physician's Practice Patterns,N04.590.748
18935893,2008-08-01T00:00:00,Physician's Practice Patterns,N05.300.625
18935893,2008-08-01T00:00:00,United States,Z01.107.567.875
19206374,2008-08-01T00:00:00,Crystallization,E05.196.300
19206374,2008-08-01T00:00:00,Crystallization,G02.149.767.505
19206374,2008-08-01T00:00:00,Crystallization,G02.842.750.505
19206374,2008-08-01T00:00:00,Diffusion,G01.595.200
19206374,2008-08-01T00:00:00,Diffusion,G02.149.767.560
19206374,2008-08-01T00:00:00,Diffusion,G02.842.750.560
19206374,2008-08-01T00:00:00,Drug Carriers,D26.255.260
19206374,2008-08-01T00:00:00,Drug Carriers,D27.720.280.260
19206374,2008-08-01T00:00:00,Drug Carriers,E02.319.300.380
19206374,2008-08-01T00:00:00,Drug Design,E05.295.500
19206374,2008-08-01T00:00:00,Drug Design,H01.158.703.007.675.500
19206374,2008-08-01T00:00:00,Drug Design,H01.181.466.675.500
19206374,2008-08-01T00:00:00,Lipids,D10
19206374,2008-08-01T00:00:00,Materials Testing,E05.570
19206374,2008-08-01T00:00:00,Molecular Conformation,G02.111.570.790
19206374,2008-08-01T00:00:00,Molecular Conformation,G02.575.500
19206374,2008-08-01T00:00:00,Molecular Conformation,G02.842.575.500
19206374,2008-08-01T00:00:00,Nanomedicine,H01.603.600
19206374,2008-08-01T00:00:00,Nanomedicine,J01.897.115.625
19206374,2008-08-01T00:00:00,Nanomedicine,J01.897.520.600.600
19206374,2008-08-01T00:00:00,Nanostructures,J01.637.512
19206374,2008-08-01T00:00:00,Pharmaceutical Preparations,D26
19206374,2008-08-01T00:00:00,Polymers,D05.750
19206374,2008-08-01T00:00:00,Polymers,D25.720
19206374,2008-08-01T00:00:00,Polymers,J01.637.051.720
19206374,2008-08-01T00:00:00,Surface Properties,G02.842.850
18677541,2008-08-02T00:00:00,Adenocarcinoma,C04.557.470.200.025
18677541,2008-08-02T00:00:00,Adult,M01.060.116
18677541,2008-08-02T00:00:00,Aged,M01.060.116.100
18677541,2008-08-02T00:00:00,Diaphragm,A02.633.567.900.300
18677541,2008-08-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18677541,2008-08-02T00:00:00,Middle Aged,M01.060.116.630
18677541,2008-08-02T00:00:00,Stomach Neoplasms,C04.588.274.476.767
18677541,2008-08-02T00:00:00,Stomach Neoplasms,C06.301.371.767
18677541,2008-08-02T00:00:00,Stomach Neoplasms,C06.405.249.767
18677541,2008-08-02T00:00:00,Stomach Neoplasms,C06.405.748.789
18677541,2008-08-02T00:00:00,Treatment Outcome,E01.789.800
18677541,2008-08-02T00:00:00,Treatment Outcome,N04.761.559.590.800
18677541,2008-08-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18676075,2008-08-03T00:00:00,Aged,M01.060.116.100
18676075,2008-08-03T00:00:00,Anticholesteremic Agents,D27.505.519.186.071.202
18676075,2008-08-03T00:00:00,Anticholesteremic Agents,D27.505.954.230.202
18676075,2008-08-03T00:00:00,Cholesterol,D04.808.247.222.284
18676075,2008-08-03T00:00:00,Cholesterol,D04.808.247.808.197
18676075,2008-08-03T00:00:00,Cholesterol,D10.570.938.208
18676075,2008-08-03T00:00:00,Cholesterol,D10.851.208
18676075,2008-08-03T00:00:00,Disease Progression,C23.550.291.656
18676075,2008-08-03T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
18676075,2008-08-03T00:00:00,Glomerular Filtration Rate,G08.852.357
18676075,2008-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18676075,2008-08-03T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
18676075,2008-08-03T00:00:00,Hypertension,C14.907.489
18676075,2008-08-03T00:00:00,Incidence,E05.318.308.985.525.375
18676075,2008-08-03T00:00:00,Incidence,L01.280.975.525.375
18676075,2008-08-03T00:00:00,Incidence,N01.224.935.597.500
18676075,2008-08-03T00:00:00,Incidence,N06.850.505.400.975.525.375
18676075,2008-08-03T00:00:00,Incidence,N06.850.520.308.985.525.375
18676075,2008-08-03T00:00:00,Kidney Diseases,C12.777.419
18676075,2008-08-03T00:00:00,Kidney Diseases,C13.351.968.419
18676075,2008-08-03T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
18676075,2008-08-03T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
18676075,2008-08-03T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
18676075,2008-08-03T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
18676075,2008-08-03T00:00:00,Middle Aged,M01.060.116.630
18676075,2008-08-03T00:00:00,Treatment Outcome,E01.789.800
18676075,2008-08-03T00:00:00,Treatment Outcome,N04.761.559.590.800
18676075,2008-08-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18672949,2008-08-04T00:00:00,Animals,B01.050
18672949,2008-08-04T00:00:00,Clinical Trials as Topic,E05.318.760.535
18672949,2008-08-04T00:00:00,Clinical Trials as Topic,E05.337.250
18672949,2008-08-04T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18672949,2008-08-04T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18672949,2008-08-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18672949,2008-08-04T00:00:00,Micelles,D05.374
18672949,2008-08-04T00:00:00,Micelles,D26.255.560
18672949,2008-08-04T00:00:00,Micelles,D27.720.280.560
18672949,2008-08-04T00:00:00,Nanoparticles,J01.637.512.600
18672949,2008-08-04T00:00:00,Surface Properties,G02.842.850
18678617,2008-08-04T00:00:00,Animals,B01.050
18678617,2008-08-04T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18678617,2008-08-04T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18678617,2008-08-04T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18678617,2008-08-04T00:00:00,Echocardiography,E01.370.350.850.220
18678617,2008-08-04T00:00:00,Echocardiography,E01.370.370.380.220
18678617,2008-08-04T00:00:00,Insulin,D06.472.699.587.740.625
18678617,2008-08-04T00:00:00,Insulin,D12.644.548.586.740.625
18678617,2008-08-04T00:00:00,Ion Channels,D12.776.157.530.400
18678617,2008-08-04T00:00:00,Ion Channels,D12.776.543.550.425
18678617,2008-08-04T00:00:00,Ion Channels,D12.776.543.585.400
18678617,2008-08-04T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
18678617,2008-08-04T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
18678617,2008-08-04T00:00:00,Mitochondrial Proteins,D12.776.575
18678617,2008-08-04T00:00:00,Myocardium,A02.633.580
18678617,2008-08-04T00:00:00,Myocardium,A07.541.704
18678617,2008-08-04T00:00:00,Myocardium,A10.690.552.750
18678617,2008-08-04T00:00:00,Oxidative Stress,G03.495.710
18678617,2008-08-04T00:00:00,Oxidative Stress,G07.700.830.750
18678617,2008-08-04T00:00:00,Oxygen Consumption,G03.730
18678617,2008-08-04T00:00:00,"RNA, Messenger",D13.444.735.544
18678617,2008-08-04T00:00:00,Reactive Oxygen Species,D01.339.431
18678617,2008-08-04T00:00:00,Reactive Oxygen Species,D01.650.775
18681898,2008-08-04T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
18681898,2008-08-04T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
18681898,2008-08-04T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
18681898,2008-08-04T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
18681898,2008-08-04T00:00:00,Amphetamine,D02.092.471.683.152.110
18681898,2008-08-04T00:00:00,Amphetamine-Related Disorders,C21.739.225
18681898,2008-08-04T00:00:00,Amphetamine-Related Disorders,F03.900.225
18681898,2008-08-04T00:00:00,Animals,B01.050
18681898,2008-08-04T00:00:00,Brain Chemistry,G02.111.100
18681898,2008-08-04T00:00:00,Brain Chemistry,G03.200
18681898,2008-08-04T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
18681898,2008-08-04T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
18681898,2008-08-04T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
18681898,2008-08-04T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
18681898,2008-08-04T00:00:00,Down-Regulation,G02.111.087.225
18681898,2008-08-04T00:00:00,Down-Regulation,G02.149.115.225
18681898,2008-08-04T00:00:00,Down-Regulation,G05.355.315.200
18681898,2008-08-04T00:00:00,Down-Regulation,G07.690.812.230
18681898,2008-08-04T00:00:00,Down-Regulation,G07.700.680.230
18681898,2008-08-04T00:00:00,Dynorphins,D12.644.400.575.180
18681898,2008-08-04T00:00:00,Dynorphins,D12.644.468.180
18681898,2008-08-04T00:00:00,Dynorphins,D12.776.641.650.575.180
18681898,2008-08-04T00:00:00,Gene Expression Regulation,G05.355.315
18681898,2008-08-04T00:00:00,Motor Activity,F01.145.632
18681898,2008-08-04T00:00:00,Motor Activity,G11.427.590.530.698
18681898,2008-08-04T00:00:00,Neurons,A08.663
18681898,2008-08-04T00:00:00,Neurons,A11.671
18681898,2008-08-04T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18681898,2008-08-04T00:00:00,Protein Precursors,D12.776.811
18678783,2008-08-05T00:00:00,Animals,B01.050
18678783,2008-08-05T00:00:00,Anticholesteremic Agents,D27.505.519.186.071.202
18678783,2008-08-05T00:00:00,Anticholesteremic Agents,D27.505.954.230.202
18678783,2008-08-05T00:00:00,Coronary Disease,C14.280.647.250
18678783,2008-08-05T00:00:00,Coronary Disease,C14.907.585.250
18678783,2008-08-05T00:00:00,Evidence-Based Medicine,H02.249.750
18678783,2008-08-05T00:00:00,Evidence-Based Medicine,H02.403.200.400
18678783,2008-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18678783,2008-08-05T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
18678783,2008-08-05T00:00:00,Risk Factors,E05.318.740.600.800.725
18678783,2008-08-05T00:00:00,Risk Factors,N05.715.350.200.700
18678783,2008-08-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18678783,2008-08-05T00:00:00,Risk Factors,N06.850.490.625.750
18678783,2008-08-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18682390,2008-08-05T00:00:00,Animals,B01.050
18682390,2008-08-05T00:00:00,Cell Survival,G04.299.316
18682390,2008-08-05T00:00:00,Integrins,D12.776.543.750.705.408
18682390,2008-08-05T00:00:00,"Models, Biological",E05.599.395
18682390,2008-08-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18682390,2008-08-05T00:00:00,Reperfusion Injury,C14.907.725
18682390,2008-08-05T00:00:00,Reperfusion Injury,C23.550.767.877
18682390,2008-08-05T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
18682390,2008-08-05T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
18682699,2008-08-05T00:00:00,Adenoviridae,B04.280.030
18682699,2008-08-05T00:00:00,Adenoviridae,B04.909.204.097
18682699,2008-08-05T00:00:00,Animals,B01.050
18682699,2008-08-05T00:00:00,Cell Line,A11.251.210
18682699,2008-08-05T00:00:00,Hela Cells,A11.251.210.190.400
18682699,2008-08-05T00:00:00,Hela Cells,A11.251.860.180.400
18682699,2008-08-05T00:00:00,Hela Cells,A11.436.340
18682699,2008-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18682699,2008-08-05T00:00:00,Inflammation,C23.550.470
18682699,2008-08-05T00:00:00,Interleukin-6,D12.644.276.374.465.506
18682699,2008-08-05T00:00:00,Interleukin-6,D12.776.467.374.465.506
18682699,2008-08-05T00:00:00,Interleukin-6,D23.529.374.465.506
18682699,2008-08-05T00:00:00,RNA Stability,G02.111.780
18682699,2008-08-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18682699,2008-08-05T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18684179,2008-08-05T00:00:00,Adolescent,M01.060.057
18684179,2008-08-05T00:00:00,Adult,M01.060.116
18684179,2008-08-05T00:00:00,Aged,M01.060.116.100
18684179,2008-08-05T00:00:00,Esophagus,A03.556.875.500
18684179,2008-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18684179,2008-08-05T00:00:00,Manometry,E05.559
18684179,2008-08-05T00:00:00,Middle Aged,M01.060.116.630
18684179,2008-08-05T00:00:00,Pressure,G01.374.715
19186217,2008-08-05T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
19186217,2008-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19186217,2008-08-05T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
18677019,2008-08-06T00:00:00,Cross Infection,C01.539.248
18677019,2008-08-06T00:00:00,Hospitals,N02.278.421
18677019,2008-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18677019,2008-08-06T00:00:00,Infection Control,N06.850.780.200.450
18677019,2008-08-06T00:00:00,Mass Screening,E01.370.500
18677019,2008-08-06T00:00:00,Mass Screening,E05.318.308.250.580
18677019,2008-08-06T00:00:00,Mass Screening,N02.421.143.827.233.443
18677019,2008-08-06T00:00:00,Mass Screening,N02.421.726.233.443
18677019,2008-08-06T00:00:00,Mass Screening,N05.715.360.300.375.500
18677019,2008-08-06T00:00:00,Mass Screening,N06.850.520.308.250.580
18677019,2008-08-06T00:00:00,Mass Screening,N06.850.780.500
18677019,2008-08-06T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
18677019,2008-08-06T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
18677019,2008-08-06T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
18677019,2008-08-06T00:00:00,Patient Admission,E02.760.400.600
18677019,2008-08-06T00:00:00,Patient Admission,N02.421.585.400.600
18677019,2008-08-06T00:00:00,Staphylococcal Infections,C01.252.410.868
18677019,2008-08-06T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
18677019,2008-08-06T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
18677019,2008-08-06T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
18683053,2008-08-06T00:00:00,Actins,D05.750.078.730.250
18683053,2008-08-06T00:00:00,Actins,D12.776.210.500.100
18683053,2008-08-06T00:00:00,Actins,D12.776.220.525.255
18683053,2008-08-06T00:00:00,Animals,B01.050
18683053,2008-08-06T00:00:00,Cell Differentiation,G04.299.151
18683053,2008-08-06T00:00:00,Collagen,D05.750.078.280
18683053,2008-08-06T00:00:00,Collagen,D12.776.860.300.250
18683053,2008-08-06T00:00:00,Muscle Contraction,G11.427.590.540
18683053,2008-08-06T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
18683053,2008-08-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18683053,2008-08-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18683053,2008-08-06T00:00:00,"Stress, Mechanical",G01.374.676.830
18683053,2008-08-06T00:00:00,"Stress, Mechanical",G01.595.540.830
18683053,2008-08-06T00:00:00,Tissue Scaffolds,E07.206.627
18683053,2008-08-06T00:00:00,Tissue Scaffolds,E07.695.825
18683053,2008-08-06T00:00:00,Urinary Bladder,A05.810.890
18688008,2008-08-07T00:00:00,Adult,M01.060.116
18688008,2008-08-07T00:00:00,Exercise Test,E01.370.370.380.250
18688008,2008-08-07T00:00:00,Exercise Test,E01.370.386.700.250
18688008,2008-08-07T00:00:00,Exercise Test,E05.333.250
18688008,2008-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18688008,2008-08-07T00:00:00,Middle Aged,M01.060.116.630
18688008,2008-08-07T00:00:00,Physical Fitness,I03.621
18688008,2008-08-07T00:00:00,Physical Fitness,N01.400.545
18688008,2008-08-07T00:00:00,Risk Factors,E05.318.740.600.800.725
18688008,2008-08-07T00:00:00,Risk Factors,N05.715.350.200.700
18688008,2008-08-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18688008,2008-08-07T00:00:00,Risk Factors,N06.850.490.625.750
18688008,2008-08-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18688008,2008-08-07T00:00:00,Stroke,C10.228.140.300.775
18688008,2008-08-07T00:00:00,Stroke,C14.907.253.855
18775426,2008-08-07T00:00:00,Animals,B01.050
18775426,2008-08-07T00:00:00,Demyelinating Diseases,C10.314
18775426,2008-08-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
18775426,2008-08-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
18775426,2008-08-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
18775426,2008-08-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
18775426,2008-08-07T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
18775426,2008-08-07T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
18775426,2008-08-07T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
18775426,2008-08-07T00:00:00,Immune Tolerance,G12.425.746.425
18775426,2008-08-07T00:00:00,Lovastatin,D02.455.426.559.847.638.400
18775426,2008-08-07T00:00:00,Lovastatin,D04.615.638.400
18775426,2008-08-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18775426,2008-08-07T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
18775426,2008-08-07T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
18775426,2008-08-07T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
18688643,2008-08-08T00:00:00,Amygdala,A08.186.211.464.090
18688643,2008-08-08T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
18688643,2008-08-08T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
18688643,2008-08-08T00:00:00,"History, 20th Century",K01.400.504.968
18688643,2008-08-08T00:00:00,Neural Pathways,A08.612
18689500,2008-08-08T00:00:00,Age Factors,N05.715.350.075
18689500,2008-08-08T00:00:00,Age Factors,N06.850.490.250
18689500,2008-08-08T00:00:00,Aging,G07.700.320.124
18689500,2008-08-08T00:00:00,Animals,B01.050
18689500,2008-08-08T00:00:00,"Antigens, CD147",D12.776.395.550.045
18689500,2008-08-08T00:00:00,"Antigens, CD147",D12.776.543.550.188
18689500,2008-08-08T00:00:00,"Antigens, CD147",D23.050.285.040
18689500,2008-08-08T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
18689500,2008-08-08T00:00:00,"Antigens, CD147",D23.101.100.110.247
18689500,2008-08-08T00:00:00,Collagen,D05.750.078.280
18689500,2008-08-08T00:00:00,Collagen,D12.776.860.300.250
18689500,2008-08-08T00:00:00,Echocardiography,E01.370.350.850.220
18689500,2008-08-08T00:00:00,Echocardiography,E01.370.370.380.220
18689500,2008-08-08T00:00:00,Fibrosis,C23.550.355
18689500,2008-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
18689500,2008-08-08T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
18689500,2008-08-08T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18689500,2008-08-08T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18689500,2008-08-08T00:00:00,Myocardium,A02.633.580
18689500,2008-08-08T00:00:00,Myocardium,A07.541.704
18689500,2008-08-08T00:00:00,Myocardium,A10.690.552.750
18689500,2008-08-08T00:00:00,Signal Transduction,G02.111.087.800
18689500,2008-08-08T00:00:00,Signal Transduction,G02.149.115.800
18689500,2008-08-08T00:00:00,Signal Transduction,G04.299.880
18689500,2008-08-08T00:00:00,Stroke Volume,E01.370.370.380.150.700
18689500,2008-08-08T00:00:00,Stroke Volume,G09.330.380.124.882
18689500,2008-08-08T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18689500,2008-08-08T00:00:00,Ventricular Remodeling,C23.300.985
18689500,2008-08-08T00:00:00,Ventricular Remodeling,G09.330.190.962.975
18689546,2008-08-08T00:00:00,Animals,B01.050
18689546,2008-08-08T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18689546,2008-08-08T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18689546,2008-08-08T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18689546,2008-08-08T00:00:00,Cell Proliferation,G04.299.233.750
18689546,2008-08-08T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18689546,2008-08-08T00:00:00,Cell Survival,G04.299.316
18689546,2008-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18689546,2008-08-08T00:00:00,Interleukin-15,D12.644.276.374.465.515
18689546,2008-08-08T00:00:00,Interleukin-15,D12.776.467.374.465.515
18689546,2008-08-08T00:00:00,Interleukin-15,D23.529.374.465.515
18689546,2008-08-08T00:00:00,Recombinant Proteins,D12.776.828
18689546,2008-08-08T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18689546,2008-08-08T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18689546,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18689546,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18689546,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18689546,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18690205,2008-08-08T00:00:00,Animals,B01.050
18690205,2008-08-08T00:00:00,Cell Movement,G04.299.283
18690205,2008-08-08T00:00:00,Cell Movement,G07.700.560.500.180
18690205,2008-08-08T00:00:00,Cell Survival,G04.299.316
18690205,2008-08-08T00:00:00,Down-Regulation,G02.111.087.225
18690205,2008-08-08T00:00:00,Down-Regulation,G02.149.115.225
18690205,2008-08-08T00:00:00,Down-Regulation,G05.355.315.200
18690205,2008-08-08T00:00:00,Down-Regulation,G07.690.812.230
18690205,2008-08-08T00:00:00,Down-Regulation,G07.700.680.230
18690205,2008-08-08T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18690205,2008-08-08T00:00:00,Genetic Vectors,G05.360.337
18690205,2008-08-08T00:00:00,Neoplasms,C04
18690205,2008-08-08T00:00:00,"Receptors, Antigen, T-Cell",D12.776.543.750.705.816.824
18690205,2008-08-08T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18690205,2008-08-08T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18690205,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18690205,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18690205,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18690205,2008-08-08T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18718443,2008-08-08T00:00:00,Amino Acid Sequence,G02.111.570.060
18718443,2008-08-08T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18718443,2008-08-08T00:00:00,Animals,B01.050
18718443,2008-08-08T00:00:00,Calcium,D01.268.552.100
18718443,2008-08-08T00:00:00,Calcium,D01.552.539.288
18718443,2008-08-08T00:00:00,Calcium,D23.119.100
18718443,2008-08-08T00:00:00,Calpain,D08.811.277.656.262.500.120
18718443,2008-08-08T00:00:00,Calpain,D08.811.277.656.300.200.120
18718443,2008-08-08T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
18718443,2008-08-08T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18718443,2008-08-08T00:00:00,Mitochondria,A11.284.835.626
18718443,2008-08-08T00:00:00,Molecular Sequence Data,L01.453.245.667
18718443,2008-08-08T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
18718443,2008-08-08T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
18718443,2008-08-08T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
18718443,2008-08-08T00:00:00,Rabbits,B01.050.150.900.649.521.700
18718443,2008-08-08T00:00:00,Recombinant Proteins,D12.776.828
18718443,2008-08-08T00:00:00,Trans-Activators,D12.776.260.755
18718443,2008-08-08T00:00:00,Trans-Activators,D12.776.930.900
18718443,2008-08-08T00:00:00,Trans-Activators,D12.776.964.925.984
18689794,2008-08-09T00:00:00,Adenoviridae,B04.280.030
18689794,2008-08-09T00:00:00,Adenoviridae,B04.909.204.097
18689794,2008-08-09T00:00:00,Animals,B01.050
18689794,2008-08-09T00:00:00,Cell Movement,G04.299.283
18689794,2008-08-09T00:00:00,Cell Movement,G07.700.560.500.180
18689794,2008-08-09T00:00:00,Cell Proliferation,G04.299.233.750
18689794,2008-08-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18689794,2008-08-09T00:00:00,"Endothelium, Vascular",A07.231.330
18689794,2008-08-09T00:00:00,"Endothelium, Vascular",A10.272.491.355
18689794,2008-08-09T00:00:00,Heart,A07.541
18689794,2008-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18689794,2008-08-09T00:00:00,Myocardial Infarction,C14.280.647.500
18689794,2008-08-09T00:00:00,Myocardial Infarction,C14.907.585.500
18689794,2008-08-09T00:00:00,Myocardium,A02.633.580
18689794,2008-08-09T00:00:00,Myocardium,A07.541.704
18689794,2008-08-09T00:00:00,Myocardium,A10.690.552.750
18689794,2008-08-09T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18689794,2008-08-09T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18689794,2008-08-09T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18689794,2008-08-09T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18689794,2008-08-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18689794,2008-08-09T00:00:00,Signal Transduction,G02.111.087.800
18689794,2008-08-09T00:00:00,Signal Transduction,G02.149.115.800
18689794,2008-08-09T00:00:00,Signal Transduction,G04.299.880
18689794,2008-08-09T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
18689794,2008-08-09T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
18689794,2008-08-09T00:00:00,Tissue Kallikreins,D23.101.840.870
18689794,2008-08-09T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18689794,2008-08-09T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18689794,2008-08-09T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18692443,2008-08-09T00:00:00,Animals,B01.050
18692443,2008-08-09T00:00:00,B-Lymphocytes,A11.063.438
18692443,2008-08-09T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
18692443,2008-08-09T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
18692443,2008-08-09T00:00:00,B-Lymphocytes,A15.382.032.438
18692443,2008-08-09T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
18692443,2008-08-09T00:00:00,Cell Proliferation,G04.299.233.750
18692443,2008-08-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18692443,2008-08-09T00:00:00,Down-Regulation,G02.111.087.225
18692443,2008-08-09T00:00:00,Down-Regulation,G02.149.115.225
18692443,2008-08-09T00:00:00,Down-Regulation,G05.355.315.200
18692443,2008-08-09T00:00:00,Down-Regulation,G07.690.812.230
18692443,2008-08-09T00:00:00,Down-Regulation,G07.700.680.230
18692443,2008-08-09T00:00:00,Gene Expression,G05.355.310
18692443,2008-08-09T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18692443,2008-08-09T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18692443,2008-08-09T00:00:00,Lymphocyte Activation,E01.450.495.482
18692443,2008-08-09T00:00:00,Lymphocyte Activation,E05.478.594.530
18692443,2008-08-09T00:00:00,Lymphocyte Activation,G12.425.747
18692443,2008-08-09T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18692443,2008-08-09T00:00:00,NFATC Transcription Factors,D12.776.930.608
18692443,2008-08-09T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
18692443,2008-08-09T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
18692443,2008-08-09T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
18692443,2008-08-09T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
18694931,2008-08-11T00:00:00,DNA-Binding Proteins,D12.776.260
18694931,2008-08-11T00:00:00,Fatty Acids,D10.251
18694931,2008-08-11T00:00:00,Gene Deletion,G05.355.600.800.320
18694931,2008-08-11T00:00:00,Gene Deletion,G05.365.590.762.320
18694931,2008-08-11T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
18694931,2008-08-11T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
18694931,2008-08-11T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
18694931,2008-08-11T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
18704101,2008-08-13T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
18704101,2008-08-13T00:00:00,Anxiety Disorders,F03.080
18704101,2008-08-13T00:00:00,Demography,I01.240
18704101,2008-08-13T00:00:00,Demography,N01.224
18704101,2008-08-13T00:00:00,Demography,N06.850.505.400
18704101,2008-08-13T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18704101,2008-08-13T00:00:00,Drug Resistance,G07.690.320
18704101,2008-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18704101,2008-08-13T00:00:00,Middle Aged,M01.060.116.630
18704101,2008-08-13T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18704101,2008-08-13T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
18704101,2008-08-13T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
18704101,2008-08-13T00:00:00,Treatment Outcome,E01.789.800
18704101,2008-08-13T00:00:00,Treatment Outcome,N04.761.559.590.800
18704101,2008-08-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18704101,2008-08-13T00:00:00,United States,Z01.107.567.875
18773928,2008-08-13T00:00:00,Animals,B01.050
18773928,2008-08-13T00:00:00,Fibroblasts,A11.329.228
18773928,2008-08-13T00:00:00,Fibroblasts,A11.872.228
18773928,2008-08-13T00:00:00,Heart,A07.541
18773928,2008-08-13T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18773928,2008-08-13T00:00:00,Retinoid X Receptor alpha,D12.776.260.698.701.500.500
18773928,2008-08-13T00:00:00,Retinoid X Receptor alpha,D12.776.826.701.500.500
18773928,2008-08-13T00:00:00,Retinoid X Receptor alpha,D12.776.930.669.701.500.500
18773928,2008-08-13T00:00:00,Retinoids,D02.455.326.271.665.202.495
18773928,2008-08-13T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
18773928,2008-08-13T00:00:00,Retinoids,D02.455.849.131.495
18773928,2008-08-13T00:00:00,Retinoids,D23.767.261.700
18773928,2008-08-13T00:00:00,Signal Transduction,G02.111.087.800
18773928,2008-08-13T00:00:00,Signal Transduction,G02.149.115.800
18773928,2008-08-13T00:00:00,Signal Transduction,G04.299.880
18773928,2008-08-13T00:00:00,"Transcription, Genetic",G02.111.087.847
18773928,2008-08-13T00:00:00,"Transcription, Genetic",G02.149.115.847
18773928,2008-08-13T00:00:00,"Transcription, Genetic",G05.355.310.700
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18773928,2008-08-13T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18701061,2008-08-14T00:00:00,Animals,B01.050
18701061,2008-08-14T00:00:00,Cocaine-Related Disorders,C21.739.300
18701061,2008-08-14T00:00:00,Cocaine-Related Disorders,F03.900.300
18701061,2008-08-14T00:00:00,Dopamine,D02.092.211.215.311.342
18701061,2008-08-14T00:00:00,Dopamine,D02.092.311.342
18701061,2008-08-14T00:00:00,Neurons,A08.663
18701061,2008-08-14T00:00:00,Neurons,A11.671
18701061,2008-08-14T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
18701061,2008-08-14T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
18703474,2008-08-14T00:00:00,Adult,M01.060.116
18703474,2008-08-14T00:00:00,Alcoholism,C21.739.100.250
18703474,2008-08-14T00:00:00,Alcoholism,F03.900.100.350
18703474,2008-08-14T00:00:00,Combined Modality Therapy,E02.186
18703474,2008-08-14T00:00:00,Dopamine,D02.092.211.215.311.342
18703474,2008-08-14T00:00:00,Dopamine,D02.092.311.342
18703474,2008-08-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18703474,2008-08-14T00:00:00,Naltrexone,D03.132.577.249.706.550
18703474,2008-08-14T00:00:00,Naltrexone,D03.549.686.750.550
18703474,2008-08-14T00:00:00,Naltrexone,D03.605.497.750.550
18703474,2008-08-14T00:00:00,Naltrexone,D04.615.723.795.706.550
18703474,2008-08-14T00:00:00,Narcotic Antagonists,D27.505.696.543
18703474,2008-08-14T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
18703474,2008-08-14T00:00:00,Narcotic Antagonists,D27.505.954.427.550
18703474,2008-08-14T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
18703474,2008-08-14T00:00:00,Practice Guidelines as Topic,N05.700.350.650
18705688,2008-08-14T00:00:00,Adolescent,M01.060.057
18705688,2008-08-14T00:00:00,Adult,M01.060.116
18705688,2008-08-14T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18705688,2008-08-14T00:00:00,Cues,F02.463.425.234
18705688,2008-08-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18705688,2008-08-14T00:00:00,Marijuana Abuse,C21.739.635
18705688,2008-08-14T00:00:00,Marijuana Abuse,F03.900.635
18705688,2008-08-14T00:00:00,Motivation,F01.658
18705688,2008-08-14T00:00:00,Motivation,F01.752.543.500.750
18705688,2008-08-14T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18705688,2008-08-14T00:00:00,Questionnaires,E05.318.308.750
18705688,2008-08-14T00:00:00,Questionnaires,L01.280.800
18705688,2008-08-14T00:00:00,Questionnaires,N05.715.360.300.695
18705688,2008-08-14T00:00:00,Questionnaires,N06.850.520.308.750
18705688,2008-08-14T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18705688,2008-08-14T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18768150,2008-08-14T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
18768150,2008-08-14T00:00:00,Animals,B01.050
18768150,2008-08-14T00:00:00,Apoptosis,G04.299.139.160
18768150,2008-08-14T00:00:00,Ceramides,D02.065.313
18768150,2008-08-14T00:00:00,Ceramides,D09.400.410.420.525.200
18768150,2008-08-14T00:00:00,Ceramides,D10.390.470.675.200
18768150,2008-08-14T00:00:00,Ceramides,D10.570.877.360.612.200
18768150,2008-08-14T00:00:00,Depression,F01.145.126.350
18768150,2008-08-14T00:00:00,Enzyme Inhibitors,D27.505.519.389
18768150,2008-08-14T00:00:00,Hippocampus,A08.186.211.464.405
18768150,2008-08-14T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
18768150,2008-08-14T00:00:00,Propanolamines,D02.033.100.624
18768150,2008-08-14T00:00:00,Propanolamines,D02.033.755.624
18768150,2008-08-14T00:00:00,Propanolamines,D02.092.063.624
18768150,2008-08-14T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
18768150,2008-08-14T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
18768150,2008-08-14T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
18768150,2008-08-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18768150,2008-08-14T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18768150,2008-08-14T00:00:00,"Stress, Psychological",F01.145.126.990
18768150,2008-08-14T00:00:00,"Stress, Psychological",F02.830.900
18416442,2008-08-15T00:00:00,Adult,M01.060.116
18416442,2008-08-15T00:00:00,Age Factors,N05.715.350.075
18416442,2008-08-15T00:00:00,Age Factors,N06.850.490.250
18416442,2008-08-15T00:00:00,Aged,M01.060.116.100
18416442,2008-08-15T00:00:00,Demography,I01.240
18416442,2008-08-15T00:00:00,Demography,N01.224
18416442,2008-08-15T00:00:00,Demography,N06.850.505.400
18416442,2008-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18416442,2008-08-15T00:00:00,Middle Aged,M01.060.116.630
18416442,2008-08-15T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
18416442,2008-08-15T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
18416442,2008-08-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18416442,2008-08-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
18416442,2008-08-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
18416442,2008-08-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
18416442,2008-08-15T00:00:00,South Carolina,Z01.107.567.875.075.662
18416442,2008-08-15T00:00:00,South Carolina,Z01.107.567.875.750.700
18701498,2008-08-15T00:00:00,Animals,B01.050
18701498,2008-08-15T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18701498,2008-08-15T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18701498,2008-08-15T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18701498,2008-08-15T00:00:00,Complement C3,D12.776.124.050.140
18701498,2008-08-15T00:00:00,Complement C3,D12.776.124.486.274.250
18701498,2008-08-15T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18701498,2008-08-15T00:00:00,Flow Cytometry,E05.200.500.386.350
18701498,2008-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18701498,2008-08-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
18701498,2008-08-15T00:00:00,Lung Neoplasms,C08.381.540
18701498,2008-08-15T00:00:00,Lung Neoplasms,C08.785.520
18701498,2008-08-15T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18701498,2008-08-15T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18701498,2008-08-15T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18701498,2008-08-15T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18701498,2008-08-15T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18701498,2008-08-15T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
18701498,2008-08-15T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
18701498,2008-08-15T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
18701498,2008-08-15T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
18701498,2008-08-15T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
18704116,2008-08-15T00:00:00,Animals,B01.050
18704116,2008-08-15T00:00:00,Apoptosis,G04.299.139.160
18704116,2008-08-15T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
18704116,2008-08-15T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
18704116,2008-08-15T00:00:00,B-Lymphocytes,A11.063.438
18704116,2008-08-15T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
18704116,2008-08-15T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
18704116,2008-08-15T00:00:00,B-Lymphocytes,A15.382.032.438
18704116,2008-08-15T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
18704116,2008-08-15T00:00:00,Cell Line,A11.251.210
18704116,2008-08-15T00:00:00,Hepatocytes,A11.436.348
18704116,2008-08-15T00:00:00,Membrane Proteins,D12.776.543
18704116,2008-08-15T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18704116,2008-08-15T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18707765,2008-08-15T00:00:00,Adult,M01.060.116
18707765,2008-08-15T00:00:00,Affect,F01.470.047
18707765,2008-08-15T00:00:00,Age of Onset,N05.715.350.075.100
18707765,2008-08-15T00:00:00,Age of Onset,N06.850.490.250.100
18707765,2008-08-15T00:00:00,Bipolar Disorder,F03.600.150.150
18707765,2008-08-15T00:00:00,California,Z01.107.567.875.580.200
18707765,2008-08-15T00:00:00,California,Z01.107.567.875.760.200
18707765,2008-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18707765,2008-08-15T00:00:00,Middle Aged,M01.060.116.630
18707765,2008-08-15T00:00:00,Psychiatric Status Rating Scales,F04.586
18707765,2008-08-15T00:00:00,Quality of Life,I01.800
18707765,2008-08-15T00:00:00,Quality of Life,K01.752.400.750
18707765,2008-08-15T00:00:00,Risk Factors,E05.318.740.600.800.725
18707765,2008-08-15T00:00:00,Risk Factors,N05.715.350.200.700
18707765,2008-08-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18707765,2008-08-15T00:00:00,Risk Factors,N06.850.490.625.750
18707765,2008-08-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18707765,2008-08-15T00:00:00,Sleep,F02.830.855
18707765,2008-08-15T00:00:00,Sleep,G11.561.600.815
18707765,2008-08-15T00:00:00,Sleep Disorders,C10.886
18707765,2008-08-15T00:00:00,Sleep Disorders,C23.888.592.796
18707765,2008-08-15T00:00:00,Sleep Disorders,F03.870
18708526,2008-08-15T00:00:00,DNA,D13.444.308
18708526,2008-08-15T00:00:00,DNA Replication,G02.111.087.222
18708526,2008-08-15T00:00:00,DNA Replication,G02.149.115.222
18708526,2008-08-15T00:00:00,DNA Replication,G05.355.200
18708526,2008-08-15T00:00:00,Escherichia coli,B03.440.450.425.325.300
18708526,2008-08-15T00:00:00,Escherichia coli,B03.660.250.150.180.100
18708526,2008-08-15T00:00:00,Escherichia coli Proteins,D12.776.097.275
18708526,2008-08-15T00:00:00,Molecular Sequence Data,L01.453.245.667
18708526,2008-08-15T00:00:00,Mutation,G05.365.590
18708526,2008-08-15T00:00:00,Protein Transport,G03.495.166.700
18708526,2008-08-15T00:00:00,Substrate Specificity,G02.111.835
19002279,2008-08-15T00:00:00,Clinical Competence,I02.399.630.210
19002279,2008-08-15T00:00:00,Clinical Competence,N04.761.210
19002279,2008-08-15T00:00:00,Curriculum,I02.158
19002279,2008-08-15T00:00:00,"Education, Pharmacy",I02.358.525
19002279,2008-08-15T00:00:00,Faculty,I02.463
19002279,2008-08-15T00:00:00,Faculty,M01.526.339
19002279,2008-08-15T00:00:00,"History, 20th Century",K01.400.504.968
19002279,2008-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19002279,2008-08-15T00:00:00,"Schools, Medical",I02.783.660.552
19002279,2008-08-15T00:00:00,"Schools, Medical",N02.278.020.578
19002279,2008-08-15T00:00:00,"Schools, Pharmacy",I02.783.660.694
19002279,2008-08-15T00:00:00,United States,Z01.107.567.875
18715779,2008-08-18T00:00:00,Antineoplastic Agents,D27.505.954.248
18715779,2008-08-18T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
18715779,2008-08-18T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
18715779,2008-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18715779,2008-08-18T00:00:00,Neoplasm Proteins,D12.776.624
18715779,2008-08-18T00:00:00,Neoplasms,C04
18715779,2008-08-18T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
18715779,2008-08-18T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
18715779,2008-08-18T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
18715779,2008-08-18T00:00:00,"Tumor Markers, Biological",D23.101.840
18702963,2008-08-19T00:00:00,Body Mass Index,E01.370.600.115.100.125
18702963,2008-08-19T00:00:00,Body Mass Index,E05.041.124.125
18702963,2008-08-19T00:00:00,Body Mass Index,G07.100.100.125
18702963,2008-08-19T00:00:00,Body Mass Index,N06.850.505.200.100.175
18702963,2008-08-19T00:00:00,Cardiovascular Diseases,C14
18702963,2008-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18702963,2008-08-19T00:00:00,Obesity,C18.654.726.500
18702963,2008-08-19T00:00:00,Obesity,C23.888.144.699.500
18702963,2008-08-19T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18702963,2008-08-19T00:00:00,Obesity,G07.100.100.160.120.699.500
18702963,2008-08-19T00:00:00,Risk Assessment,E05.318.740.600.800.715
18702963,2008-08-19T00:00:00,Risk Assessment,N04.452.871.715
18702963,2008-08-19T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18702963,2008-08-19T00:00:00,Risk Assessment,N06.850.505.715
18702963,2008-08-19T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18702963,2008-08-19T00:00:00,Risk Factors,E05.318.740.600.800.725
18702963,2008-08-19T00:00:00,Risk Factors,N05.715.350.200.700
18702963,2008-08-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18702963,2008-08-19T00:00:00,Risk Factors,N06.850.490.625.750
18702963,2008-08-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18717699,2008-08-20T00:00:00,Adult,M01.060.116
18717699,2008-08-20T00:00:00,Aged,M01.060.116.100
18717699,2008-08-20T00:00:00,Child Behavior,F01.145.179
18717699,2008-08-20T00:00:00,"Child, Preschool",M01.060.406.448
18717699,2008-08-20T00:00:00,Cognition Disorders,F03.087.250
18717699,2008-08-20T00:00:00,Demography,I01.240
18717699,2008-08-20T00:00:00,Demography,N01.224
18717699,2008-08-20T00:00:00,Demography,N06.850.505.400
18717699,2008-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18717699,2008-08-20T00:00:00,Intelligence Tests,F04.711.141.493
18717699,2008-08-20T00:00:00,Middle Aged,M01.060.116.630
18717699,2008-08-20T00:00:00,Neuropsychological Tests,F04.711.513
18717699,2008-08-20T00:00:00,Questionnaires,E05.318.308.750
18717699,2008-08-20T00:00:00,Questionnaires,L01.280.800
18717699,2008-08-20T00:00:00,Questionnaires,N05.715.360.300.695
18717699,2008-08-20T00:00:00,Questionnaires,N06.850.520.308.750
18717699,2008-08-20T00:00:00,Social Support,I01.880.656.600
18717699,2008-08-20T00:00:00,"Stress, Psychological",F01.145.126.990
18717699,2008-08-20T00:00:00,"Stress, Psychological",F02.830.900
18723473,2008-08-21T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
18723473,2008-08-21T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
18723473,2008-08-21T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
18723473,2008-08-21T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C10.314.400.250
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
18723473,2008-08-21T00:00:00,Adrenoleukodystrophy,C19.053.500.270
18723473,2008-08-21T00:00:00,Animals,B01.050
18723473,2008-08-21T00:00:00,Astrocytes,A08.637.200
18723473,2008-08-21T00:00:00,Astrocytes,A11.650.200
18723473,2008-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18723473,2008-08-21T00:00:00,Inflammation,C23.550.470
18723473,2008-08-21T00:00:00,Lipids,D10
18723473,2008-08-21T00:00:00,"Models, Biological",E05.599.395
18722629,2008-08-22T00:00:00,Evidence-Based Medicine,H02.249.750
18722629,2008-08-22T00:00:00,Evidence-Based Medicine,H02.403.200.400
18722629,2008-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18722629,2008-08-22T00:00:00,Patient Discharge,E02.760.400.610
18722629,2008-08-22T00:00:00,Patient Discharge,N02.421.585.400.610
18722629,2008-08-22T00:00:00,Risk Factors,E05.318.740.600.800.725
18722629,2008-08-22T00:00:00,Risk Factors,N05.715.350.200.700
18722629,2008-08-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18722629,2008-08-22T00:00:00,Risk Factors,N06.850.490.625.750
18722629,2008-08-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18722629,2008-08-22T00:00:00,Secondary Prevention,N02.421.726.825
18722629,2008-08-22T00:00:00,Secondary Prevention,N06.850.780.750
18722629,2008-08-22T00:00:00,Stroke,C10.228.140.300.775
18722629,2008-08-22T00:00:00,Stroke,C14.907.253.855
18723837,2008-08-22T00:00:00,Adult,M01.060.116
18723837,2008-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18723837,2008-08-22T00:00:00,Information Dissemination,F01.145.209.364
18723837,2008-08-22T00:00:00,Information Dissemination,L01.143.443
18723837,2008-08-22T00:00:00,Mental Disorders,F03
18723837,2008-08-22T00:00:00,Mental Health Services,F04.408
18723837,2008-08-22T00:00:00,Mental Health Services,N02.421.461
18723837,2008-08-22T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18723853,2008-08-23T00:00:00,Aged,M01.060.116.100
18723853,2008-08-23T00:00:00,Alzheimer Disease,C10.228.140.380.100
18723853,2008-08-23T00:00:00,Alzheimer Disease,C10.574.945.249
18723853,2008-08-23T00:00:00,Alzheimer Disease,F03.087.400.100
18723853,2008-08-23T00:00:00,Bayes Theorem,E05.318.740.600.200
18723853,2008-08-23T00:00:00,Bayes Theorem,N05.715.360.750.625.150
18723853,2008-08-23T00:00:00,Bayes Theorem,N06.850.520.830.600.200
18723853,2008-08-23T00:00:00,Brain Mapping,E01.370.350.086
18723853,2008-08-23T00:00:00,Brain Mapping,E01.370.376.149
18723853,2008-08-23T00:00:00,Brain Mapping,E05.132
18723853,2008-08-23T00:00:00,Cognition,F02.463.188
18723853,2008-08-23T00:00:00,Computer Simulation,L01.224.160
18723853,2008-08-23T00:00:00,"Data Interpretation, Statistical",E05.245.380
18723853,2008-08-23T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18723853,2008-08-23T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18723853,2008-08-23T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18723853,2008-08-23T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18723853,2008-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18723853,2008-08-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18723853,2008-08-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18723853,2008-08-23T00:00:00,Middle Aged,M01.060.116.630
18723853,2008-08-23T00:00:00,"Models, Biological",E05.599.395
19216890,2008-08-23T00:00:00,Adult,M01.060.116
19216890,2008-08-23T00:00:00,Alcoholism,C21.739.100.250
19216890,2008-08-23T00:00:00,Alcoholism,F03.900.100.350
19216890,2008-08-23T00:00:00,Anxiety,F01.470.132
19216890,2008-08-23T00:00:00,Depression,F01.145.126.350
19216890,2008-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19216890,2008-08-23T00:00:00,Paroxetine,D03.383.621.600
19216890,2008-08-23T00:00:00,Phobic Disorders,F03.080.725
19216890,2008-08-23T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
19216890,2008-08-23T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
19216890,2008-08-23T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
19216890,2008-08-23T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
18727679,2008-08-25T00:00:00,Adult,M01.060.116
18727679,2008-08-25T00:00:00,Brain Mapping,E01.370.350.086
18727679,2008-08-25T00:00:00,Brain Mapping,E01.370.376.149
18727679,2008-08-25T00:00:00,Brain Mapping,E05.132
18727679,2008-08-25T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
18727679,2008-08-25T00:00:00,Hippocampus,A08.186.211.464.405
18727679,2008-08-25T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
18727679,2008-08-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18727679,2008-08-25T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18727679,2008-08-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18727679,2008-08-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18727679,2008-08-25T00:00:00,Middle Aged,M01.060.116.630
18727679,2008-08-25T00:00:00,Sensitivity and Specificity,E05.318.740.872
18727679,2008-08-25T00:00:00,Sensitivity and Specificity,E05.318.780.800
18727679,2008-08-25T00:00:00,Sensitivity and Specificity,G17.800
18727679,2008-08-25T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18727679,2008-08-25T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18727679,2008-08-25T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18727679,2008-08-25T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18727679,2008-08-25T00:00:00,Young Adult,M01.060.116.815
18728282,2008-08-26T00:00:00,Adult,M01.060.116
18728282,2008-08-26T00:00:00,Aged,M01.060.116.100
18728282,2008-08-26T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18728282,2008-08-26T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18728282,2008-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18728282,2008-08-26T00:00:00,Incidence,E05.318.308.985.525.375
18728282,2008-08-26T00:00:00,Incidence,L01.280.975.525.375
18728282,2008-08-26T00:00:00,Incidence,N01.224.935.597.500
18728282,2008-08-26T00:00:00,Incidence,N06.850.505.400.975.525.375
18728282,2008-08-26T00:00:00,Incidence,N06.850.520.308.985.525.375
18728282,2008-08-26T00:00:00,Middle Aged,M01.060.116.630
18728282,2008-08-26T00:00:00,Questionnaires,E05.318.308.750
18728282,2008-08-26T00:00:00,Questionnaires,L01.280.800
18728282,2008-08-26T00:00:00,Questionnaires,N05.715.360.300.695
18728282,2008-08-26T00:00:00,Questionnaires,N06.850.520.308.750
18728282,2008-08-26T00:00:00,Risk Assessment,E05.318.740.600.800.715
18728282,2008-08-26T00:00:00,Risk Assessment,N04.452.871.715
18728282,2008-08-26T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18728282,2008-08-26T00:00:00,Risk Assessment,N06.850.505.715
18728282,2008-08-26T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18728282,2008-08-26T00:00:00,Risk Factors,E05.318.740.600.800.725
18728282,2008-08-26T00:00:00,Risk Factors,N05.715.350.200.700
18728282,2008-08-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18728282,2008-08-26T00:00:00,Risk Factors,N06.850.490.625.750
18728282,2008-08-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18728282,2008-08-26T00:00:00,Skin Neoplasms,C04.588.805
18728282,2008-08-26T00:00:00,Skin Neoplasms,C17.800.882
18790042,2008-08-26T00:00:00,Bilirubin,D03.383.129.578.840.249.184
18790042,2008-08-26T00:00:00,Bilirubin,D03.549.909.249.184
18790042,2008-08-26T00:00:00,Bilirubin,D04.345.783.249.184
18790042,2008-08-26T00:00:00,Bilirubin,D23.767.193.184
18790042,2008-08-26T00:00:00,Case-Control Studies,E05.318.760.500.500
18790042,2008-08-26T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18790042,2008-08-26T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18790042,2008-08-26T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18790042,2008-08-26T00:00:00,Coronary Angiography,E01.370.370.050.200
18790042,2008-08-26T00:00:00,Coronary Angiography,E01.370.370.380.200
18790042,2008-08-26T00:00:00,Coronary Artery Disease,C14.280.647.250.260
18790042,2008-08-26T00:00:00,Coronary Artery Disease,C14.907.137.126.339
18790042,2008-08-26T00:00:00,Coronary Artery Disease,C14.907.585.250.260
18790042,2008-08-26T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18790042,2008-08-26T00:00:00,Genetic Predisposition to Disease,G05.380.355
18790042,2008-08-26T00:00:00,Genetic Variation,G05.365
18790042,2008-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18790042,2008-08-26T00:00:00,Middle Aged,M01.060.116.630
18790042,2008-08-26T00:00:00,"Polymorphism, Genetic",G05.365.795
18790042,2008-08-26T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18790042,2008-08-26T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18790042,2008-08-26T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18790042,2008-08-26T00:00:00,Risk Factors,E05.318.740.600.800.725
18790042,2008-08-26T00:00:00,Risk Factors,N05.715.350.200.700
18790042,2008-08-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18790042,2008-08-26T00:00:00,Risk Factors,N06.850.490.625.750
18790042,2008-08-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18753382,2008-08-27T00:00:00,Animals,B01.050
18753382,2008-08-27T00:00:00,"Animals, Newborn",B01.050.050.282
18753382,2008-08-27T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18753382,2008-08-27T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18753382,2008-08-27T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18753382,2008-08-27T00:00:00,Hippocampus,A08.186.211.464.405
18753382,2008-08-27T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
18753382,2008-08-27T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18753382,2008-08-27T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18753382,2008-08-27T00:00:00,Membrane Proteins,D12.776.543
18753382,2008-08-27T00:00:00,Neurons,A08.663
18753382,2008-08-27T00:00:00,Neurons,A11.671
18753382,2008-08-27T00:00:00,Patch-Clamp Techniques,E05.200.500.800
18753382,2008-08-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18753382,2008-08-27T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18753382,2008-08-27T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18753382,2008-08-27T00:00:00,Seizures,C10.228.140.490.631
18753382,2008-08-27T00:00:00,Seizures,C10.597.742
18753382,2008-08-27T00:00:00,Seizures,C23.888.592.742
18753382,2008-08-27T00:00:00,Synapses,A08.850
18753382,2008-08-27T00:00:00,Synapses,A11.284.149.165.420.780
18753638,2008-08-27T00:00:00,Aged,M01.060.116.100
18753638,2008-08-27T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
18753638,2008-08-27T00:00:00,Benzimidazoles,D03.438.103
18753638,2008-08-27T00:00:00,Brain Ischemia,C10.228.140.300.150
18753638,2008-08-27T00:00:00,Brain Ischemia,C14.907.253.092
18753638,2008-08-27T00:00:00,Hemorrhage,C23.550.414
18753638,2008-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18753638,2008-08-27T00:00:00,Middle Aged,M01.060.116.630
18753638,2008-08-27T00:00:00,Myocardial Infarction,C14.280.647.500
18753638,2008-08-27T00:00:00,Myocardial Infarction,C14.907.585.500
18753638,2008-08-27T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18753638,2008-08-27T00:00:00,Secondary Prevention,N02.421.726.825
18753638,2008-08-27T00:00:00,Secondary Prevention,N06.850.780.750
18753638,2008-08-27T00:00:00,Stroke,C10.228.140.300.775
18753638,2008-08-27T00:00:00,Stroke,C14.907.253.855
18753638,2008-08-27T00:00:00,Ticlopidine,D02.886.778.834
18753638,2008-08-27T00:00:00,Ticlopidine,D03.383.903.834
18753639,2008-08-27T00:00:00,Aged,M01.060.116.100
18753639,2008-08-27T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
18753639,2008-08-27T00:00:00,Benzimidazoles,D03.438.103
18753639,2008-08-27T00:00:00,Blood Pressure,E01.370.600.875.249
18753639,2008-08-27T00:00:00,Blood Pressure,G09.330.380.076
18753639,2008-08-27T00:00:00,Cardiovascular Diseases,C14
18753639,2008-08-27T00:00:00,Creatinine,D03.383.129.308.207
18753639,2008-08-27T00:00:00,Diabetes Mellitus,C18.452.394.750
18753639,2008-08-27T00:00:00,Diabetes Mellitus,C19.246
18753639,2008-08-27T00:00:00,Heart Failure,C14.280.434
18753639,2008-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18753639,2008-08-27T00:00:00,Middle Aged,M01.060.116.630
18753639,2008-08-27T00:00:00,Myocardial Infarction,C14.280.647.500
18753639,2008-08-27T00:00:00,Myocardial Infarction,C14.907.585.500
18753639,2008-08-27T00:00:00,Potassium,D01.268.549.550
18753639,2008-08-27T00:00:00,Potassium,D01.552.528.652
18753639,2008-08-27T00:00:00,Secondary Prevention,N02.421.726.825
18753639,2008-08-27T00:00:00,Secondary Prevention,N06.850.780.750
18753639,2008-08-27T00:00:00,Stroke,C10.228.140.300.775
18753639,2008-08-27T00:00:00,Stroke,C14.907.253.855
18819774,2008-08-27T00:00:00,Adult,M01.060.116
18819774,2008-08-27T00:00:00,Anxiety Disorders,F03.080
18819774,2008-08-27T00:00:00,Attitude to Health,F01.100.150
18819774,2008-08-27T00:00:00,Attitude to Health,N05.300.150
18819774,2008-08-27T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18819774,2008-08-27T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18819774,2008-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18819774,2008-08-27T00:00:00,Prevalence,E05.318.308.985.525.750
18819774,2008-08-27T00:00:00,Prevalence,L01.280.975.525.750
18819774,2008-08-27T00:00:00,Prevalence,N01.224.935.597.750
18819774,2008-08-27T00:00:00,Prevalence,N06.850.505.400.975.525.750
18819774,2008-08-27T00:00:00,Prevalence,N06.850.520.308.985.525.750
18819774,2008-08-27T00:00:00,Questionnaires,E05.318.308.750
18819774,2008-08-27T00:00:00,Questionnaires,L01.280.800
18819774,2008-08-27T00:00:00,Questionnaires,N05.715.360.300.695
18819774,2008-08-27T00:00:00,Questionnaires,N06.850.520.308.750
18940287,2008-08-27T00:00:00,Aged,M01.060.116.100
18940287,2008-08-27T00:00:00,Chronic Disease,C23.550.291.500
18940287,2008-08-27T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18940287,2008-08-27T00:00:00,Coronary Angiography,E01.370.370.050.200
18940287,2008-08-27T00:00:00,Coronary Angiography,E01.370.370.380.200
18940287,2008-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18940287,2008-08-27T00:00:00,Middle Aged,M01.060.116.630
18940287,2008-08-27T00:00:00,Treatment Outcome,E01.789.800
18940287,2008-08-27T00:00:00,Treatment Outcome,N04.761.559.590.800
18940287,2008-08-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18757238,2008-08-29T00:00:00,Aged,M01.060.116.100
18757238,2008-08-29T00:00:00,Benzimidazoles,D03.438.103
18757238,2008-08-29T00:00:00,Cognition,F02.463.188
18757238,2008-08-29T00:00:00,Disability Evaluation,E01.370.400
18757238,2008-08-29T00:00:00,Drug Delivery Systems,E02.319.300
18757238,2008-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18757238,2008-08-29T00:00:00,Middle Aged,M01.060.116.630
18757238,2008-08-29T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18757238,2008-08-29T00:00:00,Secondary Prevention,N02.421.726.825
18757238,2008-08-29T00:00:00,Secondary Prevention,N06.850.780.750
18757238,2008-08-29T00:00:00,Stroke,C10.228.140.300.775
18757238,2008-08-29T00:00:00,Stroke,C14.907.253.855
18757238,2008-08-29T00:00:00,Ticlopidine,D02.886.778.834
18757238,2008-08-29T00:00:00,Ticlopidine,D03.383.903.834
18789909,2008-08-29T00:00:00,Animals,B01.050
18789909,2008-08-29T00:00:00,Apoptosis,G04.299.139.160
18789909,2008-08-29T00:00:00,"Behavior, Animal",F01.145.113
18789909,2008-08-29T00:00:00,Brain,A08.186.211
18789909,2008-08-29T00:00:00,Inflammation,C23.550.470
18789909,2008-08-29T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18789909,2008-08-29T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18789909,2008-08-29T00:00:00,Neuroprotective Agents,D27.505.696.706.548
18789909,2008-08-29T00:00:00,Neuroprotective Agents,D27.505.954.427.575
18789909,2008-08-29T00:00:00,Peptides,D12.644
18762292,2008-08-31T00:00:00,Adult,M01.060.116
18762292,2008-08-31T00:00:00,Animals,B01.050
18762292,2008-08-31T00:00:00,Environmental Monitoring,N06.850.460.350.080
18762292,2008-08-31T00:00:00,Environmental Monitoring,N06.850.780.375
18762292,2008-08-31T00:00:00,Environmental Pollutants,D27.888.284
18762292,2008-08-31T00:00:00,Fishes,B01.050.150.900.493
18762292,2008-08-31T00:00:00,Food Contamination,N06.850.460.400
18762292,2008-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18762292,2008-08-31T00:00:00,New York,Z01.107.567.875.075.437
18762292,2008-08-31T00:00:00,New York,Z01.107.567.875.350.530
18762292,2008-08-31T00:00:00,New York,Z01.107.567.875.500.530
18197145,2008-09-01T00:00:00,Animals,B01.050
18197145,2008-09-01T00:00:00,Endotoxins,D23.946.123.329
18197145,2008-09-01T00:00:00,Inflammation,C23.550.470
18197145,2008-09-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
18197145,2008-09-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
18197145,2008-09-01T00:00:00,Interleukin-6,D23.529.374.465.506
18197145,2008-09-01T00:00:00,Lipopolysaccharides,D09.400.500
18197145,2008-09-01T00:00:00,Lipopolysaccharides,D09.698.718.450
18197145,2008-09-01T00:00:00,Lipopolysaccharides,D10.494
18197145,2008-09-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18197145,2008-09-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18197145,2008-09-01T00:00:00,Macrophages,A11.329.372
18197145,2008-09-01T00:00:00,Macrophages,A11.627.482
18197145,2008-09-01T00:00:00,Macrophages,A11.733.397
18197145,2008-09-01T00:00:00,Macrophages,A15.382.680.397
18197145,2008-09-01T00:00:00,Macrophages,A15.382.812.522
18197145,2008-09-01T00:00:00,"Models, Biological",E05.599.395
18197145,2008-09-01T00:00:00,Phenotype,G05.695
18197145,2008-09-01T00:00:00,Sepsis,C01.539.757
18197145,2008-09-01T00:00:00,Sepsis,C23.550.470.790.500
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18197145,2008-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18345986,2008-09-01T00:00:00,Adolescent,M01.060.057
18345986,2008-09-01T00:00:00,Adult,M01.060.116
18345986,2008-09-01T00:00:00,Brain Mapping,E01.370.350.086
18345986,2008-09-01T00:00:00,Brain Mapping,E01.370.376.149
18345986,2008-09-01T00:00:00,Brain Mapping,E05.132
18345986,2008-09-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18345986,2008-09-01T00:00:00,Discrimination (Psychology),F02.463.593.257
18345986,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18345986,2008-09-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18345986,2008-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18345986,2008-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18345986,2008-09-01T00:00:00,Oxygen,D01.268.185.550
18345986,2008-09-01T00:00:00,Oxygen,D01.362.670
18345986,2008-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
18345986,2008-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
18345986,2008-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
18345986,2008-09-01T00:00:00,Photic Stimulation,E05.723.729
18345986,2008-09-01T00:00:00,Reaction Time,F02.830.650
18345986,2008-09-01T00:00:00,Reaction Time,F04.669.817
18345986,2008-09-01T00:00:00,Reaction Time,G11.561.677
18497736,2008-09-01T00:00:00,Adolescent,M01.060.057
18497736,2008-09-01T00:00:00,Adult,M01.060.116
18497736,2008-09-01T00:00:00,Aged,M01.060.116.100
18497736,2008-09-01T00:00:00,C-Reactive Protein,D12.776.034.145
18497736,2008-09-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
18497736,2008-09-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
18497736,2008-09-01T00:00:00,Depression,F01.145.126.350
18497736,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18497736,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18497736,2008-09-01T00:00:00,Obesity,C18.654.726.500
18497736,2008-09-01T00:00:00,Obesity,C23.888.144.699.500
18497736,2008-09-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18497736,2008-09-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18497736,2008-09-01T00:00:00,Questionnaires,E05.318.308.750
18497736,2008-09-01T00:00:00,Questionnaires,L01.280.800
18497736,2008-09-01T00:00:00,Questionnaires,N05.715.360.300.695
18497736,2008-09-01T00:00:00,Questionnaires,N06.850.520.308.750
18497736,2008-09-01T00:00:00,Young Adult,M01.060.116.815
18607302,2008-09-01T00:00:00,Adolescent,M01.060.057
18607302,2008-09-01T00:00:00,Adult,M01.060.116
18607302,2008-09-01T00:00:00,Aged,M01.060.116.100
18607302,2008-09-01T00:00:00,Auditory Threshold,F02.463.593.071.173
18607302,2008-09-01T00:00:00,Auditory Threshold,F02.463.593.710.190
18607302,2008-09-01T00:00:00,Child,M01.060.406
18607302,2008-09-01T00:00:00,"Child, Preschool",M01.060.406.448
18607302,2008-09-01T00:00:00,Hearing Loss,C09.218.458.341
18607302,2008-09-01T00:00:00,Hearing Loss,C10.597.751.418.341
18607302,2008-09-01T00:00:00,Hearing Loss,C23.888.592.763.393.341
18607302,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18607302,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18607302,2008-09-01T00:00:00,Prosthesis Design,E05.320.550
18607302,2008-09-01T00:00:00,Prosthesis Design,E07.695.680
18607302,2008-09-01T00:00:00,Speech Perception,F02.463.593.071.875
18607302,2008-09-01T00:00:00,Titanium,D01.268.557.800
18607302,2008-09-01T00:00:00,Titanium,D01.268.956.878
18607302,2008-09-01T00:00:00,Titanium,D01.552.547.800
18607302,2008-09-01T00:00:00,Treatment Outcome,E01.789.800
18607302,2008-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18607302,2008-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18613203,2008-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18613203,2008-09-01T00:00:00,Cell Proliferation,G04.299.233.750
18613203,2008-09-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18613203,2008-09-01T00:00:00,Cell Survival,G04.299.316
18613203,2008-09-01T00:00:00,Drug Delivery Systems,E02.319.300
18613203,2008-09-01T00:00:00,Drug Design,E05.295.500
18613203,2008-09-01T00:00:00,Drug Design,H01.158.703.007.675.500
18613203,2008-09-01T00:00:00,Drug Design,H01.181.466.675.500
18613203,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18613203,2008-09-01T00:00:00,Magnetics,H01.671.493
18613203,2008-09-01T00:00:00,Nanoparticles,J01.637.512.600
18613203,2008-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18613203,2008-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18613203,2008-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18613203,2008-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18663539,2008-09-01T00:00:00,Cardiovascular Diseases,C14
18663539,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18663539,2008-09-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
18663539,2008-09-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
18663539,2008-09-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
18663539,2008-09-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
18663539,2008-09-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
18663539,2008-09-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
18694328,2008-09-01T00:00:00,Aged,M01.060.116.100
18694328,2008-09-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18694328,2008-09-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18694328,2008-09-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18694328,2008-09-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18694328,2008-09-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18694328,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18694328,2008-09-01T00:00:00,Interleukin-4,D12.644.276.374.465.504
18694328,2008-09-01T00:00:00,Interleukin-4,D12.776.467.374.465.504
18694328,2008-09-01T00:00:00,Interleukin-4,D23.529.374.465.504
18694328,2008-09-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
18694328,2008-09-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
18694328,2008-09-01T00:00:00,Interleukin-6,D23.529.374.465.506
18694328,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18694328,2008-09-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18694328,2008-09-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18694328,2008-09-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18694328,2008-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18694328,2008-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18694328,2008-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18694328,2008-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18694328,2008-09-01T00:00:00,Smoking,F01.145.466.753
18695889,2008-09-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
18695889,2008-09-01T00:00:00,Aged,M01.060.116.100
18695889,2008-09-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
18695889,2008-09-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
18695889,2008-09-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
18695889,2008-09-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
18695889,2008-09-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
18695889,2008-09-01T00:00:00,Gene Expression,G05.355.310
18695889,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18695889,2008-09-01T00:00:00,Microtubule-Associated Proteins,D12.776.220.600.450
18695889,2008-09-01T00:00:00,Microtubule-Associated Proteins,D12.776.641.560
18695889,2008-09-01T00:00:00,"Tumor Markers, Biological",D23.101.840
18698173,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18698173,2008-09-01T00:00:00,Immune Tolerance,G12.425.746.425
18698173,2008-09-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18698173,2008-09-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18698173,2008-09-01T00:00:00,Vitamin D,D04.808.812.768
18698173,2008-09-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18698189,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18698189,2008-09-01T00:00:00,Quality of Health Care,N04.761
18698189,2008-09-01T00:00:00,Quality of Health Care,N05.715
18698189,2008-09-01T00:00:00,Rheumatic Diseases,C05.799
18698189,2008-09-01T00:00:00,Rheumatic Diseases,C17.300.775
18698189,2008-09-01T00:00:00,Rheumatology,H02.403.429.730
18704194,2008-09-01T00:00:00,Animals,B01.050
18704194,2008-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C02.256.466.313.165
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C02.928.313.165
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C04.557.386.480.100
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C04.557.386.480.150.165
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C04.619.935.313.165
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C04.925.313.165
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.100
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.150.165
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.100
18704194,2008-09-01T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.150.165
18704194,2008-09-01T00:00:00,Cell Proliferation,G04.299.233.750
18704194,2008-09-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18704194,2008-09-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
18704194,2008-09-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
18704194,2008-09-01T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
18704194,2008-09-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
18704194,2008-09-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
18704194,2008-09-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
18704194,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18704194,2008-09-01T00:00:00,"Models, Biological",E05.599.395
18704194,2008-09-01T00:00:00,Protein Kinases,D08.811.913.696.620.682
18707995,2008-09-01T00:00:00,Clinical Competence,I02.399.630.210
18707995,2008-09-01T00:00:00,Clinical Competence,N04.761.210
18707995,2008-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
18707995,2008-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18707995,2008-09-01T00:00:00,Exercise,G11.427.590.237
18707995,2008-09-01T00:00:00,Exercise,I03.350
18707995,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18707995,2008-09-01T00:00:00,Leg,A01.378.610.500
18707995,2008-09-01T00:00:00,Mass Screening,E01.370.500
18707995,2008-09-01T00:00:00,Mass Screening,E05.318.308.250.580
18707995,2008-09-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18707995,2008-09-01T00:00:00,Mass Screening,N02.421.726.233.443
18707995,2008-09-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18707995,2008-09-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18707995,2008-09-01T00:00:00,Mass Screening,N06.850.780.500
18707995,2008-09-01T00:00:00,Patient Selection,E05.581.500.653
18707995,2008-09-01T00:00:00,Patient Selection,N04.590.731
18707995,2008-09-01T00:00:00,Point-of-Care Systems,N04.452.442.452.680
18707995,2008-09-01T00:00:00,Point-of-Care Systems,N04.452.515.360.652
18707995,2008-09-01T00:00:00,Point-of-Care Systems,N04.590.874
18707995,2008-09-01T00:00:00,Posture,G11.427.695
18707995,2008-09-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
18707995,2008-09-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
18707995,2008-09-01T00:00:00,Research Design,E05.581.500
18707995,2008-09-01T00:00:00,Research Design,H01.770.644.728
18707995,2008-09-01T00:00:00,Venous Insufficiency,C14.907.952
18708943,2008-09-01T00:00:00,Algorithms,G17.035
18708943,2008-09-01T00:00:00,Algorithms,L01.224.050
18708943,2008-09-01T00:00:00,Depression,F01.145.126.350
18708943,2008-09-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
18708943,2008-09-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
18708943,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18708943,2008-09-01T00:00:00,Patient-Centered Care,N04.590.233.675
18708943,2008-09-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
18708943,2008-09-01T00:00:00,Patient-Centered Care,N04.590.720
18708943,2008-09-01T00:00:00,Pilot Projects,E05.318.760.750
18708943,2008-09-01T00:00:00,Pilot Projects,E05.337.737
18708943,2008-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
18708943,2008-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
18708943,2008-09-01T00:00:00,Secondary Prevention,N02.421.726.825
18708943,2008-09-01T00:00:00,Secondary Prevention,N06.850.780.750
18708943,2008-09-01T00:00:00,Unnecessary Procedures,N02.421.380.900
18708943,2008-09-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
18708971,2008-09-01T00:00:00,Drug Prescriptions,E02.319.307
18708971,2008-09-01T00:00:00,Drug Prescriptions,N02.421.668.778.500
18708971,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18708971,2008-09-01T00:00:00,North Carolina,Z01.107.567.875.075.475
18708971,2008-09-01T00:00:00,North Carolina,Z01.107.567.875.750.530
18708971,2008-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
18708971,2008-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
18708971,2008-09-01T00:00:00,United States,Z01.107.567.875
18708973,2008-09-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18708973,2008-09-01T00:00:00,Blood Pressure,E01.370.600.875.249
18708973,2008-09-01T00:00:00,Blood Pressure,G09.330.380.076
18708973,2008-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18708973,2008-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
18708973,2008-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18708973,2008-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18708973,2008-09-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18708973,2008-09-01T00:00:00,Diabetes Mellitus,C19.246
18708973,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18708973,2008-09-01T00:00:00,Hypertension,C14.907.489
18708973,2008-09-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
18708973,2008-09-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
18708973,2008-09-01T00:00:00,Prevalence,E05.318.308.985.525.750
18708973,2008-09-01T00:00:00,Prevalence,L01.280.975.525.750
18708973,2008-09-01T00:00:00,Prevalence,N01.224.935.597.750
18708973,2008-09-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18708973,2008-09-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18710974,2008-09-01T00:00:00,"Accidents, Traffic",N06.850.135.392
18710974,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18710974,2008-09-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
18710974,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18710974,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18710974,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18710974,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18710974,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18716122,2008-09-01T00:00:00,Adult,M01.060.116
18716122,2008-09-01T00:00:00,Aged,M01.060.116.100
18716122,2008-09-01T00:00:00,Heart Diseases,C14.280
18716122,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18716122,2008-09-01T00:00:00,Incidence,E05.318.308.985.525.375
18716122,2008-09-01T00:00:00,Incidence,L01.280.975.525.375
18716122,2008-09-01T00:00:00,Incidence,N01.224.935.597.500
18716122,2008-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18716122,2008-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18716122,2008-09-01T00:00:00,Incidental Findings,E01.410
18716122,2008-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18716122,2008-09-01T00:00:00,Lung Neoplasms,C08.381.540
18716122,2008-09-01T00:00:00,Lung Neoplasms,C08.785.520
18716122,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18716122,2008-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18716122,2008-09-01T00:00:00,Risk Assessment,N04.452.871.715
18716122,2008-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18716122,2008-09-01T00:00:00,Risk Assessment,N06.850.505.715
18716122,2008-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18716122,2008-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18716122,2008-09-01T00:00:00,Risk Factors,N05.715.350.200.700
18716122,2008-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18716122,2008-09-01T00:00:00,Risk Factors,N06.850.490.625.750
18716122,2008-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18716122,2008-09-01T00:00:00,Solitary Pulmonary Nodule,C04.588.894.797.520.966
18716122,2008-09-01T00:00:00,Solitary Pulmonary Nodule,C08.381.540.933
18716122,2008-09-01T00:00:00,Solitary Pulmonary Nodule,C08.381.884
18716122,2008-09-01T00:00:00,Solitary Pulmonary Nodule,C08.785.520.933
18716122,2008-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18716122,2008-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18716122,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18716122,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18716122,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18716122,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18716122,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18716501,2008-09-01T00:00:00,Adolescent,M01.060.057
18716501,2008-09-01T00:00:00,Anxiety,F01.470.132
18716501,2008-09-01T00:00:00,Child,M01.060.406
18716501,2008-09-01T00:00:00,Child Behavior Disorders,F03.550.300
18716501,2008-09-01T00:00:00,Fibromyalgia,C05.651.324
18716501,2008-09-01T00:00:00,Fibromyalgia,C05.799.321
18716501,2008-09-01T00:00:00,Fibromyalgia,C10.668.491.425
18716501,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18716501,2008-09-01T00:00:00,Incidence,E05.318.308.985.525.375
18716501,2008-09-01T00:00:00,Incidence,L01.280.975.525.375
18716501,2008-09-01T00:00:00,Incidence,N01.224.935.597.500
18716501,2008-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18716501,2008-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18716501,2008-09-01T00:00:00,"Interview, Psychological",F04.669.599
18716501,2008-09-01T00:00:00,Mood Disorders,F03.600
18716501,2008-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18716501,2008-09-01T00:00:00,Risk Assessment,N04.452.871.715
18716501,2008-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18716501,2008-09-01T00:00:00,Risk Assessment,N06.850.505.715
18716501,2008-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18716501,2008-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18716501,2008-09-01T00:00:00,Risk Factors,N05.715.350.200.700
18716501,2008-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18716501,2008-09-01T00:00:00,Risk Factors,N06.850.490.625.750
18716501,2008-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18716501,2008-09-01T00:00:00,United States,Z01.107.567.875
18718385,2008-09-01T00:00:00,Adult,M01.060.116
18718385,2008-09-01T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
18718385,2008-09-01T00:00:00,"Arthroplasty, Replacement",E04.650.110
18718385,2008-09-01T00:00:00,Graft Survival,G12.425.901.545.340
18718385,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18718385,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18718385,2008-09-01T00:00:00,"Ossification, Heterotopic",C23.550.751
18718385,2008-09-01T00:00:00,Quality of Life,I01.800
18718385,2008-09-01T00:00:00,Quality of Life,K01.752.400.750
18718385,2008-09-01T00:00:00,Reoperation,E04.690
18718385,2008-09-01T00:00:00,Secondary Prevention,N02.421.726.825
18718385,2008-09-01T00:00:00,Secondary Prevention,N06.850.780.750
18718385,2008-09-01T00:00:00,Temporomandibular Joint,A02.835.583.861
18718385,2008-09-01T00:00:00,Temporomandibular Joint,A14.907
18718385,2008-09-01T00:00:00,Temporomandibular Joint Disorders,C05.500.607.221.897
18718385,2008-09-01T00:00:00,Temporomandibular Joint Disorders,C05.550.905
18718385,2008-09-01T00:00:00,Temporomandibular Joint Disorders,C05.651.243.897
18718385,2008-09-01T00:00:00,Temporomandibular Joint Disorders,C07.320.610.291.897
18718385,2008-09-01T00:00:00,Temporomandibular Joint Disorders,C07.678
18718385,2008-09-01T00:00:00,Treatment Outcome,E01.789.800
18718385,2008-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18718385,2008-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18721550,2008-09-01T00:00:00,Attitude of Health Personnel,F01.100.050
18721550,2008-09-01T00:00:00,Attitude of Health Personnel,N05.300.100
18721550,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18721550,2008-09-01T00:00:00,Smoking,F01.145.466.753
18721550,2008-09-01T00:00:00,Thoracic Surgery,H02.403.810.803
18721550,2008-09-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
18721550,2008-09-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
18721550,2008-09-01T00:00:00,United States,Z01.107.567.875
18725835,2008-09-01T00:00:00,Aged,M01.060.116.100
18725835,2008-09-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18725835,2008-09-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18725835,2008-09-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18725835,2008-09-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18725835,2008-09-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18725835,2008-09-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18725835,2008-09-01T00:00:00,Family Practice,H02.403.280
18725835,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18725835,2008-09-01T00:00:00,Mass Screening,E01.370.500
18725835,2008-09-01T00:00:00,Mass Screening,E05.318.308.250.580
18725835,2008-09-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18725835,2008-09-01T00:00:00,Mass Screening,N02.421.726.233.443
18725835,2008-09-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18725835,2008-09-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18725835,2008-09-01T00:00:00,Mass Screening,N06.850.780.500
18725835,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18725835,2008-09-01T00:00:00,Organizational Innovation,N04.452.610
18725835,2008-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
18725835,2008-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
18725835,2008-09-01T00:00:00,Primary Health Care,N04.590.233.727
18725835,2008-09-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
18725835,2008-09-01T00:00:00,"Quality Assurance, Health Care",N05.700
18725835,2008-09-01T00:00:00,Research Design,E05.581.500
18725835,2008-09-01T00:00:00,Research Design,H01.770.644.728
18725835,2008-09-01T00:00:00,Social Support,I01.880.656.600
18725835,2008-09-01T00:00:00,United States,Z01.107.567.875
18729216,2008-09-01T00:00:00,Animals,B01.050
18729216,2008-09-01T00:00:00,Cell Adhesion,G04.299.117
18729216,2008-09-01T00:00:00,Cell Movement,G04.299.283
18729216,2008-09-01T00:00:00,Cell Movement,G07.700.560.500.180
18729216,2008-09-01T00:00:00,Cell Survival,G04.299.316
18729216,2008-09-01T00:00:00,Chick Embryo,A13.350.150
18729216,2008-09-01T00:00:00,Chick Embryo,A16.331.200
18729216,2008-09-01T00:00:00,Heart,A07.541
18729216,2008-09-01T00:00:00,"Models, Biological",E05.599.395
18729216,2008-09-01T00:00:00,Myocardium,A02.633.580
18729216,2008-09-01T00:00:00,Myocardium,A07.541.704
18729216,2008-09-01T00:00:00,Myocardium,A10.690.552.750
18752392,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18752392,2008-09-01T00:00:00,Research,H01.770.644
18753413,2008-09-01T00:00:00,Animals,B01.050
18753413,2008-09-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
18753413,2008-09-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
18753413,2008-09-01T00:00:00,Hepatocytes,A11.436.348
18753413,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18753413,2008-09-01T00:00:00,Liver,A03.620
18753413,2008-09-01T00:00:00,Liver Diseases,C06.552
18753413,2008-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18753413,2008-09-01T00:00:00,Signal Transduction,G02.111.087.800
18753413,2008-09-01T00:00:00,Signal Transduction,G02.149.115.800
18753413,2008-09-01T00:00:00,Signal Transduction,G04.299.880
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18753413,2008-09-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18757332,2008-09-01T00:00:00,Adult,M01.060.116
18757332,2008-09-01T00:00:00,Aged,M01.060.116.100
18757332,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18757332,2008-09-01T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
18757332,2008-09-01T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
18757332,2008-09-01T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
18757332,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18757332,2008-09-01T00:00:00,Neoplasms,C04
18757332,2008-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18757332,2008-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18757332,2008-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18757332,2008-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18757332,2008-09-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18757602,2008-09-01T00:00:00,Adult,M01.060.116
18757602,2008-09-01T00:00:00,Combined Modality Therapy,E02.186
18757602,2008-09-01T00:00:00,Community Mental Health Services,F04.408.307
18757602,2008-09-01T00:00:00,Community Mental Health Services,N02.421.143.183
18757602,2008-09-01T00:00:00,Community Mental Health Services,N02.421.461.232
18757602,2008-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
18757602,2008-09-01T00:00:00,Health Services Accessibility,N05.300.430
18757602,2008-09-01T00:00:00,Health Surveys,E05.318.308.250
18757602,2008-09-01T00:00:00,Health Surveys,N05.715.360.300.375
18757602,2008-09-01T00:00:00,Health Surveys,N06.850.520.308.250
18757602,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18757602,2008-09-01T00:00:00,Inservice Training,I02.574
18757602,2008-09-01T00:00:00,Mass Screening,E01.370.500
18757602,2008-09-01T00:00:00,Mass Screening,E05.318.308.250.580
18757602,2008-09-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18757602,2008-09-01T00:00:00,Mass Screening,N02.421.726.233.443
18757602,2008-09-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18757602,2008-09-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18757602,2008-09-01T00:00:00,Mass Screening,N06.850.780.500
18757602,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18757602,2008-09-01T00:00:00,Referral and Consultation,N04.452.758.849
18757602,2008-09-01T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
18757602,2008-09-01T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
18757602,2008-09-01T00:00:00,Substance-Related Disorders,C21.739
18757602,2008-09-01T00:00:00,Substance-Related Disorders,F03.900
18757602,2008-09-01T00:00:00,United States,Z01.107.567.875
18757646,2008-09-01T00:00:00,Adult,M01.060.116
18757646,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18757646,2008-09-01T00:00:00,Pregnancy,G08.686.785.760.769
18757646,2008-09-01T00:00:00,Premature Birth,C13.703.420.491.500
18757650,2008-09-01T00:00:00,Adult,M01.060.116
18757650,2008-09-01T00:00:00,Anti-Infective Agents,D27.505.954.122
18757650,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18757650,2008-09-01T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
18757650,2008-09-01T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
18757650,2008-09-01T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
18757650,2008-09-01T00:00:00,Staphylococcal Infections,C01.252.410.868
18757650,2008-09-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
18757650,2008-09-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
18757650,2008-09-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
18759271,2008-09-01T00:00:00,Alleles,G05.360.340.024.340.030
18759271,2008-09-01T00:00:00,Child,M01.060.406
18759271,2008-09-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18759271,2008-09-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18759271,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18759271,2008-09-01T00:00:00,Membrane Proteins,D12.776.543
18759271,2008-09-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18759271,2008-09-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18761297,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18761297,2008-09-01T00:00:00,Mood Disorders,F03.600
18761297,2008-09-01T00:00:00,Vitamin D,D04.808.812.768
18761297,2008-09-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18762777,2008-09-01T00:00:00,Animals,B01.050
18762777,2008-09-01T00:00:00,Fibroblasts,A11.329.228
18762777,2008-09-01T00:00:00,Fibroblasts,A11.872.228
18762777,2008-09-01T00:00:00,Fibrosis,C23.550.355
18762777,2008-09-01T00:00:00,Heart Failure,C14.280.434
18762777,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18762777,2008-09-01T00:00:00,Myocardial Infarction,C14.280.647.500
18762777,2008-09-01T00:00:00,Myocardial Infarction,C14.907.585.500
18762777,2008-09-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18762777,2008-09-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18762777,2008-09-01T00:00:00,"Myocytes, Cardiac",A11.620.500
18762777,2008-09-01T00:00:00,Nitric Oxide,D01.339.387
18762777,2008-09-01T00:00:00,Nitric Oxide,D01.625.550.500
18762777,2008-09-01T00:00:00,Nitric Oxide,D01.625.700.500
18762777,2008-09-01T00:00:00,Nitric Oxide,D01.650.550.587.600
18762777,2008-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18762777,2008-09-01T00:00:00,Reactive Oxygen Species,D01.339.431
18762777,2008-09-01T00:00:00,Reactive Oxygen Species,D01.650.775
18762777,2008-09-01T00:00:00,Serpins,D12.644.822.750
18762777,2008-09-01T00:00:00,Serpins,D12.644.861
18762777,2008-09-01T00:00:00,Serpins,D12.776.645.750
18762777,2008-09-01T00:00:00,Serpins,D12.776.872
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
18762777,2008-09-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
18762777,2008-09-01T00:00:00,Ventricular Remodeling,C23.300.985
18762777,2008-09-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
18765555,2008-09-01T00:00:00,Adolescent,M01.060.057
18765555,2008-09-01T00:00:00,Adult,M01.060.116
18765555,2008-09-01T00:00:00,Aged,M01.060.116.100
18765555,2008-09-01T00:00:00,Cancer Vaccines,D20.215.894.200
18765555,2008-09-01T00:00:00,Child,M01.060.406
18765555,2008-09-01T00:00:00,Combined Modality Therapy,E02.186
18765555,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18765555,2008-09-01T00:00:00,Interleukin-2,D12.644.276.374.465.502
18765555,2008-09-01T00:00:00,Interleukin-2,D12.644.276.374.480.372
18765555,2008-09-01T00:00:00,Interleukin-2,D12.776.467.374.465.502
18765555,2008-09-01T00:00:00,Interleukin-2,D12.776.467.374.480.372
18765555,2008-09-01T00:00:00,Interleukin-2,D23.529.374.465.502
18765555,2008-09-01T00:00:00,Interleukin-2,D23.529.374.480.372
18765555,2008-09-01T00:00:00,Melanoma,C04.557.465.625.650.510
18765555,2008-09-01T00:00:00,Melanoma,C04.557.580.625.650.510
18765555,2008-09-01T00:00:00,Melanoma,C04.557.665.510
18765555,2008-09-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
18765555,2008-09-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
18765555,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18765555,2008-09-01T00:00:00,Skin Neoplasms,C04.588.805
18765555,2008-09-01T00:00:00,Skin Neoplasms,C17.800.882
18765555,2008-09-01T00:00:00,Treatment Outcome,E01.789.800
18765555,2008-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18765555,2008-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18768444,2008-09-01T00:00:00,Competency-Based Education,I02.158.210
18768444,2008-09-01T00:00:00,Cultural Competency,I01.880.143.364
18768444,2008-09-01T00:00:00,Curriculum,I02.158
18768444,2008-09-01T00:00:00,"Education, Dental",I02.358.274
18768444,2008-09-01T00:00:00,Educational Measurement,I02.399
18768444,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18768444,2008-09-01T00:00:00,Program Development,N04.452.760
18768444,2008-09-01T00:00:00,Program Evaluation,E05.337.820
18768444,2008-09-01T00:00:00,Program Evaluation,N04.761.685
18768444,2008-09-01T00:00:00,Program Evaluation,N05.715.360.650
18768444,2008-09-01T00:00:00,United States,Z01.107.567.875
18771976,2008-09-01T00:00:00,Cesarean Section,E04.520.252.500
18771976,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18771976,2008-09-01T00:00:00,Infant,M01.060.703
18771976,2008-09-01T00:00:00,"Labor, Induced",E04.520.252.968
18771976,2008-09-01T00:00:00,Pre-Eclampsia,C13.703.395.249
18771976,2008-09-01T00:00:00,Pregnancy,G08.686.785.760.769
18771976,2008-09-01T00:00:00,Pregnancy Outcome,E01.789.700
18771976,2008-09-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
18772295,2008-09-01T00:00:00,Coronary Disease,C14.280.647.250
18772295,2008-09-01T00:00:00,Coronary Disease,C14.907.585.250
18772295,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18772295,2008-09-01T00:00:00,Medical Records,E05.318.308.940.968
18772295,2008-09-01T00:00:00,Medical Records,L01.280.900.968
18772295,2008-09-01T00:00:00,Medical Records,N04.452.859.564
18772295,2008-09-01T00:00:00,Medical Records,N05.715.360.300.715.500
18772295,2008-09-01T00:00:00,Medical Records,N06.850.520.308.940.968
18772295,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18772295,2008-09-01T00:00:00,Primary Health Care,N04.590.233.727
18772295,2008-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18772295,2008-09-01T00:00:00,Risk Assessment,N04.452.871.715
18772295,2008-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18772295,2008-09-01T00:00:00,Risk Assessment,N06.850.505.715
18772295,2008-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18772295,2008-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18772295,2008-09-01T00:00:00,Risk Factors,N05.715.350.200.700
18772295,2008-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18772295,2008-09-01T00:00:00,Risk Factors,N06.850.490.625.750
18772295,2008-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18772295,2008-09-01T00:00:00,United States,Z01.107.567.875
18774392,2008-09-01T00:00:00,Adult,M01.060.116
18774392,2008-09-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18774392,2008-09-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18774392,2008-09-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18774392,2008-09-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18774392,2008-09-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18774392,2008-09-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18774392,2008-09-01T00:00:00,Autoimmune Diseases,C20.111
18774392,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18774392,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18779298,2008-09-01T00:00:00,Adult,M01.060.116
18779298,2008-09-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18779298,2008-09-01T00:00:00,Body Mass Index,E05.041.124.125
18779298,2008-09-01T00:00:00,Body Mass Index,G07.100.100.125
18779298,2008-09-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18779298,2008-09-01T00:00:00,Dietary Carbohydrates,D09.301
18779298,2008-09-01T00:00:00,Dietary Carbohydrates,J02.500.362
18779298,2008-09-01T00:00:00,Energy Intake,G07.610.240.340
18779298,2008-09-01T00:00:00,Genetic Variation,G05.365
18779298,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18779298,2008-09-01T00:00:00,Lipids,D10
18779298,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18779298,2008-09-01T00:00:00,Obesity,C18.654.726.500
18779298,2008-09-01T00:00:00,Obesity,C23.888.144.699.500
18779298,2008-09-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18779298,2008-09-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18779298,2008-09-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18779298,2008-09-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18782217,2008-09-01T00:00:00,Epilepsy,C10.228.140.490
18782217,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18782218,2008-09-01T00:00:00,Developing Countries,I01.615.500.300
18782218,2008-09-01T00:00:00,Drug Resistance,G07.690.320
18782218,2008-09-01T00:00:00,Epilepsy,C10.228.140.490
18782218,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18782218,2008-09-01T00:00:00,Infant,M01.060.703
18782218,2008-09-01T00:00:00,Obesity,C18.654.726.500
18782218,2008-09-01T00:00:00,Obesity,C23.888.144.699.500
18782218,2008-09-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18782218,2008-09-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18792660,2008-09-01T00:00:00,Adolescent,M01.060.057
18792660,2008-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
18792660,2008-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
18792660,2008-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
18792660,2008-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
18792660,2008-09-01T00:00:00,Ambulatory Care,E02.760.106
18792660,2008-09-01T00:00:00,Ambulatory Care,N02.421.585.106
18792660,2008-09-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18792660,2008-09-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
18792660,2008-09-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
18792660,2008-09-01T00:00:00,Child,M01.060.406
18792660,2008-09-01T00:00:00,"Child, Preschool",M01.060.406.448
18792660,2008-09-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
18792660,2008-09-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
18792660,2008-09-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
18792660,2008-09-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
18792660,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18792660,2008-09-01T00:00:00,Medication Errors,E02.319.529
18792660,2008-09-01T00:00:00,Medication Errors,N02.421.450.500
18792660,2008-09-01T00:00:00,United States,Z01.107.567.875
18794007,2008-09-01T00:00:00,Biological Markers,D23.101
18794007,2008-09-01T00:00:00,Breast Neoplasms,C04.588.180
18794007,2008-09-01T00:00:00,Breast Neoplasms,C17.800.090.500
18794007,2008-09-01T00:00:00,"Cholesterol, HDL",D10.532.432.400
18794007,2008-09-01T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
18794007,2008-09-01T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
18794007,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18794007,2008-09-01T00:00:00,Incidence,E05.318.308.985.525.375
18794007,2008-09-01T00:00:00,Incidence,L01.280.975.525.375
18794007,2008-09-01T00:00:00,Incidence,N01.224.935.597.500
18794007,2008-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18794007,2008-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18794007,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18794007,2008-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18794007,2008-09-01T00:00:00,Risk Assessment,N04.452.871.715
18794007,2008-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18794007,2008-09-01T00:00:00,Risk Assessment,N06.850.505.715
18794007,2008-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18794007,2008-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18794007,2008-09-01T00:00:00,Risk Factors,N05.715.350.200.700
18794007,2008-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18794007,2008-09-01T00:00:00,Risk Factors,N06.850.490.625.750
18794007,2008-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18794007,2008-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18794007,2008-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18794007,2008-09-01T00:00:00,Sensitivity and Specificity,G17.800
18794007,2008-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18794007,2008-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18794007,2008-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18794007,2008-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18794315,2008-09-01T00:00:00,Adult,M01.060.116
18794315,2008-09-01T00:00:00,Breast Neoplasms,C04.588.180
18794315,2008-09-01T00:00:00,Breast Neoplasms,C17.800.090.500
18794315,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18794315,2008-09-01T00:00:00,Mammography,E01.370.350.700.500
18794315,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18794408,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18794408,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18794408,2008-09-01T00:00:00,Nasal Cavity,A04.531.449
18794408,2008-09-01T00:00:00,Nasal Obstruction,C08.460.525
18794408,2008-09-01T00:00:00,Nasal Obstruction,C08.618.846.185.525
18794408,2008-09-01T00:00:00,Nasal Obstruction,C09.603.525
18794408,2008-09-01T00:00:00,Rhinoplasty,E02.218.755
18794408,2008-09-01T00:00:00,Rhinoplasty,E04.580.677
18794408,2008-09-01T00:00:00,Rhinoplasty,E04.680.650
18794443,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18794443,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18794443,2008-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18794443,2008-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18794443,2008-09-01T00:00:00,Sensitivity and Specificity,G17.800
18794443,2008-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18794443,2008-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18794443,2008-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18794443,2008-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18794443,2008-09-01T00:00:00,Thyroid Neoplasms,C04.588.322.894
18794443,2008-09-01T00:00:00,Thyroid Neoplasms,C04.588.443.915
18794443,2008-09-01T00:00:00,Thyroid Neoplasms,C19.344.894
18794443,2008-09-01T00:00:00,Thyroid Neoplasms,C19.874.788
18794443,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18794443,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18794443,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18794443,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18794443,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18797381,2008-09-01T00:00:00,Esophagus,A03.556.875.500
18797381,2008-09-01T00:00:00,Foreign Bodies,C21.866.392
18797381,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18806676,2008-09-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18806676,2008-09-01T00:00:00,Eye Injuries,C11.297
18806676,2008-09-01T00:00:00,Eye Injuries,C21.866.260.275.250
18806676,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18806676,2008-09-01T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
18806676,2008-09-01T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
18806676,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18806676,2008-09-01T00:00:00,Ofloxacin,D03.438.810.835.322.500
18806676,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18806676,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18806676,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18806676,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18806676,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18806676,2008-09-01T00:00:00,Ulcer,C23.550.891
18812958,2008-09-01T00:00:00,Adolescent,M01.060.057
18812958,2008-09-01T00:00:00,Adult,M01.060.116
18812958,2008-09-01T00:00:00,Aged,M01.060.116.100
18812958,2008-09-01T00:00:00,"Embolization, Therapeutic",E02.520.360
18812958,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18812958,2008-09-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
18812958,2008-09-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
18812958,2008-09-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
18812958,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18812958,2008-09-01T00:00:00,Postoperative Complications,C23.550.767
18812958,2008-09-01T00:00:00,Vascular Surgical Procedures,E04.100.814
18812958,2008-09-01T00:00:00,Vision Disorders,C10.597.751.941
18812958,2008-09-01T00:00:00,Vision Disorders,C11.966
18812958,2008-09-01T00:00:00,Vision Disorders,C23.888.592.763.941
18814451,2008-09-01T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
18814451,2008-09-01T00:00:00,"Angioedemas, Hereditary",C16.320.078
18814451,2008-09-01T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
18814451,2008-09-01T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
18814451,2008-09-01T00:00:00,Bradykinin,D12.644.276.812.169
18814451,2008-09-01T00:00:00,Bradykinin,D12.644.400.090
18814451,2008-09-01T00:00:00,Bradykinin,D12.644.456.193
18814451,2008-09-01T00:00:00,Bradykinin,D12.776.467.812.169
18814451,2008-09-01T00:00:00,Bradykinin,D12.776.641.650.090
18814451,2008-09-01T00:00:00,Bradykinin,D23.469.050.375.110
18814451,2008-09-01T00:00:00,Bradykinin,D23.529.812.169
18814451,2008-09-01T00:00:00,Complement Activation,G12.425.255
18814451,2008-09-01T00:00:00,Factor XII,D12.776.124.125.450
18814451,2008-09-01T00:00:00,Factor XII,D23.119.450
18814451,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18814451,2008-09-01T00:00:00,Kallikreins,D08.811.277.656.300.760.442
18814451,2008-09-01T00:00:00,Kallikreins,D08.811.277.656.959.350.442
18814451,2008-09-01T00:00:00,Kallikreins,D12.776.124.125.597
18814451,2008-09-01T00:00:00,Kallikreins,D23.119.597
18814451,2008-09-01T00:00:00,"Models, Biological",E05.599.395
18814451,2008-09-01T00:00:00,Prekallikrein,D08.811.277.656.300.760.442.725
18814451,2008-09-01T00:00:00,Prekallikrein,D08.811.277.656.959.350.442.725
18814451,2008-09-01T00:00:00,Prekallikrein,D12.776.124.125.597.712
18814451,2008-09-01T00:00:00,Prekallikrein,D23.119.597.712
18828477,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18828477,2008-09-01T00:00:00,Prostatectomy,E04.950.774.860.625
18828477,2008-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18828477,2008-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18828477,2008-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18828477,2008-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18850643,2008-09-01T00:00:00,Electrophoresis,E05.196.401
18850643,2008-09-01T00:00:00,Electrophoresis,E05.301.300
18850643,2008-09-01T00:00:00,Electrophoresis,G02.149.767.570
18850643,2008-09-01T00:00:00,Electrophoresis,G02.842.750.570
18850643,2008-09-01T00:00:00,Nanotechnology,H01.603
18850643,2008-09-01T00:00:00,Nanotechnology,J01.897.520.600
18853877,2008-09-01T00:00:00,Adult,M01.060.116
18853877,2008-09-01T00:00:00,Aged,M01.060.116.100
18853877,2008-09-01T00:00:00,Endoscopy,E01.370.388.250
18853877,2008-09-01T00:00:00,Endoscopy,E04.800.250
18853877,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18853877,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18853877,2008-09-01T00:00:00,Mucocele,C04.182.511
18853877,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18853877,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18853877,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18853877,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18853877,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18853877,2008-09-01T00:00:00,Treatment Outcome,E01.789.800
18853877,2008-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18853877,2008-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18954501,2008-09-01T00:00:00,Chronic Disease,C23.550.291.500
18954501,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18954501,2008-09-01T00:00:00,Paranasal Sinuses,A04.531.621
18954501,2008-09-01T00:00:00,Sinusitis,C08.460.692.752
18954501,2008-09-01T00:00:00,Sinusitis,C08.730.749
18954501,2008-09-01T00:00:00,Sinusitis,C09.603.692.752
18954512,2008-09-01T00:00:00,Adolescent,M01.060.057
18954512,2008-09-01T00:00:00,Adult,M01.060.116
18954512,2008-09-01T00:00:00,Aged,M01.060.116.100
18954512,2008-09-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
18954512,2008-09-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
18954512,2008-09-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
18954512,2008-09-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
18954512,2008-09-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
18954512,2008-09-01T00:00:00,Child,M01.060.406
18954512,2008-09-01T00:00:00,"Child, Preschool",M01.060.406.448
18954512,2008-09-01T00:00:00,Endoscopy,E01.370.388.250
18954512,2008-09-01T00:00:00,Endoscopy,E04.800.250
18954512,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18954512,2008-09-01T00:00:00,Incidence,E05.318.308.985.525.375
18954512,2008-09-01T00:00:00,Incidence,L01.280.975.525.375
18954512,2008-09-01T00:00:00,Incidence,N01.224.935.597.500
18954512,2008-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18954512,2008-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18954512,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18954512,2008-09-01T00:00:00,Neurosurgical Procedures,E04.525
18954512,2008-09-01T00:00:00,Postoperative Complications,C23.550.767
18954512,2008-09-01T00:00:00,Reconstructive Surgical Procedures,E04.680
18954512,2008-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18954512,2008-09-01T00:00:00,Risk Factors,N05.715.350.200.700
18954512,2008-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18954512,2008-09-01T00:00:00,Risk Factors,N06.850.490.625.750
18954512,2008-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18954512,2008-09-01T00:00:00,Skull Base,A01.456.830
18954512,2008-09-01T00:00:00,Skull Base,A02.835.232.781.750
18954512,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18954512,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18954512,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18954512,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18954512,2008-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18978669,2008-09-01T00:00:00,"Accidents, Traffic",N06.850.135.392
18978669,2008-09-01T00:00:00,"Gait Disorders, Neurologic",C10.597.404
18978669,2008-09-01T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
18978669,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18978669,2008-09-01T00:00:00,Middle Aged,M01.060.116.630
18978669,2008-09-01T00:00:00,Quadriplegia,C10.597.622.760
18978669,2008-09-01T00:00:00,Quadriplegia,C23.888.592.636.786
18978669,2008-09-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
18978669,2008-09-01T00:00:00,Spinal Cord Injuries,C10.900.850
18978669,2008-09-01T00:00:00,Spinal Cord Injuries,C21.866.819
19189609,2008-09-01T00:00:00,Cognition,F02.463.188
19189609,2008-09-01T00:00:00,Cognitive Therapy,F04.754.137.428
19189609,2008-09-01T00:00:00,Disaster Planning,N06.230.100.035
19189609,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19189609,2008-09-01T00:00:00,Mental Disorders,F03
19189609,2008-09-01T00:00:00,Relief Work,I01.880.787.839
19189609,2008-09-01T00:00:00,Relief Work,N06.230.100.300
19189609,2008-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19189609,2008-09-01T00:00:00,"Stress, Psychological",F01.145.126.990
19189609,2008-09-01T00:00:00,"Stress, Psychological",F02.830.900
19238872,2008-09-01T00:00:00,Aged,M01.060.116.100
19238872,2008-09-01T00:00:00,Brachiocephalic Trunk,A07.231.114.145
19238872,2008-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19238872,2008-09-01T00:00:00,Stents,E07.695.750
19238872,2008-09-01T00:00:00,Tracheal Diseases,C08.907
19238872,2008-09-01T00:00:00,Tracheostomy,E04.579.935
19238872,2008-09-01T00:00:00,Tracheostomy,E04.580.900
19238872,2008-09-01T00:00:00,Tracheostomy,E04.928.780
19238872,2008-09-01T00:00:00,Vascular Fistula,C14.240.850.984
19238872,2008-09-01T00:00:00,Vascular Fistula,C14.907.933
19238872,2008-09-01T00:00:00,Vascular Fistula,C23.300.575.950
18765394,2008-09-02T00:00:00,Adult,M01.060.116
18765394,2008-09-02T00:00:00,Aged,M01.060.116.100
18765394,2008-09-02T00:00:00,Blood Flow Velocity,E01.370.370.130
18765394,2008-09-02T00:00:00,Blood Flow Velocity,G09.330.380.630.080
18765394,2008-09-02T00:00:00,Heart Failure,C14.280.434
18765394,2008-09-02T00:00:00,Heart-Assist Devices,E04.050.430
18765394,2008-09-02T00:00:00,Heart-Assist Devices,E07.695.300.300
18765394,2008-09-02T00:00:00,Heart-Assist Devices,E07.858.082.374.300
18765394,2008-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18765394,2008-09-02T00:00:00,Middle Aged,M01.060.116.630
18765947,2008-09-02T00:00:00,Animals,B01.050
18765947,2008-09-02T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
18765947,2008-09-02T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
18765947,2008-09-02T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
18765947,2008-09-02T00:00:00,Disease Progression,C23.550.291.656
18765947,2008-09-02T00:00:00,Extracellular Matrix,A11.284.295.310
18765947,2008-09-02T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18765947,2008-09-02T00:00:00,Genetic Predisposition to Disease,G05.380.355
18765947,2008-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18765947,2008-09-02T00:00:00,Marfan Syndrome,C05.116.099.674
18765947,2008-09-02T00:00:00,Marfan Syndrome,C14.240.400.725
18765947,2008-09-02T00:00:00,Marfan Syndrome,C14.280.400.725
18765947,2008-09-02T00:00:00,Marfan Syndrome,C16.131.077.550
18765947,2008-09-02T00:00:00,Marfan Syndrome,C16.131.240.400.720
18765947,2008-09-02T00:00:00,Marfan Syndrome,C16.320.540
18765947,2008-09-02T00:00:00,Marfan Syndrome,C17.300.500
18765947,2008-09-02T00:00:00,Mutation,G05.365.590
18765947,2008-09-02T00:00:00,Signal Transduction,G02.111.087.800
18765947,2008-09-02T00:00:00,Signal Transduction,G02.149.115.800
18765947,2008-09-02T00:00:00,Signal Transduction,G04.299.880
18765947,2008-09-02T00:00:00,"Telangiectasia, Hereditary Hemorrhagic",C14.907.454.900
18765947,2008-09-02T00:00:00,"Telangiectasia, Hereditary Hemorrhagic",C14.907.823.780
18765947,2008-09-02T00:00:00,"Telangiectasia, Hereditary Hemorrhagic",C15.378.463.835.900
18765947,2008-09-02T00:00:00,"Telangiectasia, Hereditary Hemorrhagic",C16.131.240.850.968
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18765947,2008-09-02T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18768400,2008-09-02T00:00:00,Animals,B01.050
18768400,2008-09-02T00:00:00,Apoptosis,G04.299.139.160
18768400,2008-09-02T00:00:00,Aprotinin,D12.776.083
18768400,2008-09-02T00:00:00,Myocardial Infarction,C14.280.647.500
18768400,2008-09-02T00:00:00,Myocardial Infarction,C14.907.585.500
18768400,2008-09-02T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18768400,2008-09-02T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18768400,2008-09-02T00:00:00,"Myocytes, Cardiac",A11.620.500
18768400,2008-09-02T00:00:00,Nitric Oxide,D01.339.387
18768400,2008-09-02T00:00:00,Nitric Oxide,D01.625.550.500
18768400,2008-09-02T00:00:00,Nitric Oxide,D01.625.700.500
18768400,2008-09-02T00:00:00,Nitric Oxide,D01.650.550.587.600
18768400,2008-09-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18768400,2008-09-02T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
18768400,2008-09-02T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
18768400,2008-09-02T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
18768400,2008-09-02T00:00:00,Serine Proteinase Inhibitors,D27.505.519.389.745.800
18768400,2008-09-02T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
18768400,2008-09-02T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
18768400,2008-09-02T00:00:00,Tissue Kallikreins,D23.101.840.870
18763020,2008-09-03T00:00:00,Animals,B01.050
18763020,2008-09-03T00:00:00,Biocompatible Materials,D25.130
18763020,2008-09-03T00:00:00,Biocompatible Materials,D27.720.102.130
18763020,2008-09-03T00:00:00,Biocompatible Materials,J01.637.051.130
18763020,2008-09-03T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18763020,2008-09-03T00:00:00,Collagen Type I,D05.750.078.280.300.100
18763020,2008-09-03T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
18763020,2008-09-03T00:00:00,Materials Testing,E05.570
18763020,2008-09-03T00:00:00,Nanostructures,J01.637.512
18763020,2008-09-03T00:00:00,Tissue Scaffolds,E07.206.627
18763020,2008-09-03T00:00:00,Tissue Scaffolds,E07.695.825
18772363,2008-09-04T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
18772363,2008-09-04T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
18772363,2008-09-04T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
18772363,2008-09-04T00:00:00,Helicobacter pylori,B03.440.500.550
18772363,2008-09-04T00:00:00,Helicobacter pylori,B03.660.150.280.550
18772363,2008-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18772363,2008-09-04T00:00:00,NF-kappa B,D12.776.260.600
18772363,2008-09-04T00:00:00,NF-kappa B,D12.776.660.600
18772363,2008-09-04T00:00:00,NF-kappa B,D12.776.930.600
18772363,2008-09-04T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18772363,2008-09-04T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18772363,2008-09-04T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18772363,2008-09-04T00:00:00,Signal Transduction,G02.111.087.800
18772363,2008-09-04T00:00:00,Signal Transduction,G02.149.115.800
18772363,2008-09-04T00:00:00,Signal Transduction,G04.299.880
18772364,2008-09-04T00:00:00,Animals,B01.050
18772364,2008-09-04T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.260.103.625.750
18772364,2008-09-04T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.930.125.625.750
18772364,2008-09-04T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
18772364,2008-09-04T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
18772364,2008-09-04T00:00:00,Oxygen,D01.268.185.550
18772364,2008-09-04T00:00:00,Oxygen,D01.362.670
18772364,2008-09-04T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
18772364,2008-09-04T00:00:00,Reperfusion Injury,C14.907.725
18772364,2008-09-04T00:00:00,Reperfusion Injury,C23.550.767.877
18772364,2008-09-04T00:00:00,Signal Transduction,G02.111.087.800
18772364,2008-09-04T00:00:00,Signal Transduction,G02.149.115.800
18772364,2008-09-04T00:00:00,Signal Transduction,G04.299.880
18775607,2008-09-04T00:00:00,Adult,M01.060.116
18775607,2008-09-04T00:00:00,Cocaine-Related Disorders,C21.739.300
18775607,2008-09-04T00:00:00,Cocaine-Related Disorders,F03.900.300
18775607,2008-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18775607,2008-09-04T00:00:00,Mental Disorders,F03
18775607,2008-09-04T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18775607,2008-09-04T00:00:00,Psychiatric Status Rating Scales,F04.586
18775607,2008-09-04T00:00:00,Self-Help Groups,N03.540.782
18775607,2008-09-04T00:00:00,Substance-Related Disorders,C21.739
18775607,2008-09-04T00:00:00,Substance-Related Disorders,F03.900
18804099,2008-09-04T00:00:00,Apoptosis,G04.299.139.160
18804099,2008-09-04T00:00:00,Caspases,D08.811.277.656.262.500.126
18804099,2008-09-04T00:00:00,Caspases,D08.811.277.656.300.200.126
18804099,2008-09-04T00:00:00,Caspases,D12.644.360.075.405
18804099,2008-09-04T00:00:00,Caspases,D12.776.476.075.405
18804099,2008-09-04T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
18804099,2008-09-04T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
18804099,2008-09-04T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
18804099,2008-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18804099,2008-09-04T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18804099,2008-09-04T00:00:00,Mitochondria,A11.284.835.626
18804099,2008-09-04T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
18804099,2008-09-04T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
18804099,2008-09-04T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
18804099,2008-09-04T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18804099,2008-09-04T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18804099,2008-09-04T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18804099,2008-09-04T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
18804099,2008-09-04T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
18804099,2008-09-04T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
18804099,2008-09-04T00:00:00,Signal Transduction,G02.111.087.800
18804099,2008-09-04T00:00:00,Signal Transduction,G02.149.115.800
18804099,2008-09-04T00:00:00,Signal Transduction,G04.299.880
18804099,2008-09-04T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18804099,2008-09-04T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18804099,2008-09-04T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18804099,2008-09-04T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
18804099,2008-09-04T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
18774213,2008-09-05T00:00:00,Adult,M01.060.116
18774213,2008-09-05T00:00:00,Aged,M01.060.116.100
18774213,2008-09-05T00:00:00,Combined Modality Therapy,E02.186
18774213,2008-09-05T00:00:00,Disease-Free Survival,E01.789.200
18774213,2008-09-05T00:00:00,Disease-Free Survival,E05.318.740.998.300
18774213,2008-09-05T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
18774213,2008-09-05T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
18774213,2008-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18774213,2008-09-05T00:00:00,Hysterectomy,E04.950.300.399
18774213,2008-09-05T00:00:00,Middle Aged,M01.060.116.630
18774213,2008-09-05T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
18774213,2008-09-05T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
18774213,2008-09-05T00:00:00,Uterine Neoplasms,C04.588.945.418.948
18774213,2008-09-05T00:00:00,Uterine Neoplasms,C13.351.500.852.762
18774213,2008-09-05T00:00:00,Uterine Neoplasms,C13.351.937.418.875
18947890,2008-09-05T00:00:00,Animals,B01.050
18947890,2008-09-05T00:00:00,Gene Expression Regulation,G05.355.315
18947890,2008-09-05T00:00:00,Hydrocortisone,D04.808.745.745.654.600
18947890,2008-09-05T00:00:00,Hydrocortisone,D06.472.040.585.353.476
18947890,2008-09-05T00:00:00,Hydrocortisone,D06.472.040.585.478.392
18947890,2008-09-05T00:00:00,Liver,A03.620
18947890,2008-09-05T00:00:00,Temperature,G01.906.595
18947890,2008-09-05T00:00:00,Temperature,G16.500.275.063.725.710
18947890,2008-09-05T00:00:00,Temperature,G16.500.750.775.710
18947890,2008-09-05T00:00:00,Temperature,N06.230.150.450
18947890,2008-09-05T00:00:00,Temperature,N06.230.300.100.725.710
18947890,2008-09-05T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18993148,2008-09-05T00:00:00,Aged,M01.060.116.100
18993148,2008-09-05T00:00:00,Cardiovascular Diseases,C14
18993148,2008-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18993148,2008-09-05T00:00:00,Middle Aged,M01.060.116.630
18993148,2008-09-05T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18993148,2008-09-05T00:00:00,Ticlopidine,D02.886.778.834
18993148,2008-09-05T00:00:00,Ticlopidine,D03.383.903.834
18774296,2008-09-06T00:00:00,"Adaptation, Physiological",G07.700.062
18774296,2008-09-06T00:00:00,"Adaptation, Physiological",G16.100.057.500
18774296,2008-09-06T00:00:00,Adult,M01.060.116
18774296,2008-09-06T00:00:00,Aged,M01.060.116.100
18774296,2008-09-06T00:00:00,Case-Control Studies,E05.318.760.500.500
18774296,2008-09-06T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18774296,2008-09-06T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18774296,2008-09-06T00:00:00,Electromyography,E01.370.405.255
18774296,2008-09-06T00:00:00,Electromyography,E01.370.530.255
18774296,2008-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18774296,2008-09-06T00:00:00,Middle Aged,M01.060.116.630
18774296,2008-09-06T00:00:00,"Muscle, Skeletal",A02.633.567
18774296,2008-09-06T00:00:00,"Muscle, Skeletal",A10.690.552.500
18774296,2008-09-06T00:00:00,Postural Balance,G11.427.690
18774296,2008-09-06T00:00:00,Postural Balance,G11.561.600.810.541.595
18774296,2008-09-06T00:00:00,Posture,G11.427.695
18774296,2008-09-06T00:00:00,Spinal Cord Injuries,C10.228.854.770
18774296,2008-09-06T00:00:00,Spinal Cord Injuries,C10.900.850
18774296,2008-09-06T00:00:00,Spinal Cord Injuries,C21.866.819
19041044,2008-09-06T00:00:00,Aged,M01.060.116.100
19041044,2008-09-06T00:00:00,Disease Management,N04.590.607
19041044,2008-09-06T00:00:00,Hemodynamics,G09.330.190.400
19041044,2008-09-06T00:00:00,Hemodynamics,G09.330.380
19041044,2008-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19041044,2008-09-06T00:00:00,Middle Aged,M01.060.116.630
19041044,2008-09-06T00:00:00,"Monitoring, Physiologic",E01.370.520
18778970,2008-09-07T00:00:00,Adult,M01.060.116
18778970,2008-09-07T00:00:00,Aged,M01.060.116.100
18778970,2008-09-07T00:00:00,Brachytherapy,E02.815.150
18778970,2008-09-07T00:00:00,Breast Neoplasms,C04.588.180
18778970,2008-09-07T00:00:00,Breast Neoplasms,C17.800.090.500
18778970,2008-09-07T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
18778970,2008-09-07T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
18778970,2008-09-07T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
18778970,2008-09-07T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
18778970,2008-09-07T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.200.025.275
18778970,2008-09-07T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.615.275
18778970,2008-09-07T00:00:00,Combined Modality Therapy,E02.186
18778970,2008-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18778970,2008-09-07T00:00:00,Middle Aged,M01.060.116.630
18778970,2008-09-07T00:00:00,Surgical Wound Infection,C01.539.947.692
18778970,2008-09-07T00:00:00,Surgical Wound Infection,C23.550.767.925
18819770,2008-09-07T00:00:00,Animals,B01.050
18819770,2008-09-07T00:00:00,Antineoplastic Agents,D27.505.954.248
18819770,2008-09-07T00:00:00,Cisplatin,D01.210.375
18819770,2008-09-07T00:00:00,Cisplatin,D01.625.125
18819770,2008-09-07T00:00:00,Cisplatin,D01.710.100
18819770,2008-09-07T00:00:00,Kidney Diseases,C12.777.419
18819770,2008-09-07T00:00:00,Kidney Diseases,C13.351.968.419
18819770,2008-09-07T00:00:00,Sex Factors,N05.715.350.675
18819770,2008-09-07T00:00:00,Sex Factors,N06.850.490.875
18782344,2008-09-08T00:00:00,Adult,M01.060.116
18782344,2008-09-08T00:00:00,Affect,F01.470.047
18782344,2008-09-08T00:00:00,Alcohol Drinking,F01.145.317.269
18782344,2008-09-08T00:00:00,Alcoholism,C21.739.100.250
18782344,2008-09-08T00:00:00,Alcoholism,F03.900.100.350
18782344,2008-09-08T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18782344,2008-09-08T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18782344,2008-09-08T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18782344,2008-09-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18782344,2008-09-08T00:00:00,Impulsive Behavior,F01.145.527
18782344,2008-09-08T00:00:00,"Models, Theoretical",E05.599
18782344,2008-09-08T00:00:00,Piperazines,D03.383.606
18782344,2008-09-08T00:00:00,Quinolones,D03.438.810.835
18782344,2008-09-08T00:00:00,Sleep,F02.830.855
18782344,2008-09-08T00:00:00,Sleep,G11.561.600.815
18782344,2008-09-08T00:00:00,"Social Control, Informal",I01.880.630
18782760,2008-09-09T00:00:00,Animals,B01.050
18782760,2008-09-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18782760,2008-09-09T00:00:00,"Models, Biological",E05.599.395
18782760,2008-09-09T00:00:00,"Models, Molecular",E05.599.595
18782760,2008-09-09T00:00:00,Protein Transport,G03.495.166.700
18782760,2008-09-09T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
18782760,2008-09-09T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
18782760,2008-09-09T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
18782760,2008-09-09T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
18782760,2008-09-09T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
18782760,2008-09-09T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
18782760,2008-09-09T00:00:00,Rhodopsin,D12.776.543.750.100.955
18782760,2008-09-09T00:00:00,Rhodopsin,D23.767.930.750.500.500
18782760,2008-09-09T00:00:00,Transducin,D08.811.277.040.330.300.200.800
18782760,2008-09-09T00:00:00,Transducin,D12.644.360.375.940
18782760,2008-09-09T00:00:00,Transducin,D12.776.157.325.332.940
18782760,2008-09-09T00:00:00,Transducin,D12.776.476.375.940
18782760,2008-09-09T00:00:00,Transducin,D12.776.543.325.800
18783368,2008-09-09T00:00:00,Adenosine,D03.438.759.590.138
18783368,2008-09-09T00:00:00,Adenosine,D13.570.583.138
18783368,2008-09-09T00:00:00,Adenosine,D13.570.800.096
18783368,2008-09-09T00:00:00,Animals,B01.050
18783368,2008-09-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18783368,2008-09-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18783368,2008-09-09T00:00:00,Neurons,A08.663
18783368,2008-09-09T00:00:00,Neurons,A11.671
18783368,2008-09-09T00:00:00,Neuropeptides,D12.644.400
18783368,2008-09-09T00:00:00,Neuropeptides,D12.776.641.650
18783368,2008-09-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18783368,2008-09-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18783368,2008-09-09T00:00:00,Sleep,F02.830.855
18783368,2008-09-09T00:00:00,Sleep,G11.561.600.815
18783368,2008-09-09T00:00:00,Wakefulness,F02.830.104.821
18783368,2008-09-09T00:00:00,Wakefulness,G11.561.600.042.738
18784297,2008-09-10T00:00:00,Action Potentials,G04.580.100
18784297,2008-09-10T00:00:00,Action Potentials,G07.265.750.100
18784297,2008-09-10T00:00:00,Action Potentials,G11.561.570.100
18784297,2008-09-10T00:00:00,Animals,B01.050
18784297,2008-09-10T00:00:00,"Behavior, Animal",F01.145.113
18784297,2008-09-10T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
18784297,2008-09-10T00:00:00,"Models, Neurological",E05.599.395.642
18784297,2008-09-10T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
18784297,2008-09-10T00:00:00,Neural Inhibition,G07.265.337.615
18784297,2008-09-10T00:00:00,Neural Inhibition,G07.700.240.615
18784297,2008-09-10T00:00:00,Neural Inhibition,G11.561.600.625
18784297,2008-09-10T00:00:00,Neurons,A08.663
18784297,2008-09-10T00:00:00,Neurons,A11.671
18784297,2008-09-10T00:00:00,Nonlinear Dynamics,E05.599.850
18784297,2008-09-10T00:00:00,Nonlinear Dynamics,H01.548.675
18784297,2008-09-10T00:00:00,Normal Distribution,E05.318.740.994.500
18784297,2008-09-10T00:00:00,Normal Distribution,G17.820.500
18784297,2008-09-10T00:00:00,Normal Distribution,N05.715.360.750.750.565
18784297,2008-09-10T00:00:00,Normal Distribution,N06.850.520.830.994.500
18784297,2008-09-10T00:00:00,Psychomotor Performance,F02.808
18784297,2008-09-10T00:00:00,Psychomotor Performance,G11.427.700
18784297,2008-09-10T00:00:00,Psychomotor Performance,G11.561.623
18784297,2008-09-10T00:00:00,Reaction Time,F02.830.650
18784297,2008-09-10T00:00:00,Reaction Time,F04.669.817
18784297,2008-09-10T00:00:00,Reaction Time,G11.561.677
18793222,2008-09-10T00:00:00,Aged,M01.060.116.100
18793222,2008-09-10T00:00:00,Heart Ventricles,A07.541.560
18793222,2008-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18793222,2008-09-10T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
19061676,2008-09-11T00:00:00,Aged,M01.060.116.100
19061676,2008-09-11T00:00:00,Depressive Disorder,F03.600.300
19061676,2008-09-11T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19061676,2008-09-11T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19061676,2008-09-11T00:00:00,Health Surveys,E05.318.308.250
19061676,2008-09-11T00:00:00,Health Surveys,N05.715.360.300.375
19061676,2008-09-11T00:00:00,Health Surveys,N06.850.520.308.250
19061676,2008-09-11T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
19061676,2008-09-11T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
19061676,2008-09-11T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
19061676,2008-09-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19061676,2008-09-11T00:00:00,Middle Aged,M01.060.116.630
19061676,2008-09-11T00:00:00,Veterans,M01.930
18791193,2008-09-12T00:00:00,Bias (Epidemiology),N05.715.350.150
18791193,2008-09-12T00:00:00,Bias (Epidemiology),N06.850.490.500
18791193,2008-09-12T00:00:00,Diagnostic Errors,E01.354
18791193,2008-09-12T00:00:00,Diagnostic Errors,N02.421.450.280
18791193,2008-09-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18791193,2008-09-12T00:00:00,"Models, Genetic",E05.599.395.397
18791193,2008-09-12T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18929007,2008-09-12T00:00:00,Avidin,D12.776.034.614.300
18929007,2008-09-12T00:00:00,Avidin,D12.776.256.317.663.300
18929007,2008-09-12T00:00:00,Avidin,D12.776.290.663.100
18929007,2008-09-12T00:00:00,Avidin,D12.776.395.175
18929007,2008-09-12T00:00:00,Biological Assay,E05.091
18929007,2008-09-12T00:00:00,Carbon,D01.268.150
18929007,2008-09-12T00:00:00,Electrodes,E07.305.250
18929007,2008-09-12T00:00:00,Porosity,G01.374.710
18929007,2008-09-12T00:00:00,Sensitivity and Specificity,E05.318.740.872
18929007,2008-09-12T00:00:00,Sensitivity and Specificity,E05.318.780.800
18929007,2008-09-12T00:00:00,Sensitivity and Specificity,G17.800
18929007,2008-09-12T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18929007,2008-09-12T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18929007,2008-09-12T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18929007,2008-09-12T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18929007,2008-09-12T00:00:00,Sepharose,D09.698.813
18929007,2008-09-12T00:00:00,"Serum Albumin, Bovine",D12.776.034.841.540
18929007,2008-09-12T00:00:00,"Serum Albumin, Bovine",D12.776.124.727.540
18963493,2008-09-12T00:00:00,Animals,B01.050
18963493,2008-09-12T00:00:00,Dog Diseases,C22.268
18963493,2008-09-12T00:00:00,Dogs,B01.050.150.900.649.147.153.200
18963493,2008-09-12T00:00:00,Ehrlichiosis,C01.252.400.054.160
18963493,2008-09-12T00:00:00,Ehrlichiosis,C01.252.400.825.200
19026306,2008-09-12T00:00:00,Adolescent,M01.060.057
19026306,2008-09-12T00:00:00,Adult,M01.060.116
19026306,2008-09-12T00:00:00,African Americans,M01.686.508.100.100
19026306,2008-09-12T00:00:00,African Americans,M01.686.754.100
19026306,2008-09-12T00:00:00,Age Factors,N05.715.350.075
19026306,2008-09-12T00:00:00,Age Factors,N06.850.490.250
19026306,2008-09-12T00:00:00,Blood Pressure,E01.370.600.875.249
19026306,2008-09-12T00:00:00,Blood Pressure,G09.330.380.076
19026306,2008-09-12T00:00:00,Brachial Artery,A07.231.114.139
19026306,2008-09-12T00:00:00,Cardiovascular Diseases,C14
19026306,2008-09-12T00:00:00,Diabetes Mellitus,C18.452.394.750
19026306,2008-09-12T00:00:00,Diabetes Mellitus,C19.246
19026306,2008-09-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
19026306,2008-09-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19026306,2008-09-12T00:00:00,Hypertension,C14.907.489
19026306,2008-09-12T00:00:00,Middle Aged,M01.060.116.630
19026306,2008-09-12T00:00:00,"Models, Statistical",E05.318.740.500
19026306,2008-09-12T00:00:00,"Models, Statistical",E05.599.835
19026306,2008-09-12T00:00:00,"Models, Statistical",N05.715.360.750.530
19026306,2008-09-12T00:00:00,"Models, Statistical",N06.850.520.830.500
19026306,2008-09-12T00:00:00,Nutrition Surveys,E05.318.308.250.600
19026306,2008-09-12T00:00:00,Nutrition Surveys,E05.318.308.585.550
19026306,2008-09-12T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
19026306,2008-09-12T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
19026306,2008-09-12T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
19026306,2008-09-12T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
19026306,2008-09-12T00:00:00,Obesity,C18.654.726.500
19026306,2008-09-12T00:00:00,Obesity,C23.888.144.699.500
19026306,2008-09-12T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19026306,2008-09-12T00:00:00,Obesity,G07.100.100.160.120.699.500
19026306,2008-09-12T00:00:00,Prevalence,E05.318.308.985.525.750
19026306,2008-09-12T00:00:00,Prevalence,L01.280.975.525.750
19026306,2008-09-12T00:00:00,Prevalence,N01.224.935.597.750
19026306,2008-09-12T00:00:00,Prevalence,N06.850.505.400.975.525.750
19026306,2008-09-12T00:00:00,Prevalence,N06.850.520.308.985.525.750
19026306,2008-09-12T00:00:00,Regression Analysis,E05.318.740.750
19026306,2008-09-12T00:00:00,Regression Analysis,N05.715.360.750.695
19026306,2008-09-12T00:00:00,Regression Analysis,N06.850.520.830.750
19026306,2008-09-12T00:00:00,Risk Factors,E05.318.740.600.800.725
19026306,2008-09-12T00:00:00,Risk Factors,N05.715.350.200.700
19026306,2008-09-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19026306,2008-09-12T00:00:00,Risk Factors,N06.850.490.625.750
19026306,2008-09-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19026306,2008-09-12T00:00:00,Smoking,F01.145.466.753
19026306,2008-09-12T00:00:00,United States,Z01.107.567.875
19026306,2008-09-12T00:00:00,Young Adult,M01.060.116.815
18791704,2008-09-13T00:00:00,Alcohol Drinking,F01.145.317.269
18791704,2008-09-13T00:00:00,Animals,B01.050
18791704,2008-09-13T00:00:00,Brain,A08.186.211
18791704,2008-09-13T00:00:00,Central Nervous System Depressants,D27.505.696.277
18791704,2008-09-13T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
18791704,2008-09-13T00:00:00,Ethanol,D02.033.375
18791704,2008-09-13T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18561323,2008-09-15T00:00:00,Antibodies,D12.776.124.486.485.114
18561323,2008-09-15T00:00:00,Antibodies,D12.776.124.790.651.114
18561323,2008-09-15T00:00:00,Antibodies,D12.776.377.715.548.114
18561323,2008-09-15T00:00:00,"Antigens, CD59",D12.776.395.550.035
18561323,2008-09-15T00:00:00,"Antigens, CD59",D12.776.543.550.159
18561323,2008-09-15T00:00:00,"Antigens, CD59",D23.050.301.264.035.159
18561323,2008-09-15T00:00:00,"Antigens, CD59",D23.101.100.110.159
18561323,2008-09-15T00:00:00,Complement System Proteins,D12.776.124.486.274
18561323,2008-09-15T00:00:00,Gene Expression,G05.355.310
18561323,2008-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18561323,2008-09-15T00:00:00,"RNA, Messenger",D13.444.735.544
18561323,2008-09-15T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
18561323,2008-09-15T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
18561323,2008-09-15T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
18561323,2008-09-15T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
18561323,2008-09-15T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
18724998,2008-09-15T00:00:00,Deep Brain Stimulation,E02.342.250
18724998,2008-09-15T00:00:00,Deep Brain Stimulation,E04.190
18724998,2008-09-15T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18724998,2008-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18757314,2008-09-15T00:00:00,Biomedical Research,H01.770.644.145
18757314,2008-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18757314,2008-09-15T00:00:00,Lung,A04.411
18757314,2008-09-15T00:00:00,Lung Diseases,C08.381
18757314,2008-09-15T00:00:00,Phenotype,G05.695
18791444,2008-09-15T00:00:00,Adult,M01.060.116
18791444,2008-09-15T00:00:00,Aged,M01.060.116.100
18791444,2008-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18791444,2008-09-15T00:00:00,Middle Aged,M01.060.116.630
18791444,2008-09-15T00:00:00,Organ Transplantation,E04.936.450
18791444,2008-09-15T00:00:00,Postoperative Complications,C23.550.767
18794373,2008-09-15T00:00:00,Amino Acid Sequence,G02.111.570.060
18794373,2008-09-15T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18794373,2008-09-15T00:00:00,Animals,B01.050
18794373,2008-09-15T00:00:00,Binding Sites,G02.111.570.120
18794373,2008-09-15T00:00:00,DNA Replication,G02.111.087.222
18794373,2008-09-15T00:00:00,DNA Replication,G02.149.115.222
18794373,2008-09-15T00:00:00,DNA Replication,G05.355.200
18794373,2008-09-15T00:00:00,DNA-Binding Proteins,D12.776.260
18794373,2008-09-15T00:00:00,"Models, Molecular",E05.599.595
18794373,2008-09-15T00:00:00,Molecular Sequence Data,L01.453.245.667
18794373,2008-09-15T00:00:00,Multiprotein Complexes,D05.500
18794373,2008-09-15T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
18794373,2008-09-15T00:00:00,Nucleic Acid Conformation,G05.360.580
18794373,2008-09-15T00:00:00,Point Mutation,G05.365.590.675
18794373,2008-09-15T00:00:00,Protein Conformation,G02.111.570.790.709
18794373,2008-09-15T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
18794373,2008-09-15T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
18794373,2008-09-15T00:00:00,Schizosaccharomyces,B01.300.107.797
18794373,2008-09-15T00:00:00,Schizosaccharomyces,B01.300.930.720
18794373,2008-09-15T00:00:00,Transcription Factors,D12.776.930
18794390,2008-09-15T00:00:00,Adult,M01.060.116
18794390,2008-09-15T00:00:00,Aged,M01.060.116.100
18794390,2008-09-15T00:00:00,Blood Pressure,E01.370.600.875.249
18794390,2008-09-15T00:00:00,Blood Pressure,G09.330.380.076
18794390,2008-09-15T00:00:00,Chronic Disease,C23.550.291.500
18794390,2008-09-15T00:00:00,Heart Failure,C14.280.434
18794390,2008-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18794390,2008-09-15T00:00:00,Middle Aged,M01.060.116.630
18794390,2008-09-15T00:00:00,"Monitoring, Physiologic",E01.370.520
18799270,2008-09-16T00:00:00,Adenocarcinoma,C04.557.470.200.025
18799270,2008-09-16T00:00:00,Case-Control Studies,E05.318.760.500.500
18799270,2008-09-16T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18799270,2008-09-16T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18799270,2008-09-16T00:00:00,European Continental Ancestry Group,M01.686.508.400
18799270,2008-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18799270,2008-09-16T00:00:00,"Polymorphism, Genetic",G05.365.795
18799270,2008-09-16T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
18799270,2008-09-16T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
18799270,2008-09-16T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
18799270,2008-09-16T00:00:00,Prostate-Specific Antigen,D23.050.285.625
18799270,2008-09-16T00:00:00,Prostate-Specific Antigen,D23.101.840.625
18799270,2008-09-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18799270,2008-09-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
18799270,2008-09-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
18799270,2008-09-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
18822276,2008-09-16T00:00:00,Animals,B01.050
18822276,2008-09-16T00:00:00,Brain,A08.186.211
18822276,2008-09-16T00:00:00,Cell Survival,G04.299.316
18822276,2008-09-16T00:00:00,Dopamine,D02.092.211.215.311.342
18822276,2008-09-16T00:00:00,Dopamine,D02.092.311.342
18822276,2008-09-16T00:00:00,Dopamine Agents,D27.505.519.625.150
18822276,2008-09-16T00:00:00,Dopamine Agents,D27.505.696.577.150
18822276,2008-09-16T00:00:00,Down-Regulation,G02.111.087.225
18822276,2008-09-16T00:00:00,Down-Regulation,G02.149.115.225
18822276,2008-09-16T00:00:00,Down-Regulation,G05.355.315.200
18822276,2008-09-16T00:00:00,Down-Regulation,G07.690.812.230
18822276,2008-09-16T00:00:00,Down-Regulation,G07.700.680.230
18822276,2008-09-16T00:00:00,Encephalitis,C02.182.500
18822276,2008-09-16T00:00:00,Encephalitis,C10.228.140.430
18822276,2008-09-16T00:00:00,Encephalitis,C10.228.228.210.150
18822276,2008-09-16T00:00:00,Encephalitis,C10.228.228.245
18822276,2008-09-16T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
18822276,2008-09-16T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
18822276,2008-09-16T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
18822276,2008-09-16T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
18822276,2008-09-16T00:00:00,Motor Activity,F01.145.632
18822276,2008-09-16T00:00:00,Motor Activity,G11.427.590.530.698
18822276,2008-09-16T00:00:00,Neurons,A08.663
18822276,2008-09-16T00:00:00,Neurons,A11.671
18822276,2008-09-16T00:00:00,Parkinsonian Disorders,C10.228.140.079.862
18822276,2008-09-16T00:00:00,Parkinsonian Disorders,C10.228.662.600
18822276,2008-09-16T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
18822276,2008-09-16T00:00:00,Substantia Nigra,A08.186.211.653.822.731
18822276,2008-09-16T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
18822276,2008-09-16T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
18822276,2008-09-16T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
18822276,2008-09-16T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
18822276,2008-09-16T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
18822276,2008-09-16T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
18799294,2008-09-17T00:00:00,Brain,A08.186.211
18799294,2008-09-17T00:00:00,Brain Mapping,E01.370.350.086
18799294,2008-09-17T00:00:00,Brain Mapping,E01.370.376.149
18799294,2008-09-17T00:00:00,Brain Mapping,E05.132
18799294,2008-09-17T00:00:00,Glucose,D09.546.359.448
18799294,2008-09-17T00:00:00,Health Status,I01.240.425
18799294,2008-09-17T00:00:00,Health Status,N01.224.425
18799294,2008-09-17T00:00:00,Health Status,N06.850.505.400.425
18799294,2008-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18799294,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18799294,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18799294,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18799294,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18799294,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18799690,2008-09-17T00:00:00,Animals,B01.050
18799690,2008-09-17T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18799690,2008-09-17T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
18799690,2008-09-17T00:00:00,Dopamine,D02.092.211.215.311.342
18799690,2008-09-17T00:00:00,Dopamine,D02.092.311.342
18799690,2008-09-17T00:00:00,Down-Regulation,G02.111.087.225
18799690,2008-09-17T00:00:00,Down-Regulation,G02.149.115.225
18799690,2008-09-17T00:00:00,Down-Regulation,G05.355.315.200
18799690,2008-09-17T00:00:00,Down-Regulation,G07.690.812.230
18799690,2008-09-17T00:00:00,Down-Regulation,G07.700.680.230
18799690,2008-09-17T00:00:00,Glutamic Acid,D12.125.067.750
18799690,2008-09-17T00:00:00,Glutamic Acid,D12.125.119.450
18799690,2008-09-17T00:00:00,Glutamic Acid,D12.125.427.300
18799690,2008-09-17T00:00:00,Long-Term Potentiation,G11.561.600.635.350
18799690,2008-09-17T00:00:00,Movement,G07.700.560
18799690,2008-09-17T00:00:00,Movement,G11.427.590.530
18799690,2008-09-17T00:00:00,Neural Pathways,A08.612
18799690,2008-09-17T00:00:00,Propionates,D02.241.081.751
18799690,2008-09-17T00:00:00,Propionates,D10.251.400.706
18799690,2008-09-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18799690,2008-09-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18799690,2008-09-17T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18799690,2008-09-17T00:00:00,Synaptic Transmission,G02.111.087.800.850
18799690,2008-09-17T00:00:00,Synaptic Transmission,G02.149.115.800.850
18799690,2008-09-17T00:00:00,Synaptic Transmission,G04.299.880.850
18799690,2008-09-17T00:00:00,Synaptic Transmission,G07.265.337.900
18799690,2008-09-17T00:00:00,Synaptic Transmission,G07.700.240.900
18799690,2008-09-17T00:00:00,Synaptic Transmission,G11.561.600.835
18799724,2008-09-17T00:00:00,Animals,B01.050
18799724,2008-09-17T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
18799724,2008-09-17T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
18799724,2008-09-17T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
18799724,2008-09-17T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
18799724,2008-09-17T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
18799724,2008-09-17T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
18799724,2008-09-17T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18799724,2008-09-17T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18799724,2008-09-17T00:00:00,Remission Induction,E02.860
18800068,2008-09-17T00:00:00,Amphetamine-Related Disorders,C21.739.225
18800068,2008-09-17T00:00:00,Amphetamine-Related Disorders,F03.900.225
18800068,2008-09-17T00:00:00,Animals,B01.050
18800068,2008-09-17T00:00:00,"Behavior, Addictive",F01.145.527.100.120
18800068,2008-09-17T00:00:00,"Behavior, Animal",F01.145.113
18800068,2008-09-17T00:00:00,Cues,F02.463.425.234
18800068,2008-09-17T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18800068,2008-09-17T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18800068,2008-09-17T00:00:00,Methamphetamine,D02.092.471.683.152.619
18800068,2008-09-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18800068,2008-09-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18800068,2008-09-17T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
18800068,2008-09-17T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
18800068,2008-09-17T00:00:00,Self Administration,E02.319.890
18800068,2008-09-17T00:00:00,Self Administration,E02.900.890
18801648,2008-09-17T00:00:00,Adult,M01.060.116
18801648,2008-09-17T00:00:00,Bipolar Disorder,F03.600.150.150
18801648,2008-09-17T00:00:00,Cognition Disorders,F03.087.250
18801648,2008-09-17T00:00:00,Depressive Disorder,F03.600.300
18801648,2008-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18801648,2008-09-17T00:00:00,Middle Aged,M01.060.116.630
18801648,2008-09-17T00:00:00,Neuropsychological Tests,F04.711.513
18801648,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18801648,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18801648,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18801648,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18801648,2008-09-17T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18801648,2008-09-17T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18851905,2008-09-17T00:00:00,Animals,B01.050
18851905,2008-09-17T00:00:00,Antineoplastic Agents,D27.505.954.248
18851905,2008-09-17T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
18851905,2008-09-17T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
18851905,2008-09-17T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
18851905,2008-09-17T00:00:00,Cisplatin,D01.210.375
18851905,2008-09-17T00:00:00,Cisplatin,D01.625.125
18851905,2008-09-17T00:00:00,Cisplatin,D01.710.100
18851905,2008-09-17T00:00:00,Clinical Trials as Topic,E05.318.760.535
18851905,2008-09-17T00:00:00,Clinical Trials as Topic,E05.337.250
18851905,2008-09-17T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18851905,2008-09-17T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18851905,2008-09-17T00:00:00,Glutathione Disulfide,D12.644.456.448.500
18851905,2008-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18851905,2008-09-17T00:00:00,Lung Neoplasms,C04.588.894.797.520
18851905,2008-09-17T00:00:00,Lung Neoplasms,C08.381.540
18851905,2008-09-17T00:00:00,Lung Neoplasms,C08.785.520
18851905,2008-09-17T00:00:00,Signal Transduction,G02.111.087.800
18851905,2008-09-17T00:00:00,Signal Transduction,G02.149.115.800
18851905,2008-09-17T00:00:00,Signal Transduction,G04.299.880
18801929,2008-09-18T00:00:00,Animals,B01.050
18801929,2008-09-18T00:00:00,Cardiomegaly,C14.280.195
18801929,2008-09-18T00:00:00,Cardiomegaly,C23.300.775.250
18801929,2008-09-18T00:00:00,"Models, Cardiovascular",E05.599.395.161
18801929,2008-09-18T00:00:00,Myocardial Contraction,G09.330.190.541
18801929,2008-09-18T00:00:00,Myocardial Contraction,G11.427.590.540.570
18801929,2008-09-18T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18801929,2008-09-18T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18801929,2008-09-18T00:00:00,"Myocytes, Cardiac",A11.620.500
18801929,2008-09-18T00:00:00,Physical Exertion,G11.427.590.780
18801929,2008-09-18T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
18801929,2008-09-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
18801929,2008-09-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
18801929,2008-09-18T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18801929,2008-09-18T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
18801929,2008-09-18T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
18801929,2008-09-18T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
18801929,2008-09-18T00:00:00,Signal Transduction,G02.111.087.800
18801929,2008-09-18T00:00:00,Signal Transduction,G02.149.115.800
18801929,2008-09-18T00:00:00,Signal Transduction,G04.299.880
18801946,2008-09-18T00:00:00,Animals,B01.050
18801946,2008-09-18T00:00:00,Cell Death,G04.299.139
18801946,2008-09-18T00:00:00,Cholestasis,C06.130.120.135
18801946,2008-09-18T00:00:00,Collagen,D05.750.078.280
18801946,2008-09-18T00:00:00,Collagen,D12.776.860.300.250
18801946,2008-09-18T00:00:00,Cyclosporine,D04.345.566.235.300
18801946,2008-09-18T00:00:00,Cyclosporine,D12.644.641.235.300
18801946,2008-09-18T00:00:00,Fibrosis,C23.550.355
18801946,2008-09-18T00:00:00,Hepatocytes,A11.436.348
18802031,2008-09-18T00:00:00,Animals,B01.050
18802031,2008-09-18T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18802031,2008-09-18T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18802031,2008-09-18T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18802031,2008-09-18T00:00:00,Colitis,C06.405.205.265
18802031,2008-09-18T00:00:00,Colitis,C06.405.469.158.188
18802031,2008-09-18T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18802031,2008-09-18T00:00:00,DNA Damage,C21.111
18802031,2008-09-18T00:00:00,DNA Damage,G05.355.180
18802031,2008-09-18T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
18802031,2008-09-18T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
18802031,2008-09-18T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
18802031,2008-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18802031,2008-09-18T00:00:00,Inflammation,C23.550.470
18802031,2008-09-18T00:00:00,Macrophages,A11.329.372
18802031,2008-09-18T00:00:00,Macrophages,A11.627.482
18802031,2008-09-18T00:00:00,Macrophages,A11.733.397
18802031,2008-09-18T00:00:00,Macrophages,A15.382.680.397
18802031,2008-09-18T00:00:00,Macrophages,A15.382.812.522
18802031,2008-09-18T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
18802031,2008-09-18T00:00:00,Plant Extracts,D20.215.784.500
18802031,2008-09-18T00:00:00,Plant Extracts,D26.667
18802031,2008-09-18T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
18802031,2008-09-18T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
18802031,2008-09-18T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
18802031,2008-09-18T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
18804220,2008-09-18T00:00:00,Aged,M01.060.116.100
18804220,2008-09-18T00:00:00,Health Surveys,E05.318.308.250
18804220,2008-09-18T00:00:00,Health Surveys,N05.715.360.300.375
18804220,2008-09-18T00:00:00,Health Surveys,N06.850.520.308.250
18804220,2008-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18804220,2008-09-18T00:00:00,Middle Aged,M01.060.116.630
18804220,2008-09-18T00:00:00,Peripheral Vascular Diseases,C14.907.617
18804220,2008-09-18T00:00:00,Stroke,C10.228.140.300.775
18804220,2008-09-18T00:00:00,Stroke,C14.907.253.855
18804951,2008-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18804951,2008-09-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18804951,2008-09-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18804951,2008-09-19T00:00:00,Middle Aged,M01.060.116.630
18804951,2008-09-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18804951,2008-09-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18804951,2008-09-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18804951,2008-09-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18804951,2008-09-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18804951,2008-09-19T00:00:00,Treatment Outcome,E01.789.800
18804951,2008-09-19T00:00:00,Treatment Outcome,N04.761.559.590.800
18804951,2008-09-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18804951,2008-09-19T00:00:00,"Ultrasonography, Doppler, Color",E01.370.350.850.850.850.850
18804951,2008-09-19T00:00:00,Vascular Neoplasms,C04.588.839.750
18804951,2008-09-19T00:00:00,Vascular Neoplasms,C14.907.936
18804951,2008-09-19T00:00:00,Vascular Surgical Procedures,E04.100.814
18806216,2008-09-19T00:00:00,Adult,M01.060.116
18806216,2008-09-19T00:00:00,Aged,M01.060.116.100
18806216,2008-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18806216,2008-09-19T00:00:00,Middle Aged,M01.060.116.630
18806216,2008-09-19T00:00:00,Speech Perception,F02.463.593.071.875
18806216,2008-09-19T00:00:00,Young Adult,M01.060.116.815
18807150,2008-09-20T00:00:00,Animals,B01.050
18807150,2008-09-20T00:00:00,Blood Vessel Prosthesis,E07.695.110
18807150,2008-09-20T00:00:00,Cell Line,A11.251.210
18807150,2008-09-20T00:00:00,Cell Survival,G04.299.316
18807150,2008-09-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18807150,2008-09-20T00:00:00,Hydrogels,D20.280.320.375
18807150,2008-09-20T00:00:00,Hydrogels,D26.255.165.320.375
18807150,2008-09-20T00:00:00,Intestinal Mucosa,A03.556.124.369
18807150,2008-09-20T00:00:00,Intestinal Mucosa,A10.615.550.444
18807150,2008-09-20T00:00:00,Materials Testing,E05.570
18807150,2008-09-20T00:00:00,Mesoderm,A16.504.660
18807150,2008-09-20T00:00:00,Tissue Engineering,E05.200.249.750
18807150,2008-09-20T00:00:00,Tissue Scaffolds,E07.206.627
18807150,2008-09-20T00:00:00,Tissue Scaffolds,E07.695.825
18809357,2008-09-21T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
18809357,2008-09-21T00:00:00,"Arthroplasty, Replacement",E04.650.110
18809357,2008-09-21T00:00:00,Employment,N01.824.245
18809357,2008-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18809357,2008-09-21T00:00:00,Pain Measurement,E01.370.376.550.600
18809357,2008-09-21T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18809357,2008-09-21T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18809357,2008-09-21T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18809357,2008-09-21T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18809357,2008-09-21T00:00:00,Spinal Fusion,E04.555.100.700
18809357,2008-09-21T00:00:00,Treatment Outcome,E01.789.800
18809357,2008-09-21T00:00:00,Treatment Outcome,N04.761.559.590.800
18809357,2008-09-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18804034,2008-09-22T00:00:00,Animals,B01.050
18804034,2008-09-22T00:00:00,Calcium,D01.268.552.100
18804034,2008-09-22T00:00:00,Calcium,D01.552.539.288
18804034,2008-09-22T00:00:00,Calcium,D23.119.100
18804034,2008-09-22T00:00:00,Drosophila melanogaster,B01.050.500.131.617.289.310.250.500
18804034,2008-09-22T00:00:00,Enzyme Inhibitors,D27.505.519.389
18804034,2008-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18804034,2008-09-22T00:00:00,Molecular Structure,G02.111.570
18804034,2008-09-22T00:00:00,Molecular Structure,G02.575
18804034,2008-09-22T00:00:00,Molecular Structure,G02.842.575
18804034,2008-09-22T00:00:00,Transglutaminases,D08.811.913.050.200.800
18809613,2008-09-22T00:00:00,Adolescent,M01.060.057
18809613,2008-09-22T00:00:00,Adult,M01.060.116
18809613,2008-09-22T00:00:00,Aged,M01.060.116.100
18809613,2008-09-22T00:00:00,Antineoplastic Agents,D27.505.954.248
18809613,2008-09-22T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
18809613,2008-09-22T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
18809613,2008-09-22T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
18809613,2008-09-22T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
18809613,2008-09-22T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
18809613,2008-09-22T00:00:00,Child,M01.060.406
18809613,2008-09-22T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
18809613,2008-09-22T00:00:00,Cyclophosphamide,D02.705.670.243
18809613,2008-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18809613,2008-09-22T00:00:00,Interleukin-15,D12.644.276.374.465.515
18809613,2008-09-22T00:00:00,Interleukin-15,D12.776.467.374.465.515
18809613,2008-09-22T00:00:00,Interleukin-15,D23.529.374.465.515
18809613,2008-09-22T00:00:00,Interleukin-2,D12.644.276.374.465.502
18809613,2008-09-22T00:00:00,Interleukin-2,D12.644.276.374.480.372
18809613,2008-09-22T00:00:00,Interleukin-2,D12.776.467.374.465.502
18809613,2008-09-22T00:00:00,Interleukin-2,D12.776.467.374.480.372
18809613,2008-09-22T00:00:00,Interleukin-2,D23.529.374.465.502
18809613,2008-09-22T00:00:00,Interleukin-2,D23.529.374.480.372
18809613,2008-09-22T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
18809613,2008-09-22T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
18809613,2008-09-22T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
18809613,2008-09-22T00:00:00,Melanoma,C04.557.465.625.650.510
18809613,2008-09-22T00:00:00,Melanoma,C04.557.580.625.650.510
18809613,2008-09-22T00:00:00,Melanoma,C04.557.665.510
18809613,2008-09-22T00:00:00,Middle Aged,M01.060.116.630
18809613,2008-09-22T00:00:00,Pilot Projects,E05.318.760.750
18809613,2008-09-22T00:00:00,Pilot Projects,E05.337.737
18809613,2008-09-22T00:00:00,Pilot Projects,N05.715.360.775.625
18809613,2008-09-22T00:00:00,Pilot Projects,N06.850.520.450.720
18809613,2008-09-22T00:00:00,Radiotherapy Dosage,E02.815.639
18809613,2008-09-22T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
18809613,2008-09-22T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
18809613,2008-09-22T00:00:00,Treatment Outcome,E01.789.800
18809613,2008-09-22T00:00:00,Treatment Outcome,N04.761.559.590.800
18809613,2008-09-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18809621,2008-09-22T00:00:00,Aged,M01.060.116.100
18809621,2008-09-22T00:00:00,Atherosclerosis,C14.907.137.126.307
18809621,2008-09-22T00:00:00,Blood Glucose,D09.546.359.448.500
18809621,2008-09-22T00:00:00,Blood Pressure,E01.370.600.875.249
18809621,2008-09-22T00:00:00,Blood Pressure,G09.330.380.076
18809621,2008-09-22T00:00:00,Diabetes Mellitus,C18.452.394.750
18809621,2008-09-22T00:00:00,Diabetes Mellitus,C19.246
18809621,2008-09-22T00:00:00,Diabetic Angiopathies,C14.907.320
18809621,2008-09-22T00:00:00,Diabetic Angiopathies,C19.246.099.500
18809621,2008-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18809621,2008-09-22T00:00:00,Middle Aged,M01.060.116.630
18809621,2008-09-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
18809621,2008-09-22T00:00:00,Risk Assessment,N04.452.871.715
18809621,2008-09-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18809621,2008-09-22T00:00:00,Risk Assessment,N06.850.505.715
18809621,2008-09-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18809621,2008-09-22T00:00:00,Risk Factors,E05.318.740.600.800.725
18809621,2008-09-22T00:00:00,Risk Factors,N05.715.350.200.700
18809621,2008-09-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18809621,2008-09-22T00:00:00,Risk Factors,N06.850.490.625.750
18809621,2008-09-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18809621,2008-09-22T00:00:00,Sex Characteristics,G08.686.815
18812433,2008-09-23T00:00:00,Aged,M01.060.116.100
18812433,2008-09-23T00:00:00,Exercise Therapy,E02.779.483
18812433,2008-09-23T00:00:00,Exercise Therapy,E02.831.387
18812433,2008-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18812433,2008-09-23T00:00:00,Middle Aged,M01.060.116.630
18812433,2008-09-23T00:00:00,Movement Disorders,C10.228.662
18812433,2008-09-23T00:00:00,"Muscle, Skeletal",A02.633.567
18812433,2008-09-23T00:00:00,"Muscle, Skeletal",A10.690.552.500
18812433,2008-09-23T00:00:00,Paresis,C10.597.636
18812433,2008-09-23T00:00:00,Paresis,C23.888.592.643
18812433,2008-09-23T00:00:00,Physical Therapy Modalities,E02.779
18812433,2008-09-23T00:00:00,Pilot Projects,E05.318.760.750
18812433,2008-09-23T00:00:00,Pilot Projects,E05.337.737
18812433,2008-09-23T00:00:00,Pilot Projects,N05.715.360.775.625
18812433,2008-09-23T00:00:00,Pilot Projects,N06.850.520.450.720
18812433,2008-09-23T00:00:00,Postural Balance,G11.427.690
18812433,2008-09-23T00:00:00,Postural Balance,G11.561.600.810.541.595
18812433,2008-09-23T00:00:00,Recovery of Function,G16.757
18812433,2008-09-23T00:00:00,"Restraint, Physical",E02.085.700
18812433,2008-09-23T00:00:00,"Restraint, Physical",E05.472.760
18812433,2008-09-23T00:00:00,Shoulder,A01.378.800.750
18812433,2008-09-23T00:00:00,Stroke,C10.228.140.300.775
18812433,2008-09-23T00:00:00,Stroke,C14.907.253.855
18812433,2008-09-23T00:00:00,Treatment Outcome,E01.789.800
18812433,2008-09-23T00:00:00,Treatment Outcome,N04.761.559.590.800
18812433,2008-09-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18812454,2008-09-23T00:00:00,Adrenal Cortex Hormones,D06.472.040
18812454,2008-09-23T00:00:00,Adult,M01.060.116
18812454,2008-09-23T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18812454,2008-09-23T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18812454,2008-09-23T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18812454,2008-09-23T00:00:00,Disability Evaluation,E01.370.400
18812454,2008-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18812454,2008-09-23T00:00:00,Middle Aged,M01.060.116.630
18812454,2008-09-23T00:00:00,Probability,E05.318.740.600
18812454,2008-09-23T00:00:00,Probability,G17.680
18812454,2008-09-23T00:00:00,Probability,N05.715.360.750.625
18812454,2008-09-23T00:00:00,Probability,N06.850.520.830.600
18812454,2008-09-23T00:00:00,Risk Assessment,E05.318.740.600.800.715
18812454,2008-09-23T00:00:00,Risk Assessment,N04.452.871.715
18812454,2008-09-23T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18812454,2008-09-23T00:00:00,Risk Assessment,N06.850.505.715
18812454,2008-09-23T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18812454,2008-09-23T00:00:00,Sarcoidosis,C15.604.515.827
18812454,2008-09-23T00:00:00,Skin Diseases,C17.800
18812454,2008-09-23T00:00:00,Treatment Outcome,E01.789.800
18812454,2008-09-23T00:00:00,Treatment Outcome,N04.761.559.590.800
18812454,2008-09-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18823402,2008-09-23T00:00:00,Algorithms,G17.035
18823402,2008-09-23T00:00:00,Algorithms,L01.224.050
18823402,2008-09-23T00:00:00,Environmental Monitoring,N06.850.460.350.080
18823402,2008-09-23T00:00:00,Environmental Monitoring,N06.850.780.375
18823402,2008-09-23T00:00:00,"Models, Theoretical",E05.599
18823402,2008-09-23T00:00:00,South Carolina,Z01.107.567.875.075.662
18823402,2008-09-23T00:00:00,South Carolina,Z01.107.567.875.750.700
18823402,2008-09-23T00:00:00,Water Movements,G16.500.240.960
18823402,2008-09-23T00:00:00,Water Movements,N06.230.850
18823402,2008-09-23T00:00:00,Water Supply,N06.850.860.510.915
18815359,2008-09-24T00:00:00,Animals,B01.050
18815359,2008-09-24T00:00:00,Body Weight,C23.888.144
18815359,2008-09-24T00:00:00,Body Weight,E01.370.600.115.100.160.120
18815359,2008-09-24T00:00:00,Body Weight,E05.041.124.160.750
18815359,2008-09-24T00:00:00,Body Weight,G07.100.100.160.120
18815359,2008-09-24T00:00:00,Body Weight,G07.700.320.249.314.120
18815359,2008-09-24T00:00:00,Colitis,C06.405.205.265
18815359,2008-09-24T00:00:00,Colitis,C06.405.469.158.188
18815359,2008-09-24T00:00:00,Colon,A03.556.124.526.356
18815359,2008-09-24T00:00:00,Colon,A03.556.249.249.356
18815359,2008-09-24T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18815359,2008-09-24T00:00:00,Gene Expression Regulation,G05.355.315
18815359,2008-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18815359,2008-09-24T00:00:00,Lysophospholipids,D10.570.755.375.760.550
18815359,2008-09-24T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
18815359,2008-09-24T00:00:00,Sphingosine,D02.033.100.700
18815359,2008-09-24T00:00:00,Sphingosine,D02.033.455.843
18815359,2008-09-24T00:00:00,Sphingosine,D02.092.063.700
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18815359,2008-09-24T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18835277,2008-09-24T00:00:00,Amino Acid Sequence,G02.111.570.060
18835277,2008-09-24T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18835277,2008-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18835277,2008-09-24T00:00:00,Molecular Sequence Data,L01.453.245.667
18835277,2008-09-24T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
18835277,2008-09-24T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
18835277,2008-09-24T00:00:00,Uracil-DNA Glycosidase,D08.811.074.249.875
18840417,2008-09-24T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
18840417,2008-09-24T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
18840417,2008-09-24T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
18840417,2008-09-24T00:00:00,Animals,B01.050
18840417,2008-09-24T00:00:00,Dynorphins,D12.644.400.575.180
18840417,2008-09-24T00:00:00,Dynorphins,D12.644.468.180
18840417,2008-09-24T00:00:00,Dynorphins,D12.776.641.650.575.180
18840417,2008-09-24T00:00:00,Electroencephalography,E01.370.376.300
18840417,2008-09-24T00:00:00,Electroencephalography,E01.370.405.245
18840417,2008-09-24T00:00:00,Hypothalamus,A08.186.211.464.482
18840417,2008-09-24T00:00:00,Hypothalamus,A08.186.211.730.317.357
18840417,2008-09-24T00:00:00,Narcotic Antagonists,D27.505.696.543
18840417,2008-09-24T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
18840417,2008-09-24T00:00:00,Narcotic Antagonists,D27.505.954.427.550
18840417,2008-09-24T00:00:00,Neural Pathways,A08.612
18840417,2008-09-24T00:00:00,Neurons,A08.663
18840417,2008-09-24T00:00:00,Neurons,A11.671
18840417,2008-09-24T00:00:00,Oligopeptides,D12.644.456
18840417,2008-09-24T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.260.108.765
18840417,2008-09-24T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.624.664.700.179
18840417,2008-09-24T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.660.760
18840417,2008-09-24T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.930.127.765
18840417,2008-09-24T00:00:00,"RNA, Messenger",D13.444.735.544
18840417,2008-09-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18840417,2008-09-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18840417,2008-09-24T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
18840417,2008-09-24T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
18840417,2008-09-24T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
18840417,2008-09-24T00:00:00,Sleep,F02.830.855
18840417,2008-09-24T00:00:00,Sleep,G11.561.600.815
18840417,2008-09-24T00:00:00,Synaptic Transmission,G02.111.087.800.850
18840417,2008-09-24T00:00:00,Synaptic Transmission,G02.149.115.800.850
18840417,2008-09-24T00:00:00,Synaptic Transmission,G04.299.880.850
18840417,2008-09-24T00:00:00,Synaptic Transmission,G07.265.337.900
18840417,2008-09-24T00:00:00,Synaptic Transmission,G07.700.240.900
18840417,2008-09-24T00:00:00,Synaptic Transmission,G11.561.600.835
18840417,2008-09-24T00:00:00,Wakefulness,F02.830.104.821
18840417,2008-09-24T00:00:00,Wakefulness,G11.561.600.042.738
18789404,2008-09-25T00:00:00,Amino Acid Sequence,G02.111.570.060
18789404,2008-09-25T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18789404,2008-09-25T00:00:00,DNA Damage,C21.111
18789404,2008-09-25T00:00:00,DNA Damage,G05.355.180
18789404,2008-09-25T00:00:00,DNA Repair,G02.111.087.219
18789404,2008-09-25T00:00:00,DNA Repair,G02.149.115.219
18789404,2008-09-25T00:00:00,DNA Repair,G05.355.195
18789404,2008-09-25T00:00:00,"DNA, Fungal",D13.444.308.300
18789404,2008-09-25T00:00:00,"DNA, Single-Stranded",D13.444.308.497
18789404,2008-09-25T00:00:00,Molecular Sequence Data,L01.453.245.667
18789404,2008-09-25T00:00:00,Schizosaccharomyces,B01.300.107.797
18789404,2008-09-25T00:00:00,Schizosaccharomyces,B01.300.930.720
18789404,2008-09-25T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
18789404,2008-09-25T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
18789404,2008-09-25T00:00:00,Thymine DNA Glycosylase,D08.811.074.249.750
18789404,2008-09-25T00:00:00,Thymine DNA Glycosylase,D08.811.277.450.430.099.750
18789404,2008-09-25T00:00:00,Uracil,D03.383.742.698.875
18824077,2008-09-25T00:00:00,Animals,B01.050
18824077,2008-09-25T00:00:00,Anoxia,C23.888.852.079
18824077,2008-09-25T00:00:00,Antioxidants,D27.505.519.217
18824077,2008-09-25T00:00:00,Antioxidants,D27.505.696.706.125
18824077,2008-09-25T00:00:00,Antioxidants,D27.720.799.047
18824077,2008-09-25T00:00:00,Biological Markers,D23.101
18824077,2008-09-25T00:00:00,Catecholamines,D02.092.211.215.311
18824077,2008-09-25T00:00:00,Catecholamines,D02.092.311
18824077,2008-09-25T00:00:00,Dietary Supplements,J02.500.456
18824077,2008-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18824077,2008-09-25T00:00:00,Oxidative Stress,G03.495.710
18824077,2008-09-25T00:00:00,Oxidative Stress,G07.700.830.750
18824077,2008-09-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18824077,2008-09-25T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18823642,2008-09-26T00:00:00,Durapatite,D01.146.360.050.300.200
18823642,2008-09-26T00:00:00,Durapatite,D01.578.122.477.300
18823642,2008-09-26T00:00:00,Durapatite,D01.695.625.675.650.075.025.300.150
18823642,2008-09-26T00:00:00,Soil Pollutants,D27.888.284.756
18823642,2008-09-26T00:00:00,Tetrachloroethylene,D02.455.526.439.880
18823642,2008-09-26T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18823642,2008-09-26T00:00:00,Zinc,D01.268.556.940
18823642,2008-09-26T00:00:00,Zinc,D01.268.956.906
18823642,2008-09-26T00:00:00,Zinc,D01.552.544.940
18823615,2008-09-27T00:00:00,Aged,M01.060.116.100
18823615,2008-09-27T00:00:00,Colon,A03.556.124.526.356
18823615,2008-09-27T00:00:00,Colon,A03.556.249.249.356
18823615,2008-09-27T00:00:00,Gastrointestinal Diseases,C06.405
18823615,2008-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18823615,2008-09-27T00:00:00,Middle Aged,M01.060.116.630
19064014,2008-09-27T00:00:00,Aged,M01.060.116.100
19064014,2008-09-27T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19064014,2008-09-27T00:00:00,Coronary Angiography,E01.370.370.050.200
19064014,2008-09-27T00:00:00,Coronary Angiography,E01.370.370.380.200
19064014,2008-09-27T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19064014,2008-09-27T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19064014,2008-09-27T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19064014,2008-09-27T00:00:00,Drug-Eluting Stents,E07.695.750.500
19064014,2008-09-27T00:00:00,Hemorrhage,C23.550.414
19064014,2008-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19064014,2008-09-27T00:00:00,Incidence,E05.318.308.985.525.375
19064014,2008-09-27T00:00:00,Incidence,L01.280.975.525.375
19064014,2008-09-27T00:00:00,Incidence,N01.224.935.597.500
19064014,2008-09-27T00:00:00,Incidence,N06.850.505.400.975.525.375
19064014,2008-09-27T00:00:00,Incidence,N06.850.520.308.985.525.375
19064014,2008-09-27T00:00:00,Middle Aged,M01.060.116.630
19064014,2008-09-27T00:00:00,Observation,E05.581.249
19064014,2008-09-27T00:00:00,Patient Compliance,F01.145.488.500
19064014,2008-09-27T00:00:00,Patient Compliance,N05.300.150.600.600
19064014,2008-09-27T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19064014,2008-09-27T00:00:00,Ticlopidine,D02.886.778.834
19064014,2008-09-27T00:00:00,Ticlopidine,D03.383.903.834
18824518,2008-09-29T00:00:00,Animals,B01.050
18824518,2008-09-29T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
18824518,2008-09-29T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
18824518,2008-09-29T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
18824518,2008-09-29T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
18824518,2008-09-29T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
18824518,2008-09-29T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
18824518,2008-09-29T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
18824518,2008-09-29T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18824518,2008-09-29T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18824518,2008-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18824518,2008-09-29T00:00:00,Inflammation,C23.550.470
18824518,2008-09-29T00:00:00,Lysophospholipids,D10.570.755.375.760.550
18824518,2008-09-29T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
18824518,2008-09-29T00:00:00,Sphingosine,D02.033.100.700
18824518,2008-09-29T00:00:00,Sphingosine,D02.033.455.843
18824518,2008-09-29T00:00:00,Sphingosine,D02.092.063.700
18804741,2008-09-30T00:00:00,"Cholesterol, LDL",D10.532.515.500
18804741,2008-09-30T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
18804741,2008-09-30T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
18804741,2008-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18804741,2008-09-30T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
18804741,2008-09-30T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
18804741,2008-09-30T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
18804741,2008-09-30T00:00:00,Neoplasms,C04
18824748,2008-09-30T00:00:00,Aged,M01.060.116.100
18824748,2008-09-30T00:00:00,Cardiopulmonary Bypass,E04.292.413
18824748,2008-09-30T00:00:00,Coronary Artery Bypass,E04.100.376.719.332
18824748,2008-09-30T00:00:00,Coronary Artery Bypass,E04.928.220.520.220
18824748,2008-09-30T00:00:00,"Heart Arrest, Induced",E04.100.376.374
18824748,2008-09-30T00:00:00,"Heart Arrest, Induced",E04.928.220.360
18824748,2008-09-30T00:00:00,Homeostasis,G07.700.360
18824748,2008-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18824748,2008-09-30T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
18824748,2008-09-30T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
18824748,2008-09-30T00:00:00,Middle Aged,M01.060.116.630
18824748,2008-09-30T00:00:00,Myocardium,A02.633.580
18824748,2008-09-30T00:00:00,Myocardium,A07.541.704
18824748,2008-09-30T00:00:00,Myocardium,A10.690.552.750
18824751,2008-09-30T00:00:00,Adolescent,M01.060.057
18824751,2008-09-30T00:00:00,Adult,M01.060.116
18824751,2008-09-30T00:00:00,Cardiopulmonary Bypass,E04.292.413
18824751,2008-09-30T00:00:00,Child,M01.060.406
18824751,2008-09-30T00:00:00,"Child, Preschool",M01.060.406.448
18824751,2008-09-30T00:00:00,Fontan Procedure,E04.035.410.295
18824751,2008-09-30T00:00:00,Fontan Procedure,E04.100.376.410.295
18824751,2008-09-30T00:00:00,Fontan Procedure,E04.928.220.370.295
18824751,2008-09-30T00:00:00,"Heart Defects, Congenital",C14.240.400
18824751,2008-09-30T00:00:00,"Heart Defects, Congenital",C14.280.400
18824751,2008-09-30T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18824751,2008-09-30T00:00:00,Hemodynamics,G09.330.190.400
18824751,2008-09-30T00:00:00,Hemodynamics,G09.330.380
18824751,2008-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18824751,2008-09-30T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
18824751,2008-09-30T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
18824751,2008-09-30T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
18824751,2008-09-30T00:00:00,Infant,M01.060.703
18824751,2008-09-30T00:00:00,"Infant, Newborn",M01.060.703.520
18824751,2008-09-30T00:00:00,Inflammation,C23.550.470
18824751,2008-09-30T00:00:00,Postoperative Care,E02.760.722.700
18824751,2008-09-30T00:00:00,Postoperative Care,E04.624
18824751,2008-09-30T00:00:00,Postoperative Care,N02.421.585.722.700
18824751,2008-09-30T00:00:00,Recovery of Function,G16.757
18824751,2008-09-30T00:00:00,Resuscitation,E02.365.647
18824751,2008-09-30T00:00:00,Risk Factors,E05.318.740.600.800.725
18824751,2008-09-30T00:00:00,Risk Factors,N05.715.350.200.700
18824751,2008-09-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18824751,2008-09-30T00:00:00,Risk Factors,N06.850.490.625.750
18824751,2008-09-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18826643,2008-09-30T00:00:00,Amino Acid Sequence,G02.111.570.060
18826643,2008-09-30T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18826643,2008-09-30T00:00:00,Animals,B01.050
18826643,2008-09-30T00:00:00,Cardiovascular System,A07
18826643,2008-09-30T00:00:00,"Endothelium, Vascular",A07.231.330
18826643,2008-09-30T00:00:00,"Endothelium, Vascular",A10.272.491.355
18826643,2008-09-30T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
18826643,2008-09-30T00:00:00,"Genes, Homeobox",G05.360.340.024.340.230.500
18826643,2008-09-30T00:00:00,Homeodomain Proteins,D12.776.260.400
18826643,2008-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18826643,2008-09-30T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
18826643,2008-09-30T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
18826643,2008-09-30T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
18826643,2008-09-30T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18826643,2008-09-30T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18826643,2008-09-30T00:00:00,Molecular Sequence Data,L01.453.245.667
18826643,2008-09-30T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
18826643,2008-09-30T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18826643,2008-09-30T00:00:00,"Transcription, Genetic",G02.111.087.847
18826643,2008-09-30T00:00:00,"Transcription, Genetic",G02.149.115.847
18826643,2008-09-30T00:00:00,"Transcription, Genetic",G05.355.310.700
18827070,2008-09-30T00:00:00,Adult,M01.060.116
18827070,2008-09-30T00:00:00,Aged,M01.060.116.100
18827070,2008-09-30T00:00:00,Cerebrovascular Disorders,C10.228.140.300
18827070,2008-09-30T00:00:00,Cerebrovascular Disorders,C14.907.253
18827070,2008-09-30T00:00:00,Cognition Disorders,F03.087.250
18827070,2008-09-30T00:00:00,Dementia,C10.228.140.380
18827070,2008-09-30T00:00:00,Dementia,F03.087.400
18827070,2008-09-30T00:00:00,Enteral Nutrition,E02.421.360
18827070,2008-09-30T00:00:00,Enteral Nutrition,E02.642.500.360
18827070,2008-09-30T00:00:00,Gastrostomy,E04.210.496
18827070,2008-09-30T00:00:00,Gastrostomy,E04.579.408
18827070,2008-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18827070,2008-09-30T00:00:00,Middle Aged,M01.060.116.630
18827070,2008-09-30T00:00:00,Risk Factors,E05.318.740.600.800.725
18827070,2008-09-30T00:00:00,Risk Factors,N05.715.350.200.700
18827070,2008-09-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18827070,2008-09-30T00:00:00,Risk Factors,N06.850.490.625.750
18827070,2008-09-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18827070,2008-09-30T00:00:00,Serum Albumin,D12.776.034.841
18827070,2008-09-30T00:00:00,Serum Albumin,D12.776.124.050.700
18827070,2008-09-30T00:00:00,Serum Albumin,D12.776.124.727
18827070,2008-09-30T00:00:00,Sex Factors,N05.715.350.675
18827070,2008-09-30T00:00:00,Sex Factors,N06.850.490.875
18827070,2008-09-30T00:00:00,Young Adult,M01.060.116.815
18828802,2008-09-30T00:00:00,Alcohol Drinking,F01.145.317.269
18828802,2008-09-30T00:00:00,Animals,B01.050
18828802,2008-09-30T00:00:00,Glucocorticoids,D06.472.040.543
18828802,2008-09-30T00:00:00,Glucocorticoids,D27.505.696.399.472.488
18828802,2008-09-30T00:00:00,Memory Disorders,C10.597.606.525
18828802,2008-09-30T00:00:00,Memory Disorders,C23.888.592.604.529
18828802,2008-09-30T00:00:00,Memory Disorders,F01.700.625
18828802,2008-09-30T00:00:00,Substance Withdrawal Syndrome,C21.739.835
18828802,2008-09-30T00:00:00,Substance Withdrawal Syndrome,F03.900.825
18473154,2008-10-01T00:00:00,Community Networks,I01.880.656.300
18473154,2008-10-01T00:00:00,Community Networks,L01.700.508.300.184
18473154,2008-10-01T00:00:00,Community Networks,N02.421.143.202
18473154,2008-10-01T00:00:00,Exercise,G11.427.590.237
18473154,2008-10-01T00:00:00,Exercise,I03.350
18473154,2008-10-01T00:00:00,Health Promotion,N02.370
18473154,2008-10-01T00:00:00,Health Promotion,N02.421.726.507
18473154,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18473154,2008-10-01T00:00:00,United States,Z01.107.567.875
18521931,2008-10-01T00:00:00,Animals,B01.050
18521931,2008-10-01T00:00:00,Apoptosis,G04.299.139.160
18521931,2008-10-01T00:00:00,Calpain,D08.811.277.656.262.500.120
18521931,2008-10-01T00:00:00,Calpain,D08.811.277.656.300.200.120
18521931,2008-10-01T00:00:00,Caspases,D08.811.277.656.262.500.126
18521931,2008-10-01T00:00:00,Caspases,D08.811.277.656.300.200.126
18521931,2008-10-01T00:00:00,Caspases,D12.644.360.075.405
18521931,2008-10-01T00:00:00,Caspases,D12.776.476.075.405
18521931,2008-10-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
18521931,2008-10-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
18521931,2008-10-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
18521931,2008-10-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
18521931,2008-10-01T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
18521931,2008-10-01T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
18521931,2008-10-01T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
18521931,2008-10-01T00:00:00,Neurons,A08.663
18521931,2008-10-01T00:00:00,Neurons,A11.671
18521931,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18521931,2008-10-01T00:00:00,Spinal Cord,A08.186.854
18552708,2008-10-01T00:00:00,Acetylcysteine,D02.886.030.230.259
18552708,2008-10-01T00:00:00,Acetylcysteine,D12.125.166.230.259
18552708,2008-10-01T00:00:00,Animals,B01.050
18552708,2008-10-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18552708,2008-10-01T00:00:00,Inflammation,C23.550.470
18552708,2008-10-01T00:00:00,Lipopolysaccharides,D09.400.500
18552708,2008-10-01T00:00:00,Lipopolysaccharides,D09.698.718.450
18552708,2008-10-01T00:00:00,Lipopolysaccharides,D10.494
18552708,2008-10-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18552708,2008-10-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18552708,2008-10-01T00:00:00,Maternal-Fetal Exchange,G08.686.785.760.769.455
18552708,2008-10-01T00:00:00,Phospholipids,D10.570.755
18552708,2008-10-01T00:00:00,Phospholipids,D10.695
18552708,2008-10-01T00:00:00,Pregnancy,G08.686.785.760.769
18552708,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18605810,2008-10-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
18605810,2008-10-01T00:00:00,Environmental Monitoring,N06.850.780.375
18605810,2008-10-01T00:00:00,Geologic Sediments,G01.311.500
18605810,2008-10-01T00:00:00,Geologic Sediments,G16.500.320
18605810,2008-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18605810,2008-10-01T00:00:00,Risk Assessment,N04.452.871.715
18605810,2008-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18605810,2008-10-01T00:00:00,Risk Assessment,N06.850.505.715
18605810,2008-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18605810,2008-10-01T00:00:00,Rivers,G01.311.750
18605810,2008-10-01T00:00:00,Rivers,G16.500.275.280.500
18605810,2008-10-01T00:00:00,Rivers,N06.230.232.500
18605810,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18605810,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18605810,2008-10-01T00:00:00,Water Movements,G16.500.240.960
18605810,2008-10-01T00:00:00,Water Movements,N06.230.850
18607311,2008-10-01T00:00:00,Adolescent,M01.060.057
18607311,2008-10-01T00:00:00,Adult,M01.060.116
18607311,2008-10-01T00:00:00,African Americans,M01.686.508.100.100
18607311,2008-10-01T00:00:00,African Americans,M01.686.754.100
18607311,2008-10-01T00:00:00,Behavior Therapy,F04.754.137
18607311,2008-10-01T00:00:00,Chlamydia Infections,C01.252.400.210.210
18607311,2008-10-01T00:00:00,Chlamydia Infections,C01.252.810.301
18607311,2008-10-01T00:00:00,Chlamydia Infections,C01.539.778.281.301
18607311,2008-10-01T00:00:00,Chlamydia Infections,C12.294.668.281.301
18607311,2008-10-01T00:00:00,Chlamydia Infections,C13.351.500.711.281.301
18607311,2008-10-01T00:00:00,Chlamydia trachomatis,B03.440.190.190.190.750
18607311,2008-10-01T00:00:00,Depression,F01.145.126.350
18607311,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18607311,2008-10-01T00:00:00,Mexican Americans,M01.686.754.441.500
18607311,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
18607311,2008-10-01T00:00:00,Sexual Behavior,F01.145.802
18607311,2008-10-01T00:00:00,Sexually Transmitted Diseases,C01.539.778
18607311,2008-10-01T00:00:00,Sexually Transmitted Diseases,C02.800
18607311,2008-10-01T00:00:00,Sexually Transmitted Diseases,C12.294.668
18607311,2008-10-01T00:00:00,Sexually Transmitted Diseases,C13.351.500.711
18754743,2008-10-01T00:00:00,Adult,M01.060.116
18754743,2008-10-01T00:00:00,Aged,M01.060.116.100
18754743,2008-10-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18754743,2008-10-01T00:00:00,Hip Prosthesis,E07.695.400.400
18754743,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18754743,2008-10-01T00:00:00,Joint Prosthesis,E07.695.400
18754743,2008-10-01T00:00:00,Knee Prosthesis,E07.695.400.410
18754743,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
18754743,2008-10-01T00:00:00,Prosthesis-Related Infections,C01.539.685
18754743,2008-10-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
18754743,2008-10-01T00:00:00,Treatment Outcome,E01.789.800
18754743,2008-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18754743,2008-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18760199,2008-10-01T00:00:00,Adolescent,M01.060.057
18760199,2008-10-01T00:00:00,Adult,M01.060.116
18760199,2008-10-01T00:00:00,Alleles,G05.360.340.024.340.030
18760199,2008-10-01T00:00:00,Cyclosporine,D04.345.566.235.300
18760199,2008-10-01T00:00:00,Cyclosporine,D12.644.641.235.300
18760199,2008-10-01T00:00:00,Graft Rejection,G12.425.901.545.328
18760199,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18760199,2008-10-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18760199,2008-10-01T00:00:00,Kidney Transplantation,E02.870.500
18760199,2008-10-01T00:00:00,Kidney Transplantation,E04.936.450.485
18760199,2008-10-01T00:00:00,Kidney Transplantation,E04.950.774.400
18760199,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
18760199,2008-10-01T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
18760199,2008-10-01T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
18760199,2008-10-01T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
18760199,2008-10-01T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
18760199,2008-10-01T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
18760199,2008-10-01T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
18760199,2008-10-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18778191,2008-10-01T00:00:00,Aged,M01.060.116.100
18778191,2008-10-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18778191,2008-10-01T00:00:00,Alzheimer Disease,C10.574.945.249
18778191,2008-10-01T00:00:00,Alzheimer Disease,F03.087.400.100
18778191,2008-10-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18778191,2008-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18778191,2008-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18778191,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18778191,2008-10-01T00:00:00,Psychotic Disorders,F03.700.675
18778191,2008-10-01T00:00:00,Risperidone,D03.383.742.698.685
18780217,2008-10-01T00:00:00,Animals,B01.050
18780217,2008-10-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18780217,2008-10-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18780217,2008-10-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18780217,2008-10-01T00:00:00,Autoimmune Diseases,C20.111
18780217,2008-10-01T00:00:00,Cell Proliferation,G04.299.233.750
18780217,2008-10-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18780217,2008-10-01T00:00:00,Lymphocyte Activation,E01.450.495.482
18780217,2008-10-01T00:00:00,Lymphocyte Activation,E05.478.594.530
18780217,2008-10-01T00:00:00,Lymphocyte Activation,G12.425.747
18780217,2008-10-01T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18780217,2008-10-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
18780217,2008-10-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
18780217,2008-10-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
18780217,2008-10-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18780217,2008-10-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18780217,2008-10-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18780217,2008-10-01T00:00:00,Trichloroethylene,D02.455.526.439.939
18784134,2008-10-01T00:00:00,Animals,B01.050
18784134,2008-10-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18784134,2008-10-01T00:00:00,Endothelin-1,D12.644.276.400.225
18784134,2008-10-01T00:00:00,Endothelin-1,D12.776.467.400.225
18784134,2008-10-01T00:00:00,Endothelin-1,D23.529.400.225
18784134,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18784134,2008-10-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
18784134,2008-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18784134,2008-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18784134,2008-10-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18784134,2008-10-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18784134,2008-10-01T00:00:00,"Scleroderma, Systemic",C17.300.799
18784134,2008-10-01T00:00:00,"Scleroderma, Systemic",C17.800.784
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18784134,2008-10-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
18784144,2008-10-01T00:00:00,Antirheumatic Agents,D27.505.954.329
18784144,2008-10-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
18784144,2008-10-01T00:00:00,Cyclophosphamide,D02.705.670.243
18784144,2008-10-01T00:00:00,Exercise Test,E01.370.370.380.250
18784144,2008-10-01T00:00:00,Exercise Test,E01.370.386.700.250
18784144,2008-10-01T00:00:00,Exercise Test,E05.333.250
18784144,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18784144,2008-10-01T00:00:00,Lung,A04.411
18784144,2008-10-01T00:00:00,Pulmonary Fibrosis,C08.381.765
18784144,2008-10-01T00:00:00,"Scleroderma, Systemic",C17.300.799
18784144,2008-10-01T00:00:00,"Scleroderma, Systemic",C17.800.784
18784144,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18784144,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18784144,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18784144,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18784144,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18784144,2008-10-01T00:00:00,Treatment Outcome,E01.789.800
18784144,2008-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18784144,2008-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18784150,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18784150,2008-10-01T00:00:00,Lung,A04.411
18784150,2008-10-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
18784150,2008-10-01T00:00:00,Pulmonary Fibrosis,C08.381.765
18784150,2008-10-01T00:00:00,"Scleroderma, Systemic",C17.300.799
18784150,2008-10-01T00:00:00,"Scleroderma, Systemic",C17.800.784
18784150,2008-10-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18784150,2008-10-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18784150,2008-10-01T00:00:00,Sensitivity and Specificity,G17.800
18784150,2008-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18784150,2008-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18784150,2008-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18784150,2008-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18790396,2008-10-01T00:00:00,Breast Neoplasms,C04.588.180
18790396,2008-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
18790396,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18790396,2008-10-01T00:00:00,North Carolina,Z01.107.567.875.075.475
18790396,2008-10-01T00:00:00,North Carolina,Z01.107.567.875.750.530
18790396,2008-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
18790396,2008-10-01T00:00:00,Prevalence,L01.280.975.525.750
18790396,2008-10-01T00:00:00,Prevalence,N01.224.935.597.750
18790396,2008-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18790396,2008-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18794050,2008-10-01T00:00:00,Clinical Laboratory Techniques,E05.200
18794050,2008-10-01T00:00:00,"Efficiency, Organizational",N04.452.227
18794050,2008-10-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18794050,2008-10-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18794050,2008-10-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18794050,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18794050,2008-10-01T00:00:00,Length of Stay,E02.760.400.480
18794050,2008-10-01T00:00:00,Length of Stay,N02.421.585.400.480
18794050,2008-10-01T00:00:00,Patient Care,E02.760
18794050,2008-10-01T00:00:00,Patient Care,N02.421.585
18794050,2008-10-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
18794050,2008-10-01T00:00:00,"Quality Assurance, Health Care",N05.700
18797415,2008-10-01T00:00:00,Animals,B01.050
18797415,2008-10-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
18797415,2008-10-01T00:00:00,"Glomerulonephritis, Membranoproliferative",C12.777.419.570.363.615
18797415,2008-10-01T00:00:00,"Glomerulonephritis, Membranoproliferative",C13.351.968.419.570.363.615
18797415,2008-10-01T00:00:00,"Glomerulonephritis, Membranoproliferative",C20.425
18797415,2008-10-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
18797415,2008-10-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
18797415,2008-10-01T00:00:00,Lupus Nephritis,C17.300.480.680
18797415,2008-10-01T00:00:00,Lupus Nephritis,C20.111.590.560
18797415,2008-10-01T00:00:00,Lysine,D12.125.068.555
18797415,2008-10-01T00:00:00,Lysine,D12.125.095.647
18797415,2008-10-01T00:00:00,Lysine,D12.125.142.497
18797415,2008-10-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
18797415,2008-10-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
18797415,2008-10-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
18797415,2008-10-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
18797415,2008-10-01T00:00:00,Proteinuria,C12.777.934.734
18797415,2008-10-01T00:00:00,Proteinuria,C13.351.968.934.734
18797415,2008-10-01T00:00:00,Proteinuria,C23.888.942.750
18805174,2008-10-01T00:00:00,Animals,B01.050
18805174,2008-10-01T00:00:00,Biocompatible Materials,D25.130
18805174,2008-10-01T00:00:00,Biocompatible Materials,D27.720.102.130
18805174,2008-10-01T00:00:00,Biocompatible Materials,J01.637.051.130
18805174,2008-10-01T00:00:00,Myocardial Infarction,C14.280.647.500
18805174,2008-10-01T00:00:00,Myocardial Infarction,C14.907.585.500
18805174,2008-10-01T00:00:00,Probability,E05.318.740.600
18805174,2008-10-01T00:00:00,Probability,G17.680
18805174,2008-10-01T00:00:00,Probability,N05.715.360.750.625
18805174,2008-10-01T00:00:00,Probability,N06.850.520.830.600
18805174,2008-10-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18805174,2008-10-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18805174,2008-10-01T00:00:00,Sensitivity and Specificity,G17.800
18805174,2008-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18805174,2008-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18805174,2008-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18805174,2008-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18805174,2008-10-01T00:00:00,Swine,B01.050.150.900.649.077.880
18805174,2008-10-01T00:00:00,Ventricular Remodeling,C23.300.985
18805174,2008-10-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
18805200,2008-10-01T00:00:00,Adult,M01.060.116
18805200,2008-10-01T00:00:00,"Anastomosis, Surgical",E04.035
18805200,2008-10-01T00:00:00,"Diagnosis, Differential",E01.171
18805200,2008-10-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
18805200,2008-10-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
18805200,2008-10-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
18805200,2008-10-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
18805200,2008-10-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
18805200,2008-10-01T00:00:00,Esophageal Stenosis,C06.405.117.544
18805200,2008-10-01T00:00:00,"Granuloma, Plasma Cell",C23.550.382.875
18805200,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18805200,2008-10-01T00:00:00,Inflammation,C23.550.470
18805200,2008-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18805200,2008-10-01T00:00:00,Risk Assessment,N04.452.871.715
18805200,2008-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18805200,2008-10-01T00:00:00,Risk Assessment,N06.850.505.715
18805200,2008-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18805200,2008-10-01T00:00:00,Syndrome,C23.550.288.500
18805200,2008-10-01T00:00:00,Treatment Outcome,E01.789.800
18805200,2008-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18805200,2008-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18806478,2008-10-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
18806478,2008-10-01T00:00:00,Catheter Ablation,E02.148.110
18806478,2008-10-01T00:00:00,Catheter Ablation,E02.148.442.110
18806478,2008-10-01T00:00:00,Catheter Ablation,E02.154.402.110
18806478,2008-10-01T00:00:00,Catheter Ablation,E04.014.170.402.110
18806478,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18806478,2008-10-01T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
18806478,2008-10-01T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
18808340,2008-10-01T00:00:00,Carrier State,N06.850.160
18808340,2008-10-01T00:00:00,Cross Infection,C01.539.248
18808340,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18808340,2008-10-01T00:00:00,Incidence,E05.318.308.985.525.375
18808340,2008-10-01T00:00:00,Incidence,L01.280.975.525.375
18808340,2008-10-01T00:00:00,Incidence,N01.224.935.597.500
18808340,2008-10-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18808340,2008-10-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18808340,2008-10-01T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
18808340,2008-10-01T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
18808340,2008-10-01T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
18808340,2008-10-01T00:00:00,Population Surveillance,E05.318.308.250.700
18808340,2008-10-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
18808340,2008-10-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
18808340,2008-10-01T00:00:00,Population Surveillance,N06.850.780.675
18808340,2008-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
18808340,2008-10-01T00:00:00,Prevalence,L01.280.975.525.750
18808340,2008-10-01T00:00:00,Prevalence,N01.224.935.597.750
18808340,2008-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18808340,2008-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18808340,2008-10-01T00:00:00,Staphylococcal Infections,C01.252.410.868
18808340,2008-10-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
18808340,2008-10-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
18808340,2008-10-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
18808475,2008-10-01T00:00:00,Adolescent,M01.060.057
18808475,2008-10-01T00:00:00,Adolescent Behavior,F01.145.022
18808475,2008-10-01T00:00:00,Crime Victims,M01.135
18808475,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18808475,2008-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
18808475,2008-10-01T00:00:00,Prevalence,L01.280.975.525.750
18808475,2008-10-01T00:00:00,Prevalence,N01.224.935.597.750
18808475,2008-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18808475,2008-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18808475,2008-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18808475,2008-10-01T00:00:00,Risk Factors,N05.715.350.200.700
18808475,2008-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18808475,2008-10-01T00:00:00,Risk Factors,N06.850.490.625.750
18808475,2008-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18808475,2008-10-01T00:00:00,Risk-Taking,F01.145.722
18808475,2008-10-01T00:00:00,Rural Population,N01.600.725
18808475,2008-10-01T00:00:00,Sexual Behavior,F01.145.802
18808475,2008-10-01T00:00:00,Substance-Related Disorders,C21.739
18808475,2008-10-01T00:00:00,Substance-Related Disorders,F03.900
18808475,2008-10-01T00:00:00,Violence,I01.198.240.856
18808475,2008-10-01T00:00:00,Violence,I01.880.735.900
18809060,2008-10-01T00:00:00,Adult,M01.060.116
18809060,2008-10-01T00:00:00,Aged,M01.060.116.100
18809060,2008-10-01T00:00:00,Brachytherapy,E02.815.150
18809060,2008-10-01T00:00:00,Breast Neoplasms,C04.588.180
18809060,2008-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
18809060,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18809060,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
18809060,2008-10-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18809060,2008-10-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18809060,2008-10-01T00:00:00,Patient Satisfaction,N05.715.360.600
18809060,2008-10-01T00:00:00,Quality of Life,I01.800
18809060,2008-10-01T00:00:00,Quality of Life,K01.752.400.750
18809060,2008-10-01T00:00:00,Questionnaires,E05.318.308.750
18809060,2008-10-01T00:00:00,Questionnaires,L01.280.800
18809060,2008-10-01T00:00:00,Questionnaires,N05.715.360.300.695
18809060,2008-10-01T00:00:00,Questionnaires,N06.850.520.308.750
18809862,2008-10-01T00:00:00,Animals,B01.050
18809862,2008-10-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18809862,2008-10-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18809862,2008-10-01T00:00:00,Lipids,D10
18809862,2008-10-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
18809862,2008-10-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
18812822,2008-10-01T00:00:00,Emergency Medicine,H02.403.250
18812822,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18812822,2008-10-01T00:00:00,Intensive Care,E02.760.190.400
18812822,2008-10-01T00:00:00,Intensive Care,N02.421.585.190.400
18812822,2008-10-01T00:00:00,Intensive Care Units,N02.278.388.493
18812822,2008-10-01T00:00:00,Needs Assessment,I02.594
18812822,2008-10-01T00:00:00,Needs Assessment,N03.349.380.565
18812822,2008-10-01T00:00:00,Needs Assessment,N05.300.537
18812822,2008-10-01T00:00:00,Specialization,H02.811
18812822,2008-10-01T00:00:00,United States,Z01.107.567.875
18816827,2008-10-01T00:00:00,Algorithms,G17.035
18816827,2008-10-01T00:00:00,Algorithms,L01.224.050
18816827,2008-10-01T00:00:00,Brain,A08.186.211
18816827,2008-10-01T00:00:00,Computer Simulation,L01.224.160
18816827,2008-10-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
18816827,2008-10-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
18816827,2008-10-01T00:00:00,Image Enhancement,E01.370.350.600.350
18816827,2008-10-01T00:00:00,Image Enhancement,L01.224.308.380
18816827,2008-10-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
18816827,2008-10-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
18816827,2008-10-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
18816827,2008-10-01T00:00:00,"Models, Biological",E05.599.395
18816827,2008-10-01T00:00:00,"Models, Statistical",E05.318.740.500
18816827,2008-10-01T00:00:00,"Models, Statistical",E05.599.835
18816827,2008-10-01T00:00:00,"Models, Statistical",N05.715.360.750.530
18816827,2008-10-01T00:00:00,"Models, Statistical",N06.850.520.830.500
18816827,2008-10-01T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
18816827,2008-10-01T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
18816827,2008-10-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18816827,2008-10-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18816827,2008-10-01T00:00:00,Sensitivity and Specificity,G17.800
18816827,2008-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18816827,2008-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18816827,2008-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18816827,2008-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18816835,2008-10-01T00:00:00,Actins,D05.750.078.730.250
18816835,2008-10-01T00:00:00,Actins,D12.776.210.500.100
18816835,2008-10-01T00:00:00,Actins,D12.776.220.525.255
18816835,2008-10-01T00:00:00,Animals,B01.050
18816835,2008-10-01T00:00:00,Endothelial Cells,A11.436.275
18816835,2008-10-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18816835,2008-10-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18816835,2008-10-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18816835,2008-10-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18816864,2008-10-01T00:00:00,Animals,B01.050
18816864,2008-10-01T00:00:00,Cell Lineage,G04.172
18816864,2008-10-01T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
18816864,2008-10-01T00:00:00,Cell Lineage,G08.686.155
18816864,2008-10-01T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
18816864,2008-10-01T00:00:00,Heart,A07.541
18816864,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18816864,2008-10-01T00:00:00,Mesoderm,A16.504.660
18816864,2008-10-01T00:00:00,Myocardium,A02.633.580
18816864,2008-10-01T00:00:00,Myocardium,A07.541.704
18816864,2008-10-01T00:00:00,Myocardium,A10.690.552.750
18821675,2008-10-01T00:00:00,Adolescent,M01.060.057
18821675,2008-10-01T00:00:00,Adult,M01.060.116
18821675,2008-10-01T00:00:00,African Americans,M01.686.508.100.100
18821675,2008-10-01T00:00:00,African Americans,M01.686.754.100
18821675,2008-10-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
18821675,2008-10-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
18821675,2008-10-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
18821675,2008-10-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18821675,2008-10-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18821675,2008-10-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18821675,2008-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18821675,2008-10-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18821675,2008-10-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18821675,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
18821675,2008-10-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
18821675,2008-10-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18821675,2008-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18821675,2008-10-01T00:00:00,Risk Factors,N05.715.350.200.700
18821675,2008-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18821675,2008-10-01T00:00:00,Risk Factors,N06.850.490.625.750
18821675,2008-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18821872,2008-10-01T00:00:00,Adult,M01.060.116
18821872,2008-10-01T00:00:00,Alcohol Drinking,F01.145.317.269
18821872,2008-10-01T00:00:00,Alcoholism,C21.739.100.250
18821872,2008-10-01T00:00:00,Alcoholism,F03.900.100.350
18821872,2008-10-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18821872,2008-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
18821872,2008-10-01T00:00:00,Blood Pressure,G09.330.380.076
18821872,2008-10-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18821872,2008-10-01T00:00:00,Body Mass Index,E05.041.124.125
18821872,2008-10-01T00:00:00,Body Mass Index,G07.100.100.125
18821872,2008-10-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18821872,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18821872,2008-10-01T00:00:00,Hypertension,C14.907.489
18821872,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
18821872,2008-10-01T00:00:00,Regression Analysis,E05.318.740.750
18821872,2008-10-01T00:00:00,Regression Analysis,N05.715.360.750.695
18821872,2008-10-01T00:00:00,Regression Analysis,N06.850.520.830.750
18821877,2008-10-01T00:00:00,Adolescent,M01.060.057
18821877,2008-10-01T00:00:00,Adult,M01.060.116
18821877,2008-10-01T00:00:00,Aged,M01.060.116.100
18821877,2008-10-01T00:00:00,Health Behavior,F01.145.488
18821877,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18821877,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
18821877,2008-10-01T00:00:00,Motivation,F01.658
18821877,2008-10-01T00:00:00,Motivation,F01.752.543.500.750
18821877,2008-10-01T00:00:00,Nicotine,D03.132.760.570
18821877,2008-10-01T00:00:00,Nicotine,D03.383.725.518
18821877,2008-10-01T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
18821877,2008-10-01T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
18821877,2008-10-01T00:00:00,Smoking,F01.145.466.753
18821877,2008-10-01T00:00:00,Smoking Cessation,F01.145.940.700
18821877,2008-10-01T00:00:00,United States,Z01.107.567.875
18828734,2008-10-01T00:00:00,Adolescent,M01.060.057
18828734,2008-10-01T00:00:00,Alleles,G05.360.340.024.340.030
18828734,2008-10-01T00:00:00,Blood Flow Velocity,E01.370.370.130
18828734,2008-10-01T00:00:00,Blood Flow Velocity,G09.330.380.630.080
18828734,2008-10-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
18828734,2008-10-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
18828734,2008-10-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
18828734,2008-10-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18828734,2008-10-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18828734,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18828734,2008-10-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18828734,2008-10-01T00:00:00,Young Adult,M01.060.116.815
18829738,2008-10-01T00:00:00,Animals,B01.050
18829738,2008-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
18829738,2008-10-01T00:00:00,Blood Pressure,G09.330.380.076
18829738,2008-10-01T00:00:00,Creatinine,D03.383.129.308.207
18829738,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18829738,2008-10-01T00:00:00,Kidney Glomerulus,A05.810.453.324.359
18829738,2008-10-01T00:00:00,Kidney Glomerulus,A05.810.453.736.520
18829738,2008-10-01T00:00:00,Kidney Tubules,A05.810.453.736.560
18829738,2008-10-01T00:00:00,Neuropeptides,D12.644.400
18829738,2008-10-01T00:00:00,Neuropeptides,D12.776.641.650
18829738,2008-10-01T00:00:00,Oxidative Stress,G03.495.710
18829738,2008-10-01T00:00:00,Oxidative Stress,G07.700.830.750
18829738,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18829738,2008-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18829738,2008-10-01T00:00:00,Superoxides,D01.248.497.158.685.750.850
18829738,2008-10-01T00:00:00,Superoxides,D01.339.431.374.850
18829738,2008-10-01T00:00:00,Superoxides,D01.339.431.750
18829738,2008-10-01T00:00:00,Superoxides,D01.650.550.750.800
18832171,2008-10-01T00:00:00,Animals,B01.050
18832171,2008-10-01T00:00:00,B-Lymphocytes,A11.063.438
18832171,2008-10-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
18832171,2008-10-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
18832171,2008-10-01T00:00:00,B-Lymphocytes,A15.382.032.438
18832171,2008-10-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
18832171,2008-10-01T00:00:00,"Immunity, Innate",G12.450.575
18832171,2008-10-01T00:00:00,Immunologic Memory,G12.450.050.500
18832515,2008-10-01T00:00:00,Adult,M01.060.116
18832515,2008-10-01T00:00:00,Anxiety Disorders,F03.080
18832515,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18832515,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
18834354,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
18834354,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
18834354,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
18834354,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
18834354,2008-10-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18834354,2008-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18834354,2008-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18834354,2008-10-01T00:00:00,Drug Interactions,G07.690.812.240
18834354,2008-10-01T00:00:00,Drug Interactions,G07.700.680.240
18834354,2008-10-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18834354,2008-10-01T00:00:00,Flow Cytometry,E05.200.500.386.350
18834354,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18834354,2008-10-01T00:00:00,Neoplasm Proteins,D12.776.624
18834354,2008-10-01T00:00:00,Substrate Specificity,G02.111.835
18840084,2008-10-01T00:00:00,Cross Infection,C01.539.248
18840084,2008-10-01T00:00:00,Evidence-Based Medicine,H02.249.750
18840084,2008-10-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18840084,2008-10-01T00:00:00,Hospitals,N02.278.421
18840084,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840084,2008-10-01T00:00:00,Infection Control,N06.850.780.200.450
18840085,2008-10-01T00:00:00,Anti-Infective Agents,D27.505.954.122
18840085,2008-10-01T00:00:00,Bacteremia,C01.252.100
18840085,2008-10-01T00:00:00,Bacteremia,C01.539.757.100
18840085,2008-10-01T00:00:00,Bacteremia,C23.550.470.790.500.100
18840085,2008-10-01T00:00:00,"Catheterization, Central Venous",E02.148.167
18840085,2008-10-01T00:00:00,Critical Care,E02.760.190
18840085,2008-10-01T00:00:00,Critical Care,N02.421.585.190
18840085,2008-10-01T00:00:00,Cross Infection,C01.539.248
18840085,2008-10-01T00:00:00,Hospitals,N02.278.421
18840085,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840085,2008-10-01T00:00:00,Infection Control,N06.850.780.200.450
18840087,2008-10-01T00:00:00,Critical Care,E02.760.190
18840087,2008-10-01T00:00:00,Critical Care,N02.421.585.190
18840087,2008-10-01T00:00:00,Hospitals,N02.278.421
18840087,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840087,2008-10-01T00:00:00,Infection Control,N06.850.780.200.450
18840087,2008-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
18840087,2008-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
18840087,2008-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
18840087,2008-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
18840087,2008-10-01T00:00:00,"Respiration, Artificial",E02.365.647.729
18840087,2008-10-01T00:00:00,"Respiration, Artificial",E02.880.820
18840088,2008-10-01T00:00:00,Hospitals,N02.278.421
18840088,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840088,2008-10-01T00:00:00,Infection Control,N06.850.780.200.450
18840088,2008-10-01T00:00:00,Urinary Catheterization,E01.370.390.820
18840088,2008-10-01T00:00:00,Urinary Catheterization,E02.148.947
18840088,2008-10-01T00:00:00,Urinary Tract Infections,C01.539.895
18840088,2008-10-01T00:00:00,Urinary Tract Infections,C12.777.892
18840088,2008-10-01T00:00:00,Urinary Tract Infections,C13.351.968.892
18840089,2008-10-01T00:00:00,Critical Care,E02.760.190
18840089,2008-10-01T00:00:00,Critical Care,N02.421.585.190
18840089,2008-10-01T00:00:00,Cross Infection,C01.539.248
18840089,2008-10-01T00:00:00,Hospitals,N02.278.421
18840089,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840089,2008-10-01T00:00:00,Infection Control,N06.850.780.200.450
18840089,2008-10-01T00:00:00,"Surgical Procedures, Operative",E04
18840089,2008-10-01T00:00:00,Surgical Wound Infection,C01.539.947.692
18840089,2008-10-01T00:00:00,Surgical Wound Infection,C23.550.767.925
18840090,2008-10-01T00:00:00,Cross Infection,C01.539.248
18840090,2008-10-01T00:00:00,Hospitals,N02.278.421
18840090,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840090,2008-10-01T00:00:00,Infection Control,N06.850.780.200.450
18840090,2008-10-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
18840090,2008-10-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
18840090,2008-10-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
18840090,2008-10-01T00:00:00,Staphylococcal Infections,C01.252.410.868
18840091,2008-10-01T00:00:00,Clostridium Infections,C01.252.410.222
18840091,2008-10-01T00:00:00,Clostridium difficile,B03.300.390.400.200.250
18840091,2008-10-01T00:00:00,Clostridium difficile,B03.510.415.400.200.250
18840091,2008-10-01T00:00:00,Critical Care,E02.760.190
18840091,2008-10-01T00:00:00,Critical Care,N02.421.585.190
18840091,2008-10-01T00:00:00,Cross Infection,C01.539.248
18840091,2008-10-01T00:00:00,Hospitals,N02.278.421
18840091,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840091,2008-10-01T00:00:00,Infection Control,N06.850.780.200.450
18840853,2008-10-01T00:00:00,Delivery of Health Care,N04.590.374
18840853,2008-10-01T00:00:00,Delivery of Health Care,N05.300
18840853,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18841074,2008-10-01T00:00:00,Animals,B01.050
18841074,2008-10-01T00:00:00,Aprotinin,D12.776.083
18841074,2008-10-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18841074,2008-10-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18841074,2008-10-01T00:00:00,"Models, Animal",E05.598
18841074,2008-10-01T00:00:00,Myocardium,A02.633.580
18841074,2008-10-01T00:00:00,Myocardium,A07.541.704
18841074,2008-10-01T00:00:00,Myocardium,A10.690.552.750
18841074,2008-10-01T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.073.750
18841074,2008-10-01T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.705.852.760.597
18841074,2008-10-01T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.050.301.264.035.908
18841074,2008-10-01T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.101.100.110.912
18841074,2008-10-01T00:00:00,Reperfusion Injury,C14.907.725
18841074,2008-10-01T00:00:00,Reperfusion Injury,C23.550.767.877
18841074,2008-10-01T00:00:00,Serine Proteinase Inhibitors,D27.505.519.389.745.800
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18841074,2008-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18841074,2008-10-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18849558,2008-10-01T00:00:00,Chylothorax,C08.528.142
18849558,2008-10-01T00:00:00,Enteral Nutrition,E02.421.360
18849558,2008-10-01T00:00:00,Enteral Nutrition,E02.642.500.360
18849558,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18849558,2008-10-01T00:00:00,Parenteral Nutrition,E02.421.505
18849558,2008-10-01T00:00:00,Parenteral Nutrition,E02.642.500.505
18854677,2008-10-01T00:00:00,Combined Modality Therapy,E02.186
18854677,2008-10-01T00:00:00,"Diagnosis, Differential",E01.171
18854677,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18854683,2008-10-01T00:00:00,Adult,M01.060.116
18854683,2008-10-01T00:00:00,Animals,B01.050
18854683,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18855865,2008-10-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
18855865,2008-10-01T00:00:00,Esophagus,A03.556.875.500
18855865,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18855865,2008-10-01T00:00:00,Manometry,E05.559
18855865,2008-10-01T00:00:00,Pressure,G01.374.715
18922407,2008-10-01T00:00:00,"Anesthetics, Inhalation",D27.505.696.277.100.035.060
18922407,2008-10-01T00:00:00,"Anesthetics, Inhalation",D27.505.954.427.210.100.035.060
18922407,2008-10-01T00:00:00,Benzodiazepines,D03.438.079.080
18922407,2008-10-01T00:00:00,Conscious Sedation,E03.250
18922407,2008-10-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18922407,2008-10-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18922407,2008-10-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18922407,2008-10-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18922407,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18922407,2008-10-01T00:00:00,Ketamine,D02.455.426.392.368.367.652
18922407,2008-10-01T00:00:00,Perioperative Care,E02.760.722
18922407,2008-10-01T00:00:00,Perioperative Care,E04.604
18922407,2008-10-01T00:00:00,Perioperative Care,N02.421.585.722
18922407,2008-10-01T00:00:00,Postoperative Care,E02.760.722.700
18922407,2008-10-01T00:00:00,Postoperative Care,E04.624
18922407,2008-10-01T00:00:00,Postoperative Care,N02.421.585.722.700
18922407,2008-10-01T00:00:00,Preoperative Care,E02.760.795
18922407,2008-10-01T00:00:00,Preoperative Care,E04.641
18922407,2008-10-01T00:00:00,Preoperative Care,N02.421.585.795
18922407,2008-10-01T00:00:00,Propofol,D02.755.773
18925692,2008-10-01T00:00:00,Angiotensin II,D06.472.699.094.078
18925692,2008-10-01T00:00:00,Angiotensin II,D12.644.400.070.078
18925692,2008-10-01T00:00:00,Angiotensin II,D12.644.456.073.041
18925692,2008-10-01T00:00:00,Angiotensin II,D12.644.548.058.078
18925692,2008-10-01T00:00:00,Angiotensin II,D12.776.641.650.070.078
18925692,2008-10-01T00:00:00,Angiotensin II,D23.469.050.050.050
18925692,2008-10-01T00:00:00,Animals,B01.050
18925692,2008-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
18925692,2008-10-01T00:00:00,Blood Pressure,G09.330.380.076
18925692,2008-10-01T00:00:00,Hypertension,C14.907.489
18925692,2008-10-01T00:00:00,Phenotype,G05.695
18925692,2008-10-01T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
18925692,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18925692,2008-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18925692,2008-10-01T00:00:00,Risk Factors,N05.715.350.200.700
18925692,2008-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18925692,2008-10-01T00:00:00,Risk Factors,N06.850.490.625.750
18925692,2008-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18928983,2008-10-01T00:00:00,Adult,M01.060.116
18928983,2008-10-01T00:00:00,Ambulatory Care,E02.760.106
18928983,2008-10-01T00:00:00,Ambulatory Care,N02.421.585.106
18928983,2008-10-01T00:00:00,Hospitalization,E02.760.400
18928983,2008-10-01T00:00:00,Hospitalization,N02.421.585.400
18928983,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18928983,2008-10-01T00:00:00,Hydroxyprogesterones,D04.808.745.745.654.829.395
18928983,2008-10-01T00:00:00,Hydroxyprogesterones,D06.472.334.851.687.750.478
18928983,2008-10-01T00:00:00,Pregnancy,G08.686.785.760.769
18928983,2008-10-01T00:00:00,Pregnancy Outcome,E01.789.700
18928983,2008-10-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
18928983,2008-10-01T00:00:00,Premature Birth,C13.703.420.491.500
18928983,2008-10-01T00:00:00,Progestins,D27.505.696.399.472.858
18928983,2008-10-01T00:00:00,Secondary Prevention,N02.421.726.825
18928983,2008-10-01T00:00:00,Secondary Prevention,N06.850.780.750
18928985,2008-10-01T00:00:00,Adult,M01.060.116
18928985,2008-10-01T00:00:00,Health Promotion,N02.370
18928985,2008-10-01T00:00:00,Health Promotion,N02.421.726.507
18928985,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18928985,2008-10-01T00:00:00,Pregnancy,G08.686.785.760.769
18928985,2008-10-01T00:00:00,Pregnancy Outcome,E01.789.700
18928985,2008-10-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
18928985,2008-10-01T00:00:00,Premature Birth,C13.703.420.491.500
18928985,2008-10-01T00:00:00,Referral and Consultation,N04.452.758.849
18928985,2008-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18928985,2008-10-01T00:00:00,Risk Assessment,N04.452.871.715
18928985,2008-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18928985,2008-10-01T00:00:00,Risk Assessment,N06.850.505.715
18928985,2008-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18928985,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18928985,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18928985,2008-10-01T00:00:00,United States,Z01.107.567.875
18929049,2008-10-01T00:00:00,Endocrine Disruptors,D27.505.696.353
18929049,2008-10-01T00:00:00,Endocrine Disruptors,D27.888.284.295
18929049,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18929049,2008-10-01T00:00:00,Pregnancy,G08.686.785.760.769
18929049,2008-10-01T00:00:00,Pregnancy Outcome,E01.789.700
18929049,2008-10-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
18929049,2008-10-01T00:00:00,Reproduction,G08.686.785.760
18938142,2008-10-01T00:00:00,Calcium,D01.268.552.100
18938142,2008-10-01T00:00:00,Calcium,D01.552.539.288
18938142,2008-10-01T00:00:00,Calcium,D23.119.100
18938142,2008-10-01T00:00:00,Cell Culture Techniques,E05.200.249.249
18938142,2008-10-01T00:00:00,Cell Line,A11.251.210
18938142,2008-10-01T00:00:00,Gene Expression Regulation,G05.355.315
18938142,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18938142,2008-10-01T00:00:00,Kidney,A05.810.453
18938142,2008-10-01T00:00:00,RNA,D13.444.735
18938142,2008-10-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
18938142,2008-10-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
18938142,2008-10-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
18938240,2008-10-01T00:00:00,Amino Acid Sequence,G02.111.570.060
18938240,2008-10-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18938240,2008-10-01T00:00:00,Angiotensin II,D06.472.699.094.078
18938240,2008-10-01T00:00:00,Angiotensin II,D12.644.400.070.078
18938240,2008-10-01T00:00:00,Angiotensin II,D12.644.456.073.041
18938240,2008-10-01T00:00:00,Angiotensin II,D12.644.548.058.078
18938240,2008-10-01T00:00:00,Angiotensin II,D12.776.641.650.070.078
18938240,2008-10-01T00:00:00,Angiotensin II,D23.469.050.050.050
18938240,2008-10-01T00:00:00,Animals,B01.050
18938240,2008-10-01T00:00:00,Arrestins,D12.776.306.090
18938240,2008-10-01T00:00:00,Arrestins,D12.776.543.090
18938240,2008-10-01T00:00:00,Cell Line,A11.251.210
18938240,2008-10-01T00:00:00,Clathrin,D12.776.543.990.200
18938240,2008-10-01T00:00:00,Endocytosis,G04.299.482
18938240,2008-10-01T00:00:00,"Fluorescent Antibody Technique, Direct",E01.450.495.435.375.300
18938240,2008-10-01T00:00:00,"Fluorescent Antibody Technique, Direct",E05.200.750.551.512.240.300
18938240,2008-10-01T00:00:00,"Fluorescent Antibody Technique, Direct",E05.478.594.430.375.300
18938240,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18938240,2008-10-01T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
18938240,2008-10-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
18938240,2008-10-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
18938240,2008-10-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
18938240,2008-10-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
18938240,2008-10-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18938240,2008-10-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18938240,2008-10-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18938240,2008-10-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18938240,2008-10-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
18938240,2008-10-01T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
18950044,2008-10-01T00:00:00,Animals,B01.050
18950044,2008-10-01T00:00:00,Larva,B05.500.500
18950044,2008-10-01T00:00:00,Larva,G07.700.320.500.550.500.500
18950044,2008-10-01T00:00:00,Zea mays,B01.650.388.100.822.966
18950044,2008-10-01T00:00:00,Zea mays,J02.500.200.909
18950044,2008-10-01T00:00:00,Zea mays,J02.500.300.100.977
18952588,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
18952588,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
18952588,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
18952588,2008-10-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
18952588,2008-10-01T00:00:00,Animals,B01.050
18952588,2008-10-01T00:00:00,"Antigens, CD147",D12.776.395.550.045
18952588,2008-10-01T00:00:00,"Antigens, CD147",D12.776.543.550.188
18952588,2008-10-01T00:00:00,"Antigens, CD147",D23.050.285.040
18952588,2008-10-01T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
18952588,2008-10-01T00:00:00,"Antigens, CD147",D23.101.100.110.247
18952588,2008-10-01T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18952588,2008-10-01T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18952588,2008-10-01T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18952588,2008-10-01T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18952588,2008-10-01T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18952588,2008-10-01T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18952588,2008-10-01T00:00:00,Astrocytoma,C04.557.465.625.600.380.080
18952588,2008-10-01T00:00:00,Astrocytoma,C04.557.470.670.380.080
18952588,2008-10-01T00:00:00,Astrocytoma,C04.557.580.625.600.380.080
18952588,2008-10-01T00:00:00,Child,M01.060.406
18952588,2008-10-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18952588,2008-10-01T00:00:00,Glioma,C04.557.465.625.600.380
18952588,2008-10-01T00:00:00,Glioma,C04.557.470.670.380
18952588,2008-10-01T00:00:00,Glioma,C04.557.580.625.600.380
18952588,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18952588,2008-10-01T00:00:00,Hyaluronic Acid,D09.698.373.475
18952588,2008-10-01T00:00:00,Neoplasm Proteins,D12.776.624
18952588,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18952589,2008-10-01T00:00:00,Animals,B01.050
18952589,2008-10-01T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18952589,2008-10-01T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18952589,2008-10-01T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18952589,2008-10-01T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18952589,2008-10-01T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18952589,2008-10-01T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18952589,2008-10-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
18952589,2008-10-01T00:00:00,Brain Neoplasms,C10.228.140.211
18952589,2008-10-01T00:00:00,Brain Neoplasms,C10.551.240.250
18952589,2008-10-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
18952589,2008-10-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
18952589,2008-10-01T00:00:00,Down-Regulation,G02.111.087.225
18952589,2008-10-01T00:00:00,Down-Regulation,G02.149.115.225
18952589,2008-10-01T00:00:00,Down-Regulation,G05.355.315.200
18952589,2008-10-01T00:00:00,Down-Regulation,G07.690.812.230
18952589,2008-10-01T00:00:00,Down-Regulation,G07.700.680.230
18952589,2008-10-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18952589,2008-10-01T00:00:00,Extracellular Matrix,A11.284.295.310
18952589,2008-10-01T00:00:00,Glioma,C04.557.465.625.600.380
18952589,2008-10-01T00:00:00,Glioma,C04.557.470.670.380
18952589,2008-10-01T00:00:00,Glioma,C04.557.580.625.600.380
18952589,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18952589,2008-10-01T00:00:00,Hyaluronic Acid,D09.698.373.475
18952589,2008-10-01T00:00:00,Neoplasm Invasiveness,C04.697.645
18952589,2008-10-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18952589,2008-10-01T00:00:00,Neoplastic Stem Cells,A11.872.650
18952589,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18952589,2008-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18952589,2008-10-01T00:00:00,Stem Cells,A11.872
18952589,2008-10-01T00:00:00,"Tumor Markers, Biological",D23.101.840
18971509,2008-10-01T00:00:00,Age Factors,N05.715.350.075
18971509,2008-10-01T00:00:00,Age Factors,N06.850.490.250
18971509,2008-10-01T00:00:00,Attention,F02.830.104.214
18971509,2008-10-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
18971509,2008-10-01T00:00:00,Child,M01.060.406
18971509,2008-10-01T00:00:00,Decision Making,F02.463.785.373
18971509,2008-10-01T00:00:00,Exercise,G11.427.590.237
18971509,2008-10-01T00:00:00,Exercise,I03.350
18971509,2008-10-01T00:00:00,Functional Laterality,F02.830.297.425
18971509,2008-10-01T00:00:00,Functional Laterality,G11.561.225.425
18971509,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18971509,2008-10-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
18971509,2008-10-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
18971509,2008-10-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
18971509,2008-10-01T00:00:00,Psychomotor Performance,F02.808
18971509,2008-10-01T00:00:00,Psychomotor Performance,G11.427.700
18971509,2008-10-01T00:00:00,Psychomotor Performance,G11.561.623
18973565,2008-10-01T00:00:00,Animals,B01.050
18973565,2008-10-01T00:00:00,Gene Transfer Techniques,E05.393.350
18973565,2008-10-01T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
18973565,2008-10-01T00:00:00,Genetic Vectors,G05.360.337
18973565,2008-10-01T00:00:00,Green Fluorescent Proteins,D12.776.532.265
18973565,2008-10-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18973565,2008-10-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18973565,2008-10-01T00:00:00,Narcolepsy,C10.886.425.800.200.750
18973565,2008-10-01T00:00:00,Narcolepsy,F03.870.400.800.200.750
18973565,2008-10-01T00:00:00,Neurons,A08.663
18973565,2008-10-01T00:00:00,Neurons,A11.671
18973565,2008-10-01T00:00:00,Neuropeptides,D12.644.400
18973565,2008-10-01T00:00:00,Neuropeptides,D12.776.641.650
18973565,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18973565,2008-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18973565,2008-10-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
18973565,2008-10-01T00:00:00,Sleep,F02.830.855
18973565,2008-10-01T00:00:00,Sleep,G11.561.600.815
18973565,2008-10-01T00:00:00,Treatment Outcome,E01.789.800
18973565,2008-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18973565,2008-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18973577,2008-10-01T00:00:00,Aging,G07.700.320.124
18973577,2008-10-01T00:00:00,Animals,B01.050
18973577,2008-10-01T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
18973577,2008-10-01T00:00:00,Dopamine,D02.092.211.215.311.342
18973577,2008-10-01T00:00:00,Dopamine,D02.092.311.342
18973577,2008-10-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
18973577,2008-10-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
18973577,2008-10-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
18973577,2008-10-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
18973577,2008-10-01T00:00:00,Motor Activity,F01.145.632
18973577,2008-10-01T00:00:00,Motor Activity,G11.427.590.530.698
18973577,2008-10-01T00:00:00,Neural Pathways,A08.612
18973577,2008-10-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
18973577,2008-10-01T00:00:00,Parkinson Disease,C10.228.662.600.400
18973577,2008-10-01T00:00:00,Parkinson Disease,C10.574.812
18973577,2008-10-01T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
18973577,2008-10-01T00:00:00,Substantia Nigra,A08.186.211.653.822.731
18991878,2008-10-01T00:00:00,Animals,B01.050
18991878,2008-10-01T00:00:00,Apoptosis,G04.299.139.160
18991878,2008-10-01T00:00:00,Calpain,D08.811.277.656.262.500.120
18991878,2008-10-01T00:00:00,Calpain,D08.811.277.656.300.200.120
18991878,2008-10-01T00:00:00,Cell Line,A11.251.210
18991878,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18991878,2008-10-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
18991878,2008-10-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
18991878,2008-10-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
18991878,2008-10-01T00:00:00,Parkinson Disease,C10.228.662.600.400
18991878,2008-10-01T00:00:00,Parkinson Disease,C10.574.812
18991878,2008-10-01T00:00:00,Parkinsonian Disorders,C10.228.140.079.862
18991878,2008-10-01T00:00:00,Parkinsonian Disorders,C10.228.662.600
18991878,2008-10-01T00:00:00,Spinal Cord,A08.186.854
18991878,2008-10-01T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
18991878,2008-10-01T00:00:00,Substantia Nigra,A08.186.211.653.822.731
19011471,2008-10-01T00:00:00,Adolescent,M01.060.057
19011471,2008-10-01T00:00:00,"Histiocytosis, Sinus",C15.604.250.410.450
19011471,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19011471,2008-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19011471,2008-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19011471,2008-10-01T00:00:00,Orbital Diseases,C11.675
19011471,2008-10-01T00:00:00,Salvage Therapy,E02.186.800
19011471,2008-10-01T00:00:00,Salvage Therapy,E02.895
19011471,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19011471,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19011471,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19011471,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19011471,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19011471,2008-10-01T00:00:00,Treatment Outcome,E01.789.800
19011471,2008-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19011471,2008-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19011471,2008-10-01T00:00:00,Vision Disorders,C10.597.751.941
19011471,2008-10-01T00:00:00,Vision Disorders,C11.966
19011471,2008-10-01T00:00:00,Vision Disorders,C23.888.592.763.941
19033736,2008-10-01T00:00:00,Clinical Competence,I02.399.630.210
19033736,2008-10-01T00:00:00,Clinical Competence,N04.761.210
19033736,2008-10-01T00:00:00,Clinical Nursing Research,H02.478.395.234
19033736,2008-10-01T00:00:00,Clinical Nursing Research,N04.590.233.508.613.234
19033736,2008-10-01T00:00:00,Community Networks,I01.880.656.300
19033736,2008-10-01T00:00:00,Community Networks,L01.700.508.300.184
19033736,2008-10-01T00:00:00,Community Networks,N02.421.143.202
19033736,2008-10-01T00:00:00,Community-Institutional Relations,N04.452.822.210
19033736,2008-10-01T00:00:00,Cooperative Behavior,F01.145.813.115
19033736,2008-10-01T00:00:00,Curriculum,I02.158
19033736,2008-10-01T00:00:00,"Education, Nursing, Graduate",I02.358.337.450
19033736,2008-10-01T00:00:00,"Education, Nursing, Graduate",I02.358.462.565
19033736,2008-10-01T00:00:00,Evidence-Based Nursing,H02.249.875
19033736,2008-10-01T00:00:00,Evidence-Based Nursing,H02.478.197
19033736,2008-10-01T00:00:00,Hispanic Americans,M01.686.754.441
19033736,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19033736,2008-10-01T00:00:00,Interinstitutional Relations,N04.452.822.400
19033736,2008-10-01T00:00:00,"Models, Educational",E05.599.545
19033736,2008-10-01T00:00:00,"Models, Educational",I02.903.302
19033736,2008-10-01T00:00:00,Nurse Midwives,M01.526.485.650.620
19033736,2008-10-01T00:00:00,Nurse Midwives,N02.360.650.620
19033736,2008-10-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
19033736,2008-10-01T00:00:00,Nurse's Role,N05.300.100.337
19033736,2008-10-01T00:00:00,Nursing Faculty Practice,N04.452.758.388
19033736,2008-10-01T00:00:00,Program Development,N04.452.760
19033736,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19033736,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19058734,2008-10-01T00:00:00,African Americans,M01.686.508.100.100
19058734,2008-10-01T00:00:00,African Americans,M01.686.754.100
19058734,2008-10-01T00:00:00,Aged,M01.060.116.100
19058734,2008-10-01T00:00:00,Dementia,C10.228.140.380
19058734,2008-10-01T00:00:00,Dementia,F03.087.400
19058734,2008-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19058734,2008-10-01T00:00:00,Health Behavior,F01.145.488
19058734,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19058734,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
19058734,2008-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19058734,2008-10-01T00:00:00,Risk Factors,N05.715.350.200.700
19058734,2008-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19058734,2008-10-01T00:00:00,Risk Factors,N06.850.490.625.750
19058734,2008-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19058734,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19058734,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19073425,2008-10-01T00:00:00,Animals,B01.050
19073425,2008-10-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19073425,2008-10-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
19073425,2008-10-01T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
19073425,2008-10-01T00:00:00,"Extinction, Psychological",F02.463.425.770.232
19073425,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19073425,2008-10-01T00:00:00,"Models, Neurological",E05.599.395.642
19073425,2008-10-01T00:00:00,Neural Pathways,A08.612
19073425,2008-10-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19073425,2008-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19073425,2008-10-01T00:00:00,Substance-Related Disorders,C21.739
19073425,2008-10-01T00:00:00,Substance-Related Disorders,F03.900
19081875,2008-10-01T00:00:00,Hip Fractures,C21.866.404.061.425
19081875,2008-10-01T00:00:00,Hip Fractures,C21.866.404.484
19081875,2008-10-01T00:00:00,Hip Fractures,C21.866.531.750
19081875,2008-10-01T00:00:00,Hip Fractures,C21.866.558.276.425
19081875,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19081875,2008-10-01T00:00:00,Postoperative Complications,C23.550.767
19081875,2008-10-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
19081875,2008-10-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
19090876,2008-10-01T00:00:00,Aged,M01.060.116.100
19090876,2008-10-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
19090876,2008-10-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19090876,2008-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
19090876,2008-10-01T00:00:00,Blood Pressure,G09.330.380.076
19090876,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19090876,2008-10-01T00:00:00,Hypertension,C14.907.489
19090876,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
19090876,2008-10-01T00:00:00,Treatment Outcome,E01.789.800
19090876,2008-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19090876,2008-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19106446,2008-10-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
19106446,2008-10-01T00:00:00,Alzheimer Disease,C10.574.945.249
19106446,2008-10-01T00:00:00,Alzheimer Disease,F03.087.400.100
19106446,2008-10-01T00:00:00,Animals,B01.050
19106446,2008-10-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
19123760,2008-10-01T00:00:00,Adult,M01.060.116
19123760,2008-10-01T00:00:00,Child,M01.060.406
19123760,2008-10-01T00:00:00,Child Abuse,I01.198.240.856.350.250
19123760,2008-10-01T00:00:00,Child Abuse,I01.880.735.900.350.250
19123760,2008-10-01T00:00:00,Child Abuse,I01.880.787.293.292
19123760,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19123760,2008-10-01T00:00:00,Referral and Consultation,N04.452.758.849
19123760,2008-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19128662,2008-10-01T00:00:00,Adrenal Cortex Hormones,D06.472.040
19128662,2008-10-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
19128662,2008-10-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
19128662,2008-10-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
19128662,2008-10-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
19128662,2008-10-01T00:00:00,"Biopsy, Needle",E04.074.119
19128662,2008-10-01T00:00:00,Combined Modality Therapy,E02.186
19128662,2008-10-01T00:00:00,Fibrosis,C23.550.355
19128662,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19128662,2008-10-01T00:00:00,Laryngoscopy,E01.370.386.460
19128662,2008-10-01T00:00:00,Laryngoscopy,E01.370.388.250.525
19128662,2008-10-01T00:00:00,Laryngoscopy,E04.580.373
19128662,2008-10-01T00:00:00,Laryngoscopy,E04.800.250.525
19128662,2008-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19128662,2008-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19128662,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
19128662,2008-10-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
19128662,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19128662,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19128662,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19128662,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19128662,2008-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19410117,2008-10-01T00:00:00,Adolescent,M01.060.057
19410117,2008-10-01T00:00:00,Adult,M01.060.116
19410117,2008-10-01T00:00:00,Bacteria,B03
19410117,2008-10-01T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
19410117,2008-10-01T00:00:00,Child,M01.060.406
19410117,2008-10-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19410117,2008-10-01T00:00:00,Cystic Fibrosis,C06.689.202
19410117,2008-10-01T00:00:00,Cystic Fibrosis,C08.381.187
19410117,2008-10-01T00:00:00,Cystic Fibrosis,C16.320.190
19410117,2008-10-01T00:00:00,Cystic Fibrosis,C16.614.213
19410117,2008-10-01T00:00:00,Endoscopy,E01.370.388.250
19410117,2008-10-01T00:00:00,Endoscopy,E04.800.250
19410117,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19410117,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
19410117,2008-10-01T00:00:00,Paranasal Sinuses,A04.531.621
19421338,2008-10-01T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
19421338,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19421338,2008-10-01T00:00:00,Movement,G07.700.560
19421338,2008-10-01T00:00:00,Movement,G11.427.590.530
19421338,2008-10-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19421338,2008-10-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19421338,2008-10-01T00:00:00,Visual Perception,F02.463.593.932
19463359,2008-10-01T00:00:00,Adult,M01.060.116
19463359,2008-10-01T00:00:00,Aged,M01.060.116.100
19463359,2008-10-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
19463359,2008-10-01T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
19463359,2008-10-01T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
19463359,2008-10-01T00:00:00,Catheterization,E02.148
19463359,2008-10-01T00:00:00,Catheterization,E05.157
19463359,2008-10-01T00:00:00,Coronary Aneurysm,C14.280.647.250.250
19463359,2008-10-01T00:00:00,Coronary Aneurysm,C14.907.055.395
19463359,2008-10-01T00:00:00,Coronary Aneurysm,C14.907.585.250.250
19463359,2008-10-01T00:00:00,Dyspnea,C08.618.326
19463359,2008-10-01T00:00:00,Dyspnea,C23.888.852.371
19463359,2008-10-01T00:00:00,Ethanol,D02.033.375
19463359,2008-10-01T00:00:00,Exercise Tolerance,G11.427.680.270
19463359,2008-10-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
19463359,2008-10-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
19463359,2008-10-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
19463359,2008-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19463359,2008-10-01T00:00:00,Middle Aged,M01.060.116.630
19463359,2008-10-01T00:00:00,Mitral Valve Insufficiency,C14.280.484.461
19463359,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19463359,2008-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19463359,2008-10-01T00:00:00,Treatment Outcome,E01.789.800
19463359,2008-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19463359,2008-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19463359,2008-10-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18832745,2008-10-02T00:00:00,African Continental Ancestry Group,M01.686.508.100
18832745,2008-10-02T00:00:00,Aged,M01.060.116.100
18832745,2008-10-02T00:00:00,Anticoagulants,D27.505.954.502.119
18832745,2008-10-02T00:00:00,"Constriction, Pathologic",C23.300.287
18832745,2008-10-02T00:00:00,Continental Population Groups,M01.686.508
18832745,2008-10-02T00:00:00,European Continental Ancestry Group,M01.686.508.400
18832745,2008-10-02T00:00:00,Hemodynamics,G09.330.190.400
18832745,2008-10-02T00:00:00,Hemodynamics,G09.330.380
18832745,2008-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18832745,2008-10-02T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18832745,2008-10-02T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18832745,2008-10-02T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18832745,2008-10-02T00:00:00,Middle Aged,M01.060.116.630
18832745,2008-10-02T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18832745,2008-10-02T00:00:00,Risk Factors,E05.318.740.600.800.725
18832745,2008-10-02T00:00:00,Risk Factors,N05.715.350.200.700
18832745,2008-10-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18832745,2008-10-02T00:00:00,Risk Factors,N06.850.490.625.750
18832745,2008-10-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18832745,2008-10-02T00:00:00,United States,Z01.107.567.875
18832745,2008-10-02T00:00:00,Warfarin,D03.438.150.446.520.914
18832745,2008-10-02T00:00:00,Warfarin,D03.830.219.446.520.914
18835935,2008-10-03T00:00:00,African Americans,M01.686.508.100.100
18835935,2008-10-03T00:00:00,African Americans,M01.686.754.100
18835935,2008-10-03T00:00:00,"Chromosomes, Human, Pair 3",A11.284.187.520.300.235.250
18835935,2008-10-03T00:00:00,"Chromosomes, Human, Pair 3",G05.360.162.520.300.235.250
18835935,2008-10-03T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18835935,2008-10-03T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18835935,2008-10-03T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18835935,2008-10-03T00:00:00,Genetic Predisposition to Disease,G05.380.355
18835935,2008-10-03T00:00:00,Genome-Wide Association Study,E05.318.416.249
18835935,2008-10-03T00:00:00,Genome-Wide Association Study,E05.318.780.392
18835935,2008-10-03T00:00:00,Genome-Wide Association Study,E05.393.385.500
18835935,2008-10-03T00:00:00,Genome-Wide Association Study,E05.393.522.500
18835935,2008-10-03T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
18835935,2008-10-03T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
18835935,2008-10-03T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
18835935,2008-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18835935,2008-10-03T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18835935,2008-10-03T00:00:00,South Carolina,Z01.107.567.875.075.662
18835935,2008-10-03T00:00:00,South Carolina,Z01.107.567.875.750.700
18838163,2008-10-05T00:00:00,Adsorption,G02.149.047
18838163,2008-10-05T00:00:00,Adsorption,G02.149.767.029
18838163,2008-10-05T00:00:00,Adsorption,G02.842.750.029
18838163,2008-10-05T00:00:00,Adult,M01.060.116
18838163,2008-10-05T00:00:00,Animals,B01.050
18838163,2008-10-05T00:00:00,Cell Adhesion,G04.299.117
18838163,2008-10-05T00:00:00,Cell Proliferation,G04.299.233.750
18838163,2008-10-05T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18838163,2008-10-05T00:00:00,Dermis,A17.815.180
18838163,2008-10-05T00:00:00,Fibroblasts,A11.329.228
18838163,2008-10-05T00:00:00,Fibroblasts,A11.872.228
18838163,2008-10-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18838163,2008-10-05T00:00:00,Magnetics,H01.671.493
18838163,2008-10-05T00:00:00,Nanoparticles,J01.637.512.600
18838163,2008-10-05T00:00:00,Osteoblasts,A11.329.629
18838163,2008-10-05T00:00:00,Polymethyl Methacrylate,D02.241.081.069.800.550.500
18838163,2008-10-05T00:00:00,Polymethyl Methacrylate,D05.750.716.822.111.650.605.500
18838163,2008-10-05T00:00:00,Polymethyl Methacrylate,D25.720.716.822.111.650.605.500
18838163,2008-10-05T00:00:00,Polymethyl Methacrylate,J01.637.051.720.716.822.111.650.605.500
18838163,2008-10-05T00:00:00,Quaternary Ammonium Compounds,D01.625.075
18838163,2008-10-05T00:00:00,Quaternary Ammonium Compounds,D02.092.877
18838163,2008-10-05T00:00:00,Quaternary Ammonium Compounds,D02.675.276
18838163,2008-10-05T00:00:00,Temperature,G01.906.595
18838163,2008-10-05T00:00:00,Temperature,G16.500.275.063.725.710
18838163,2008-10-05T00:00:00,Temperature,G16.500.750.775.710
18838163,2008-10-05T00:00:00,Temperature,N06.230.150.450
18838163,2008-10-05T00:00:00,Temperature,N06.230.300.100.725.710
18840697,2008-10-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18840697,2008-10-07T00:00:00,Judgment,F02.463.785.626
18840697,2008-10-07T00:00:00,Laryngoscopy,E01.370.386.460
18840697,2008-10-07T00:00:00,Laryngoscopy,E01.370.388.250.525
18840697,2008-10-07T00:00:00,Laryngoscopy,E04.580.373
18840697,2008-10-07T00:00:00,Laryngoscopy,E04.800.250.525
18840697,2008-10-07T00:00:00,Phonation,G09.772.770.680
18840697,2008-10-07T00:00:00,Visual Perception,F02.463.593.932
18840697,2008-10-07T00:00:00,Vocal Cords,A04.329.364.737
18840757,2008-10-07T00:00:00,Animals,B01.050
18840757,2008-10-07T00:00:00,Brain,A08.186.211
18840757,2008-10-07T00:00:00,C-Reactive Protein,D12.776.034.145
18840757,2008-10-07T00:00:00,C-Reactive Protein,D12.776.124.050.120
18840757,2008-10-07T00:00:00,C-Reactive Protein,D12.776.124.486.157
18840757,2008-10-07T00:00:00,Cocaine,D02.145.074.722.388
18840757,2008-10-07T00:00:00,Cocaine,D03.132.889.354
18840757,2008-10-07T00:00:00,Cocaine,D03.605.869.388
18840757,2008-10-07T00:00:00,Cocaine,D04.075.080.875.099.722.388
18840757,2008-10-07T00:00:00,Conditioning (Psychology),F02.463.425.179
18840757,2008-10-07T00:00:00,Extracellular Matrix,A11.284.295.310
18840757,2008-10-07T00:00:00,Gene Deletion,G05.355.600.800.320
18840757,2008-10-07T00:00:00,Gene Deletion,G05.365.590.762.320
18840757,2008-10-07T00:00:00,Glutamic Acid,D12.125.067.750
18840757,2008-10-07T00:00:00,Glutamic Acid,D12.125.119.450
18840757,2008-10-07T00:00:00,Glutamic Acid,D12.125.427.300
18840757,2008-10-07T00:00:00,Glycine,D12.125.481
18840757,2008-10-07T00:00:00,Locomotion,G07.700.560.500
18840757,2008-10-07T00:00:00,Locomotion,G11.427.590.530.568
18840757,2008-10-07T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
18840757,2008-10-07T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
18840757,2008-10-07T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
18840757,2008-10-07T00:00:00,Motor Activity,F01.145.632
18840757,2008-10-07T00:00:00,Motor Activity,G11.427.590.530.698
18840757,2008-10-07T00:00:00,Nerve Tissue Proteins,D12.776.641
18840757,2008-10-07T00:00:00,Neurons,A08.663
18840757,2008-10-07T00:00:00,Neurons,A11.671
18840757,2008-10-07T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
18840757,2008-10-07T00:00:00,Synapses,A08.850
18840757,2008-10-07T00:00:00,Synapses,A11.284.149.165.420.780
18955083,2008-10-07T00:00:00,Animals,B01.050
18955083,2008-10-07T00:00:00,Cell Culture Techniques,E05.200.249.249
18955083,2008-10-07T00:00:00,Cell Survival,G04.299.316
18955083,2008-10-07T00:00:00,Electric Stimulation,E05.723.402
18955083,2008-10-07T00:00:00,Nerve Tissue Proteins,D12.776.641
18955083,2008-10-07T00:00:00,Neurons,A08.663
18955083,2008-10-07T00:00:00,Neurons,A11.671
18955083,2008-10-07T00:00:00,Patch-Clamp Techniques,E05.200.500.800
18955083,2008-10-07T00:00:00,Regeneration,G16.100.856
18843260,2008-10-08T00:00:00,Animals,B01.050
18843260,2008-10-08T00:00:00,Apoptosis,G04.299.139.160
18843260,2008-10-08T00:00:00,Cell Proliferation,G04.299.233.750
18843260,2008-10-08T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18843260,2008-10-08T00:00:00,Creatinine,D03.383.129.308.207
18843260,2008-10-08T00:00:00,Kidney,A05.810.453
18843260,2008-10-08T00:00:00,Kidney Tubules,A05.810.453.736.560
18843260,2008-10-08T00:00:00,Monocytes,A11.118.637.555.652
18843260,2008-10-08T00:00:00,Monocytes,A11.148.580
18843260,2008-10-08T00:00:00,Monocytes,A11.627.624
18843260,2008-10-08T00:00:00,Monocytes,A11.733.547
18843260,2008-10-08T00:00:00,Monocytes,A15.145.229.637.555.652
18843260,2008-10-08T00:00:00,Monocytes,A15.378.316.580
18843260,2008-10-08T00:00:00,Monocytes,A15.382.490.555.652
18843260,2008-10-08T00:00:00,Monocytes,A15.382.680.547
18843260,2008-10-08T00:00:00,Monocytes,A15.382.812.547
18843260,2008-10-08T00:00:00,Neutrophils,A11.118.637.415.583
18843260,2008-10-08T00:00:00,Neutrophils,A11.627.340.583
18843260,2008-10-08T00:00:00,Neutrophils,A11.733.689
18843260,2008-10-08T00:00:00,Neutrophils,A15.145.229.637.415.583
18843260,2008-10-08T00:00:00,Neutrophils,A15.382.490.315.583
18843260,2008-10-08T00:00:00,Neutrophils,A15.382.680.689
18843260,2008-10-08T00:00:00,Reperfusion Injury,C14.907.725
18843260,2008-10-08T00:00:00,Reperfusion Injury,C23.550.767.877
18950610,2008-10-08T00:00:00,Diagnostic Errors,E01.354
18950610,2008-10-08T00:00:00,Diagnostic Errors,N02.421.450.280
18950610,2008-10-08T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
18950610,2008-10-08T00:00:00,HIV Seropositivity,C02.800.801.400.500
18950610,2008-10-08T00:00:00,HIV Seropositivity,C20.673.480.500
18950610,2008-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18950610,2008-10-08T00:00:00,Sensitivity and Specificity,E05.318.740.872
18950610,2008-10-08T00:00:00,Sensitivity and Specificity,E05.318.780.800
18950610,2008-10-08T00:00:00,Sensitivity and Specificity,G17.800
18950610,2008-10-08T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18950610,2008-10-08T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18950610,2008-10-08T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18950610,2008-10-08T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18950610,2008-10-08T00:00:00,Young Adult,M01.060.116.815
18842004,2008-10-09T00:00:00,Animals,B01.050
18842004,2008-10-09T00:00:00,Cell Division,G04.299.134.220
18842004,2008-10-09T00:00:00,Cell Division,G04.299.233.750.500
18842004,2008-10-09T00:00:00,Cell Division,G05.355.105
18842004,2008-10-09T00:00:00,Cell Division,G07.700.320.249.410.750.500
18842004,2008-10-09T00:00:00,Cell Line,A11.251.210
18842004,2008-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18842004,2008-10-09T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18842004,2008-10-09T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18842004,2008-10-09T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18842004,2008-10-09T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
18842004,2008-10-09T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
18842004,2008-10-09T00:00:00,"Models, Biological",E05.599.395
18842004,2008-10-09T00:00:00,RNA Interference,G05.355.315.203.374.790
18842004,2008-10-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18842004,2008-10-09T00:00:00,Recombinant Proteins,D12.776.828
18842004,2008-10-09T00:00:00,Signal Transduction,G02.111.087.800
18842004,2008-10-09T00:00:00,Signal Transduction,G02.149.115.800
18842004,2008-10-09T00:00:00,Signal Transduction,G04.299.880
18842004,2008-10-09T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
18843354,2008-10-09T00:00:00,Animals,B01.050
18843354,2008-10-09T00:00:00,Cocaine,D02.145.074.722.388
18843354,2008-10-09T00:00:00,Cocaine,D03.132.889.354
18843354,2008-10-09T00:00:00,Cocaine,D03.605.869.388
18843354,2008-10-09T00:00:00,Cocaine,D04.075.080.875.099.722.388
18843354,2008-10-09T00:00:00,Cocaine-Related Disorders,C21.739.300
18843354,2008-10-09T00:00:00,Cocaine-Related Disorders,F03.900.300
18843354,2008-10-09T00:00:00,Dendrites,A08.663.256
18843354,2008-10-09T00:00:00,Dendrites,A11.284.180.225
18843354,2008-10-09T00:00:00,Dendrites,A11.671.240
18843354,2008-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18843354,2008-10-09T00:00:00,Neuronal Plasticity,G11.561.600.635
18843354,2008-10-09T00:00:00,Synapses,A08.850
18843354,2008-10-09T00:00:00,Synapses,A11.284.149.165.420.780
18843354,2008-10-09T00:00:00,Transcription Factors,D12.776.930
18640916,2008-10-12T00:00:00,Animals,B01.050
18640916,2008-10-12T00:00:00,Brain Mapping,E01.370.350.086
18640916,2008-10-12T00:00:00,Brain Mapping,E01.370.376.149
18640916,2008-10-12T00:00:00,Brain Mapping,E05.132
18640916,2008-10-12T00:00:00,Cocaine,D02.145.074.722.388
18640916,2008-10-12T00:00:00,Cocaine,D03.132.889.354
18640916,2008-10-12T00:00:00,Cocaine,D03.605.869.388
18640916,2008-10-12T00:00:00,Cocaine,D04.075.080.875.099.722.388
18640916,2008-10-12T00:00:00,Cognition,F02.463.188
18640916,2008-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18640916,2008-10-12T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18640916,2008-10-12T00:00:00,Substance-Related Disorders,C21.739
18640916,2008-10-12T00:00:00,Substance-Related Disorders,F03.900
18852244,2008-10-13T00:00:00,Amino Acid Sequence,G02.111.570.060
18852244,2008-10-13T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18852244,2008-10-13T00:00:00,Animals,B01.050
18852244,2008-10-13T00:00:00,Molecular Sequence Data,L01.453.245.667
18852244,2008-10-13T00:00:00,Rabbits,B01.050.150.900.649.521.700
18852244,2008-10-13T00:00:00,Recombinant Proteins,D12.776.828
18852295,2008-10-13T00:00:00,Animals,B01.050
18852295,2008-10-13T00:00:00,Apoptosis,G04.299.139.160
18852295,2008-10-13T00:00:00,Cell Cycle Proteins,D12.776.167
18852295,2008-10-13T00:00:00,Chromosome Aberrations,C23.550.210
18852295,2008-10-13T00:00:00,Chromosome Aberrations,G05.365.590.175
18852295,2008-10-13T00:00:00,DNA Damage,C21.111
18852295,2008-10-13T00:00:00,DNA Damage,G05.355.180
18852295,2008-10-13T00:00:00,DNA-Binding Proteins,D12.776.260
18852295,2008-10-13T00:00:00,Fibroblasts,A11.329.228
18852295,2008-10-13T00:00:00,Fibroblasts,A11.872.228
18852295,2008-10-13T00:00:00,Gamma Rays,G01.201.875.750.400
18852295,2008-10-13T00:00:00,Gene Expression Regulation,G05.355.315
18852295,2008-10-13T00:00:00,Histones,D12.776.660.470
18852295,2008-10-13T00:00:00,Histones,D12.776.664.469
18852295,2008-10-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18852295,2008-10-13T00:00:00,Nerve Tissue Proteins,D12.776.641
18852295,2008-10-13T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
18852295,2008-10-13T00:00:00,"Recombination, Genetic",G05.355.760
18852295,2008-10-13T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
18852295,2008-10-13T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
18852295,2008-10-13T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
18852295,2008-10-13T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
18852295,2008-10-13T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
18951974,2008-10-14T00:00:00,Binding Sites,G02.111.570.120
18951974,2008-10-14T00:00:00,Breast Neoplasms,C04.588.180
18951974,2008-10-14T00:00:00,Breast Neoplasms,C17.800.090.500
18951974,2008-10-14T00:00:00,Epidermal Growth Factor,D06.472.317.350
18951974,2008-10-14T00:00:00,Epidermal Growth Factor,D12.644.276.561
18951974,2008-10-14T00:00:00,Epidermal Growth Factor,D12.776.467.561
18951974,2008-10-14T00:00:00,Epidermal Growth Factor,D23.529.561
18951974,2008-10-14T00:00:00,Glycoproteins,D09.400.430
18951974,2008-10-14T00:00:00,Glycoproteins,D12.776.395
18951974,2008-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18951974,2008-10-14T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
18951974,2008-10-14T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
18951974,2008-10-14T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
18951974,2008-10-14T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
18951974,2008-10-14T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
18951974,2008-10-14T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
18951974,2008-10-14T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
18726893,2008-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18726893,2008-10-15T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18726893,2008-10-15T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18726893,2008-10-15T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18726893,2008-10-15T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18726893,2008-10-15T00:00:00,Ovarian Neoplasms,C04.588.322.455
18726893,2008-10-15T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
18726893,2008-10-15T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
18726893,2008-10-15T00:00:00,Ovarian Neoplasms,C19.344.410
18726893,2008-10-15T00:00:00,Ovarian Neoplasms,C19.391.630.705
18821661,2008-10-15T00:00:00,Adolescent,M01.060.057
18821661,2008-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18821661,2008-10-15T00:00:00,Peer Group,F01.829.316.483
18821661,2008-10-15T00:00:00,Questionnaires,E05.318.308.750
18821661,2008-10-15T00:00:00,Questionnaires,L01.280.800
18821661,2008-10-15T00:00:00,Questionnaires,N05.715.360.300.695
18821661,2008-10-15T00:00:00,Questionnaires,N06.850.520.308.750
18821661,2008-10-15T00:00:00,Risk Factors,E05.318.740.600.800.725
18821661,2008-10-15T00:00:00,Risk Factors,N05.715.350.200.700
18821661,2008-10-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18821661,2008-10-15T00:00:00,Risk Factors,N06.850.490.625.750
18821661,2008-10-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18821661,2008-10-15T00:00:00,Self Concept,F01.752.747.792
18855050,2008-10-15T00:00:00,"Data Interpretation, Statistical",E05.245.380
18855050,2008-10-15T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18855050,2008-10-15T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18855050,2008-10-15T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18855050,2008-10-15T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18855050,2008-10-15T00:00:00,Deglutition,G10.261.326.215
18855050,2008-10-15T00:00:00,Deglutition Disorders,C06.405.117.119
18855050,2008-10-15T00:00:00,Deglutition Disorders,C09.775.174
18855050,2008-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18855050,2008-10-15T00:00:00,Regression Analysis,E05.318.740.750
18855050,2008-10-15T00:00:00,Regression Analysis,N05.715.360.750.695
18855050,2008-10-15T00:00:00,Regression Analysis,N06.850.520.830.750
18855050,2008-10-15T00:00:00,United States,Z01.107.567.875
18922924,2008-10-15T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
18922924,2008-10-15T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
18922924,2008-10-15T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
18922924,2008-10-15T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
18922924,2008-10-15T00:00:00,Breast Neoplasms,C04.588.180
18922924,2008-10-15T00:00:00,Breast Neoplasms,C17.800.090.500
18922924,2008-10-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18922924,2008-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18922924,2008-10-15T00:00:00,MicroRNAs,D13.150.650.319
18922924,2008-10-15T00:00:00,MicroRNAs,D13.444.735.150.319
18922924,2008-10-15T00:00:00,MicroRNAs,D13.444.735.790.099
18922924,2008-10-15T00:00:00,Phenotype,G05.695
18922924,2008-10-15T00:00:00,Protein Biosynthesis,G02.111.087.675.871
18922924,2008-10-15T00:00:00,Protein Biosynthesis,G02.149.115.675.871
18922924,2008-10-15T00:00:00,Protein Biosynthesis,G03.495.770.871
18922924,2008-10-15T00:00:00,Protein Biosynthesis,G05.355.310.670
18922924,2008-10-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
18922924,2008-10-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
18922924,2008-10-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
18922924,2008-10-15T00:00:00,"RNA, Messenger",D13.444.735.544
18923152,2008-10-15T00:00:00,Animals,B01.050
18923152,2008-10-15T00:00:00,Cell Differentiation,G04.299.151
18923152,2008-10-15T00:00:00,Cell Movement,G04.299.283
18923152,2008-10-15T00:00:00,Cell Movement,G07.700.560.500.180
18923152,2008-10-15T00:00:00,"Embryo, Nonmammalian",A13.350
18923152,2008-10-15T00:00:00,"Embryo, Nonmammalian",A16.331
18923152,2008-10-15T00:00:00,Endocardium,A07.541.207
18923152,2008-10-15T00:00:00,Epithelial Cells,A11.436
18923152,2008-10-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
18923152,2008-10-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
18923152,2008-10-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
18923152,2008-10-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
18923152,2008-10-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
18923152,2008-10-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
18923152,2008-10-15T00:00:00,Mesoderm,A16.504.660
18923152,2008-10-15T00:00:00,Morphogenesis,G07.700.320.500
18927447,2008-10-16T00:00:00,Aged,M01.060.116.100
18927447,2008-10-16T00:00:00,Brain Infarction,C10.228.140.300.150.477
18927447,2008-10-16T00:00:00,Brain Infarction,C10.228.140.300.775.200
18927447,2008-10-16T00:00:00,Brain Infarction,C14.907.253.092.477
18927447,2008-10-16T00:00:00,Brain Infarction,C14.907.253.855.200
18927447,2008-10-16T00:00:00,Brain Ischemia,C10.228.140.300.150
18927447,2008-10-16T00:00:00,Brain Ischemia,C14.907.253.092
18927447,2008-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18927447,2008-10-16T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18927447,2008-10-16T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18927447,2008-10-16T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18927447,2008-10-16T00:00:00,Middle Aged,M01.060.116.630
18927447,2008-10-16T00:00:00,Postoperative Complications,C23.550.767
18927447,2008-10-16T00:00:00,Stents,E07.695.750
18927447,2008-10-16T00:00:00,Treatment Outcome,E01.789.800
18927447,2008-10-16T00:00:00,Treatment Outcome,N04.761.559.590.800
18927447,2008-10-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18925400,2008-10-17T00:00:00,Adolescent,M01.060.057
18925400,2008-10-17T00:00:00,Adult,M01.060.116
18925400,2008-10-17T00:00:00,Aged,M01.060.116.100
18925400,2008-10-17T00:00:00,Calcium,D01.268.552.100
18925400,2008-10-17T00:00:00,Calcium,D01.552.539.288
18925400,2008-10-17T00:00:00,Calcium,D23.119.100
18925400,2008-10-17T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18925400,2008-10-17T00:00:00,Coronary Angiography,E01.370.370.050.200
18925400,2008-10-17T00:00:00,Coronary Angiography,E01.370.370.380.200
18925400,2008-10-17T00:00:00,Coronary Artery Bypass,E04.100.376.719.332
18925400,2008-10-17T00:00:00,Coronary Artery Bypass,E04.928.220.520.220
18925400,2008-10-17T00:00:00,Heart,A07.541
18925400,2008-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18925400,2008-10-17T00:00:00,Middle Aged,M01.060.116.630
18925400,2008-10-17T00:00:00,Myocardium,A02.633.580
18925400,2008-10-17T00:00:00,Myocardium,A07.541.704
18925400,2008-10-17T00:00:00,Myocardium,A10.690.552.750
18925400,2008-10-17T00:00:00,Pulmonary Veins,A07.231.908.713
18925400,2008-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18925400,2008-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18925400,2008-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18925400,2008-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18925400,2008-10-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18928257,2008-10-17T00:00:00,Cobalt,D01.268.556.185
18928257,2008-10-17T00:00:00,Cobalt,D01.268.956.155
18928257,2008-10-17T00:00:00,Cobalt,D01.552.544.185
18928257,2008-10-17T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
18928257,2008-10-17T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
18928257,2008-10-17T00:00:00,Nickel,D01.268.556.607
18928257,2008-10-17T00:00:00,Nickel,D01.268.956.625
18928257,2008-10-17T00:00:00,Nickel,D01.552.544.607
18928257,2008-10-17T00:00:00,Nitric Oxide,D01.339.387
18928257,2008-10-17T00:00:00,Nitric Oxide,D01.625.550.500
18928257,2008-10-17T00:00:00,Nitric Oxide,D01.625.700.500
18928257,2008-10-17T00:00:00,Nitric Oxide,D01.650.550.587.600
18928257,2008-10-17T00:00:00,Organometallic Compounds,D01.632
18928257,2008-10-17T00:00:00,Organometallic Compounds,D02.691
19101240,2008-10-17T00:00:00,Adolescent,M01.060.057
19101240,2008-10-17T00:00:00,Adult,M01.060.116
19101240,2008-10-17T00:00:00,Biological Markers,D23.101
19101240,2008-10-17T00:00:00,Cardiovascular Diseases,C14
19101240,2008-10-17T00:00:00,Child,M01.060.406
19101240,2008-10-17T00:00:00,Exercise,G11.427.590.237
19101240,2008-10-17T00:00:00,Exercise,I03.350
19101240,2008-10-17T00:00:00,Exercise Test,E01.370.370.380.250
19101240,2008-10-17T00:00:00,Exercise Test,E01.370.386.700.250
19101240,2008-10-17T00:00:00,Exercise Test,E05.333.250
19101240,2008-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19101240,2008-10-17T00:00:00,Risk Factors,E05.318.740.600.800.725
19101240,2008-10-17T00:00:00,Risk Factors,N05.715.350.200.700
19101240,2008-10-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19101240,2008-10-17T00:00:00,Risk Factors,N06.850.490.625.750
19101240,2008-10-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19101240,2008-10-17T00:00:00,Young Adult,M01.060.116.815
18930185,2008-10-18T00:00:00,Adolescent,M01.060.057
18930185,2008-10-18T00:00:00,Adult,M01.060.116
18930185,2008-10-18T00:00:00,African Americans,M01.686.508.100.100
18930185,2008-10-18T00:00:00,African Americans,M01.686.754.100
18930185,2008-10-18T00:00:00,Aged,M01.060.116.100
18930185,2008-10-18T00:00:00,Alcoholism,C21.739.100.250
18930185,2008-10-18T00:00:00,Alcoholism,F03.900.100.350
18930185,2008-10-18T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18930185,2008-10-18T00:00:00,Genetic Predisposition to Disease,G05.380.355
18930185,2008-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18930185,2008-10-18T00:00:00,Middle Aged,M01.060.116.630
18930185,2008-10-18T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18930185,2008-10-18T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
18930185,2008-10-18T00:00:00,Young Adult,M01.060.116.815
18936471,2008-10-20T00:00:00,Adult,M01.060.116
18936471,2008-10-20T00:00:00,Aged,M01.060.116.100
18936471,2008-10-20T00:00:00,Alleles,G05.360.340.024.340.030
18936471,2008-10-20T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
18936471,2008-10-20T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
18936471,2008-10-20T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
18936471,2008-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18936471,2008-10-20T00:00:00,Lung Neoplasms,C04.588.894.797.520
18936471,2008-10-20T00:00:00,Lung Neoplasms,C08.381.540
18936471,2008-10-20T00:00:00,Lung Neoplasms,C08.785.520
18936471,2008-10-20T00:00:00,Middle Aged,M01.060.116.630
18936471,2008-10-20T00:00:00,"Polymorphism, Genetic",G05.365.795
18936471,2008-10-20T00:00:00,Vitamin D,D04.808.812.768
18940895,2008-10-21T00:00:00,Adult,M01.060.116
18940895,2008-10-21T00:00:00,Environmental Exposure,N06.850.460.350
18940895,2008-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18940895,2008-10-21T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
18940895,2008-10-21T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
18940895,2008-10-21T00:00:00,Pregnancy,G08.686.785.760.769
19021836,2008-10-21T00:00:00,Adolescent,M01.060.057
19021836,2008-10-21T00:00:00,Adult,M01.060.116
19021836,2008-10-21T00:00:00,Aged,M01.060.116.100
19021836,2008-10-21T00:00:00,Brain,A08.186.211
19021836,2008-10-21T00:00:00,Brain Ischemia,C10.228.140.300.150
19021836,2008-10-21T00:00:00,Brain Ischemia,C14.907.253.092
19021836,2008-10-21T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
19021836,2008-10-21T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
19021836,2008-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19021836,2008-10-21T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
19021836,2008-10-21T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
19021836,2008-10-21T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
19021836,2008-10-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19021836,2008-10-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19021836,2008-10-21T00:00:00,Middle Aged,M01.060.116.630
19021836,2008-10-21T00:00:00,Risk Factors,E05.318.740.600.800.725
19021836,2008-10-21T00:00:00,Risk Factors,N05.715.350.200.700
19021836,2008-10-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19021836,2008-10-21T00:00:00,Risk Factors,N06.850.490.625.750
19021836,2008-10-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19021836,2008-10-21T00:00:00,Treatment Outcome,E01.789.800
19021836,2008-10-21T00:00:00,Treatment Outcome,N04.761.559.590.800
19021836,2008-10-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19021836,2008-10-21T00:00:00,Young Adult,M01.060.116.815
18945876,2008-10-22T00:00:00,Alkaline Ceramidase,D08.811.277.087.250.300
18945876,2008-10-22T00:00:00,Cell Adhesion,G04.299.117
18945876,2008-10-22T00:00:00,Down-Regulation,G02.111.087.225
18945876,2008-10-22T00:00:00,Down-Regulation,G02.149.115.225
18945876,2008-10-22T00:00:00,Down-Regulation,G05.355.315.200
18945876,2008-10-22T00:00:00,Down-Regulation,G07.690.812.230
18945876,2008-10-22T00:00:00,Down-Regulation,G07.700.680.230
18945876,2008-10-22T00:00:00,Extracellular Matrix,A11.284.295.310
18945876,2008-10-22T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
18945876,2008-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18945876,2008-10-22T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
18945876,2008-10-22T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
18945876,2008-10-22T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
18945876,2008-10-22T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
18945876,2008-10-22T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
18945876,2008-10-22T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
18945876,2008-10-22T00:00:00,Protein Transport,G03.495.166.700
18945876,2008-10-22T00:00:00,Signal Transduction,G02.111.087.800
18945876,2008-10-22T00:00:00,Signal Transduction,G02.149.115.800
18945876,2008-10-22T00:00:00,Signal Transduction,G04.299.880
18945876,2008-10-22T00:00:00,Sphingosine,D02.033.100.700
18945876,2008-10-22T00:00:00,Sphingosine,D02.033.455.843
18945876,2008-10-22T00:00:00,Sphingosine,D02.092.063.700
18947837,2008-10-22T00:00:00,Aging,G07.700.320.124
18947837,2008-10-22T00:00:00,Biological Markers,D23.101
18947837,2008-10-22T00:00:00,Bipolar Disorder,F03.600.150.150
18947837,2008-10-22T00:00:00,"Brain Diseases, Metabolic",C10.228.140.163
18947837,2008-10-22T00:00:00,"Brain Diseases, Metabolic",C18.452.132
18947837,2008-10-22T00:00:00,Brain Mapping,E01.370.350.086
18947837,2008-10-22T00:00:00,Brain Mapping,E01.370.376.149
18947837,2008-10-22T00:00:00,Brain Mapping,E05.132
18947837,2008-10-22T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18947837,2008-10-22T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
18947837,2008-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18947837,2008-10-22T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18947837,2008-10-22T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
18947837,2008-10-22T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
18947837,2008-10-22T00:00:00,Limbic System,A08.186.211.464
18947837,2008-10-22T00:00:00,Middle Aged,M01.060.116.630
18947837,2008-10-22T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18947837,2008-10-22T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18947837,2008-10-22T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18947837,2008-10-22T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18947837,2008-10-22T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18947837,2008-10-22T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
18947857,2008-10-22T00:00:00,Aging,G07.700.320.124
18947857,2008-10-22T00:00:00,Agriculture,J01.040
18947857,2008-10-22T00:00:00,Animals,B01.050
18947857,2008-10-22T00:00:00,Environmental Monitoring,N06.850.460.350.080
18947857,2008-10-22T00:00:00,Environmental Monitoring,N06.850.780.375
18947857,2008-10-22T00:00:00,Environmental Pollutants,D27.888.284
18947857,2008-10-22T00:00:00,Kidney,A05.810.453
18976682,2008-10-22T00:00:00,Adolescent,M01.060.057
18976682,2008-10-22T00:00:00,Adult,M01.060.116
18976682,2008-10-22T00:00:00,Aged,M01.060.116.100
18976682,2008-10-22T00:00:00,Attention,F02.830.104.214
18976682,2008-10-22T00:00:00,Bipolar Disorder,F03.600.150.150
18976682,2008-10-22T00:00:00,Cognition,F02.463.188
18976682,2008-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18976682,2008-10-22T00:00:00,Intelligence,F01.752.543
18976682,2008-10-22T00:00:00,Middle Aged,M01.060.116.630
18976682,2008-10-22T00:00:00,Neuropsychological Tests,F04.711.513
18976682,2008-10-22T00:00:00,Psychiatric Status Rating Scales,F04.586
18976682,2008-10-22T00:00:00,Psychomotor Performance,F02.808
18976682,2008-10-22T00:00:00,Psychomotor Performance,G11.427.700
18976682,2008-10-22T00:00:00,Psychomotor Performance,G11.561.623
18976682,2008-10-22T00:00:00,Smoking,F01.145.466.753
18976682,2008-10-22T00:00:00,Young Adult,M01.060.116.815
18977314,2008-10-22T00:00:00,Algorithms,G17.035
18977314,2008-10-22T00:00:00,Algorithms,L01.224.050
18977314,2008-10-22T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18977314,2008-10-22T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18977314,2008-10-22T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18977314,2008-10-22T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18977314,2008-10-22T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18977314,2008-10-22T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18977314,2008-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18977314,2008-10-22T00:00:00,Mass Screening,E01.370.500
18977314,2008-10-22T00:00:00,Mass Screening,E05.318.308.250.580
18977314,2008-10-22T00:00:00,Mass Screening,N02.421.143.827.233.443
18977314,2008-10-22T00:00:00,Mass Screening,N02.421.726.233.443
18977314,2008-10-22T00:00:00,Mass Screening,N05.715.360.300.375.500
18977314,2008-10-22T00:00:00,Mass Screening,N06.850.520.308.250.580
18977314,2008-10-22T00:00:00,Mass Screening,N06.850.780.500
18977314,2008-10-22T00:00:00,Primary Health Care,N04.590.233.727
18977314,2008-10-22T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18977314,2008-10-22T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18977314,2008-10-22T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18977314,2008-10-22T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19337501,2008-10-22T00:00:00,Clinical Laboratory Techniques,E05.200
19337501,2008-10-22T00:00:00,Endocrine Disruptors,D27.505.696.353
19337501,2008-10-22T00:00:00,Endocrine Disruptors,D27.888.284.295
19337501,2008-10-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
19337501,2008-10-22T00:00:00,Risk Assessment,N04.452.871.715
19337501,2008-10-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19337501,2008-10-22T00:00:00,Risk Assessment,N06.850.505.715
19337501,2008-10-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18947406,2008-10-23T00:00:00,Animals,B01.050
18947406,2008-10-23T00:00:00,Apoptosis,G04.299.139.160
18947406,2008-10-23T00:00:00,Brain,A08.186.211
18947406,2008-10-23T00:00:00,Brain Infarction,C10.228.140.300.150.477
18947406,2008-10-23T00:00:00,Brain Infarction,C10.228.140.300.775.200
18947406,2008-10-23T00:00:00,Brain Infarction,C14.907.253.092.477
18947406,2008-10-23T00:00:00,Brain Infarction,C14.907.253.855.200
18947406,2008-10-23T00:00:00,Brain Ischemia,C10.228.140.300.150
18947406,2008-10-23T00:00:00,Brain Ischemia,C14.907.253.092
18947406,2008-10-23T00:00:00,Encephalitis,C02.182.500
18947406,2008-10-23T00:00:00,Encephalitis,C10.228.140.430
18947406,2008-10-23T00:00:00,Encephalitis,C10.228.228.210.150
18947406,2008-10-23T00:00:00,Encephalitis,C10.228.228.245
18947406,2008-10-23T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
18947406,2008-10-23T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
18947406,2008-10-23T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
18947406,2008-10-23T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
18947406,2008-10-23T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
18947406,2008-10-23T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
18947406,2008-10-23T00:00:00,Microcirculation,G09.330.190.163.645
18947406,2008-10-23T00:00:00,Neurons,A08.663
18947406,2008-10-23T00:00:00,Neurons,A11.671
18947406,2008-10-23T00:00:00,"RNA, Messenger",D13.444.735.544
18947406,2008-10-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18947406,2008-10-23T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18947406,2008-10-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18948368,2008-10-23T00:00:00,Heart Arrest,C14.280.383
18948368,2008-10-23T00:00:00,Heart Diseases,C14.280
18948368,2008-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18948368,2008-10-23T00:00:00,Reperfusion Injury,C14.907.725
18948368,2008-10-23T00:00:00,Reperfusion Injury,C23.550.767.877
18948368,2008-10-23T00:00:00,Resuscitation,E02.365.647
18948368,2008-10-23T00:00:00,Syndrome,C23.550.288.500
18948614,2008-10-23T00:00:00,Adult,M01.060.116
18948614,2008-10-23T00:00:00,Aged,M01.060.116.100
18948614,2008-10-23T00:00:00,Biological Markers,D23.101
18948614,2008-10-23T00:00:00,Brain Ischemia,C10.228.140.300.150
18948614,2008-10-23T00:00:00,Brain Ischemia,C14.907.253.092
18948614,2008-10-23T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
18948614,2008-10-23T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
18948614,2008-10-23T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
18948614,2008-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18948614,2008-10-23T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
18948614,2008-10-23T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
18948614,2008-10-23T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
18948614,2008-10-23T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
18948614,2008-10-23T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
18948614,2008-10-23T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
18948614,2008-10-23T00:00:00,Middle Aged,M01.060.116.630
18948614,2008-10-23T00:00:00,S100 Proteins,D12.776.157.125.750
18948614,2008-10-23T00:00:00,S100 Proteins,D12.776.641.655
18948614,2008-10-23T00:00:00,Stroke,C10.228.140.300.775
18948614,2008-10-23T00:00:00,Stroke,C14.907.253.855
18948614,2008-10-23T00:00:00,Young Adult,M01.060.116.815
18948969,2008-10-23T00:00:00,Alleles,G05.360.340.024.340.030
18948969,2008-10-23T00:00:00,Animals,B01.050
18948969,2008-10-23T00:00:00,DNA,D13.444.308
18948969,2008-10-23T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18948969,2008-10-23T00:00:00,Genetic Predisposition to Disease,G05.380.355
18948969,2008-10-23T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
18948969,2008-10-23T00:00:00,Mutation,G05.365.590
18948969,2008-10-23T00:00:00,Obesity,C18.654.726.500
18948969,2008-10-23T00:00:00,Obesity,C23.888.144.699.500
18948969,2008-10-23T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18948969,2008-10-23T00:00:00,Obesity,G07.100.100.160.120.699.500
18948969,2008-10-23T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18949442,2008-10-24T00:00:00,"Hernia, Ventral",C23.300.707.374.937
18949442,2008-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18949442,2008-10-24T00:00:00,Laparoscopy,E01.370.388.250.520
18949442,2008-10-24T00:00:00,Laparoscopy,E04.800.250.520
18949442,2008-10-24T00:00:00,Middle Aged,M01.060.116.630
18949442,2008-10-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18949442,2008-10-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18949442,2008-10-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18949442,2008-10-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18949442,2008-10-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18952894,2008-10-24T00:00:00,Animals,B01.050
18952894,2008-10-24T00:00:00,Cell Differentiation,G04.299.151
18952894,2008-10-24T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18952894,2008-10-24T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18952894,2008-10-24T00:00:00,Osteoblasts,A11.329.629
18952894,2008-10-24T00:00:00,Osteoclasts,A11.329.372.700
18952894,2008-10-24T00:00:00,Osteoclasts,A11.627.482.700
18952894,2008-10-24T00:00:00,RANK Ligand,D12.644.276.374.750.562
18952894,2008-10-24T00:00:00,RANK Ligand,D12.644.276.972.562
18952894,2008-10-24T00:00:00,RANK Ligand,D12.776.467.374.750.562
18952894,2008-10-24T00:00:00,RANK Ligand,D12.776.467.972.562
18952894,2008-10-24T00:00:00,RANK Ligand,D23.529.374.750.562
18952894,2008-10-24T00:00:00,RANK Ligand,D23.529.972.562
18952894,2008-10-24T00:00:00,Stem Cells,A11.872
18952940,2008-10-24T00:00:00,Communicable Diseases,C01.539.221
18952940,2008-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18952940,2008-10-24T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
18952940,2008-10-24T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
18952940,2008-10-24T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
18952940,2008-10-24T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
18952940,2008-10-24T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
18952940,2008-10-24T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
18952940,2008-10-24T00:00:00,United States,Z01.107.567.875
18953021,2008-10-24T00:00:00,Animals,B01.050
18953021,2008-10-24T00:00:00,Enzyme Inhibitors,D27.505.519.389
18953021,2008-10-24T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
18953021,2008-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18953021,2008-10-24T00:00:00,Huntington Disease,C10.228.140.079.545
18953021,2008-10-24T00:00:00,Huntington Disease,C10.228.140.380.278
18953021,2008-10-24T00:00:00,Huntington Disease,C10.228.662.262.249.750
18953021,2008-10-24T00:00:00,Huntington Disease,C10.574.500.497
18953021,2008-10-24T00:00:00,Huntington Disease,C16.320.400.430
18953021,2008-10-24T00:00:00,Huntington Disease,F03.087.250.400
18953021,2008-10-24T00:00:00,Huntington Disease,F03.087.400.390
18953021,2008-10-24T00:00:00,Neoplasm Proteins,D12.776.624
18953021,2008-10-24T00:00:00,Neoplasms,C04
19007381,2008-10-24T00:00:00,Adult,M01.060.116
19007381,2008-10-24T00:00:00,Aged,M01.060.116.100
19007381,2008-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19007381,2008-10-24T00:00:00,Middle Aged,M01.060.116.630
19007381,2008-10-24T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
19007381,2008-10-24T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
19007381,2008-10-24T00:00:00,Prostatectomy,E04.950.774.860.625
19007381,2008-10-24T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19007381,2008-10-24T00:00:00,Prostatic Neoplasms,C12.294.260.750
19007381,2008-10-24T00:00:00,Prostatic Neoplasms,C12.294.565.625
19007381,2008-10-24T00:00:00,Prostatic Neoplasms,C12.758.409.750
19007381,2008-10-24T00:00:00,Risk Factors,E05.318.740.600.800.725
19007381,2008-10-24T00:00:00,Risk Factors,N05.715.350.200.700
19007381,2008-10-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19007381,2008-10-24T00:00:00,Risk Factors,N06.850.490.625.750
19007381,2008-10-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18952364,2008-10-26T00:00:00,Adult,M01.060.116
18952364,2008-10-26T00:00:00,Aged,M01.060.116.100
18952364,2008-10-26T00:00:00,Diastole,G09.330.190.541.295
18952364,2008-10-26T00:00:00,Diastole,G11.427.590.540.554.250
18952364,2008-10-26T00:00:00,Diastole,G11.427.590.540.570.295
18952364,2008-10-26T00:00:00,Heart Ventricles,A07.541.560
18952364,2008-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18952364,2008-10-26T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
18952364,2008-10-26T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
18952364,2008-10-26T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
18952364,2008-10-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18952364,2008-10-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18952364,2008-10-26T00:00:00,Myocardial Infarction,C14.280.647.500
18952364,2008-10-26T00:00:00,Myocardial Infarction,C14.907.585.500
18952364,2008-10-26T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18953693,2008-10-26T00:00:00,Adult,M01.060.116
18953693,2008-10-26T00:00:00,Breast Neoplasms,C04.588.180
18953693,2008-10-26T00:00:00,Breast Neoplasms,C17.800.090.500
18953693,2008-10-26T00:00:00,Case-Control Studies,E05.318.760.500.500
18953693,2008-10-26T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18953693,2008-10-26T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18953693,2008-10-26T00:00:00,Demography,I01.240
18953693,2008-10-26T00:00:00,Demography,N01.224
18953693,2008-10-26T00:00:00,Demography,N06.850.505.400
18953693,2008-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18953693,2008-10-26T00:00:00,Incidence,E05.318.308.985.525.375
18953693,2008-10-26T00:00:00,Incidence,L01.280.975.525.375
18953693,2008-10-26T00:00:00,Incidence,N01.224.935.597.500
18953693,2008-10-26T00:00:00,Incidence,N06.850.505.400.975.525.375
18953693,2008-10-26T00:00:00,Incidence,N06.850.520.308.985.525.375
18953693,2008-10-26T00:00:00,Middle Aged,M01.060.116.630
18953693,2008-10-26T00:00:00,New York,Z01.107.567.875.075.437
18953693,2008-10-26T00:00:00,New York,Z01.107.567.875.350.530
18953693,2008-10-26T00:00:00,New York,Z01.107.567.875.500.530
18953693,2008-10-26T00:00:00,Risk Factors,E05.318.740.600.800.725
18953693,2008-10-26T00:00:00,Risk Factors,N05.715.350.200.700
18953693,2008-10-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18953693,2008-10-26T00:00:00,Risk Factors,N06.850.490.625.750
18953693,2008-10-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18953693,2008-10-26T00:00:00,Smoking,F01.145.466.753
18953693,2008-10-26T00:00:00,Tonsillectomy,E04.580.848
18955019,2008-10-26T00:00:00,Brachytherapy,E02.815.150
18955019,2008-10-26T00:00:00,Breast Neoplasms,C04.588.180
18955019,2008-10-26T00:00:00,Breast Neoplasms,C17.800.090.500
18955019,2008-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18955019,2008-10-26T00:00:00,Middle Aged,M01.060.116.630
18955019,2008-10-26T00:00:00,Osteoporosis,C05.116.198.579
18955019,2008-10-26T00:00:00,Radiation Injuries,C21.866.733
18955019,2008-10-26T00:00:00,Radiation Injuries,N06.850.810.300.360
18955380,2008-10-27T00:00:00,Adult,M01.060.116
18955380,2008-10-27T00:00:00,Anoxia,C23.888.852.079
18955380,2008-10-27T00:00:00,Blood Pressure,E01.370.600.875.249
18955380,2008-10-27T00:00:00,Blood Pressure,G09.330.380.076
18955380,2008-10-27T00:00:00,Cross-Over Studies,E05.318.780.150
18955380,2008-10-27T00:00:00,Cross-Over Studies,N05.715.360.780.150
18955380,2008-10-27T00:00:00,Cross-Over Studies,N06.850.520.445.150
18955380,2008-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18955380,2008-10-27T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
18955380,2008-10-27T00:00:00,Iron,D01.268.556.412
18955380,2008-10-27T00:00:00,Iron,D01.268.956.287
18955380,2008-10-27T00:00:00,Iron,D01.552.544.412
18955380,2008-10-27T00:00:00,Oxygen,D01.268.185.550
18955380,2008-10-27T00:00:00,Oxygen,D01.362.670
18955380,2008-10-27T00:00:00,Pulmonary Artery,A07.231.114.715
18955380,2008-10-27T00:00:00,Pulmonary Circulation,G09.330.190.163.770
18955380,2008-10-27T00:00:00,Pulmonary Circulation,G09.772.770.690
18955380,2008-10-27T00:00:00,Young Adult,M01.060.116.815
18955671,2008-10-27T00:00:00,Aged,M01.060.116.100
18955671,2008-10-27T00:00:00,"Arrhythmias, Cardiac",C14.280.067
18955671,2008-10-27T00:00:00,"Arrhythmias, Cardiac",C23.550.073
18955671,2008-10-27T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
18955671,2008-10-27T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
18955671,2008-10-27T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
18955671,2008-10-27T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
18955671,2008-10-27T00:00:00,"Defibrillators, Implantable",E07.695.175
18955671,2008-10-27T00:00:00,Heart Failure,C14.280.434
18955671,2008-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18955671,2008-10-27T00:00:00,Middle Aged,M01.060.116.630
18955671,2008-10-27T00:00:00,Risk Assessment,E05.318.740.600.800.715
18955671,2008-10-27T00:00:00,Risk Assessment,N04.452.871.715
18955671,2008-10-27T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18955671,2008-10-27T00:00:00,Risk Assessment,N06.850.505.715
18955671,2008-10-27T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18963541,2008-10-27T00:00:00,Adult,M01.060.116
18963541,2008-10-27T00:00:00,Aged,M01.060.116.100
18963541,2008-10-27T00:00:00,Antineoplastic Agents,D27.505.954.248
18963541,2008-10-27T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18963541,2008-10-27T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18963541,2008-10-27T00:00:00,Combined Modality Therapy,E02.186
18963541,2008-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18963541,2008-10-27T00:00:00,Hypopharyngeal Neoplasms,C04.588.443.665.710.485
18963541,2008-10-27T00:00:00,Hypopharyngeal Neoplasms,C07.550.745.436
18963541,2008-10-27T00:00:00,Hypopharyngeal Neoplasms,C09.647.710.485
18963541,2008-10-27T00:00:00,Hypopharyngeal Neoplasms,C09.775.549.485
18963541,2008-10-27T00:00:00,Microcirculation,G09.330.190.163.645
18963541,2008-10-27T00:00:00,Middle Aged,M01.060.116.630
18963541,2008-10-27T00:00:00,Mouth Neoplasms,C04.588.443.591
18963541,2008-10-27T00:00:00,Mouth Neoplasms,C07.465.565
18963541,2008-10-27T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18963541,2008-10-27T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18963541,2008-10-27T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
18963541,2008-10-27T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
18963541,2008-10-27T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
18963541,2008-10-27T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
18963541,2008-10-27T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18963541,2008-10-27T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18963541,2008-10-27T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18963541,2008-10-27T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18963541,2008-10-27T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18963541,2008-10-27T00:00:00,Radiotherapy Dosage,E02.815.639
18963541,2008-10-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18963541,2008-10-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18963541,2008-10-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18963541,2008-10-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18963541,2008-10-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18963541,2008-10-27T00:00:00,Treatment Outcome,E01.789.800
18963541,2008-10-27T00:00:00,Treatment Outcome,N04.761.559.590.800
18963541,2008-10-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18957486,2008-10-28T00:00:00,Evidence-Based Medicine,H02.249.750
18957486,2008-10-28T00:00:00,Evidence-Based Medicine,H02.403.200.400
18957486,2008-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18957486,2008-10-28T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18957486,2008-10-28T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18957486,2008-10-28T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18957486,2008-10-28T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18957486,2008-10-28T00:00:00,Research Design,E05.581.500
18957486,2008-10-28T00:00:00,Research Design,H01.770.644.728
18957486,2008-10-28T00:00:00,"Scleroderma, Systemic",C17.300.799
18957486,2008-10-28T00:00:00,"Scleroderma, Systemic",C17.800.784
18957486,2008-10-28T00:00:00,Treatment Outcome,E01.789.800
18957486,2008-10-28T00:00:00,Treatment Outcome,N04.761.559.590.800
18957486,2008-10-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18957576,2008-10-28T00:00:00,Allosteric Regulation,G02.111.087.040
18957576,2008-10-28T00:00:00,Allosteric Regulation,G02.149.115.040
18957576,2008-10-28T00:00:00,Epithelial Cells,A11.436
18957576,2008-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18957576,2008-10-28T00:00:00,Muscles,A02.633
18957576,2008-10-28T00:00:00,Muscles,A10.690
18957576,2008-10-28T00:00:00,Neurons,A08.663
18957576,2008-10-28T00:00:00,Neurons,A11.671
18957576,2008-10-28T00:00:00,"Receptors, Nicotinic",D12.776.543.750.720.360.550
18963256,2008-10-28T00:00:00,Cognition Disorders,F03.087.250
18963256,2008-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18963256,2008-10-28T00:00:00,New York,Z01.107.567.875.075.437
18963256,2008-10-28T00:00:00,New York,Z01.107.567.875.350.530
18963256,2008-10-28T00:00:00,New York,Z01.107.567.875.500.530
18963256,2008-10-28T00:00:00,Prevalence,E05.318.308.985.525.750
18963256,2008-10-28T00:00:00,Prevalence,L01.280.975.525.750
18963256,2008-10-28T00:00:00,Prevalence,N01.224.935.597.750
18963256,2008-10-28T00:00:00,Prevalence,N06.850.505.400.975.525.750
18963256,2008-10-28T00:00:00,Prevalence,N06.850.520.308.985.525.750
18963256,2008-10-28T00:00:00,Risk Assessment,E05.318.740.600.800.715
18963256,2008-10-28T00:00:00,Risk Assessment,N04.452.871.715
18963256,2008-10-28T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18963256,2008-10-28T00:00:00,Risk Assessment,N06.850.505.715
18963256,2008-10-28T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18963256,2008-10-28T00:00:00,Risk Factors,E05.318.740.600.800.725
18963256,2008-10-28T00:00:00,Risk Factors,N05.715.350.200.700
18963256,2008-10-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18963256,2008-10-28T00:00:00,Risk Factors,N06.850.490.625.750
18963256,2008-10-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18963350,2008-10-28T00:00:00,Heart Arrest,C14.280.383
18963350,2008-10-28T00:00:00,Heart Diseases,C14.280
18963350,2008-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18963350,2008-10-28T00:00:00,Reperfusion Injury,C14.907.725
18963350,2008-10-28T00:00:00,Reperfusion Injury,C23.550.767.877
18963350,2008-10-28T00:00:00,Syndrome,C23.550.288.500
18958449,2008-10-29T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
18958449,2008-10-29T00:00:00,Molecular Structure,G02.111.570
18958449,2008-10-29T00:00:00,Molecular Structure,G02.575
18958449,2008-10-29T00:00:00,Molecular Structure,G02.842.575
18958449,2008-10-29T00:00:00,Muramidase,D08.811.277.450.642
18958449,2008-10-29T00:00:00,Polymers,D05.750
18958449,2008-10-29T00:00:00,Polymers,D25.720
18958449,2008-10-29T00:00:00,Polymers,J01.637.051.720
18958449,2008-10-29T00:00:00,Surface Properties,G02.842.850
18958449,2008-10-29T00:00:00,Transferrin,D12.776.124.050.800
18958449,2008-10-29T00:00:00,Transferrin,D12.776.124.790.223.839
18958449,2008-10-29T00:00:00,Transferrin,D12.776.157.427.500
18958449,2008-10-29T00:00:00,Transferrin,D12.776.377.715.182.839
18958449,2008-10-29T00:00:00,Transferrin,D12.776.556.579.500
18973878,2008-10-29T00:00:00,Embryonic Development,G07.700.320.500.325.180
18973878,2008-10-29T00:00:00,Embryonic Development,G08.686.785.760.170.104
18973878,2008-10-29T00:00:00,Environmental Pollutants,D27.888.284
18973878,2008-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18973878,2008-10-29T00:00:00,"Hydrocarbons, Chlorinated",D02.455.526.439
18973878,2008-10-29T00:00:00,New York,Z01.107.567.875.075.437
18973878,2008-10-29T00:00:00,New York,Z01.107.567.875.350.530
18973878,2008-10-29T00:00:00,New York,Z01.107.567.875.500.530
18973878,2008-10-29T00:00:00,Pregnancy,G08.686.785.760.769
18973878,2008-10-29T00:00:00,Reproduction,G08.686.785.760
19010300,2008-10-29T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
19010300,2008-10-29T00:00:00,DNA-Directed DNA Polymerase,D08.811.913.696.445.308.300
19010300,2008-10-29T00:00:00,Genetic Variation,G05.365
19010300,2008-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19010300,2008-10-29T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19010300,2008-10-29T00:00:00,Mitochondria,A11.284.835.626
19010300,2008-10-29T00:00:00,Mitochondrial Diseases,C18.452.660
19010300,2008-10-29T00:00:00,"Models, Molecular",E05.599.595
19010300,2008-10-29T00:00:00,Mutation,G05.365.590
19010300,2008-10-29T00:00:00,"Polymorphism, Genetic",G05.365.795
19010300,2008-10-29T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19010300,2008-10-29T00:00:00,Protein Conformation,G02.111.570.790.709
19010300,2008-10-29T00:00:00,"Transcription, Genetic",G02.111.087.847
19010300,2008-10-29T00:00:00,"Transcription, Genetic",G02.149.115.847
19010300,2008-10-29T00:00:00,"Transcription, Genetic",G05.355.310.700
20633390,2008-10-29T00:00:00,Electric Stimulation Therapy,E02.342
20633390,2008-10-29T00:00:00,Electric Stimulation Therapy,E02.779.468
20633390,2008-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633390,2008-10-29T00:00:00,Periodicals as Topic,L01.178.682.829.678
18972115,2008-10-30T00:00:00,Adult,M01.060.116
18972115,2008-10-30T00:00:00,Aged,M01.060.116.100
18972115,2008-10-30T00:00:00,Coronary Artery Disease,C14.280.647.250.260
18972115,2008-10-30T00:00:00,Coronary Artery Disease,C14.907.137.126.339
18972115,2008-10-30T00:00:00,Coronary Artery Disease,C14.907.585.250.260
18972115,2008-10-30T00:00:00,Heart,A07.541
18972115,2008-10-30T00:00:00,Hemodynamics,G09.330.190.400
18972115,2008-10-30T00:00:00,Hemodynamics,G09.330.380
18972115,2008-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18972115,2008-10-30T00:00:00,Middle Aged,M01.060.116.630
18972115,2008-10-30T00:00:00,Myocardial Perfusion Imaging,E01.370.350.710.600.500
18972115,2008-10-30T00:00:00,Myocardial Perfusion Imaging,E01.370.370.380.500
18972115,2008-10-30T00:00:00,Myocardial Perfusion Imaging,E01.370.384.730.354.500
18972115,2008-10-30T00:00:00,Myocardium,A02.633.580
18972115,2008-10-30T00:00:00,Myocardium,A07.541.704
18972115,2008-10-30T00:00:00,Myocardium,A10.690.552.750
18972115,2008-10-30T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
18972115,2008-10-30T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
18972115,2008-10-30T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
18972115,2008-10-30T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
18972115,2008-10-30T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
18972115,2008-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18972115,2008-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18972115,2008-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18972115,2008-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18972115,2008-10-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18974832,2008-10-31T00:00:00,Animals,B01.050
18974832,2008-10-31T00:00:00,Bone Marrow Cells,A11.148
18974832,2008-10-31T00:00:00,Bone Marrow Cells,A15.378.316
18974832,2008-10-31T00:00:00,Cell Proliferation,G04.299.233.750
18974832,2008-10-31T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18974832,2008-10-31T00:00:00,Chlorambucil,D02.455.526.728.650.156
18974832,2008-10-31T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
18974832,2008-10-31T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
18974832,2008-10-31T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
18974832,2008-10-31T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
18974832,2008-10-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18974832,2008-10-31T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
18974832,2008-10-31T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
18974832,2008-10-31T00:00:00,"Models, Biological",E05.599.395
18974832,2008-10-31T00:00:00,Nylons,D05.750.716.392
18974832,2008-10-31T00:00:00,Nylons,D25.720.716.392
18974832,2008-10-31T00:00:00,Nylons,J01.576.885.800.600
18974832,2008-10-31T00:00:00,Nylons,J01.637.051.720.716.392
18974832,2008-10-31T00:00:00,Nylons,J01.637.548
18974832,2008-10-31T00:00:00,Piperazines,D03.383.606
18974832,2008-10-31T00:00:00,Pyrimidines,D03.383.742
18974832,2008-10-31T00:00:00,Substrate Specificity,G02.111.835
18978212,2008-10-31T00:00:00,Adolescent,M01.060.057
18978212,2008-10-31T00:00:00,Adult,M01.060.116
18978212,2008-10-31T00:00:00,Brain,A08.186.211
18978212,2008-10-31T00:00:00,Brain Mapping,E01.370.350.086
18978212,2008-10-31T00:00:00,Brain Mapping,E01.370.376.149
18978212,2008-10-31T00:00:00,Brain Mapping,E05.132
18978212,2008-10-31T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
18978212,2008-10-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18978212,2008-10-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18978212,2008-10-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18978212,2008-10-31T00:00:00,Motor Activity,F01.145.632
18978212,2008-10-31T00:00:00,Motor Activity,G11.427.590.530.698
18978212,2008-10-31T00:00:00,Photic Stimulation,E05.723.729
18978212,2008-10-31T00:00:00,Speech Perception,F02.463.593.071.875
18978212,2008-10-31T00:00:00,Video Recording,L01.240.960
18978212,2008-10-31T00:00:00,Visual Perception,F02.463.593.932
18978212,2008-10-31T00:00:00,Young Adult,M01.060.116.815
18978727,2008-10-31T00:00:00,Adolescent,M01.060.057
18978727,2008-10-31T00:00:00,Adult,M01.060.116
18978727,2008-10-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18978727,2008-10-31T00:00:00,Middle Aged,M01.060.116.630
18978727,2008-10-31T00:00:00,Retina,A09.371.729
18978727,2008-10-31T00:00:00,"Tomography, Optical Coherence",E01.370.350.825.805.500
18978727,2008-10-31T00:00:00,Visual Acuity,E01.370.380.850.950
18978727,2008-10-31T00:00:00,Visual Acuity,F02.463.593.932.901
18978727,2008-10-31T00:00:00,Visual Acuity,G14.940
18978727,2008-10-31T00:00:00,Young Adult,M01.060.116.815
18478575,2008-11-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
18478575,2008-11-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
18478575,2008-11-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
18478575,2008-11-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
18478575,2008-11-01T00:00:00,Brain,A08.186.211
18478575,2008-11-01T00:00:00,Brain Infarction,C10.228.140.300.150.477
18478575,2008-11-01T00:00:00,Brain Infarction,C10.228.140.300.775.200
18478575,2008-11-01T00:00:00,Brain Infarction,C14.907.253.092.477
18478575,2008-11-01T00:00:00,Brain Infarction,C14.907.253.855.200
18478575,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18478575,2008-11-01T00:00:00,Infant,M01.060.703
18478575,2008-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18478575,2008-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18478575,2008-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18478575,2008-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18478575,2008-11-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18478575,2008-11-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18623212,2008-11-01T00:00:00,Copper,D01.268.556.195
18623212,2008-11-01T00:00:00,Copper,D01.268.956.170
18623212,2008-11-01T00:00:00,Copper,D01.552.544.195
18623212,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18623212,2008-11-01T00:00:00,Infant,M01.060.703
18623212,2008-11-01T00:00:00,Neural Tube Defects,C10.500.680
18623212,2008-11-01T00:00:00,Neural Tube Defects,C16.131.666.680
18623212,2008-11-01T00:00:00,Pancytopenia,C15.378.700
18623212,2008-11-01T00:00:00,Short Bowel Syndrome,C06.405.469.637.832
18623212,2008-11-01T00:00:00,Short Bowel Syndrome,C23.550.767.882
18774901,2008-11-01T00:00:00,Animals,B01.050
18774901,2008-11-01T00:00:00,Cardiovascular Diseases,C14
18774901,2008-11-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18774901,2008-11-01T00:00:00,Diabetes Mellitus,C19.246
18774901,2008-11-01T00:00:00,Glutathione,D12.644.456.448
18774901,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18774901,2008-11-01T00:00:00,"Models, Biological",E05.599.395
18774901,2008-11-01T00:00:00,Neoplasms,C04
18774901,2008-11-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
18774901,2008-11-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
18774901,2008-11-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
18774901,2008-11-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
18774901,2008-11-01T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
18774901,2008-11-01T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
18774901,2008-11-01T00:00:00,Signal Transduction,G02.111.087.800
18774901,2008-11-01T00:00:00,Signal Transduction,G02.149.115.800
18774901,2008-11-01T00:00:00,Signal Transduction,G04.299.880
18827566,2008-11-01T00:00:00,Adolescent,M01.060.057
18827566,2008-11-01T00:00:00,Adult,M01.060.116
18827566,2008-11-01T00:00:00,Aged,M01.060.116.100
18827566,2008-11-01T00:00:00,Child,M01.060.406
18827566,2008-11-01T00:00:00,Diphtheria Toxin,D08.811.913.400.725.115.220
18827566,2008-11-01T00:00:00,Diphtheria Toxin,D23.946.123.305
18827566,2008-11-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
18827566,2008-11-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
18827566,2008-11-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
18827566,2008-11-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
18827566,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18827566,2008-11-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18827566,2008-11-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18827566,2008-11-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18827566,2008-11-01T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
18827566,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
18827566,2008-11-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
18832997,2008-11-01T00:00:00,Animals,B01.050
18832997,2008-11-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18832997,2008-11-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18832997,2008-11-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18832997,2008-11-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
18832997,2008-11-01T00:00:00,Brain Neoplasms,C10.228.140.211
18832997,2008-11-01T00:00:00,Brain Neoplasms,C10.551.240.250
18832997,2008-11-01T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18832997,2008-11-01T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18832997,2008-11-01T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18832997,2008-11-01T00:00:00,Immunization,E02.095.465.425.400
18832997,2008-11-01T00:00:00,Immunization,E05.478.550
18832997,2008-11-01T00:00:00,Immunization,N02.421.726.758.310
18832997,2008-11-01T00:00:00,Immunization,N06.850.780.200.425
18832997,2008-11-01T00:00:00,Immunization,N06.850.780.680.310
18832997,2008-11-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
18832997,2008-11-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
18832997,2008-11-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18832997,2008-11-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18843145,2008-11-01T00:00:00,Child,M01.060.406
18843145,2008-11-01T00:00:00,Child Abuse,I01.198.240.856.350.250
18843145,2008-11-01T00:00:00,Child Abuse,I01.880.735.900.350.250
18843145,2008-11-01T00:00:00,Child Abuse,I01.880.787.293.292
18843145,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18843145,2008-11-01T00:00:00,Internet,L01.224.230.110.500
18843145,2008-11-01T00:00:00,Social Support,I01.880.656.600
18843145,2008-11-01T00:00:00,Teaching,I02.903
18846543,2008-11-01T00:00:00,Animals,B01.050
18846543,2008-11-01T00:00:00,Cell Survival,G04.299.316
18846543,2008-11-01T00:00:00,Hepatocytes,A11.436.348
18846543,2008-11-01T00:00:00,Iron,D01.268.556.412
18846543,2008-11-01T00:00:00,Iron,D01.268.956.287
18846543,2008-11-01T00:00:00,Iron,D01.552.544.412
18846543,2008-11-01T00:00:00,Iron Overload,C18.452.565.500
18846543,2008-11-01T00:00:00,Liver,A03.620
18846543,2008-11-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18846543,2008-11-01T00:00:00,"Microscopy, Confocal",E05.595.395
18846543,2008-11-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
18846543,2008-11-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
18846543,2008-11-01T00:00:00,Oxidative Stress,G03.495.710
18846543,2008-11-01T00:00:00,Oxidative Stress,G07.700.830.750
18846543,2008-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18846543,2008-11-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18855559,2008-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18855559,2008-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18855559,2008-11-01T00:00:00,Hepacivirus,B04.450.410
18855559,2008-11-01T00:00:00,Hepacivirus,B04.820.250.475
18855559,2008-11-01T00:00:00,Hepacivirus,B04.909.777.310.475
18855559,2008-11-01T00:00:00,Hepatitis C,C02.440.440
18855559,2008-11-01T00:00:00,Hepatitis C,C02.782.350.350
18855559,2008-11-01T00:00:00,Hepatitis C,C06.552.380.705.440
18855559,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18855559,2008-11-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18855559,2008-11-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18855559,2008-11-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
18855559,2008-11-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
18940640,2008-11-01T00:00:00,Deglutition,G10.261.326.215
18940640,2008-11-01T00:00:00,Deglutition Disorders,C06.405.117.119
18940640,2008-11-01T00:00:00,Deglutition Disorders,C09.775.174
18940640,2008-11-01T00:00:00,Fluoroscopy,E01.370.350.700.225
18940640,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18941102,2008-11-01T00:00:00,Adolescent,M01.060.057
18941102,2008-11-01T00:00:00,Adult,M01.060.116
18941102,2008-11-01T00:00:00,Aged,M01.060.116.100
18941102,2008-11-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
18941102,2008-11-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18941102,2008-11-01T00:00:00,Coronary Angiography,E01.370.370.050.200
18941102,2008-11-01T00:00:00,Coronary Angiography,E01.370.370.380.200
18941102,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18941102,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
18941102,2008-11-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18941102,2008-11-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18941102,2008-11-01T00:00:00,Sensitivity and Specificity,G17.800
18941102,2008-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18941102,2008-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18941102,2008-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18941102,2008-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18941102,2008-11-01T00:00:00,Thoracic Injuries,C21.866.891
18941428,2008-11-01T00:00:00,Adolescent,M01.060.057
18941428,2008-11-01T00:00:00,Adult,M01.060.116
18941428,2008-11-01T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
18941428,2008-11-01T00:00:00,"Arthroplasty, Replacement",E04.650.110
18941428,2008-11-01T00:00:00,Disability Evaluation,E01.370.400
18941428,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18941428,2008-11-01T00:00:00,Joint Prosthesis,E07.695.400
18941428,2008-11-01T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
18941428,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
18941428,2008-11-01T00:00:00,Postoperative Complications,C23.550.767
18941428,2008-11-01T00:00:00,Young Adult,M01.060.116.815
18949789,2008-11-01T00:00:00,Cell Membrane,A11.284.149
18949789,2008-11-01T00:00:00,Computer Simulation,L01.224.160
18949789,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18949789,2008-11-01T00:00:00,"Models, Molecular",E05.599.595
18949789,2008-11-01T00:00:00,Nanoparticles,J01.637.512.600
18949789,2008-11-01T00:00:00,Nuclear Envelope,A11.284.149.165.630
18949789,2008-11-01T00:00:00,Nuclear Envelope,A11.284.149.450.700
18949789,2008-11-01T00:00:00,Nuclear Envelope,A11.284.430.106.279.692
18949789,2008-11-01T00:00:00,Nuclear Envelope,A11.284.835.514.700
18957937,2008-11-01T00:00:00,Animals,B01.050
18957937,2008-11-01T00:00:00,Cell Line,A11.251.210
18957937,2008-11-01T00:00:00,Hela Cells,A11.251.210.190.400
18957937,2008-11-01T00:00:00,Hela Cells,A11.251.860.180.400
18957937,2008-11-01T00:00:00,Hela Cells,A11.436.340
18957937,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18957937,2008-11-01T00:00:00,Interferon Type I,D12.644.276.374.440.890
18957937,2008-11-01T00:00:00,Interferon Type I,D12.644.276.718.500
18957937,2008-11-01T00:00:00,Interferon Type I,D12.776.467.374.440.890
18957937,2008-11-01T00:00:00,Interferon Type I,D12.776.467.718.500
18957937,2008-11-01T00:00:00,Interferon Type I,D23.529.374.440.890
18957937,2008-11-01T00:00:00,Interferon Type I,D23.529.718.500
18957937,2008-11-01T00:00:00,Interferon-alpha,D12.644.276.374.440.890.250
18957937,2008-11-01T00:00:00,Interferon-alpha,D12.644.276.718.500.250
18957937,2008-11-01T00:00:00,Interferon-alpha,D12.776.467.374.440.890.250
18957937,2008-11-01T00:00:00,Interferon-alpha,D12.776.467.718.500.250
18957937,2008-11-01T00:00:00,Interferon-alpha,D23.529.374.440.890.250
18957937,2008-11-01T00:00:00,Interferon-alpha,D23.529.718.500.250
18971382,2008-11-01T00:00:00,Activities of Daily Living,E02.831.067
18971382,2008-11-01T00:00:00,Activities of Daily Living,I03.050
18971382,2008-11-01T00:00:00,Activities of Daily Living,N02.421.784.110
18971382,2008-11-01T00:00:00,Aged,M01.060.116.100
18971382,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18971382,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
18971382,2008-11-01T00:00:00,Physical Therapy Modalities,E02.779
18971382,2008-11-01T00:00:00,Recovery of Function,G16.757
18971382,2008-11-01T00:00:00,Stroke,C10.228.140.300.775
18971382,2008-11-01T00:00:00,Stroke,C14.907.253.855
18971382,2008-11-01T00:00:00,Walking,G11.427.590.530.568.900
18971382,2008-11-01T00:00:00,Walking,G11.427.590.530.698.940
18971382,2008-11-01T00:00:00,Walking,I03.450.642.845.940
18971657,2008-11-01T00:00:00,Cultural Diversity,I01.076.201.450.350
18971657,2008-11-01T00:00:00,Cultural Diversity,I01.880.143.450
18971657,2008-11-01T00:00:00,Curriculum,I02.158
18971657,2008-11-01T00:00:00,"History, 20th Century",K01.400.504.968
18971657,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18971657,2008-11-01T00:00:00,Leadership,F01.752.609
18971657,2008-11-01T00:00:00,"Physicians, Family",M01.526.485.810.770
18971657,2008-11-01T00:00:00,"Physicians, Family",N02.360.810.770
18971657,2008-11-01T00:00:00,Primary Health Care,N04.590.233.727
18971657,2008-11-01T00:00:00,Societies,N03.540.828
18971657,2008-11-01T00:00:00,"Students, Medical",I02.851.686.602
18971657,2008-11-01T00:00:00,"Students, Medical",M01.848.769.602
18971657,2008-11-01T00:00:00,United States,Z01.107.567.875
18972438,2008-11-01T00:00:00,"History, 20th Century",K01.400.504.968
18972438,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18972438,2008-11-01T00:00:00,Liver Diseases,C06.552
18972438,2008-11-01T00:00:00,"Societies, Medical",N03.540.828.589
18972438,2008-11-01T00:00:00,United States,Z01.107.567.875
18974135,2008-11-01T00:00:00,Breast Neoplasms,C04.588.180
18974135,2008-11-01T00:00:00,Breast Neoplasms,C17.800.090.500
18974135,2008-11-01T00:00:00,"Carcinoma, Lobular",C04.557.470.200.025.305
18974135,2008-11-01T00:00:00,"Carcinoma, Lobular",C04.557.470.615.305
18974135,2008-11-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18974135,2008-11-01T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
18974135,2008-11-01T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
18974135,2008-11-01T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
18974135,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18974135,2008-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
18974135,2008-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18974135,2008-11-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18974135,2008-11-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18974135,2008-11-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18974135,2008-11-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18974135,2008-11-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
18974135,2008-11-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
18974135,2008-11-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
18977996,2008-11-01T00:00:00,Adolescent,M01.060.057
18977996,2008-11-01T00:00:00,Animals,B01.050
18977996,2008-11-01T00:00:00,Breast Feeding,G07.610.220.500.500
18977996,2008-11-01T00:00:00,Breast Feeding,G07.610.593.185
18977996,2008-11-01T00:00:00,Breast Feeding,G07.700.620.185
18977996,2008-11-01T00:00:00,Child,M01.060.406
18977996,2008-11-01T00:00:00,Cholecalciferol,D04.808.247.222.159
18977996,2008-11-01T00:00:00,Cholecalciferol,D04.808.247.808.146
18977996,2008-11-01T00:00:00,Cholecalciferol,D04.808.812.768.196
18977996,2008-11-01T00:00:00,Cholecalciferol,D10.570.938.146
18977996,2008-11-01T00:00:00,Fetus,A16.378
18977996,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18977996,2008-11-01T00:00:00,Infant,M01.060.703
18977996,2008-11-01T00:00:00,Infant Food,J02.500.525.500
18977996,2008-11-01T00:00:00,Vitamin D,D04.808.812.768
18977996,2008-11-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18978830,2008-11-01T00:00:00,Animals,B01.050
18978830,2008-11-01T00:00:00,Calcium,D01.268.552.100
18978830,2008-11-01T00:00:00,Calcium,D01.552.539.288
18978830,2008-11-01T00:00:00,Calcium,D23.119.100
18978830,2008-11-01T00:00:00,Ion Channels,D12.776.157.530.400
18978830,2008-11-01T00:00:00,Ion Channels,D12.776.543.550.425
18978830,2008-11-01T00:00:00,Ion Channels,D12.776.543.585.400
18978830,2008-11-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18978830,2008-11-01T00:00:00,Mitochondria,A11.284.835.626
18978830,2008-11-01T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
18978830,2008-11-01T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
18978830,2008-11-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
18978830,2008-11-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
18978830,2008-11-01T00:00:00,Mitochondrial Proteins,D12.776.575
18978830,2008-11-01T00:00:00,"Models, Biological",E05.599.395
18978830,2008-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18984475,2008-11-01T00:00:00,Angiotensin II,D06.472.699.094.078
18984475,2008-11-01T00:00:00,Angiotensin II,D12.644.400.070.078
18984475,2008-11-01T00:00:00,Angiotensin II,D12.644.456.073.041
18984475,2008-11-01T00:00:00,Angiotensin II,D12.644.548.058.078
18984475,2008-11-01T00:00:00,Angiotensin II,D12.776.641.650.070.078
18984475,2008-11-01T00:00:00,Angiotensin II,D23.469.050.050.050
18984475,2008-11-01T00:00:00,Chronic Disease,C23.550.291.500
18984475,2008-11-01T00:00:00,Collagen,D05.750.078.280
18984475,2008-11-01T00:00:00,Collagen,D12.776.860.300.250
18984475,2008-11-01T00:00:00,Extracellular Matrix,A11.284.295.310
18984475,2008-11-01T00:00:00,Hepatic Stellate Cells,A11.561
18984475,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.644.276.718.550
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
18984475,2008-11-01T00:00:00,Interferon-gamma,D12.776.467.718.550
18984475,2008-11-01T00:00:00,Interferon-gamma,D23.529.374.440.893
18984475,2008-11-01T00:00:00,Interferon-gamma,D23.529.374.480.350
18984475,2008-11-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
18984475,2008-11-01T00:00:00,Interferon-gamma,D23.529.718.550
18984475,2008-11-01T00:00:00,Liver Cirrhosis,C06.552.630
18984475,2008-11-01T00:00:00,Pyridones,D03.383.725.791
18987399,2008-11-01T00:00:00,Calcinosis,C18.452.174.130
18987399,2008-11-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
18987399,2008-11-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
18987399,2008-11-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
18987399,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18987399,2008-11-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
18988716,2008-11-01T00:00:00,Adult,M01.060.116
18988716,2008-11-01T00:00:00,Aged,M01.060.116.100
18988716,2008-11-01T00:00:00,Blood Glucose,D09.546.359.448.500
18988716,2008-11-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18988716,2008-11-01T00:00:00,Diabetes Mellitus,C19.246
18988716,2008-11-01T00:00:00,Health Surveys,E05.318.308.250
18988716,2008-11-01T00:00:00,Health Surveys,N05.715.360.300.375
18988716,2008-11-01T00:00:00,Health Surveys,N06.850.520.308.250
18988716,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18988716,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
18988716,2008-11-01T00:00:00,Pilot Projects,E05.318.760.750
18988716,2008-11-01T00:00:00,Pilot Projects,E05.337.737
18988716,2008-11-01T00:00:00,Pilot Projects,N05.715.360.775.625
18988716,2008-11-01T00:00:00,Pilot Projects,N06.850.520.450.720
18988716,2008-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18988716,2008-11-01T00:00:00,Risk Assessment,N04.452.871.715
18988716,2008-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18988716,2008-11-01T00:00:00,Risk Assessment,N06.850.505.715
18988716,2008-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18990729,2008-11-01T00:00:00,Healthcare Disparities,N04.590.374.380
18990729,2008-11-01T00:00:00,Healthcare Disparities,N05.300.493
18990729,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18990729,2008-11-01T00:00:00,Neoplasms,C04
18992242,2008-11-01T00:00:00,Animals,B01.050
18992242,2008-11-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18992242,2008-11-01T00:00:00,Aqueous Humor,A09.371.060.067.070
18992242,2008-11-01T00:00:00,Aqueous Humor,A12.207.270.040
18992242,2008-11-01T00:00:00,Calcium,D01.268.552.100
18992242,2008-11-01T00:00:00,Calcium,D01.552.539.288
18992242,2008-11-01T00:00:00,Calcium,D23.119.100
18992242,2008-11-01T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
18992242,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18992242,2008-11-01T00:00:00,Intraocular Pressure,G14.440
18992242,2008-11-01T00:00:00,Ocular Hypertension,C11.525
18992242,2008-11-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
18992242,2008-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19004686,2008-11-01T00:00:00,Computer Graphics,L01.224.108
19004686,2008-11-01T00:00:00,Computer Graphics,L01.296.110
19004686,2008-11-01T00:00:00,Crime,I01.198.240
19004686,2008-11-01T00:00:00,Crime,I01.880.735.191
19004686,2008-11-01T00:00:00,Decision Making,F02.463.785.373
19004686,2008-11-01T00:00:00,"Pattern Recognition, Automated",L01.725
19004686,2008-11-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
19004686,2008-11-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
19004686,2008-11-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
19004686,2008-11-01T00:00:00,Photography,E01.370.350.600
19004686,2008-11-01T00:00:00,Photography,E05.712
19004686,2008-11-01T00:00:00,Software,L01.224.900
19004686,2008-11-01T00:00:00,User-Computer Interface,L01.224.900.910
19018225,2008-11-01T00:00:00,Catheterization,E02.148
19018225,2008-11-01T00:00:00,Catheterization,E05.157
19018225,2008-11-01T00:00:00,Child,M01.060.406
19018225,2008-11-01T00:00:00,"Child, Preschool",M01.060.406.448
19018225,2008-11-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
19018225,2008-11-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
19018225,2008-11-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19018225,2008-11-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19018225,2008-11-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19018225,2008-11-01T00:00:00,Endoscopy,E01.370.388.250
19018225,2008-11-01T00:00:00,Endoscopy,E04.800.250
19018225,2008-11-01T00:00:00,Foreign Bodies,C21.866.392
19018225,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19018225,2008-11-01T00:00:00,Magnetics,H01.671.493
19018225,2008-11-01T00:00:00,Nasal Cavity,A04.531.449
19018225,2008-11-01T00:00:00,Nasal Obstruction,C08.460.525
19018225,2008-11-01T00:00:00,Nasal Obstruction,C08.618.846.185.525
19018225,2008-11-01T00:00:00,Nasal Obstruction,C09.603.525
19018225,2008-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19018225,2008-11-01T00:00:00,Risk Assessment,N04.452.871.715
19018225,2008-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19018225,2008-11-01T00:00:00,Risk Assessment,N06.850.505.715
19018225,2008-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19018225,2008-11-01T00:00:00,Treatment Outcome,E01.789.800
19018225,2008-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19018225,2008-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19021820,2008-11-01T00:00:00,Adult,M01.060.116
19021820,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19021820,2008-11-01T00:00:00,Lipids,D10
19021820,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
19021820,2008-11-01T00:00:00,Taste,F02.830.816.724
19021820,2008-11-01T00:00:00,Taste,G11.561.600.810.724
19021820,2008-11-01T00:00:00,United States,Z01.107.567.875
19021820,2008-11-01T00:00:00,Water,D01.455.900
19021820,2008-11-01T00:00:00,Water,D01.650.550.925
19021820,2008-11-01T00:00:00,Young Adult,M01.060.116.815
19024226,2008-11-01T00:00:00,Attitude of Health Personnel,F01.100.050
19024226,2008-11-01T00:00:00,Attitude of Health Personnel,N05.300.100
19024226,2008-11-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19024226,2008-11-01T00:00:00,Clinical Trials as Topic,E05.337.250
19024226,2008-11-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19024226,2008-11-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19024226,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19024226,2008-11-01T00:00:00,Minority Groups,I01.880.371
19024226,2008-11-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
19024226,2008-11-01T00:00:00,Parkinson Disease,C10.228.662.600.400
19024226,2008-11-01T00:00:00,Parkinson Disease,C10.574.812
19024226,2008-11-01T00:00:00,Referral and Consultation,N04.452.758.849
19033832,2008-11-01T00:00:00,Adolescent,M01.060.057
19033832,2008-11-01T00:00:00,Adult,M01.060.116
19033832,2008-11-01T00:00:00,Aged,M01.060.116.100
19033832,2008-11-01T00:00:00,Brain Injuries,C10.228.140.199
19033832,2008-11-01T00:00:00,Brain Injuries,C10.900.300.087
19033832,2008-11-01T00:00:00,Brain Injuries,C21.866.260.118
19033832,2008-11-01T00:00:00,Brain Injuries,C21.866.915.300.200
19033832,2008-11-01T00:00:00,Child,M01.060.406
19033832,2008-11-01T00:00:00,"Child, Preschool",M01.060.406.448
19033832,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19033832,2008-11-01T00:00:00,Incidence,E05.318.308.985.525.375
19033832,2008-11-01T00:00:00,Incidence,L01.280.975.525.375
19033832,2008-11-01T00:00:00,Incidence,N01.224.935.597.500
19033832,2008-11-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19033832,2008-11-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19033832,2008-11-01T00:00:00,Infant,M01.060.703
19033832,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
19033832,2008-11-01T00:00:00,"Models, Biological",E05.599.395
19033832,2008-11-01T00:00:00,Prevalence,E05.318.308.985.525.750
19033832,2008-11-01T00:00:00,Prevalence,L01.280.975.525.750
19033832,2008-11-01T00:00:00,Prevalence,N01.224.935.597.750
19033832,2008-11-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
19033832,2008-11-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
19033832,2008-11-01T00:00:00,United States,Z01.107.567.875
19033832,2008-11-01T00:00:00,Young Adult,M01.060.116.815
19034740,2008-11-01T00:00:00,Adult,M01.060.116
19034740,2008-11-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19034740,2008-11-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19034740,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034740,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
19034740,2008-11-01T00:00:00,Secondary Prevention,N02.421.726.825
19034740,2008-11-01T00:00:00,Secondary Prevention,N06.850.780.750
19034743,2008-11-01T00:00:00,Alcohol Drinking,F01.145.317.269
19034743,2008-11-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
19034743,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19034743,2008-11-01T00:00:00,Marijuana Abuse,C21.739.635
19034743,2008-11-01T00:00:00,Marijuana Abuse,F03.900.635
19034743,2008-11-01T00:00:00,Substance-Related Disorders,C21.739
19034743,2008-11-01T00:00:00,Substance-Related Disorders,F03.900
19034743,2008-11-01T00:00:00,Tobacco Use Disorder,C21.739.912
19034743,2008-11-01T00:00:00,Tobacco Use Disorder,F03.900.912
19041595,2008-11-01T00:00:00,Adult,M01.060.116
19041595,2008-11-01T00:00:00,African Americans,M01.686.508.100.100
19041595,2008-11-01T00:00:00,African Americans,M01.686.754.100
19041595,2008-11-01T00:00:00,Crime Victims,M01.135
19041595,2008-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19041595,2008-11-01T00:00:00,Health Status Disparities,I01.240.425.675
19041595,2008-11-01T00:00:00,Health Status Disparities,N01.224.425.437
19041595,2008-11-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
19041595,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19041595,2008-11-01T00:00:00,Mental Disorders,F03
19041595,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
19041595,2008-11-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
19041595,2008-11-01T00:00:00,Primary Health Care,N04.590.233.727
19041595,2008-11-01T00:00:00,Questionnaires,E05.318.308.750
19041595,2008-11-01T00:00:00,Questionnaires,L01.280.800
19041595,2008-11-01T00:00:00,Questionnaires,N05.715.360.300.695
19041595,2008-11-01T00:00:00,Questionnaires,N06.850.520.308.750
19041595,2008-11-01T00:00:00,United States,Z01.107.567.875
19041595,2008-11-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
19041595,2008-11-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
19041595,2008-11-01T00:00:00,Veterans,M01.930
19041595,2008-11-01T00:00:00,Violence,I01.198.240.856
19041595,2008-11-01T00:00:00,Violence,I01.880.735.900
19049721,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19049721,2008-11-01T00:00:00,"Infant, Newborn",M01.060.703.520
19049721,2008-11-01T00:00:00,Radiation Dosage,E05.799.513
19049721,2008-11-01T00:00:00,Radiation Dosage,G01.201.875.740
19049721,2008-11-01T00:00:00,Radiation Dosage,N06.850.810.250
19049721,2008-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19049721,2008-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19049721,2008-11-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19049721,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19049721,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19049721,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19049721,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19049721,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19049747,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19049747,2008-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19049747,2008-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19049747,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
19049747,2008-11-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
19049747,2008-11-01T00:00:00,Myocardial Contraction,G09.330.190.541
19049747,2008-11-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
19049747,2008-11-01T00:00:00,Myocardial Ischemia,C14.280.647
19049747,2008-11-01T00:00:00,Myocardial Ischemia,C14.907.585
19049747,2008-11-01T00:00:00,Myocardium,A02.633.580
19049747,2008-11-01T00:00:00,Myocardium,A07.541.704
19049747,2008-11-01T00:00:00,Myocardium,A10.690.552.750
19049747,2008-11-01T00:00:00,"Stress, Physiological",G07.700.830
19049753,2008-11-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
19049753,2008-11-01T00:00:00,Cytokines,D12.644.276.374
19049753,2008-11-01T00:00:00,Cytokines,D12.776.467.374
19049753,2008-11-01T00:00:00,Cytokines,D23.529.374
19049753,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19049753,2008-11-01T00:00:00,Isoxazoles,D03.383.129.385
19049753,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
19049753,2008-11-01T00:00:00,Thiophenes,D02.886.778
19049753,2008-11-01T00:00:00,Thiophenes,D03.383.903
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19049753,2008-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19062675,2008-11-01T00:00:00,Adult,M01.060.116
19062675,2008-11-01T00:00:00,Collagen,D05.750.078.280
19062675,2008-11-01T00:00:00,Collagen,D12.776.860.300.250
19062675,2008-11-01T00:00:00,"Hernia, Ventral",C23.300.707.374.937
19062675,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19062675,2008-11-01T00:00:00,Intestinal Fistula,C06.267.550
19062675,2008-11-01T00:00:00,Intestinal Fistula,C06.405.469.471
19062675,2008-11-01T00:00:00,Intestinal Fistula,C23.300.575.185.550
19062675,2008-11-01T00:00:00,"Skin, Artificial",E07.858.082.800
19062675,2008-11-01T00:00:00,Surgical Flaps,A10.850.710
19062675,2008-11-01T00:00:00,Surgical Flaps,E07.862.710
19062675,2008-11-01T00:00:00,Suture Techniques,E04.901
19062679,2008-11-01T00:00:00,Adult,M01.060.116
19062679,2008-11-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19062679,2008-11-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19062679,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19062679,2008-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19062679,2008-11-01T00:00:00,Risk Factors,N05.715.350.200.700
19062679,2008-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19062679,2008-11-01T00:00:00,Risk Factors,N06.850.490.625.750
19062679,2008-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19062679,2008-11-01T00:00:00,Wounds and Injuries,C21.866
19067372,2008-11-01T00:00:00,African Americans,M01.686.508.100.100
19067372,2008-11-01T00:00:00,African Americans,M01.686.754.100
19067372,2008-11-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
19067372,2008-11-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19067372,2008-11-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19067372,2008-11-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19067372,2008-11-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19067372,2008-11-01T00:00:00,Diabetes Complications,C19.246.099
19067372,2008-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19067372,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19067372,2008-11-01T00:00:00,Hypertension,C14.907.489
19067372,2008-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19067372,2008-11-01T00:00:00,Risk Factors,N05.715.350.200.700
19067372,2008-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19067372,2008-11-01T00:00:00,Risk Factors,N06.850.490.625.750
19067372,2008-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19067372,2008-11-01T00:00:00,Stroke,C10.228.140.300.775
19067372,2008-11-01T00:00:00,Stroke,C14.907.253.855
19077839,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19077839,2008-11-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
19077839,2008-11-01T00:00:00,Nurse's Role,N05.300.100.337
19077839,2008-11-01T00:00:00,Nursing,H02.478
19077839,2008-11-01T00:00:00,Nursing,N04.452.758.377
19077839,2008-11-01T00:00:00,Quality of Life,I01.800
19077839,2008-11-01T00:00:00,Quality of Life,K01.752.400.750
19077839,2008-11-01T00:00:00,Workload,N04.452.677.950
19088517,2008-11-01T00:00:00,Attitude to Health,F01.100.150
19088517,2008-11-01T00:00:00,Attitude to Health,N05.300.150
19088517,2008-11-01T00:00:00,"Child, Preschool",M01.060.406.448
19088517,2008-11-01T00:00:00,Chronic Disease,C23.550.291.500
19088517,2008-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
19088517,2008-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
19088517,2008-11-01T00:00:00,Hospitalization,E02.760.400
19088517,2008-11-01T00:00:00,Hospitalization,N02.421.585.400
19088517,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19088517,2008-11-01T00:00:00,Infant,M01.060.703
19088517,2008-11-01T00:00:00,Influenza Vaccines,D20.215.894.899.302
19088517,2008-11-01T00:00:00,"Influenza, Human",C02.782.620.365
19088517,2008-11-01T00:00:00,"Influenza, Human",C08.730.310
19088517,2008-11-01T00:00:00,Parents,F01.829.263.500.320
19088517,2008-11-01T00:00:00,Parents,I01.880.225.500.340
19088517,2008-11-01T00:00:00,Parents,M01.620
19088517,2008-11-01T00:00:00,Questionnaires,E05.318.308.750
19088517,2008-11-01T00:00:00,Questionnaires,L01.280.800
19088517,2008-11-01T00:00:00,Questionnaires,N05.715.360.300.695
19088517,2008-11-01T00:00:00,Questionnaires,N06.850.520.308.750
19088519,2008-11-01T00:00:00,Aged,M01.060.116.100
19088519,2008-11-01T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.055.239.075
19088519,2008-11-01T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.109.139.075
19088519,2008-11-01T00:00:00,Coronary Artery Bypass,E04.100.376.719.332
19088519,2008-11-01T00:00:00,Coronary Artery Bypass,E04.928.220.520.220
19088519,2008-11-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19088519,2008-11-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19088519,2008-11-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19088519,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19088519,2008-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
19088519,2008-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
19088519,2008-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
19088519,2008-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
19088519,2008-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
19088519,2008-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
19088519,2008-11-01T00:00:00,Middle Aged,M01.060.116.630
19088519,2008-11-01T00:00:00,Postoperative Complications,C23.550.767
19102134,2008-11-01T00:00:00,Disease Outbreaks,N06.850.290
19102134,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19102134,2008-11-01T00:00:00,Respiratory Tract Infections,C01.539.739
19102134,2008-11-01T00:00:00,Respiratory Tract Infections,C08.730
19102134,2008-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19102134,2008-11-01T00:00:00,Risk Factors,N05.715.350.200.700
19102134,2008-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19102134,2008-11-01T00:00:00,Risk Factors,N06.850.490.625.750
19102134,2008-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19102134,2008-11-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19123648,2008-11-01T00:00:00,Computer-Aided Design,L01.224.108.150
19123648,2008-11-01T00:00:00,Computer-Aided Design,L01.296.110.150
19123648,2008-11-01T00:00:00,Equipment Failure Analysis,E05.325.192
19123648,2008-11-01T00:00:00,Image Enhancement,E01.370.350.600.350
19123648,2008-11-01T00:00:00,Image Enhancement,L01.224.308.380
19123648,2008-11-01T00:00:00,Luminescent Measurements,E05.196.712.516
19123648,2008-11-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19123648,2008-11-01T00:00:00,"Microscopy, Confocal",E05.595.395
19123648,2008-11-01T00:00:00,"Microscopy, Fluorescence, Multiphoton",E01.370.350.515.458.500
19123648,2008-11-01T00:00:00,"Microscopy, Fluorescence, Multiphoton",E05.595.458.500
19123648,2008-11-01T00:00:00,"Phantoms, Imaging",E07.671
19123648,2008-11-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
19123648,2008-11-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
19123648,2008-11-01T00:00:00,Sensitivity and Specificity,G17.800
19123648,2008-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19123648,2008-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19123648,2008-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19123648,2008-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19123648,2008-11-01T00:00:00,Subtraction Technique,E01.370.350.760
19128205,2008-11-01T00:00:00,Animals,B01.050
19128205,2008-11-01T00:00:00,Brain,A08.186.211
19128205,2008-11-01T00:00:00,Cocaine,D02.145.074.722.388
19128205,2008-11-01T00:00:00,Cocaine,D03.132.889.354
19128205,2008-11-01T00:00:00,Cocaine,D03.605.869.388
19128205,2008-11-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
19128205,2008-11-01T00:00:00,Cocaine-Related Disorders,C21.739.300
19128205,2008-11-01T00:00:00,Cocaine-Related Disorders,F03.900.300
19128205,2008-11-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
19128205,2008-11-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
19128205,2008-11-01T00:00:00,Glutamic Acid,D12.125.067.750
19128205,2008-11-01T00:00:00,Glutamic Acid,D12.125.119.450
19128205,2008-11-01T00:00:00,Glutamic Acid,D12.125.427.300
19128205,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19128205,2008-11-01T00:00:00,Signal Transduction,G02.111.087.800
19128205,2008-11-01T00:00:00,Signal Transduction,G02.149.115.800
19128205,2008-11-01T00:00:00,Signal Transduction,G04.299.880
19128205,2008-11-01T00:00:00,Synaptic Transmission,G02.111.087.800.850
19128205,2008-11-01T00:00:00,Synaptic Transmission,G02.149.115.800.850
19128205,2008-11-01T00:00:00,Synaptic Transmission,G04.299.880.850
19128205,2008-11-01T00:00:00,Synaptic Transmission,G07.265.337.900
19128205,2008-11-01T00:00:00,Synaptic Transmission,G07.700.240.900
19128205,2008-11-01T00:00:00,Synaptic Transmission,G11.561.600.835
19178805,2008-11-01T00:00:00,Cadaver,C23.550.260.224
19178805,2008-11-01T00:00:00,Clinical Competence,I02.399.630.210
19178805,2008-11-01T00:00:00,Clinical Competence,N04.761.210
19178805,2008-11-01T00:00:00,Endoscopy,E01.370.388.250
19178805,2008-11-01T00:00:00,Endoscopy,E04.800.250
19178805,2008-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19178805,2008-11-01T00:00:00,Paranasal Sinuses,A04.531.621
19178805,2008-11-01T00:00:00,Skull Base,A01.456.830
19178805,2008-11-01T00:00:00,Skull Base,A02.835.232.781.750
19178805,2008-11-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
19178805,2008-11-01T00:00:00,"Surgery, Computer-Assisted",E04.749
19178805,2008-11-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
19178805,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19178805,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19178805,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19178805,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19178805,2008-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18986991,2008-11-04T00:00:00,Amino Acid Sequence,G02.111.570.060
18986991,2008-11-04T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18986991,2008-11-04T00:00:00,Catalytic Domain,G02.111.570.120.704
18986991,2008-11-04T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
18986991,2008-11-04T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
18986991,2008-11-04T00:00:00,"Models, Molecular",E05.599.595
18986991,2008-11-04T00:00:00,Molecular Sequence Data,L01.453.245.667
18986991,2008-11-04T00:00:00,Mutation,G05.365.590
18986991,2008-11-04T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
18986991,2008-11-04T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
18986991,2008-11-04T00:00:00,Penicillin-Binding Proteins,D08.811.710
18986991,2008-11-04T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
18986991,2008-11-04T00:00:00,Protein Denaturation,G02.111.087.685
18986991,2008-11-04T00:00:00,Protein Denaturation,G02.149.115.685
18986991,2008-11-04T00:00:00,Temperature,G01.906.595
18986991,2008-11-04T00:00:00,Temperature,G16.500.275.063.725.710
18986991,2008-11-04T00:00:00,Temperature,G16.500.750.775.710
18986991,2008-11-04T00:00:00,Temperature,N06.230.150.450
18986991,2008-11-04T00:00:00,Temperature,N06.230.300.100.725.710
18980799,2008-11-05T00:00:00,Aged,M01.060.116.100
18980799,2008-11-05T00:00:00,Brain Infarction,C10.228.140.300.150.477
18980799,2008-11-05T00:00:00,Brain Infarction,C10.228.140.300.775.200
18980799,2008-11-05T00:00:00,Brain Infarction,C14.907.253.092.477
18980799,2008-11-05T00:00:00,Brain Infarction,C14.907.253.855.200
18980799,2008-11-05T00:00:00,Brain Ischemia,C10.228.140.300.150
18980799,2008-11-05T00:00:00,Brain Ischemia,C14.907.253.092
18980799,2008-11-05T00:00:00,C-Reactive Protein,D12.776.034.145
18980799,2008-11-05T00:00:00,C-Reactive Protein,D12.776.124.050.120
18980799,2008-11-05T00:00:00,C-Reactive Protein,D12.776.124.486.157
18980799,2008-11-05T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
18980799,2008-11-05T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
18980799,2008-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18980799,2008-11-05T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18980799,2008-11-05T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
18980799,2008-11-05T00:00:00,Metabolic Syndrome X,C18.452.625
18980799,2008-11-05T00:00:00,Middle Aged,M01.060.116.630
18980799,2008-11-05T00:00:00,Regression Analysis,E05.318.740.750
18980799,2008-11-05T00:00:00,Regression Analysis,N05.715.360.750.695
18980799,2008-11-05T00:00:00,Regression Analysis,N06.850.520.830.750
18980799,2008-11-05T00:00:00,Risk Factors,E05.318.740.600.800.725
18980799,2008-11-05T00:00:00,Risk Factors,N05.715.350.200.700
18980799,2008-11-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18980799,2008-11-05T00:00:00,Risk Factors,N06.850.490.625.750
18980799,2008-11-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18980799,2008-11-05T00:00:00,Stroke,C10.228.140.300.775
18980799,2008-11-05T00:00:00,Stroke,C14.907.253.855
18985316,2008-11-05T00:00:00,Adult,M01.060.116
18985316,2008-11-05T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
18985316,2008-11-05T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
18985316,2008-11-05T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
18985316,2008-11-05T00:00:00,"Antigens, CD",D23.050.301.264.035
18985316,2008-11-05T00:00:00,"Antigens, CD",D23.101.100.110
18985316,2008-11-05T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
18985316,2008-11-05T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
18985316,2008-11-05T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
18985316,2008-11-05T00:00:00,Eye Proteins,D12.776.306
18985316,2008-11-05T00:00:00,Growth Hormone,D06.472.699.631.525.425
18985316,2008-11-05T00:00:00,Growth Hormone,D12.644.548.691.525.425
18985316,2008-11-05T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
18985316,2008-11-05T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
18985316,2008-11-05T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
18985316,2008-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18985316,2008-11-05T00:00:00,Membrane Proteins,D12.776.543
18985316,2008-11-05T00:00:00,Pre-Eclampsia,C13.703.395.249
18985316,2008-11-05T00:00:00,Pregnancy,G08.686.785.760.769
18985316,2008-11-05T00:00:00,Pregnancy Complications,C13.703
18985316,2008-11-05T00:00:00,"Receptors, Cell Surface",D12.776.543.750
18985316,2008-11-05T00:00:00,Serpins,D12.644.822.750
18985316,2008-11-05T00:00:00,Serpins,D12.644.861
18985316,2008-11-05T00:00:00,Serpins,D12.776.645.750
18985316,2008-11-05T00:00:00,Serpins,D12.776.872
18985316,2008-11-05T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D08.811.913.696.620.682.725.400.950.100
18985316,2008-11-05T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.060.750.100
18985316,2008-11-05T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.750.400.910.100
18987115,2008-11-05T00:00:00,Animals,B01.050
18987115,2008-11-05T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
18987115,2008-11-05T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
18987115,2008-11-05T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
18987115,2008-11-05T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
18987115,2008-11-05T00:00:00,Glomerulonephritis,C12.777.419.570.363
18987115,2008-11-05T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
18987115,2008-11-05T00:00:00,Kidney Glomerulus,A05.810.453.324.359
18987115,2008-11-05T00:00:00,Kidney Glomerulus,A05.810.453.736.520
18987115,2008-11-05T00:00:00,Protein Isoforms,D12.776.800
18987115,2008-11-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18990698,2008-11-06T00:00:00,Animals,B01.050
18990698,2008-11-06T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18990698,2008-11-06T00:00:00,Glutathione,D12.644.456.448
18990698,2008-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18990698,2008-11-06T00:00:00,Neoplasm Proteins,D12.776.624
18990698,2008-11-06T00:00:00,Neoplasms,C04
18990698,2008-11-06T00:00:00,Oxidative Stress,G03.495.710
18990698,2008-11-06T00:00:00,Oxidative Stress,G07.700.830.750
18990698,2008-11-06T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
18990698,2008-11-06T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
18990698,2008-11-06T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
18990698,2008-11-06T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
18990698,2008-11-06T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
18990698,2008-11-06T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
18997675,2008-11-06T00:00:00,Adult,M01.060.116
18997675,2008-11-06T00:00:00,Animals,B01.050
18997675,2008-11-06T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
18997675,2008-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18997675,2008-11-06T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
18997675,2008-11-06T00:00:00,Naltrexone,D03.132.577.249.706.550
18997675,2008-11-06T00:00:00,Naltrexone,D03.549.686.750.550
18997675,2008-11-06T00:00:00,Naltrexone,D03.605.497.750.550
18997675,2008-11-06T00:00:00,Naltrexone,D04.615.723.795.706.550
18997675,2008-11-06T00:00:00,Narcotic Antagonists,D27.505.696.543
18997675,2008-11-06T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
18997675,2008-11-06T00:00:00,Narcotic Antagonists,D27.505.954.427.550
18997675,2008-11-06T00:00:00,Obesity,C18.654.726.500
18997675,2008-11-06T00:00:00,Obesity,C23.888.144.699.500
18997675,2008-11-06T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18997675,2008-11-06T00:00:00,Obesity,G07.100.100.160.120.699.500
18997675,2008-11-06T00:00:00,United States,Z01.107.567.875
18997675,2008-11-06T00:00:00,Weight Loss,C23.888.144.243.963
18997675,2008-11-06T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18999159,2008-11-06T00:00:00,Breast Neoplasms,C04.588.180
18999159,2008-11-06T00:00:00,Breast Neoplasms,C17.800.090.500
18999159,2008-11-06T00:00:00,Computer Simulation,L01.224.160
18999159,2008-11-06T00:00:00,"Diagnosis, Computer-Assisted",E01.158
18999159,2008-11-06T00:00:00,"Diagnosis, Computer-Assisted",L01.700.508.100.158
18999159,2008-11-06T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18999159,2008-11-06T00:00:00,Genetic Predisposition to Disease,G05.380.355
18999159,2008-11-06T00:00:00,Genetic Testing,E01.370.427
18999159,2008-11-06T00:00:00,Genetic Testing,E05.393.435
18999159,2008-11-06T00:00:00,Genetic Testing,N02.421.143.827.233.221
18999159,2008-11-06T00:00:00,Genetic Testing,N02.421.308.430
18999159,2008-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18999159,2008-11-06T00:00:00,"Models, Genetic",E05.599.395.397
18999159,2008-11-06T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18999159,2008-11-06T00:00:00,Risk Assessment,E05.318.740.600.800.715
18999159,2008-11-06T00:00:00,Risk Assessment,N04.452.871.715
18999159,2008-11-06T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18999159,2008-11-06T00:00:00,Risk Assessment,N06.850.505.715
18999159,2008-11-06T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18999159,2008-11-06T00:00:00,Risk Factors,E05.318.740.600.800.725
18999159,2008-11-06T00:00:00,Risk Factors,N05.715.350.200.700
18999159,2008-11-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18999159,2008-11-06T00:00:00,Risk Factors,N06.850.490.625.750
18999159,2008-11-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18999255,2008-11-06T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18999255,2008-11-06T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18999255,2008-11-06T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18999255,2008-11-06T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18999255,2008-11-06T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18999255,2008-11-06T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18999255,2008-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18999255,2008-11-06T00:00:00,Mutation,G05.365.590
18999255,2008-11-06T00:00:00,Neoplasm Proteins,D12.776.624
18999255,2008-11-06T00:00:00,"Tumor Markers, Biological",D23.101.840
19038680,2008-11-07T00:00:00,Aged,M01.060.116.100
19038680,2008-11-07T00:00:00,"Cardiac Pacing, Artificial",E02.145
19038680,2008-11-07T00:00:00,Cross-Over Studies,E05.318.780.150
19038680,2008-11-07T00:00:00,Cross-Over Studies,N05.715.360.780.150
19038680,2008-11-07T00:00:00,Cross-Over Studies,N06.850.520.445.150
19038680,2008-11-07T00:00:00,Heart,A07.541
19038680,2008-11-07T00:00:00,Heart Failure,C14.280.434
19038680,2008-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19038680,2008-11-07T00:00:00,Middle Aged,M01.060.116.630
19038680,2008-11-07T00:00:00,Treatment Outcome,E01.789.800
19038680,2008-11-07T00:00:00,Treatment Outcome,N04.761.559.590.800
19038680,2008-11-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19038680,2008-11-07T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
19038680,2008-11-07T00:00:00,Ventricular Remodeling,C23.300.985
19038680,2008-11-07T00:00:00,Ventricular Remodeling,G09.330.190.962.975
19006645,2008-11-08T00:00:00,Apoptosis,G04.299.139.160
19006645,2008-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19006645,2008-11-08T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19006645,2008-11-08T00:00:00,Prostatic Neoplasms,C12.294.260.750
19006645,2008-11-08T00:00:00,Prostatic Neoplasms,C12.294.565.625
19006645,2008-11-08T00:00:00,Prostatic Neoplasms,C12.758.409.750
19006645,2008-11-08T00:00:00,"Receptors, Transferrin",D12.776.157.905.500
19006645,2008-11-08T00:00:00,"Receptors, Transferrin",D12.776.543.750.850
19006645,2008-11-08T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19006645,2008-11-08T00:00:00,Transferrin,D12.776.124.050.800
19006645,2008-11-08T00:00:00,Transferrin,D12.776.124.790.223.839
19006645,2008-11-08T00:00:00,Transferrin,D12.776.157.427.500
19006645,2008-11-08T00:00:00,Transferrin,D12.776.377.715.182.839
19006645,2008-11-08T00:00:00,Transferrin,D12.776.556.579.500
19001022,2008-11-10T00:00:00,Blood Glucose,D09.546.359.448.500
19001022,2008-11-10T00:00:00,Cardiac Surgical Procedures,E04.100.376
19001022,2008-11-10T00:00:00,Cardiac Surgical Procedures,E04.928.220
19001022,2008-11-10T00:00:00,Child,M01.060.406
19001022,2008-11-10T00:00:00,"Child, Preschool",M01.060.406.448
19001022,2008-11-10T00:00:00,"Heart Defects, Congenital",C14.240.400
19001022,2008-11-10T00:00:00,"Heart Defects, Congenital",C14.280.400
19001022,2008-11-10T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19001022,2008-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19001022,2008-11-10T00:00:00,Hyperglycemia,C18.452.394.952
19001022,2008-11-10T00:00:00,Hypoglycemic Agents,D27.505.696.422
19001022,2008-11-10T00:00:00,"Infant, Newborn",M01.060.703.520
19001022,2008-11-10T00:00:00,"Infant, Premature",M01.060.703.520.520
19001022,2008-11-10T00:00:00,Insulin,D06.472.699.587.740.625
19001022,2008-11-10T00:00:00,Insulin,D12.644.548.586.740.625
19001022,2008-11-10T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
19001022,2008-11-10T00:00:00,"Monitoring, Intraoperative",E04.510
19001092,2008-11-10T00:00:00,Animals,B01.050
19001092,2008-11-10T00:00:00,Cell Line,A11.251.210
19001092,2008-11-10T00:00:00,Collagen,D05.750.078.280
19001092,2008-11-10T00:00:00,Collagen,D12.776.860.300.250
19001092,2008-11-10T00:00:00,Collagen Type I,D05.750.078.280.300.100
19001092,2008-11-10T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
19001092,2008-11-10T00:00:00,Down-Regulation,G02.111.087.225
19001092,2008-11-10T00:00:00,Down-Regulation,G02.149.115.225
19001092,2008-11-10T00:00:00,Down-Regulation,G05.355.315.200
19001092,2008-11-10T00:00:00,Down-Regulation,G07.690.812.230
19001092,2008-11-10T00:00:00,Down-Regulation,G07.700.680.230
19001092,2008-11-10T00:00:00,Fibroblasts,A11.329.228
19001092,2008-11-10T00:00:00,Fibroblasts,A11.872.228
19001092,2008-11-10T00:00:00,Gene Expression Regulation,G05.355.315
19001092,2008-11-10T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19001092,2008-11-10T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19001092,2008-11-10T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19001092,2008-11-10T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
19001092,2008-11-10T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
19001092,2008-11-10T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
19001092,2008-11-10T00:00:00,Skin,A17.815
19581953,2008-11-10T00:00:00,Computer-Aided Design,L01.224.108.150
19581953,2008-11-10T00:00:00,Computer-Aided Design,L01.296.110.150
19581953,2008-11-10T00:00:00,Crystallization,E05.196.300
19581953,2008-11-10T00:00:00,Crystallization,G02.149.767.505
19581953,2008-11-10T00:00:00,Crystallization,G02.842.750.505
19581953,2008-11-10T00:00:00,Equipment Failure Analysis,E05.325.192
19581953,2008-11-10T00:00:00,Materials Testing,E05.570
19581953,2008-11-10T00:00:00,Optical Fibers,E07.632.750
19581953,2008-11-10T00:00:00,Sensitivity and Specificity,E05.318.740.872
19581953,2008-11-10T00:00:00,Sensitivity and Specificity,E05.318.780.800
19581953,2008-11-10T00:00:00,Sensitivity and Specificity,G17.800
19581953,2008-11-10T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19581953,2008-11-10T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19581953,2008-11-10T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19581953,2008-11-10T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19001508,2008-11-11T00:00:00,Aged,M01.060.116.100
19001508,2008-11-11T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
19001508,2008-11-11T00:00:00,Cardiovascular Diseases,C14
19001508,2008-11-11T00:00:00,Heart Failure,C14.280.434
19001508,2008-11-11T00:00:00,Hospitalization,E02.760.400
19001508,2008-11-11T00:00:00,Hospitalization,N02.421.585.400
19001508,2008-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19001508,2008-11-11T00:00:00,Middle Aged,M01.060.116.630
19001508,2008-11-11T00:00:00,Quality of Life,I01.800
19001508,2008-11-11T00:00:00,Quality of Life,K01.752.400.750
19001508,2008-11-11T00:00:00,Stroke Volume,E01.370.370.380.150.700
19001508,2008-11-11T00:00:00,Stroke Volume,G09.330.380.124.882
19014900,2008-11-11T00:00:00,Animals,B01.050
19014900,2008-11-11T00:00:00,Ethanol,D02.033.375
19014900,2008-11-11T00:00:00,Hepatocytes,A11.436.348
19014900,2008-11-11T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
19014900,2008-11-11T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
19014900,2008-11-11T00:00:00,Oxygen Consumption,G03.730
19014900,2008-11-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19002671,2008-11-12T00:00:00,Adult,M01.060.116
19002671,2008-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19002671,2008-11-12T00:00:00,Marijuana Abuse,C21.739.635
19002671,2008-11-12T00:00:00,Marijuana Abuse,F03.900.635
19002671,2008-11-12T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19002671,2008-11-12T00:00:00,Questionnaires,E05.318.308.750
19002671,2008-11-12T00:00:00,Questionnaires,L01.280.800
19002671,2008-11-12T00:00:00,Questionnaires,N05.715.360.300.695
19002671,2008-11-12T00:00:00,Questionnaires,N06.850.520.308.750
19002671,2008-11-12T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19002671,2008-11-12T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19002671,2008-11-12T00:00:00,Young Adult,M01.060.116.815
19008064,2008-11-12T00:00:00,Calcinosis,C18.452.174.130
19008064,2008-11-12T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19008064,2008-11-12T00:00:00,Coronary Angiography,E01.370.370.050.200
19008064,2008-11-12T00:00:00,Coronary Angiography,E01.370.370.380.200
19008064,2008-11-12T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19008064,2008-11-12T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19008064,2008-11-12T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19008064,2008-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19008064,2008-11-12T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19008064,2008-11-12T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19008064,2008-11-12T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19008064,2008-11-12T00:00:00,Sensitivity and Specificity,E05.318.740.872
19008064,2008-11-12T00:00:00,Sensitivity and Specificity,E05.318.780.800
19008064,2008-11-12T00:00:00,Sensitivity and Specificity,G17.800
19008064,2008-11-12T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19008064,2008-11-12T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19008064,2008-11-12T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19008064,2008-11-12T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19008064,2008-11-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19008064,2008-11-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19008064,2008-11-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19008064,2008-11-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19008064,2008-11-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19081391,2008-11-12T00:00:00,Adrenal Cortex Hormones,D06.472.040
19081391,2008-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19081391,2008-11-12T00:00:00,Sarcoidosis,C15.604.515.827
19008067,2008-11-13T00:00:00,Bias (Epidemiology),N05.715.350.150
19008067,2008-11-13T00:00:00,Bias (Epidemiology),N06.850.490.500
19008067,2008-11-13T00:00:00,Clinical Trials as Topic,E05.318.760.535
19008067,2008-11-13T00:00:00,Clinical Trials as Topic,E05.337.250
19008067,2008-11-13T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19008067,2008-11-13T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19008067,2008-11-13T00:00:00,Computer Simulation,L01.224.160
19008067,2008-11-13T00:00:00,"Data Interpretation, Statistical",E05.245.380
19008067,2008-11-13T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19008067,2008-11-13T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19008067,2008-11-13T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19008067,2008-11-13T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19008067,2008-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19008067,2008-11-13T00:00:00,"Models, Statistical",E05.318.740.500
19008067,2008-11-13T00:00:00,"Models, Statistical",E05.599.835
19008067,2008-11-13T00:00:00,"Models, Statistical",N05.715.360.750.530
19008067,2008-11-13T00:00:00,"Models, Statistical",N06.850.520.830.500
19008067,2008-11-13T00:00:00,Patient Dropouts,M01.643.673
19008067,2008-11-13T00:00:00,Substance-Related Disorders,C21.739
19008067,2008-11-13T00:00:00,Substance-Related Disorders,F03.900
19008067,2008-11-13T00:00:00,Treatment Outcome,E01.789.800
19008067,2008-11-13T00:00:00,Treatment Outcome,N04.761.559.590.800
19008067,2008-11-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19008117,2008-11-13T00:00:00,Animals,B01.050
19008117,2008-11-13T00:00:00,Fatty Acids,D10.251
19008117,2008-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19008117,2008-11-13T00:00:00,Insulin Resistance,C18.452.394.968.500
19008117,2008-11-13T00:00:00,Insulin Resistance,G07.690.320.617
19008117,2008-11-13T00:00:00,Metabolic Diseases,C18.452
19008117,2008-11-13T00:00:00,"Models, Biological",E05.599.395
19008117,2008-11-13T00:00:00,Obesity,C18.654.726.500
19008117,2008-11-13T00:00:00,Obesity,C23.888.144.699.500
19008117,2008-11-13T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19008117,2008-11-13T00:00:00,Obesity,G07.100.100.160.120.699.500
19008117,2008-11-13T00:00:00,Sphingolipids,D10.570.877
19008117,2008-11-13T00:00:00,Sphingolipids,D10.808
19008457,2008-11-13T00:00:00,Algorithms,G17.035
19008457,2008-11-13T00:00:00,Algorithms,L01.224.050
19008457,2008-11-13T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
19008457,2008-11-13T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
19008457,2008-11-13T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
19008457,2008-11-13T00:00:00,Clinical Laboratory Techniques,E05.200
19008457,2008-11-13T00:00:00,Fibrin,D12.776.124.270
19008457,2008-11-13T00:00:00,Fibrin Fibrinogen Degradation Products,D12.776.124.270.300
19008457,2008-11-13T00:00:00,Fibrin Fibrinogen Degradation Products,D12.776.811.300.290
19008457,2008-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19008457,2008-11-13T00:00:00,"Models, Biological",E05.599.395
19008457,2008-11-13T00:00:00,Pulmonary Embolism,C08.381.746
19008457,2008-11-13T00:00:00,Pulmonary Embolism,C14.907.355.350.700
19008457,2008-11-13T00:00:00,Venous Thromboembolism,C14.907.355.590.700
19008457,2008-11-13T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
19008457,2008-11-13T00:00:00,Venous Thrombosis,C14.907.355.830.925
19008490,2008-11-13T00:00:00,Adult,M01.060.116
19008490,2008-11-13T00:00:00,Anoxia,C23.888.852.079
19008490,2008-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19008490,2008-11-13T00:00:00,Lymphocytes,A11.118.637.555.567
19008490,2008-11-13T00:00:00,Lymphocytes,A15.145.229.637.555.567
19008490,2008-11-13T00:00:00,Lymphocytes,A15.382.490.555.567
19008490,2008-11-13T00:00:00,Oxygen,D01.268.185.550
19008490,2008-11-13T00:00:00,Oxygen,D01.362.670
19008490,2008-11-13T00:00:00,Phenotype,G05.695
19008490,2008-11-13T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
19008490,2008-11-13T00:00:00,"RNA, Messenger",D13.444.735.544
19008490,2008-11-13T00:00:00,"Transcription, Genetic",G02.111.087.847
19008490,2008-11-13T00:00:00,"Transcription, Genetic",G02.149.115.847
19008490,2008-11-13T00:00:00,"Transcription, Genetic",G05.355.310.700
19008490,2008-11-13T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19008490,2008-11-13T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19008490,2008-11-13T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19008490,2008-11-13T00:00:00,Young Adult,M01.060.116.815
19037915,2008-11-14T00:00:00,Animals,B01.050
19037915,2008-11-14T00:00:00,Gene Expression Regulation,G05.355.315
19037915,2008-11-14T00:00:00,Hair,A17.360
19037915,2008-11-14T00:00:00,Homeodomain Proteins,D12.776.260.400
19037915,2008-11-14T00:00:00,Mutation,G05.365.590
18804287,2008-11-15T00:00:00,Animals,B01.050
18804287,2008-11-15T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18804287,2008-11-15T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18804287,2008-11-15T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18804287,2008-11-15T00:00:00,Central Nervous System,A08.186
18804287,2008-11-15T00:00:00,Cytokines,D12.644.276.374
18804287,2008-11-15T00:00:00,Cytokines,D12.776.467.374
18804287,2008-11-15T00:00:00,Cytokines,D23.529.374
18804287,2008-11-15T00:00:00,Down-Regulation,G02.111.087.225
18804287,2008-11-15T00:00:00,Down-Regulation,G02.149.115.225
18804287,2008-11-15T00:00:00,Down-Regulation,G05.355.315.200
18804287,2008-11-15T00:00:00,Down-Regulation,G07.690.812.230
18804287,2008-11-15T00:00:00,Down-Regulation,G07.700.680.230
18804287,2008-11-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
18804287,2008-11-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
18804287,2008-11-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
18804287,2008-11-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
18804287,2008-11-15T00:00:00,Glycoproteins,D09.400.430
18804287,2008-11-15T00:00:00,Glycoproteins,D12.776.395
18804287,2008-11-15T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18804287,2008-11-15T00:00:00,Interleukin-6,D12.644.276.374.465.506
18804287,2008-11-15T00:00:00,Interleukin-6,D12.776.467.374.465.506
18804287,2008-11-15T00:00:00,Interleukin-6,D23.529.374.465.506
18804287,2008-11-15T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
18804287,2008-11-15T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
18804287,2008-11-15T00:00:00,Peptide Fragments,D12.644.541
18804287,2008-11-15T00:00:00,Peptides,D12.644
18804287,2008-11-15T00:00:00,"RNA, Messenger",D13.444.735.544
18804287,2008-11-15T00:00:00,"Receptors, Antigen, T-Cell",D12.776.543.750.705.816.824
19006243,2008-11-15T00:00:00,Aged,M01.060.116.100
19006243,2008-11-15T00:00:00,Cardiovascular Diseases,C14
19006243,2008-11-15T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19006243,2008-11-15T00:00:00,Coronary Angiography,E01.370.370.050.200
19006243,2008-11-15T00:00:00,Coronary Angiography,E01.370.370.380.200
19006243,2008-11-15T00:00:00,Embolism,C14.907.355.350
19006243,2008-11-15T00:00:00,Filtration,E05.196.454
19006243,2008-11-15T00:00:00,Filtration,G01.595.280
19006243,2008-11-15T00:00:00,Filtration,G02.149.767.600
19006243,2008-11-15T00:00:00,Filtration,G02.842.750.600
19006243,2008-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19006243,2008-11-15T00:00:00,Prosthesis Design,E05.320.550
19006243,2008-11-15T00:00:00,Prosthesis Design,E07.695.680
19006243,2008-11-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
19006243,2008-11-15T00:00:00,Risk Assessment,N04.452.871.715
19006243,2008-11-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19006243,2008-11-15T00:00:00,Risk Assessment,N06.850.505.715
19006243,2008-11-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19006243,2008-11-15T00:00:00,Stents,E07.695.750
19006243,2008-11-15T00:00:00,Treatment Outcome,E01.789.800
19006243,2008-11-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19006243,2008-11-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19006243,2008-11-15T00:00:00,Vascular Patency,G09.330.920
19011532,2008-11-15T00:00:00,Adult,M01.060.116
19011532,2008-11-15T00:00:00,Aged,M01.060.116.100
19011532,2008-11-15T00:00:00,Bone Plates,E07.695.125
19011532,2008-11-15T00:00:00,Bone Plates,E07.858.442.660.110
19011532,2008-11-15T00:00:00,Bone Plates,E07.858.690.650.110
19011532,2008-11-15T00:00:00,Bone Screws,E07.695.130
19011532,2008-11-15T00:00:00,Bone Screws,E07.858.442.660.115
19011532,2008-11-15T00:00:00,Bone Screws,E07.858.690.650.115
19011532,2008-11-15T00:00:00,Cadaver,C23.550.260.224
19011532,2008-11-15T00:00:00,Cervical Vertebrae,A02.835.232.834.151
19011532,2008-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19011532,2008-11-15T00:00:00,Materials Testing,E05.570
19011532,2008-11-15T00:00:00,Middle Aged,M01.060.116.630
19011532,2008-11-15T00:00:00,Prosthesis Design,E05.320.550
19011532,2008-11-15T00:00:00,Prosthesis Design,E07.695.680
19011532,2008-11-15T00:00:00,Spinal Fusion,E04.555.100.700
19011532,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19011532,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19011532,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19011532,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19011532,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19011532,2008-11-15T00:00:00,Young Adult,M01.060.116.815
19011863,2008-11-15T00:00:00,Aged,M01.060.116.100
19011863,2008-11-15T00:00:00,Atherosclerosis,C14.907.137.126.307
19011863,2008-11-15T00:00:00,Blood Vessels,A07.231
19011863,2008-11-15T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19011863,2008-11-15T00:00:00,Coronary Angiography,E01.370.370.050.200
19011863,2008-11-15T00:00:00,Coronary Angiography,E01.370.370.380.200
19011863,2008-11-15T00:00:00,Coronary Vessels,A07.231.114.269
19011863,2008-11-15T00:00:00,Coronary Vessels,A07.231.908.194
19011863,2008-11-15T00:00:00,"Endothelium, Vascular",A07.231.330
19011863,2008-11-15T00:00:00,"Endothelium, Vascular",A10.272.491.355
19011863,2008-11-15T00:00:00,Hemodynamics,G09.330.190.400
19011863,2008-11-15T00:00:00,Hemodynamics,G09.330.380
19011863,2008-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19011863,2008-11-15T00:00:00,Middle Aged,M01.060.116.630
19011863,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19011863,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19011863,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19011863,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19011863,2008-11-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19018133,2008-11-15T00:00:00,Age Factors,N05.715.350.075
19018133,2008-11-15T00:00:00,Age Factors,N06.850.490.250
19018133,2008-11-15T00:00:00,Aged,M01.060.116.100
19018133,2008-11-15T00:00:00,Atherosclerosis,C14.907.137.126.307
19018133,2008-11-15T00:00:00,California,Z01.107.567.875.580.200
19018133,2008-11-15T00:00:00,California,Z01.107.567.875.760.200
19018133,2008-11-15T00:00:00,Ethnic Groups,M01.686.754
19018133,2008-11-15T00:00:00,Ethnic Groups,N01.224.317
19018133,2008-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19018133,2008-11-15T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19018133,2008-11-15T00:00:00,Metabolic Syndrome X,C18.452.625
19018133,2008-11-15T00:00:00,Middle Aged,M01.060.116.630
19018133,2008-11-15T00:00:00,Risk Factors,E05.318.740.600.800.725
19018133,2008-11-15T00:00:00,Risk Factors,N05.715.350.200.700
19018133,2008-11-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19018133,2008-11-15T00:00:00,Risk Factors,N06.850.490.625.750
19018133,2008-11-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19018133,2008-11-15T00:00:00,Smoking,F01.145.466.753
19018133,2008-11-15T00:00:00,Stroke,C10.228.140.300.775
19018133,2008-11-15T00:00:00,Stroke,C14.907.253.855
19010609,2008-11-17T00:00:00,Amphetamine-Related Disorders,C21.739.225
19010609,2008-11-17T00:00:00,Amphetamine-Related Disorders,F03.900.225
19010609,2008-11-17T00:00:00,Animals,B01.050
19010609,2008-11-17T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19010609,2008-11-17T00:00:00,Methamphetamine,D02.092.471.683.152.619
19010609,2008-11-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19010609,2008-11-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19010609,2008-11-17T00:00:00,Self Administration,E02.319.890
19010609,2008-11-17T00:00:00,Self Administration,E02.900.890
19015280,2008-11-17T00:00:00,"Child, Preschool",M01.060.406.448
19015280,2008-11-17T00:00:00,Emergency Medical Services,N02.421.297
19015280,2008-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19015280,2008-11-17T00:00:00,Infant,M01.060.703
19015280,2008-11-17T00:00:00,Regression Analysis,E05.318.740.750
19015280,2008-11-17T00:00:00,Regression Analysis,N05.715.360.750.695
19015280,2008-11-17T00:00:00,Regression Analysis,N06.850.520.830.750
19007692,2008-11-18T00:00:00,Adult,M01.060.116
19007692,2008-11-18T00:00:00,Aged,M01.060.116.100
19007692,2008-11-18T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
19007692,2008-11-18T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
19007692,2008-11-18T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19007692,2008-11-18T00:00:00,Catheter Ablation,E02.148.110
19007692,2008-11-18T00:00:00,Catheter Ablation,E02.148.442.110
19007692,2008-11-18T00:00:00,Catheter Ablation,E02.154.402.110
19007692,2008-11-18T00:00:00,Catheter Ablation,E04.014.170.402.110
19007692,2008-11-18T00:00:00,Combined Modality Therapy,E02.186
19007692,2008-11-18T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
19007692,2008-11-18T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
19007692,2008-11-18T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
19007692,2008-11-18T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
19007692,2008-11-18T00:00:00,"Defibrillators, Implantable",E07.695.175
19007692,2008-11-18T00:00:00,Ethanol,D02.033.375
19007692,2008-11-18T00:00:00,Heart Septum,A07.541.459
19007692,2008-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19007692,2008-11-18T00:00:00,Middle Aged,M01.060.116.630
19007692,2008-11-18T00:00:00,Primary Prevention,N02.421.726.758
19007692,2008-11-18T00:00:00,Primary Prevention,N06.850.780.680
19007692,2008-11-18T00:00:00,Probability,E05.318.740.600
19007692,2008-11-18T00:00:00,Probability,G17.680
19007692,2008-11-18T00:00:00,Probability,N05.715.360.750.625
19007692,2008-11-18T00:00:00,Probability,N06.850.520.830.600
19007692,2008-11-18T00:00:00,Risk Assessment,E05.318.740.600.800.715
19007692,2008-11-18T00:00:00,Risk Assessment,N04.452.871.715
19007692,2008-11-18T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19007692,2008-11-18T00:00:00,Risk Assessment,N06.850.505.715
19007692,2008-11-18T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19007692,2008-11-18T00:00:00,Treatment Outcome,E01.789.800
19007692,2008-11-18T00:00:00,Treatment Outcome,N04.761.559.590.800
19007692,2008-11-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19015662,2008-11-18T00:00:00,Blood Glucose,D09.546.359.448.500
19015662,2008-11-18T00:00:00,"Cholesterol, HDL",D10.532.432.400
19015662,2008-11-18T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
19015662,2008-11-18T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
19015662,2008-11-18T00:00:00,Combined Modality Therapy,E02.186
19015662,2008-11-18T00:00:00,"Diet, Reducing",E02.642.249.285
19015662,2008-11-18T00:00:00,"Diet, Reducing",G07.610.240.285
19015662,2008-11-18T00:00:00,Dietary Carbohydrates,D09.301
19015662,2008-11-18T00:00:00,Dietary Carbohydrates,J02.500.362
19015662,2008-11-18T00:00:00,Exercise Therapy,E02.779.483
19015662,2008-11-18T00:00:00,Exercise Therapy,E02.831.387
19015662,2008-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19015662,2008-11-18T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19015662,2008-11-18T00:00:00,Metabolic Syndrome X,C18.452.625
19015662,2008-11-18T00:00:00,Middle Aged,M01.060.116.630
19015662,2008-11-18T00:00:00,Remission Induction,E02.860
19015662,2008-11-18T00:00:00,Weight Loss,C23.888.144.243.963
19015662,2008-11-18T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19018011,2008-11-18T00:00:00,Animals,B01.050
19018011,2008-11-18T00:00:00,Cell Adhesion,G04.299.117
19018011,2008-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19018011,2008-11-18T00:00:00,MicroRNAs,D13.150.650.319
19018011,2008-11-18T00:00:00,MicroRNAs,D13.444.735.150.319
19018011,2008-11-18T00:00:00,MicroRNAs,D13.444.735.790.099
19018011,2008-11-18T00:00:00,"Models, Biological",E05.599.395
19018011,2008-11-18T00:00:00,"RNA Processing, Post-Transcriptional",G02.111.087.750
19018011,2008-11-18T00:00:00,"RNA Processing, Post-Transcriptional",G02.149.115.750
19018011,2008-11-18T00:00:00,"RNA Processing, Post-Transcriptional",G03.495.839
19018011,2008-11-18T00:00:00,"RNA Processing, Post-Transcriptional",G05.355.315.700
19018011,2008-11-18T00:00:00,Signal Transduction,G02.111.087.800
19018011,2008-11-18T00:00:00,Signal Transduction,G02.149.115.800
19018011,2008-11-18T00:00:00,Signal Transduction,G04.299.880
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D23.529.374.687
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
19018011,2008-11-18T00:00:00,Transforming Growth Factor beta,D23.529.960.720
19084053,2008-11-18T00:00:00,Action Potentials,G04.580.100
19084053,2008-11-18T00:00:00,Action Potentials,G07.265.750.100
19084053,2008-11-18T00:00:00,Action Potentials,G11.561.570.100
19084053,2008-11-18T00:00:00,Animals,B01.050
19084053,2008-11-18T00:00:00,Cocaine,D02.145.074.722.388
19084053,2008-11-18T00:00:00,Cocaine,D03.132.889.354
19084053,2008-11-18T00:00:00,Cocaine,D03.605.869.388
19084053,2008-11-18T00:00:00,Cocaine,D04.075.080.875.099.722.388
19084053,2008-11-18T00:00:00,Computer Simulation,L01.224.160
19084053,2008-11-18T00:00:00,Cystine,D01.248.497.158.874.390.369
19084053,2008-11-18T00:00:00,Cystine,D01.875.350.850.150.369
19084053,2008-11-18T00:00:00,Cystine,D02.886.030.230.369
19084053,2008-11-18T00:00:00,Cystine,D02.886.520.150.087
19084053,2008-11-18T00:00:00,Cystine,D12.125.095.369
19084053,2008-11-18T00:00:00,Cystine,D12.125.119.369
19084053,2008-11-18T00:00:00,Cystine,D12.125.166.230.369
19084053,2008-11-18T00:00:00,Glutamic Acid,D12.125.067.750
19084053,2008-11-18T00:00:00,Glutamic Acid,D12.125.119.450
19084053,2008-11-18T00:00:00,Glutamic Acid,D12.125.427.300
19084053,2008-11-18T00:00:00,"Models, Biological",E05.599.395
19084053,2008-11-18T00:00:00,Neuroglia,A08.637
19084053,2008-11-18T00:00:00,Neuroglia,A11.650
19084053,2008-11-18T00:00:00,Neurons,A08.663
19084053,2008-11-18T00:00:00,Neurons,A11.671
19084053,2008-11-18T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19084053,2008-11-18T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19084053,2008-11-18T00:00:00,Synapses,A08.850
19084053,2008-11-18T00:00:00,Synapses,A11.284.149.165.420.780
19084053,2008-11-18T00:00:00,Synaptic Transmission,G02.111.087.800.850
19084053,2008-11-18T00:00:00,Synaptic Transmission,G02.149.115.800.850
19084053,2008-11-18T00:00:00,Synaptic Transmission,G04.299.880.850
19084053,2008-11-18T00:00:00,Synaptic Transmission,G07.265.337.900
19084053,2008-11-18T00:00:00,Synaptic Transmission,G07.700.240.900
19084053,2008-11-18T00:00:00,Synaptic Transmission,G11.561.600.835
19020331,2008-11-20T00:00:00,Cyclosporine,D04.345.566.235.300
19020331,2008-11-20T00:00:00,Cyclosporine,D12.644.641.235.300
19020331,2008-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19020331,2008-11-20T00:00:00,Myocardial Infarction,C14.280.647.500
19020331,2008-11-20T00:00:00,Myocardial Infarction,C14.907.585.500
19020331,2008-11-20T00:00:00,Myocardial Reperfusion Injury,C14.280.238.615
19020331,2008-11-20T00:00:00,Myocardial Reperfusion Injury,C14.280.647.625
19020331,2008-11-20T00:00:00,Myocardial Reperfusion Injury,C14.907.585.625
19020331,2008-11-20T00:00:00,Myocardial Reperfusion Injury,C14.907.725.600
19020331,2008-11-20T00:00:00,Myocardial Reperfusion Injury,C23.550.767.877.500
19020331,2008-11-20T00:00:00,Premedication,E02.319.703
19022866,2008-11-20T00:00:00,Adult,M01.060.116
19022866,2008-11-20T00:00:00,Aged,M01.060.116.100
19022866,2008-11-20T00:00:00,Brain Ischemia,C10.228.140.300.150
19022866,2008-11-20T00:00:00,Brain Ischemia,C14.907.253.092
19022866,2008-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19022866,2008-11-20T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
19022866,2008-11-20T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
19022866,2008-11-20T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
19022866,2008-11-20T00:00:00,Middle Aged,M01.060.116.630
19022866,2008-11-20T00:00:00,Stroke,C10.228.140.300.775
19022866,2008-11-20T00:00:00,Stroke,C14.907.253.855
19023276,2008-11-20T00:00:00,Adult,M01.060.116
19023276,2008-11-20T00:00:00,Alcoholism,C21.739.100.250
19023276,2008-11-20T00:00:00,Alcoholism,F03.900.100.350
19023276,2008-11-20T00:00:00,Blood Pressure,E01.370.600.875.249
19023276,2008-11-20T00:00:00,Blood Pressure,G09.330.380.076
19023276,2008-11-20T00:00:00,DNA,D13.444.308
19023276,2008-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19023276,2008-11-20T00:00:00,Hypertension,C14.907.489
19023276,2008-11-20T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19023276,2008-11-20T00:00:00,Risk Factors,E05.318.740.600.800.725
19023276,2008-11-20T00:00:00,Risk Factors,N05.715.350.200.700
19023276,2008-11-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19023276,2008-11-20T00:00:00,Risk Factors,N06.850.490.625.750
19023276,2008-11-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19027047,2008-11-21T00:00:00,Animals,B01.050
19027047,2008-11-21T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
19027047,2008-11-21T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
19027047,2008-11-21T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
19027047,2008-11-21T00:00:00,Dendritic Cells,A11.066.270
19027047,2008-11-21T00:00:00,Dendritic Cells,A11.436.270
19027047,2008-11-21T00:00:00,Dendritic Cells,A15.382.066.270
19027047,2008-11-21T00:00:00,Dendritic Cells,A15.382.812.260
19027047,2008-11-21T00:00:00,Lymphocyte Activation,E01.450.495.482
19027047,2008-11-21T00:00:00,Lymphocyte Activation,E05.478.594.530
19027047,2008-11-21T00:00:00,Lymphocyte Activation,G12.425.747
19027047,2008-11-21T00:00:00,Lymphocyte Activation,G12.450.050.400.545
19027047,2008-11-21T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
19027047,2008-11-21T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
19027047,2008-11-21T00:00:00,Vaccination,E02.095.465.425.400.530.890
19027047,2008-11-21T00:00:00,Vaccination,E05.478.550.600.890
19027047,2008-11-21T00:00:00,Vaccination,N02.421.726.758.310.890
19027047,2008-11-21T00:00:00,Vaccination,N06.850.780.200.425.900
19027047,2008-11-21T00:00:00,Vaccination,N06.850.780.680.310.890
19028825,2008-11-21T00:00:00,Bias (Epidemiology),N05.715.350.150
19028825,2008-11-21T00:00:00,Bias (Epidemiology),N06.850.490.500
19028825,2008-11-21T00:00:00,Clinical Laboratory Techniques,E05.200
19028825,2008-11-21T00:00:00,Fatty Acids,D10.251
19028825,2008-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19028825,2008-11-21T00:00:00,Mass Screening,E01.370.500
19028825,2008-11-21T00:00:00,Mass Screening,E05.318.308.250.580
19028825,2008-11-21T00:00:00,Mass Screening,N02.421.143.827.233.443
19028825,2008-11-21T00:00:00,Mass Screening,N02.421.726.233.443
19028825,2008-11-21T00:00:00,Mass Screening,N05.715.360.300.375.500
19028825,2008-11-21T00:00:00,Mass Screening,N06.850.520.308.250.580
19028825,2008-11-21T00:00:00,Mass Screening,N06.850.780.500
19028825,2008-11-21T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19028825,2008-11-21T00:00:00,Prostatic Neoplasms,C12.294.260.750
19028825,2008-11-21T00:00:00,Prostatic Neoplasms,C12.294.565.625
19028825,2008-11-21T00:00:00,Prostatic Neoplasms,C12.758.409.750
19028825,2008-11-21T00:00:00,Regression Analysis,E05.318.740.750
19028825,2008-11-21T00:00:00,Regression Analysis,N05.715.360.750.695
19028825,2008-11-21T00:00:00,Regression Analysis,N06.850.520.830.750
19028825,2008-11-21T00:00:00,Vitamin K,D02.455.426.559.847.638.721.374
19028825,2008-11-21T00:00:00,Vitamin K,D02.455.849.291.523.500
19028825,2008-11-21T00:00:00,Vitamin K,D04.615.638.721.374
19028839,2008-11-21T00:00:00,Amino Acid Sequence,G02.111.570.060
19028839,2008-11-21T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19028839,2008-11-21T00:00:00,Ceramides,D02.065.313
19028839,2008-11-21T00:00:00,Ceramides,D09.400.410.420.525.200
19028839,2008-11-21T00:00:00,Ceramides,D10.390.470.675.200
19028839,2008-11-21T00:00:00,Ceramides,D10.570.877.360.612.200
19028839,2008-11-21T00:00:00,"Chromosomal Proteins, Non-Histone",D12.776.660.235
19028839,2008-11-21T00:00:00,"Chromosomal Proteins, Non-Histone",D12.776.664.235
19028839,2008-11-21T00:00:00,Down-Regulation,G02.111.087.225
19028839,2008-11-21T00:00:00,Down-Regulation,G02.149.115.225
19028839,2008-11-21T00:00:00,Down-Regulation,G05.355.315.200
19028839,2008-11-21T00:00:00,Down-Regulation,G07.690.812.230
19028839,2008-11-21T00:00:00,Down-Regulation,G07.700.680.230
19028839,2008-11-21T00:00:00,Gene Expression Regulation,G05.355.315
19028839,2008-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19028839,2008-11-21T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
19028839,2008-11-21T00:00:00,Protein Phosphatase 2,D12.644.360.583
19028839,2008-11-21T00:00:00,Protein Phosphatase 2,D12.776.476.561
19028839,2008-11-21T00:00:00,Signal Transduction,G02.111.087.800
19028839,2008-11-21T00:00:00,Signal Transduction,G02.149.115.800
19028839,2008-11-21T00:00:00,Signal Transduction,G04.299.880
19028839,2008-11-21T00:00:00,Sphingolipids,D10.570.877
19028839,2008-11-21T00:00:00,Sphingolipids,D10.808
19028839,2008-11-21T00:00:00,Transcription Factors,D12.776.930
19059733,2008-11-21T00:00:00,Adolescent,M01.060.057
19059733,2008-11-21T00:00:00,Adult,M01.060.116
19059733,2008-11-21T00:00:00,Health Behavior,F01.145.488
19059733,2008-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19059733,2008-11-21T00:00:00,Middle Aged,M01.060.116.630
19059733,2008-11-21T00:00:00,Risk-Taking,F01.145.722
19059733,2008-11-21T00:00:00,Substance-Related Disorders,C21.739
19059733,2008-11-21T00:00:00,Substance-Related Disorders,F03.900
19059733,2008-11-21T00:00:00,Young Adult,M01.060.116.815
19110381,2008-11-21T00:00:00,Adolescent,M01.060.057
19110381,2008-11-21T00:00:00,Adult,M01.060.116
19110381,2008-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19110381,2008-11-21T00:00:00,Risk Factors,E05.318.740.600.800.725
19110381,2008-11-21T00:00:00,Risk Factors,N05.715.350.200.700
19110381,2008-11-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19110381,2008-11-21T00:00:00,Risk Factors,N06.850.490.625.750
19110381,2008-11-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19110381,2008-11-21T00:00:00,Sex Factors,N05.715.350.675
19110381,2008-11-21T00:00:00,Sex Factors,N06.850.490.875
19110381,2008-11-21T00:00:00,Sex Offenses,I01.198.240.748
19110381,2008-11-21T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19110381,2008-11-21T00:00:00,Substance-Related Disorders,C21.739
19110381,2008-11-21T00:00:00,Substance-Related Disorders,F03.900
19110381,2008-11-21T00:00:00,Violence,I01.198.240.856
19110381,2008-11-21T00:00:00,Violence,I01.880.735.900
19110381,2008-11-21T00:00:00,Young Adult,M01.060.116.815
19027154,2008-11-22T00:00:00,Animals,B01.050
19027154,2008-11-22T00:00:00,Biological Markers,D23.101
19027154,2008-11-22T00:00:00,Bone Marrow Cells,A11.148
19027154,2008-11-22T00:00:00,Bone Marrow Cells,A15.378.316
19027154,2008-11-22T00:00:00,Cattle,B01.050.150.900.649.077.380.271
19027154,2008-11-22T00:00:00,Cell Differentiation,G04.299.151
19027154,2008-11-22T00:00:00,Endothelial Cells,A11.436.275
19027154,2008-11-22T00:00:00,Gene Expression Regulation,G05.355.315
19027154,2008-11-22T00:00:00,"Lipoproteins, LDL",D10.532.515
19027154,2008-11-22T00:00:00,"Lipoproteins, LDL",D12.776.521.550
19027154,2008-11-22T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19027154,2008-11-22T00:00:00,"Microscopy, Confocal",E05.595.395
19027154,2008-11-22T00:00:00,"Models, Biological",E05.599.395
19027154,2008-11-22T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
19027154,2008-11-22T00:00:00,Phenotype,G05.695
19027154,2008-11-22T00:00:00,"RNA, Messenger",D13.444.735.544
19027154,2008-11-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19027154,2008-11-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19027154,2008-11-22T00:00:00,Stromal Cells,A11.329.830
19027154,2008-11-22T00:00:00,Tissue Scaffolds,E07.206.627
19027154,2008-11-22T00:00:00,Tissue Scaffolds,E07.695.825
19028393,2008-11-22T00:00:00,Adult,M01.060.116
19028393,2008-11-22T00:00:00,Aged,M01.060.116.100
19028393,2008-11-22T00:00:00,Cause of Death,E05.318.308.985.550.250
19028393,2008-11-22T00:00:00,Cause of Death,L01.280.975.550.250
19028393,2008-11-22T00:00:00,Cause of Death,N01.224.935.698.100
19028393,2008-11-22T00:00:00,Cause of Death,N06.850.505.400.975.550.250
19028393,2008-11-22T00:00:00,Cause of Death,N06.850.520.308.985.550.250
19028393,2008-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19028393,2008-11-22T00:00:00,Middle Aged,M01.060.116.630
19028393,2008-11-22T00:00:00,Prevalence,E05.318.308.985.525.750
19028393,2008-11-22T00:00:00,Prevalence,L01.280.975.525.750
19028393,2008-11-22T00:00:00,Prevalence,N01.224.935.597.750
19028393,2008-11-22T00:00:00,Prevalence,N06.850.505.400.975.525.750
19028393,2008-11-22T00:00:00,Prevalence,N06.850.520.308.985.525.750
19028393,2008-11-22T00:00:00,Stroke,C10.228.140.300.775
19028393,2008-11-22T00:00:00,Stroke,C14.907.253.855
19029486,2008-11-24T00:00:00,Adult,M01.060.116
19029486,2008-11-24T00:00:00,African Continental Ancestry Group,M01.686.508.100
19029486,2008-11-24T00:00:00,Aged,M01.060.116.100
19029486,2008-11-24T00:00:00,Aging,G07.700.320.124
19029486,2008-11-24T00:00:00,Blood Pressure,E01.370.600.875.249
19029486,2008-11-24T00:00:00,Blood Pressure,G09.330.380.076
19029486,2008-11-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
19029486,2008-11-24T00:00:00,Genetic Variation,G05.365
19029486,2008-11-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19029486,2008-11-24T00:00:00,Hypertension,C14.907.489
19029486,2008-11-24T00:00:00,Middle Aged,M01.060.116.630
19029486,2008-11-24T00:00:00,"Models, Biological",E05.599.395
19029486,2008-11-24T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
19029486,2008-11-24T00:00:00,United States,Z01.107.567.875
19029520,2008-11-25T00:00:00,Adult,M01.060.116
19029520,2008-11-25T00:00:00,Aged,M01.060.116.100
19029520,2008-11-25T00:00:00,Brain,A08.186.211
19029520,2008-11-25T00:00:00,Brain Ischemia,C10.228.140.300.150
19029520,2008-11-25T00:00:00,Brain Ischemia,C14.907.253.092
19029520,2008-11-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19029520,2008-11-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19029520,2008-11-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19029520,2008-11-25T00:00:00,Middle Aged,M01.060.116.630
19029520,2008-11-25T00:00:00,Risk Factors,E05.318.740.600.800.725
19029520,2008-11-25T00:00:00,Risk Factors,N05.715.350.200.700
19029520,2008-11-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19029520,2008-11-25T00:00:00,Risk Factors,N06.850.490.625.750
19029520,2008-11-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19029520,2008-11-25T00:00:00,Stroke,C10.228.140.300.775
19029520,2008-11-25T00:00:00,Stroke,C14.907.253.855
19053977,2008-11-25T00:00:00,Adult,M01.060.116
19053977,2008-11-25T00:00:00,Alcoholism,C21.739.100.250
19053977,2008-11-25T00:00:00,Alcoholism,F03.900.100.350
19053977,2008-11-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19053977,2008-11-25T00:00:00,Middle Aged,M01.060.116.630
19053977,2008-11-25T00:00:00,Naltrexone,D03.132.577.249.706.550
19053977,2008-11-25T00:00:00,Naltrexone,D03.549.686.750.550
19053977,2008-11-25T00:00:00,Naltrexone,D03.605.497.750.550
19053977,2008-11-25T00:00:00,Naltrexone,D04.615.723.795.706.550
19053977,2008-11-25T00:00:00,Narcotic Antagonists,D27.505.696.543
19053977,2008-11-25T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
19053977,2008-11-25T00:00:00,Narcotic Antagonists,D27.505.954.427.550
19053977,2008-11-25T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19053977,2008-11-25T00:00:00,Treatment Outcome,E01.789.800
19053977,2008-11-25T00:00:00,Treatment Outcome,N04.761.559.590.800
19053977,2008-11-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19067488,2008-11-25T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
19067488,2008-11-25T00:00:00,Animals,B01.050
19067488,2008-11-25T00:00:00,Brain,A08.186.211
19067488,2008-11-25T00:00:00,Brain Neoplasms,C04.588.614.250.195
19067488,2008-11-25T00:00:00,Brain Neoplasms,C10.228.140.211
19067488,2008-11-25T00:00:00,Brain Neoplasms,C10.551.240.250
19067488,2008-11-25T00:00:00,Enzyme Inhibitors,D27.505.519.389
19067488,2008-11-25T00:00:00,Glioma,C04.557.465.625.600.380
19067488,2008-11-25T00:00:00,Glioma,C04.557.470.670.380
19067488,2008-11-25T00:00:00,Glioma,C04.557.580.625.600.380
19067488,2008-11-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19067488,2008-11-25T00:00:00,Neoplasm Invasiveness,C04.697.645
19067488,2008-11-25T00:00:00,Neoplasm Invasiveness,C23.550.727.645
19067488,2008-11-25T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19206410,2008-11-25T00:00:00,Animals,B01.050
19206410,2008-11-25T00:00:00,Diagnostic Imaging,E01.370.350
19206410,2008-11-25T00:00:00,Fluorescent Dyes,D27.720.233.348
19206410,2008-11-25T00:00:00,Fluorescent Dyes,D27.720.470.330.348
19206410,2008-11-25T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
19206410,2008-11-25T00:00:00,Green Fluorescent Proteins,D12.776.532.265
19206410,2008-11-25T00:00:00,Macrophages,A11.329.372
19206410,2008-11-25T00:00:00,Macrophages,A11.627.482
19206410,2008-11-25T00:00:00,Macrophages,A11.733.397
19206410,2008-11-25T00:00:00,Macrophages,A15.382.680.397
19206410,2008-11-25T00:00:00,Macrophages,A15.382.812.522
19206410,2008-11-25T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
19206410,2008-11-25T00:00:00,"Microscopy, Fluorescence",E05.595.458
19206410,2008-11-25T00:00:00,Nanoparticles,J01.637.512.600
19206410,2008-11-25T00:00:00,Optics and Photonics,H01.671.617
19206410,2008-11-25T00:00:00,Optics and Photonics,J01.293.688
19206410,2008-11-25T00:00:00,Polymers,D05.750
19206410,2008-11-25T00:00:00,Polymers,D25.720
19206410,2008-11-25T00:00:00,Polymers,J01.637.051.720
19206410,2008-11-25T00:00:00,Quantum Dots,E07.595.650
19206410,2008-11-25T00:00:00,Quantum Dots,J01.637.512.600.650
19036932,2008-11-26T00:00:00,Bacterial Proteins,D12.776.097
19036932,2008-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19036932,2008-11-26T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19038915,2008-11-26T00:00:00,Adolescent,M01.060.057
19038915,2008-11-26T00:00:00,Adult,M01.060.116
19038915,2008-11-26T00:00:00,Aged,M01.060.116.100
19038915,2008-11-26T00:00:00,Aging,G07.700.320.124
19038915,2008-11-26T00:00:00,Blood-Brain Barrier,A07.035
19038915,2008-11-26T00:00:00,Blood-Brain Barrier,A08.186.211.035
19038915,2008-11-26T00:00:00,Brain,A08.186.211
19038915,2008-11-26T00:00:00,Brain Ischemia,C10.228.140.300.150
19038915,2008-11-26T00:00:00,Brain Ischemia,C14.907.253.092
19038915,2008-11-26T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
19038915,2008-11-26T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
19038915,2008-11-26T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
19038915,2008-11-26T00:00:00,"Cholesterol, LDL",D10.532.515.500
19038915,2008-11-26T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
19038915,2008-11-26T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
19038915,2008-11-26T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
19038915,2008-11-26T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
19038915,2008-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19038915,2008-11-26T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19038915,2008-11-26T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19038915,2008-11-26T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19038915,2008-11-26T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
19038915,2008-11-26T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
19038915,2008-11-26T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
19038915,2008-11-26T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
19038915,2008-11-26T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
19038915,2008-11-26T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
19038915,2008-11-26T00:00:00,Middle Aged,M01.060.116.630
19038915,2008-11-26T00:00:00,Risk Factors,E05.318.740.600.800.725
19038915,2008-11-26T00:00:00,Risk Factors,N05.715.350.200.700
19038915,2008-11-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19038915,2008-11-26T00:00:00,Risk Factors,N06.850.490.625.750
19038915,2008-11-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19038915,2008-11-26T00:00:00,Stroke,C10.228.140.300.775
19038915,2008-11-26T00:00:00,Stroke,C14.907.253.855
19038915,2008-11-26T00:00:00,Thrombolytic Therapy,E02.319.913
19038915,2008-11-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19038915,2008-11-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19038915,2008-11-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19038915,2008-11-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19038915,2008-11-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19038915,2008-11-26T00:00:00,Young Adult,M01.060.116.815
19037703,2008-11-27T00:00:00,Adult,M01.060.116
19037703,2008-11-27T00:00:00,Aged,M01.060.116.100
19037703,2008-11-27T00:00:00,Antineoplastic Agents,D27.505.954.248
19037703,2008-11-27T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19037703,2008-11-27T00:00:00,Catheter Ablation,E02.148.110
19037703,2008-11-27T00:00:00,Catheter Ablation,E02.148.442.110
19037703,2008-11-27T00:00:00,Catheter Ablation,E02.154.402.110
19037703,2008-11-27T00:00:00,Catheter Ablation,E04.014.170.402.110
19037703,2008-11-27T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
19037703,2008-11-27T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
19037703,2008-11-27T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
19037703,2008-11-27T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
19037703,2008-11-27T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
19037703,2008-11-27T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
19037703,2008-11-27T00:00:00,Combined Modality Therapy,E02.186
19037703,2008-11-27T00:00:00,Hepatectomy,E04.210.556
19037703,2008-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19037703,2008-11-27T00:00:00,Liver Neoplasms,C04.588.274.623
19037703,2008-11-27T00:00:00,Liver Neoplasms,C06.301.623
19037703,2008-11-27T00:00:00,Liver Neoplasms,C06.552.697
19037703,2008-11-27T00:00:00,Middle Aged,M01.060.116.630
19038053,2008-11-27T00:00:00,African Continental Ancestry Group,M01.686.508.100
19038053,2008-11-27T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
19038053,2008-11-27T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
19038053,2008-11-27T00:00:00,European Continental Ancestry Group,M01.686.508.400
19038053,2008-11-27T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19038053,2008-11-27T00:00:00,Genetic Predisposition to Disease,G05.380.355
19038053,2008-11-27T00:00:00,Heart Ventricles,A07.541.560
19038053,2008-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19038053,2008-11-27T00:00:00,Hypertension,C14.907.489
19038053,2008-11-27T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
19038053,2008-11-27T00:00:00,Metabolic Syndrome X,C18.452.625
19038053,2008-11-27T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
19038053,2008-11-27T00:00:00,Risk Factors,E05.318.740.600.800.725
19038053,2008-11-27T00:00:00,Risk Factors,N05.715.350.200.700
19038053,2008-11-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19038053,2008-11-27T00:00:00,Risk Factors,N06.850.490.625.750
19038053,2008-11-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19039312,2008-11-27T00:00:00,Animals,B01.050
19039312,2008-11-27T00:00:00,Antioxidants,D27.505.519.217
19039312,2008-11-27T00:00:00,Antioxidants,D27.505.696.706.125
19039312,2008-11-27T00:00:00,Antioxidants,D27.720.799.047
19039312,2008-11-27T00:00:00,Calcium,D01.268.552.100
19039312,2008-11-27T00:00:00,Calcium,D01.552.539.288
19039312,2008-11-27T00:00:00,Calcium,D23.119.100
19039312,2008-11-27T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
19039312,2008-11-27T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
19039312,2008-11-27T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
19039312,2008-11-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19039312,2008-11-27T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19039312,2008-11-27T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
19039312,2008-11-27T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
19039312,2008-11-27T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
19039312,2008-11-27T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
19039312,2008-11-27T00:00:00,Signal Transduction,G02.111.087.800
19039312,2008-11-27T00:00:00,Signal Transduction,G02.149.115.800
19039312,2008-11-27T00:00:00,Signal Transduction,G04.299.880
19091637,2008-11-27T00:00:00,Collagen,D05.750.078.280
19091637,2008-11-27T00:00:00,Collagen,D12.776.860.300.250
19091637,2008-11-27T00:00:00,Elastin,D05.750.078.421
19091637,2008-11-27T00:00:00,Elastin,D12.776.860.300.350
19091637,2008-11-27T00:00:00,Extracellular Matrix,A11.284.295.310
19091637,2008-11-27T00:00:00,Heart Valve Prosthesis,E07.695.310
19091637,2008-11-27T00:00:00,Neomycin,D09.408.051.623
19091637,2008-11-27T00:00:00,"Stress, Mechanical",G01.374.676.830
19091637,2008-11-27T00:00:00,"Stress, Mechanical",G01.595.540.830
19038400,2008-11-28T00:00:00,Abdominal Pain,C23.888.646.100
19038400,2008-11-28T00:00:00,Abdominal Pain,C23.888.821.030
19038400,2008-11-28T00:00:00,Arthralgia,C05.550.091
19038400,2008-11-28T00:00:00,Arthralgia,C23.888.646.130
19038400,2008-11-28T00:00:00,Arthralgia,F02.830.816.444.350
19038400,2008-11-28T00:00:00,Arthralgia,G11.561.600.810.444.350
19038400,2008-11-28T00:00:00,Cough,C08.618.248
19038400,2008-11-28T00:00:00,Cough,C23.888.852.293
19038400,2008-11-28T00:00:00,Diarrhea,C23.888.821.214
19038400,2008-11-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19038400,2008-11-28T00:00:00,Infant,M01.060.703
19038400,2008-11-28T00:00:00,North America,Z01.107.567
19038400,2008-11-28T00:00:00,Prevalence,E05.318.308.985.525.750
19038400,2008-11-28T00:00:00,Prevalence,L01.280.975.525.750
19038400,2008-11-28T00:00:00,Prevalence,N01.224.935.597.750
19038400,2008-11-28T00:00:00,Prevalence,N06.850.505.400.975.525.750
19038400,2008-11-28T00:00:00,Prevalence,N06.850.520.308.985.525.750
19038400,2008-11-28T00:00:00,Rhinitis,C08.460.799
19038400,2008-11-28T00:00:00,Rhinitis,C08.730.674
19038400,2008-11-28T00:00:00,Rhinitis,C09.603.799
19038400,2008-11-28T00:00:00,Vomiting,C23.888.821.937
19042974,2008-11-28T00:00:00,Animals,B01.050
19042974,2008-11-28T00:00:00,Genomics,H01.158.273.180.350
19042974,2008-11-28T00:00:00,Genomics,H01.158.273.343.350
19042974,2008-11-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19042974,2008-11-28T00:00:00,Proteins,D12.776
19043694,2008-11-29T00:00:00,Animals,B01.050
19043694,2008-11-29T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19043694,2008-11-29T00:00:00,"Behavior, Animal",F01.145.113
19043694,2008-11-29T00:00:00,Cues,F02.463.425.234
19043694,2008-11-29T00:00:00,Naltrexone,D03.132.577.249.706.550
19043694,2008-11-29T00:00:00,Naltrexone,D03.549.686.750.550
19043694,2008-11-29T00:00:00,Naltrexone,D03.605.497.750.550
19043694,2008-11-29T00:00:00,Naltrexone,D04.615.723.795.706.550
19043694,2008-11-29T00:00:00,Narcotic Antagonists,D27.505.696.543
19043694,2008-11-29T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
19043694,2008-11-29T00:00:00,Narcotic Antagonists,D27.505.954.427.550
19043694,2008-11-29T00:00:00,Narcotics,D27.505.696.277.600
19043694,2008-11-29T00:00:00,Narcotics,D27.505.696.663.850.014.760
19043694,2008-11-29T00:00:00,Narcotics,D27.505.954.427.040.550
19043694,2008-11-29T00:00:00,Narcotics,D27.505.954.427.210.600
19043694,2008-11-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19043694,2008-11-29T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19043694,2008-11-29T00:00:00,Reinforcement (Psychology),F02.463.425.770
19043694,2008-11-29T00:00:00,Secondary Prevention,N02.421.726.825
19043694,2008-11-29T00:00:00,Secondary Prevention,N06.850.780.750
19043694,2008-11-29T00:00:00,Self Administration,E02.319.890
19043694,2008-11-29T00:00:00,Self Administration,E02.900.890
19043694,2008-11-29T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19043694,2008-11-29T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19067772,2008-11-29T00:00:00,Adolescent,M01.060.057
19067772,2008-11-29T00:00:00,Adult,M01.060.116
19067772,2008-11-29T00:00:00,Brain,A08.186.211
19067772,2008-11-29T00:00:00,Crime,I01.198.240
19067772,2008-11-29T00:00:00,Crime,I01.880.735.191
19067772,2008-11-29T00:00:00,Forensic Medicine,H02.403.330
19067772,2008-11-29T00:00:00,Forensic Medicine,I01.198.780.937
19067772,2008-11-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19067772,2008-11-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19067772,2008-11-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19067772,2008-11-29T00:00:00,Middle Aged,M01.060.116.630
19067772,2008-11-29T00:00:00,Oxygen,D01.268.185.550
19067772,2008-11-29T00:00:00,Oxygen,D01.362.670
19067772,2008-11-29T00:00:00,Sensitivity and Specificity,E05.318.740.872
19067772,2008-11-29T00:00:00,Sensitivity and Specificity,E05.318.780.800
19067772,2008-11-29T00:00:00,Sensitivity and Specificity,G17.800
19067772,2008-11-29T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19067772,2008-11-29T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19067772,2008-11-29T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19067772,2008-11-29T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19067772,2008-11-29T00:00:00,Videotape Recording,J01.897.280.500.846.734
19067772,2008-11-29T00:00:00,Videotape Recording,J01.897.280.500.898.840
19067772,2008-11-29T00:00:00,Videotape Recording,L01.178.590.875.840
19067772,2008-11-29T00:00:00,Videotape Recording,L01.178.820.090.846.734
19067772,2008-11-29T00:00:00,Videotape Recording,L01.178.820.090.898.840
19067772,2008-11-29T00:00:00,Videotape Recording,L01.240.940.840
19067772,2008-11-29T00:00:00,Videotape Recording,L01.240.960.880
19067772,2008-11-29T00:00:00,Young Adult,M01.060.116.815
18683239,2008-12-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
18683239,2008-12-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
18683239,2008-12-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
18683239,2008-12-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
18683239,2008-12-01T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
18683239,2008-12-01T00:00:00,Animals,B01.050
18683239,2008-12-01T00:00:00,Astrocytes,A08.637.200
18683239,2008-12-01T00:00:00,Astrocytes,A11.650.200
18683239,2008-12-01T00:00:00,Cell Survival,G04.299.316
18683239,2008-12-01T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
18683239,2008-12-01T00:00:00,Gene Expression Profiling,E05.393.332
18683239,2008-12-01T00:00:00,Gene Expression Regulation,G05.355.315
18683239,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18683239,2008-12-01T00:00:00,Neurons,A08.663
18683239,2008-12-01T00:00:00,Neurons,A11.671
18683239,2008-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18683239,2008-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18683239,2008-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18683239,2008-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18683239,2008-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18683239,2008-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18683239,2008-12-01T00:00:00,RNA-Binding Proteins,D12.776.157.725
18683239,2008-12-01T00:00:00,RNA-Binding Proteins,D12.776.664.962
18683239,2008-12-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18683239,2008-12-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18683239,2008-12-01T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
18683239,2008-12-01T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
18683239,2008-12-01T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
18683239,2008-12-01T00:00:00,Spinal Cord,A08.186.854
18683239,2008-12-01T00:00:00,Superoxide Dismutase,D08.811.682.881
18779725,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18779725,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18779725,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18779725,2008-12-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18779725,2008-12-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18779725,2008-12-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18779725,2008-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18779725,2008-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18779725,2008-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18779725,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18779725,2008-12-01T00:00:00,Neoplasm Invasiveness,C04.697.645
18779725,2008-12-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
18828149,2008-12-01T00:00:00,Algorithms,G17.035
18828149,2008-12-01T00:00:00,Algorithms,L01.224.050
18828149,2008-12-01T00:00:00,Arteries,A07.231.114
18828149,2008-12-01T00:00:00,Artifacts,E05.047
18828149,2008-12-01T00:00:00,Blood Flow Velocity,E01.370.370.130
18828149,2008-12-01T00:00:00,Blood Flow Velocity,G09.330.380.630.080
18828149,2008-12-01T00:00:00,Brain,A08.186.211
18828149,2008-12-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
18828149,2008-12-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18828149,2008-12-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18828149,2008-12-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18828149,2008-12-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18828149,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18828149,2008-12-01T00:00:00,Image Enhancement,E01.370.350.600.350
18828149,2008-12-01T00:00:00,Image Enhancement,L01.224.308.380
18828149,2008-12-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
18828149,2008-12-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
18828149,2008-12-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
18828149,2008-12-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
18828149,2008-12-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
18828149,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
18828149,2008-12-01T00:00:00,Regression Analysis,E05.318.740.750
18828149,2008-12-01T00:00:00,Regression Analysis,N05.715.360.750.695
18828149,2008-12-01T00:00:00,Regression Analysis,N06.850.520.830.750
18828149,2008-12-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
18828149,2008-12-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
18828149,2008-12-01T00:00:00,Sensitivity and Specificity,G17.800
18828149,2008-12-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
18828149,2008-12-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
18828149,2008-12-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
18828149,2008-12-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
18971676,2008-12-01T00:00:00,Clinical Laboratory Techniques,E05.200
18971676,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18971676,2008-12-01T00:00:00,Vitamin D,D04.808.812.768
18986277,2008-12-01T00:00:00,Bacteria,B03
18986277,2008-12-01T00:00:00,Bacterial Infections,C01.252
18986277,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18986277,2008-12-01T00:00:00,Molecular Diagnostic Techniques,E05.200.880
18986277,2008-12-01T00:00:00,Molecular Diagnostic Techniques,E05.393.520
18986277,2008-12-01T00:00:00,Virus Diseases,C02
18986277,2008-12-01T00:00:00,Viruses,B04
18998241,2008-12-01T00:00:00,Aged,M01.060.116.100
18998241,2008-12-01T00:00:00,Auditory Threshold,F02.463.593.071.173
18998241,2008-12-01T00:00:00,Auditory Threshold,F02.463.593.710.190
18998241,2008-12-01T00:00:00,Cognition Disorders,F03.087.250
18998241,2008-12-01T00:00:00,"Evoked Potentials, Auditory",G07.265.500.370
18998241,2008-12-01T00:00:00,"Evoked Potentials, Auditory",G11.561.270.370
18998241,2008-12-01T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G07.265.500.370.300
18998241,2008-12-01T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G11.561.270.370.300
18998241,2008-12-01T00:00:00,Hearing,F02.830.816.263
18998241,2008-12-01T00:00:00,Hearing,G11.561.600.810.263
18998241,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18998241,2008-12-01T00:00:00,"Otoacoustic Emissions, Spontaneous",G11.561.600.810.263.570
18998241,2008-12-01T00:00:00,Presbycusis,C09.218.458.341.887.772
18998241,2008-12-01T00:00:00,Presbycusis,C10.597.751.418.341.887.772
18998241,2008-12-01T00:00:00,Presbycusis,C23.888.592.763.393.341.887.772
18998241,2008-12-01T00:00:00,Speech Perception,F02.463.593.071.875
19006590,2008-12-01T00:00:00,Adult,M01.060.116
19006590,2008-12-01T00:00:00,Aged,M01.060.116.100
19006590,2008-12-01T00:00:00,Attitude of Health Personnel,F01.100.050
19006590,2008-12-01T00:00:00,Attitude of Health Personnel,N05.300.100
19006590,2008-12-01T00:00:00,Caregivers,M01.085
19006590,2008-12-01T00:00:00,Caregivers,M01.526.485.200
19006590,2008-12-01T00:00:00,Caregivers,N02.360.200
19006590,2008-12-01T00:00:00,Health Services Accessibility,N04.590.374.350
19006590,2008-12-01T00:00:00,Health Services Accessibility,N05.300.430
19006590,2008-12-01T00:00:00,Home Care Services,N02.421.143.524
19006590,2008-12-01T00:00:00,Home Care Services,N02.421.539.089
19006590,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19006590,2008-12-01T00:00:00,Interpersonal Relations,F01.829.401
19006590,2008-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19006590,2008-12-01T00:00:00,Lung Neoplasms,C08.381.540
19006590,2008-12-01T00:00:00,Lung Neoplasms,C08.785.520
19006590,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19006590,2008-12-01T00:00:00,Palliative Care,E02.760.666
19006590,2008-12-01T00:00:00,Palliative Care,N02.421.585.666
19006590,2008-12-01T00:00:00,Population Surveillance,E05.318.308.250.700
19006590,2008-12-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
19006590,2008-12-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
19006590,2008-12-01T00:00:00,Population Surveillance,N06.850.780.675
19006590,2008-12-01T00:00:00,Questionnaires,E05.318.308.750
19006590,2008-12-01T00:00:00,Questionnaires,L01.280.800
19006590,2008-12-01T00:00:00,Questionnaires,N05.715.360.300.695
19006590,2008-12-01T00:00:00,Questionnaires,N06.850.520.308.750
19006590,2008-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19006590,2008-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19012290,2008-12-01T00:00:00,Adult,M01.060.116
19012290,2008-12-01T00:00:00,Electric Stimulation,E05.723.402
19012290,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19012290,2008-12-01T00:00:00,Isometric Contraction,G11.427.590.540.472
19012290,2008-12-01T00:00:00,Leg,A01.378.610.500
19012290,2008-12-01T00:00:00,Muscle Contraction,G11.427.590.540
19012290,2008-12-01T00:00:00,"Muscle, Skeletal",A02.633.567
19012290,2008-12-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
19012290,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19012296,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
19012296,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
19012296,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
19012296,2008-12-01T00:00:00,Antineoplastic Agents,D27.505.954.248
19012296,2008-12-01T00:00:00,Drug Delivery Systems,E02.319.300
19012296,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19012296,2008-12-01T00:00:00,Nanoparticles,J01.637.512.600
19012296,2008-12-01T00:00:00,Polyethylene Glycols,D02.033.455.250.700
19012296,2008-12-01T00:00:00,Polyethylene Glycols,D05.750.741
19012296,2008-12-01T00:00:00,Polyethylene Glycols,D25.720.741
19012296,2008-12-01T00:00:00,Polyethylene Glycols,J01.637.051.720.741
19012296,2008-12-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
19012296,2008-12-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
19012296,2008-12-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
19012296,2008-12-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
19012296,2008-12-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
19012296,2008-12-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
19012296,2008-12-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
19012296,2008-12-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
19012296,2008-12-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
19017999,2008-12-01T00:00:00,Animals,B01.050
19017999,2008-12-01T00:00:00,Complement C3,D12.776.124.050.140
19017999,2008-12-01T00:00:00,Complement C3,D12.776.124.486.274.250
19017999,2008-12-01T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
19017999,2008-12-01T00:00:00,Lung Diseases,C08.381
19017999,2008-12-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19017999,2008-12-01T00:00:00,Reperfusion Injury,C14.907.725
19017999,2008-12-01T00:00:00,Reperfusion Injury,C23.550.767.877
19019761,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19019761,2008-12-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19019761,2008-12-01T00:00:00,Uncertainty,E05.318.740.600.900
19019761,2008-12-01T00:00:00,Uncertainty,F02.463.785.373.820
19019761,2008-12-01T00:00:00,Uncertainty,G17.680.875
19019761,2008-12-01T00:00:00,Uncertainty,N05.715.360.750.625.850
19019761,2008-12-01T00:00:00,Uncertainty,N06.850.520.830.600.900
19020124,2008-12-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
19020124,2008-12-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
19020124,2008-12-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
19020124,2008-12-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
19020124,2008-12-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
19020124,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19020124,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19025941,2008-12-01T00:00:00,Adolescent,M01.060.057
19025941,2008-12-01T00:00:00,Adult,M01.060.116
19025941,2008-12-01T00:00:00,Age Factors,N05.715.350.075
19025941,2008-12-01T00:00:00,Age Factors,N06.850.490.250
19025941,2008-12-01T00:00:00,Aged,M01.060.116.100
19025941,2008-12-01T00:00:00,Aging,G07.700.320.124
19025941,2008-12-01T00:00:00,Brain Mapping,E01.370.350.086
19025941,2008-12-01T00:00:00,Brain Mapping,E01.370.376.149
19025941,2008-12-01T00:00:00,Brain Mapping,E05.132
19025941,2008-12-01T00:00:00,Child,M01.060.406
19025941,2008-12-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
19025941,2008-12-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
19025941,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19025941,2008-12-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19025941,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19025941,2008-12-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19033173,2008-12-01T00:00:00,Adolescent,M01.060.057
19033173,2008-12-01T00:00:00,Adult,M01.060.116
19033173,2008-12-01T00:00:00,Aged,M01.060.116.100
19033173,2008-12-01T00:00:00,Crime Victims,M01.135
19033173,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19033173,2008-12-01T00:00:00,Mental Health Services,F04.408
19033173,2008-12-01T00:00:00,Mental Health Services,N02.421.461
19033173,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19033173,2008-12-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
19033173,2008-12-01T00:00:00,Rape,I01.198.240.748.640
19033173,2008-12-01T00:00:00,Regression Analysis,E05.318.740.750
19033173,2008-12-01T00:00:00,Regression Analysis,N05.715.360.750.695
19033173,2008-12-01T00:00:00,Regression Analysis,N06.850.520.830.750
19033173,2008-12-01T00:00:00,United States,Z01.107.567.875
19033173,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19035492,2008-12-01T00:00:00,Child,M01.060.406
19035492,2008-12-01T00:00:00,"Child, Preschool",M01.060.406.448
19035492,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19035492,2008-12-01T00:00:00,Linkage Disequilibrium,G05.540.500
19035492,2008-12-01T00:00:00,"Polymorphism, Genetic",G05.365.795
19035492,2008-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19035492,2008-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19035492,2008-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19035492,2008-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19035492,2008-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19035492,2008-12-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19035722,2008-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
19035722,2008-12-01T00:00:00,Blood Pressure,G09.330.380.076
19035722,2008-12-01T00:00:00,Brain,A08.186.211
19035722,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19035722,2008-12-01T00:00:00,Intracranial Pressure,G11.561.170.505
19035722,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19035722,2008-12-01T00:00:00,Oxygen,D01.268.185.550
19035722,2008-12-01T00:00:00,Oxygen,D01.362.670
19035722,2008-12-01T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
19035722,2008-12-01T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
19035722,2008-12-01T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
19041478,2008-12-01T00:00:00,Adolescent,M01.060.057
19041478,2008-12-01T00:00:00,Adult,M01.060.116
19041478,2008-12-01T00:00:00,Eye Injuries,C11.297
19041478,2008-12-01T00:00:00,Eye Injuries,C21.866.260.275.250
19041478,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19041478,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19041478,2008-12-01T00:00:00,Military Medicine,H02.403.500
19041478,2008-12-01T00:00:00,Military Personnel,M01.526.625
19041478,2008-12-01T00:00:00,United States,Z01.107.567.875
19041478,2008-12-01T00:00:00,Visual Acuity,E01.370.380.850.950
19041478,2008-12-01T00:00:00,Visual Acuity,F02.463.593.932.901
19041478,2008-12-01T00:00:00,Visual Acuity,G14.940
19041478,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19041764,2008-12-01T00:00:00,Animals,B01.050
19041764,2008-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
19041764,2008-12-01T00:00:00,Blood Pressure,G09.330.380.076
19041764,2008-12-01T00:00:00,Circadian Rhythm,G07.180.562.190
19041764,2008-12-01T00:00:00,Eating,G07.610.593.260
19041764,2008-12-01T00:00:00,Eating,G07.700.620.260
19041764,2008-12-01T00:00:00,Eating,G10.261.326.240
19041764,2008-12-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
19041764,2008-12-01T00:00:00,Mutation,G05.365.590
19041764,2008-12-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19041764,2008-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19041764,2008-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19041764,2008-12-01T00:00:00,"RNA, Messenger",D13.444.735.544
19047237,2008-12-01T00:00:00,Adolescent,M01.060.057
19047237,2008-12-01T00:00:00,Age Factors,N05.715.350.075
19047237,2008-12-01T00:00:00,Age Factors,N06.850.490.250
19047237,2008-12-01T00:00:00,Body Image,F02.463.593.112
19047237,2008-12-01T00:00:00,Child,M01.060.406
19047237,2008-12-01T00:00:00,"Child, Preschool",M01.060.406.448
19047237,2008-12-01T00:00:00,Exercise Tolerance,G11.427.680.270
19047237,2008-12-01T00:00:00,Funnel Chest,C05.116.099.386
19047237,2008-12-01T00:00:00,Funnel Chest,C05.660.386
19047237,2008-12-01T00:00:00,Funnel Chest,C16.131.621.386
19047237,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19047237,2008-12-01T00:00:00,Motor Activity,F01.145.632
19047237,2008-12-01T00:00:00,Motor Activity,G11.427.590.530.698
19047237,2008-12-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
19047237,2008-12-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
19047237,2008-12-01T00:00:00,Patient Satisfaction,N05.715.360.600
19047237,2008-12-01T00:00:00,Probability,E05.318.740.600
19047237,2008-12-01T00:00:00,Probability,G17.680
19047237,2008-12-01T00:00:00,Probability,N05.715.360.750.625
19047237,2008-12-01T00:00:00,Probability,N06.850.520.830.600
19047237,2008-12-01T00:00:00,Quality of Life,I01.800
19047237,2008-12-01T00:00:00,Quality of Life,K01.752.400.750
19047237,2008-12-01T00:00:00,Questionnaires,E05.318.308.750
19047237,2008-12-01T00:00:00,Questionnaires,L01.280.800
19047237,2008-12-01T00:00:00,Questionnaires,N05.715.360.300.695
19047237,2008-12-01T00:00:00,Questionnaires,N06.850.520.308.750
19047237,2008-12-01T00:00:00,Reconstructive Surgical Procedures,E04.680
19047237,2008-12-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
19047237,2008-12-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
19047237,2008-12-01T00:00:00,Sensitivity and Specificity,G17.800
19047237,2008-12-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19047237,2008-12-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19047237,2008-12-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19047237,2008-12-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19047237,2008-12-01T00:00:00,Sex Factors,N05.715.350.675
19047237,2008-12-01T00:00:00,Sex Factors,N06.850.490.875
19047237,2008-12-01T00:00:00,United States,Z01.107.567.875
19047237,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19047749,2008-12-01T00:00:00,Bacterial Proteins,D12.776.097
19047749,2008-12-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
19047749,2008-12-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
19047749,2008-12-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
19047749,2008-12-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
19047749,2008-12-01T00:00:00,Nickel,D01.268.556.607
19047749,2008-12-01T00:00:00,Nickel,D01.268.956.625
19047749,2008-12-01T00:00:00,Nickel,D01.552.544.607
19047749,2008-12-01T00:00:00,Proteomics,H01.158.201.843
19047749,2008-12-01T00:00:00,Proteomics,H01.158.273.180.350.700
19047749,2008-12-01T00:00:00,Proteomics,H01.158.273.343.350.700
19047749,2008-12-01T00:00:00,Proteomics,H01.181.122.738
19047749,2008-12-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
19049981,2008-12-01T00:00:00,Amino Acid Sequence,G02.111.570.060
19049981,2008-12-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19049981,2008-12-01T00:00:00,Animals,B01.050
19049981,2008-12-01T00:00:00,Carrier Proteins,D12.776.157
19049981,2008-12-01T00:00:00,Cell Membrane,A11.284.149
19049981,2008-12-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
19049981,2008-12-01T00:00:00,Eye Proteins,D12.776.306
19049981,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19049981,2008-12-01T00:00:00,Molecular Sequence Data,L01.453.245.667
19049981,2008-12-01T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
19049981,2008-12-01T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
19049981,2008-12-01T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
19057025,2008-12-01T00:00:00,Aged,M01.060.116.100
19057025,2008-12-01T00:00:00,Cause of Death,E05.318.308.985.550.250
19057025,2008-12-01T00:00:00,Cause of Death,L01.280.975.550.250
19057025,2008-12-01T00:00:00,Cause of Death,N01.224.935.698.100
19057025,2008-12-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
19057025,2008-12-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
19057025,2008-12-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19057025,2008-12-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19057025,2008-12-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19057025,2008-12-01T00:00:00,Coronary Artery Bypass,E04.100.376.719.332
19057025,2008-12-01T00:00:00,Coronary Artery Bypass,E04.928.220.520.220
19057025,2008-12-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19057025,2008-12-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19057025,2008-12-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19057025,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19057025,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19057025,2008-12-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
19057277,2008-12-01T00:00:00,Carcinoid Tumor,C04.557.465.625.650.200
19057277,2008-12-01T00:00:00,Carcinoid Tumor,C04.557.470.200.025.200
19057277,2008-12-01T00:00:00,Carcinoid Tumor,C04.557.580.625.650.200
19057277,2008-12-01T00:00:00,"Diagnosis, Differential",E01.171
19057277,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19057277,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19057277,2008-12-01T00:00:00,Technetium Tc 99m Exametazime,D01.632.825.562
19057277,2008-12-01T00:00:00,Technetium Tc 99m Exametazime,D02.092.570.665.810
19057277,2008-12-01T00:00:00,Technetium Tc 99m Exametazime,D02.691.825.562
19057277,2008-12-01T00:00:00,Thymectomy,E04.928.770
19057277,2008-12-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
19057277,2008-12-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
19057277,2008-12-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
19057277,2008-12-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
19057277,2008-12-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
19064753,2008-12-01T00:00:00,Aged,M01.060.116.100
19064753,2008-12-01T00:00:00,Brain Mapping,E01.370.350.086
19064753,2008-12-01T00:00:00,Brain Mapping,E01.370.376.149
19064753,2008-12-01T00:00:00,Brain Mapping,E05.132
19064753,2008-12-01T00:00:00,Geriatric Assessment,E05.318.308.225
19064753,2008-12-01T00:00:00,Geriatric Assessment,I01.240.425.350
19064753,2008-12-01T00:00:00,Geriatric Assessment,L01.280.360
19064753,2008-12-01T00:00:00,Geriatric Assessment,N01.224.425.350
19064753,2008-12-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
19064753,2008-12-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
19064753,2008-12-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
19064753,2008-12-01T00:00:00,Hippocampus,A08.186.211.464.405
19064753,2008-12-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
19064753,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19064753,2008-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19064753,2008-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19064753,2008-12-01T00:00:00,Neurologic Examination,E01.370.376.550
19064753,2008-12-01T00:00:00,Neurologic Examination,E01.370.600.550
19064753,2008-12-01T00:00:00,Neuropsychological Tests,F04.711.513
19064753,2008-12-01T00:00:00,Parkinsonian Disorders,C10.228.140.079.862
19064753,2008-12-01T00:00:00,Parkinsonian Disorders,C10.228.662.600
19065084,2008-12-01T00:00:00,Aged,M01.060.116.100
19065084,2008-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
19065084,2008-12-01T00:00:00,Blood Pressure,G09.330.380.076
19065084,2008-12-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19065084,2008-12-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19065084,2008-12-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19065084,2008-12-01T00:00:00,Chronic Disease,C23.550.291.500
19065084,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19065084,2008-12-01T00:00:00,Leg,A01.378.610.500
19065084,2008-12-01T00:00:00,Microcirculation,G09.330.190.163.645
19065084,2008-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19065084,2008-12-01T00:00:00,Risk Assessment,N04.452.871.715
19065084,2008-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19065084,2008-12-01T00:00:00,Risk Assessment,N06.850.505.715
19065084,2008-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19065084,2008-12-01T00:00:00,Skin,A17.815
19065084,2008-12-01T00:00:00,Varicose Ulcer,C14.907.927.730
19065084,2008-12-01T00:00:00,Varicose Ulcer,C17.800.893.592.730
19065084,2008-12-01T00:00:00,Venous Insufficiency,C14.907.952
19067934,2008-12-01T00:00:00,Adolescent,M01.060.057
19067934,2008-12-01T00:00:00,Health Surveys,E05.318.308.250
19067934,2008-12-01T00:00:00,Health Surveys,N05.715.360.300.375
19067934,2008-12-01T00:00:00,Health Surveys,N06.850.520.308.250
19067934,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19067934,2008-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19067934,2008-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19067934,2008-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19067934,2008-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19067934,2008-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19067934,2008-12-01T00:00:00,Risk-Taking,F01.145.722
19067934,2008-12-01T00:00:00,Sexual Behavior,F01.145.802
19067934,2008-12-01T00:00:00,Sexuality,F01.145.802.975
19067934,2008-12-01T00:00:00,Sexuality,G08.686.867
19067934,2008-12-01T00:00:00,Sexually Transmitted Diseases,C01.539.778
19067934,2008-12-01T00:00:00,Sexually Transmitted Diseases,C02.800
19067934,2008-12-01T00:00:00,Sexually Transmitted Diseases,C12.294.668
19067934,2008-12-01T00:00:00,Sexually Transmitted Diseases,C13.351.500.711
19067934,2008-12-01T00:00:00,Students,I02.233.748
19067934,2008-12-01T00:00:00,Students,I02.851
19067934,2008-12-01T00:00:00,Students,M01.848
19067934,2008-12-01T00:00:00,United States,Z01.107.567.875
19067934,2008-12-01T00:00:00,Universities,I02.783.850
19067934,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19071985,2008-12-01T00:00:00,Adolescent,M01.060.057
19071985,2008-12-01T00:00:00,Cues,F02.463.425.234
19071985,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19071985,2008-12-01T00:00:00,Imagination,F02.463.188.634
19071985,2008-12-01T00:00:00,Marijuana Abuse,C21.739.635
19071985,2008-12-01T00:00:00,Marijuana Abuse,F03.900.635
19071985,2008-12-01T00:00:00,Motivation,F01.658
19071985,2008-12-01T00:00:00,Motivation,F01.752.543.500.750
19071985,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19072562,2008-12-01T00:00:00,Adult,M01.060.116
19072562,2008-12-01T00:00:00,Genetic Testing,E01.370.427
19072562,2008-12-01T00:00:00,Genetic Testing,E05.393.435
19072562,2008-12-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
19072562,2008-12-01T00:00:00,Genetic Testing,N02.421.308.430
19072562,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19072562,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19072562,2008-12-01T00:00:00,Questionnaires,E05.318.308.750
19072562,2008-12-01T00:00:00,Questionnaires,L01.280.800
19072562,2008-12-01T00:00:00,Questionnaires,N05.715.360.300.695
19072562,2008-12-01T00:00:00,Questionnaires,N06.850.520.308.750
19072562,2008-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19072562,2008-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19072562,2008-12-01T00:00:00,alpha 1-Antitrypsin Deficiency,C17.300.050
19073849,2008-12-01T00:00:00,Adult,M01.060.116
19073849,2008-12-01T00:00:00,African Americans,M01.686.508.100.100
19073849,2008-12-01T00:00:00,African Americans,M01.686.754.100
19073849,2008-12-01T00:00:00,Child,M01.060.406
19073849,2008-12-01T00:00:00,"Child, Preschool",M01.060.406.448
19073849,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19073849,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19073849,2008-12-01T00:00:00,Mutation,G05.365.590
19073849,2008-12-01T00:00:00,Phenotype,G05.695
19073858,2008-12-01T00:00:00,Anticonvulsants,D27.505.954.427.080
19073858,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19073858,2008-12-01T00:00:00,Pediatrics,H02.403.670
19076431,2008-12-01T00:00:00,Animals,B01.050
19076431,2008-12-01T00:00:00,Antioxidants,D27.505.519.217
19076431,2008-12-01T00:00:00,Antioxidants,D27.505.696.706.125
19076431,2008-12-01T00:00:00,Antioxidants,D27.720.799.047
19076431,2008-12-01T00:00:00,Astrocytes,A08.637.200
19076431,2008-12-01T00:00:00,Astrocytes,A11.650.200
19076431,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19076431,2008-12-01T00:00:00,"Models, Animal",E05.598
19076431,2008-12-01T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
19076431,2008-12-01T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
19076431,2008-12-01T00:00:00,Neurodegenerative Diseases,C10.574
19076431,2008-12-01T00:00:00,Neurons,A08.663
19076431,2008-12-01T00:00:00,Neurons,A11.671
19076431,2008-12-01T00:00:00,Oxidative Stress,G03.495.710
19076431,2008-12-01T00:00:00,Oxidative Stress,G07.700.830.750
19077611,2008-12-01T00:00:00,Academic Medical Centers,N02.278.020
19077611,2008-12-01T00:00:00,Adolescent,M01.060.057
19077611,2008-12-01T00:00:00,Adult,M01.060.116
19077611,2008-12-01T00:00:00,Aged,M01.060.116.100
19077611,2008-12-01T00:00:00,Hemorrhage,C23.550.414
19077611,2008-12-01T00:00:00,Hepatectomy,E04.210.556
19077611,2008-12-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
19077611,2008-12-01T00:00:00,Hospital Mortality,L01.280.975.550.400
19077611,2008-12-01T00:00:00,Hospital Mortality,N01.224.935.698.400
19077611,2008-12-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
19077611,2008-12-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
19077611,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19077611,2008-12-01T00:00:00,Length of Stay,E02.760.400.480
19077611,2008-12-01T00:00:00,Length of Stay,N02.421.585.400.480
19077611,2008-12-01T00:00:00,Liver,A03.620
19077611,2008-12-01T00:00:00,Liver Transplantation,E04.210.650
19077611,2008-12-01T00:00:00,Liver Transplantation,E04.936.450.490
19077611,2008-12-01T00:00:00,Liver Transplantation,E04.936.580.490
19077611,2008-12-01T00:00:00,Patient Care Team,N04.590.715
19077611,2008-12-01T00:00:00,Postoperative Complications,C23.550.767
19077611,2008-12-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
19077611,2008-12-01T00:00:00,"Wounds, Penetrating",C21.866.986
19077623,2008-12-01T00:00:00,"Accidents, Traffic",N06.850.135.392
19077623,2008-12-01T00:00:00,Adolescent,M01.060.057
19077623,2008-12-01T00:00:00,Adult,M01.060.116
19077623,2008-12-01T00:00:00,Equipment Failure,E05.325
19077623,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19077623,2008-12-01T00:00:00,Multiple Trauma,C21.866.640
19077623,2008-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19077623,2008-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19077623,2008-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19077623,2008-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19077623,2008-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19077623,2008-12-01T00:00:00,Wounds and Injuries,C21.866
19077623,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19084155,2008-12-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
19084155,2008-12-01T00:00:00,Bacteremia,C01.252.100
19084155,2008-12-01T00:00:00,Bacteremia,C01.539.757.100
19084155,2008-12-01T00:00:00,Bacteremia,C23.550.470.790.500.100
19084155,2008-12-01T00:00:00,Cross Infection,C01.539.248
19084155,2008-12-01T00:00:00,Hospital Costs,N03.219.151.400.687
19084155,2008-12-01T00:00:00,Hospital Costs,N03.219.262.500
19084155,2008-12-01T00:00:00,Hospital Costs,N05.300.375.500
19084155,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19084155,2008-12-01T00:00:00,Infection Control,N06.850.780.200.450
19084155,2008-12-01T00:00:00,Length of Stay,E02.760.400.480
19084155,2008-12-01T00:00:00,Length of Stay,N02.421.585.400.480
19086827,2008-12-01T00:00:00,Bone Density Conservation Agents,D27.505.696.242
19086827,2008-12-01T00:00:00,Bone and Bones,A02.835.232
19086827,2008-12-01T00:00:00,Bone and Bones,A10.165.265
19086827,2008-12-01T00:00:00,Calcium,D01.268.552.100
19086827,2008-12-01T00:00:00,Calcium,D01.552.539.288
19086827,2008-12-01T00:00:00,Calcium,D23.119.100
19086827,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19086827,2008-12-01T00:00:00,"Immunity, Innate",G12.450.575
19086827,2008-12-01T00:00:00,"Milk, Human",A12.200.467
19086827,2008-12-01T00:00:00,"Milk, Human",J02.200.700.500
19086827,2008-12-01T00:00:00,"Milk, Human",J02.500.350.525.500
19086827,2008-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19086827,2008-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19086827,2008-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19086827,2008-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19086827,2008-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19086827,2008-12-01T00:00:00,Vitamin D,D04.808.812.768
19086827,2008-12-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19090632,2008-12-01T00:00:00,"Anastomosis, Surgical",E04.035
19090632,2008-12-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
19090632,2008-12-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
19090632,2008-12-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
19090632,2008-12-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
19090632,2008-12-01T00:00:00,Carotid Stenosis,C14.907.137.230
19090632,2008-12-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
19090632,2008-12-01T00:00:00,Femoral Artery,A07.231.114.351
19090632,2008-12-01T00:00:00,"Heart Arrest, Induced",E04.100.376.374
19090632,2008-12-01T00:00:00,"Heart Arrest, Induced",E04.928.220.360
19090632,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19090632,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19090632,2008-12-01T00:00:00,Stroke,C10.228.140.300.775
19090632,2008-12-01T00:00:00,Stroke,C14.907.253.855
19090632,2008-12-01T00:00:00,Suture Techniques,E04.901
19090632,2008-12-01T00:00:00,Treatment Outcome,E01.789.800
19090632,2008-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19090632,2008-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19090632,2008-12-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
19090632,2008-12-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
19090632,2008-12-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
19090632,2008-12-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
19090632,2008-12-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
19090632,2008-12-01T00:00:00,Vascular Surgical Procedures,E04.100.814
19092562,2008-12-01T00:00:00,Calcinosis,C18.452.174.130
19092562,2008-12-01T00:00:00,"Child, Preschool",M01.060.406.448
19092562,2008-12-01T00:00:00,Combined Modality Therapy,E02.186
19092562,2008-12-01T00:00:00,"Diagnosis, Differential",E01.171
19092562,2008-12-01T00:00:00,"Hemangioma, Cavernous",C04.557.645.375.385
19092562,2008-12-01T00:00:00,"Hemangioma, Cavernous",C14.907.454.385
19092562,2008-12-01T00:00:00,"Hemangioma, Cavernous",C15.378.463.835.385
19092562,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19092562,2008-12-01T00:00:00,"Muscle, Skeletal",A02.633.567
19092562,2008-12-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
19092562,2008-12-01T00:00:00,Rhabdomyosarcoma,C04.557.450.590.550.660
19092562,2008-12-01T00:00:00,Rhabdomyosarcoma,C04.557.450.795.550.660
19092562,2008-12-01T00:00:00,Streptococcal Infections,C01.252.410.890
19092562,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19092562,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19092562,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19092562,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19092562,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19092562,2008-12-01T00:00:00,Vancomycin,D09.400.420.925
19092562,2008-12-01T00:00:00,Vancomycin,D12.644.233.925
19095102,2008-12-01T00:00:00,Adolescent,M01.060.057
19095102,2008-12-01T00:00:00,Adult,M01.060.116
19095102,2008-12-01T00:00:00,Aged,M01.060.116.100
19095102,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19095102,2008-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
19095102,2008-12-01T00:00:00,Laparoscopy,E04.800.250.520
19095102,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19095102,2008-12-01T00:00:00,"Wounds, Stab",C21.866.986.950
19095102,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19097526,2008-12-01T00:00:00,"Accidents, Traffic",N06.850.135.392
19097526,2008-12-01T00:00:00,Adult,M01.060.116
19097526,2008-12-01T00:00:00,Contrast Media,D27.720.259
19097526,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19097526,2008-12-01T00:00:00,Incidental Findings,E01.410
19097526,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19097526,2008-12-01T00:00:00,Multiple Trauma,C21.866.640
19097526,2008-12-01T00:00:00,Pulmonary Embolism,C08.381.746
19097526,2008-12-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
19097526,2008-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19097526,2008-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19097526,2008-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19097526,2008-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19097526,2008-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19097526,2008-12-01T00:00:00,Thoracic Injuries,C21.866.891
19097526,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19097526,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19097526,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19097526,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19097526,2008-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19100382,2008-12-01T00:00:00,Animals,B01.050
19100382,2008-12-01T00:00:00,Ion Channels,D12.776.157.530.400
19100382,2008-12-01T00:00:00,Ion Channels,D12.776.543.550.425
19100382,2008-12-01T00:00:00,Ion Channels,D12.776.543.585.400
19100382,2008-12-01T00:00:00,Liver,A03.620
19100382,2008-12-01T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
19100382,2008-12-01T00:00:00,Mitochondrial Proteins,D12.776.575
19100382,2008-12-01T00:00:00,Reperfusion Injury,C14.907.725
19100382,2008-12-01T00:00:00,Reperfusion Injury,C23.550.767.877
19100399,2008-12-01T00:00:00,Adult,M01.060.116
19100399,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
19100399,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
19100399,2008-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
19100399,2008-12-01T00:00:00,Antilymphocyte Serum,A12.207.152.846.500.203
19100399,2008-12-01T00:00:00,Antilymphocyte Serum,D12.776.124.486.485.114.573.203
19100399,2008-12-01T00:00:00,Antilymphocyte Serum,D12.776.124.790.651.114.573.203
19100399,2008-12-01T00:00:00,Antilymphocyte Serum,D12.776.377.715.548.114.573.203
19100399,2008-12-01T00:00:00,Antilymphocyte Serum,D20.215.401.203
19100399,2008-12-01T00:00:00,Creatinine,D03.383.129.308.207
19100399,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19100399,2008-12-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
19100399,2008-12-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
19100399,2008-12-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
19100399,2008-12-01T00:00:00,Immunosuppression,E02.095.465.425.450
19100399,2008-12-01T00:00:00,Immunosuppression,E05.478.610
19100399,2008-12-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
19100399,2008-12-01T00:00:00,Kidney Transplantation,E02.870.500
19100399,2008-12-01T00:00:00,Kidney Transplantation,E04.936.450.485
19100399,2008-12-01T00:00:00,Kidney Transplantation,E04.950.774.400
19100399,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19100399,2008-12-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
19100399,2008-12-01T00:00:00,Treatment Outcome,E01.789.800
19100399,2008-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19100399,2008-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19120226,2008-12-01T00:00:00,Animals,B01.050
19120226,2008-12-01T00:00:00,Dog Diseases,C22.268
19120226,2008-12-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
19120226,2008-12-01T00:00:00,Ehrlichiosis,C01.252.400.054.160
19120226,2008-12-01T00:00:00,Ehrlichiosis,C01.252.400.825.200
19155428,2008-12-01T00:00:00,Adult,M01.060.116
19155428,2008-12-01T00:00:00,Bone and Bones,A02.835.232
19155428,2008-12-01T00:00:00,Bone and Bones,A10.165.265
19155428,2008-12-01T00:00:00,Breast Feeding,G07.610.220.500.500
19155428,2008-12-01T00:00:00,Breast Feeding,G07.610.593.185
19155428,2008-12-01T00:00:00,Breast Feeding,G07.700.620.185
19155428,2008-12-01T00:00:00,Dietary Supplements,J02.500.456
19155428,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19155428,2008-12-01T00:00:00,Infant,M01.060.703
19155428,2008-12-01T00:00:00,Infant Nutritional Physiological Phenomena,G07.610.220.500
19155428,2008-12-01T00:00:00,"Milk, Human",A12.200.467
19155428,2008-12-01T00:00:00,"Milk, Human",J02.200.700.500
19155428,2008-12-01T00:00:00,"Milk, Human",J02.500.350.525.500
19155428,2008-12-01T00:00:00,Vitamin D,D04.808.812.768
19155428,2008-12-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19198699,2008-12-01T00:00:00,Cardiovascular Diseases,C14
19198699,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19198699,2008-12-01T00:00:00,Neoplasms,C04
19198699,2008-12-01T00:00:00,Respiratory Tract Diseases,C08
19198699,2008-12-01T00:00:00,Smoking,F01.145.466.753
19198699,2008-12-01T00:00:00,Smoking Cessation,F01.145.940.700
19202473,2008-12-01T00:00:00,"Education, Medical",I02.358.399
19202473,2008-12-01T00:00:00,Educational Measurement,I02.399
19202473,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19202473,2008-12-01T00:00:00,School Admission Criteria,I02.399.750
19202473,2008-12-01T00:00:00,"Schools, Medical",I02.783.660.552
19202473,2008-12-01T00:00:00,"Schools, Medical",N02.278.020.578
19202473,2008-12-01T00:00:00,United States,Z01.107.567.875
19206810,2008-12-01T00:00:00,Acoustic Stimulation,E02.037
19206810,2008-12-01T00:00:00,Acoustic Stimulation,E02.190.888.030
19206810,2008-12-01T00:00:00,Acoustic Stimulation,E05.723.136
19206810,2008-12-01T00:00:00,Adolescent,M01.060.057
19206810,2008-12-01T00:00:00,Adult,M01.060.116
19206810,2008-12-01T00:00:00,Age Factors,N05.715.350.075
19206810,2008-12-01T00:00:00,Age Factors,N06.850.490.250
19206810,2008-12-01T00:00:00,Aged,M01.060.116.100
19206810,2008-12-01T00:00:00,Aging,G07.700.320.124
19206810,2008-12-01T00:00:00,Auditory Threshold,F02.463.593.071.173
19206810,2008-12-01T00:00:00,Auditory Threshold,F02.463.593.710.190
19206810,2008-12-01T00:00:00,Cues,F02.463.425.234
19206810,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19206810,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19206810,2008-12-01T00:00:00,"Models, Neurological",E05.599.395.642
19206810,2008-12-01T00:00:00,"Pattern Recognition, Physiological",F02.463.593.524
19206810,2008-12-01T00:00:00,Speech Perception,F02.463.593.071.875
19206810,2008-12-01T00:00:00,Young Adult,M01.060.116.815
19326611,2008-12-01T00:00:00,Adult,M01.060.116
19326611,2008-12-01T00:00:00,Aged,M01.060.116.100
19326611,2008-12-01T00:00:00,"Blood Loss, Surgical",C23.550.414.300
19326611,2008-12-01T00:00:00,"Blood Loss, Surgical",C23.550.505.300
19326611,2008-12-01T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
19326611,2008-12-01T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
19326611,2008-12-01T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
19326611,2008-12-01T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
19326611,2008-12-01T00:00:00,Cysts,C04.182
19326611,2008-12-01T00:00:00,Cysts,C23.300.306
19326611,2008-12-01T00:00:00,Hepatectomy,E04.210.556
19326611,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19326611,2008-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
19326611,2008-12-01T00:00:00,Laparoscopy,E04.800.250.520
19326611,2008-12-01T00:00:00,Length of Stay,E02.760.400.480
19326611,2008-12-01T00:00:00,Length of Stay,N02.421.585.400.480
19326611,2008-12-01T00:00:00,Liver,A03.620
19326611,2008-12-01T00:00:00,Liver Diseases,C06.552
19326611,2008-12-01T00:00:00,Liver Neoplasms,C04.588.274.623
19326611,2008-12-01T00:00:00,Liver Neoplasms,C06.301.623
19326611,2008-12-01T00:00:00,Liver Neoplasms,C06.552.697
19326611,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19326611,2008-12-01T00:00:00,"Pain, Postoperative",C23.550.767.700
19326611,2008-12-01T00:00:00,"Pain, Postoperative",C23.888.646.530
19326611,2008-12-01T00:00:00,Postoperative Complications,C23.550.767
19326611,2008-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19326611,2008-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19326612,2008-12-01T00:00:00,Adult,M01.060.116
19326612,2008-12-01T00:00:00,Alcohol Drinking,F01.145.317.269
19326612,2008-12-01T00:00:00,Alphapapillomavirus,B04.280.535.050
19326612,2008-12-01T00:00:00,Alphapapillomavirus,B04.909.204.210.655.050
19326612,2008-12-01T00:00:00,Alphapapillomavirus,B04.909.574.204.655.050
19326612,2008-12-01T00:00:00,Alphapapillomavirus,B04.909.624.050
19326612,2008-12-01T00:00:00,"Antibodies, Viral",D12.776.124.486.485.114.254
19326612,2008-12-01T00:00:00,"Antibodies, Viral",D12.776.124.790.651.114.254
19326612,2008-12-01T00:00:00,"Antibodies, Viral",D12.776.377.715.548.114.254
19326612,2008-12-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19326612,2008-12-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19326612,2008-12-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19326612,2008-12-01T00:00:00,Clinical Trials as Topic,E05.337.250
19326612,2008-12-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19326612,2008-12-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19326612,2008-12-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19326612,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19326612,2008-12-01T00:00:00,Middle Aged,M01.060.116.630
19326612,2008-12-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
19326612,2008-12-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
19326612,2008-12-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
19326612,2008-12-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
19326612,2008-12-01T00:00:00,Papillomavirus Infections,C02.256.650
19326612,2008-12-01T00:00:00,Papillomavirus Infections,C02.928.725
19326612,2008-12-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
19326612,2008-12-01T00:00:00,"RNA, Viral",D13.444.735.828
19326612,2008-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19326612,2008-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19326612,2008-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19326612,2008-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19326612,2008-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19326612,2008-12-01T00:00:00,Smoking,F01.145.466.753
19326612,2008-12-01T00:00:00,Tongue Neoplasms,C04.588.443.591.925
19326612,2008-12-01T00:00:00,Tongue Neoplasms,C07.465.565.925
19326612,2008-12-01T00:00:00,Tongue Neoplasms,C07.465.910.874
19496379,2008-12-01T00:00:00,Adolescent,M01.060.057
19496379,2008-12-01T00:00:00,Child,M01.060.406
19496379,2008-12-01T00:00:00,"Child, Preschool",M01.060.406.448
19496379,2008-12-01T00:00:00,Developing Countries,I01.615.500.300
19496379,2008-12-01T00:00:00,Dietary Supplements,J02.500.456
19496379,2008-12-01T00:00:00,Enteral Nutrition,E02.421.360
19496379,2008-12-01T00:00:00,Enteral Nutrition,E02.642.500.360
19496379,2008-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19496379,2008-12-01T00:00:00,Infant,M01.060.703
19496379,2008-12-01T00:00:00,Military Medicine,H02.403.500
19050193,2008-12-03T00:00:00,Adult,M01.060.116
19050193,2008-12-03T00:00:00,Anticonvulsants,D27.505.954.427.080
19050193,2008-12-03T00:00:00,Decision Support Techniques,E05.245
19050193,2008-12-03T00:00:00,Decision Support Techniques,L01.700.508.190
19050193,2008-12-03T00:00:00,Drug Resistance,G07.690.320
19050193,2008-12-03T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
19050193,2008-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19050193,2008-12-03T00:00:00,Middle Aged,M01.060.116.630
19050193,2008-12-03T00:00:00,Monte Carlo Method,E05.318.740.525
19050193,2008-12-03T00:00:00,Monte Carlo Method,L01.906.575.422
19050193,2008-12-03T00:00:00,Monte Carlo Method,N05.715.360.750.540
19050193,2008-12-03T00:00:00,Monte Carlo Method,N06.850.520.830.525
19050193,2008-12-03T00:00:00,Quality of Life,I01.800
19050193,2008-12-03T00:00:00,Quality of Life,K01.752.400.750
19050193,2008-12-03T00:00:00,Seizures,C10.228.140.490.631
19050193,2008-12-03T00:00:00,Seizures,C10.597.742
19050193,2008-12-03T00:00:00,Seizures,C23.888.592.742
19050193,2008-12-03T00:00:00,Treatment Outcome,E01.789.800
19050193,2008-12-03T00:00:00,Treatment Outcome,N04.761.559.590.800
19050193,2008-12-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19050193,2008-12-03T00:00:00,Young Adult,M01.060.116.815
19052543,2008-12-03T00:00:00,African Americans,M01.686.508.100.100
19052543,2008-12-03T00:00:00,African Americans,M01.686.754.100
19052543,2008-12-03T00:00:00,Case-Control Studies,E05.318.760.500.500
19052543,2008-12-03T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19052543,2008-12-03T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19052543,2008-12-03T00:00:00,Cocaine,D02.145.074.722.388
19052543,2008-12-03T00:00:00,Cocaine,D03.132.889.354
19052543,2008-12-03T00:00:00,Cocaine,D03.605.869.388
19052543,2008-12-03T00:00:00,Cocaine,D04.075.080.875.099.722.388
19052543,2008-12-03T00:00:00,Cocaine-Related Disorders,C21.739.300
19052543,2008-12-03T00:00:00,Cocaine-Related Disorders,F03.900.300
19052543,2008-12-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
19052543,2008-12-03T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19052543,2008-12-03T00:00:00,Genetic Predisposition to Disease,G05.380.355
19052543,2008-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19052543,2008-12-03T00:00:00,Linkage Disequilibrium,G05.540.500
19052543,2008-12-03T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19052543,2008-12-03T00:00:00,Regression Analysis,E05.318.740.750
19052543,2008-12-03T00:00:00,Regression Analysis,N05.715.360.750.695
19052543,2008-12-03T00:00:00,Regression Analysis,N06.850.520.830.750
19052543,2008-12-03T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
19052543,2008-12-03T00:00:00,United States,Z01.107.567.875
19056188,2008-12-03T00:00:00,Alcohol Drinking,F01.145.317.269
19056188,2008-12-03T00:00:00,Data Collection,E05.318.308
19056188,2008-12-03T00:00:00,Data Collection,L01.280
19056188,2008-12-03T00:00:00,Data Collection,N05.715.360.300
19056188,2008-12-03T00:00:00,Data Collection,N06.850.520.308
19056188,2008-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19056188,2008-12-03T00:00:00,Internationality,I01.615
19056188,2008-12-03T00:00:00,Smoking,F01.145.466.753
19056188,2008-12-03T00:00:00,Smoking Cessation,F01.145.940.700
19056188,2008-12-03T00:00:00,United States,Z01.107.567.875
19056272,2008-12-03T00:00:00,Aged,M01.060.116.100
19056272,2008-12-03T00:00:00,Gait,E01.370.600.250
19056272,2008-12-03T00:00:00,Gait,G11.427.590.530.389
19056272,2008-12-03T00:00:00,Hemiplegia,C10.597.622.295
19056272,2008-12-03T00:00:00,Hemiplegia,C23.888.592.636.312
19056272,2008-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19056272,2008-12-03T00:00:00,Middle Aged,M01.060.116.630
19056272,2008-12-03T00:00:00,Stroke,C10.228.140.300.775
19056272,2008-12-03T00:00:00,Stroke,C14.907.253.855
19056272,2008-12-03T00:00:00,Walking,G11.427.590.530.568.900
19056272,2008-12-03T00:00:00,Walking,G11.427.590.530.698.940
19056272,2008-12-03T00:00:00,Walking,I03.450.642.845.940
19055839,2008-12-04T00:00:00,Apoptosis,G04.299.139.160
19055839,2008-12-04T00:00:00,Cancer Vaccines,D20.215.894.200
19055839,2008-12-04T00:00:00,Cell Proliferation,G04.299.233.750
19055839,2008-12-04T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19055839,2008-12-04T00:00:00,Cell Survival,G04.299.316
19055839,2008-12-04T00:00:00,Gamma Rays,G01.201.875.750.400
19055839,2008-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19055839,2008-12-04T00:00:00,Melanoma,C04.557.465.625.650.510
19055839,2008-12-04T00:00:00,Melanoma,C04.557.580.625.650.510
19055839,2008-12-04T00:00:00,Melanoma,C04.557.665.510
19076315,2008-12-05T00:00:00,Adult,M01.060.116
19076315,2008-12-05T00:00:00,Aged,M01.060.116.100
19076315,2008-12-05T00:00:00,Cardiovascular Diseases,C14
19076315,2008-12-05T00:00:00,Cause of Death,E05.318.308.985.550.250
19076315,2008-12-05T00:00:00,Cause of Death,L01.280.975.550.250
19076315,2008-12-05T00:00:00,Cause of Death,N01.224.935.698.100
19076315,2008-12-05T00:00:00,Cause of Death,N06.850.505.400.975.550.250
19076315,2008-12-05T00:00:00,Cause of Death,N06.850.520.308.985.550.250
19076315,2008-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19076315,2008-12-05T00:00:00,Middle Aged,M01.060.116.630
19076315,2008-12-05T00:00:00,Personality,F01.752
19076315,2008-12-05T00:00:00,Risk Factors,E05.318.740.600.800.725
19076315,2008-12-05T00:00:00,Risk Factors,N05.715.350.200.700
19076315,2008-12-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19076315,2008-12-05T00:00:00,Risk Factors,N06.850.490.625.750
19076315,2008-12-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19076315,2008-12-05T00:00:00,Sex Factors,N05.715.350.675
19076315,2008-12-05T00:00:00,Sex Factors,N06.850.490.875
19076315,2008-12-05T00:00:00,South Carolina,Z01.107.567.875.075.662
19076315,2008-12-05T00:00:00,South Carolina,Z01.107.567.875.750.700
19478972,2008-12-05T00:00:00,Environmental Health,H02.229
19478972,2008-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19478972,2008-12-05T00:00:00,Pediatrics,H02.403.670
19076107,2008-12-06T00:00:00,Communication,F01.145.209
19076107,2008-12-06T00:00:00,Communication,L01.143
19076107,2008-12-06T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
19076107,2008-12-06T00:00:00,"Emergency Service, Hospital",N02.421.297.195
19076107,2008-12-06T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
19076107,2008-12-06T00:00:00,HIV Infections,C02.782.815.616.400
19076107,2008-12-06T00:00:00,HIV Infections,C02.800.801.400
19076107,2008-12-06T00:00:00,HIV Infections,C20.673.480
19076107,2008-12-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19076107,2008-12-06T00:00:00,Mandatory Reporting,F01.145.209.259.300
19076107,2008-12-06T00:00:00,Mandatory Reporting,I01.880.604.583.527
19076107,2008-12-06T00:00:00,Mandatory Reporting,I01.880.604.622.249
19076107,2008-12-06T00:00:00,Mandatory Reporting,N03.706.535.615
19076107,2008-12-06T00:00:00,Mandatory Reporting,N03.706.657.249
19076107,2008-12-06T00:00:00,Terminology as Topic,L01.143.506.598.400
19251200,2008-12-06T00:00:00,Aged,M01.060.116.100
19251200,2008-12-06T00:00:00,Atrial Fibrillation,C14.280.067.198
19251200,2008-12-06T00:00:00,Atrial Fibrillation,C23.550.073.198
19251200,2008-12-06T00:00:00,"Cardiac Pacing, Artificial",E02.145
19251200,2008-12-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19251200,2008-12-06T00:00:00,"Pacemaker, Artificial",E07.858.082.748
19073234,2008-12-07T00:00:00,Actins,D05.750.078.730.250
19073234,2008-12-07T00:00:00,Actins,D12.776.210.500.100
19073234,2008-12-07T00:00:00,Actins,D12.776.220.525.255
19073234,2008-12-07T00:00:00,Animals,B01.050
19073234,2008-12-07T00:00:00,Chronic Disease,C23.550.291.500
19073234,2008-12-07T00:00:00,Cocaine,D02.145.074.722.388
19073234,2008-12-07T00:00:00,Cocaine,D03.132.889.354
19073234,2008-12-07T00:00:00,Cocaine,D03.605.869.388
19073234,2008-12-07T00:00:00,Cocaine,D04.075.080.875.099.722.388
19073234,2008-12-07T00:00:00,Cocaine-Related Disorders,C21.739.300
19073234,2008-12-07T00:00:00,Cocaine-Related Disorders,F03.900.300
19073234,2008-12-07T00:00:00,Dendrites,A08.663.256
19073234,2008-12-07T00:00:00,Dendrites,A11.284.180.225
19073234,2008-12-07T00:00:00,Dendrites,A11.671.240
19073234,2008-12-07T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
19073234,2008-12-07T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
19073234,2008-12-07T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
19073234,2008-12-07T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
19073234,2008-12-07T00:00:00,Down-Regulation,G02.111.087.225
19073234,2008-12-07T00:00:00,Down-Regulation,G02.149.115.225
19073234,2008-12-07T00:00:00,Down-Regulation,G05.355.315.200
19073234,2008-12-07T00:00:00,Down-Regulation,G07.690.812.230
19073234,2008-12-07T00:00:00,Down-Regulation,G07.700.680.230
19073234,2008-12-07T00:00:00,Integrin beta3,D12.776.543.750.705.408.200.750
19073234,2008-12-07T00:00:00,Integrin beta3,D23.050.301.264.035.302
19073234,2008-12-07T00:00:00,Integrin beta3,D23.101.100.110.299
19073234,2008-12-07T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19073234,2008-12-07T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19073234,2008-12-07T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19064903,2008-12-08T00:00:00,Adult,M01.060.116
19064903,2008-12-08T00:00:00,Age Factors,N05.715.350.075
19064903,2008-12-08T00:00:00,Age Factors,N06.850.490.250
19064903,2008-12-08T00:00:00,Aged,M01.060.116.100
19064903,2008-12-08T00:00:00,Deglutition,G10.261.326.215
19064903,2008-12-08T00:00:00,Fluoroscopy,E01.370.350.700.225
19064903,2008-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19064903,2008-12-08T00:00:00,Manometry,E05.559
19064903,2008-12-08T00:00:00,Pressure,G01.374.715
19064903,2008-12-08T00:00:00,Sex Factors,N05.715.350.675
19064903,2008-12-08T00:00:00,Sex Factors,N06.850.490.875
19064903,2008-12-08T00:00:00,Young Adult,M01.060.116.815
19065132,2008-12-09T00:00:00,Animals,B01.050
19065132,2008-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19065132,2008-12-09T00:00:00,Kidney,A05.810.453
19065132,2008-12-09T00:00:00,Kidney Diseases,C12.777.419
19065132,2008-12-09T00:00:00,Kidney Diseases,C13.351.968.419
19065132,2008-12-09T00:00:00,Renin-Angiotensin System,G03.495.805
19065132,2008-12-09T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
19066337,2008-12-09T00:00:00,Ceramides,D02.065.313
19066337,2008-12-09T00:00:00,Ceramides,D09.400.410.420.525.200
19066337,2008-12-09T00:00:00,Ceramides,D10.390.470.675.200
19066337,2008-12-09T00:00:00,Ceramides,D10.570.877.360.612.200
19066337,2008-12-09T00:00:00,Membrane Proteins,D12.776.543
19066337,2008-12-09T00:00:00,"Models, Genetic",E05.599.395.397
19066337,2008-12-09T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
19066337,2008-12-09T00:00:00,Sphingolipids,D10.570.877
19066337,2008-12-09T00:00:00,Sphingolipids,D10.808
19110059,2008-12-09T00:00:00,Animals,B01.050
19110059,2008-12-09T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
19110059,2008-12-09T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
19110059,2008-12-09T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
19110059,2008-12-09T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
19110059,2008-12-09T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
19110059,2008-12-09T00:00:00,Methamphetamine,D02.092.471.683.152.619
19110059,2008-12-09T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
19110059,2008-12-09T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
19110059,2008-12-09T00:00:00,Microglia,A08.637.400
19110059,2008-12-09T00:00:00,Microglia,A11.650.400
19110059,2008-12-09T00:00:00,Motor Activity,F01.145.632
19110059,2008-12-09T00:00:00,Motor Activity,G11.427.590.530.698
19110059,2008-12-09T00:00:00,Neurons,A08.663
19110059,2008-12-09T00:00:00,Neurons,A11.671
19110059,2008-12-09T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
19110059,2008-12-09T00:00:00,Substantia Nigra,A08.186.211.653.822.731
19110059,2008-12-09T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
19110059,2008-12-09T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
19110059,2008-12-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
19110059,2008-12-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
19110059,2008-12-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
19110059,2008-12-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
18759375,2008-12-10T00:00:00,Bayes Theorem,E05.318.740.600.200
18759375,2008-12-10T00:00:00,Bayes Theorem,N05.715.360.750.625.150
18759375,2008-12-10T00:00:00,Bayes Theorem,N06.850.520.830.600.200
18759375,2008-12-10T00:00:00,Communicable Diseases,C01.539.221
18759375,2008-12-10T00:00:00,Disease Outbreaks,N06.850.290
18759375,2008-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18759375,2008-12-10T00:00:00,Monte Carlo Method,E05.318.740.525
18759375,2008-12-10T00:00:00,Monte Carlo Method,L01.906.575.422
18759375,2008-12-10T00:00:00,Monte Carlo Method,N05.715.360.750.540
18759375,2008-12-10T00:00:00,Monte Carlo Method,N06.850.520.830.525
18759375,2008-12-10T00:00:00,Population Surveillance,E05.318.308.250.700
18759375,2008-12-10T00:00:00,Population Surveillance,N05.715.360.300.375.625
18759375,2008-12-10T00:00:00,Population Surveillance,N06.850.520.308.250.700
18759375,2008-12-10T00:00:00,Population Surveillance,N06.850.780.675
18759375,2008-12-10T00:00:00,South Carolina,Z01.107.567.875.075.662
18759375,2008-12-10T00:00:00,South Carolina,Z01.107.567.875.750.700
19074031,2008-12-10T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
19074031,2008-12-10T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
19074031,2008-12-10T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
19074031,2008-12-10T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
19074031,2008-12-10T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
19074031,2008-12-10T00:00:00,Animals,B01.050
19074031,2008-12-10T00:00:00,Astrocytes,A08.637.200
19074031,2008-12-10T00:00:00,Astrocytes,A11.650.200
19074031,2008-12-10T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
19074031,2008-12-10T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
19074031,2008-12-10T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
19074031,2008-12-10T00:00:00,Glutathione,D12.644.456.448
19074031,2008-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19074031,2008-12-10T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
19074031,2008-12-10T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
19074031,2008-12-10T00:00:00,Motor Neurons,A08.663.655.500
19074031,2008-12-10T00:00:00,Motor Neurons,A11.671.655.500
19074031,2008-12-10T00:00:00,"Muscle, Skeletal",A02.633.567
19074031,2008-12-10T00:00:00,"Muscle, Skeletal",A10.690.552.500
19074031,2008-12-10T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
19074031,2008-12-10T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
19074031,2008-12-10T00:00:00,Spinal Cord,A08.186.854
19074031,2008-12-10T00:00:00,Superoxide Dismutase,D08.811.682.881
19084345,2008-12-10T00:00:00,Aged,M01.060.116.100
19084345,2008-12-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19084345,2008-12-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19084345,2008-12-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19084345,2008-12-10T00:00:00,Cisplatin,D01.210.375
19084345,2008-12-10T00:00:00,Cisplatin,D01.625.125
19084345,2008-12-10T00:00:00,Cisplatin,D01.710.100
19084345,2008-12-10T00:00:00,Combined Modality Therapy,E02.186
19084345,2008-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19084345,2008-12-10T00:00:00,Lung Neoplasms,C04.588.894.797.520
19084345,2008-12-10T00:00:00,Lung Neoplasms,C08.381.540
19084345,2008-12-10T00:00:00,Lung Neoplasms,C08.785.520
19084345,2008-12-10T00:00:00,Middle Aged,M01.060.116.630
19135442,2008-12-10T00:00:00,Age Factors,N05.715.350.075
19135442,2008-12-10T00:00:00,Age Factors,N06.850.490.250
19135442,2008-12-10T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
19135442,2008-12-10T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
19135442,2008-12-10T00:00:00,Animals,B01.050
19135442,2008-12-10T00:00:00,Down Syndrome,C10.597.606.643.220
19135442,2008-12-10T00:00:00,Down Syndrome,C16.131.077.327
19135442,2008-12-10T00:00:00,Down Syndrome,C16.131.260.260
19135442,2008-12-10T00:00:00,Down Syndrome,C16.320.180.260
19135442,2008-12-10T00:00:00,Gene Expression Regulation,G05.355.315
19135442,2008-12-10T00:00:00,Memory Disorders,C10.597.606.525
19135442,2008-12-10T00:00:00,Memory Disorders,C23.888.592.604.529
19135442,2008-12-10T00:00:00,Memory Disorders,F01.700.625
19135442,2008-12-10T00:00:00,"Memory, Short-Term",F02.463.425.540.407
19135442,2008-12-10T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19135442,2008-12-10T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19135442,2008-12-10T00:00:00,Psychomotor Performance,F02.808
19135442,2008-12-10T00:00:00,Psychomotor Performance,G11.427.700
19135442,2008-12-10T00:00:00,Psychomotor Performance,G11.561.623
19135442,2008-12-10T00:00:00,Reactive Oxygen Species,D01.339.431
19135442,2008-12-10T00:00:00,Reactive Oxygen Species,D01.650.775
19135442,2008-12-10T00:00:00,Trisomy,C23.550.210.050.750
19135442,2008-12-10T00:00:00,Trisomy,G05.365.590.175.050.750
19135442,2008-12-10T00:00:00,Trisomy,G05.700.131.750
19440493,2008-12-10T00:00:00,Adult,M01.060.116
19440493,2008-12-10T00:00:00,Aged,M01.060.116.100
19440493,2008-12-10T00:00:00,Breast Neoplasms,C04.588.180
19440493,2008-12-10T00:00:00,Breast Neoplasms,C17.800.090.500
19440493,2008-12-10T00:00:00,Glutathione Transferase,D08.811.913.225.500
19440493,2008-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19440493,2008-12-10T00:00:00,Middle Aged,M01.060.116.630
19440493,2008-12-10T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D02.455.426.559.847
19440493,2008-12-10T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D04.615
19440493,2008-12-10T00:00:00,"Polymorphism, Genetic",G05.365.795
19440493,2008-12-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
19440493,2008-12-10T00:00:00,Risk Assessment,N04.452.871.715
19440493,2008-12-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19440493,2008-12-10T00:00:00,Risk Assessment,N06.850.505.715
19440493,2008-12-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19440493,2008-12-10T00:00:00,Risk Factors,E05.318.740.600.800.725
19440493,2008-12-10T00:00:00,Risk Factors,N05.715.350.200.700
19440493,2008-12-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19440493,2008-12-10T00:00:00,Risk Factors,N06.850.490.625.750
19440493,2008-12-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19440493,2008-12-10T00:00:00,Smoking,F01.145.466.753
19074192,2008-12-11T00:00:00,Adolescent,M01.060.057
19074192,2008-12-11T00:00:00,Adult,M01.060.116
19074192,2008-12-11T00:00:00,Aged,M01.060.116.100
19074192,2008-12-11T00:00:00,Chronic Disease,C23.550.291.500
19074192,2008-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19074192,2008-12-11T00:00:00,Middle Aged,M01.060.116.630
19074192,2008-12-11T00:00:00,Risk Factors,E05.318.740.600.800.725
19074192,2008-12-11T00:00:00,Risk Factors,N05.715.350.200.700
19074192,2008-12-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19074192,2008-12-11T00:00:00,Risk Factors,N06.850.490.625.750
19074192,2008-12-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19074192,2008-12-11T00:00:00,Young Adult,M01.060.116.815
19082649,2008-12-11T00:00:00,"Abnormalities, Multiple",C16.131.077
19082649,2008-12-11T00:00:00,"Heart Defects, Congenital",C14.240.400
19082649,2008-12-11T00:00:00,"Heart Defects, Congenital",C14.280.400
19082649,2008-12-11T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19082649,2008-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19082649,2008-12-11T00:00:00,Incidence,E05.318.308.985.525.375
19082649,2008-12-11T00:00:00,Incidence,L01.280.975.525.375
19082649,2008-12-11T00:00:00,Incidence,N01.224.935.597.500
19082649,2008-12-11T00:00:00,Incidence,N06.850.505.400.975.525.375
19082649,2008-12-11T00:00:00,Incidence,N06.850.520.308.985.525.375
19082649,2008-12-11T00:00:00,"Infant, Newborn",M01.060.703.520
19082649,2008-12-11T00:00:00,Mass Screening,E01.370.500
19082649,2008-12-11T00:00:00,Mass Screening,E05.318.308.250.580
19082649,2008-12-11T00:00:00,Mass Screening,N02.421.143.827.233.443
19082649,2008-12-11T00:00:00,Mass Screening,N02.421.726.233.443
19082649,2008-12-11T00:00:00,Mass Screening,N05.715.360.300.375.500
19082649,2008-12-11T00:00:00,Mass Screening,N06.850.520.308.250.580
19082649,2008-12-11T00:00:00,Mass Screening,N06.850.780.500
19082649,2008-12-11T00:00:00,South Carolina,Z01.107.567.875.075.662
19082649,2008-12-11T00:00:00,South Carolina,Z01.107.567.875.750.700
19082649,2008-12-11T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
19082649,2008-12-11T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
19082649,2008-12-11T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
19082649,2008-12-11T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
19070345,2008-12-12T00:00:00,Animals,B01.050
19070345,2008-12-12T00:00:00,B-Lymphocytes,A11.063.438
19070345,2008-12-12T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
19070345,2008-12-12T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
19070345,2008-12-12T00:00:00,B-Lymphocytes,A15.382.032.438
19070345,2008-12-12T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
19070345,2008-12-12T00:00:00,Endogenous Retroviruses,B04.820.650.250
19070345,2008-12-12T00:00:00,Endogenous Retroviruses,B04.909.574.807.250
19070345,2008-12-12T00:00:00,Endogenous Retroviruses,B04.909.777.731.250
19070345,2008-12-12T00:00:00,Endogenous Retroviruses,G02.111.570.080.708.330.800.175
19070345,2008-12-12T00:00:00,Endogenous Retroviruses,G05.360.080.708.330.800.175
19070345,2008-12-12T00:00:00,Endogenous Retroviruses,G05.360.340.024.425.800.175
19070345,2008-12-12T00:00:00,Interleukin-2,D12.644.276.374.465.502
19070345,2008-12-12T00:00:00,Interleukin-2,D12.644.276.374.480.372
19070345,2008-12-12T00:00:00,Interleukin-2,D12.776.467.374.465.502
19070345,2008-12-12T00:00:00,Interleukin-2,D12.776.467.374.480.372
19070345,2008-12-12T00:00:00,Interleukin-2,D23.529.374.465.502
19070345,2008-12-12T00:00:00,Interleukin-2,D23.529.374.480.372
19070345,2008-12-12T00:00:00,Membrane Proteins,D12.776.543
19070345,2008-12-12T00:00:00,Mutation,G05.365.590
19070345,2008-12-12T00:00:00,Superantigens,D23.050.820
19070345,2008-12-12T00:00:00,Transcriptional Activation,G05.355.315.800
19070345,2008-12-12T00:00:00,Viral Matrix Proteins,D12.776.964.970.880.940
19074264,2008-12-12T00:00:00,Animals,B01.050
19074264,2008-12-12T00:00:00,Dendrites,A08.663.256
19074264,2008-12-12T00:00:00,Dendrites,A11.284.180.225
19074264,2008-12-12T00:00:00,Dendrites,A11.671.240
19074264,2008-12-12T00:00:00,Morphogenesis,G07.700.320.500
19074264,2008-12-12T00:00:00,Mutation,G05.365.590
19074264,2008-12-12T00:00:00,Neuronal Plasticity,G11.561.600.635
19074264,2008-12-12T00:00:00,Protein Biosynthesis,G02.111.087.675.871
19074264,2008-12-12T00:00:00,Protein Biosynthesis,G02.149.115.675.871
19074264,2008-12-12T00:00:00,Protein Biosynthesis,G03.495.770.871
19074264,2008-12-12T00:00:00,Protein Biosynthesis,G05.355.310.670
19074264,2008-12-12T00:00:00,"RNA, Messenger",D13.444.735.544
19074264,2008-12-12T00:00:00,RNA-Binding Proteins,D12.776.157.725
19074264,2008-12-12T00:00:00,RNA-Binding Proteins,D12.776.664.962
19074264,2008-12-12T00:00:00,Transcription Factors,D12.776.930
19074264,2008-12-12T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
19074574,2008-12-12T00:00:00,"Adaptation, Physiological",G07.700.062
19074574,2008-12-12T00:00:00,"Adaptation, Physiological",G16.100.057.500
19074574,2008-12-12T00:00:00,Animals,B01.050
19074574,2008-12-12T00:00:00,Gene Expression Profiling,E05.393.332
19074574,2008-12-12T00:00:00,Gene Expression Regulation,G05.355.315
19074574,2008-12-12T00:00:00,MicroRNAs,D13.150.650.319
19074574,2008-12-12T00:00:00,MicroRNAs,D13.444.735.150.319
19074574,2008-12-12T00:00:00,MicroRNAs,D13.444.735.790.099
19074574,2008-12-12T00:00:00,"Muscle, Skeletal",A02.633.567
19074574,2008-12-12T00:00:00,"Muscle, Skeletal",A10.690.552.500
19074574,2008-12-12T00:00:00,Muscular Atrophy,C10.597.613.612
19074574,2008-12-12T00:00:00,Muscular Atrophy,C23.300.070.500
19074574,2008-12-12T00:00:00,Muscular Atrophy,C23.888.592.608.612
19074574,2008-12-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19074574,2008-12-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19074574,2008-12-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19074574,2008-12-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19074574,2008-12-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19074574,2008-12-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19074574,2008-12-12T00:00:00,Polymerase Chain Reaction,E05.393.620.500
19074574,2008-12-12T00:00:00,Protein Kinases,D08.811.913.696.620.682
19074574,2008-12-12T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19074574,2008-12-12T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19074574,2008-12-12T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19074574,2008-12-12T00:00:00,"RNA, Messenger",D13.444.735.544
19074574,2008-12-12T00:00:00,Space Flight,J01.937.285.850
19074574,2008-12-12T00:00:00,Weightlessness,G01.595.060.535.369.400.900
19134541,2008-12-12T00:00:00,Adolescent,M01.060.057
19134541,2008-12-12T00:00:00,Equipment Failure,E05.325
19134541,2008-12-12T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
19134541,2008-12-12T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
19134541,2008-12-12T00:00:00,Heart-Assist Devices,E04.050.430
19134541,2008-12-12T00:00:00,Heart-Assist Devices,E07.695.300.300
19134541,2008-12-12T00:00:00,Heart-Assist Devices,E07.858.082.374.300
19134541,2008-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19134541,2008-12-12T00:00:00,Lung Diseases,C08.381
19134541,2008-12-12T00:00:00,"Shock, Cardiogenic",C14.280.647.500.750
19134541,2008-12-12T00:00:00,"Shock, Cardiogenic",C14.907.585.500.750
19134541,2008-12-12T00:00:00,"Shock, Cardiogenic",C23.550.835.550
19135649,2008-12-13T00:00:00,"Adaptation, Psychological",F01.058
19135649,2008-12-13T00:00:00,Adolescent,M01.060.057
19135649,2008-12-13T00:00:00,Adolescent Behavior,F01.145.022
19135649,2008-12-13T00:00:00,African Americans,M01.686.508.100.100
19135649,2008-12-13T00:00:00,African Americans,M01.686.754.100
19135649,2008-12-13T00:00:00,Alcohol Drinking,F01.145.317.269
19135649,2008-12-13T00:00:00,Child,M01.060.406
19135649,2008-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19135649,2008-12-13T00:00:00,Juvenile Delinquency,I01.880.735.479
19135649,2008-12-13T00:00:00,"Stress, Psychological",F01.145.126.990
19135649,2008-12-13T00:00:00,"Stress, Psychological",F02.830.900
19502065,2008-12-14T00:00:00,Adenosine,D03.438.759.590.138
19502065,2008-12-14T00:00:00,Adenosine,D13.570.583.138
19502065,2008-12-14T00:00:00,Adenosine,D13.570.800.096
19502065,2008-12-14T00:00:00,Animals,B01.050
19502065,2008-12-14T00:00:00,Cardiotonic Agents,D27.505.954.411.222
19502065,2008-12-14T00:00:00,Cardiotonic Agents,D27.720.799.080
19502065,2008-12-14T00:00:00,Heart,A07.541
19502065,2008-12-14T00:00:00,Myocardial Contraction,G09.330.190.541
19502065,2008-12-14T00:00:00,Myocardial Contraction,G11.427.590.540.570
19502065,2008-12-14T00:00:00,Myocardial Reperfusion Injury,C14.280.238.615
19502065,2008-12-14T00:00:00,Myocardial Reperfusion Injury,C14.280.647.625
19502065,2008-12-14T00:00:00,Myocardial Reperfusion Injury,C14.907.585.625
19502065,2008-12-14T00:00:00,Myocardial Reperfusion Injury,C14.907.725.600
19502065,2008-12-14T00:00:00,Myocardial Reperfusion Injury,C23.550.767.877.500
19502065,2008-12-14T00:00:00,Myocardium,A02.633.580
19502065,2008-12-14T00:00:00,Myocardium,A07.541.704
19502065,2008-12-14T00:00:00,Myocardium,A10.690.552.750
19050249,2008-12-15T00:00:00,Animals,B01.050
19050249,2008-12-15T00:00:00,Cytokines,D12.644.276.374
19050249,2008-12-15T00:00:00,Cytokines,D12.776.467.374
19050249,2008-12-15T00:00:00,Cytokines,D23.529.374
19050249,2008-12-15T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
19050249,2008-12-15T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
19050249,2008-12-15T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
19050249,2008-12-15T00:00:00,Hyperglycemia,C18.452.394.952
19050249,2008-12-15T00:00:00,"Immunity, Innate",G12.450.575
19050249,2008-12-15T00:00:00,Membrane Proteins,D12.776.543
19050249,2008-12-15T00:00:00,Nerve Tissue Proteins,D12.776.641
19074869,2008-12-15T00:00:00,Amino Acid Sequence,G02.111.570.060
19074869,2008-12-15T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19074869,2008-12-15T00:00:00,Apoptosis,G04.299.139.160
19074869,2008-12-15T00:00:00,Breast Neoplasms,C04.588.180
19074869,2008-12-15T00:00:00,Breast Neoplasms,C17.800.090.500
19074869,2008-12-15T00:00:00,Case-Control Studies,E05.318.760.500.500
19074869,2008-12-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19074869,2008-12-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19074869,2008-12-15T00:00:00,European Continental Ancestry Group,M01.686.508.400
19074869,2008-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19074869,2008-12-15T00:00:00,Molecular Sequence Data,L01.453.245.667
19074869,2008-12-15T00:00:00,Pilot Projects,E05.318.760.750
19074869,2008-12-15T00:00:00,Pilot Projects,E05.337.737
19074869,2008-12-15T00:00:00,Pilot Projects,N05.715.360.775.625
19074869,2008-12-15T00:00:00,Pilot Projects,N06.850.520.450.720
19074869,2008-12-15T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19074991,2008-12-15T00:00:00,Adult,M01.060.116
19074991,2008-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19074991,2008-12-15T00:00:00,Middle Aged,M01.060.116.630
19075030,2008-12-15T00:00:00,Alkanes,D02.455.326.146
19075030,2008-12-15T00:00:00,Ceramides,D02.065.313
19075030,2008-12-15T00:00:00,Ceramides,D09.400.410.420.525.200
19075030,2008-12-15T00:00:00,Ceramides,D10.390.470.675.200
19075030,2008-12-15T00:00:00,Ceramides,D10.570.877.360.612.200
19075030,2008-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19075105,2008-12-15T00:00:00,American Heart Association,N03.540.630.780.110
19075105,2008-12-15T00:00:00,Heart Diseases,C14.280
19075105,2008-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19075105,2008-12-15T00:00:00,Stroke,C10.228.140.300.775
19075105,2008-12-15T00:00:00,Stroke,C14.907.253.855
19075105,2008-12-15T00:00:00,United States,Z01.107.567.875
19086273,2008-12-16T00:00:00,Amino Acid Sequence,G02.111.570.060
19086273,2008-12-16T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19086273,2008-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19086273,2008-12-16T00:00:00,Insulin,D06.472.699.587.740.625
19086273,2008-12-16T00:00:00,Insulin,D12.644.548.586.740.625
19086273,2008-12-16T00:00:00,Molecular Sequence Data,L01.453.245.667
19086273,2008-12-16T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
19086273,2008-12-16T00:00:00,Protein Conformation,G02.111.570.790.709
19086273,2008-12-16T00:00:00,Protein Folding,G01.154.100.640
19086273,2008-12-16T00:00:00,Protein Folding,G01.595.100.640
19086273,2008-12-16T00:00:00,Protein Folding,G02.111.087.690
19086273,2008-12-16T00:00:00,Protein Folding,G02.149.115.690
19086273,2008-12-16T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
19086273,2008-12-16T00:00:00,Proteins,D12.776
19121299,2008-12-16T00:00:00,Amino Acid Sequence,G02.111.570.060
19121299,2008-12-16T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19121299,2008-12-16T00:00:00,Cell Line,A11.251.210
19121299,2008-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19121299,2008-12-16T00:00:00,Molecular Sequence Data,L01.453.245.667
19121299,2008-12-16T00:00:00,Recombinant Proteins,D12.776.828
19121299,2008-12-16T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
19121299,2008-12-16T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
19360943,2008-12-16T00:00:00,Adsorption,G02.149.047
19360943,2008-12-16T00:00:00,Adsorption,G02.149.767.029
19360943,2008-12-16T00:00:00,Adsorption,G02.842.750.029
19360943,2008-12-16T00:00:00,Computer Simulation,L01.224.160
19360943,2008-12-16T00:00:00,Lactic Acid,D02.241.511.459.450
19360943,2008-12-16T00:00:00,"Models, Biological",E05.599.395
19360943,2008-12-16T00:00:00,"Models, Molecular",E05.599.595
19360943,2008-12-16T00:00:00,Molecular Conformation,G02.111.570.790
19360943,2008-12-16T00:00:00,Molecular Conformation,G02.575.500
19360943,2008-12-16T00:00:00,Molecular Conformation,G02.842.575.500
19360943,2008-12-16T00:00:00,Peptides,D12.644
19360943,2008-12-16T00:00:00,Polymers,D05.750
19360943,2008-12-16T00:00:00,Polymers,D25.720
19360943,2008-12-16T00:00:00,Polymers,J01.637.051.720
19360943,2008-12-16T00:00:00,Surface Properties,G02.842.850
19095991,2008-12-18T00:00:00,Aged,M01.060.116.100
19095991,2008-12-18T00:00:00,Anticoagulants,D27.505.954.502.119
19095991,2008-12-18T00:00:00,Cerebrovascular Disorders,C10.228.140.300
19095991,2008-12-18T00:00:00,Cerebrovascular Disorders,C14.907.253
19095991,2008-12-18T00:00:00,"Constriction, Pathologic",C23.300.287
19095991,2008-12-18T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19095991,2008-12-18T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19095991,2008-12-18T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19095991,2008-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19095991,2008-12-18T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
19095991,2008-12-18T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
19095991,2008-12-18T00:00:00,Middle Aged,M01.060.116.630
19095991,2008-12-18T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19095991,2008-12-18T00:00:00,Stroke,C10.228.140.300.775
19095991,2008-12-18T00:00:00,Stroke,C14.907.253.855
19095991,2008-12-18T00:00:00,Treatment Outcome,E01.789.800
19095991,2008-12-18T00:00:00,Treatment Outcome,N04.761.559.590.800
19095991,2008-12-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19095991,2008-12-18T00:00:00,Warfarin,D03.438.150.446.520.914
19095991,2008-12-18T00:00:00,Warfarin,D03.830.219.446.520.914
19367794,2008-12-18T00:00:00,Alkanes,D02.455.326.146
19367794,2008-12-18T00:00:00,Computer Simulation,L01.224.160
19367794,2008-12-18T00:00:00,Fluorine Compounds,D01.303
19367794,2008-12-18T00:00:00,"Models, Molecular",E05.599.595
19367794,2008-12-18T00:00:00,Polymers,D05.750
19367794,2008-12-18T00:00:00,Polymers,D25.720
19367794,2008-12-18T00:00:00,Polymers,J01.637.051.720
19367794,2008-12-18T00:00:00,Protons,D01.248.497.300.459.700
19367794,2008-12-18T00:00:00,Protons,D01.435.550
19367794,2008-12-18T00:00:00,Protons,G01.249.765
19367794,2008-12-18T00:00:00,Water,D01.455.900
19367794,2008-12-18T00:00:00,Water,D01.650.550.925
19096224,2008-12-19T00:00:00,Aged,M01.060.116.100
19096224,2008-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19096224,2008-12-19T00:00:00,Influenza Vaccines,D20.215.894.899.302
19096224,2008-12-19T00:00:00,"Influenza, Human",C02.782.620.365
19096224,2008-12-19T00:00:00,"Influenza, Human",C08.730.310
19096224,2008-12-19T00:00:00,Middle Aged,M01.060.116.630
19096224,2008-12-19T00:00:00,Stroke,C10.228.140.300.775
19096224,2008-12-19T00:00:00,Stroke,C14.907.253.855
19096224,2008-12-19T00:00:00,Vaccination,E02.095.465.425.400.530.890
19096224,2008-12-19T00:00:00,Vaccination,E05.478.550.600.890
19096224,2008-12-19T00:00:00,Vaccination,N02.421.726.758.310.890
19096224,2008-12-19T00:00:00,Vaccination,N06.850.780.200.425.900
19096224,2008-12-19T00:00:00,Vaccination,N06.850.780.680.310.890
19100966,2008-12-19T00:00:00,Animals,B01.050
19100966,2008-12-19T00:00:00,Cocaine,D02.145.074.722.388
19100966,2008-12-19T00:00:00,Cocaine,D03.132.889.354
19100966,2008-12-19T00:00:00,Cocaine,D03.605.869.388
19100966,2008-12-19T00:00:00,Cocaine,D04.075.080.875.099.722.388
19100966,2008-12-19T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
19100966,2008-12-19T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
19100966,2008-12-19T00:00:00,"Extinction, Psychological",F02.463.425.770.232
19100966,2008-12-19T00:00:00,Pyrazoles,D03.383.129.539
19100966,2008-12-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19100966,2008-12-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19100966,2008-12-19T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
19100966,2008-12-19T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
19103434,2008-12-21T00:00:00,Acetylcysteine,D02.886.030.230.259
19103434,2008-12-21T00:00:00,Acetylcysteine,D12.125.166.230.259
19103434,2008-12-21T00:00:00,Amygdala,A08.186.211.464.090
19103434,2008-12-21T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
19103434,2008-12-21T00:00:00,Animals,B01.050
19103434,2008-12-21T00:00:00,Brain,A08.186.211
19103434,2008-12-21T00:00:00,Carbon Monoxide,D01.200.250
19103434,2008-12-21T00:00:00,Carbon Monoxide,D01.362.200
19103434,2008-12-21T00:00:00,Carbon Monoxide,D01.650.550.250
19103434,2008-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19103434,2008-12-21T00:00:00,Middle Aged,M01.060.116.630
19103434,2008-12-21T00:00:00,Nicotine,D03.132.760.570
19103434,2008-12-21T00:00:00,Nicotine,D03.383.725.518
19103434,2008-12-21T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
19103434,2008-12-21T00:00:00,Pilot Projects,E05.318.760.750
19103434,2008-12-21T00:00:00,Pilot Projects,E05.337.737
19103434,2008-12-21T00:00:00,Pilot Projects,N05.715.360.775.625
19103434,2008-12-21T00:00:00,Pilot Projects,N06.850.520.450.720
19103434,2008-12-21T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19103434,2008-12-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19103434,2008-12-21T00:00:00,Self Administration,E02.319.890
19103434,2008-12-21T00:00:00,Self Administration,E02.900.890
19103434,2008-12-21T00:00:00,Substance Withdrawal Syndrome,C21.739.835
19103434,2008-12-21T00:00:00,Substance Withdrawal Syndrome,F03.900.825
19103434,2008-12-21T00:00:00,Tobacco Use Disorder,C21.739.912
19103434,2008-12-21T00:00:00,Tobacco Use Disorder,F03.900.912
19103434,2008-12-21T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
19103434,2008-12-21T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
19104006,2008-12-22T00:00:00,Adolescent,M01.060.057
19104006,2008-12-22T00:00:00,Adult,M01.060.116
19104006,2008-12-22T00:00:00,African Continental Ancestry Group,M01.686.508.100
19104006,2008-12-22T00:00:00,Blood Pressure,E01.370.600.875.249
19104006,2008-12-22T00:00:00,Blood Pressure,G09.330.380.076
19104006,2008-12-22T00:00:00,Child,M01.060.406
19104006,2008-12-22T00:00:00,Environment,G16.500.275
19104006,2008-12-22T00:00:00,Environment,N06.230
19104006,2008-12-22T00:00:00,European Continental Ancestry Group,M01.686.508.400
19104006,2008-12-22T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
19104006,2008-12-22T00:00:00,Genetic Predisposition to Disease,G05.380.355
19104006,2008-12-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19104006,2008-12-22T00:00:00,Hypertension,C14.907.489
19104006,2008-12-22T00:00:00,"Models, Genetic",E05.599.395.397
19104006,2008-12-22T00:00:00,Phenotype,G05.695
19104006,2008-12-22T00:00:00,Regression Analysis,E05.318.740.750
19104006,2008-12-22T00:00:00,Regression Analysis,N05.715.360.750.695
19104006,2008-12-22T00:00:00,Regression Analysis,N06.850.520.830.750
19104006,2008-12-22T00:00:00,Sodium,D01.268.549.750
19104006,2008-12-22T00:00:00,Sodium,D01.552.528.850
19104006,2008-12-22T00:00:00,"Stress, Psychological",F01.145.126.990
19104006,2008-12-22T00:00:00,"Stress, Psychological",F02.830.900
19104006,2008-12-22T00:00:00,Young Adult,M01.060.116.815
19106159,2008-12-23T00:00:00,Animals,B01.050
19106159,2008-12-23T00:00:00,Cell Cycle Proteins,D12.776.167
19106159,2008-12-23T00:00:00,Circadian Rhythm,G07.180.562.190
19106159,2008-12-23T00:00:00,Down-Regulation,G02.111.087.225
19106159,2008-12-23T00:00:00,Down-Regulation,G02.149.115.225
19106159,2008-12-23T00:00:00,Down-Regulation,G05.355.315.200
19106159,2008-12-23T00:00:00,Down-Regulation,G07.690.812.230
19106159,2008-12-23T00:00:00,Down-Regulation,G07.700.680.230
19106159,2008-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19106159,2008-12-23T00:00:00,Intestinal Mucosa,A03.556.124.369
19106159,2008-12-23T00:00:00,Intestinal Mucosa,A10.615.550.444
19106159,2008-12-23T00:00:00,Motor Activity,F01.145.632
19106159,2008-12-23T00:00:00,Motor Activity,G11.427.590.530.698
19106159,2008-12-23T00:00:00,Nuclear Proteins,D12.776.660
19106159,2008-12-23T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
19106159,2008-12-23T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
19106159,2008-12-23T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
19106159,2008-12-23T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
19106159,2008-12-23T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
19106159,2008-12-23T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
19106159,2008-12-23T00:00:00,Trans-Activators,D12.776.260.755
19106159,2008-12-23T00:00:00,Trans-Activators,D12.776.930.900
19106159,2008-12-23T00:00:00,Trans-Activators,D12.776.964.925.984
19106159,2008-12-23T00:00:00,Transcription Factors,D12.776.930
19106159,2008-12-23T00:00:00,beta Catenin,D12.776.091.249
19106159,2008-12-23T00:00:00,beta Catenin,D12.776.220.145.500
19106159,2008-12-23T00:00:00,beta Catenin,D12.776.930.130
19106426,2008-12-23T00:00:00,Autistic Disorder,F03.550.325.125
19106426,2008-12-23T00:00:00,Child,M01.060.406
19106426,2008-12-23T00:00:00,Continental Population Groups,M01.686.508
19106426,2008-12-23T00:00:00,Ethnic Groups,M01.686.754
19106426,2008-12-23T00:00:00,Ethnic Groups,N01.224.317
19106426,2008-12-23T00:00:00,Health Status Disparities,I01.240.425.675
19106426,2008-12-23T00:00:00,Health Status Disparities,N01.224.425.437
19106426,2008-12-23T00:00:00,Health Status Disparities,N06.850.505.400.425.675
19106426,2008-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19106426,2008-12-23T00:00:00,Population Surveillance,E05.318.308.250.700
19106426,2008-12-23T00:00:00,Population Surveillance,N05.715.360.300.375.625
19106426,2008-12-23T00:00:00,Population Surveillance,N06.850.520.308.250.700
19106426,2008-12-23T00:00:00,Population Surveillance,N06.850.780.675
19106426,2008-12-23T00:00:00,Risk Assessment,E05.318.740.600.800.715
19106426,2008-12-23T00:00:00,Risk Assessment,N04.452.871.715
19106426,2008-12-23T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19106426,2008-12-23T00:00:00,Risk Assessment,N06.850.505.715
19106426,2008-12-23T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19106426,2008-12-23T00:00:00,United States,Z01.107.567.875
19107118,2008-12-23T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
19107118,2008-12-23T00:00:00,Animals,B01.050
19107118,2008-12-23T00:00:00,Ceramides,D02.065.313
19107118,2008-12-23T00:00:00,Ceramides,D09.400.410.420.525.200
19107118,2008-12-23T00:00:00,Ceramides,D10.390.470.675.200
19107118,2008-12-23T00:00:00,Ceramides,D10.570.877.360.612.200
19107118,2008-12-23T00:00:00,Enzyme Inhibitors,D27.505.519.389
19107118,2008-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19107118,2008-12-23T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
19107118,2008-12-23T00:00:00,Propanolamines,D02.033.100.624
19107118,2008-12-23T00:00:00,Propanolamines,D02.033.755.624
19107118,2008-12-23T00:00:00,Propanolamines,D02.092.063.624
19107118,2008-12-23T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19107118,2008-12-23T00:00:00,Prostatic Neoplasms,C12.294.260.750
19107118,2008-12-23T00:00:00,Prostatic Neoplasms,C12.294.565.625
19107118,2008-12-23T00:00:00,Prostatic Neoplasms,C12.758.409.750
19107118,2008-12-23T00:00:00,Radiation-Sensitizing Agents,D27.505.696.750
19107118,2008-12-23T00:00:00,Sensitivity and Specificity,E05.318.740.872
19107118,2008-12-23T00:00:00,Sensitivity and Specificity,E05.318.780.800
19107118,2008-12-23T00:00:00,Sensitivity and Specificity,G17.800
19107118,2008-12-23T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19107118,2008-12-23T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19107118,2008-12-23T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19107118,2008-12-23T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19107118,2008-12-23T00:00:00,Sphingosine,D02.033.100.700
19107118,2008-12-23T00:00:00,Sphingosine,D02.033.455.843
19107118,2008-12-23T00:00:00,Sphingosine,D02.092.063.700
19109557,2008-12-24T00:00:00,Age of Onset,N05.715.350.075.100
19109557,2008-12-24T00:00:00,Age of Onset,N06.850.490.250.100
19109557,2008-12-24T00:00:00,Aged,M01.060.116.100
19109557,2008-12-24T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19109557,2008-12-24T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19109557,2008-12-24T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19109557,2008-12-24T00:00:00,Enzyme Inhibitors,D27.505.519.389
19109557,2008-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19109557,2008-12-24T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
19109557,2008-12-24T00:00:00,Quinolones,D03.438.810.835
19135119,2008-12-24T00:00:00,Animals,B01.050
19135119,2008-12-24T00:00:00,Antineoplastic Agents,D27.505.954.248
19135119,2008-12-24T00:00:00,Cisplatin,D01.210.375
19135119,2008-12-24T00:00:00,Cisplatin,D01.625.125
19135119,2008-12-24T00:00:00,Cisplatin,D01.710.100
19135119,2008-12-24T00:00:00,Enzyme Inhibitors,D27.505.519.389
19135119,2008-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19135119,2008-12-24T00:00:00,Isoxazoles,D03.383.129.385
19135119,2008-12-24T00:00:00,Kidney Diseases,C12.777.419
19135119,2008-12-24T00:00:00,Kidney Diseases,C13.351.968.419
19135119,2008-12-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19162407,2008-12-24T00:00:00,Adolescent,M01.060.057
19162407,2008-12-24T00:00:00,Adult,M01.060.116
19162407,2008-12-24T00:00:00,Ethanol,D02.033.375
19162407,2008-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19162407,2008-12-24T00:00:00,Rape,I01.198.240.748.640
19162407,2008-12-24T00:00:00,Students,I02.233.748
19162407,2008-12-24T00:00:00,Students,I02.851
19162407,2008-12-24T00:00:00,Students,M01.848
19162407,2008-12-24T00:00:00,Substance-Related Disorders,C21.739
19162407,2008-12-24T00:00:00,Substance-Related Disorders,F03.900
19162407,2008-12-24T00:00:00,United States,Z01.107.567.875
19162407,2008-12-24T00:00:00,Young Adult,M01.060.116.815
19100764,2008-12-25T00:00:00,Animals,B01.050
19100764,2008-12-25T00:00:00,Antimicrobial Cationic Peptides,D12.644.050
19100764,2008-12-25T00:00:00,Antimicrobial Cationic Peptides,D12.776.543.695.054
19100764,2008-12-25T00:00:00,RNA Interference,G05.355.315.203.374.790
19109580,2008-12-25T00:00:00,Brain Ischemia,C10.228.140.300.150
19109580,2008-12-25T00:00:00,Brain Ischemia,C14.907.253.092
19109580,2008-12-25T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
19109580,2008-12-25T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
19109580,2008-12-25T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
19109580,2008-12-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19109580,2008-12-25T00:00:00,Stroke,C10.228.140.300.775
19109580,2008-12-25T00:00:00,Stroke,C14.907.253.855
19109580,2008-12-25T00:00:00,Thrombolytic Therapy,E02.319.913
19109580,2008-12-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
19109580,2008-12-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
19109580,2008-12-25T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
19109580,2008-12-25T00:00:00,Tissue Plasminogen Activator,D23.119.970
19150655,2008-12-25T00:00:00,Aging,G07.700.320.124
19150655,2008-12-25T00:00:00,Algorithms,G17.035
19150655,2008-12-25T00:00:00,Algorithms,L01.224.050
19150655,2008-12-25T00:00:00,Animals,B01.050
19150655,2008-12-25T00:00:00,Brain,A08.186.211
19150655,2008-12-25T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
19150655,2008-12-25T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
19150655,2008-12-25T00:00:00,Image Enhancement,E01.370.350.600.350
19150655,2008-12-25T00:00:00,Image Enhancement,L01.224.308.380
19150655,2008-12-25T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
19150655,2008-12-25T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
19150655,2008-12-25T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
19150655,2008-12-25T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
19150655,2008-12-25T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
19150655,2008-12-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19150655,2008-12-25T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19150655,2008-12-25T00:00:00,Sensitivity and Specificity,E05.318.740.872
19150655,2008-12-25T00:00:00,Sensitivity and Specificity,E05.318.780.800
19150655,2008-12-25T00:00:00,Sensitivity and Specificity,G17.800
19150655,2008-12-25T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19150655,2008-12-25T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19150655,2008-12-25T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19150655,2008-12-25T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19162436,2008-12-25T00:00:00,Cyclonic Storms,G16.500.240.135.500
19162436,2008-12-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19162436,2008-12-25T00:00:00,Life Change Events,F01.829.458.410
19162436,2008-12-25T00:00:00,"Polymorphism, Genetic",G05.365.795
19162436,2008-12-25T00:00:00,Prevalence,E05.318.308.985.525.750
19162436,2008-12-25T00:00:00,Prevalence,L01.280.975.525.750
19162436,2008-12-25T00:00:00,Prevalence,N01.224.935.597.750
19162436,2008-12-25T00:00:00,Prevalence,N06.850.505.400.975.525.750
19162436,2008-12-25T00:00:00,Prevalence,N06.850.520.308.985.525.750
19162436,2008-12-25T00:00:00,RGS Proteins,D12.644.360.325.150.750
19162436,2008-12-25T00:00:00,RGS Proteins,D12.776.402.150.750
19162436,2008-12-25T00:00:00,RGS Proteins,D12.776.476.325.150.750
19162436,2008-12-25T00:00:00,Risk Factors,E05.318.740.600.800.725
19162436,2008-12-25T00:00:00,Risk Factors,N05.715.350.200.700
19162436,2008-12-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19162436,2008-12-25T00:00:00,Risk Factors,N06.850.490.625.750
19162436,2008-12-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19162436,2008-12-25T00:00:00,Social Support,I01.880.656.600
19162436,2008-12-25T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19112177,2008-12-27T00:00:00,Cell Line,A11.251.210
19112177,2008-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.644.360.225.600
19112177,2008-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.167.187.600
19112177,2008-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.476.225.600
19112177,2008-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.624.776.355.600
19112177,2008-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19112177,2008-12-27T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
19112177,2008-12-27T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
19112177,2008-12-27T00:00:00,Nerve Tissue Proteins,D12.776.641
19112177,2008-12-27T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
19112177,2008-12-27T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
19112177,2008-12-27T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
19112177,2008-12-27T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
19112177,2008-12-27T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
19112177,2008-12-27T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
19112177,2008-12-27T00:00:00,Proto-Oncogene Proteins pp60(c-src),D08.811.913.696.620.682.725.800.630
19112177,2008-12-27T00:00:00,Proto-Oncogene Proteins pp60(c-src),D12.776.624.664.700.202
19112177,2008-12-27T00:00:00,S-Phase Kinase-Associated Proteins,D12.776.157.743
19112177,2008-12-27T00:00:00,"Transcription, Genetic",G02.111.087.847
19112177,2008-12-27T00:00:00,"Transcription, Genetic",G02.149.115.847
19112177,2008-12-27T00:00:00,"Transcription, Genetic",G05.355.310.700
20633397,2008-12-27T00:00:00,Animals,B01.050
20633397,2008-12-27T00:00:00,Electric Stimulation Therapy,E02.342
20633397,2008-12-27T00:00:00,Electric Stimulation Therapy,E02.779.468
20633397,2008-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633397,2008-12-27T00:00:00,Periodicals as Topic,L01.178.682.829.678
19115170,2008-12-29T00:00:00,"Brain Diseases, Metabolic",C10.228.140.163
19115170,2008-12-29T00:00:00,"Brain Diseases, Metabolic",C18.452.132
19115170,2008-12-29T00:00:00,Brain Injuries,C10.228.140.199
19115170,2008-12-29T00:00:00,Brain Injuries,C10.900.300.087
19115170,2008-12-29T00:00:00,Brain Injuries,C21.866.260.118
19115170,2008-12-29T00:00:00,Brain Injuries,C21.866.915.300.200
19115170,2008-12-29T00:00:00,Brain Ischemia,C10.228.140.300.150
19115170,2008-12-29T00:00:00,Brain Ischemia,C14.907.253.092
19115170,2008-12-29T00:00:00,Diagnostic Imaging,E01.370.350
19115170,2008-12-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19115170,2008-12-29T00:00:00,Intensive Care,E02.760.190.400
19115170,2008-12-29T00:00:00,Intensive Care,N02.421.585.190.400
19115170,2008-12-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19115170,2008-12-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19115170,2008-12-29T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
19115170,2008-12-29T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
19115170,2008-12-29T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
19115170,2008-12-29T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
19115170,2008-12-29T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
19115170,2008-12-29T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
19115170,2008-12-29T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
19115170,2008-12-29T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
19115170,2008-12-29T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
19115170,2008-12-29T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
19115170,2008-12-29T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
19053230,2008-12-30T00:00:00,Animals,B01.050
19053230,2008-12-30T00:00:00,Calcium,D01.268.552.100
19053230,2008-12-30T00:00:00,Calcium,D01.552.539.288
19053230,2008-12-30T00:00:00,Calcium,D23.119.100
19053230,2008-12-30T00:00:00,Dogs,B01.050.150.900.649.147.153.200
19053230,2008-12-30T00:00:00,"Muscle, Skeletal",A02.633.567
19053230,2008-12-30T00:00:00,"Muscle, Skeletal",A10.690.552.500
19053230,2008-12-30T00:00:00,Myocardium,A02.633.580
19053230,2008-12-30T00:00:00,Myocardium,A07.541.704
19053230,2008-12-30T00:00:00,Myocardium,A10.690.552.750
19053230,2008-12-30T00:00:00,Nitric Oxide,D01.339.387
19053230,2008-12-30T00:00:00,Nitric Oxide,D01.625.550.500
19053230,2008-12-30T00:00:00,Nitric Oxide,D01.625.700.500
19053230,2008-12-30T00:00:00,Nitric Oxide,D01.650.550.587.600
19053230,2008-12-30T00:00:00,Oxygen,D01.268.185.550
19053230,2008-12-30T00:00:00,Oxygen,D01.362.670
19053230,2008-12-30T00:00:00,Peroxynitrous Acid,D01.625.600.800
19053230,2008-12-30T00:00:00,Peroxynitrous Acid,D01.625.700.750
19053230,2008-12-30T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
19053230,2008-12-30T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
19053230,2008-12-30T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
19053230,2008-12-30T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
19053230,2008-12-30T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
19053230,2008-12-30T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
19053230,2008-12-30T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
19118257,2008-12-31T00:00:00,Animals,B01.050
19118257,2008-12-31T00:00:00,Blood Pressure,E01.370.600.875.249
19118257,2008-12-31T00:00:00,Blood Pressure,G09.330.380.076
19118257,2008-12-31T00:00:00,Cardiomegaly,C14.280.195
19118257,2008-12-31T00:00:00,Cardiomegaly,C23.300.775.250
19118257,2008-12-31T00:00:00,Diastole,G09.330.190.541.295
19118257,2008-12-31T00:00:00,Diastole,G11.427.590.540.554.250
19118257,2008-12-31T00:00:00,Diastole,G11.427.590.540.570.295
19118257,2008-12-31T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
19118257,2008-12-31T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
19118257,2008-12-31T00:00:00,Myocardium,A02.633.580
19118257,2008-12-31T00:00:00,Myocardium,A07.541.704
19118257,2008-12-31T00:00:00,Myocardium,A10.690.552.750
19118257,2008-12-31T00:00:00,Osteonectin,D12.776.157.125.715
19118257,2008-12-31T00:00:00,Osteonectin,D12.776.395.600
19118257,2008-12-31T00:00:00,Procollagen,D12.776.811.690
19118257,2008-12-31T00:00:00,Procollagen,D12.776.860.300.250.600
19118257,2008-12-31T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
19118257,2008-12-31T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
19118257,2008-12-31T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
19118257,2008-12-31T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
19118257,2008-12-31T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
19118257,2008-12-31T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
19122831,2008-12-31T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
19122831,2008-12-31T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
19122831,2008-12-31T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
19122831,2008-12-31T00:00:00,Animals,B01.050
19122831,2008-12-31T00:00:00,"Animals, Newborn",B01.050.050.282
19122831,2008-12-31T00:00:00,Antibodies,D12.776.124.486.485.114
19122831,2008-12-31T00:00:00,Antibodies,D12.776.124.790.651.114
19122831,2008-12-31T00:00:00,Antibodies,D12.776.377.715.548.114
19122831,2008-12-31T00:00:00,Cell Differentiation,G04.299.151
19122831,2008-12-31T00:00:00,Eye,A01.456.505.420
19122831,2008-12-31T00:00:00,Eye,A09.371
19122831,2008-12-31T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19122831,2008-12-31T00:00:00,"Lens, Crystalline",A09.371.060.500
19122831,2008-12-31T00:00:00,Membrane Proteins,D12.776.543
19122831,2008-12-31T00:00:00,Nerve Tissue Proteins,D12.776.641
19122831,2008-12-31T00:00:00,Protein Transport,G03.495.166.700
19122831,2008-12-31T00:00:00,"RNA, Messenger",D13.444.735.544
19122831,2008-12-31T00:00:00,Retina,A09.371.729
18633826,2009-01-01T00:00:00,Adolescent,M01.060.057
18633826,2009-01-01T00:00:00,Adult,M01.060.116
18633826,2009-01-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
18633826,2009-01-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18633826,2009-01-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18633826,2009-01-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18633826,2009-01-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18633826,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18633826,2009-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18633826,2009-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18633826,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
18633826,2009-01-01T00:00:00,"Models, Statistical",E05.318.740.500
18633826,2009-01-01T00:00:00,"Models, Statistical",E05.599.835
18633826,2009-01-01T00:00:00,"Models, Statistical",N05.715.360.750.530
18633826,2009-01-01T00:00:00,"Models, Statistical",N06.850.520.830.500
18633826,2009-01-01T00:00:00,Oxygen,D01.268.185.550
18633826,2009-01-01T00:00:00,Oxygen,D01.362.670
18633826,2009-01-01T00:00:00,Young Adult,M01.060.116.815
18833580,2009-01-01T00:00:00,Adult,M01.060.116
18833580,2009-01-01T00:00:00,Alleles,G05.360.340.024.340.030
18833580,2009-01-01T00:00:00,Anxiety Disorders,F03.080
18833580,2009-01-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
18833580,2009-01-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18833580,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18833580,2009-01-01T00:00:00,Life Change Events,F01.829.458.410
18833580,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
18833580,2009-01-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18833580,2009-01-01T00:00:00,Prevalence,E05.318.308.985.525.750
18833580,2009-01-01T00:00:00,Prevalence,L01.280.975.525.750
18833580,2009-01-01T00:00:00,Prevalence,N01.224.935.597.750
18833580,2009-01-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
18833580,2009-01-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
18833580,2009-01-01T00:00:00,RGS Proteins,D12.644.360.325.150.750
18833580,2009-01-01T00:00:00,RGS Proteins,D12.776.402.150.750
18833580,2009-01-01T00:00:00,RGS Proteins,D12.776.476.325.150.750
18833580,2009-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18833580,2009-01-01T00:00:00,Young Adult,M01.060.116.815
18932227,2009-01-01T00:00:00,Animals,B01.050
18932227,2009-01-01T00:00:00,Carrier Proteins,D12.776.157
18932227,2009-01-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18932227,2009-01-01T00:00:00,Cocaine,D02.145.074.722.388
18932227,2009-01-01T00:00:00,Cocaine,D03.132.889.354
18932227,2009-01-01T00:00:00,Cocaine,D03.605.869.388
18932227,2009-01-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
18932227,2009-01-01T00:00:00,Dopamine,D02.092.211.215.311.342
18932227,2009-01-01T00:00:00,Dopamine,D02.092.311.342
18932227,2009-01-01T00:00:00,Glutamic Acid,D12.125.067.750
18932227,2009-01-01T00:00:00,Glutamic Acid,D12.125.119.450
18932227,2009-01-01T00:00:00,Glutamic Acid,D12.125.427.300
18932227,2009-01-01T00:00:00,Limbic System,A08.186.211.464
18932227,2009-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18932227,2009-01-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18932227,2009-01-01T00:00:00,Signal Transduction,G02.111.087.800
18932227,2009-01-01T00:00:00,Signal Transduction,G02.149.115.800
18932227,2009-01-01T00:00:00,Signal Transduction,G04.299.880
18932227,2009-01-01T00:00:00,"Transcription, Genetic",G02.111.087.847
18932227,2009-01-01T00:00:00,"Transcription, Genetic",G02.149.115.847
18932227,2009-01-01T00:00:00,"Transcription, Genetic",G05.355.310.700
19050658,2009-01-01T00:00:00,Aged,M01.060.116.100
19050658,2009-01-01T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
19050658,2009-01-01T00:00:00,Carotid Artery Diseases,C14.907.253.123
19050658,2009-01-01T00:00:00,Cerebrovascular Disorders,C10.228.140.300
19050658,2009-01-01T00:00:00,Cerebrovascular Disorders,C14.907.253
19050658,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19050658,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19050658,2009-01-01T00:00:00,Stents,E07.695.750
19050658,2009-01-01T00:00:00,Stroke,C10.228.140.300.775
19050658,2009-01-01T00:00:00,Stroke,C14.907.253.855
19050658,2009-01-01T00:00:00,Vascular Surgical Procedures,E04.100.814
19051222,2009-01-01T00:00:00,Amphetamine,D02.092.471.683.152.110
19051222,2009-01-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
19051222,2009-01-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
19051222,2009-01-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
19051222,2009-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19051222,2009-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
19051222,2009-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19051222,2009-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19051222,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19051222,2009-01-01T00:00:00,Methylphenidate,D02.241.223.601.600
19051222,2009-01-01T00:00:00,Methylphenidate,D03.383.621.460
19057378,2009-01-01T00:00:00,Adolescent,M01.060.057
19057378,2009-01-01T00:00:00,Adult,M01.060.116
19057378,2009-01-01T00:00:00,Aged,M01.060.116.100
19057378,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19057378,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19057378,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19057378,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19057378,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19057378,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19057378,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19057378,2009-01-01T00:00:00,Stroke,C10.228.140.300.775
19057378,2009-01-01T00:00:00,Stroke,C14.907.253.855
19064218,2009-01-01T00:00:00,Curriculum,I02.158
19064218,2009-01-01T00:00:00,Internship and Residency,I02.358.399.644
19064218,2009-01-01T00:00:00,Radiology,H02.403.740
19064218,2009-01-01T00:00:00,United States,Z01.107.567.875
19077690,2009-01-01T00:00:00,Animals,B01.050
19077690,2009-01-01T00:00:00,Feedback,L01.143.283.425
19077690,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19077690,2009-01-01T00:00:00,Kidney Glomerulus,A05.810.453.324.359
19077690,2009-01-01T00:00:00,Kidney Glomerulus,A05.810.453.736.520
19077690,2009-01-01T00:00:00,Signal Transduction,G02.111.087.800
19077690,2009-01-01T00:00:00,Signal Transduction,G02.149.115.800
19077690,2009-01-01T00:00:00,Signal Transduction,G04.299.880
19077745,2009-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19077745,2009-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19077745,2009-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19077745,2009-01-01T00:00:00,Dysplastic Nevus Syndrome,C04.557.665.560.260
19077745,2009-01-01T00:00:00,Dysplastic Nevus Syndrome,C04.700.305
19077745,2009-01-01T00:00:00,Dysplastic Nevus Syndrome,C16.320.700.305
19077745,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19077745,2009-01-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
19077745,2009-01-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
19077745,2009-01-01T00:00:00,Observation,E05.581.249
19077745,2009-01-01T00:00:00,Reoperation,E04.690
19077745,2009-01-01T00:00:00,Skin Neoplasms,C04.588.805
19077745,2009-01-01T00:00:00,Skin Neoplasms,C17.800.882
19081394,2009-01-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
19081394,2009-01-01T00:00:00,Enalapril,D12.644.456.345.360
19081394,2009-01-01T00:00:00,"Heart Defects, Congenital",C14.240.400
19081394,2009-01-01T00:00:00,"Heart Defects, Congenital",C14.280.400
19081394,2009-01-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19081394,2009-01-01T00:00:00,Heart Ventricles,A07.541.560
19081394,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19081394,2009-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
19093963,2009-01-01T00:00:00,Animals,B01.050
19093963,2009-01-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
19093963,2009-01-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
19093963,2009-01-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
19093963,2009-01-01T00:00:00,Chronic Disease,C23.550.291.500
19093963,2009-01-01T00:00:00,"Immunity, Innate",G12.450.575
19093963,2009-01-01T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
19093963,2009-01-01T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.782.815.616.850
19093963,2009-01-01T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.839.850
19093963,2009-01-01T00:00:00,Simian Acquired Immunodeficiency Syndrome,C22.735.500.850
19097097,2009-01-01T00:00:00,Brain,A08.186.211
19097097,2009-01-01T00:00:00,Computer-Aided Design,L01.224.108.150
19097097,2009-01-01T00:00:00,Computer-Aided Design,L01.296.110.150
19097097,2009-01-01T00:00:00,Equipment Failure Analysis,E05.325.192
19097097,2009-01-01T00:00:00,Head,A01.456
19097097,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19097097,2009-01-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
19097097,2009-01-01T00:00:00,Magnetics,H01.671.493
19097097,2009-01-01T00:00:00,"Phantoms, Imaging",E07.671
19097097,2009-01-01T00:00:00,Protons,D01.248.497.300.459.700
19097097,2009-01-01T00:00:00,Protons,D01.435.550
19097097,2009-01-01T00:00:00,Protons,G01.249.765
19097097,2009-01-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
19097097,2009-01-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
19097097,2009-01-01T00:00:00,Sensitivity and Specificity,G17.800
19097097,2009-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19097097,2009-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19097097,2009-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19097097,2009-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19097097,2009-01-01T00:00:00,Transducers,E07.305.812
19098640,2009-01-01T00:00:00,Clavicle,A02.835.232.087.227
19098640,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19098640,2009-01-01T00:00:00,Infant,M01.060.703
19101261,2009-01-01T00:00:00,Adult,M01.060.116
19101261,2009-01-01T00:00:00,Attitude of Health Personnel,F01.100.050
19101261,2009-01-01T00:00:00,Attitude of Health Personnel,N05.300.100
19101261,2009-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19101261,2009-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19101261,2009-01-01T00:00:00,Decision Making,F02.463.785.373
19101261,2009-01-01T00:00:00,Disease Progression,C23.550.291.656
19101261,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19101261,2009-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19101261,2009-01-01T00:00:00,Lung Neoplasms,C08.381.540
19101261,2009-01-01T00:00:00,Lung Neoplasms,C08.785.520
19101261,2009-01-01T00:00:00,Physician's Practice Patterns,N04.590.748
19101261,2009-01-01T00:00:00,Physician's Practice Patterns,N05.300.625
19101261,2009-01-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
19101261,2009-01-01T00:00:00,Physician-Patient Relations,N05.300.660.625
19101261,2009-01-01T00:00:00,Pneumonectomy,E04.928.600.600
19101261,2009-01-01T00:00:00,Postoperative Complications,C23.550.767
19101261,2009-01-01T00:00:00,Renal Dialysis,E02.870.300
19101261,2009-01-01T00:00:00,Renal Dialysis,E02.912.800
19101261,2009-01-01T00:00:00,Renal Insufficiency,C12.777.419.780
19101261,2009-01-01T00:00:00,Renal Insufficiency,C13.351.968.419.780
19101261,2009-01-01T00:00:00,Total Quality Management,N04.452.955
19101261,2009-01-01T00:00:00,Total Quality Management,N04.761.700.675
19101261,2009-01-01T00:00:00,Total Quality Management,N05.700.792
19101331,2009-01-01T00:00:00,Adult,M01.060.116
19101331,2009-01-01T00:00:00,Angiography,E01.370.350.700.060
19101331,2009-01-01T00:00:00,Angiography,E01.370.370.050
19101331,2009-01-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
19101331,2009-01-01T00:00:00,Combined Modality Therapy,E02.186
19101331,2009-01-01T00:00:00,Fibrosis,C23.550.355
19101331,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19101331,2009-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
19101331,2009-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
19101331,2009-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
19101331,2009-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
19101331,2009-01-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
19101331,2009-01-01T00:00:00,Pulmonary Artery,A07.231.114.715
19101331,2009-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19101331,2009-01-01T00:00:00,Risk Assessment,N04.452.871.715
19101331,2009-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19101331,2009-01-01T00:00:00,Risk Assessment,N06.850.505.715
19101331,2009-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19101331,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19101331,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19101331,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19101331,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19101331,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19101331,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19101331,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19101331,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19104359,2009-01-01T00:00:00,Adult,M01.060.116
19104359,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19104359,2009-01-01T00:00:00,Obesity,C18.654.726.500
19104359,2009-01-01T00:00:00,Obesity,C23.888.144.699.500
19104359,2009-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19104359,2009-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19104359,2009-01-01T00:00:00,"Obstetric Labor, Premature",C13.703.420.491
19104359,2009-01-01T00:00:00,Pregnancy,G08.686.785.760.769
19104359,2009-01-01T00:00:00,Pregnancy Complications,C13.703
19104359,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19104359,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19104359,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19104359,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19104359,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19104359,2009-01-01T00:00:00,Uterine Contraction,G08.686.785.760.769.326.700
19104359,2009-01-01T00:00:00,Uterine Contraction,G11.427.590.540.890
19106608,2009-01-01T00:00:00,Animals,B01.050
19106608,2009-01-01T00:00:00,Apoptosis,G04.299.139.160
19106608,2009-01-01T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
19106608,2009-01-01T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
19106608,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19106608,2009-01-01T00:00:00,Membrane Proteins,D12.776.543
19106608,2009-01-01T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
19106608,2009-01-01T00:00:00,"Transcription, Genetic",G02.111.087.847
19106608,2009-01-01T00:00:00,"Transcription, Genetic",G02.149.115.847
19106608,2009-01-01T00:00:00,"Transcription, Genetic",G05.355.310.700
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
19106608,2009-01-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
19106728,2009-01-01T00:00:00,Adult,M01.060.116
19106728,2009-01-01T00:00:00,Aged,M01.060.116.100
19106728,2009-01-01T00:00:00,Chronic Disease,C23.550.291.500
19106728,2009-01-01T00:00:00,Directive Counseling,F02.784.176.279
19106728,2009-01-01T00:00:00,Directive Counseling,F04.408.413.349
19106728,2009-01-01T00:00:00,Directive Counseling,N02.421.461.363.349
19106728,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19106728,2009-01-01T00:00:00,Medication Adherence,F01.145.488.500.500
19106728,2009-01-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
19106728,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19106728,2009-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19106728,2009-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19106728,2009-01-01T00:00:00,Program Evaluation,E05.337.820
19106728,2009-01-01T00:00:00,Program Evaluation,N04.761.685
19106728,2009-01-01T00:00:00,Program Evaluation,N05.715.360.650
19106728,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19106728,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19106728,2009-01-01T00:00:00,United States,Z01.107.567.875
19109138,2009-01-01T00:00:00,Animals,B01.050
19109138,2009-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
19109138,2009-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
19109138,2009-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
19109138,2009-01-01T00:00:00,Carrier Proteins,D12.776.157
19109138,2009-01-01T00:00:00,Cryptococcus neoformans,B01.300.381.258.366
19109138,2009-01-01T00:00:00,Cryptococcus neoformans,B01.300.930.316.366
19109138,2009-01-01T00:00:00,Hela Cells,A11.251.210.190.400
19109138,2009-01-01T00:00:00,Hela Cells,A11.251.860.180.400
19109138,2009-01-01T00:00:00,Hela Cells,A11.436.340
19109138,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19110143,2009-01-01T00:00:00,Adult,M01.060.116
19110143,2009-01-01T00:00:00,Aged,M01.060.116.100
19110143,2009-01-01T00:00:00,Brain Ischemia,C10.228.140.300.150
19110143,2009-01-01T00:00:00,Brain Ischemia,C14.907.253.092
19110143,2009-01-01T00:00:00,Critical Pathways,N04.590.233.624.625
19110143,2009-01-01T00:00:00,Critical Pathways,N04.590.275
19110143,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19110143,2009-01-01T00:00:00,Immunization Schedule,E02.095.465.425.400.470
19110143,2009-01-01T00:00:00,Immunization Schedule,E05.478.550.545
19110143,2009-01-01T00:00:00,Influenza Vaccines,D20.215.894.899.302
19110143,2009-01-01T00:00:00,"Influenza, Human",C02.782.620.365
19110143,2009-01-01T00:00:00,"Influenza, Human",C08.730.310
19110143,2009-01-01T00:00:00,Inpatients,M01.643.470
19110143,2009-01-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
19110143,2009-01-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
19110143,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19110143,2009-01-01T00:00:00,Program Development,N04.452.760
19110143,2009-01-01T00:00:00,Program Evaluation,E05.337.820
19110143,2009-01-01T00:00:00,Program Evaluation,N04.761.685
19110143,2009-01-01T00:00:00,Program Evaluation,N05.715.360.650
19110143,2009-01-01T00:00:00,Seasons,G01.910.645.661
19110143,2009-01-01T00:00:00,Seasons,G16.500.275.071.590
19110143,2009-01-01T00:00:00,Seasons,N06.230.300.100.250.525
19110143,2009-01-01T00:00:00,Stroke,C10.228.140.300.775
19110143,2009-01-01T00:00:00,Stroke,C14.907.253.855
19114570,2009-01-01T00:00:00,Adult,M01.060.116
19114570,2009-01-01T00:00:00,Aged,M01.060.116.100
19114570,2009-01-01T00:00:00,Bipolar Disorder,F03.600.150.150
19114570,2009-01-01T00:00:00,Hospitalization,E02.760.400
19114570,2009-01-01T00:00:00,Hospitalization,N02.421.585.400
19114570,2009-01-01T00:00:00,"Hospitals, Psychiatric",N02.278.421.556.508
19114570,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19114570,2009-01-01T00:00:00,Length of Stay,E02.760.400.480
19114570,2009-01-01T00:00:00,Length of Stay,N02.421.585.400.480
19114570,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19114570,2009-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19114570,2009-01-01T00:00:00,Risk Assessment,N04.452.871.715
19114570,2009-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19114570,2009-01-01T00:00:00,Risk Assessment,N06.850.505.715
19114570,2009-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19114570,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19114570,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19114570,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19114570,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19114570,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19114570,2009-01-01T00:00:00,Substance-Related Disorders,C21.739
19114570,2009-01-01T00:00:00,Substance-Related Disorders,F03.900
19114570,2009-01-01T00:00:00,United States,Z01.107.567.875
19114774,2009-01-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
19114774,2009-01-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
19114774,2009-01-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
19114774,2009-01-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
19114774,2009-01-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
19114774,2009-01-01T00:00:00,"Diagnosis, Differential",E01.171
19114774,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19114774,2009-01-01T00:00:00,United States,Z01.107.567.875
19116871,2009-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
19116871,2009-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19116871,2009-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19116871,2009-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19116871,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19116871,2009-01-01T00:00:00,Incidence,E05.318.308.985.525.375
19116871,2009-01-01T00:00:00,Incidence,L01.280.975.525.375
19116871,2009-01-01T00:00:00,Incidence,N01.224.935.597.500
19116871,2009-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19116871,2009-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19116871,2009-01-01T00:00:00,Nasopharyngeal Neoplasms,C04.588.443.665.710.650
19116871,2009-01-01T00:00:00,Nasopharyngeal Neoplasms,C07.550.350.650
19116871,2009-01-01T00:00:00,Nasopharyngeal Neoplasms,C07.550.745.650
19116871,2009-01-01T00:00:00,Nasopharyngeal Neoplasms,C09.647.710.650
19116871,2009-01-01T00:00:00,Nasopharyngeal Neoplasms,C09.775.350.650
19116871,2009-01-01T00:00:00,Nasopharyngeal Neoplasms,C09.775.549.650
19116871,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19116871,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19116871,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19116871,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19116871,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19117304,2009-01-01T00:00:00,Adult,M01.060.116
19117304,2009-01-01T00:00:00,Aged,M01.060.116.100
19117304,2009-01-01T00:00:00,"Diagnosis, Differential",E01.171
19117304,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19117304,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19117304,2009-01-01T00:00:00,Tonsillectomy,E04.580.848
19124497,2009-01-01T00:00:00,Diet,E05.272
19124497,2009-01-01T00:00:00,Diet,G07.610.240
19124497,2009-01-01T00:00:00,Glutathione Transferase,D08.811.913.225.500
19124497,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19124497,2009-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19124497,2009-01-01T00:00:00,Lung Neoplasms,C08.381.540
19124497,2009-01-01T00:00:00,Lung Neoplasms,C08.785.520
19124500,2009-01-01T00:00:00,African Americans,M01.686.508.100.100
19124500,2009-01-01T00:00:00,African Americans,M01.686.754.100
19124500,2009-01-01T00:00:00,Aged,M01.060.116.100
19124500,2009-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
19124500,2009-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
19124500,2009-01-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
19124500,2009-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19124500,2009-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19124500,2009-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19124500,2009-01-01T00:00:00,Cytokines,D12.644.276.374
19124500,2009-01-01T00:00:00,Cytokines,D12.776.467.374
19124500,2009-01-01T00:00:00,Cytokines,D23.529.374
19124500,2009-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19124500,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19124500,2009-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19124500,2009-01-01T00:00:00,Lung Neoplasms,C08.381.540
19124500,2009-01-01T00:00:00,Lung Neoplasms,C08.785.520
19125852,2009-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19125852,2009-01-01T00:00:00,Benzazepines,D03.438.079
19125852,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19125852,2009-01-01T00:00:00,Hypertension,C14.907.489
19125852,2009-01-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
19125852,2009-01-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
19125852,2009-01-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
19125852,2009-01-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
19125852,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19125852,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19125852,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19125852,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19130355,2009-01-01T00:00:00,Adolescent,M01.060.057
19130355,2009-01-01T00:00:00,Affect,F01.470.047
19130355,2009-01-01T00:00:00,Attention,F02.830.104.214
19130355,2009-01-01T00:00:00,Child,M01.060.406
19130355,2009-01-01T00:00:00,Culture,I01.076.201.450
19130355,2009-01-01T00:00:00,Culture,I01.880.143
19130355,2009-01-01T00:00:00,Depression,F01.145.126.350
19130355,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19130355,2009-01-01T00:00:00,Personality Inventory,F04.711.647.513
19130355,2009-01-01T00:00:00,Psychometrics,F04.711.780
19130355,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19130355,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19130355,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19130355,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19130355,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19130355,2009-01-01T00:00:00,Sex Factors,N05.715.350.675
19130355,2009-01-01T00:00:00,Sex Factors,N06.850.490.875
19130355,2009-01-01T00:00:00,Thinking,F02.463.785
19130360,2009-01-01T00:00:00,Adolescent,M01.060.057
19130360,2009-01-01T00:00:00,Antisocial Personality Disorder,F03.675.050
19130360,2009-01-01T00:00:00,Combined Modality Therapy,E02.186
19130360,2009-01-01T00:00:00,Education,I02
19130360,2009-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
19130360,2009-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
19130360,2009-01-01T00:00:00,Family Therapy,F04.754.864.581.273
19130360,2009-01-01T00:00:00,Guideline Adherence,N04.761.337
19130360,2009-01-01T00:00:00,Guideline Adherence,N05.715.360.395
19130360,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19130360,2009-01-01T00:00:00,Juvenile Delinquency,I01.880.735.479
19130360,2009-01-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
19130360,2009-01-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
19130360,2009-01-01T00:00:00,Patient Care Team,N04.590.715
19130360,2009-01-01T00:00:00,Patient Compliance,F01.145.488.500
19130360,2009-01-01T00:00:00,Patient Compliance,N05.300.150.600.600
19130360,2009-01-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
19130360,2009-01-01T00:00:00,"Quality Assurance, Health Care",N05.700
19130360,2009-01-01T00:00:00,Referral and Consultation,N04.452.758.849
19130360,2009-01-01T00:00:00,Secondary Prevention,N02.421.726.825
19130360,2009-01-01T00:00:00,Secondary Prevention,N06.850.780.750
19130360,2009-01-01T00:00:00,Social Support,I01.880.656.600
19130933,2009-01-01T00:00:00,Adolescent,M01.060.057
19130933,2009-01-01T00:00:00,Adult,M01.060.116
19130933,2009-01-01T00:00:00,Aged,M01.060.116.100
19130933,2009-01-01T00:00:00,Asthma,C08.127.108
19130933,2009-01-01T00:00:00,Asthma,C08.381.495.108
19130933,2009-01-01T00:00:00,Asthma,C08.674.095
19130933,2009-01-01T00:00:00,Asthma,C20.543.480.680.095
19130933,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19130933,2009-01-01T00:00:00,Incidence,E05.318.308.985.525.375
19130933,2009-01-01T00:00:00,Incidence,L01.280.975.525.375
19130933,2009-01-01T00:00:00,Incidence,N01.224.935.597.500
19130933,2009-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19130933,2009-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19130933,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19130933,2009-01-01T00:00:00,Myocardial Infarction,C14.280.647.500
19130933,2009-01-01T00:00:00,Myocardial Infarction,C14.907.585.500
19130933,2009-01-01T00:00:00,Questionnaires,E05.318.308.750
19130933,2009-01-01T00:00:00,Questionnaires,L01.280.800
19130933,2009-01-01T00:00:00,Questionnaires,N05.715.360.300.695
19130933,2009-01-01T00:00:00,Questionnaires,N06.850.520.308.750
19130933,2009-01-01T00:00:00,Sex Factors,N05.715.350.675
19130933,2009-01-01T00:00:00,Sex Factors,N06.850.490.875
19130933,2009-01-01T00:00:00,Stroke,C10.228.140.300.775
19130933,2009-01-01T00:00:00,Stroke,C14.907.253.855
19131823,2009-01-01T00:00:00,Adolescent,M01.060.057
19131823,2009-01-01T00:00:00,Adult,M01.060.116
19131823,2009-01-01T00:00:00,Aged,M01.060.116.100
19131823,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19131823,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19131823,2009-01-01T00:00:00,Poisson Distribution,E05.318.740.994.750
19131823,2009-01-01T00:00:00,Poisson Distribution,G17.820.750
19131823,2009-01-01T00:00:00,Poisson Distribution,N05.715.360.750.750.620
19131823,2009-01-01T00:00:00,Poisson Distribution,N06.850.520.830.994.750
19131823,2009-01-01T00:00:00,Population Surveillance,E05.318.308.250.700
19131823,2009-01-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
19131823,2009-01-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
19131823,2009-01-01T00:00:00,Population Surveillance,N06.850.780.675
19131823,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19131823,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19131823,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19131823,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19131823,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19131823,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19131823,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19131823,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19131823,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19131823,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19132573,2009-01-01T00:00:00,Adolescent,M01.060.057
19132573,2009-01-01T00:00:00,Adult,M01.060.116
19132573,2009-01-01T00:00:00,Aged,M01.060.116.100
19132573,2009-01-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
19132573,2009-01-01T00:00:00,Family Practice,H02.403.280
19132573,2009-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
19132573,2009-01-01T00:00:00,Health Services Accessibility,N05.300.430
19132573,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19132573,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19132573,2009-01-01T00:00:00,Patient Compliance,F01.145.488.500
19132573,2009-01-01T00:00:00,Patient Compliance,N05.300.150.600.600
19132573,2009-01-01T00:00:00,Regression Analysis,E05.318.740.750
19132573,2009-01-01T00:00:00,Regression Analysis,N05.715.360.750.695
19132573,2009-01-01T00:00:00,Regression Analysis,N06.850.520.830.750
19132573,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19132573,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19132573,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19136870,2009-01-01T00:00:00,Disasters,N06.230.100
19136870,2009-01-01T00:00:00,Environmental Health,H02.229
19136870,2009-01-01T00:00:00,Health Status,I01.240.425
19136870,2009-01-01T00:00:00,Health Status,N01.224.425
19136870,2009-01-01T00:00:00,Health Status,N06.850.505.400.425
19136870,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19136870,2009-01-01T00:00:00,United States,Z01.107.567.875
19140909,2009-01-01T00:00:00,Anti-Arrhythmia Agents,D27.505.954.411.097
19140909,2009-01-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
19140909,2009-01-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
19140909,2009-01-01T00:00:00,Combined Modality Therapy,E02.186
19140909,2009-01-01T00:00:00,Electric Countershock,E02.342.287
19140909,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19140909,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19140909,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19140909,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19140909,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19145165,2009-01-01T00:00:00,"History, 20th Century",K01.400.504.968
19145165,2009-01-01T00:00:00,Hospitals,N02.278.421
19145165,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19145165,2009-01-01T00:00:00,Neurosurgery,H02.403.810.425
19147541,2009-01-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
19147541,2009-01-01T00:00:00,Apoptosis,G04.299.139.160
19147541,2009-01-01T00:00:00,"Genes, p53",G05.360.340.024.340.375.249.385
19147541,2009-01-01T00:00:00,"Genes, p53",G05.360.340.024.340.415.400.385
19147541,2009-01-01T00:00:00,Genetic Variation,G05.365
19147541,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19147541,2009-01-01T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
19147541,2009-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19147541,2009-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19147541,2009-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19147541,2009-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19147541,2009-01-01T00:00:00,RNA Interference,G05.355.315.203.374.790
19147541,2009-01-01T00:00:00,Substrate Specificity,G02.111.835
19147541,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
19147541,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
19147541,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
19147541,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
19148016,2009-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19148016,2009-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19148016,2009-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19148016,2009-01-01T00:00:00,"Child, Preschool",M01.060.406.448
19148016,2009-01-01T00:00:00,Dehydration,C18.452.950.179
19148016,2009-01-01T00:00:00,Dehydration,C23.550.274
19148016,2009-01-01T00:00:00,Fluid Therapy,E02.319.360
19148016,2009-01-01T00:00:00,Gastroenteritis,C06.405.205
19148016,2009-01-01T00:00:00,Glucose,D09.546.359.448
19148016,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19148016,2009-01-01T00:00:00,Infant,M01.060.703
19148016,2009-01-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
19148016,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19148016,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19148016,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19148016,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19149513,2009-01-01T00:00:00,Animals,B01.050
19149513,2009-01-01T00:00:00,Cytokines,D12.644.276.374
19149513,2009-01-01T00:00:00,Cytokines,D12.776.467.374
19149513,2009-01-01T00:00:00,Cytokines,D23.529.374
19149513,2009-01-01T00:00:00,Disease Progression,C23.550.291.656
19149513,2009-01-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
19149513,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19149513,2009-01-01T00:00:00,Lipopolysaccharides,D09.400.500
19149513,2009-01-01T00:00:00,Lipopolysaccharides,D09.698.718.450
19149513,2009-01-01T00:00:00,Lipopolysaccharides,D10.494
19149513,2009-01-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
19149513,2009-01-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
19149513,2009-01-01T00:00:00,Periodontal Diseases,C07.465.714
19149513,2009-01-01T00:00:00,Signal Transduction,G02.111.087.800
19149513,2009-01-01T00:00:00,Signal Transduction,G02.149.115.800
19149513,2009-01-01T00:00:00,Signal Transduction,G04.299.880
19149513,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
19149513,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
19149513,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
19149513,2009-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
19149544,2009-01-01T00:00:00,"Adaptation, Physiological",G07.700.062
19149544,2009-01-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
19149544,2009-01-01T00:00:00,Cardiomegaly,C14.280.195
19149544,2009-01-01T00:00:00,Cardiomegaly,C23.300.775.250
19149544,2009-01-01T00:00:00,Cell Proliferation,G04.299.233.750
19149544,2009-01-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19149544,2009-01-01T00:00:00,Cell Survival,G04.299.316
19149544,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19149544,2009-01-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19149544,2009-01-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19149544,2009-01-01T00:00:00,"Myocytes, Cardiac",A11.620.500
19149544,2009-01-01T00:00:00,Protein Kinases,D08.811.913.696.620.682
19154835,2009-01-01T00:00:00,Adult,M01.060.116
19154835,2009-01-01T00:00:00,Cause of Death,E05.318.308.985.550.250
19154835,2009-01-01T00:00:00,Cause of Death,L01.280.975.550.250
19154835,2009-01-01T00:00:00,Cause of Death,N01.224.935.698.100
19154835,2009-01-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
19154835,2009-01-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
19154835,2009-01-01T00:00:00,Health Behavior,F01.145.488
19154835,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19154835,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19154835,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19154835,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19154835,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19154835,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19154835,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19154835,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19154835,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19159852,2009-01-01T00:00:00,Aged,M01.060.116.100
19159852,2009-01-01T00:00:00,Calcinosis,C18.452.174.130
19159852,2009-01-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
19159852,2009-01-01T00:00:00,Coronary Angiography,E01.370.370.050.200
19159852,2009-01-01T00:00:00,Coronary Angiography,E01.370.370.380.200
19159852,2009-01-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
19159852,2009-01-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
19159852,2009-01-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
19159852,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19159852,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19159852,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19159852,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19159852,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19159852,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19159852,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19159852,2009-01-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
19161542,2009-01-01T00:00:00,Adult,M01.060.116
19161542,2009-01-01T00:00:00,Dietary Supplements,J02.500.456
19161542,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19161542,2009-01-01T00:00:00,Infant,M01.060.703
19161542,2009-01-01T00:00:00,Infant Nutritional Physiological Phenomena,G07.610.220.500
19161542,2009-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
19161542,2009-01-01T00:00:00,"Milk, Human",A12.200.467
19161542,2009-01-01T00:00:00,"Milk, Human",J02.200.700.500
19161542,2009-01-01T00:00:00,"Milk, Human",J02.500.350.525.500
19161542,2009-01-01T00:00:00,Vitamin D,D04.808.812.768
19161542,2009-01-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
19184542,2009-01-01T00:00:00,Animals,B01.050
19184542,2009-01-01T00:00:00,Antioxidants,D27.505.519.217
19184542,2009-01-01T00:00:00,Antioxidants,D27.505.696.706.125
19184542,2009-01-01T00:00:00,Antioxidants,D27.720.799.047
19184542,2009-01-01T00:00:00,Copper,D01.268.556.195
19184542,2009-01-01T00:00:00,Copper,D01.268.956.170
19184542,2009-01-01T00:00:00,Copper,D01.552.544.195
19184542,2009-01-01T00:00:00,DNA Damage,C21.111
19184542,2009-01-01T00:00:00,DNA Damage,G05.355.180
19184542,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19184542,2009-01-01T00:00:00,Iron,D01.268.556.412
19184542,2009-01-01T00:00:00,Iron,D01.268.956.287
19184542,2009-01-01T00:00:00,Iron,D01.552.544.412
19184542,2009-01-01T00:00:00,Oxidative Stress,G03.495.710
19184542,2009-01-01T00:00:00,Oxidative Stress,G07.700.830.750
19191156,2009-01-01T00:00:00,Animals,B01.050
19191156,2009-01-01T00:00:00,Anoxia,C23.888.852.079
19191156,2009-01-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
19191156,2009-01-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
19191156,2009-01-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
19191156,2009-01-01T00:00:00,Cytokines,D12.644.276.374
19191156,2009-01-01T00:00:00,Cytokines,D12.776.467.374
19191156,2009-01-01T00:00:00,Cytokines,D23.529.374
19191156,2009-01-01T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
19191156,2009-01-01T00:00:00,Gene Expression Profiling,E05.393.332
19191156,2009-01-01T00:00:00,"Hernia, Ventral",C23.300.707.374.937
19191156,2009-01-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
19191156,2009-01-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
19191156,2009-01-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
19191156,2009-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
19191156,2009-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
19191156,2009-01-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
19191156,2009-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19191156,2009-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19191156,2009-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19191156,2009-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19191156,2009-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19191156,2009-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19191156,2009-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19191156,2009-01-01T00:00:00,Tissue Engineering,E05.200.249.750
19191156,2009-01-01T00:00:00,Transcription Factors,D12.776.930
19192104,2009-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
19192104,2009-01-01T00:00:00,Diabetes Mellitus,C19.246
19192104,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19192104,2009-01-01T00:00:00,Oral Health,N01.400.535
19192104,2009-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
19192104,2009-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19192104,2009-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
19192104,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19192104,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19197191,2009-01-01T00:00:00,Delivery of Health Care,N04.590.374
19197191,2009-01-01T00:00:00,Delivery of Health Care,N05.300
19197191,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19197191,2009-01-01T00:00:00,Leadership,F01.752.609
19197191,2009-01-01T00:00:00,Nurse Administrators,M01.526.070.670
19197191,2009-01-01T00:00:00,Nurse Administrators,M01.526.485.650.580
19197191,2009-01-01T00:00:00,Nurse Administrators,N02.360.650.580
19197191,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19197191,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19204652,2009-01-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
19204652,2009-01-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
19204652,2009-01-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
19204652,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19204652,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19204652,2009-01-01T00:00:00,Piperazines,D03.383.606
19204652,2009-01-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19204652,2009-01-01T00:00:00,Quinolones,D03.438.810.835
19204652,2009-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19204652,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19204652,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19204652,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19204652,2009-01-01T00:00:00,Veterans,M01.930
19208957,2009-01-01T00:00:00,African Americans,M01.686.508.100.100
19208957,2009-01-01T00:00:00,African Americans,M01.686.754.100
19208957,2009-01-01T00:00:00,Ethnic Groups,M01.686.754
19208957,2009-01-01T00:00:00,Ethnic Groups,N01.224.317
19208957,2009-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19208957,2009-01-01T00:00:00,Health Behavior,F01.145.488
19208957,2009-01-01T00:00:00,Health Status,I01.240.425
19208957,2009-01-01T00:00:00,Health Status,N01.224.425
19208957,2009-01-01T00:00:00,Health Status,N06.850.505.400.425
19208957,2009-01-01T00:00:00,Hispanic Americans,M01.686.754.441
19208957,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19208957,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19208957,2009-01-01T00:00:00,Quality of Life,I01.800
19208957,2009-01-01T00:00:00,Quality of Life,K01.752.400.750
19208957,2009-01-01T00:00:00,Questionnaires,E05.318.308.750
19208957,2009-01-01T00:00:00,Questionnaires,L01.280.800
19208957,2009-01-01T00:00:00,Questionnaires,N05.715.360.300.695
19208957,2009-01-01T00:00:00,Questionnaires,N06.850.520.308.750
19208957,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19208957,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19208957,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19208958,2009-01-01T00:00:00,Adult,M01.060.116
19208958,2009-01-01T00:00:00,African Americans,M01.686.508.100.100
19208958,2009-01-01T00:00:00,African Americans,M01.686.754.100
19208958,2009-01-01T00:00:00,Ethnic Groups,M01.686.754
19208958,2009-01-01T00:00:00,Ethnic Groups,N01.224.317
19208958,2009-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19208958,2009-01-01T00:00:00,Hispanic Americans,M01.686.754.441
19208958,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19208958,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19208958,2009-01-01T00:00:00,Pressure Ulcer,C17.800.893.665
19208958,2009-01-01T00:00:00,Prevalence,E05.318.308.985.525.750
19208958,2009-01-01T00:00:00,Prevalence,L01.280.975.525.750
19208958,2009-01-01T00:00:00,Prevalence,N01.224.935.597.750
19208958,2009-01-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
19208958,2009-01-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
19208958,2009-01-01T00:00:00,Quality of Life,I01.800
19208958,2009-01-01T00:00:00,Quality of Life,K01.752.400.750
19208958,2009-01-01T00:00:00,Social Support,I01.880.656.600
19208958,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19208958,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19208958,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19213291,2009-01-01T00:00:00,Asperger Syndrome,F03.550.325.100
19213291,2009-01-01T00:00:00,Autistic Disorder,F03.550.325.125
19213291,2009-01-01T00:00:00,Biomedical Research,H01.770.644.145
19213291,2009-01-01T00:00:00,"Diagnosis, Differential",E01.171
19213291,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19213294,2009-01-01T00:00:00,Adolescent,M01.060.057
19213294,2009-01-01T00:00:00,Autistic Disorder,F03.550.325.125
19213294,2009-01-01T00:00:00,Child,M01.060.406
19213294,2009-01-01T00:00:00,Child Health Services,N02.421.143.130
19213294,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19213294,2009-01-01T00:00:00,Insurance Claim Reporting,N03.219.521.576.210
19213294,2009-01-01T00:00:00,Primary Health Care,N04.590.233.727
19213389,2009-01-01T00:00:00,General Surgery,H02.403.810.300
19213389,2009-01-01T00:00:00,"History, 20th Century",K01.400.504.968
19213389,2009-01-01T00:00:00,"Hospitals, Teaching",N02.278.020.300
19213389,2009-01-01T00:00:00,"Hospitals, Teaching",N02.278.421.639
19213389,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19213389,2009-01-01T00:00:00,Internship and Residency,I02.358.399.644
19213389,2009-01-01T00:00:00,Rural Health Services,N02.421.816
19213389,2009-01-01T00:00:00,"Schools, Medical",I02.783.660.552
19213389,2009-01-01T00:00:00,"Schools, Medical",N02.278.020.578
19213395,2009-01-01T00:00:00,Adult,M01.060.116
19213395,2009-01-01T00:00:00,Algorithms,G17.035
19213395,2009-01-01T00:00:00,Algorithms,L01.224.050
19213395,2009-01-01T00:00:00,Endoscopy,E01.370.388.250
19213395,2009-01-01T00:00:00,Endoscopy,E04.800.250
19213395,2009-01-01T00:00:00,Gastrostomy,E04.210.496
19213395,2009-01-01T00:00:00,Gastrostomy,E04.579.408
19213395,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19213395,2009-01-01T00:00:00,Incidence,E05.318.308.985.525.375
19213395,2009-01-01T00:00:00,Incidence,L01.280.975.525.375
19213395,2009-01-01T00:00:00,Incidence,N01.224.935.597.500
19213395,2009-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19213395,2009-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19213395,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19213395,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19213395,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19213395,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19213395,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19219661,2009-01-01T00:00:00,Adult,M01.060.116
19219661,2009-01-01T00:00:00,Attitude of Health Personnel,F01.100.050
19219661,2009-01-01T00:00:00,Attitude of Health Personnel,N05.300.100
19219661,2009-01-01T00:00:00,Emotions,F01.470
19219661,2009-01-01T00:00:00,Health Personnel,M01.526.485
19219661,2009-01-01T00:00:00,Health Personnel,N02.360
19219661,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19219661,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19219661,2009-01-01T00:00:00,Patient Care,E02.760
19219661,2009-01-01T00:00:00,Patient Care,N02.421.585
19219661,2009-01-01T00:00:00,Self-Injurious Behavior,F01.145.126.980
19219661,2009-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19219661,2009-01-01T00:00:00,Substance-Related Disorders,C21.739
19219661,2009-01-01T00:00:00,Substance-Related Disorders,F03.900
19219661,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19219661,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19219661,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19250414,2009-01-01T00:00:00,Dermis,A17.815.180
19250414,2009-01-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
19250414,2009-01-01T00:00:00,Hand,A01.378.800.667
19250414,2009-01-01T00:00:00,"Hand Deformities, Congenital",C05.390.408
19250414,2009-01-01T00:00:00,"Hand Deformities, Congenital",C05.660.585.988.425
19250414,2009-01-01T00:00:00,"Hand Deformities, Congenital",C16.131.621.585.425
19250414,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19250414,2009-01-01T00:00:00,Incontinentia Pigmenti,C16.131.077.445
19250414,2009-01-01T00:00:00,Incontinentia Pigmenti,C16.131.831.580
19250414,2009-01-01T00:00:00,Incontinentia Pigmenti,C16.320.850.420
19250414,2009-01-01T00:00:00,Incontinentia Pigmenti,C17.800.621.497
19250414,2009-01-01T00:00:00,Incontinentia Pigmenti,C17.800.804.580
19250414,2009-01-01T00:00:00,Incontinentia Pigmenti,C17.800.827.420
19250414,2009-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
19250414,2009-01-01T00:00:00,NF-kappa B,D12.776.260.600
19250414,2009-01-01T00:00:00,NF-kappa B,D12.776.660.600
19250414,2009-01-01T00:00:00,NF-kappa B,D12.776.930.600
19250414,2009-01-01T00:00:00,Phenotype,G05.695
19250414,2009-01-01T00:00:00,Signal Transduction,G02.111.087.800
19250414,2009-01-01T00:00:00,Signal Transduction,G02.149.115.800
19250414,2009-01-01T00:00:00,Signal Transduction,G04.299.880
19251055,2009-01-01T00:00:00,Animals,B01.050
19251055,2009-01-01T00:00:00,Gene Expression Regulation,G05.355.315
19251055,2009-01-01T00:00:00,Genetic Variation,G05.365
19251055,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19251055,2009-01-01T00:00:00,Insulin-Like Growth Factor II,D12.644.276.937.420
19251055,2009-01-01T00:00:00,Insulin-Like Growth Factor II,D12.776.124.862.425
19251055,2009-01-01T00:00:00,Insulin-Like Growth Factor II,D12.776.467.937.420
19251055,2009-01-01T00:00:00,Insulin-Like Growth Factor II,D23.529.937.420
19251055,2009-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19251055,2009-01-01T00:00:00,"Receptor, IGF Type 2",D12.776.543.750.750.400.780.410
19253320,2009-01-01T00:00:00,Animals,B01.050
19253320,2009-01-01T00:00:00,Biosensing Techniques,E05.601.123
19253320,2009-01-01T00:00:00,Cell Line,A11.251.210
19253320,2009-01-01T00:00:00,Diagnostic Imaging,E01.370.350
19253320,2009-01-01T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
19253320,2009-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
19253320,2009-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
19253320,2009-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
19253320,2009-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
19253320,2009-01-01T00:00:00,Fluorescent Dyes,D27.720.233.348
19253320,2009-01-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
19253320,2009-01-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
19253320,2009-01-01T00:00:00,Nanoparticles,J01.637.512.600
19253320,2009-01-01T00:00:00,Oxygen,D01.268.185.550
19253320,2009-01-01T00:00:00,Oxygen,D01.362.670
19253320,2009-01-01T00:00:00,Polymers,D05.750
19253320,2009-01-01T00:00:00,Polymers,D25.720
19253320,2009-01-01T00:00:00,Polymers,J01.637.051.720
19254048,2009-01-01T00:00:00,Computer Simulation,L01.224.160
19254048,2009-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19254048,2009-01-01T00:00:00,HIV Infections,C02.782.815.616.400
19254048,2009-01-01T00:00:00,HIV Infections,C02.800.801.400
19254048,2009-01-01T00:00:00,HIV Infections,C20.673.480
19254048,2009-01-01T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
19254048,2009-01-01T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
19254048,2009-01-01T00:00:00,Health Care Costs,N03.219.151.400
19254048,2009-01-01T00:00:00,Health Care Costs,N05.300.375
19254048,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19254048,2009-01-01T00:00:00,Markov Chains,E05.318.740.600.500
19254048,2009-01-01T00:00:00,Markov Chains,E05.318.740.996.500
19254048,2009-01-01T00:00:00,Markov Chains,G17.830.500
19254048,2009-01-01T00:00:00,Markov Chains,N05.715.360.750.625.500
19254048,2009-01-01T00:00:00,Markov Chains,N05.715.360.750.770.500
19254048,2009-01-01T00:00:00,Markov Chains,N06.850.520.830.600.500
19254048,2009-01-01T00:00:00,Markov Chains,N06.850.520.830.996.500
19254048,2009-01-01T00:00:00,"Models, Statistical",E05.318.740.500
19254048,2009-01-01T00:00:00,"Models, Statistical",E05.599.835
19254048,2009-01-01T00:00:00,"Models, Statistical",N05.715.360.750.530
19254048,2009-01-01T00:00:00,"Models, Statistical",N06.850.520.830.500
19254048,2009-01-01T00:00:00,Ritonavir,D02.886.675.653
19254048,2009-01-01T00:00:00,Ritonavir,D03.383.129.708.653
19284262,2009-01-01T00:00:00,Adolescent,M01.060.057
19284262,2009-01-01T00:00:00,Adult,M01.060.116
19284262,2009-01-01T00:00:00,Aged,M01.060.116.100
19284262,2009-01-01T00:00:00,Attitude to Health,F01.100.150
19284262,2009-01-01T00:00:00,Attitude to Health,N05.300.150
19284262,2009-01-01T00:00:00,Critical Illness,C23.550.291.625
19284262,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19284262,2009-01-01T00:00:00,Intensive Care Units,N02.278.388.493
19284262,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19284262,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19323181,2009-01-01T00:00:00,California,Z01.107.567.875.580.200
19323181,2009-01-01T00:00:00,California,Z01.107.567.875.760.200
19323181,2009-01-01T00:00:00,Carbon,D01.268.150
19323181,2009-01-01T00:00:00,Trees,B01.650.915
19327036,2009-01-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
19327036,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19327036,2009-01-01T00:00:00,Smoking Cessation,F01.145.940.700
19327036,2009-01-01T00:00:00,Social Environment,I01.880.656
19327036,2009-01-01T00:00:00,Tobacco Use Disorder,C21.739.912
19327036,2009-01-01T00:00:00,Tobacco Use Disorder,F03.900.912
19327261,2009-01-01T00:00:00,Cerebral Palsy,C10.228.140.140.254
19327261,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19327261,2009-01-01T00:00:00,Incidence,E05.318.308.985.525.375
19327261,2009-01-01T00:00:00,Incidence,L01.280.975.525.375
19327261,2009-01-01T00:00:00,Incidence,N01.224.935.597.500
19327261,2009-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
19327261,2009-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
19327261,2009-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
19327261,2009-01-01T00:00:00,North Carolina,Z01.107.567.875.075.475
19327261,2009-01-01T00:00:00,North Carolina,Z01.107.567.875.750.530
19327261,2009-01-01T00:00:00,Seasons,G01.910.645.661
19327261,2009-01-01T00:00:00,Seasons,G16.500.275.071.590
19327261,2009-01-01T00:00:00,Seasons,N06.230.300.100.250.525
19363258,2009-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
19363258,2009-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
19363258,2009-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
19363258,2009-01-01T00:00:00,Animals,B01.050
19363258,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19363258,2009-01-01T00:00:00,Metals,D01.552
19407363,2009-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
19407363,2009-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19407363,2009-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19407363,2009-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19407363,2009-01-01T00:00:00,Glutathione Transferase,D08.811.913.225.500
19407363,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19407363,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19407363,2009-01-01T00:00:00,"Polymorphism, Genetic",G05.365.795
19407363,2009-01-01T00:00:00,Prostatic Hyperplasia,C12.294.565.500
19407363,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19407363,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19407363,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19407363,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19407363,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19407363,2009-01-01T00:00:00,Smoking,F01.145.466.753
19431064,2009-01-01T00:00:00,Animals,B01.050
19431064,2009-01-01T00:00:00,"Heart Defects, Congenital",C14.240.400
19431064,2009-01-01T00:00:00,"Heart Defects, Congenital",C14.280.400
19431064,2009-01-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
19431064,2009-01-01T00:00:00,Heart Diseases,C14.280
19431064,2009-01-01T00:00:00,Heart Failure,C14.280.434
19431064,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19463024,2009-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
19463024,2009-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
19463024,2009-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
19463024,2009-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
19463024,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19463024,2009-01-01T00:00:00,"Models, Biological",E05.599.395
19463024,2009-01-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
19463024,2009-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19463024,2009-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19463024,2009-01-01T00:00:00,Secondary Prevention,N02.421.726.825
19463024,2009-01-01T00:00:00,Secondary Prevention,N06.850.780.750
19513667,2009-01-01T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
19513667,2009-01-01T00:00:00,DNA-Directed DNA Polymerase,D08.811.913.696.445.308.300
19513667,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19513667,2009-01-01T00:00:00,Mitochondrial Diseases,C18.452.660
19513667,2009-01-01T00:00:00,Mutation,G05.365.590
19513667,2009-01-01T00:00:00,Recombinant Proteins,D12.776.828
19537226,2009-01-01T00:00:00,Adolescent,M01.060.057
19537226,2009-01-01T00:00:00,Adult,M01.060.116
19537226,2009-01-01T00:00:00,African Americans,M01.686.508.100.100
19537226,2009-01-01T00:00:00,African Americans,M01.686.754.100
19537226,2009-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19537226,2009-01-01T00:00:00,Health Behavior,F01.145.488
19537226,2009-01-01T00:00:00,Health Surveys,E05.318.308.250
19537226,2009-01-01T00:00:00,Health Surveys,N05.715.360.300.375
19537226,2009-01-01T00:00:00,Health Surveys,N06.850.520.308.250
19537226,2009-01-01T00:00:00,Hispanic Americans,M01.686.754.441
19537226,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19537226,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19537226,2009-01-01T00:00:00,Obesity,C18.654.726.500
19537226,2009-01-01T00:00:00,Obesity,C23.888.144.699.500
19537226,2009-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
19537226,2009-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
19537226,2009-01-01T00:00:00,Self Concept,F01.752.747.792
19537226,2009-01-01T00:00:00,Weight Loss,C23.888.144.243.963
19537226,2009-01-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
19537226,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19537227,2009-01-01T00:00:00,African Americans,M01.686.508.100.100
19537227,2009-01-01T00:00:00,African Americans,M01.686.754.100
19537227,2009-01-01T00:00:00,Aged,M01.060.116.100
19537227,2009-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19537227,2009-01-01T00:00:00,Health Status Disparities,I01.240.425.675
19537227,2009-01-01T00:00:00,Health Status Disparities,N01.224.425.437
19537227,2009-01-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
19537227,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19537227,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19537227,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19537227,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19537227,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19537227,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19537227,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19537227,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19537227,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19537227,2009-01-01T00:00:00,Stroke,C10.228.140.300.775
19537227,2009-01-01T00:00:00,Stroke,C14.907.253.855
19537227,2009-01-01T00:00:00,Veterans,M01.930
19542624,2009-01-01T00:00:00,Aged,M01.060.116.100
19542624,2009-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
19542624,2009-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
19542624,2009-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
19542624,2009-01-01T00:00:00,Genome-Wide Association Study,E05.318.416.249
19542624,2009-01-01T00:00:00,Genome-Wide Association Study,E05.318.780.392
19542624,2009-01-01T00:00:00,Genome-Wide Association Study,E05.393.385.500
19542624,2009-01-01T00:00:00,Genome-Wide Association Study,E05.393.522.500
19542624,2009-01-01T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
19542624,2009-01-01T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
19542624,2009-01-01T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
19542624,2009-01-01T00:00:00,Herpes Simplex,C02.256.466.382
19542624,2009-01-01T00:00:00,Herpes Simplex,C02.825.320
19542624,2009-01-01T00:00:00,Herpes Simplex,C17.800.838.790.320
19542624,2009-01-01T00:00:00,"Herpesvirus 1, Human",B04.280.382.100.750.390
19542624,2009-01-01T00:00:00,"Herpesvirus 1, Human",B04.909.204.382.100.750.390
19542624,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
19542624,2009-01-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
19542624,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19542624,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19542624,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19542624,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19542624,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19554819,2009-01-01T00:00:00,Adolescent,M01.060.057
19554819,2009-01-01T00:00:00,Adult,M01.060.116
19554819,2009-01-01T00:00:00,Developing Countries,I01.615.500.300
19554819,2009-01-01T00:00:00,HIV Infections,C02.782.815.616.400
19554819,2009-01-01T00:00:00,HIV Infections,C02.800.801.400
19554819,2009-01-01T00:00:00,HIV Infections,C20.673.480
19554819,2009-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
19554819,2009-01-01T00:00:00,Health Services Accessibility,N05.300.430
19554819,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19554819,2009-01-01T00:00:00,Informed Consent,I01.880.604.473.650.718
19554819,2009-01-01T00:00:00,Informed Consent,I01.880.604.583.427
19554819,2009-01-01T00:00:00,Informed Consent,N03.706.437.650.312
19554819,2009-01-01T00:00:00,Informed Consent,N03.706.535.489
19554819,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19554819,2009-01-01T00:00:00,Patient Selection,E05.581.500.653
19554819,2009-01-01T00:00:00,Patient Selection,N04.590.731
19554819,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19554819,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19554819,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19554819,2009-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19554819,2009-01-01T00:00:00,Research Design,E05.581.500
19554819,2009-01-01T00:00:00,Research Design,H01.770.644.728
19554819,2009-01-01T00:00:00,Sexually Transmitted Diseases,C01.539.778
19554819,2009-01-01T00:00:00,Sexually Transmitted Diseases,C02.800
19554819,2009-01-01T00:00:00,Sexually Transmitted Diseases,C12.294.668
19554819,2009-01-01T00:00:00,Sexually Transmitted Diseases,C13.351.500.711
19554819,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19569464,2009-01-01T00:00:00,Activities of Daily Living,E02.831.067
19569464,2009-01-01T00:00:00,Activities of Daily Living,I03.050
19569464,2009-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
19569464,2009-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
19569464,2009-01-01T00:00:00,Health Behavior,F01.145.488
19569464,2009-01-01T00:00:00,Health Status,I01.240.425
19569464,2009-01-01T00:00:00,Health Status,N01.224.425
19569464,2009-01-01T00:00:00,Health Status,N06.850.505.400.425
19569464,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19569464,2009-01-01T00:00:00,Physical Fitness,I03.621
19569464,2009-01-01T00:00:00,Physical Fitness,N01.400.545
19569464,2009-01-01T00:00:00,Prescription Drugs,D26.670
19569464,2009-01-01T00:00:00,Questionnaires,E05.318.308.750
19569464,2009-01-01T00:00:00,Questionnaires,L01.280.800
19569464,2009-01-01T00:00:00,Questionnaires,N05.715.360.300.695
19569464,2009-01-01T00:00:00,Questionnaires,N06.850.520.308.750
19569464,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19569464,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19569464,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19569464,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19569464,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19569464,2009-01-01T00:00:00,Smoking,F01.145.466.753
19569464,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19569464,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19569464,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19569466,2009-01-01T00:00:00,Adult,M01.060.116
19569466,2009-01-01T00:00:00,Baclofen,D02.241.081.160.050.350.100
19569466,2009-01-01T00:00:00,Electromyography,E01.370.405.255
19569466,2009-01-01T00:00:00,Electromyography,E01.370.530.255
19569466,2009-01-01T00:00:00,Evoked Potentials,G07.265.500
19569466,2009-01-01T00:00:00,Evoked Potentials,G11.561.270
19569466,2009-01-01T00:00:00,H-Reflex,G11.561.600.765.643.474
19569466,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19569466,2009-01-01T00:00:00,"Injections, Spinal",E02.319.267.530.580
19569466,2009-01-01T00:00:00,Physical Stimulation,E05.723
19569466,2009-01-01T00:00:00,Reaction Time,F02.830.650
19569466,2009-01-01T00:00:00,Reaction Time,F04.669.817
19569466,2009-01-01T00:00:00,Reaction Time,G11.561.677
19569466,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19569466,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19569466,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19595310,2009-01-01T00:00:00,Animals,B01.050
19595310,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19595310,2009-01-01T00:00:00,Lymphocytes,A11.118.637.555.567
19595310,2009-01-01T00:00:00,Lymphocytes,A15.145.229.637.555.567
19595310,2009-01-01T00:00:00,Lymphocytes,A15.382.490.555.567
19595310,2009-01-01T00:00:00,Neoplasms,C04
19595310,2009-01-01T00:00:00,Oxidative Stress,G03.495.710
19595310,2009-01-01T00:00:00,Oxidative Stress,G07.700.830.750
19614556,2009-01-01T00:00:00,"Adaptation, Psychological",F01.058
19614556,2009-01-01T00:00:00,Adolescent,M01.060.057
19614556,2009-01-01T00:00:00,Adult,M01.060.116
19614556,2009-01-01T00:00:00,Age Factors,N05.715.350.075
19614556,2009-01-01T00:00:00,Age Factors,N06.850.490.250
19614556,2009-01-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
19614556,2009-01-01T00:00:00,Disaster Planning,N06.230.100.035
19614556,2009-01-01T00:00:00,Disasters,N06.230.100
19614556,2009-01-01T00:00:00,Fear,F01.470.361
19614556,2009-01-01T00:00:00,Health Status,I01.240.425
19614556,2009-01-01T00:00:00,Health Status,N01.224.425
19614556,2009-01-01T00:00:00,Health Status,N06.850.505.400.425
19614556,2009-01-01T00:00:00,Health Surveys,E05.318.308.250
19614556,2009-01-01T00:00:00,Health Surveys,N05.715.360.300.375
19614556,2009-01-01T00:00:00,Health Surveys,N06.850.520.308.250
19614556,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19614556,2009-01-01T00:00:00,Life Change Events,F01.829.458.410
19614556,2009-01-01T00:00:00,Questionnaires,E05.318.308.750
19614556,2009-01-01T00:00:00,Questionnaires,L01.280.800
19614556,2009-01-01T00:00:00,Questionnaires,N05.715.360.300.695
19614556,2009-01-01T00:00:00,Questionnaires,N06.850.520.308.750
19614556,2009-01-01T00:00:00,Secondary Prevention,N02.421.726.825
19614556,2009-01-01T00:00:00,Secondary Prevention,N06.850.780.750
19614556,2009-01-01T00:00:00,Self Concept,F01.752.747.792
19614556,2009-01-01T00:00:00,Social Support,I01.880.656.600
19614556,2009-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19614556,2009-01-01T00:00:00,"Stress, Psychological",F01.145.126.990
19614556,2009-01-01T00:00:00,"Stress, Psychological",F02.830.900
19622691,2009-01-01T00:00:00,Adult,M01.060.116
19622691,2009-01-01T00:00:00,Anxiety,F01.470.132
19622691,2009-01-01T00:00:00,Brain,A08.186.211
19622691,2009-01-01T00:00:00,Brain Mapping,E01.370.350.086
19622691,2009-01-01T00:00:00,Brain Mapping,E01.370.376.149
19622691,2009-01-01T00:00:00,Brain Mapping,E05.132
19622691,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19622691,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19632566,2009-01-01T00:00:00,Adolescent,M01.060.057
19632566,2009-01-01T00:00:00,Age Factors,N05.715.350.075
19632566,2009-01-01T00:00:00,Age Factors,N06.850.490.250
19632566,2009-01-01T00:00:00,Anesthesia,E03.155
19632566,2009-01-01T00:00:00,Child,M01.060.406
19632566,2009-01-01T00:00:00,"Child, Preschool",M01.060.406.448
19632566,2009-01-01T00:00:00,Funnel Chest,C05.116.099.386
19632566,2009-01-01T00:00:00,Funnel Chest,C05.660.386
19632566,2009-01-01T00:00:00,Funnel Chest,C16.131.621.386
19632566,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19632566,2009-01-01T00:00:00,Infant,M01.060.703
19632566,2009-01-01T00:00:00,Patient Selection,E05.581.500.653
19632566,2009-01-01T00:00:00,Patient Selection,N04.590.731
19632566,2009-01-01T00:00:00,Postoperative Care,E02.760.722.700
19632566,2009-01-01T00:00:00,Postoperative Care,E04.624
19632566,2009-01-01T00:00:00,Postoperative Care,N02.421.585.722.700
19632566,2009-01-01T00:00:00,Thoracic Surgical Procedures,E04.928
19632566,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19632566,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19632566,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19632566,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19632567,2009-01-01T00:00:00,Funnel Chest,C05.116.099.386
19632567,2009-01-01T00:00:00,Funnel Chest,C05.660.386
19632567,2009-01-01T00:00:00,Funnel Chest,C16.131.621.386
19632567,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19632567,2009-01-01T00:00:00,Patient Selection,E05.581.500.653
19632567,2009-01-01T00:00:00,Patient Selection,N04.590.731
19632567,2009-01-01T00:00:00,Thoracic Surgical Procedures,E04.928
19632567,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19632567,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19632567,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19647124,2009-01-01T00:00:00,Cannabinoids,D02.455.849.090
19647124,2009-01-01T00:00:00,"Hepatitis, Autoimmune",C06.552.380.350.050
19647124,2009-01-01T00:00:00,"Hepatitis, Autoimmune",C20.111.567
19647124,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19694306,2009-01-01T00:00:00,Algorithms,G17.035
19694306,2009-01-01T00:00:00,Algorithms,L01.224.050
19694306,2009-01-01T00:00:00,Angiography,E01.370.350.700.060
19694306,2009-01-01T00:00:00,Angiography,E01.370.370.050
19694306,2009-01-01T00:00:00,Artificial Intelligence,L01.224.065
19694306,2009-01-01T00:00:00,Breast Diseases,C17.800.090
19694306,2009-01-01T00:00:00,Calcinosis,C18.452.174.130
19694306,2009-01-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
19694306,2009-01-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19694306,2009-01-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19694306,2009-01-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19694306,2009-01-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19694306,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19694306,2009-01-01T00:00:00,Mammography,E01.370.350.700.500
19694306,2009-01-01T00:00:00,"Pattern Recognition, Automated",L01.725
19694306,2009-01-01T00:00:00,Peripheral Vascular Diseases,C14.907.617
19694306,2009-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
19694306,2009-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
19694306,2009-01-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
19694306,2009-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
19694306,2009-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
19694306,2009-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
19694306,2009-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
19694306,2009-01-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
19694306,2009-01-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
19694306,2009-01-01T00:00:00,Sensitivity and Specificity,G17.800
19694306,2009-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
19694306,2009-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
19694306,2009-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
19694306,2009-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
19694306,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
19694306,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
19694306,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
19694306,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
19694306,2009-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
19711221,2009-01-01T00:00:00,Adolescent,M01.060.057
19711221,2009-01-01T00:00:00,Adult,M01.060.116
19711221,2009-01-01T00:00:00,Aged,M01.060.116.100
19711221,2009-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19711221,2009-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19711221,2009-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19711221,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19711221,2009-01-01T00:00:00,Laryngoscopy,E01.370.386.460
19711221,2009-01-01T00:00:00,Laryngoscopy,E01.370.388.250.525
19711221,2009-01-01T00:00:00,Laryngoscopy,E04.580.373
19711221,2009-01-01T00:00:00,Laryngoscopy,E04.800.250.525
19711221,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19711221,2009-01-01T00:00:00,North Carolina,Z01.107.567.875.075.475
19711221,2009-01-01T00:00:00,North Carolina,Z01.107.567.875.750.530
19711221,2009-01-01T00:00:00,Phonation,G09.772.770.680
19711221,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19711221,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19711221,2009-01-01T00:00:00,Stroboscopy,E01.370.350.755
19711221,2009-01-01T00:00:00,Voice Disorders,C08.360.940
19711221,2009-01-01T00:00:00,Voice Disorders,C09.400.940
19711221,2009-01-01T00:00:00,Voice Disorders,C10.597.975
19711221,2009-01-01T00:00:00,Voice Disorders,C23.888.592.979
19711221,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19715380,2009-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
19715380,2009-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
19715380,2009-01-01T00:00:00,Decision Support Techniques,E05.245
19715380,2009-01-01T00:00:00,Decision Support Techniques,L01.700.508.190
19715380,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19715380,2009-01-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
19715380,2009-01-01T00:00:00,Markov Chains,E05.318.740.600.500
19715380,2009-01-01T00:00:00,Markov Chains,E05.318.740.996.500
19715380,2009-01-01T00:00:00,Markov Chains,G17.830.500
19715380,2009-01-01T00:00:00,Markov Chains,N05.715.360.750.625.500
19715380,2009-01-01T00:00:00,Markov Chains,N05.715.360.750.770.500
19715380,2009-01-01T00:00:00,Markov Chains,N06.850.520.830.600.500
19715380,2009-01-01T00:00:00,Markov Chains,N06.850.520.830.996.500
19715380,2009-01-01T00:00:00,Medicare,N03.219.521.346.506.564.663
19715380,2009-01-01T00:00:00,Medicare,N03.219.521.576.343.840
19715380,2009-01-01T00:00:00,Medicare,N03.706.615.696
19715380,2009-01-01T00:00:00,Quality of Life,I01.800
19715380,2009-01-01T00:00:00,Quality of Life,K01.752.400.750
19715380,2009-01-01T00:00:00,United States,Z01.107.567.875
19723250,2009-01-01T00:00:00,Bibliometrics,L01.178.682.099.325
19723250,2009-01-01T00:00:00,Bibliometrics,L01.453.183.291
19723250,2009-01-01T00:00:00,Biomedical Research,H01.770.644.145
19723250,2009-01-01T00:00:00,Conflict of Interest,K01.316.130
19723250,2009-01-01T00:00:00,Conflict of Interest,N05.350.225
19723250,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19723250,2009-01-01T00:00:00,United States,Z01.107.567.875
19763489,2009-01-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
19763489,2009-01-01T00:00:00,Sphingolipids,D10.570.877
19763489,2009-01-01T00:00:00,Sphingolipids,D10.808
19763489,2009-01-01T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
19777862,2009-01-01T00:00:00,Adult,M01.060.116
19777862,2009-01-01T00:00:00,Aged,M01.060.116.100
19777862,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19777862,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19777862,2009-01-01T00:00:00,Mouth Diseases,C07.465
19777862,2009-01-01T00:00:00,Oral Health,N01.400.535
19777862,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19777862,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19777862,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19777862,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19777862,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19777862,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19777862,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19777862,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19777862,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19777862,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19777862,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19810625,2009-01-01T00:00:00,Activities of Daily Living,E02.831.067
19810625,2009-01-01T00:00:00,Activities of Daily Living,I03.050
19810625,2009-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
19810625,2009-01-01T00:00:00,Adult,M01.060.116
19810625,2009-01-01T00:00:00,Disability Evaluation,E01.370.400
19810625,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19810625,2009-01-01T00:00:00,Locomotion,G07.700.560.500
19810625,2009-01-01T00:00:00,Locomotion,G11.427.590.530.568
19810625,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19810625,2009-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
19810625,2009-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
19810625,2009-01-01T00:00:00,Questionnaires,E05.318.308.750
19810625,2009-01-01T00:00:00,Questionnaires,L01.280.800
19810625,2009-01-01T00:00:00,Questionnaires,N05.715.360.300.695
19810625,2009-01-01T00:00:00,Questionnaires,N06.850.520.308.750
19810625,2009-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
19810625,2009-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
19810625,2009-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
19810625,2009-01-01T00:00:00,Walking,G11.427.590.530.568.900
19810625,2009-01-01T00:00:00,Walking,G11.427.590.530.698.940
19810625,2009-01-01T00:00:00,Walking,I03.450.642.845.940
19810625,2009-01-01T00:00:00,Wheelchairs,E07.796.980
19813112,2009-01-01T00:00:00,Adult,M01.060.116
19813112,2009-01-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
19813112,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19813112,2009-01-01T00:00:00,Imagination,F02.463.188.634
19813112,2009-01-01T00:00:00,Life Change Events,F01.829.458.410
19813112,2009-01-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19813112,2009-01-01T00:00:00,RGS Proteins,D12.644.360.325.150.750
19813112,2009-01-01T00:00:00,RGS Proteins,D12.776.402.150.750
19813112,2009-01-01T00:00:00,RGS Proteins,D12.776.476.325.150.750
19813112,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19813112,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19813112,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19813112,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19813112,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19813112,2009-01-01T00:00:00,Self-Injurious Behavior,F01.145.126.980
19813112,2009-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19813112,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19842171,2009-01-01T00:00:00,Adult,M01.060.116
19842171,2009-01-01T00:00:00,Alcoholism,C21.739.100.250
19842171,2009-01-01T00:00:00,Alcoholism,F03.900.100.350
19842171,2009-01-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19842171,2009-01-01T00:00:00,Health Surveys,E05.318.308.250
19842171,2009-01-01T00:00:00,Health Surveys,N05.715.360.300.375
19842171,2009-01-01T00:00:00,Health Surveys,N06.850.520.308.250
19842171,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19842171,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19842171,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19842171,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19842171,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19842171,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19842171,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19842171,2009-01-01T00:00:00,Sex Offenses,I01.198.240.748
19842171,2009-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19842171,2009-01-01T00:00:00,Substance-Related Disorders,C21.739
19842171,2009-01-01T00:00:00,Substance-Related Disorders,F03.900
19842171,2009-01-01T00:00:00,United States,Z01.107.567.875
19842171,2009-01-01T00:00:00,Violence,I01.198.240.856
19842171,2009-01-01T00:00:00,Violence,I01.880.735.900
19843440,2009-01-01T00:00:00,Disability Evaluation,E01.370.400
19843440,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19843440,2009-01-01T00:00:00,Low Back Pain,C10.597.617.152.400
19843440,2009-01-01T00:00:00,Low Back Pain,C23.888.592.612.107.400
19843440,2009-01-01T00:00:00,Low Back Pain,C23.888.646.172.500
19843440,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19843440,2009-01-01T00:00:00,Orthopedic Procedures,E02.718
19843440,2009-01-01T00:00:00,Orthopedic Procedures,E04.555
19843440,2009-01-01T00:00:00,Pain Measurement,E01.370.376.550.600
19843440,2009-01-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
19843440,2009-01-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
19843440,2009-01-01T00:00:00,Patient Satisfaction,N05.715.360.600
19852561,2009-01-01T00:00:00,Animals,B01.050
19852561,2009-01-01T00:00:00,Environmental Exposure,N06.850.460.350
19852561,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19852561,2009-01-01T00:00:00,"Models, Biological",E05.599.395
19852561,2009-01-01T00:00:00,Neoplasms,C04
19852561,2009-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19852561,2009-01-01T00:00:00,Risk Assessment,N04.452.871.715
19852561,2009-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19852561,2009-01-01T00:00:00,Risk Assessment,N06.850.505.715
19852561,2009-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19852561,2009-01-01T00:00:00,Trichloroethylene,D02.455.526.439.939
19852561,2009-01-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
19921973,2009-01-01T00:00:00,Adult,M01.060.116
19921973,2009-01-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19921973,2009-01-01T00:00:00,Down-Regulation,G02.111.087.225
19921973,2009-01-01T00:00:00,Down-Regulation,G02.149.115.225
19921973,2009-01-01T00:00:00,Down-Regulation,G05.355.315.200
19921973,2009-01-01T00:00:00,Down-Regulation,G07.690.812.230
19921973,2009-01-01T00:00:00,Down-Regulation,G07.700.680.230
19921973,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19921973,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19921973,2009-01-01T00:00:00,Personality Inventory,F04.711.647.513
19921973,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19921973,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19921973,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19921973,2009-01-01T00:00:00,Young Adult,M01.060.116.815
19943706,2009-01-01T00:00:00,Antineoplastic Agents,D27.505.954.248
19943706,2009-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19943706,2009-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19943706,2009-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19943706,2009-01-01T00:00:00,Breast Neoplasms,C04.588.180
19943706,2009-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
19943706,2009-01-01T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
19943706,2009-01-01T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
19943706,2009-01-01T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
19943706,2009-01-01T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
19943706,2009-01-01T00:00:00,Combined Modality Therapy,E02.186
19943706,2009-01-01T00:00:00,Drug Delivery Systems,E02.319.300
19943706,2009-01-01T00:00:00,Drug Design,E05.295.500
19943706,2009-01-01T00:00:00,Drug Design,H01.158.703.007.675.500
19943706,2009-01-01T00:00:00,Drug Design,H01.181.466.675.500
19943706,2009-01-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
19943706,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19943706,2009-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
19943706,2009-01-01T00:00:00,Liver Neoplasms,C06.301.623
19943706,2009-01-01T00:00:00,Liver Neoplasms,C06.552.697
19943706,2009-01-01T00:00:00,Patient Selection,E05.581.500.653
19943706,2009-01-01T00:00:00,Patient Selection,N04.590.731
19943706,2009-01-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
19943706,2009-01-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
19943706,2009-01-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
19943706,2009-01-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
19943706,2009-01-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
19943706,2009-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19943706,2009-01-01T00:00:00,Risk Assessment,N04.452.871.715
19943706,2009-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19943706,2009-01-01T00:00:00,Risk Assessment,N06.850.505.715
19943706,2009-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19943706,2009-01-01T00:00:00,Signal Transduction,G02.111.087.800
19943706,2009-01-01T00:00:00,Signal Transduction,G02.149.115.800
19943706,2009-01-01T00:00:00,Signal Transduction,G04.299.880
19943706,2009-01-01T00:00:00,Treatment Outcome,E01.789.800
19943706,2009-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19943706,2009-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19943706,2009-01-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
19943706,2009-01-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
19943706,2009-01-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
19960581,2009-01-01T00:00:00,Communicable Disease Control,N06.850.780.200
19960581,2009-01-01T00:00:00,Communicable Diseases,C01.539.221
19960581,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19960581,2009-01-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
19960581,2009-01-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
19960581,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19960581,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
19960581,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19960581,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
19960581,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19963663,2009-01-01T00:00:00,Cell Separation,E05.200.500.363
19963663,2009-01-01T00:00:00,Equipment Failure Analysis,E05.325.192
19963663,2009-01-01T00:00:00,Tissue Engineering,E05.200.249.750
19963820,2009-01-01T00:00:00,Algorithms,G17.035
19963820,2009-01-01T00:00:00,Algorithms,L01.224.050
19963820,2009-01-01T00:00:00,Animals,B01.050
19963820,2009-01-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19963820,2009-01-01T00:00:00,Catheter Ablation,E02.148.110
19963820,2009-01-01T00:00:00,Catheter Ablation,E02.148.442.110
19963820,2009-01-01T00:00:00,Catheter Ablation,E02.154.402.110
19963820,2009-01-01T00:00:00,Catheter Ablation,E04.014.170.402.110
19963820,2009-01-01T00:00:00,Electrodes,E07.305.250
19963820,2009-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19963820,2009-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19963820,2009-01-01T00:00:00,"Phantoms, Imaging",E07.671
19963820,2009-01-01T00:00:00,Skin,A17.815
19963820,2009-01-01T00:00:00,Swine,B01.050.150.900.649.077.880
19963820,2009-01-01T00:00:00,Temperature,G01.906.595
19963820,2009-01-01T00:00:00,Temperature,G16.500.275.063.725.710
19963820,2009-01-01T00:00:00,Temperature,G16.500.750.775.710
19963820,2009-01-01T00:00:00,Temperature,N06.230.150.450
19963820,2009-01-01T00:00:00,Temperature,N06.230.300.100.725.710
19995494,2009-01-01T00:00:00,Adult,M01.060.116
19995494,2009-01-01T00:00:00,Aged,M01.060.116.100
19995494,2009-01-01T00:00:00,Bone Plates,E07.695.125
19995494,2009-01-01T00:00:00,Bone Plates,E07.858.442.660.110
19995494,2009-01-01T00:00:00,Bone Plates,E07.858.690.650.110
19995494,2009-01-01T00:00:00,Femoral Fractures,C21.866.404.061
19995494,2009-01-01T00:00:00,Femoral Fractures,C21.866.558.276
19995494,2009-01-01T00:00:00,Fracture Fixation,E04.555.300
19995494,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19995494,2009-01-01T00:00:00,Humeral Fractures,C21.866.088.390
19995494,2009-01-01T00:00:00,Humeral Fractures,C21.866.404.500
19995494,2009-01-01T00:00:00,Joints,A02.835.583
19995494,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
19995494,2009-01-01T00:00:00,Tibial Fractures,C21.866.404.875
19995494,2009-01-01T00:00:00,Tibial Fractures,C21.866.558.857
19995496,2009-01-01T00:00:00,Bone Plates,E07.695.125
19995496,2009-01-01T00:00:00,Bone Plates,E07.858.442.660.110
19995496,2009-01-01T00:00:00,Bone Plates,E07.858.690.650.110
19995496,2009-01-01T00:00:00,"Fracture Fixation, Internal",E04.555.300.300
19995496,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19995496,2009-01-01T00:00:00,Humeral Fractures,C21.866.088.390
19995496,2009-01-01T00:00:00,Humeral Fractures,C21.866.404.500
20002930,2009-01-01T00:00:00,Color,G01.201.875.770.578.199
20002930,2009-01-01T00:00:00,Color,G01.590.540.199
20002930,2009-01-01T00:00:00,Composite Resins,D05.750.716.822.308
20002930,2009-01-01T00:00:00,Composite Resins,D25.339.816.500
20002930,2009-01-01T00:00:00,Composite Resins,D25.720.716.822.308
20002930,2009-01-01T00:00:00,Composite Resins,J01.637.051.339.816.500
20002930,2009-01-01T00:00:00,Composite Resins,J01.637.051.720.716.822.308
20002930,2009-01-01T00:00:00,Dental Materials,D25.339
20002930,2009-01-01T00:00:00,Dental Materials,D27.720.102.339
20002930,2009-01-01T00:00:00,Dental Materials,J01.637.051.339
20002930,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20002930,2009-01-01T00:00:00,Materials Testing,E05.570
20002930,2009-01-01T00:00:00,Surface Properties,G02.842.850
20011813,2009-01-01T00:00:00,Adult,M01.060.116
20011813,2009-01-01T00:00:00,Allied Health Personnel,M01.526.485.067
20011813,2009-01-01T00:00:00,Allied Health Personnel,N02.360.067
20011813,2009-01-01T00:00:00,Arthritis,C05.550.114
20011813,2009-01-01T00:00:00,Disease Progression,C23.550.291.656
20011813,2009-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20011813,2009-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20011813,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20011813,2009-01-01T00:00:00,Pilot Projects,E05.318.760.750
20011813,2009-01-01T00:00:00,Pilot Projects,E05.337.737
20011813,2009-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
20011813,2009-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
20011813,2009-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20011813,2009-01-01T00:00:00,Risk Factors,N05.715.350.200.700
20011813,2009-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20011813,2009-01-01T00:00:00,Risk Factors,N06.850.490.625.750
20011813,2009-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20014913,2009-01-01T00:00:00,Adolescent,M01.060.057
20014913,2009-01-01T00:00:00,Adult,M01.060.116
20014913,2009-01-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20014913,2009-01-01T00:00:00,Cocaine,D02.145.074.722.388
20014913,2009-01-01T00:00:00,Cocaine,D03.132.889.354
20014913,2009-01-01T00:00:00,Cocaine,D03.605.869.388
20014913,2009-01-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
20014913,2009-01-01T00:00:00,Cocaine-Related Disorders,C21.739.300
20014913,2009-01-01T00:00:00,Cocaine-Related Disorders,F03.900.300
20014913,2009-01-01T00:00:00,Cues,F02.463.425.234
20014913,2009-01-01T00:00:00,Cycloserine,D03.383.129.385.162
20014913,2009-01-01T00:00:00,Cycloserine,D03.383.129.462.600.162
20014913,2009-01-01T00:00:00,Cycloserine,D12.125.837.150
20014913,2009-01-01T00:00:00,"Extinction, Psychological",F02.463.425.770.232
20014913,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20014913,2009-01-01T00:00:00,Pilot Projects,E05.318.760.750
20014913,2009-01-01T00:00:00,Pilot Projects,E05.337.737
20014913,2009-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
20014913,2009-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
20014913,2009-01-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
20039582,2009-01-01T00:00:00,Disability Evaluation,E01.370.400
20039582,2009-01-01T00:00:00,Geriatric Assessment,E05.318.308.225
20039582,2009-01-01T00:00:00,Geriatric Assessment,I01.240.425.350
20039582,2009-01-01T00:00:00,Geriatric Assessment,L01.280.360
20039582,2009-01-01T00:00:00,Geriatric Assessment,N01.224.425.350
20039582,2009-01-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
20039582,2009-01-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20039582,2009-01-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
20039582,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20039582,2009-01-01T00:00:00,Walking,G11.427.590.530.568.900
20039582,2009-01-01T00:00:00,Walking,G11.427.590.530.698.940
20039582,2009-01-01T00:00:00,Walking,I03.450.642.845.940
20069949,2009-01-01T00:00:00,Activities of Daily Living,E02.831.067
20069949,2009-01-01T00:00:00,Activities of Daily Living,I03.050
20069949,2009-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
20069949,2009-01-01T00:00:00,African Americans,M01.686.508.100.100
20069949,2009-01-01T00:00:00,African Americans,M01.686.754.100
20069949,2009-01-01T00:00:00,Aged,M01.060.116.100
20069949,2009-01-01T00:00:00,Attitude to Health,F01.100.150
20069949,2009-01-01T00:00:00,Attitude to Health,N05.300.150
20069949,2009-01-01T00:00:00,Cognition,F02.463.188
20069949,2009-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20069949,2009-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20069949,2009-01-01T00:00:00,Geriatric Assessment,E05.318.308.225
20069949,2009-01-01T00:00:00,Geriatric Assessment,I01.240.425.350
20069949,2009-01-01T00:00:00,Geriatric Assessment,L01.280.360
20069949,2009-01-01T00:00:00,Geriatric Assessment,N01.224.425.350
20069949,2009-01-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
20069949,2009-01-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20069949,2009-01-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
20069949,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20069949,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
20069949,2009-01-01T00:00:00,Quality of Life,I01.800
20069949,2009-01-01T00:00:00,Quality of Life,K01.752.400.750
20069949,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20069949,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20070134,2009-01-01T00:00:00,Adult,M01.060.116
20070134,2009-01-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
20070134,2009-01-01T00:00:00,Disasters,N06.230.100
20070134,2009-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20070134,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20070134,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
20070134,2009-01-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20070134,2009-01-01T00:00:00,Sex Characteristics,G08.686.815
20070134,2009-01-01T00:00:00,Smoking,F01.145.466.753
20070134,2009-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20164630,2009-01-01T00:00:00,Bioreactors,E07.115
20164630,2009-01-01T00:00:00,Bioreactors,J01.897.120.115
20164630,2009-01-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
20164630,2009-01-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
20164630,2009-01-01T00:00:00,"RNA, Messenger",D13.444.735.544
20164630,2009-01-01T00:00:00,"Stress, Mechanical",G01.374.676.830
20164630,2009-01-01T00:00:00,"Stress, Mechanical",G01.595.540.830
20344867,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20344867,2009-01-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
20344867,2009-01-01T00:00:00,"Schools, Pharmacy",I02.783.660.694
20344867,2009-01-01T00:00:00,Societies,N03.540.828
20391862,2009-01-01T00:00:00,Adult,M01.060.116
20391862,2009-01-01T00:00:00,Child,M01.060.406
20391862,2009-01-01T00:00:00,Child Abuse,I01.198.240.856.350.250
20391862,2009-01-01T00:00:00,Child Abuse,I01.880.735.900.350.250
20391862,2009-01-01T00:00:00,Child Abuse,I01.880.787.293.292
20391862,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20391862,2009-01-01T00:00:00,Life Change Events,F01.829.458.410
20391862,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
20391862,2009-01-01T00:00:00,Personality Inventory,F04.711.647.513
20391862,2009-01-01T00:00:00,Smoking,F01.145.466.753
20539835,2009-01-01T00:00:00,Brain Mapping,E01.370.350.086
20539835,2009-01-01T00:00:00,Brain Mapping,E01.370.376.149
20539835,2009-01-01T00:00:00,Brain Mapping,E05.132
20539835,2009-01-01T00:00:00,Electroencephalography,E01.370.376.300
20539835,2009-01-01T00:00:00,Electroencephalography,E01.370.405.245
20539835,2009-01-01T00:00:00,Head,A01.456
20539835,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20539835,2009-01-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20539835,2009-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20539835,2009-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20666712,2009-01-01T00:00:00,"Electrodes, Implanted",E07.305.250.319
20666712,2009-01-01T00:00:00,Electroencephalography,E01.370.376.300
20666712,2009-01-01T00:00:00,Electroencephalography,E01.370.405.245
20666712,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20666712,2009-01-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
20666712,2009-01-01T00:00:00,Parkinson Disease,C10.228.662.600.400
20666712,2009-01-01T00:00:00,Parkinson Disease,C10.574.812
20666712,2009-01-01T00:00:00,"Technology Assessment, Biomedical",N03.880
20666712,2009-01-01T00:00:00,"Technology Assessment, Biomedical",N05.715.360.825
20666712,2009-01-01T00:00:00,User-Computer Interface,L01.224.900.910
20669400,2009-01-01T00:00:00,Adolescent,M01.060.057
20669400,2009-01-01T00:00:00,Adult,M01.060.116
20669400,2009-01-01T00:00:00,African Americans,M01.686.508.100.100
20669400,2009-01-01T00:00:00,African Americans,M01.686.754.100
20669400,2009-01-01T00:00:00,Aged,M01.060.116.100
20669400,2009-01-01T00:00:00,Christianity,K01.844.188
20669400,2009-01-01T00:00:00,Exercise,G11.427.590.237
20669400,2009-01-01T00:00:00,Exercise,I03.350
20669400,2009-01-01T00:00:00,Health Promotion,N02.370
20669400,2009-01-01T00:00:00,Health Promotion,N02.421.726.507
20669400,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20669400,2009-01-01T00:00:00,Middle Aged,M01.060.116.630
20669400,2009-01-01T00:00:00,Social Support,I01.880.656.600
20669400,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20669400,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23098288,2009-01-01T00:00:00,Activities of Daily Living,E02.831.067
23098288,2009-01-01T00:00:00,Activities of Daily Living,I03.050
23098288,2009-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
23098288,2009-01-01T00:00:00,Aged,M01.060.116.100
23098288,2009-01-01T00:00:00,Disability Evaluation,E01.370.400
23098288,2009-01-01T00:00:00,Health Status,I01.240.425
23098288,2009-01-01T00:00:00,Health Status,N01.224.425
23098288,2009-01-01T00:00:00,Health Status,N06.850.505.400.425
23098288,2009-01-01T00:00:00,Home Care Services,N02.421.143.524
23098288,2009-01-01T00:00:00,Home Care Services,N02.421.539.089
23098288,2009-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23098288,2009-01-01T00:00:00,Locomotion,G07.700.560.500
23098288,2009-01-01T00:00:00,Locomotion,G11.427.590.530.568
23098288,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23098288,2009-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
